Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),-0.7314407026498383,-2.3779499478094017,0.0,0.0,0.0,16/35,7.74%,KSR1;IRAG1;APOE;PDE7B;ADCY1;AKAP6;GUCY1B1;RAPGEF3;HTR2C;CAP2;RAPGEF2;RIMS2;EPHA5;PDE4D;AHR;PDE2A
prerank,cAMP-mediated signaling (GO:0019933),-0.7297499701682848,-2.134327744244155,0.0,0.010785226963169433,0.019,12/24,7.74%,KSR1;PDE7B;ADCY1;AKAP6;RAPGEF3;CAP2;RAPGEF2;RIMS2;EPHA5;PDE4D;AHR;PDE2A
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),-0.6042173564084052,-2.0201819946693194,0.0,0.055560260113297094,0.147,21/41,19.92%,IL34;TGFA;GRM5;NEDD9;ACE;EPHA4;GPRC5B;DOCK3;LRP8;NTRK2;GAS6;ADRA2A;NOX4;ERBB3;HBEGF;CSF1R;RELN;FBXW7;BDNF;FCGR1A;PRNP
prerank,bicarbonate transport (GO:0015701),0.8368932184618844,2.0003411549598966,0.0,0.017116988503209255,0.014,5/25,4.18%,SLC26A7;SLC4A10;SLC4A4;SLC26A6;SLC4A2
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.49695012822370394,-1.9879799797104403,0.0,0.0725551632067762,0.232,46/91,18.16%,RPL37;RPL27A;RPL19;RPS13;RPS9;RPS3;RPS14;RPL18A;RPL38;RPS19;RPS8;RPS11;RPL34;RPL18;RPL7;RPS25;RPL21;RPL23A;RPLP2;RPS21;RPL26;RPS4X;RPL41;RPS29;RPL35A;RPL10A;RPL11;RPS5;SSR1;RPS16;RPL4;ARL6IP1;RPS7;RPS23;RPS15;RPL36;RPS18;RPL37A;RPL32;RPS20;RPL29;RPL13;RPL36A;RPL23;RPL17;RPL9
prerank,organic anion transport (GO:0015711),0.7158997723768997,1.9858887294652132,0.0,0.015103225149890518,0.027,10/76,2.44%,SLC26A7;SLC4A10;SLC4A4;SLC23A1;SLCO3A1;SLCO2A1;LRRC8D;SLCO4A1;ABCG2;SLC26A6
prerank,cGMP-mediated signaling (GO:0019934),-0.7882827123380679,-1.9757046134496086,0.0,0.0703981178141423,0.276,6/13,7.74%,IRAG1;APOE;GUCY1B1;HTR2C;KCNC2;PDE2A
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.5626767289673232,-1.9734921831311785,0.0,0.0609528735948818,0.286,18/46,12.12%,ATP1A2;GRM7;CDH2;SHANK3;DGKI;GRM5;GRM3;NRXN1;GRM1;SYT1;MEF2C;OPHN1;CACNG7;CACNG4;GRM8;TPRG1L;CACNG3;CACNG2
prerank,positive regulation of blood coagulation (GO:0030194),0.8738944384355952,1.9656833918841417,0.0,0.019802006307634235,0.052,5/17,3.59%,F3;THBS1;ST3GAL4;THBD;ANO6
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.7110760053351897,-1.940006687392166,0.0,0.0850212047616084,0.421,6/19,3.74%,TJP1;OCLN;CLDN5;PRKCH;ROCK2;F11R
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.4939295820380199,-1.931879878184384,0.0,0.08321783077263688,0.453,46/87,19.73%,RPL37;RPL27A;RPL19;RPS13;RPS9;RPS3;RPS14;RPL18A;RPL38;RPS19;RPS8;RPS11;RPL34;RPL18;RPL7;RPS25;RPL21;RPL23A;RPLP2;RPS21;RPL26;RPS4X;RPL41;RPS29;RPL35A;RPL10A;RPL11;RPS5;RPS16;RPL4;RPS7;RPS23;RPS15;RPL36;RPS18;RPL37A;RPL32;RPS20;RPL29;RPL13;RPL36A;RPL23;RPL17;RPL9;SRP14;SEC61A2
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.7847453124492815,-1.9306216340574185,0.0,0.07527870536919273,0.459,7/12,15.76%,IL34;LYN;CSF1;MAPK1;BST2;PTK2;CSF1R
prerank,ion homeostasis (GO:0050801),0.7701489545479464,1.9296743861589554,0.0,0.04178558958136377,0.131,7/30,5.28%,SLC4A10;SLC4A4;FHL1;WNK1;CAMK2D;SLC4A2;RANGRF
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.6906755654011882,1.9185213525996785,0.0,0.04309453576102095,0.166,17/79,5.94%,SLIT2;BMPER;THBS1;CRIM1;HTRA3;VWC2;NEDD4;SMAD6;FGF2;SKIL;SMAD9;BMPR1A;NOG;SKI;EMILIN1;ATP2B4;NBL1
prerank,protein targeting to ER (GO:0045047),-0.46509810283336983,-1.8994584211692687,0.0,0.10824445970308233,0.622,46/99,18.16%,RPL37;RPL27A;RPL19;RPS13;RPS9;RPS3;RPS14;RPL18A;RPL38;RPS19;RPS8;RPS11;RPL34;RPL18;RPL7;RPS25;RPL21;RPL23A;RPLP2;RPS21;RPL26;RPS4X;RPL41;RPS29;RPL35A;RPL10A;ZFAND2A;RPL11;RPS5;RPS16;RPL4;RPS7;RPS23;RPS15;RPL36;RPS18;SGTA;RPL37A;RPL32;RPS20;RPL29;RPL13;RPL36A;RPL23;RPL17;RPL9
prerank,inorganic anion transport (GO:0015698),0.7154399393466123,1.896434945310665,0.0,0.06209103672732768,0.257,8/53,3.71%,SLC26A7;SLC4A10;CLIC4;ANO9;SLC26A6;SLC34A2;ANO6;CLIC1
prerank,regulation of cell junction assembly (GO:1901888),-0.6221493758482135,-1.895268980929091,0.0038314176245210726,0.10357383248928002,0.649,8/27,5.75%,TJP1;OCLN;CLDN5;PRKCH;RAPGEF2;ROCK2;F11R;MEF2C
prerank,response to ketone (GO:1901654),0.8086562414113755,1.893853033634139,0.0,0.056529214132447374,0.268,4/24,3.17%,SLIT3;SLIT2;THBS1;TGFB3
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.7430092655599037,-1.8859297579777894,0.0028089887640449437,0.10891445107503679,0.697,4/15,4.23%,PLTP;APOE;ABCA5;ABCG1
prerank,regulation of cellular pH (GO:0030641),0.7671508678427829,1.878588215068793,0.0013245033112582781,0.0748868247015405,0.378,11/29,11.45%,SLC4A10;SLC4A4;SLC9A2;SLC9B1;SLC26A6;SLC4A2;ATP1A4;SLC9A1;TM9SF4;SLC9A8;CHP1
prerank,regulation of intracellular pH (GO:0051453),0.7522042954792267,1.8723914146170277,0.0012787723785166241,0.07752988910277134,0.422,6/34,4.18%,SLC4A10;SLC4A4;SLC9A2;SLC9B1;SLC26A6;SLC4A2
prerank,response to glucocorticoid (GO:0051384),0.7791059738814888,1.8517754523443777,0.0,0.10995147909120298,0.563,5/26,7.81%,SLIT3;SLIT2;ADAM9;ANXA1;FAM107A
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.6858067953551986,-1.8464837873506172,0.0,0.16351309130175756,0.848,6/16,7.58%,APOE;NOS3;GUCY1B1;KCNC2;NDNF;GUCY1A1
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.8062873767003174,1.841007194970385,0.0014326647564469914,0.12540253609303037,0.645,9/20,13.14%,SMOC2;THBS1;FGF2;LRIT3;NOG;SULF1;FGFBP3;CREB3L1;NPTN
prerank,embryonic skeletal system development (GO:0048706),0.7310295647225798,1.8385161235925906,0.0,0.12082580119912414,0.662,12/35,7.75%,SIX1;KIAA1217;PCSK5;WNT9A;WNT11;HOXA3;XYLT1;HOXC4;HOXB3;NOG;HOXB4;SULF1
prerank,cellular component maintenance (GO:0043954),-0.7471136643411701,-1.8358684061810775,0.002717391304347826,0.1722834956454338,0.876,4/12,8.97%,IGF1R;INSR;ITGA3;CLDN1
prerank,carboxylic acid transmembrane transport (GO:1905039),0.7128711497669212,1.826906011761628,0.0012804097311139564,0.14220267371896922,0.737,8/40,4.99%,SLC38A2;SLC23A1;SLC23A2;SLC38A1;SLC5A6;SLC16A1;SLC38A6;SLC7A9
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.881127228266392,1.822286561773836,0.0033277870216306157,0.14628552359465388,0.776,3/11,1.66%,BMP4;EGFR;DDX5
prerank,collagen fibril organization (GO:0030199),0.6500518246347773,1.8203510229058883,0.0,0.14062780750675838,0.783,21/88,5.44%,COL25A1;COL8A1;COL12A1;COL6A2;COL8A2;TLL1;PLOD2;ADAMTS2;COL6A1;BMP1;DDR2;COL5A2;CYP1B1;LOXL1;COL3A1;OPTC;COL6A3;COL11A1;ADAMTS3;TGFBR1;NF1
prerank,mesonephric tubule development (GO:0072164),0.8157932520014841,1.818748911662606,0.0031007751937984496,0.1359290263490147,0.792,5/15,1.87%,SLIT2;SIX1;BMP4;PKD1;WNT11
prerank,regulation of BMP signaling pathway (GO:0030510),0.6603309901010483,1.817542529667163,0.0011723329425556857,0.13101307463356013,0.798,19/73,7.92%,BMPER;BMP4;CRIM1;HTRA3;FSTL1;VWC2;FOXD1;CCN1;SMAD6;SKIL;SMAD9;SFRP4;ZNF423;BMPR1A;NOG;SKI;NBL1;SULF1;SMAD2
prerank,sulfate transport (GO:0008272),0.8614470858776351,1.8167287889086625,0.0,0.12541270661501683,0.8,3/14,2.44%,SLC26A7;SLC26A2;SLC26A6
prerank,sulfur compound transport (GO:0072348),0.7572364143973854,1.811772818595104,0.004081632653061225,0.13073563664835056,0.837,5/27,2.44%,SLC26A7;SLC5A6;LRRC8D;ABCG2;SLC26A6
prerank,cation transport (GO:0006812),0.6087993126078576,1.8112905376254107,0.0,0.12550780099559022,0.838,19/167,4.76%,SLC47A1;SLC4A4;PIEZO2;SLC23A1;KCNK5;SLC9B2;KCNJ2;KCNB2;SLC5A6;SLC12A2;KCNJ15;KCNMB3;KCNMB2;ATP1B1;FGF13;KCNS3;ANO6;TRPM7;TRPM6
prerank,ureteric bud morphogenesis (GO:0060675),0.8026321084322736,1.8077265025313947,0.00291970802919708,0.12907264159842946,0.867,4/16,2.22%,SIX1;BMP4;WNT11;FGF2
prerank,chloride transport (GO:0006821),0.6519529710814955,1.8048234425790934,0.0,0.13016234038269284,0.883,11/74,4.12%,SLC26A7;SLC4A10;SLC12A7;SLC12A2;CLIC4;ANO9;SLC26A6;GABRA3;ANO6;CLIC1;GLRB
prerank,carbohydrate transport (GO:0008643),0.8706728309343139,1.7938272465521876,0.003169572107765452,0.15396534160047814,0.932,3/11,2.44%,SLC23A1;SLC23A2;SLC26A6
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.8028807642968455,1.7930807527707744,0.0045871559633027525,0.14985755620946925,0.934,7/18,8.34%,BMP4;EGFR;DDX5;ESR1;NCOR1;ZC3H12A;NCOR2
prerank,central nervous system neuron development (GO:0021954),-0.6789441960989637,-1.7895894718653587,0.0026954177897574125,0.26838873885317394,0.974,7/15,9.51%,MAP2;RAPGEF2;LHX6;B4GALT6;NTRK2;MAPT;HSP90AB1
prerank,vasculature development (GO:0001944),-0.6539489568236622,-1.7894650081660175,0.002890173410404624,0.25192084116812236,0.974,13/16,23.64%,ERRFI1;PDGFRB;NOTCH4;CDH5;SOX18;PIK3CA;ACVRL1;APLNR;FBXW7;PDGFRA;ACVR2B;FOXF1;FLT4
prerank,positive regulation of phosphatase activity (GO:0010922),-0.6230954676724167,-1.7830106218800434,0.01,0.25255887097175916,0.981,9/21,9.75%,ITGA1;PDGFRB;MEF2C;PPP1R15B;CALM1;BMP2;HSP90AB1;CD300A;MAGI2
prerank,positive regulation of chemotaxis (GO:0050921),0.6893349633771864,1.7823626963011894,0.0012594458438287153,0.17370722685727416,0.957,8/43,3.16%,SMOC2;F3;THBS1;MET;NTRK3;FGF2;NRP1;VEGFA
prerank,ureteric bud development (GO:0001657),0.7888195532039671,1.7793893496691218,0.0030441400304414,0.17686263912705127,0.965,5/17,2.08%,SLIT2;SIX1;BMP4;WNT11;GPC3
prerank,cytoplasmic translation (GO:0002181),-0.46183857784582205,-1.7787904352624422,0.0,0.24985775798009188,0.987,44/91,18.16%,RPL37;RPL27A;RPL19;RPS13;RPS9;RPS3;RPS14;RPL18A;RPL38;RPS19;RPS8;RPS11;RPL34;RPL18;RPL7;RPS25;RPL21;RPL23A;RPS21;RPL26;RPS4X;RPL41;RPS29;RPL35A;RPL10A;RPL11;RPS5;RPS16;RPL4;RPS7;RPS23;RPS15;RPL36;RPS18;RPL37A;RPL32;RPS20;EIF3I;RPL29;RPL13;RPL36A;RPL23;RPL17;RPL9
prerank,endodermal cell differentiation (GO:0035987),0.7237814225094796,1.7760494001647882,0.004137931034482759,0.1803436958638779,0.968,8/31,7.37%,COL8A1;COL12A1;COL6A1;ITGB5;COL11A1;SETD2;INHBA;FN1
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.6972560963946876,1.7755008329711968,0.0025477707006369425,0.17552105227765624,0.97,12/39,6.60%,SLIT2;SIX1;BMP4;LRP6;MET;PKD1;SEMA3E;FGF2;NRP1;VEGFA;GLI2;TGFBR2
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.6710138475656294,1.773173432821424,0.0036363636363636364,0.17675981434044286,0.976,12/51,5.94%,BMPER;CRIM1;HTRA3;FSTL1;VWC2;SMAD6;SKIL;SMAD9;BMPR1A;NOG;SKI;NBL1
prerank,glutamate receptor signaling pathway (GO:0007215),-0.5435377125402578,-1.7707963166749223,0.0,0.2578133679808349,0.991,13/37,5.95%,PLCB1;GRM7;GRID2;GRIK2;GRIA4;GRM5;GRM3;APP;GRM1;GRIN2A;GRIN2B;CPEB4;GRIN1
prerank,regulation of sensory perception of pain (GO:0051930),0.8570834374371893,1.7677079157837243,0.0015360983102918587,0.18764918180675086,0.984,5/11,5.45%,CCN3;MGLL;TMEM100;CCL3;ACP3
prerank,positive regulation of hemostasis (GO:1900048),0.8760548696322618,1.7673845067072078,0.0045662100456621,0.17686505951569712,0.984,2/10,0.22%,THBS1;ST3GAL4
prerank,positive regulation of coagulation (GO:0050820),0.8760548696322618,1.7673845067072078,0.0045662100456621,0.17686505951569712,0.984,2/10,0.22%,THBS1;ST3GAL4
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.7161417231148011,-1.767005438047723,0.014492753623188406,0.2540411187415637,0.994,5/11,6.47%,PLCB1;IGF1R;IGF1;PIK3R1;GHR
prerank,ion transport (GO:0006811),0.6149640736960762,1.7644177862882933,0.001092896174863388,0.1804454010837425,0.985,12/111,4.18%,SLC26A7;PIEZO2;SLC26A2;SLC9A2;SLC12A7;SLC12A2;SLC24A3;WNK1;SLC26A6;ANO6;GLRB;SLC4A2
prerank,cellular response to copper ion (GO:0071280),-0.6789380627589746,-1.7643744515603488,0.0030120481927710845,0.2488539381545155,0.994,12/16,21.07%,MT3;MT2A;PRNP;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B;SNCA
prerank,cellular response to drug (GO:0035690),-0.5865190376415196,-1.756900745893151,0.003952569169960474,0.25590402158065656,0.996,10/25,13.11%,PDE4B;ACER2;PPM1E;TFRC;RAP2A;MEF2C;AIM2;GAS6;KCNQ1;CERS1
prerank,monosaccharide transmembrane transport (GO:0015749),0.8106499800532367,1.752814508340066,0.0029585798816568047,0.2116228371002307,0.99,2/16,0.14%,SLC23A1;SLC23A2
prerank,acetylcholine receptor signaling pathway (GO:0095500),-0.6385516106844109,-1.7517640263857377,0.00625,0.2576091958040826,0.996,11/20,27.11%,PLCB1;CHRM2;CHRM3;GNA11;GRK2;LYPD1;RGS10;CHRM1;GNB1;LY6G6D;CHRNB2
prerank,melanocyte differentiation (GO:0030318),-0.7189509131868682,-1.7496581603605343,0.0027397260273972603,0.25226809279383056,0.997,7/11,12.19%,LRMDA;KIT;MITF;ENPP1;MEF2C;SLC24A5;MREG
prerank,positive regulation of RNA metabolic process (GO:0051254),0.6668872979002503,1.7484664396065,0.0038022813688212928,0.22021940670935605,0.992,6/45,5.14%,SLC38A2;BMP4;EGFR;DDX5;U2AF2;ZC3H18
prerank,positive regulation of heart contraction (GO:0045823),-0.6200306602879916,-1.7418372896242507,0.006802721088435374,0.26006123633736916,0.999,7/19,13.08%,ATP1A2;RYR2;ATP2A2;EDN1;ADM;KCNQ1;CHGA
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.7364503543125589,-1.7398744844899405,0.010723860589812333,0.2554892051589962,0.999,6/10,16.25%,LYN;RAPGEF2;CXCL12;AXL;GAS6;CCL19
prerank,response to amyloid-beta (GO:1904645),-0.5157716365635318,-1.7386092397104813,0.004629629629629629,0.24889543974937137,0.999,14/44,6.07%,IGF1R;IGF1;GRM5;APP;VCAM1;GRIN2A;SNX6;GJA1;CASP4;EPHA4;CACNA1B;GRIN1;LGMN;CACNA2D1
prerank,regulation of fibrinolysis (GO:0051917),0.8072293847675696,1.7348696043736789,0.008928571428571428,0.2638029992847544,0.997,2/13,2.68%,THBS1;THBD
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.7808658018016235,1.7347489977592785,0.005970149253731343,0.2571630228224602,0.997,4/16,2.22%,SIX1;BMP4;FOXD1;FGF2
prerank,aorta development (GO:0035904),-0.6748951752393155,-1.7316032277854465,0.009146341463414634,0.2575848361723193,0.999,9/14,15.36%,ROBO1;ROBO2;PDGFRB;ADAMTS9;TBX1;PDE2A;TBX2;EFEMP2;APLNR
prerank,organic acid transport (GO:0015849),0.6108362448195553,1.7268578574029922,0.0,0.28314572623110545,0.997,18/94,8.75%,SLC26A7;SLC38A2;SLC23A1;SLC23A2;SLC38A1;SLC5A6;LRRC8D;ABCG2;SLC16A1;SLC26A6;SLC10A2;FOLR2;SLC7A9;SLC27A3;SLC51A;SLC25A32;SLC38A3;RXRA
prerank,response to copper ion (GO:0046688),-0.6342357733718235,-1.720652942675642,0.0,0.2771025711289551,0.999,16/20,31.82%,MT3;MT2A;PRNP;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B;SNCA;AQP1;IL1A;ATP5F1D;HSF1
prerank,regulation of phagocytosis (GO:0050764),-0.4887546550734704,-1.7203490840203473,0.0,0.2686175163948169,0.999,20/53,19.26%,CAMK1D;MERTK;TGM2;DYSF;IL15RA;SIRPA;DOCK2;SYT7;GATA2;SYT11;SPHK1;GAS6;RACK1;SNX3;TULP1;CD47;LYAR;HCK;PYCARD;CALR
prerank,regulation of muscle cell differentiation (GO:0051147),0.6930201527087664,1.7201837505908575,0.005291005291005291,0.30451716349223706,0.999,8/31,6.53%,CDON;BOC;HDAC9;ID2;ABL1;CTNNA1;MEF2A;MAPK12
prerank,sprouting angiogenesis (GO:0002040),0.6533575889016826,1.718919338407082,0.0,0.30254277179422356,0.999,11/51,3.16%,SLIT2;BMPER;RSPO3;THBS1;BMP4;PGF;SEMA3E;PTK2B;FGF2;NRP1;VEGFA
prerank,endoderm formation (GO:0001706),0.6806714368226341,1.7185259486176818,0.005291005291005291,0.2965389328210212,0.999,8/35,7.37%,COL8A1;COL12A1;COL6A1;ITGB5;COL11A1;SETD2;INHBA;FN1
prerank,response to hexose (GO:0009746),0.7178486480524728,1.7163366367973414,0.008174386920980926,0.29844452363648744,0.999,2/25,0.67%,THBS1;TCF7L2
prerank,hippo signaling (GO:0035329),-0.5742438405433082,-1.7155073096234925,0.004166666666666667,0.27206604790962896,0.999,6/26,6.89%,TJP1;AMOTL2;AMOTL1;YWHAB;TEAD4;TEAD2
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),-0.5763101689159082,-1.7100113970257906,0.006993006993006993,0.278056632644212,1.0,7/23,10.18%,IGF1;EFNB2;AKAP6;PIEZO1;MEF2C;PROX1;EDN1
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.42184549886454153,-1.7091955371233618,0.0,0.2712647993766858,1.0,48/110,18.16%,RPL37;RPL27A;RPL19;RPS13;RPS9;RPS3;RPS14;RPL18A;RPL38;RPS19;RPS8;RPS11;RPL34;RPL18;RPL7;RPS25;RPL21;RPL23A;RPLP2;RPS21;RPL26;RPS4X;RPL41;RPS29;RPL35A;RPL10A;RPL11;MAGOH;RPS5;CTIF;RPS16;RPL4;SMG7;RPS7;RPS23;RPS15;RPL36;RPS18;RPL37A;RPL32;RPS20;RPL29;RPL13;RPL36A;HELZ2;RPL23;RPL17;RPL9
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),-0.7116690275877033,-1.7057328731634323,0.002840909090909091,0.27231256206740373,1.0,9/11,21.81%,MERTK;CXCL12;AXL;GAS6;CCL19;NOD2;SELENOS;HCLS1;IRF7
prerank,negative regulation of calcium ion transport (GO:0051926),-0.6528375214181866,-1.7047995466856456,0.016574585635359115,0.26680130284993686,1.0,3/15,11.56%,ATP1A2;SLC30A1;ADRA2A
prerank,axon extension (GO:0048675),0.7263623224240462,1.7045924811846802,0.008534850640113799,0.34646096018260486,0.999,5/23,3.10%,SLIT3;SLIT2;ULK2;SLIT1;NRP1
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.7753275634007262,1.7043387014104296,0.014018691588785047,0.3398225658725367,0.999,5/15,4.73%,SIX1;BMP4;VEGFA;SMO;NOG
prerank,maintenance of blood-brain barrier (GO:0035633),-0.5576803136043175,-1.7016762500227158,0.012448132780082987,0.26728842781955764,1.0,18/30,13.15%,TJP1;GJB6;LAMA2;PECAM1;OCLN;CLDN5;ESAM;MBP;SLC1A1;F11R;GJA1;ACTB;JAM3;JAM2;CLDN1;CDH5;LAMC1;WNK3
prerank,positive regulation of wound healing (GO:0090303),0.6747908163491305,1.7016193808085875,0.003870967741935484,0.3442192825272826,0.999,9/36,7.87%,SMOC2;THBS1;ST3GAL4;PRKCE;PLPP3;FOXC2;ANXA1;ITGB1;DMTN
prerank,cellular response to amyloid-beta (GO:1904646),-0.5325327350976023,-1.701060551846237,0.0040650406504065045,0.2616543760057371,1.0,13/35,6.07%,IGF1R;IGF1;GRM5;APP;VCAM1;GRIN2A;SNX6;GJA1;CASP4;EPHA4;GRIN1;LGMN;CACNA2D1
prerank,transepithelial transport (GO:0070633),0.7846853236448194,1.7000391220089488,0.004792332268370607,0.3439814249717819,0.999,5/15,2.44%,SLC23A1;SLC23A2;SLC12A2;ABCG2;SLC26A6
prerank,response to interferon-alpha (GO:0035455),-0.6301360843417333,-1.697000582259317,0.0030120481927710845,0.2645992882949822,1.0,10/16,17.41%,IFNAR1;IFITM1;IFITM3;AXL;IFNAR2;BST2;IFITM2;GAS6;ADAR;PDE12
prerank,cell differentiation in spinal cord (GO:0021515),-0.7207975554738819,-1.6960749025122412,0.017191977077363897,0.25990134346211097,1.0,4/10,10.06%,SOX6;SOX13;MDGA2;ZC4H2
prerank,amino acid transmembrane transport (GO:0003333),0.6427140285001696,1.695626257353131,0.0049079754601227,0.3569502658829445,0.999,7/45,4.99%,SLC47A1;SLC38A2;SLC38A1;LRRC8D;SFXN3;SLC38A6;SLC7A9
prerank,regulation of T cell migration (GO:2000404),-0.6168543768185423,-1.6938897141210703,0.006711409395973154,0.25869837583929595,1.0,9/18,18.37%,APOD;LRCH1;APP;RIPOR2;CXCL12;CD200;DOCK8;CD200R1;PYCARD
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.752490779642236,1.6911454618321442,0.01430615164520744,0.3703856200994679,0.999,4/17,3.07%,SLIT2;FSTL1;LRIT3;SFRP4
prerank,response to alcohol (GO:0097305),0.6900010909321707,1.6877572625162407,0.01094391244870041,0.3785464132126301,0.999,7/27,7.92%,SLIT3;SLIT2;ADH7;CCL3;TGFBR1;TGFBR2;SMAD2
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.8397583156522884,1.687106548958245,0.0016339869281045752,0.37435860738195303,1.0,3/11,5.94%,SLIT2;CCN3;NBL1
prerank,digestive tract development (GO:0048565),0.6842073948955197,1.6862548873137615,0.005312084993359893,0.37059168534456854,1.0,12/33,8.39%,PCSK5;PKD1;RARB;COBL;SMO;GLI3;CLMP;EPHB3;NIPBL;GLI2;AGR2;GATA4
prerank,detection of mechanical stimulus (GO:0050982),0.7329177156248741,1.6818795522594787,0.01282051282051282,0.38474497913887773,1.0,3/19,1.53%,PIEZO2;PKD1;CSRP3
prerank,anterior/posterior pattern specification (GO:0009952),0.6338023052223564,1.6810206254574664,0.0036363636363636364,0.381684146523837,1.0,19/53,13.41%,PCSK5;HES1;HOXA5;HOXA3;HOXB6;HOXC6;HOXC4;TGFBR1;HOXA6;HOXB3;SKI;BHLHE40;HOXB4;SMAD2;GATA4;HES3;HOXB5;LRP5;HOXA7
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.7017003808414055,-1.6762126377560418,0.01871657754010695,0.29411863951224143,1.0,5/10,14.46%,PDE4B;CACNB2;CACNA2D1;CALM1;NOS1AP
prerank,chemokine-mediated signaling pathway (GO:0070098),0.6457319210457062,1.6755335130263078,0.014248704663212436,0.40088807496622986,1.0,9/42,9.92%,STK39;WNK1;PTK2B;CXCL2;CCL3;CCL1;FOXC1;CIB1;CCL7
prerank,pharyngeal system development (GO:0060037),0.7620222784134573,1.67060742632202,0.023952095808383235,0.41853325257793583,1.0,6/15,4.73%,BMP4;HES1;BMP5;BMPR1A;TGFBR1;NOG
prerank,negative regulation of interleukin-12 production (GO:0032695),0.777342204909294,1.6701886616754837,0.010852713178294573,0.41307320784950574,1.0,3/14,4.61%,THBS1;CMKLR1;IRAK3
prerank,regulation of dendrite extension (GO:1903859),-0.6070071772770126,-1.6697485682896833,0.02821316614420063,0.30425078573806763,1.0,9/18,19.80%,NEDD4L;RIMS1;RIMS2;SYT1;SYT4;RNF157;RASAL1;CPNE5;SYT2
prerank,positive regulation of dendrite extension (GO:1903861),-0.6149741215185472,-1.667029595294859,0.029940119760479042,0.30365088259730943,1.0,9/17,19.80%,NEDD4L;RIMS1;RIMS2;SYT1;SYT4;RNF157;RASAL1;CPNE5;SYT2
prerank,gastrulation (GO:0007369),0.7546763083877757,1.66493412635268,0.02108433734939759,0.43359504623299727,1.0,8/15,18.74%,GPC3;NR4A3;SMAD2;LRP5;MEGF8;NPHP3;MKKS;TASOR
prerank,positive regulation of potassium ion transport (GO:0043268),0.6504857171097012,1.6623909188670871,0.007623888182973317,0.4398163323821567,1.0,6/38,1.84%,KCNJ2;FHL1;KCNJ15;KCNMB3;KCNMB2;ANK2
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.5981548787394829,-1.66188235973195,0.02556818181818182,0.31018669282503825,1.0,7/18,13.57%,IGF1;IGFBP2;RPS3;IL18;HMGB1;ICOSLG;CD24
prerank,embryonic digestive tract development (GO:0048566),0.7341206971412896,1.6614782818810672,0.01566951566951567,0.43725970032824285,1.0,6/18,6.46%,PCSK5;RARB;ID2;GLI3;NIPBL;GLI2
prerank,vitamin transport (GO:0051180),0.6778132199143395,1.6607707485606622,0.018691588785046728,0.43356324996952383,1.0,7/29,10.16%,SLC23A1;SLC5A6;ABCG2;FOLR2;GC;SLC25A32;SLC52A3
prerank,water-soluble vitamin metabolic process (GO:0006767),0.6055100535298109,1.6598695402734764,0.002372479240806643,0.43104439515217596,1.0,10/68,5.71%,SLC23A1;SLC23A2;AOX1;SLC5A6;MMACHC;VNN1;RFK;PNPO;FOLR2;NNMT
prerank,ventricular septum morphogenesis (GO:0060412),0.6856900999635125,1.6585117653925665,0.00535475234270415,0.43135135828628185,1.0,9/27,6.60%,SLIT3;SLIT2;BMP4;ZFPM2;HES1;BMPR1A;TGFBR1;NOG;TGFBR2
prerank,acute inflammatory response (GO:0002526),0.7149180627063348,1.6584799461330322,0.005925925925925926,0.4246962983153871,1.0,4/23,3.91%,F3;LBP;ANO6;VNN1
prerank,organic cation transport (GO:0015695),0.729898710865493,1.65838305267818,0.009817671809256662,0.41864252212352787,1.0,1/20,0.01%,SLC47A1
prerank,neutral amino acid transport (GO:0015804),0.6828447070343073,1.6575383906170629,0.013422818791946308,0.41605899928298407,1.0,5/28,5.58%,SLC38A2;SLC38A1;SLC38A6;SLC7A9;SLC6A7
prerank,primary neural tube formation (GO:0014020),0.687196165309814,1.656047389555588,0.008032128514056224,0.4171388740135924,1.0,6/30,5.65%,LRP6;COBL;LMO4;PRICKLE1;GRHL2;SKI
prerank,extracellular matrix organization (GO:0030198),0.5451134897632474,1.6557293780155755,0.0,0.41252092573581567,1.0,54/276,8.79%,COL25A1;COL8A1;ADAMTSL3;COL12A1;SH3PXD2A;SMOC2;THBS1;ADAMTS17;COL6A2;COL8A2;TLL1;ADAMTSL1;VIT;THSD4;PLOD2;ADAMTS2;MFAP5;COL6A1;SMOC1;CDH1;BMP1;DDR2;COL5A2;CYP1B1;GSN;FGF2;LOXL1;COL3A1;ITGB8;ITGB5;OPTC;DSPP;MMP28;COL6A3;HTRA1;COL11A1;ELN;CAPN2;ADAMTS3;TIMP1;TGFBR1;HAS1;NF1;BGN;CD44;FN1;ITGB1;TIMP2;KIF9;ADAMTS6;COL17A1;ADAMTSL5;MMP16;P3H1
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.7790473127323208,1.651206610817787,0.01032448377581121,0.42884275175600906,1.0,4/14,10.84%,THBS1;FGF2;SULF1;CREB3L1
prerank,carboxylic acid transport (GO:0046942),0.6207527199951586,1.6500156809665452,0.004830917874396135,0.42843544966259484,1.0,8/55,5.58%,SLC38A2;SLC23A1;SLC23A2;SLC38A1;SLC16A9;SLC16A1;SLC38A6;SLC6A7
prerank,B cell receptor signaling pathway (GO:0050853),-0.5075111158963884,-1.6489542033888516,0.0040650406504065045,0.3385471849570236,1.0,11/32,13.74%,PRKCB;BCL2;RFTN1;TEC;MEF2C;VAV3;CD38;BMX;NFATC2;SH2B2;BLNK
prerank,peptide cross-linking (GO:0018149),0.6910873201831617,1.6486263323930612,0.022408963585434174,0.42911858656827034,1.0,8/25,8.84%,THBS1;COL3A1;DSP;ANXA1;ABCA7;FN1;TGM5;TGM6
prerank,tube closure (GO:0060606),0.6825434146672003,1.6483378271268705,0.009370816599732263,0.4246629832051377,1.0,6/31,5.65%,LRP6;COBL;LMO4;PRICKLE1;GRHL2;SKI
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.578638507382388,1.6423446856547268,0.0011185682326621924,0.4494188394833626,1.0,34/104,17.26%,BMPER;CCN3;CRIM1;HTRA3;VWC2;SMAD6;SKIL;HTRA4;SMAD9;PMEPA1;BMPR1A;CD109;TGFBR1;NOG;SPRED2;SKI;EMILIN1;NBL1;TGFBR2;IL17RD;SMAD2;CHRD;LEMD2;TGFB1I1;LDLRAD4;SORL1;ACVR1;WFIKKN1;FAM89B;UBE2D3;SMAD4;PIN1;BCL9L;SMAD7
prerank,cellular response to zinc ion (GO:0071294),-0.639052574546673,-1.6416706172531577,0.02046783625730994,0.3499230653248076,1.0,13/15,24.75%,GLRA1;ATP13A2;MT3;MT2A;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B;HVCN1
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.7197961761242124,-1.6415745186634605,0.020618556701030927,0.34270736663626206,1.0,3/10,11.56%,ATP1A2;BIN1;ADRA2A
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.6088443797078841,1.6396239133907866,0.005980861244019139,0.45666911551390427,1.0,13/56,6.78%,BMPER;BMP4;SMAD6;BMP5;PMEPA1;TGFB3;BMPR1A;GDF10;TGFBR1;NOG;EMILIN1;BMP6;INHBA
prerank,motor neuron axon guidance (GO:0008045),0.7669755899661733,1.6382040352813798,0.019877675840978593,0.45697460960276853,1.0,4/15,4.50%,SLIT2;NTN1;SLIT1;TMEFF1
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.7703313085650458,1.6378005527026371,0.014018691588785047,0.45301620396258285,1.0,4/14,4.13%,STK39;WNK1;PTK2B;CCL3
prerank,positive regulation of positive chemotaxis (GO:0050927),0.7471037185185003,1.637532774884453,0.018922852983988356,0.44843330252060903,1.0,4/15,3.16%,F3;PGF;NTRK3;VEGFA
prerank,cellular response to chemokine (GO:1990869),0.6213360197859922,1.636689535874968,0.012755102040816327,0.4468070131139473,1.0,11/46,10.42%,STK39;SLC12A2;WNK1;PTK2B;CXCL2;CCL3;CCL1;ZC3H12A;FOXC1;CCL7;RHOA
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.6075022526165546,-1.6361445548615423,0.011940298507462687,0.3505403028692248,1.0,6/18,14.25%,PLCB1;CHRM2;CHRM3;GNA11;GRK2;OPRM1
prerank,nucleotide biosynthetic process (GO:0009165),0.7339967619786653,1.6337307561764935,0.016877637130801686,0.4554074188572544,1.0,4/18,8.41%,ME1;PRPS2;NMNAT2;NMNAT1
prerank,regulation of acrosome reaction (GO:0060046),-0.7061698937919049,-1.6330672225728424,0.024,0.3520105987682314,1.0,2/10,10.12%,PLCB1;GLRA1
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.7517895799096836,1.6328055298145023,0.02225519287833828,0.45396343745890344,1.0,5/15,6.60%,SIX1;TGFBR1;TWIST1;NIPBL;TGFBR2
prerank,regulation of T cell chemotaxis (GO:0010819),0.7947155374653796,1.6316497522405073,0.02254428341384863,0.4533358888949222,1.0,2/11,1.59%,STK39;WNK1
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.8050126757939794,1.631180487984123,0.029173419773095625,0.4499642337248864,1.0,2/10,1.59%,STK39;WNK1
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.6933267336589716,1.6303614842541205,0.01675977653631285,0.4481728575169545,1.0,6/24,6.53%,CDON;BOC;ABL1;CTNNA1;MEF2A;MAPK12
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.6298336472774339,1.628126861284819,0.013210039630118891,0.4539823251279943,1.0,13/43,11.50%,BMP4;KLF5;NFIB;DDX5;FGF2;KLF4;STAT3;FOXO3;NFATC4;NFATC3;EGR1;ATOH8;TEAD1
prerank,heart development (GO:0007507),0.5434662135673685,1.6271559344441424,0.0010615711252653928,0.4534203950356418,1.0,36/150,10.56%,MICAL2;BMP4;PLCE1;ZFPM2;PCSK5;CACNA1C;PKD1;NTRK3;SGCD;CSRP3;BMP5;GPC3;HDAC9;FOXL1;COL3A1;AKAP13;VEGFA;ID2;PDLIM7;FOXC2;TGFBR1;NIPBL;DNAAF4;NF1;MEF2A;ECE1;GLI2;TCF25;TGFBR2;FN1;GATA4;FOXC1;ALPK3;POU4F1;TAB2;BCOR
prerank,chordate embryonic development (GO:0043009),0.5987470857161417,1.6261335294627828,0.007361963190184049,0.4529664521620891,1.0,15/55,5.88%,KIAA1217;PCSK5;PKD1;MBNL1;BMP5;FUT8;WNT11;GRHL2;VEGFA;TGFB3;XYLT1;TGFBR1;NOG;FGFR1;DACT1
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.6653128720753946,1.626091983047793,0.014588859416445624,0.447886727216327,1.0,9/31,6.60%,SIX1;HOXA3;HOXC4;TGFBR1;HOXB3;NOG;TWIST1;HOXB4;TGFBR2
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.6978707934227575,1.6243688062956438,0.01878612716763006,0.45075893727044897,1.0,7/21,6.37%,BMP4;CCN3;TGFB3;BMPR1A;TGFBR1;BMP6;NUP93
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.7216687468184364,1.6225332723849264,0.024024024024024024,0.45449265863935695,1.0,4/17,3.07%,BMP4;TMEM100;FGF2;SFRP4
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.7693753074478737,1.622135888161831,0.017857142857142856,0.4514563292931694,1.0,6/14,13.65%,ME1;NMNAT2;NMNAT1;AK4;AK3;AK1
prerank,regulation of endothelial cell migration (GO:0010594),0.5773780007121858,1.620577599990498,0.0011235955056179776,0.4541595740443005,1.0,20/85,9.65%,SLIT2;BMPER;SMOC2;THBS1;FOXP1;BMP4;RHOJ;PTK2B;FGF2;NRP1;VEGFA;FOXC2;BCAS3;ABL1;NF1;ZC3H12A;ANXA3;GPI;KRIT1;AAMP
prerank,thymus development (GO:0048538),0.7535283287192625,1.6162327859753118,0.026234567901234566,0.4702358722675437,1.0,4/13,4.68%,SIX1;HES1;TGFBR1;EPHB3
prerank,protein deacetylation (GO:0006476),0.6293170107741385,1.6148383913384927,0.012626262626262626,0.4719101197377749,1.0,15/41,16.42%,HDAC4;HDAC9;RBM14;RCOR3;SIRT6;MIER1;MTA1;BRMS1L;BRMS1;TBL1X;RCOR1;SIRT3;MSL3;MORF4L1;PRDM5
prerank,histone deacetylation (GO:0016575),0.6272709351789958,1.614156262977427,0.015037593984962405,0.4702137429999248,1.0,16/43,16.42%,HDAC4;HDAC9;RBM14;HDAC8;RCOR3;PER1;SIRT6;MIER1;MTA1;BRMS1L;BRMS1;TBL1X;RCOR1;MSL3;MORF4L1;PRDM5
prerank,histone H3 deacetylation (GO:0070932),0.7437681758792487,1.6135701681679666,0.01903367496339678,0.4686927089777373,1.0,5/15,6.64%,HDAC4;HDAC9;HDAC8;PER1;SIRT6
prerank,circulatory system development (GO:0072359),0.5502917388330943,1.6123360403132136,0.0021668472372697724,0.47016074922746914,1.0,34/118,13.64%,MICAL2;PLCE1;NXN;ZFPM2;PCSK5;CACNA1C;PKD1;NTRK3;HDAC9;FOXL1;COL3A1;AKAP13;ID2;PDLIM7;FOXC2;TGFBR1;DNAAF4;NF1;MEF2A;ECE1;GLI2;TCF25;TGFBR2;FN1;FOXC1;ALPK3;POU4F1;TAB2;BCOR;ZFPM1;CDKN1B;NCOA6;PDLIM4;ACVR1
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.6866206284356934,1.6120234123930994,0.01867816091954023,0.4667525872364083,1.0,8/23,9.59%,SIX1;BMP4;FGF2;VEGFA;SMO;NOG;SIRT6;SIX4
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.6341062177477766,1.609018384182542,0.01913265306122449,0.4766910024456511,1.0,8/39,5.28%,STK39;FHL1;FXYD5;NEDD4;PTPN3;ANK2;WWP2;RANGRF
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.6466840614738547,-1.6083892311879389,0.04057971014492753,0.4201728329815118,1.0,9/12,23.94%,MAP2;STMN1;DYRK1A;CDH5;CLIP3;STMN2;ARHGEF7;SNCA;TUBB4A
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.7008652134769737,1.6083049549348511,0.01878612716763006,0.4755666547707364,1.0,2/19,3.00%,SLC26A2;PAPSS2
prerank,positive regulation of epithelial cell migration (GO:0010634),0.5650030063151076,1.607615624945773,0.0022371364653243847,0.4740887118767655,1.0,16/92,4.52%,SMOC2;THBS1;FOXP1;BMP4;DOCK5;ADAM9;PRKCE;PTK2B;FGF2;NRP1;VEGFA;RAB25;FOXC2;BCAS3;PLCG2;ABL1
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.6874419280287591,1.6061760691732256,0.02063273727647868,0.476305377143714,1.0,5/23,12.21%,SLC12A7;SLC12A2;ATP6V0A4;SLC9A1;SLC12A8
prerank,regulation of mononuclear cell migration (GO:0071675),0.6888758065205189,1.6059031433212614,0.02046783625730994,0.4728256538839323,1.0,4/23,2.28%,SLIT2;THBS1;BMP5;CMKLR1
prerank,steroid hormone mediated signaling pathway (GO:0043401),0.7597030621858015,1.6052906394448532,0.03076923076923077,0.4711910105096236,1.0,3/13,3.19%,BMP4;NR3C2;ESR1
prerank,regulation of multicellular organism growth (GO:0040014),-0.6138801412736512,-1.605164251015987,0.03550295857988166,0.4222003018505596,1.0,4/15,6.47%,IGF1;APP;PTCH1;GHR
prerank,negative regulation of protein localization to cell surface (GO:2000009),-0.6679316311757703,-1.6050260570735233,0.029649595687331536,0.41449588169817075,1.0,6/11,12.57%,NEDD4L;ACTN2;PICALM;LEPROTL1;GPM6B;TAX1BP3
prerank,secretion (GO:0046903),-0.6322194255751996,-1.6023225704430355,0.01764705882352941,0.41485199768280373,1.0,6/14,13.40%,RIMS1;SLC22A6;NPR1;SLC22A4;SLC22A2;FBLN5
prerank,BMP signaling pathway (GO:0030509),0.590383070502537,1.5988527996251167,0.008293838862559242,0.49829889889354007,1.0,15/62,9.27%,BMP4;DDX5;SMAD6;BMP5;TMEM100;SMAD9;TGFB3;BMPR1A;NOG;USP15;BMP6;SMAD2;RUNX2;CHRD;PDCD4
prerank,regulation of cAMP-mediated signaling (GO:0043949),-0.5571513733389394,-1.5979306472389936,0.026515151515151516,0.42040596819061465,1.0,9/24,8.26%,PEX5L;RAPGEF2;PRKAR2B;PDE4D;PRKAR1B;PRKAR1A;MGRN1;PDE2A;RNF157
prerank,regulation of protein import into nucleus (GO:0042306),0.6258014075383423,1.597212384849514,0.02666666666666667,0.5013980303126154,1.0,12/36,13.58%,BMP4;CDH1;PRKCD;ZIC1;MDFIC;UBR5;BAG3;ZC3H12A;MAVS;CHP1;JUP;DMAP1
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.6523338760509158,1.5971794874845973,0.007822685788787484,0.49676665121582764,1.0,8/35,5.68%,NR3C2;NEDD4;DDX5;RBFOX2;PMEPA1;ESR1;DDX17;UBR5
prerank,L-glutamate transmembrane transport (GO:0015813),-0.6793261093311724,-1.5963915276259943,0.02349869451697128,0.4174506773496507,1.0,4/10,5.34%,SLC1A3;SLC1A1;SLC1A2;SLC25A13
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.6110740302052217,1.5940994599834084,0.014267185473411154,0.5069839219654759,1.0,8/43,4.96%,THBS1;FOXP1;BMP4;IGFBP5;FGF2;BMPR1A;ID2;NR4A3
prerank,negative regulation of myotube differentiation (GO:0010832),0.7607102277764112,1.5937379752116356,0.03834355828220859,0.5042501077146625,1.0,4/12,9.62%,CCN3;HDAC4;CEACAM5;TMEM119
prerank,import into cell (GO:0098657),0.6149842445193742,1.593315967144343,0.020432692307692308,0.5016508264600674,1.0,6/41,3.32%,SLC47A1;SLC38A1;SLC12A7;SLC5A6;LRRC8D;SLC39A14
prerank,limb morphogenesis (GO:0035108),0.6967450703277327,1.5930193614073513,0.024745269286754003,0.4984526171792614,1.0,6/20,5.65%,PCSK5;LRP6;MBNL1;GLI3;NIPBL;SKI
prerank,negative regulation of leukocyte migration (GO:0002686),0.7929332189570902,1.5893796201073902,0.03605015673981191,0.5116606541991396,1.0,3/10,5.81%,SLIT2;BMP5;EMILIN1
prerank,skeletal system morphogenesis (GO:0048705),0.6116348490061305,1.5881155609848279,0.01797175866495507,0.513591294151142,1.0,16/42,16.78%,SIX1;LRP6;HOXA3;SFRP4;HOXC4;TGFBR1;HOXB3;FGFR1;SKI;HOXB4;LRP5;DYNC2I1;HOXD3;MEGF8;HHIP;FGFR3
prerank,regulation of sequestering of calcium ion (GO:0051282),0.7476373329795521,1.5880755789284073,0.029185867895545316,0.5092034379255648,1.0,4/12,6.07%,UBASH3B;ANK2;PTK2B;DIAPH1
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.7494043495019009,1.587985880547079,0.02635431918008785,0.5051872879635357,1.0,4/15,2.22%,SMOC2;THBS1;MET;FGF2
prerank,skeletal system development (GO:0001501),0.5388470500355168,1.5871894980161987,0.001076426264800861,0.5046773596869849,1.0,36/148,9.25%,KIAA1217;CDH11;TLL1;PCSK5;EXT1;PKD1;ALPL;BMP1;TNFRSF11B;BMP5;WNT11;GNAS;CMKLR1;AKAP13;PAPSS2;ITGB8;NPR3;DSPP;XYLT1;GDF10;TGFBR1;PTHLH;NOG;FGFR1;ZBTB16;BMP6;MYOC;GLI2;CD44;SLC10A7;SULF1;EVC;PHEX;MMP16;P3H1;CHRD
prerank,ganglioside biosynthetic process (GO:0001574),-0.5992432068045389,-1.5858314544273353,0.027700831024930747,0.44264952610852215,1.0,5/15,8.98%,ST6GALNAC3;ST8SIA4;ST3GAL1;ST8SIA6;B4GALT6
prerank,embryonic limb morphogenesis (GO:0030326),0.6272195381651745,1.5852173444802689,0.018205461638491547,0.5097185266963341,1.0,11/34,7.02%,LRP6;CACNA1C;MBNL1;AFF3;GLI3;NOG;TWIST1;NIPBL;SKI;ECE1;CREBBP
prerank,ceramide transport (GO:0035627),-0.6468192825416765,-1.5843792943793165,0.029490616621983913,0.4388400483004444,1.0,7/12,25.14%,PLTP;CERT1;ABCB4;ABCA2;PLEKHA3;GLTP;CPTP
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.6102517560901185,1.5802621820185014,0.023166023166023165,0.5293072814024851,1.0,15/46,14.46%,TCF7L2;NEDD4;CDH1;PRKCD;GSK3B;ZIC1;EMD;UBR5;BAG3;ZC3H12A;MAVS;XPO4;JUP;DMAP1;KHDRBS1
prerank,activation of protein kinase A activity (GO:0034199),-0.5885068570779384,-1.5789662340944646,0.027777777777777776,0.4493788218839076,1.0,6/16,6.42%,ADCY5;ADCY1;PRKAR2B;PRKAR1B;ADCY7;PRKAR1A
prerank,neural tube closure (GO:0001843),0.6439970383323466,1.5789568126487892,0.01453104359313078,0.5309020300409664,1.0,6/34,5.65%,LRP6;COBL;LMO4;PRICKLE1;GRHL2;SKI
prerank,xenobiotic transport (GO:0042908),0.7130464363145734,1.5770901903943344,0.02145922746781116,0.5359682362231205,1.0,2/17,2.16%,SLC47A1;ABCG2
prerank,modulation of chemical synaptic transmission (GO:0050804),-0.3938642099605627,-1.5770016099871245,0.0,0.44796082899721923,1.0,31/107,11.18%,ATP1A2;GRM7;LRRC4C;CDH2;GRID2;GRIK2;NRG3;DGKI;MCTP1;GRM5;GRM3;APP;DLGAP1;RIMS1;GRM1;RIMS2;MCTP2;EIF4EBP2;SYT1;MEF2C;CACNA1B;OPHN1;ABR;LGI1;TMEM108;LRP8;KCTD13;GRM8;IQSEC2;SLC8A3;TPRG1L
prerank,cardiac right ventricle morphogenesis (GO:0003215),0.7809040664303769,1.576396948970676,0.023064250411861616,0.5349249284040495,1.0,5/11,12.02%,BMP4;ZFPM2;BMPR1A;GATA4;JAG1
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.6724955923379625,1.5757924235636243,0.02021563342318059,0.5335885538649933,1.0,4/25,3.81%,THBS1;EGFR;NRP1;FZD7
prerank,negative regulation of cellular protein localization (GO:1903828),-0.4896840214055358,-1.5754725469978514,0.016129032258064516,0.44567499237351516,1.0,12/34,12.57%,MFHAS1;NEDD4L;ACTN2;RIPOR2;PICALM;ROCK2;ANKRD13A;MAPT;LEPROTL1;GPM6B;MAP1A;TAX1BP3
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.6418593612911707,-1.5749002054521453,0.029023746701846966,0.440201208405844,1.0,7/11,22.47%,MECOM;WNT5A;ETV6;CD34;YJEFN3;WNT2B;WNT10B
prerank,response to cholesterol (GO:0070723),0.7087239213466564,1.5740623640219067,0.030523255813953487,0.5374501392594926,1.0,8/17,9.97%,LRP6;SMO;CCL3;TGFBR1;TGFBR2;SMAD2;GRAMD1A;GRAMD1C
prerank,establishment of endothelial barrier (GO:0061028),-0.4946154113290212,-1.5722104574959554,0.03383458646616541,0.44141941381663996,1.0,9/29,7.74%,TJP1;PECAM1;PPP1R16B;RAPGEF3;RAPGEF2;F11R;PDE4D;ROBO4;PDE2A
prerank,cardiac muscle cell contraction (GO:0086003),0.700026959647982,1.5721422045875206,0.030973451327433628,0.5424781361214774,1.0,5/19,1.97%,KCNJ2;CACNA1C;CACNA1G;CAMK2D;GSN
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.502792734771107,-1.572017393679815,0.02857142857142857,0.4350975327695929,1.0,14/26,23.83%,LYN;PICALM;ROCK2;MBP;GRIN2B;EPHA4;GRIN1;AIM2;APH1B;PYCARD;PSME2;AGER;TTBK1;VSIR
prerank,positive regulation of macrophage activation (GO:0043032),0.7048029157449511,1.571703232509949,0.0424597364568082,0.5403025309312867,1.0,5/17,8.33%,THBS1;LBP;CCL3;IL33;TLR4
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.5887030448388235,-1.5713984735120887,0.03260869565217391,0.430030285307054,1.0,8/15,26.84%,PRKCH;CSF1;IL18;LPL;MSR1;CD36;AGT;PLA2G5
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.669197350794651,-1.570303629106644,0.0326975476839237,0.42626535489818895,1.0,4/10,7.11%,SEMA6A;DCN;CADM4;DAB2IP
prerank,epithelial tube morphogenesis (GO:0060562),0.6418858219163655,1.568860211451153,0.02340702210663199,0.5505531567811167,1.0,5/32,1.09%,SLIT2;BMP4;MET;PKD1;HES1
prerank,regulation of monocyte chemotaxis (GO:0090025),0.6749210468716778,1.5685792206581854,0.034139402560455195,0.5476872467288032,1.0,5/24,5.94%,SLIT2;CCN3;ANO6;CCL1;NBL1
prerank,extracellular structure organization (GO:0043062),0.5188167484519964,1.567597750087368,0.0010245901639344263,0.5481351971991748,1.0,39/204,8.49%,COL8A1;ADAMTSL3;SH3PXD2A;SMOC2;THBS1;ADAMTS17;COL6A2;COL8A2;ADAMTSL1;VIT;THSD4;ADAMTS2;MFAP5;COL6A1;SMOC1;CDH1;DDR2;COL5A2;FGF2;LOXL1;COL3A1;ITGB8;ITGB5;DSPP;MMP28;COL6A3;COL11A1;ELN;ADAMTS3;TGFBR1;NF1;BGN;CD44;FN1;ITGB1;ADAMTS6;COL17A1;ADAMTSL5;MMP16
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.5653788014500868,-1.5675691505342952,0.030120481927710843,0.42772486876525395,1.0,6/18,21.03%,APOE;TMCC2;ABCG1;APH1B;NSG1;ADAM19
prerank,response to purine-containing compound (GO:0014074),-0.5775469414653529,-1.5669252871910098,0.04195804195804196,0.4232872318991532,1.0,6/17,10.41%,RYR2;ABCC9;TRPC3;P2RY1;STAT1;P2RX7
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.6551310750323054,1.5663479922389314,0.022696929238985315,0.5503123696085043,1.0,2/27,0.16%,SLC47A1;SLC38A1
prerank,positive regulation of leukocyte activation (GO:0002696),0.6992264868283028,1.56621117052538,0.03216374269005848,0.5467052853736412,1.0,5/18,8.33%,THBS1;LBP;CD2;IL33;TLR4
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.5738212324001455,-1.5658436402227318,0.020066889632107024,0.4203643140163659,1.0,12/18,26.39%,MSRA;ASPA;SLC25A13;ASPG;GOT2;ASNS;FOLH1;ADI1;SMS;GOT1;ASS1;NAT8L
prerank,positive regulation of cell communication (GO:0010647),-0.5184246435695289,-1.5651087561475099,0.018726591760299626,0.4165030138569951,1.0,9/28,10.18%,WLS;GRIK2;ANK3;RIMS1;RIMS2;SYT1;LGI1;KCTD13;EDN1
prerank,negative regulation of actin filament polymerization (GO:0030837),0.6712657450523906,1.5650843820386962,0.036312849162011177,0.5479465694948911,1.0,3/22,1.97%,SLIT2;PRKCD;GSN
prerank,negative regulation of T cell differentiation (GO:0045581),0.8035097313130048,1.5638300691141893,0.026402640264026403,0.549935536060347,1.0,3/10,7.73%,BMP4;GLI3;IRF1
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.5863956360176059,-1.5637559101718137,0.01834862385321101,0.41441884436271953,1.0,7/17,9.75%,ITGA1;PDGFRB;PPP1R15B;CALM1;HSP90AB1;CD300A;MAGI2
prerank,catecholamine biosynthetic process (GO:0042423),-0.6526666545286876,-1.562359723150538,0.04040404040404041,0.412020527110273,1.0,4/11,21.07%,MOXD1;GCH1;DDC;SNCA
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.6480020320366046,1.5620611024029343,0.04027777777777778,0.5541000530690877,1.0,16/27,23.55%,USP2;ID2;ATOH7;PER1;BHLHE40;CRY2;PER3;MTA1;CRTC1;PDE6B;SIK1;FBXL6;PPP1CC;PML;FBXL8;TP53
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.6132253878444258,1.5615580126414206,0.016602809706257982,0.5522593438646836,1.0,10/39,5.28%,STK39;FXYD5;NEDD4;PTPN3;WNK1;CAMK2D;PRKCE;FGF13;SLMAP;RANGRF
prerank,photoperiodism (GO:0009648),0.6382580600992307,1.5611663718689819,0.04059539918809202,0.5499315178512266,1.0,16/28,23.55%,USP2;ID2;ATOH7;PER1;BHLHE40;CRY2;PER3;MTA1;CRTC1;PDE6B;SIK1;FBXL6;PPP1CC;PML;FBXL8;TP53
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.7411123092309017,1.561060234206188,0.05457463884430177,0.546458730858601,1.0,7/12,16.35%,SIX1;VEGFA;SMO;NOG;SIX4;SOX9;GDNF
prerank,regulation of interleukin-1 production (GO:0032652),0.711004407906479,1.5593678471861545,0.041666666666666664,0.5504286499071211,1.0,4/15,8.33%,FOXP1;ANXA1;NLRP12;TLR4
prerank,regulation of cardiac conduction (GO:1903779),-0.44064352730553885,-1.5592473211154345,0.018518518518518517,0.4152040026603991,1.0,17/54,12.19%,ATP1A2;ITPR1;ATP1B3;SLC8A1;RYR2;ABCC9;NPR1;ATP2A2;TRPC1;ATP1B2;ATP2A3;DMPK;SLC8A3;FXYD6;ATP2B1;AHCYL1;ACE2
prerank,external encapsulating structure organization (GO:0045229),0.5166833237914948,1.558670221812168,0.003080082135523614,0.5493798148272676,1.0,29/205,4.09%,COL8A1;ADAMTSL3;SH3PXD2A;SMOC2;THBS1;ADAMTS17;COL6A2;COL8A2;ADAMTSL1;VIT;THSD4;ADAMTS2;MFAP5;COL6A1;SMOC1;CDH1;DDR2;COL5A2;FGF2;LOXL1;COL3A1;ITGB8;ITGB5;DSPP;MMP28;COL6A3;COL11A1;ELN;ADAMTS3
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.6479158918254364,1.5537483718389953,0.04353932584269663,0.5688881473125429,1.0,5/27,6.48%,BMP4;EGFR;DDX5;STAT3;AGO2
prerank,B cell homeostasis (GO:0001782),-0.673783914607111,-1.5527295783298156,0.03773584905660377,0.42759462714752444,1.0,4/10,5.75%,DOCK10;LYN;DOCK11;MEF2C
prerank,negative regulation of cellular component movement (GO:0051271),-0.5906641944456722,-1.552616559003774,0.043478260869565216,0.42226680997077376,1.0,4/15,1.83%,FRMD5;SPOCK3;TGFBR3;FBLN1
prerank,negative chemotaxis (GO:0050919),0.6259750829170838,1.5503817692733552,0.037383177570093455,0.5813428358781773,1.0,8/33,5.77%,SLIT3;SLIT2;NTN1;SEMA3E;UNC5C;SLIT1;SEMA3C;SEMA3D
prerank,nucleotide metabolic process (GO:0009117),0.661951926932738,1.549804268023452,0.0340599455040872,0.5802463521255061,1.0,9/23,14.97%,ME1;FHIT;NUDT5;NMNAT2;NMNAT1;CTPS2;AK4;AK1;REXO2
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.7442966877112764,1.5480320392798224,0.03283582089552239,0.5851924384624485,1.0,1/13,0.02%,SLC4A10
prerank,in utero embryonic development (GO:0001701),0.6400398676124043,1.54768380932091,0.04874651810584958,0.5828345296849949,1.0,6/25,4.48%,PKD1;MBNL1;FUT8;VEGFA;TGFB3;TGFBR1
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.5549795173276223,1.5436290671378468,0.013921113689095127,0.5989669647237333,1.0,18/76,13.18%,RASSF2;EGFR;CCN3;NR3C2;TCIM;NFAT5;EZR;LIMS1;NLRP12;ZC3H12A;TLR4;PDCD4;RHOA;EIF2AK2;TRIM44;IFI35;CPNE1;DLG1
prerank,mesenchyme development (GO:0060485),0.7007517531968633,1.5427785569379655,0.053929121725731895,0.599094597612324,1.0,4/15,8.39%,BMP4;WNT11;TGFBR1;GATA4
prerank,regulation of MAPK cascade (GO:0043408),-0.3606530638927738,-1.5402540053122762,0.0,0.45399922663872505,1.0,41/157,10.41%,FLT1;IGF1R;IGF1;PHLPP1;KSR1;LYN;TEK;TNIK;KIT;LPAR1;TGFBR3;JCAD;PAK1;EPHB1;PELI2;ROCK2;KDR;EPHA7;INSR;RIT2;PAK3;SPRED1;ROR2;RYK;LBH;DAG1;TBX1;EPHA8;MAP4K4;ZDHHC17;MAPK1;DAB2IP;NRK;BMP2;NTRK2;PAK5;PTPRJ;FAS;MAP2K1;FLT3;P2RX7
prerank,cellular response to reactive oxygen species (GO:0034614),0.5659005411711292,1.5401544348013916,0.025149700598802394,0.6083103618473035,1.0,8/59,6.12%,EGFR;MAP3K5;PRKCD;CYP1B1;NFE2L2;ABL1;ANXA1;PRDX5
prerank,inorganic anion transmembrane transport (GO:0098661),0.5711749374071745,1.539947066810137,0.023174971031286212,0.605378928076991,1.0,8/63,4.12%,SLC26A2;SLC12A7;SLC5A6;SLC12A2;ANO9;GABRA3;ANO6;GLRB
prerank,response to progesterone (GO:0032570),0.6859186935183899,1.5362850143577262,0.04698972099853157,0.6201149767250483,1.0,2/18,3.17%,THBS1;TGFB3
prerank,inositol phosphate-mediated signaling (GO:0048016),0.6757628337355747,1.535540089529093,0.04661654135338346,0.6196843004697257,1.0,8/19,15.76%,PLCE1;PPP3CA;NFAT5;NFATC4;NFATC3;NMUR2;NFATC1;PPP3CC
prerank,glycine transport (GO:0015816),-0.6598061475865536,-1.5344936746448214,0.043596730245231606,0.4651064622920867,1.0,5/10,22.42%,SLC6A9;SLC38A5;SLC6A17;SLC6A5;SLC36A2
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.6787237336589234,-1.5340381291818301,0.05037783375314862,0.4604413305645888,1.0,6/10,21.96%,LYN;KIT;CD24;CD40;BTLA;BAG6
prerank,T cell migration (GO:0072678),0.7134289057458354,1.5334337139191105,0.05847076461769116,0.6265729428287238,1.0,2/13,4.13%,SLC12A2;CCL3
prerank,negative regulation of cartilage development (GO:0061037),0.73256204048302,1.5332290540496347,0.039619651347068144,0.6234827584919458,1.0,4/13,4.56%,WNT9A;WNT11;TGFBR1;PTHLH
prerank,amino sugar metabolic process (GO:0006040),-0.6504428715103499,-1.5325834009164645,0.034482758620689655,0.45898808546989356,1.0,3/10,2.05%,ST6GAL1;ST3GAL1;CSGALNACT1
prerank,gland development (GO:0048732),0.5666287795395772,1.5325159640625856,0.020731707317073172,0.6229979686162174,1.0,14/59,7.70%,SIX1;MET;HES1;COBL;WNT11;EZR;IGSF3;TGFB3;TGFBR1;EPHB3;ANXA1;NF1;GLI2;DKK3
prerank,negative regulation of endocytosis (GO:0045806),-0.5069161123385293,-1.5324003206045196,0.04861111111111111,0.4537614303802505,1.0,8/24,11.17%,PRKD1;MCTP1;PICALM;NR1H3;SYT11;RAC1;CD300A;NR1H2
prerank,regulation of fibroblast migration (GO:0010762),0.6746471474008959,1.5314078763844285,0.04189944134078212,0.6247667463218508,1.0,8/20,8.58%,THBS1;DDR2;PRKCE;FGF2;HAS1;ITGB1;DMTN;CORO1C
prerank,purine nucleotide metabolic process (GO:0006163),0.6627006287903742,1.5310330782303547,0.03193033381712627,0.6226569536904645,1.0,7/24,11.49%,NT5C1A;PRPS2;FHIT;NT5E;DNPH1;XDH;NUDT15
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.7320060198222682,1.5309169915035958,0.06097560975609756,0.6191269363296515,1.0,4/12,5.94%,SLIT2;CCN3;BMP5;NBL1
prerank,positive regulation of DNA metabolic process (GO:0051054),0.5652443062328001,1.5307505938668415,0.019347037484885126,0.6158192945531984,1.0,20/61,14.62%,SMOC2;EGFR;EYA2;FGF2;EYA4;RAD51;SIRT6;WRN;UIMC1;STPG4;PARP3;DHX36;MECP2;RAD50;EYA3;BRCA1;TIGAR;RNF8;ATRX;BRCC3
prerank,atrioventricular valve development (GO:0003171),0.7127007359828912,1.530464478219492,0.046579330422125184,0.6133403493343497,1.0,6/14,13.64%,SLIT3;BMPR1A;TGFBR2;ZFPM1;MDM4;ACVR1
prerank,negative regulation of protein processing (GO:0010955),0.7445106075251267,1.5299743511448654,0.040625,0.6118032515952874,1.0,3/12,6.05%,THBS1;GAS1;ACP4
prerank,cellular response to hydrogen peroxide (GO:0070301),0.6143594621901829,1.5287224781821667,0.036939313984168866,0.6142363023167365,1.0,6/33,5.34%,MAP3K5;PRKCD;CYP1B1;NFE2L2;ABL1;ANXA1
prerank,spinal cord development (GO:0021510),0.7427656359277225,1.528676647434613,0.05538922155688623,0.6106291282120294,1.0,4/12,6.46%,VIT;PKD1;NF1;GLI2
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.5834916004928942,1.528108064784335,0.024173027989821884,0.6094357157128569,1.0,8/46,4.96%,THBS1;FOXP1;BMP4;TCF7L2;IGFBP5;ID2;ELN;NR4A3
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.5888357143760615,1.5276573472485182,0.028277634961439587,0.6079803284088429,1.0,8/44,3.59%,KCNJ2;KCNJ15;KCNMB3;KCNMB2;WNK1;ANK2;ATP1B1;ANO6
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.6185398932587449,1.5274033766953907,0.03234152652005175,0.605598678008136,1.0,13/32,10.83%,THBS1;RHOJ;MEOX2;HDAC9;FGF2;VEGFA;FOXC2;KLF4;ANXA1;STARD13;CIB1;RHOA;MAP3K3
prerank,metanephros development (GO:0001656),0.6346516074668167,1.5272529483287316,0.03462603878116344,0.602544099652731,1.0,6/26,5.44%,SIX1;BMP4;PKD1;FOXD1;NIPBL;NF1
prerank,regulation of telomere maintenance (GO:0032204),0.6318901512765551,1.5262662755601775,0.038781163434903045,0.6035977678103895,1.0,13/26,24.90%,HDAC8;SMG6;SIRT6;DHX36;RAD50;ATRX;YLPM1;XRCC5;ERCC4;PML;NBN;USP7;GNL3
prerank,atrioventricular valve morphogenesis (GO:0003181),0.6766668624466292,1.5257816183581663,0.04067321178120617,0.6024222187632348,1.0,8/19,13.64%,SLIT3;SMAD6;BMPR1A;TGFBR2;GATA4;ZFPM1;MDM4;ACVR1
prerank,regulation of regulated secretory pathway (GO:1903305),-0.46486206297851995,-1.5222421606958871,0.027237354085603113,0.479342058814227,1.0,15/34,20.91%,RIMS1;RIMS2;SYT1;SYT7;SYT10;SYT4;SYT11;SYT12;SYT6;SYT13;RAB3A;RIMS4;RAB15;SYT2;SYT15
prerank,odontogenesis (GO:0042476),0.6079699487813518,1.5219149172894357,0.03978779840848806,0.6179751546279851,1.0,11/35,11.98%,BMP4;LRP6;EDA;PITX2;TGFB3;ACP4;GLI2;INHBA;FOXC1;BCOR;COL1A2
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),-0.47887949632050036,-1.5207293620845874,0.023255813953488372,0.4782418990885086,1.0,14/32,23.43%,CEMIP;AKAP6;TRPC3;GRIN1;TRPC1;P2RX7;CX3CL1;APLNR;PLCG1;THY1;SNCA;F2R;GPER1;CAV1
prerank,muscle cell differentiation (GO:0042692),-0.476992425386342,-1.5203229009979236,0.016736401673640166,0.47367712433032944,1.0,11/32,9.05%,WNT5B;SPEG;SGCZ;TBX18;MRTFB;TBX1;MEF2C;SYNE1;TMEM204;HEY2;GATA6
prerank,vesicle transport along actin filament (GO:0030050),-0.5428840501664582,-1.520107439803043,0.02786377708978328,0.46845450213740103,1.0,13/19,33.39%,MYO1B;FNBP1L;MYO5A;ACTN4;MYO6;MYO5C;MYO1F;MYO1G;MYO15A;MYO7A;MYO1H;MYO1D;MYO1A
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.5182008619760303,1.5190336792689616,0.0075107296137339056,0.6284458050421714,1.0,40/128,18.32%,BMP4;ADAM9;DDX5;SMAD6;BMP5;TMEM100;COL3A1;SMAD9;TGFB3;ITGB5;BMPR1A;ID1;GDF10;TGFBR1;USP15;LTBP2;SKI;BMP6;TGFBR2;INHBA;ITGB1;SMAD2;RUNX2;NLK;PDCD4;RHOA;TGFB1I1;MAP3K7;COL1A2;PARD3;ACVR1;PARD6A;INHBB;RNF111;MEGF8;SMAD4;SMAD7;TWSG1;SMURF1;RGMB
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.6673865391766358,1.5182335961586808,0.047128129602356406,0.6284328385621711,1.0,4/20,3.59%,THBS1;GSN;SFRP4;ANO6
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.4306961484802375,-1.5172752799397282,0.011494252873563218,0.471048289313491,1.0,12/57,14.45%,ADCY5;GRM7;LPAR1;ADCY1;CHRM2;ADCY7;PDE2A;CHRM3;GRM8;ADRA2A;OPRM1;GNAI1
prerank,regulation of membrane depolarization (GO:0003254),0.6792515288967489,1.5170842691817574,0.043795620437956206,0.6302539894989433,1.0,9/18,17.77%,FHL1;PTPN3;CAMK2D;RANGRF;ABCD1;SCN1B;SCN3B;SMAD7;LRRK2
prerank,response to sterol (GO:0036314),0.7455796209877007,1.5153012111579136,0.0594679186228482,0.6356521477187256,1.0,5/11,7.92%,CCL3;TGFBR1;TGFBR2;RORA;SMAD2
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.5726997958315256,-1.5151536012909472,0.061946902654867256,0.4719546109070347,1.0,4/15,3.26%,GRM7;GRM5;GRM3;GRM1
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.5331279488990217,1.51457032603291,0.011376564277588168,0.6356621709752354,1.0,19/86,10.43%,THBS1;BMP4;FOXD1;CCN1;BMP5;TGFB3;ZNF423;GIPC1;BMPR1A;GDF10;TGFBR1;BMP6;NUP93;INHBA;CREBBP;SULF1;SMAD2;TTK;TGFB1I1
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.6932652971332478,1.5125972775642411,0.05082212257100149,0.641913565756575,1.0,4/17,10.91%,EGFR;PKD1;CCND1;CCNYL1
prerank,dendritic spine organization (GO:0097061),-0.496410533304371,-1.5121115317417178,0.04435483870967742,0.47550765980958853,1.0,8/26,7.72%,IGF1R;DOCK10;SHANK3;EPHB1;INSR;PAK3;LGMN;ITGA3
prerank,positive regulation of phagocytosis (GO:0050766),-0.4381667910008068,-1.5118323694732785,0.005291005291005291,0.4711126883399915,1.0,23/47,26.84%,CAMK1D;MERTK;IL15RA;SIRPA;DOCK2;GATA2;RAB31;PTPRJ;C2;GAS6;TULP1;CD47;LYAR;C4B;PYCARD;CALR;C3;CD300LF;CCL2;TREM2;TUB;AHSG;PLA2G5
prerank,regulation of response to stress (GO:0080134),0.7542295512905726,1.511449286996806,0.06341463414634146,0.6439125401501385,1.0,1/10,0.06%,SLC38A2
prerank,chemical homeostasis (GO:0048878),0.5545030865830497,1.5111797691645157,0.02751196172248804,0.641657173921052,1.0,9/61,11.46%,SLC4A10;SLC4A4;WNK1;SLC4A2;ACOX3;PNPLA3;TLCD1;RBP1;ANGPTL3
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.5637142572266016,1.511011484087868,0.031287605294825514,0.6389821573664218,1.0,8/54,3.49%,KCNJ2;STK39;FHL1;NEDD4;KCNJ15;KCNMB3;KCNMB2;WWP2
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.612819276215662,-1.509985825657955,0.042328042328042326,0.47101804738428493,1.0,3/11,3.74%,TJP1;RAPGEF2;F11R
prerank,sodium ion transport (GO:0006814),0.5357398553033048,1.5088103794323628,0.017162471395881007,0.6462741961757915,1.0,9/85,3.59%,SLC4A4;SLC23A1;SLC9B2;SLC5A6;SLC12A2;SLC24A3;ATP1B1;FGF13;ANO6
prerank,osteoclast differentiation (GO:0030316),0.6508748906929194,1.5086550958064524,0.04005722460658083,0.6434031123039535,1.0,3/22,2.25%,FOXP1;ANXA2;GAB2
prerank,regulation of macrophage chemotaxis (GO:0010758),0.6441765261255337,1.5080474440787854,0.04943502824858757,0.6428228430839655,1.0,4/21,3.23%,THBS1;PTK2B;CMKLR1;MTUS1
prerank,negative regulation of heart contraction (GO:0045822),-0.6313267698051828,-1.5080373340421342,0.06162464985994398,0.4714322956434215,1.0,4/11,12.14%,ATP1A2;PDE4D;SPTBN4;GRK2
prerank,hexose transmembrane transport (GO:0008645),-0.5180895507386999,-1.5078778544108726,0.036065573770491806,0.46671707912034516,1.0,5/21,12.62%,SLC2A1;SLC2A12;SLC5A3;PPARD;SLC50A1
prerank,regulation of protein tyrosine kinase activity (GO:0061097),-0.45006691659094583,-1.5078505976722718,0.03286384976525822,0.46165296672419653,1.0,17/38,19.92%,IL34;GRM5;NEDD9;APP;ACE;EPHA4;GPRC5B;LRP8;GAS6;NOX4;ERBB3;CSF1R;RELN;HYAL2;THY1;FCGR1A;PRNP
prerank,transition metal ion transport (GO:0000041),-0.4592967881777429,-1.5066065490090745,0.027131782945736434,0.4604290123417086,1.0,15/35,17.33%,CP;SLC30A10;TRPC3;ATP2C1;TFRC;SLC39A8;TRPC4;TRPC6;TRPC1;SLC30A1;ATOX1;FTH1;SLC31A1;MT3;TRPC7
prerank,response to zinc ion (GO:0010043),-0.5046550448234951,-1.5053500406719003,0.03103448275862069,0.45908378114488074,1.0,18/25,27.62%,PAM;CRIP1;GLRA1;ATP13A2;MT3;MT2A;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B;KHK;HVCN1;SLC30A4;HAAO
prerank,positive regulation of endothelial cell migration (GO:0010595),0.532152674946151,1.5052589035208463,0.02378255945639864,0.6535510577314235,1.0,14/84,5.14%,SMOC2;THBS1;FOXP1;BMP4;MET;PTK2B;PLPP3;FGF2;NRP1;VEGFA;FOXC2;BCAS3;ABL1;FGFR1
prerank,mesenchymal to epithelial transition (GO:0060231),0.7272083302308748,1.505150137451337,0.0656,0.6505299386814483,1.0,2/10,3.81%,BMP4;FZD7
prerank,epiboly involved in wound healing (GO:0090505),0.6845769394099233,1.5051153976501412,0.058646616541353384,0.647083697079328,1.0,5/16,10.42%,TMEFF2;CCN1;MRTFA;CD44;RHOA
prerank,lung epithelium development (GO:0060428),0.7421758404128598,1.5042163652822653,0.064,0.6479088888426331,1.0,3/10,3.06%,BMP4;PKD1;GRHL2
prerank,regulation of cell killing (GO:0031341),0.7013218532103682,1.5039166858661042,0.054380664652567974,0.6458371431403185,1.0,3/16,3.81%,CFH;CD55;FZD7
prerank,response to hydrogen peroxide (GO:0042542),0.5765777174773777,1.50105152176048,0.032663316582914576,0.6559421467010921,1.0,7/45,5.34%,MAP3K5;ADAM9;PRKCD;CYP1B1;NFE2L2;ABL1;ANXA1
prerank,regulation of dopamine secretion (GO:0014059),-0.49353600428989086,-1.500223873947218,0.03985507246376811,0.46936598463797036,1.0,15/25,27.11%,SYT1;SYT7;SYT10;SYT4;SYT11;SYT12;SYT6;SYT13;SYT2;KCNA2;SYT15;SNCA;CHRNA4;DRD2;CHRNB2
prerank,androgen receptor signaling pathway (GO:0030521),0.731490623462117,1.4986996619033646,0.05642633228840126,0.6643284914571953,1.0,3/11,3.35%,DDX5;PMEPA1;DDX17
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.7391311966393272,1.4983120740068334,0.051036682615629984,0.6628710272722941,1.0,3/11,1.65%,MAP3K5;PRKCD;CYP1B1
prerank,positive regulation of locomotion (GO:0040017),0.630872616122851,1.4975143396425121,0.04908835904628331,0.6634863048373948,1.0,4/27,4.98%,THBS1;NTN1;CCDC25;TWIST1
prerank,negative regulation of cell growth (GO:0030308),0.5126305836153365,1.4973599716507002,0.00974025974025974,0.6605951457984378,1.0,9/121,2.21%,SLIT3;SLIT2;FHL1;CCN3;NDRG3;OSGIN2;ULK2;WNT11;FGF13
prerank,positive regulation of protein import into nucleus (GO:0042307),0.6165646880055482,1.4962995389486116,0.06647807637906648,0.6622871343298978,1.0,9/28,13.58%,CDH1;PRKCD;ZIC1;UBR5;BAG3;ZC3H12A;MAVS;JUP;DMAP1
prerank,negative regulation of insulin secretion (GO:0046676),0.6909817032624905,1.4962917086477037,0.048672566371681415,0.6588202615119438,1.0,4/17,4.71%,CCN3;KCNB1;IRS1;KLF7
prerank,response to prostaglandin E (GO:0034695),-0.6376950499848318,-1.4948945404415055,0.0625,0.4804225166589225,1.0,6/10,25.41%,TGFBR3;GNG2;CCL19;SFRP1;GNB1;PTGER4
prerank,epithelial cell differentiation (GO:0030855),0.5309273036885039,1.4948073926709686,0.02244668911335578,0.6626712264274948,1.0,18/88,12.58%,SIX1;BMP4;FSTL1;CASP6;ANXA4;BDH2;EHF;GRHL2;VEGFA;FZD7;ANXA1;TDRD7;GSTA2;DNPH1;ANXA7;RHCG;JAG1;PTER
prerank,ventricular septum development (GO:0003281),0.5939023056636863,1.4938847313754307,0.03316326530612245,0.663803878141087,1.0,8/37,6.60%,SLIT3;SLIT2;ZFPM2;HES1;BMPR1A;TGFBR1;NOG;TGFBR2
prerank,regulation of osteoblast proliferation (GO:0033688),0.6633833322805758,1.4936611915725841,0.06966618287373004,0.6615579707929996,1.0,7/17,13.38%,CCN1;NELL1;NPR3;TMEM119;RHOA;EIF2AK2;PLXNB1
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.6951558226588436,1.4932385178728247,0.07250755287009064,0.6604987288780274,1.0,4/14,5.02%,SLIT2;IGFBP5;BMPR1A;LRP1
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.6624092645642674,1.4930113495841455,0.05604719764011799,0.6582047801663112,1.0,2/16,1.93%,ST3GAL4;NFAT5
prerank,cellular response to peptide (GO:1901653),-0.4275506619694176,-1.4930101239950861,0.0,0.48074944922665575,1.0,14/56,6.07%,IGF1R;IGF1;GRM5;APP;VCAM1;GRIN2A;NOD1;SNX6;GJA1;CASP4;EPHA4;GRIN1;LGMN;CACNA2D1
prerank,aorta morphogenesis (GO:0035909),-0.5492878169059623,-1.491591982329928,0.05519480519480519,0.4802913255688462,1.0,11/17,15.33%,ENG;MYLK;PDGFRB;ADAMTS9;RBPJ;TBX1;PROX1;HEY2;TBX2;EFEMP2;ACVRL1
prerank,negative regulation of phosphorylation (GO:0042326),0.5306149965428812,1.4914771606889772,0.019165727170236752,0.6626727211236408,1.0,22/85,12.33%,SLIT2;BMP4;LRP6;HDAC4;NTRK3;PID1;PLPP3;NIBAN1;KLHL31;IBTK;PFKFB1;INHBA;NCOR1;ZC3H12A;CORO1C;CDKN2C;CIB1;XDH;EPHB2;CHP1;CDKN1C;CDKN1B
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.6873449035421948,1.4910701160108866,0.07342143906020558,0.6614287928397973,1.0,3/15,3.94%,PIEZO2;TMEM120A;COL11A1
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.6517758097930026,1.490984773224292,0.04843304843304843,0.6585363940567324,1.0,1/21,0.09%,SLIT2
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.5554748152216753,1.4908162191288803,0.039192399049881234,0.656044435475497,1.0,32/57,27.83%,FZR1;FOXN3;CHEK2;TICRR;WAC;TOPBP1;TRIM39;CCND1;UIMC1;CLSPN;FBXO31;RAD17;BRCA1;BRCC3;PRKDC;CDK2;CDKN1A;MDC1;DTL;DONSON;ATF2;NBN;CHEK1;TAOK1;ABRAXAS1;ATM;TP53;RAD9A;RAD9B;MRNIP;RPS27L;PLK1
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.7336511157657805,1.4907468860757322,0.06836248012718601,0.6531676854437745,1.0,3/11,2.70%,RSPO3;MLLT3;PLEKHA4
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.623190383061604,1.490267444613164,0.049575070821529746,0.6520767114381399,1.0,7/25,7.92%,BMP4;FOXD1;CCN1;ZNF423;BMPR1A;SULF1;SMAD2
prerank,cartilage development (GO:0051216),0.5681712329140173,1.4893106949532944,0.03654080389768575,0.6535112924061085,1.0,11/49,8.72%,BMP4;CCN3;NFIB;PKD1;FGF2;ITGB8;SLC39A14;ZBTB16;CD44;SULF1;RUNX2
prerank,cellular response to estradiol stimulus (GO:0071392),0.6631784623917135,1.489159402277784,0.05865102639296188,0.6509190965837469,1.0,4/18,10.39%,EGFR;ESR1;LCOR;POU4F1
prerank,basement membrane organization (GO:0071711),-0.5840954685779267,-1.4889084501797585,0.04297994269340974,0.4834543017757638,1.0,9/14,23.19%,NID1;NID2;LAMB1;COL4A1;LAMB2;CTSS;LAMB3;NTNG1;NTNG2
prerank,cellular response to BMP stimulus (GO:0071773),0.546790554090563,1.4879167733680536,0.02813599062133646,0.6537340485979377,1.0,13/66,9.27%,BMP4;DDX5;SMAD6;BMP5;TMEM100;SMAD9;TGFB3;BMPR1A;USP15;BMP6;SMAD2;RUNX2;PDCD4
prerank,positive regulation of cell cycle (GO:0045787),0.5573213749962576,1.4873221599475048,0.03402187120291616,0.6534859509299035,1.0,11/62,12.33%,SMOC2;EGFR;LRP6;PKD1;USP2;RARA;CCND1;CCNB1;CCNYL1;ANKRD17;CDKN1B
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.6968914526494845,1.4869077436821572,0.0703012912482066,0.6524986194187498,1.0,5/15,5.14%,SMOC2;MET;FGF2;VEGFA;FGFR1
prerank,regulation of cholesterol storage (GO:0010885),-0.575072976105367,-1.486601959398336,0.0480225988700565,0.48523617544580944,1.0,9/15,24.12%,PPARA;ABCG1;NR1H3;PPARD;NR1H2;LPL;MSR1;ABCA1;TREM2
prerank,positive regulation of CREB transcription factor activity (GO:0032793),-0.538509400548024,-1.4859898215901826,0.04966887417218543,0.4824722258214923,1.0,10/18,16.76%,CAMK1D;PRKD1;ADCY1;RPS6KA5;EPHA5;CD200;LRP8;RPS6KA4;RELN;CRTC3
prerank,embryonic organ morphogenesis (GO:0048562),0.5771731185824187,1.4857097082126303,0.04773869346733668,0.6550645106192483,1.0,9/42,6.56%,SIX1;MFAP5;HES1;HOXA3;ID2;HOXC4;HOXB3;NIPBL;HOXB4
prerank,inositol phosphate biosynthetic process (GO:0032958),0.7323127345627137,1.4854516722038227,0.07644305772230889,0.653223000017471,1.0,4/11,7.90%,FGF2;IP6K1;IP6K2;PPIP5K1
prerank,endothelial cell proliferation (GO:0001935),0.6756102397859589,1.4849409295297138,0.0791044776119403,0.6525222565800617,1.0,6/17,13.18%,BMPER;BMP4;PROK2;NRARP;ITGB1BP1;DLG1
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.48873934603422875,-1.484368397085012,0.045454545454545456,0.4821608036063902,1.0,10/27,16.28%,PRKCH;PPARA;ABCA5;CSF1;ABCG1;NR1H3;IL18;NR1H2;LPL;MSR1
prerank,positive regulation of DNA replication (GO:0045740),0.6681562815076878,1.4829412017300618,0.06706408345752608,0.6590787304165622,1.0,7/16,21.28%,EGFR;GLI2;STN1;BCAR3;DHX9;EGF;BRPF3
prerank,negative regulation of leukocyte activation (GO:0002695),-0.575273458295459,-1.4827018312399465,0.05789473684210526,0.4822303752774697,1.0,10/15,23.11%,IL31RA;NR1H3;LRFN5;CD200;CD300A;CD84;GRN;MILR1;CD300LF;GPER1
prerank,regulation of interleukin-12 production (GO:0032655),0.5691266067052249,1.4822088879525592,0.03934010152284264,0.659665722475361,1.0,9/47,11.28%,THBS1;FOXP1;CMKLR1;PLCG2;IRAK3;TLR4;MAST2;RIPK2;TLR8
prerank,renal water homeostasis (GO:0003091),-0.5131165657060471,-1.4818100223949897,0.05128205128205128,0.48022341556749487,1.0,9/23,14.73%,ADCY5;ADCY1;PRKAR2B;PRKAR1B;ADCY7;PRKAR1A;WFS1;AQP4;PRKACB
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.6166453384049874,1.4801820310087601,0.06130790190735695,0.6667847236000639,1.0,11/25,13.18%,CACNA1C;CAMK2D;ANK2;FGF13;DSP;DSG2;RANGRF;AKAP9;TRPM4;JUP;DLG1
prerank,alcohol catabolic process (GO:0046164),-0.6506062012001086,-1.4795711650330206,0.05699481865284974,0.4823560772234274,1.0,2/10,1.77%,APOE;CYP27A1
prerank,regulation of ion transmembrane transport (GO:0034765),0.5896065728719974,1.4794900839321652,0.06283422459893048,0.6670211152518629,1.0,6/33,3.59%,KCNJ2;NEDD4;KCNJ15;WNK1;WWP2;ANO6
prerank,signal peptide processing (GO:0006465),0.716541428851035,1.4787944555763708,0.06984126984126984,0.6672316515436297,1.0,1/11,0.66%,PCSK5
prerank,AMP metabolic process (GO:0046033),0.7091133554110934,1.4780853582021214,0.06069802731411229,0.6674402202065014,1.0,10/13,23.14%,NT5C1A;NT5E;AMPD3;XDH;AK4;AK3;AMPD2;NUDT2;ADSS2;ADSL
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.5767194009869375,1.4779309158298415,0.041237113402061855,0.6650149068246833,1.0,6/41,2.82%,KCNJ2;KCNJ15;KCNMB3;KCNMB2;ANK2;CLTRN
prerank,aortic valve development (GO:0003176),0.5957858329493684,1.4778493760667424,0.05141388174807198,0.6623370221828686,1.0,7/34,5.81%,SLIT3;SLIT2;BMP4;SMAD6;ELN;TWIST1;EMILIN1
prerank,membrane repolarization during action potential (GO:0086011),0.6930571987240651,1.4759281385986411,0.07462686567164178,0.6685601532863672,1.0,2/13,1.98%,KCNJ2;ATP1B1
prerank,aminoglycan biosynthetic process (GO:0006023),0.5554338080532055,1.4755828460322296,0.037641154328732745,0.6672300035484661,1.0,13/49,11.61%,GPC6;EXT1;GPC3;HS6ST2;B3GNT2;HEXA;HS3ST1;XYLT1;HAS1;SLC35D2;B4GAT1;B3GALT6;B3GNT9
prerank,cellular response to glucagon stimulus (GO:0071377),-0.549531897049893,-1.4753121334555972,0.05448717948717949,0.49030295424687226,1.0,8/17,14.73%,ADCY5;ADCY1;PRKAR2B;PRKAR1B;ADCY7;PRKAR1A;CYSLTR2;PRKACB
prerank,cellular response to fatty acid (GO:0071398),0.698046682239783,1.4750183977585236,0.08850931677018634,0.6669418711395491,1.0,4/12,10.80%,PID1;IRS1;ZC3H12A;PDK3
prerank,regulation of myotube differentiation (GO:0010830),0.6238589088568373,1.4747632365711572,0.06983240223463687,0.6650270404939369,1.0,6/24,11.89%,CCN3;HDAC4;HDAC9;CEACAM5;TMEM119;ATP11A
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.702047966119359,1.4746735318948034,0.05446293494704992,0.6624461347795118,1.0,6/14,12.96%,THBS1;MEOX2;KLF4;STARD13;RHOA;ITGB1BP1
prerank,glucose transmembrane transport (GO:1904659),-0.5292320638423902,-1.4740254984844405,0.06752411575562701,0.4894976079682045,1.0,4/18,7.36%,SLC2A1;SORT1;SLC5A3;PPARD
prerank,cellular response to organic substance (GO:0071310),0.5099321888029469,1.4731063262920492,0.0187018701870187,0.6669139746892948,1.0,19/116,6.93%,SLIT3;SLIT2;RAMP1;DPYSL3;PID1;CYP1B1;NFAT5;IGFBP5;BMPR1A;KLF4;CCL3;TGFBR1;EMD;PTPN2;STAT3;SHC1;ERBB2;TGFBR2;NLRP12
prerank,regulation of activated T cell proliferation (GO:0046006),-0.4802542841691674,-1.4727362780296804,0.06274509803921569,0.48877145812698186,1.0,12/30,21.91%,IGF1;IGFBP2;RPS3;PRKAR1A;IL18;HMGB1;ICOSLG;CD24;PYCARD;PRNP;AGER;CD274
prerank,response to estradiol (GO:0032355),0.5810475796588671,1.4725575906766477,0.07436918990703852,0.6664653666591152,1.0,7/31,12.77%,EGFR;ESR1;STAT3;ANXA1;LCOR;POU4F1;STRN3
prerank,regulation of nervous system process (GO:0031644),-0.516125055577081,-1.4721032977593491,0.06927710843373494,0.4861976683607231,1.0,13/18,26.27%,NOS3;APP;DLGAP1;HTR2C;ROCK2;TMEM108;SLC8A3;SLC8A2;NPTXR;NPTX1;DLGAP2;NPTX2;BEGAIN
prerank,aortic valve morphogenesis (GO:0003180),0.610150171417036,1.4715904163259177,0.05928853754940711,0.6680255373961248,1.0,7/30,5.81%,SLIT3;SLIT2;BMP4;SMAD6;ELN;TWIST1;EMILIN1
prerank,histone H4 deacetylation (GO:0070933),0.7326966062305343,1.471529475012675,0.0696594427244582,0.6653205617584661,1.0,4/10,10.93%,HDAC4;HDAC9;HDAC8;RCOR1
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.7359481972806204,1.470439056099785,0.06646525679758308,0.6674957231952942,1.0,4/10,1.91%,STK39;NEDD4;CAMK2D;PRKCE
prerank,negative regulation of locomotion (GO:0040013),-0.5908622412189661,-1.4695437136160068,0.09734513274336283,0.4889602729474263,1.0,3/12,1.83%,FRMD5;SPOCK3;FBLN1
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.715357690974955,1.468905075879389,0.07561728395061729,0.6719493621018839,1.0,2/11,3.27%,THBS1;BMPR1A
prerank,actin filament depolymerization (GO:0030042),0.7266212023655325,1.4687487642305304,0.07028753993610223,0.6696867186710957,1.0,2/11,1.97%,MICAL2;GSN
prerank,response to UV (GO:0009411),0.512145301455067,1.4674316254989794,0.02011173184357542,0.6730586306462274,1.0,28/95,20.11%,EGFR;SCARA3;NEDD4;PRKCD;UBE4B;ERCC5;UBE2A;CREBBP;WRN;UVSSA;CCND1;KDM1A;USP1;PARP1;DHX36;EIF2S1;ZBTB1;PRIMPOL;UBE2B;USP28;CIRBP;PCLAF;USP47;MAP3K4;DTL;CAT;ATR;ERCC4
prerank,positive regulation of Ras protein signal transduction (GO:0046579),-0.39388473132683444,-1.467249845327167,0.012578616352201259,0.4911913241813042,1.0,13/62,9.45%,ROBO1;AUTS2;IGF1;LYN;ARHGEF3;LPAR1;RASGRF1;F11R;MAP4K4;NOTCH1;ADGRG1;RAC1;MMD2
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.5311007529980256,-1.467228363751114,0.05211726384364821,0.4868191757749034,1.0,10/17,25.07%,COX7B;NDUFA4;COX4I1;AFG1L;COX5B;CYCS;COX7C;COX6C;COX6B1;COX4I2
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.6991483817935145,1.4669261529306779,0.06870229007633588,0.672667003951182,1.0,3/12,8.34%,FOXP1;NCOR1;NCOR2
prerank,actin filament-based transport (GO:0099515),-0.5112108668785684,-1.4665069191884703,0.03536977491961415,0.4843722466494844,1.0,13/21,33.39%,MYO1B;FNBP1L;MYO5A;ACTN4;MYO6;MYO5C;MYO1F;MYO1G;MYO15A;MYO7A;MYO1H;MYO1D;MYO1A
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.611086745357726,-1.4642602123549013,0.07065217391304347,0.48669746646669343,1.0,7/11,17.38%,EFNB2;SOX6;MEF2C;FRS2;BMP2;MYOCD;GREM1
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.5516310701689564,-1.4636028620830688,0.06460674157303371,0.48437193948307516,1.0,8/17,8.68%,MAML3;MAML2;NOTCH3;RBPJ;PLXND1;NOTCH1;NOTCH4;STAT1
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.6734391870168428,1.4631719013879094,0.0693815987933635,0.6879442776860233,1.0,5/16,9.37%,DDX5;RBFOX2;ESR1;DDX17;TADA3
prerank,regulation of vasculature development (GO:1901342),0.6083371784738018,1.4628213519207904,0.060689655172413794,0.6866108433443764,1.0,5/26,6.56%,BMPER;FGF2;NF1;PROK2;ERBB2
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.5974079770965511,1.4615999200358456,0.06711409395973154,0.6894200946317837,1.0,5/30,8.63%,FOXP1;DDX5;NCOR1;NCOR2;KDM1A
prerank,positive regulation of nervous system development (GO:0051962),-0.4294493351475787,-1.4609039495298868,0.03,0.48802938861563766,1.0,11/42,11.08%,IL1RAPL1;GRID2;EPHB1;NRXN1;TGM2;SYNDIG1;MME;CUX2;SRPX2;LRRC4B;PTPRD
prerank,regulation of blood coagulation (GO:0030193),0.6114582155462868,1.459792848824486,0.06986301369863014,0.6954023996934777,1.0,3/27,2.68%,THBS1;ST3GAL4;THBD
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.6258014007687182,-1.4594998148876759,0.09192200557103064,0.4877525917998866,1.0,6/10,14.54%,SHANK3;APP;SYP;NETO1;SYNGR1;CAMK2B
prerank,anion transport (GO:0006820),0.5899583719606768,1.4593997714516524,0.0703851261620186,0.694332750415662,1.0,4/33,4.18%,SLC26A7;LRRC8D;ABCG2;SLC4A2
prerank,positive regulation of chromosome organization (GO:2001252),0.6760701723072418,1.4592246474249964,0.0754414125200642,0.6922951494200523,1.0,10/15,27.46%,SIRT6;DHX36;RAD50;DDX11;ATRX;PML;NBN;RAD21;GNL3;SHCBP1L
prerank,defense response to virus (GO:0051607),-0.36572456970913525,-1.4589072335575444,0.0,0.4852514120453194,1.0,34/100,19.42%,SERINC3;AGBL4;BCL2;ABCC9;BCL2L1;TRIM56;SERINC5;IFIT2;IFIT1;ZDHHC1;SAMHD1;IFITM1;OAS2;IFITM3;IFNAR2;BST2;NDUFAF4;STAT1;AKAP1;RNASEL;IFITM2;IRF2;IFIT3;EXOSC5;RTP4;TLR7;SHFL;CD40;MLKL;NLRC5;PDE12;PYCARD;ZBP1;STAT2
prerank,muscle cell migration (GO:0014812),0.7185202532359894,1.4584047512466496,0.08201892744479496,0.6933081337372106,1.0,5/10,13.73%,SIX1;CCN3;AAMP;ITGB1BP1;ITGB3
prerank,regulation of ossification (GO:0030278),0.5772844378371892,1.4581880864252728,0.06463878326996197,0.6914527231717805,1.0,8/36,5.84%,BMP4;LRP6;DDR2;SMAD6;SGMS2;TXLNG;TWIST1;ZBTB16
prerank,skeletal muscle organ development (GO:0060538),0.6118802707765835,1.4581000190977749,0.06327372764786796,0.689052524146665,1.0,4/26,4.64%,SIX1;CSRP3;DISP1;LARGE1
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.6606383194680208,1.4575713341693695,0.06704707560627675,0.6885895973060641,1.0,3/18,3.08%,CCN3;KCNB1;IRS1
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.6916572067111091,1.456874200429073,0.09375,0.6889786324324468,1.0,4/13,7.63%,BMP4;NFIB;NFATC4;NFATC3
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.5699495474108788,1.45648282337743,0.05215123859191656,0.6880621632817755,1.0,9/38,8.50%,KCNJ2;CACNA1C;CACNA1G;CAMK2D;ANK2;DSP;DSG2;AKAP9;TRPM4
prerank,smooth muscle contraction (GO:0006939),-0.5694071306898988,-1.4556508826419847,0.08641975308641975,0.4905948810372981,1.0,7/14,8.26%,MYLK;SLC8A1;ROCK2;PIK3C2A;MYH11;BDKRB2;ACTA2
prerank,embryonic appendage morphogenesis (GO:0035113),0.6763260801229148,1.454857783783128,0.08864696734059098,0.6928091773695458,1.0,3/12,5.65%,LRP6;MBNL1;SKI
prerank,defense response to symbiont (GO:0140546),-0.373391391027389,-1.4548086274331167,0.0,0.48914176403550785,1.0,32/92,19.42%,SERINC3;AGBL4;BCL2;ABCC9;BCL2L1;TRIM56;SERINC5;IFIT2;IFIT1;SAMHD1;IFITM1;OAS2;IFITM3;IFNAR2;BST2;NDUFAF4;STAT1;RNASEL;IFITM2;IRF2;IFIT3;EXOSC5;RTP4;TLR7;SHFL;CD40;MLKL;NLRC5;PDE12;PYCARD;ZBP1;STAT2
prerank,B cell proliferation (GO:0042100),-0.5216775021153973,-1.4547047840570493,0.05825242718446602,0.4853597252220863,1.0,6/17,22.36%,BCL2;MEF2C;CD40;CD180;HSPD1;CTPS1
prerank,actin nucleation (GO:0045010),-0.5037403621322281,-1.4545204895387085,0.045454545454545456,0.48183467386246737,1.0,6/21,11.91%,ARPC4;SPIRE1;ARPC5;IQGAP2;LMOD1;ARPC3
prerank,base conversion or substitution editing (GO:0016553),-0.6124903614627277,-1.453966891863851,0.07964601769911504,0.47943628890822343,1.0,3/11,12.78%,APOBEC1;ADARB2;ADAR
prerank,regulation of B cell proliferation (GO:0030888),-0.42303435487002505,-1.4538366185329095,0.03755868544600939,0.4758891719890726,1.0,15/44,15.87%,LYN;BCL2;TFRC;TNFRSF21;AHR;MEF2C;VAV3;CD38;CD300A;NFATC2;CD81;MIF;CD40;TYROBP;CD74
prerank,positive regulation of protein import (GO:1904591),0.5893895816299197,1.4535333961587396,0.0763888888888889,0.6963700966446653,1.0,9/30,13.58%,CDH1;PRKCD;ZIC1;UBR5;BAG3;ZC3H12A;MAVS;JUP;DMAP1
prerank,nucleotide catabolic process (GO:0009166),0.6794210910696413,1.4534439259477592,0.08755760368663594,0.6939716196015411,1.0,7/16,11.49%,NT5C1A;NT5E;DNPH1;DERA;VCP;XDH;NUDT15
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.6349796522632914,-1.4533536830209612,0.0807799442896936,0.47328485711691326,1.0,4/10,8.83%,APOD;LRCH1;RIPOR2;CD200
prerank,neurotransmitter secretion (GO:0007269),-0.4314566743817247,-1.4524068312156035,0.05188679245283019,0.47229097156826044,1.0,10/44,7.00%,NRXN1;SYN2;RIMS1;RIMS2;LIN7A;SNAP25;SYT1;HSPA8;SYT10;PTPRN2
prerank,negative regulation of B cell proliferation (GO:0030889),-0.602163042154264,-1.4510030595522552,0.06282722513089005,0.47221552166881237,1.0,4/11,15.39%,LYN;TNFRSF21;CD300A;TYROBP
prerank,lymphocyte proliferation (GO:0046651),-0.5000338288442467,-1.4508275105593187,0.053003533568904596,0.4690068274964518,1.0,9/22,22.72%,BCL2;MEF2C;FLT3;MSN;CD40;PPP3CB;HSPD1;CTPS1;PIK3CG
prerank,regulation of heart contraction (GO:0008016),-0.35922090835220516,-1.4504053925032891,0.009900990099009901,0.4665223458557323,1.0,22/90,12.55%,ATP1A2;ITPR1;ATP1B3;SLC8A1;RYR2;ABCC9;NPR1;PDE4D;ATP2A2;TRPC1;CALM1;ATP1B2;DES;ATP2A3;DMPK;SLC8A3;FXYD6;KCNQ1;ATP2B1;AHCYL1;ACE2;TBX2
prerank,regulation of B cell activation (GO:0050864),-0.4908662869996329,-1.4487144308248967,0.04744525547445255,0.4675802519712618,1.0,15/25,39.00%,AHR;SH3KBP1;TNIP2;SAMSN1;NOD2;ZFP36L1;BANK1;IL4I1;IKZF3;THEMIS2;LAPTM5;FOXJ1;CD22;TNFAIP3;IL6
prerank,positive regulation of glucose import (GO:0046326),-0.5196290222215801,-1.448544791750579,0.0660377358490566,0.46442092357418485,1.0,5/21,3.89%,IGF1;OSBPL8;OCLN;PIK3R1;INSR
prerank,negative regulation of growth (GO:0045926),0.4956093254625047,1.4481345427312446,0.018338727076591153,0.7168997537814701,1.0,12/121,7.53%,SLIT3;SLIT2;FHL1;CCN3;NDRG3;OSGIN2;WNT11;NOTCH2;NDUFS3;INHBA;SERTAD3;IP6K2
prerank,sensory perception of sound (GO:0007605),-0.37822498879966077,-1.4481116483980694,0.016,0.462125644423271,1.0,21/88,12.33%,GRM7;COL4A3;KIT;DCDC2;CEMIP;CACNA1D;USP53;RIPOR2;ADGRV1;PCDH15;EYA1;TBX1;CLIC5;EPS8L2;NDUFB9;WFS1;GRAP;CCDC50;KCNQ1;SPTBN4;WHRN
prerank,regulation of peptide hormone secretion (GO:0090276),-0.38450482870469793,-1.4476826890900834,0.024539877300613498,0.4598057194911002,1.0,12/67,6.47%,ITPR1;RAPGEF4;SLC2A1;CHD7;CACNA1D;CACNA1E;RAPGEF3;HTR2C;DPP4;SNAP25;KCNC2;SYT7
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.44886520660619855,-1.4472537385624624,0.051587301587301584,0.45749119267284266,1.0,12/32,23.11%,CEMIP;AKAP6;TRPC1;CALM1;JPH2;CX3CL1;APLNR;PLCG1;THY1;SNCA;F2R;GPER1
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.610230388849916,1.4472416867932314,0.08089260808926081,0.7185384842835634,1.0,12/27,16.62%,FXYD5;PTPN3;CAMK2D;SLMAP;SNTA1;RANGRF;ATP2B4;DLG1;SCN1B;COMMD1;SCN3B;FXYD2
prerank,regulation of smooth muscle contraction (GO:0006940),0.6468609278348784,1.4463320046292412,0.07174231332357248,0.7199894189263805,1.0,6/20,12.40%,KCNB2;PLCE1;ADRB2;PROK2;NMUR2;CTTN
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.6496974088942385,1.4461524860777353,0.0824891461649783,0.7179915531898959,1.0,5/17,4.52%,NTRK3;BAIAP2L1;NRP1;BCAS3;ABL1
prerank,response to laminar fluid shear stress (GO:0034616),0.7202085659072984,1.4452283693087717,0.07153965785381027,0.7197673527965958,1.0,3/10,4.12%,SMAD6;NFE2L2;KLF4
prerank,sodium ion import across plasma membrane (GO:0098719),0.6541295636080011,1.4449638021300675,0.0791044776119403,0.7183318524211806,1.0,2/17,0.50%,SLC9A2;SLC12A2
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.6165412954193427,1.444124580100363,0.081267217630854,0.7196207316457758,1.0,5/25,7.29%,SLIT2;PRKCD;CDK10;ARHGAP44;LIMK2
prerank,lipid phosphorylation (GO:0046834),-0.6085396029994459,-1.443482028257714,0.07795698924731183,0.4639257329530494,1.0,4/10,7.53%,DGKB;DGKI;DGKD;DGKG
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.4934107196753137,1.4434684383233545,0.022316684378320937,0.7199442774282859,1.0,27/136,11.45%,TCF7L2;PKD1;HES1;HDAC4;CYP1B1;ANXA4;CMKLR1;MDFI;PTGIS;SFRP4;ESR1;ID2;ID1;WWP2;KLF4;IRAK3;TAX1BP1;BHLHE40;GLIS2;NLRP12;ZC3H12A;KDM1A;SFRP5;BRMS1;ERBIN;KEAP1;CHP1
prerank,response to interleukin-4 (GO:0070670),-0.6273908473573092,-1.4429597406638963,0.07365439093484419,0.4619999040950398,1.0,4/10,18.28%,LEF1;TCF7;XBP1;JAK3
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.5392327286518223,1.4420739187954372,0.055952380952380955,0.7239954947311561,1.0,15/55,18.97%,FBXL7;FHL1;PSMB2;AURKA;PSMD11;PSMC1;CUL1;PSMC6;PSMD1;PSMD4;USP47;PSMA6;PSMD14;PSMD12;PSMD7
prerank,neuron remodeling (GO:0016322),-0.6292902383637703,-1.4405753758455995,0.06933333333333333,0.4648677939920644,1.0,7/10,23.06%,ADGRB3;APP;EPHA8;C1QA;CX3CL1;C3;RND1
prerank,potassium ion homeostasis (GO:0055075),0.6222694140592371,1.4404829278871145,0.0651872399445215,0.7287770090104558,1.0,8/23,9.70%,SLC12A7;KCNJ2;SLC12A2;ATP1B1;ATP12A;ATP1A3;ATP1A4;ATP1A1
prerank,"phagocytosis, engulfment (GO:0006911)",0.5716295019970665,1.440155426818076,0.05778894472361809,0.7275231420965362,1.0,4/36,1.97%,THBS1;GULP1;RHOBTB1;GSN
prerank,histone modification (GO:0016570),0.4985176150763414,1.4399829549720635,0.02185792349726776,0.7254954673946631,1.0,34/109,19.38%,EYA2;HDAC4;CCNA2;PRKCD;HDAC9;EYA4;RBM14;RCOR3;PRMT8;MIER1;UBE2A;CREBBP;EHMT1;MTA1;BRMS1L;BRMS1;NSD1;TBL1X;RCOR1;EYA3;MSL3;MORF4L1;UBE2B;KAT6B;CDK2;PRDM5;PHF20L1;TRRAP;PARP2;PHF20;PRMT6;USP21;USP16;HDAC2
prerank,regulation of axon guidance (GO:1902667),0.7194209071694868,1.4399739351884733,0.09295352323838081,0.7227146905962857,1.0,2/10,3.16%,NRP1;VEGFA
prerank,anterograde trans-synaptic signaling (GO:0098916),-0.32320727467012617,-1.4396968398390713,0.0,0.4639150512319635,1.0,55/224,10.12%,SLC1A3;UNC13C;GRM7;DTNA;NOVA1;GRIK2;KCND2;PDE7B;GRIA4;GRM5;GRM3;GABRG3;NRXN1;CACNA1E;DLGAP1;APBA1;HTR2C;SLC6A1;SYN2;GRM1;MBP;GRIN2A;KCNQ3;SLC1A1;GABRB3;RIT2;PRKAR2B;GABRB1;GRIN2B;CACNB4;CHRM2;SNAP25;CACNB2;GABRA2;SLC1A2;PRKAR1B;PLP1;GABRB2;SYT1;GRIA1;CACNA1B;GRIN1;APBA2;GPR176;PRKAR1A;SYT10;MAPK1;GABBR2;CALM1;CHRM3;RPS6KA1;GLRA3;CACNB1;GRIA3;GLRA1
prerank,negative regulation of vascular permeability (GO:0043116),0.6917611370784786,1.4389970128814171,0.10599078341013825,0.7246632391416583,1.0,2/12,3.16%,SLIT2;VEGFA
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.607345553537991,1.4386078578551653,0.07493188010899182,0.7238123837539199,1.0,3/26,1.81%,SMOC2;HES1;USP2
prerank,response to chemokine (GO:1990868),0.6764989764356167,1.4380455211317869,0.11746031746031746,0.7238321919920327,1.0,6/13,10.42%,STK39;SLC12A2;WNK1;ZC3H12A;FOXC1;RHOA
prerank,protein localization to organelle (GO:0033365),0.48777221022253225,1.4379523441025164,0.01939655172413793,0.7214845241641213,1.0,45/133,23.42%,SIX1;BMP4;BBS9;CSRP3;ANK2;ZNF423;TRAM2;EMD;GBF1;CNTLN;RAB6A;WDR35;LMNA;TULP2;ABCA7;TSPAN17;GAK;SIX4;RAB35;ARL3;STX5;TIA1;EHD1;SORL1;DCP1A;ROPN1;BICD1;TOR1B;DVL1;VAMP2;SSB;LRRK2;COG3;DHX9;ZBTB7A;RAB33B;RAB11A;TOR1AIP1;BICD2;MTCH2;FAM83H;PAQR3;YWHAE;BBS2;GCC2
prerank,regulation of Wnt signaling pathway (GO:0030111),0.49788674793251303,1.4372392134617327,0.032679738562091505,0.7224088896472982,1.0,23/108,9.08%,RSPO3;NXN;TCF7L1;TRABD2B;CTNND2;GPC3;MDFI;FOXL1;RSPO4;SFRP4;ESR1;FZD7;GRB10;EMD;MDFIC;LRP1;SKI;DACT1;TSKU;TIAM1;SULF1;NLK;SFRP5
prerank,neuron maturation (GO:0042551),-0.5185087513509936,-1.437039910140557,0.07975460122699386,0.46758008674120133,1.0,11/18,28.59%,ADGRB3;APP;EPHA8;B4GALT6;C1QA;CX3CL1;C3;ACTL6B;RND1;SRRM4;SCARF1
prerank,negative regulation of coagulation (GO:0050819),-0.541988386255589,-1.4369571694979275,0.07267441860465117,0.46439959945989934,1.0,6/14,11.41%,VTN;APOE;HS3ST5;CD34;EDN1;TFPI
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.5771607684303827,-1.4369420798084647,0.09657320872274143,0.46112447982854876,1.0,6/12,21.58%,SERINC3;SERINC5;CBS;SEPHS2;GGT1;CTH
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.6750645661150279,1.436727585507206,0.10793650793650794,0.7221057897232883,1.0,6/13,6.37%,BMP4;TGFB3;BMPR1A;TGFBR1;BMP6;NUP93
prerank,vasculogenesis (GO:0001570),-0.44614552212634834,-1.4366893505825302,0.04365079365079365,0.458514697290436,1.0,11/32,11.66%,ENG;PDGFRB;TGFBR3;KDR;SPRED1;RASIP1;SOX17;NOTCH1;HEY2;ADM;SOX18
prerank,purine nucleotide catabolic process (GO:0006195),0.6866715828132313,1.436268847600826,0.09733124018838304,0.7215428081545936,1.0,5/13,11.49%,NT5C1A;NT5E;DNPH1;XDH;NUDT15
prerank,water transport (GO:0006833),-0.588667231322848,-1.4362249073347761,0.09907120743034056,0.4566321477306557,1.0,3/12,13.88%,AQP11;PDPN;AQP4
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.6907127699266982,1.4331411736477466,0.08461538461538462,0.7338123377337784,1.0,3/13,6.46%,BMP4;VNN1;GLI2
prerank,response to glucagon (GO:0033762),-0.5181770194070489,-1.4330098193753251,0.0738255033557047,0.4619889337433926,1.0,9/19,16.42%,ADCY5;ADCY1;PRKAR2B;PRKAR1B;ADCY7;PRKAR1A;CYSLTR2;PRKACB;CRY1
prerank,axon development (GO:0061564),-0.3850178673037829,-1.4321718621011534,0.017857142857142856,0.46081652502546977,1.0,24/78,12.24%,GRM7;NREP;ANK3;CTNNA2;APP;CNTN4;DCC;PAK3;DSCAML1;BAIAP2;RYK;ACTB;PLP1;RTN4;ZDHHC17;RTN4RL1;LMTK2;MAPT;CAMSAP2;SEMA5A;PLPPR4;SPTBN4;MAP1A;SLITRK5
prerank,regulation of interleukin-8 production (GO:0032677),0.515636929141894,1.4320837678611158,0.05170387779083431,0.7360946142091711,1.0,14/69,13.32%,F3;LBP;ANXA4;CD2;KLF4;TLR1;STAT3;ANXA1;C5AR2;TLR4;MAVS;TLR8;MYD88;TIRAP
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.6741812833480466,1.431322121535969,0.10263929618768329,0.7370787145476546,1.0,3/13,4.96%,MET;NFE2L2;NR4A3
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.5605315690167028,1.4307733637128008,0.06700379266750948,0.7368577206957738,1.0,20/43,23.47%,FZR1;FOXN3;NABP1;TICRR;TOPBP1;TRIM39;UIMC1;CLSPN;RAD17;BRCA1;BRCC3;CDKN1A;DTL;DONSON;CHFR;NBN;CHEK1;TAOK1;ABRAXAS1;ATM
prerank,protein deacylation (GO:0035601),0.6014564885626158,1.4304257048665834,0.08321579689703808,0.7357955665801107,1.0,6/23,13.62%,HDAC4;LYPLA2;SIRT6;ABHD17B;LYPLAL1;SIRT3
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.6045689011089059,-1.4301799164958864,0.10140845070422536,0.4627301890555553,1.0,3/10,3.63%,ENG;ERRFI1;ENPP1
prerank,regulation of sprouting angiogenesis (GO:1903670),0.5708755230203358,1.4296753043971822,0.08289473684210526,0.7367884534683985,1.0,6/33,4.12%,BMPER;THBS1;RHOJ;FGF2;VEGFA;KLF4
prerank,neuron differentiation (GO:0030182),0.4800842617211592,1.4293583719053473,0.012578616352201259,0.7357121533431719,1.0,25/165,7.25%,VSX1;PBX3;WNT9A;LRP6;MET;WNK1;WNT11;PBX1;PITX2;VEGFA;ID2;FZD1;FZD7;ITM2C;TGFBR1;ATOH7;THOC2;ACSL3;CTF1;GLI2;ERBB2;NRBP2;NR4A2;INHBA;TENM1
prerank,positive regulation of RNA splicing (GO:0033120),0.5861892455967606,1.4285184115626124,0.07795698924731183,0.7370742694273554,1.0,9/29,15.49%,SLC38A2;CELF3;U2AF2;DAZAP1;THRAP3;RBM3;CELF4;RBMX;CIRBP
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.5261453814944473,1.428142218297039,0.05041031652989449,0.7361958694170114,1.0,18/65,18.97%,FBXL7;FHL1;PSMB2;NABP1;AURKA;PSMD11;PSMC1;CUL1;PSMC6;PSMD1;PSMD4;USP47;ZFYVE19;PSMA6;PSMD14;PSMD12;CHFR;PSMD7
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.7096932477977308,1.4274668008357732,0.104199066874028,0.7366822326868903,1.0,2/10,1.82%,LRP6;BMP5
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.5921485376052558,1.4271303443661216,0.07458563535911603,0.7356438047042084,1.0,11/27,13.18%,CACNA1C;CAMK2D;ANK2;FGF13;DSP;DSG2;RANGRF;AKAP9;TRPM4;JUP;DLG1
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.6193400910024331,1.4269790036106296,0.08273894436519258,0.7337150412768715,1.0,4/21,7.92%,LRP6;GSK3B;FZD1;CSNK1A1
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.7154034037831212,1.4259924838992437,0.0781758957654723,0.7332444387764172,1.0,6/10,15.76%,PPP3CA;NFAT5;NFATC4;NFATC3;NFATC1;PPP3CC
prerank,calcineurin-mediated signaling (GO:0097720),0.7154034037831212,1.4259924838992437,0.0781758957654723,0.7332444387764172,1.0,6/10,15.76%,PPP3CA;NFAT5;NFATC4;NFATC3;NFATC1;PPP3CC
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.6858037119896454,1.4256294169705435,0.0916030534351145,0.732236719320585,1.0,3/12,7.62%,BMP4;NEDD4;NUP214
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.5900350912663925,1.4255169438059156,0.07352941176470588,0.7301217943041499,1.0,17/32,23.47%,FZR1;FOXN3;TICRR;TOPBP1;TRIM39;UIMC1;CLSPN;BRCA1;BRCC3;CDKN1A;DTL;DONSON;NBN;CHEK1;TAOK1;ABRAXAS1;ATM
prerank,artery morphogenesis (GO:0048844),0.5867755627512353,1.425347960761578,0.07761966364812418,0.7283646369862687,1.0,9/30,5.44%,BMP4;HES1;NRP1;VEGFA;BMPR1A;TGFBR1;NOG;LRP1;NF1
prerank,neuromuscular junction development (GO:0007528),-0.4844567226656196,-1.4248560788290074,0.06498194945848375,0.47365681378536945,1.0,9/24,10.06%,PDZRN3;UNC13C;ANK3;PPFIBP2;PPFIBP1;CACNB4;CACNB2;CACNB1;ZC4H2
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.6635968160523059,1.4245404407702322,0.10566615620214395,0.7295515956267021,1.0,3/14,9.27%,THBS1;ANO6;PDCD4
prerank,embryonic eye morphogenesis (GO:0048048),0.7056026824886895,1.4244311773485017,0.09841269841269841,0.7274826474604426,1.0,2/11,0.98%,LRP6;MFAP5
prerank,regulation of plasminogen activation (GO:0010755),0.6910248317504741,1.4241848264402932,0.10681114551083591,0.7259369584442582,1.0,1/12,0.19%,THBS1
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.6719267512714522,1.4241054225854537,0.07373271889400922,0.7237754178182383,1.0,7/14,19.06%,SEC31A;SEC24B;SEC23A;MIA3;SEC24D;RAB1A;SEC23B
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.6416233384307408,1.4227887347898507,0.08571428571428572,0.727656197058953,1.0,9/16,23.47%,SMG6;SLX4;PARP1;DHX36;NAF1;HNRNPA2B1;ERCC4;TNKS2;ATM
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.5979033813292249,1.4227393258234386,0.08207934336525308,0.7253114111218952,1.0,8/26,8.37%,STK39;FHL1;NEDD4;ANK2;ATP1B1;WWP2;ITGB1;AKAP9
prerank,cellular response to interleukin-4 (GO:0071353),-0.6102644428728666,-1.4205529851074672,0.08943089430894309,0.4815000213179972,1.0,4/10,18.28%,LEF1;TCF7;XBP1;JAK3
prerank,nuclear migration (GO:0007097),0.6672684345116522,1.420331118835284,0.09487951807228916,0.7340028062061096,1.0,5/13,9.42%,CLMN;DOCK7;PCM1;PAFAH1B1;HOOK3
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.6225292899302599,1.4197972302569954,0.08477011494252873,0.7341313184754714,1.0,6/19,17.40%,LBP;PRKCE;PIK3AP1;TLR4;TIRAP;SCIMP
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.4334387770742284,-1.4197646196794198,0.030837004405286344,0.48014134482964854,1.0,11/35,16.40%,VTN;SGIP1;B2M;PICALM;HIP1R;SNAP91;RAC1;TNK2;HIP1;CCL19;BMP2K
prerank,regulation of glycogen metabolic process (GO:0070873),0.6828166414716952,1.419063198676845,0.09419152276295134,0.7350063235888875,1.0,2/12,5.50%,PPP1R3B;PPP1R3C
prerank,carboxylic acid metabolic process (GO:0019752),0.5644955180655092,1.4189369719598226,0.07407407407407407,0.7330650322067409,1.0,4/33,4.90%,SLC23A1;SLC23A2;PTGIS;CYP2S1
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.5789885275979749,-1.4186534760549576,0.10734463276836158,0.4799458900462025,1.0,3/11,5.75%,LYN;RAPGEF2;MEF2C
prerank,regulation of neuron projection development (GO:0010975),-0.32962958583677593,-1.418454493441519,0.0,0.4773541453898792,1.0,47/163,10.36%,CAMK1D;EFNB2;IL1RAPL1;LYN;PTK7;CSMD3;LRRC4C;CDH2;APOE;PRKD1;LPAR1;SHANK3;ITGA6;SPOCK1;PAK1;TENM3;PPFIA2;CTNNA2;TOX;WNT5A;RAPGEF2;DCC;SERPINI1;LRRC7;RIT2;PAK3;ROR2;FUT9;NDNF;EPHA4;CFL1;MAG;DAB2IP;RTN4RL1;PTPRO;PLPPR5;DENND5A;KIF1A;TWF2;ATP1B2;NTRK2;CRMP1;RUFY3;MAGI2;PLK5;CAMSAP2;NDRG4
prerank,regulation of cell growth (GO:0001558),0.4682951907480487,1.4177867034800602,0.006166495375128468,0.735814008895235,1.0,34/204,12.59%,SLIT3;SLIT2;FHL1;EGFR;CCN3;PLCE1;NDRG3;OSGIN2;CAMK2D;WNT11;DCUN1D5;TGFBR1;DDX49;NDUFS3;ERBB2;INHBA;SERTAD3;CDK11B;LTBP4;IP6K2;FAM107A;DNPH1;CEP43;EIF4G2;TMC8;CDKN2C;CIB1;KLHL22;RBBP7;SGK3;FXN;CDKN1B;RPS6KA3;BRAT1
prerank,positive regulation of angiogenesis (GO:0045766),0.4889483369292696,1.417630826841297,0.028888888888888888,0.7341023614748715,1.0,20/108,8.52%,BMPER;SMOC2;F3;THBS1;PGF;CYP1B1;FGF2;PTGIS;ITGB8;VEGFA;FOXC2;KLF4;HIPK1;TWIST1;AGO2;SIRT6;ITGB1;ZC3H12A;GATA4;ANXA3
prerank,eye development (GO:0001654),0.5361319265841566,1.416938441829215,0.07,0.7349553607968193,1.0,12/54,10.05%,PBX3;CACNA1C;SMOC1;COL5A2;PBX1;PITX2;HIPK1;NIPBL;SKI;TSKU;FOXC1;ATF6
prerank,protein localization to cilium (GO:0061512),0.5801066642310723,1.4155645985584013,0.08235294117647059,0.73904774904069,1.0,8/32,14.22%,BBS9;ZNF423;INVS;WDR35;TULP2;ARL3;EHD1;ROPN1
prerank,lymphocyte mediated immunity (GO:0002449),0.6969728406442017,1.4152102921895149,0.1095679012345679,0.7381934366471182,1.0,3/12,12.02%,CD55;CD46;JAG1
prerank,reverse cholesterol transport (GO:0043691),-0.5803399751345095,-1.414883980728697,0.08771929824561403,0.4833807561987871,1.0,3/13,4.23%,APOE;ABCA5;ABCG1
prerank,vascular transport (GO:0010232),0.5069482986070377,1.414634289651067,0.056140350877192984,0.7383956639388757,1.0,10/81,2.30%,SLC4A4;SLC38A2;SLC38A1;SLC5A6;SLCO3A1;SLC12A2;SLC24A3;SLC2A13;ABCG2;SLC16A1
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.5253966953150601,1.4146105359905585,0.056220095693779906,0.7360136681517662,1.0,10/59,6.60%,STK39;CIT;WNK1;PRKCD;CAMK2D;GSK3B;CDK10;HIPK1;TGFBR1;TGFBR2
prerank,regulation of viral entry into host cell (GO:0046596),-0.4519088405193593,-1.4143985942145498,0.05508474576271186,0.48138106015576876,1.0,12/30,16.12%,HS3ST5;LY6E;LGALS1;TRIM14;IFITM1;IFITM3;IFITM2;TRIM62;NECTIN2;SNX3;CD74;P4HB
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.5218329831260163,-1.4136613614762223,0.08620689655172414,0.4801316457287841,1.0,7/19,9.74%,IGF1;APOE;RTN1;PICALM;RTN4;NTRK2;BIN1
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.6406299716375481,1.41360662178145,0.10714285714285714,0.7381583822480049,1.0,3/16,3.16%,THBS1;FGF2;VEGFA
prerank,regulation of cell death (GO:0010941),0.4995731882057388,1.412197394424587,0.04666666666666667,0.741951371311377,1.0,20/94,12.68%,BMP4;CCN3;ACER3;CCN5;CCN1;WNT11;FGF2;SRGAP2;LRP1;SRSF6;AGR2;ZC3H12A;NOA1;BECN1;RIPK2;CHP1;ATG5;CLU;CDKN1B;CELF1
prerank,pancreas development (GO:0031016),0.6817826588562192,1.4121894969581559,0.11607142857142858,0.7395345872345841,1.0,2/12,0.88%,TCF7L2;MET
prerank,early endosome to Golgi transport (GO:0034498),0.6796846686465964,1.4119135304298573,0.0981012658227848,0.738383219258707,1.0,6/11,17.53%,SNX2;RAB6A;STX5;TRAPPC10;SNX8;SURF4
prerank,positive regulation of organelle organization (GO:0010638),0.5725673467138158,1.4116160762126597,0.08874172185430464,0.7374878343805313,1.0,6/32,5.34%,ANXA2;SORBS3;ATL3;ADRB2;GSK3B;ANXA1
prerank,retina homeostasis (GO:0001895),-0.4801722344150776,-1.4115280025407895,0.07220216606498195,0.4824256214169053,1.0,8/23,18.04%,B2M;ACTB;POTEF;ATP1B2;HSPB1;WHRN;TULP1;SOD1
prerank,positive regulation of synapse assembly (GO:0051965),-0.4733206808654989,-1.411148447338298,0.0778688524590164,0.48029367323139527,1.0,9/27,11.08%,IL1RAPL1;GRID2;EPHB1;NRXN1;SYNDIG1;CUX2;SRPX2;LRRC4B;PTPRD
prerank,Golgi to endosome transport (GO:0006895),0.6380810011343805,1.4109841319277552,0.101620029455081,0.7379980514717324,1.0,4/16,5.51%,VPS13A;VPS13C;GBF1;KIF16B
prerank,endothelial cell migration (GO:0043542),0.5644985783239831,1.4107861133263946,0.08900523560209424,0.7365372369393233,1.0,12/37,13.11%,CCN3;FSTL1;CYP1B1;NRP1;VEGFA;GIPC1;ID1;ABL1;STARD13;RHOA;S100A2;NR4A1
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.6375315209906111,1.4106546359290635,0.09615384615384616,0.7346989292187025,1.0,4/17,5.20%,ADRA1B;ADRB2;AKAP13;ADCY9
prerank,potassium ion import across plasma membrane (GO:1990573),0.545269779385454,1.4105445393724707,0.07615480649188515,0.7327516019961494,1.0,5/41,1.98%,SLC12A7;KCNJ2;SLC12A2;KCNJ15;ATP1B1
prerank,entry into host (GO:0044409),0.68167077002752,1.4101295634578157,0.1066066066066066,0.7323418646736666,1.0,2/13,1.25%,MET;CDH1
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.6122715732847314,1.4098033042485285,0.09654178674351585,0.7315060341038481,1.0,4/20,1.91%,STK39;NEDD4;CAMK2D;PRKCE
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.653291794746064,1.4092888373012595,0.11836115326251896,0.7314784939422324,1.0,8/16,18.46%,DDX5;DDX17;SRSF6;CDK13;CELF4;SRSF1;HNRNPM;DHX9
prerank,transport across blood-brain barrier (GO:0150104),0.5036257164747155,1.4092403717244208,0.0570430733410943,0.7293405514209631,1.0,10/83,2.30%,SLC4A4;SLC38A2;SLC38A1;SLC5A6;SLCO3A1;SLC12A2;SLC24A3;SLC2A13;ABCG2;SLC16A1
prerank,positive regulation of immune system process (GO:0002684),0.6469409474956074,1.4090679709756564,0.10683760683760683,0.7278403435013374,1.0,4/16,18.04%,VEGFA;ANXA1;MIA3;NCKAP1L
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.5343971107314358,1.4087687546824796,0.07645631067961164,0.7268531318844977,1.0,12/50,12.13%,EGFR;NR3C2;TCIM;NFAT5;LIMS1;NLRP12;TLR4;PDCD4;RHOA;EIF2AK2;TRIM44;IFI35
prerank,engulfment of apoptotic cell (GO:0043652),0.6500297112473447,1.4067418204787685,0.10334788937409024,0.7338409375474847,1.0,2/15,1.89%,THBS1;RHOBTB1
prerank,renal system development (GO:0072001),0.5286340413978032,1.406345767390609,0.0690505548705302,0.7333635437286187,1.0,12/52,10.41%,SIX1;BMP4;PCSK5;PKD1;VEGFA;TGFBR1;GLI2;PYGO2;SULF1;FOXC1;PYGO1;ARL3
prerank,endothelial tube morphogenesis (GO:0061154),0.7072312296617206,1.4059157717336201,0.109375,0.7330352708711533,1.0,3/10,10.42%,BMP4;STARD13;RHOA
prerank,glycosaminoglycan metabolic process (GO:0030203),0.521380579322254,1.4057192040501993,0.07064555420219244,0.7316705180003881,1.0,14/54,15.34%,GPC6;EXT1;GPC3;HS6ST2;HEXA;HS3ST1;XYLT1;HAS1;SLC35D2;B3GALT6;GPC4;NAGLU;HS2ST1;IDUA
prerank,cellular response to heat (GO:0034605),0.5651444739911761,1.4047254675565217,0.07294429708222812,0.733862080208954,1.0,7/35,10.53%,THBS1;TCIM;BAG3;CLPB;VCP;RBBP7;DHX36
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.6481945243748718,1.4047177449758397,0.09597523219814241,0.7316379843235715,1.0,4/15,4.12%,BMPER;FGF2;VEGFA;KLF4
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.47916400143574905,-1.4044824691351536,0.08424908424908426,0.4949074165273023,1.0,9/23,11.74%,ACSL1;ELOVL7;FAR2;ACSL4;HACD1;HACD2;ACSBG1;DGAT1;ACSL5
prerank,negative regulation of myoblast differentiation (GO:0045662),0.646615931249137,1.4044313164793334,0.11556240369799692,0.730694973762616,1.0,2/13,2.37%,BMP4;PRICKLE1
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.6276512466974093,1.4042250556079143,0.0891812865497076,0.7293012839977154,1.0,4/20,10.91%,EGFR;PKD1;CCND1;CCNYL1
prerank,skin development (GO:0043588),0.513618597356051,1.404091957290171,0.0625,0.7275795575716713,1.0,10/65,6.23%,CLIC4;MET;PKD1;ADAM9;COL5A2;COL3A1;ASPRV1;DSP;ANXA1;BCR
prerank,histone deubiquitination (GO:0016578),0.6162250490016092,1.4040147756271582,0.1111111111111111,0.7257223990902228,1.0,10/18,25.01%,USP15;UIMC1;BRCC3;TRRAP;USP49;USP21;USP16;USP36;USP7;ENY2
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.6208154066513345,-1.403544750841543,0.10263157894736842,0.49429063631030545,1.0,5/10,10.31%,LYN;MAPK1;RNF13;FAS;MAP2K1
prerank,negative regulation of telomere maintenance (GO:0032205),0.6358681428253229,1.4022552970957782,0.11128284389489954,0.7315320681164306,1.0,8/15,23.47%,SMG6;SLX4;PARP1;RAD50;ERCC4;NBN;TNKS2;ATM
prerank,canonical Wnt signaling pathway (GO:0060070),0.5124407879462026,1.4019070646777883,0.060498220640569395,0.7308849078670946,1.0,13/68,9.08%,TCF7L1;TCF7L2;WNT9A;LRP6;WNT11;PLPP3;SFRP4;GSK3B;FZD1;FZD7;NR4A2;CSNK1A1;SFRP5
prerank,hyaluronan metabolic process (GO:0030212),0.5971989460791547,1.4014056714009575,0.09452054794520548,0.7308359815140703,1.0,8/23,11.45%,FGF2;SPAM1;HEXA;HAS1;LYVE1;CD44;SLC9A1;CHP1
prerank,protein modification by small protein removal (GO:0070646),0.4615925873003971,1.4001018523019269,0.007121057985757884,0.7345048343169622,1.0,112/252,26.92%,CCNA2;USP2;USP46;OTUD1;ADRB2;ESR1;PSMB2;TGFBR1;IL33;USP24;USP15;USP25;USP13;MYSM1;BARD1;IKBKG;ADRM1;PSMD11;SMAD2;ZC3H12A;BECN1;UIMC1;PSMC1;VCP;SENP5;USP1;TADA3;IFIH1;CLSPN;USP34;CDC20;DESI1;DESI2;RHOA;MAP3K7;RAD23B;WDR48;PSMC6;KEAP1;TRAF2;MDM4;BRCA1;USP40;COPS7B;RNF123;COPS5;ZRANB1;USP4;BRCC3;PSMD1;USP28;INO80E;ABRAXAS2;TRAF6;PSMD4;TNIP1;SMAD4;FOXK1;USP47;OTUD5;HCFC1;POLB;SMAD7;PSMA6;OTUD4;TRRAP;ACTR5;COPS8;OTUD3;USP49;PSMD14;PSMD12;COPS3;PSMD7;VCPIP1;USP21;USP16;MBD5;COPS2;USP19;USP10;USP32;FOXK2;TRAF3;YY1;PSME3;USP30;USP36;USP9X;SENP1;SUDS3;TADA2B;ABRAXAS1;TP53;OGT;PSMD3;USP7;USP33;PSMB6;USP42;UBB;INO80;SENP7;KDM1B;SENP6;RHOT1;UBA52;RPS27A;FOXO4;MCRS1;TOMM20;SENP2
prerank,positive regulation of interleukin-8 production (GO:0032757),0.5319666710103109,1.397783621634091,0.074719800747198,0.742429866081447,1.0,10/49,13.32%,F3;LBP;CD2;TLR1;STAT3;TLR4;MAVS;TLR8;MYD88;TIRAP
prerank,cellular response to mechanical stimulus (GO:0071260),0.5348139280424433,1.3977304741751093,0.07607361963190185,0.7404424780757236,1.0,10/46,12.31%,PIEZO2;CRADD;CASP2;IRF1;TLR4;SLC9A1;MAP2K4;TLR8;MAP3K1;MYD88
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.591463793355485,1.3972397011829885,0.07625899280575539,0.7381443506037558,1.0,7/23,16.42%,THBS1;GIPC1;CREBBP;TGFB1I1;CDKN1C;RNF111;SMAD4
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.591463793355485,1.3972397011829885,0.07625899280575539,0.7381443506037558,1.0,7/23,16.42%,THBS1;GIPC1;CREBBP;TGFB1I1;CDKN1C;RNF111;SMAD4
prerank,skeletal muscle tissue development (GO:0007519),0.5751581252097677,1.397175903477108,0.10196078431372549,0.7362300677721106,1.0,6/32,10.11%,SIX1;CSRP3;SKI;SIX4;MYORG;LEMD2
prerank,peptidyl-threonine modification (GO:0018210),0.509105432141392,1.3962451397940816,0.05476190476190476,0.7380985320756877,1.0,18/66,16.39%,STK39;CIT;WNK1;PRKCD;CAMK2D;GSK3B;CDK10;HIPK1;TGFBR1;GALNT13;TGFBR2;NLK;GALNT11;MARK2;ACVR1;PRKCA;PRKDC;MAP3K10
prerank,endocrine system development (GO:0035270),0.6062542550262238,1.3961648830665274,0.10962962962962963,0.7362018258038774,1.0,6/21,7.70%,SIX1;WNT11;TGFBR1;NF1;GLI2;DKK3
prerank,negative regulation of nuclear division (GO:0051784),0.6771195933005981,1.3956414036693219,0.1104,0.7363841128934915,1.0,3/11,11.59%,BMP4;TOM1L1;FBXO5
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.6197229244574156,1.3954124939069474,0.10240963855421686,0.7352506951999918,1.0,3/18,3.23%,SLIT2;PTK2B;MTUS1
prerank,regulation of astrocyte differentiation (GO:0048710),0.6714629381413729,1.3952584069690013,0.10569105691056911,0.7337933217942962,1.0,4/12,4.73%,HES1;ID2;CLCF1;NOG
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),-0.512442402872672,-1.3943681015954539,0.0673076923076923,0.5165428694978484,1.0,3/17,3.85%,ANK3;AKAP6;KCNAB1
prerank,response to UV-A (GO:0070141),0.6585325380100221,1.3937344653705357,0.09146341463414634,0.7385818665826894,1.0,3/14,8.30%,EGFR;TIMP1;CCND1
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.6344107208169619,1.3936751837101982,0.10612855007473841,0.7366879401445227,1.0,5/16,12.29%,DPYSL3;NT5C1A;NT5E;DPYSL2;UPP2
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.5455430346276633,1.3936493066257132,0.13288590604026845,0.7346131941869819,1.0,8/33,11.50%,KLF5;FGF2;KLF4;STAT3;FOXO3;EGR1;ATOH8;TEAD1
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.5004132023902722,1.3929762261631236,0.05707762557077625,0.7354976238149706,1.0,8/74,4.48%,THBS1;BMP4;EYA2;TCF7L2;BMP5;EYA4;GSK3B;TGFBR1
prerank,cellular response to purine-containing compound (GO:0071415),-0.5807559389132745,-1.3928390851752142,0.11331444759206799,0.5177402263165841,1.0,4/10,15.71%,SLC8A1;RYR2;P2RY1;CASQ2
prerank,kidney development (GO:0001822),0.5134677412824724,1.3926487228165862,0.06155632984901278,0.7347711696634007,1.0,15/65,10.41%,SIX1;BMP4;PCSK5;PKD1;VEGFA;TGFBR1;NIPBL;NF1;ZBTB16;GLI2;PYGO2;SULF1;FOXC1;PYGO1;ARL3
prerank,peptidyl-proline modification (GO:0018208),0.590803205465737,1.392434930811138,0.09798657718120805,0.7335630601338589,1.0,6/25,17.88%,FKBP5;NKTR;FKBP10;PPIC;PIN1;PPIL6
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.5237494139249187,1.392329446660732,0.09335038363171355,0.7318074395912556,1.0,8/47,10.33%,THBS1;PID1;PRKCD;PLCG2;TGFBR2;ZC3H12A;TLR4;XDH
prerank,acylglycerol catabolic process (GO:0046464),0.5717855300954721,1.3922244671445896,0.09504685408299866,0.7301812797128959,1.0,6/30,12.97%,MGLL;LYPLA2;FABP12;PNPLA3;ABHD6;PNPLA2
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.6027292696445387,1.3914204666535974,0.10235131396957123,0.7315242023415945,1.0,9/22,17.25%,NEDD4;RNF126;RNF115;MVB12B;TOM1L1;VPS37A;VPS37B;SNF8;PTPN23
prerank,organic substance transport (GO:0071702),0.47807042437792424,1.3908667687317835,0.03938730853391685,0.7318496320093405,1.0,17/121,11.37%,SLC47A1;SLC23A1;RAMP1;ABCD3;SLCO2A1;ABCG2;DISP1;LMAN2L;RUFY1;ABCA7;ABCD1;SLC6A2;SCAMP2;MIA3;CMTM6;SLC22A18;RHCG
prerank,sodium-independent organic anion transport (GO:0043252),0.6863653928334732,1.3900105075735913,0.11345218800648298,0.7336330309293907,1.0,3/10,1.29%,SLCO3A1;SLCO2A1;SLCO4A1
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.5826461946389462,1.389525240828405,0.1094391244870041,0.733674402514615,1.0,16/25,29.52%,CDK12;CDK13;WDR43;NELFE;RNF8;RECQL5;BRD4;HEXIM1;TCERG1;LARP7;EAPP;SUPT4H1;ELL;NELFA;EAF1;RNF168
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.5855226839983128,1.388772762561271,0.09375,0.7349260912633147,1.0,12/27,15.83%,IRAK3;TLR1;TAB3;IRAK4;TLR4;MAP3K7;TAB2;MAP3K1;MYD88;TIRAP;TRAF6;TNIP1
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.5348972080414965,1.3883628707178974,0.09125,0.7346460433325913,1.0,14/44,17.51%,THBS1;NGF;VEGFA;KLF4;CAST;CD44;IGBP1;RPS6KA3;RAF1;DPEP1;CARD16;USP47;CST7;PCID2
prerank,metal ion export (GO:0070839),0.5710415982912731,1.3882992955684932,0.1051930758988016,0.7327873768381065,1.0,9/31,9.77%,SLC4A4;KCNK5;ATP1B1;ATP2B4;ATP12A;ATP1A3;ATP1A4;ATP1A1;SLC9A1
prerank,regulation of NMDA receptor activity (GO:2000310),-0.4313461242392713,-1.3880304940484351,0.06451612903225806,0.5276549732333338,1.0,15/32,15.97%,GRIA4;ACTN2;APP;GRIN2A;LRRC7;GRIN2B;SLC6A9;MEF2C;GRIA1;GRIN1;GRIA3;OPRM1;CAMK2B;CAMK2A;RELN
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.565494748713313,-1.3876688875136938,0.12105263157894737,0.5254128975010763,1.0,2/12,8.02%,IL1R1;IL18
prerank,polyamine metabolic process (GO:0006595),0.658589143670393,1.3876496748551392,0.12442396313364056,0.7335303672374794,1.0,5/13,17.08%,SRM;SMOX;ODC1;PAOX;OAZ2
prerank,positive regulation of protein export from nucleus (GO:0046827),0.6362093806420476,1.3875019780971247,0.13063763608087092,0.7320795586645149,1.0,5/15,10.49%,TCF7L2;GSK3B;EMD;BAG3;XPO4
prerank,cardiac muscle tissue development (GO:0048738),0.5228317782105034,1.3870393541975747,0.07654921020656136,0.7320086355699934,1.0,8/50,3.86%,BMP4;SGCD;CACNA1G;CSRP3;BMP5;AKAP13;BMPR1A;NOTCH2
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.582981821680532,1.3863262227592763,0.10461956521739131,0.7331452396569824,1.0,12/26,23.60%,FOXP1;PER1;CRY2;NCOR1;NCOR2;BRCA1;STRN3;PIAS2;ZBTB7A;HEYL;CNOT1;DAB2
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.6650570374361707,1.385950396536864,0.11144578313253012,0.7327679840041296,1.0,7/14,13.09%,ENTPD6;NUDT5;ENTPD2;ENTPD5;NUDT15;ENTPD7;NUDT1
prerank,positive regulation of lipid catabolic process (GO:0050996),0.6142370353004847,1.3857719005691378,0.11627906976744186,0.7315514247532486,1.0,6/19,12.97%,PRKCD;IRS1;TWIST1;ABCD1;ANGPTL3;PNPLA2
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.6688231489281523,1.3854489196955655,0.11165048543689321,0.7308842215128503,1.0,1/12,0.48%,TMEFF2
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.519442120417705,1.3842947075570597,0.08140947752126367,0.7338047671948562,1.0,15/55,16.26%,THBS1;PID1;CYP1B1;COQ7;TGFBR2;ZC3H12A;XDH;EIF6;PDK3;ARF4;BRCA1;AATF;RNF41;ALOX5;CDKN1A
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.5617978604142483,-1.3841141369730077,0.11168831168831168,0.5321861908521052,1.0,5/12,6.47%,UNC13C;RIMS1;RIMS2;SYT1;SYT7
prerank,nitrogen compound transport (GO:0071705),0.4690218224438434,1.383548499806269,0.03923647932131495,0.7350570012544876,1.0,20/141,11.52%,SLC38A2;SLC23A1;SLC38A1;SLC12A2;RAMP1;LRRC8D;ABCG2;TMEM30B;SCARB2;SLC7A9;LMAN2L;RUFY1;SLC6A2;SLC38A3;SCAMP2;MIA3;CMTM6;SLC52A3;RHCG;SLC25A45
prerank,positive regulation of embryonic development (GO:0040019),-0.4917361545117634,-1.3825758744807073,0.10101010101010101,0.5328672063504131,1.0,5/19,7.15%,PLCB1;WNT4;OSR1;CFL1;TENM4
prerank,negative regulation of complement activation (GO:0045916),0.7006613939125572,1.3820657642114598,0.125,0.7395670735105618,1.0,4/10,13.87%,CD55;SERPING1;CD46;CR1L
prerank,negative regulation of protein modification process (GO:0031400),0.4905323957537558,1.382003574226525,0.06264236902050115,0.7378146778397707,1.0,19/79,11.45%,SLIT2;LRP6;NTRK3;PID1;PLPP3;NIBAN1;KLHL31;GSK3B;SNTA1;IBTK;ATP2B4;ZC3H12A;CORO1C;P3H1;PTPA;CIB1;XDH;EPHB2;CHP1
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.6194968398938522,1.38186412014042,0.11621233859397417,0.7363808452898767,1.0,5/18,9.62%,CCN3;HDAC4;FZD7;CEACAM5;TMEM119
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.6821439558600811,1.3817253051627334,0.14263074484944532,0.7350016156186793,1.0,2/10,3.08%,PRKCE;IRS1
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.6692783933850078,1.3816691481324495,0.12682926829268293,0.733204652431025,1.0,5/12,8.34%,ESR1;STAT3;NCOR1;ZC3H12A;NCOR2
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.5192471022159237,-1.380895978591845,0.11987381703470032,0.5346100695679253,1.0,6/17,18.04%,APOE;FGF1;ABCG1;KPNB1;ABCA2;SOD1
prerank,striated muscle tissue development (GO:0014706),0.5754020507619569,1.379993266831889,0.10975609756097561,0.7383534473322475,1.0,4/29,1.82%,SIX1;SGCD;CSRP3;BMP5
prerank,polyol biosynthetic process (GO:0046173),0.6355005871424755,1.3799596470705884,0.12217194570135746,0.7364889233119242,1.0,5/16,7.90%,ACER3;FGF2;IP6K1;IP6K2;PPIP5K1
prerank,actin polymerization or depolymerization (GO:0008154),0.527256862284914,1.3798419084745943,0.07035175879396985,0.7350209026595098,1.0,9/50,7.81%,MICAL2;VILL;COBL;ABI1;GSN;PSTPIP1;DIAPH1;FLII;FAM107A
prerank,establishment of epithelial cell polarity (GO:0090162),0.6073254670841005,1.3792666618681895,0.12389380530973451,0.7354062932778048,1.0,8/19,16.49%,CYTH3;EZR;SYNE4;RHOA;PARD3;MYO9A;GOLPH3;CAMSAP3
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.5611693460516306,1.3792172643247878,0.10219922380336352,0.733651341676214,1.0,10/33,12.96%,THBS1;MEOX2;FGF2;KLF4;ATP2B4;STARD13;RHOA;MECP2;JUP;ITGB1BP1
prerank,regulation of filopodium assembly (GO:0051489),0.5422538130679686,1.3791273884122304,0.09635416666666667,0.7320704642984289,1.0,11/38,7.87%,DPYSL3;PRKCD;ARAP1;NRP1;TGFB3;PALM;BCAS3;ARHGAP44;TENM1;RHOQ;DMTN
prerank,visual perception (GO:0007601),0.48721322690015906,1.3786888496800875,0.04728132387706856,0.7320406696893104,1.0,15/84,16.03%,SLC4A10;EYA4;CACNA1F;PITPNA;COL11A1;RDH12;TULP2;CRYBB3;SFRP5;ATF6;DHRS3;EYA3;MYO9A;EFEMP1;PAX6
prerank,ceramide biosynthetic process (GO:0046513),-0.41608370075019036,-1.377718416579123,0.061611374407582936,0.5400279014798209,1.0,13/40,15.96%,ST6GALNAC3;ST8SIA4;CERS4;SGMS1;DEGS2;ST8SIA6;B4GALT6;ASAH1;CERS2;CERS1;SMPD1;SPTLC2;CLN8
prerank,regulation of DNA replication (GO:0006275),0.5164690419279839,1.3775528066288578,0.09313725490196079,0.7348920580889218,1.0,19/49,21.92%,EGFR;CCNA2;GLI2;DSCC1;STN1;ANKRD17;FBXO5;ESCO1;ORC3;BCAR3;RAD17;TSPYL2;DHX9;ATR;S100A11;WAPL;EGF;BRPF3;GTPBP4
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.5621858848696943,1.3767702528440966,0.09259259259259259,0.7363679181147508,1.0,8/34,9.61%,DOCK5;NRP1;LIMS1;ABL1;MYOC;DMTN;S100A10;CIB1
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.47560031316570367,1.3762138596926248,0.05429864253393665,0.7369626056516694,1.0,19/95,7.97%,ST3GAL4;GPC6;EXT1;DSE;GPC3;HS6ST2;UST;B3GNT2;CHST13;HEXA;HS3ST1;XYLT1;HAS1;BGN;CHST11;B4GALT1;SLC10A7;SLC35D2;CHST5
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.5197101938336217,1.3754866920724391,0.07673568818514007,0.7382653567668794,1.0,13/53,14.62%,EGFR;EYA2;PRKCD;DDX5;EYA4;SPRED2;UIMC1;NSMCE1;EYA3;BRCA1;TIGAR;RNF8;BRCC3
prerank,response to glucose (GO:0009749),0.52479140236305,1.3751597473403427,0.09057071960297766,0.7377759443228665,1.0,5/46,3.32%,THBS1;TCF7L2;UNC13B;KCNB1;SLC39A14
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.5220572108403129,1.3749931136234639,0.09791921664626684,0.7365021502128543,1.0,6/48,8.23%,SLIT3;SLIT2;IRAK3;PTPN2;PALM3;ARG1
prerank,neuron cell-cell adhesion (GO:0007158),-0.5417034586804199,-1.3748818040063946,0.13202247191011235,0.5447957170875461,1.0,6/14,10.38%,ASTN2;NRXN1;CNTN4;NRXN3;NCAM2;ASTN1
prerank,negative regulation of protein phosphorylation (GO:0001933),0.4667596857074994,1.3745252263322987,0.029692470837751856,0.7365801943223685,1.0,33/150,11.45%,SLIT2;RASSF2;LRP6;UBASH3B;NTRK3;PID1;PRKCD;SMAD6;PLPP3;NIBAN1;PMEPA1;KLHL31;NOG;TWIST1;SPRED2;NF1;IBTK;EMILIN1;NCK2;NLRP12;DMTN;CEP43;ZC3H12A;MLXIPL;CORO1C;CIB1;XDH;DUSP19;QARS1;DNAJC3;LDLRAD4;EPHB2;CHP1
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.6729974040099104,1.374468527898689,0.11912225705329153,0.7348997406136868,1.0,5/12,12.64%,CHEK2;TICRR;TOPBP1;CLSPN;RAD17
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.4527955213664694,-1.3744675429230788,0.06859205776173286,0.5428251112323116,1.0,6/26,18.36%,ATP1A2;CALM1;ADRA2A;UBQLN1;CASQ2;GNB5
prerank,potassium ion transmembrane transport (GO:0071805),0.47085523823371245,1.374135934671748,0.043897216274089934,0.7343506168876447,1.0,11/135,3.07%,SLC9A2;KCNK5;SLC12A7;KCNJ2;KCNB2;SLC12A2;SLC24A3;KCNJ15;ATP1B1;KCNB1;KCNS3
prerank,chemical synaptic transmission (GO:0007268),-0.30600352078747095,-1.3735345811132516,0.0,0.5420977227819026,1.0,54/284,7.00%,SLC1A3;UNC13C;GRM7;DTNA;NOVA1;GRID2;GRIK2;APOE;KCND2;PDE7B;CDH8;GRIA4;GRM5;GRM3;GABRG3;NRXN1;CACNA1E;DLGAP1;APBA1;HTR2C;SLC6A1;SYN2;RIMS1;GRM1;MBP;GRIN2A;KCNQ3;SLC1A1;GABRB3;RIT2;PRKAR2B;LIN7A;GABRB1;GRIN2B;CACNB4;CHRM2;SNAP25;CACNB2;GABRA2;SLC1A2;PRKAR1B;PLP1;GABRB2;SYT1;GRIA1;CACNA1B;GRIN1;APBA2;GPR176;HSPA8;PRKAR1A;SYT10;MAPK1;PTPRN2
prerank,regulation of B cell apoptotic process (GO:0002902),0.6515638179188804,1.3734613499233086,0.1419753086419753,0.7353304082221958,1.0,1/12,0.23%,FOXP1
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.4802874100912967,1.3730388437984862,0.052338530066815145,0.7350837753342299,1.0,28/95,17.26%,THBS1;HTRA3;SMAD6;SKIL;HTRA4;PMEPA1;GIPC1;CD109;TGFBR1;SPRED2;SKI;EMILIN1;TGFBR2;CREBBP;LTBP4;DKK3;IL17RD;SMAD2;TGFB1I1;LDLRAD4;CDKN1C;WFIKKN1;FAM89B;RNF111;SMAD4;PIN1;BCL9L;SMAD7
prerank,negative regulation of signaling receptor activity (GO:2000272),-0.45657233765993416,-1.3729756761440937,0.09025270758122744,0.5403984673003659,1.0,8/25,12.19%,ERRFI1;PPARA;CBLB;SNX6;SLC6A9;ZFYVE28;CNRIP1;ACE2
prerank,regulation of mitotic cell cycle (GO:0007346),0.4651027556758913,1.3724102546819357,0.03419689119170984,0.7357957404802277,1.0,54/171,19.15%,SMOC2;FZR1;PTPN3;USP2;CCDC8;TTC28;CDK10;PSMB2;GAS1;GBF1;ANAPC5;NEK7;CDK11B;PSMD11;ANAPC10;FOXC1;PSMC1;CDC16;CUL1;ANAPC11;CDC20;CDK13;CCNB1;ANGEL2;PSMC6;BTG3;MAD2L1;FBXO5;CDKN1C;ANAPC16;RPRM;CDKN1B;PRMT5;PIM2;SRA1;PRKCA;PSMD1;PSMD4;SCRIB;PIN1;SIK1;RPS6KB1;IQGAP1;RB1;RNF20;PSMA6;UBE2S;TMEM8B;PSMD14;PSMD12;TTL;TRIM35;PSMD7;BORA
prerank,regulation of RNA splicing (GO:0043484),0.5010773383122493,1.3723356029828642,0.07425149700598803,0.7341936620624903,1.0,17/69,15.38%,SLC38A2;AHNAK2;MBNL1;AHNAK;CLK2;CLK1;U2AF2;SON;RBM39;CLK4;CELF1;TIA1;FUS;HNRNPH1;RRP1B;KHDRBS1;SNRNP70
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.6421077113541572,1.372080203003007,0.140625,0.7334094992116424,1.0,4/14,11.32%,PKD1;MDFI;G3BP2;KEAP1
prerank,myotube differentiation (GO:0014902),-0.5050741007338262,-1.3719702372391878,0.11842105263157894,0.5400572633033474,1.0,5/17,7.65%,IGF1;ADGRB3;SORT1;MEF2C;JAM2
prerank,positive regulation of synaptic transmission (GO:0050806),-0.38993106587854887,-1.3718262951544393,0.03278688524590164,0.5372946640285583,1.0,22/72,12.12%,GRIK2;ADCY1;SHANK3;SLC24A2;NRXN1;APP;RIMS1;GRIN2A;RIMS2;PRKCZ;GRIN2B;SYT1;LGMN;CACNG7;CACNG4;LGI1;SHANK2;KCTD13;SLC8A3;PLK2;CACNG3;CACNG2
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),-0.36883821363342284,-1.3715851068205704,0.05970149253731343,0.5347808046103475,1.0,13/72,4.28%,FLT1;IGF1R;IGF1;PDGFD;LYN;TEK;PDGFRB;KIT;PIK3R1;DCN;KDR;INSR;ROR2
prerank,inorganic cation import across plasma membrane (GO:0098659),0.49589797267993924,1.3713673042500623,0.06050228310502283,0.7345370076240328,1.0,14/75,9.77%,SLC9A2;SLC12A7;KCNJ2;SLC12A2;KCNJ15;ATP1B1;SLC39A14;ATP2B4;TRPM4;ATP12A;ATP1A3;ATP1A4;ATP1A1;SLC9A1
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.6124818106889726,1.3712131387329007,0.11223021582733812,0.7332964346236844,1.0,7/17,13.64%,BMP4;BMPR1A;NOTCH2;NOG;GALNT11;JAG1;ACVR1
prerank,protein deubiquitination (GO:0016579),0.45216104535250745,1.3709110683806809,0.014256619144602852,0.7327961235769131,1.0,95/242,24.41%,CCNA2;USP2;USP46;OTUD1;ADRB2;ESR1;PSMB2;TGFBR1;IL33;USP24;USP15;USP25;USP13;MYSM1;BARD1;IKBKG;ADRM1;PSMD11;SMAD2;ZC3H12A;BECN1;UIMC1;PSMC1;VCP;USP1;TADA3;IFIH1;CLSPN;USP34;CDC20;DESI2;RHOA;MAP3K7;RAD23B;WDR48;PSMC6;KEAP1;TRAF2;MDM4;BRCA1;USP40;RNF123;COPS5;ZRANB1;USP4;BRCC3;PSMD1;USP28;INO80E;ABRAXAS2;TRAF6;PSMD4;TNIP1;SMAD4;FOXK1;USP47;OTUD5;HCFC1;POLB;SMAD7;PSMA6;OTUD4;TRRAP;ACTR5;OTUD3;USP49;PSMD14;PSMD12;PSMD7;VCPIP1;USP21;USP16;MBD5;USP19;USP10;USP32;FOXK2;TRAF3;YY1;PSME3;USP30;USP36;USP9X;SUDS3;TADA2B;ABRAXAS1;TP53;OGT;PSMD3;USP7;USP33;PSMB6;USP42;UBB;INO80
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),-0.467558612204936,-1.3706475591466822,0.1048951048951049,0.5343646397527027,1.0,8/24,11.65%,TEK;KDR;NDNF;GATA2;TNIP2;SEMA5A;GAS6;CDH5
prerank,Wnt signaling pathway (GO:0016055),0.48381817918500086,1.369466239458601,0.07003444316877153,0.7369166642564864,1.0,18/92,9.72%,NXN;TCF7L1;TCF7L2;WNT9A;LRP6;WNT11;PLPP3;SFRP4;GSK3B;FZD1;FZD7;PLCG2;NR4A2;STRN;CSNK1A1;SFRP5;CUL1;USP34
prerank,monocarboxylic acid transport (GO:0015718),0.5319800387609737,1.3693366914544511,0.07329192546583851,0.7355744625376281,1.0,8/51,2.90%,SLC5A6;SLCO3A1;SLC16A9;SLCO2A1;ABCG2;SLC16A1;SLC26A6;SLC10A2
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.5027429746403455,1.3692491569251526,0.09205983889528194,0.7340525198061849,1.0,15/69,13.32%,THBS1;LBP;CD2;CCL3;PLCG2;TLR1;IL33;TWIST1;STAT3;TLR4;MAVS;IFIH1;EPHB2;CLU;TIRAP
prerank,dopaminergic neuron differentiation (GO:0071542),0.6085884470981782,1.3690025403532808,0.13744740532959326,0.7331730009303141,1.0,3/19,6.71%,LRP6;VEGFA;NR4A2
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.5207259882103337,1.3679422930260134,0.09481668773704172,0.7356694521074787,1.0,20/45,22.78%,BMP4;PTPN3;GAS1;NABP1;FOXC1;ANGEL2;TOM1L1;BTG3;MAD2L1;CDKN1C;ZW10;CDKN1B;SCRIB;ZWILCH;CHFR;TRIM35;WEE1;AURKAIP1;CHEK1;PRCC
prerank,autophagy of nucleus (GO:0044804),0.6224233244041504,1.3677906121598393,0.13043478260869565,0.7344656542664644,1.0,6/16,13.98%,ULK2;WDR45B;ATG3;RB1CC1;ATG5;WIPI2
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.5600473460898492,1.3676246857649452,0.11803713527851459,0.7333286221438466,1.0,17/29,31.10%,ERCC5;MNAT1;CHD1L;PARP1;RAD23B;CDK7;GTF2H3;CETN2;UBB;UBA52;GTF2H4;RPS27A;DDB1;ERCC2;DDB2;XPA;GTF2H5
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.5045170472684132,-1.367228836720282,0.09309309309309309,0.5406813466928075,1.0,4/18,1.74%,UNC13C;GRID2;GRIK2;CDH8
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.5434860316487982,-1.3659289986632888,0.13055555555555556,0.5410430116256343,1.0,7/12,16.03%,PODXL;PROM1;PTPRO;MAGI2;BASP1;CD24;KLF15
prerank,outflow tract septum morphogenesis (GO:0003148),0.567541611930442,1.3649848399070688,0.11954992967651196,0.7424377050791964,1.0,8/24,6.60%,BMP4;ZFPM2;SMAD6;NRP1;BMPR1A;SEMA3C;PARVA;TGFBR2
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.6417989404837052,1.364273685753252,0.13574660633484162,0.7434033967153363,1.0,6/14,18.10%,CARD14;MAP3K7;TRAF2;TIRAP;TRAF6;COPS8
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.6477995609078272,1.3638508802006097,0.14427860696517414,0.7435306442120168,1.0,4/12,5.43%,DOCK5;IGFBP5;NR4A3;DOCK7
prerank,fatty acid beta-oxidation (GO:0006635),0.509941619090866,1.3637210145063094,0.09783989834815757,0.7421569548447363,1.0,20/51,23.66%,ABCD3;EHHADH;BDH2;AUH;ACOX3;ABCD1;ECHDC1;DECR1;ETFDH;ACOT8;ETFA;ACOX1;ECHDC2;ACADL;CROT;CRAT;ACADS;ACADVL;ECI1;HADHA
prerank,regulation of protein catabolic process (GO:0042176),0.4799399402894358,1.362864312504825,0.054945054945054944,0.7440455836000904,1.0,31/99,18.62%,WWP1;EGFR;NEDD4;FZR1;GPC3;WWP2;GSK3B;IRAK3;CHEK2;DACT1;BARD1;ZDHHC2;VCP;IDE;ODC1;MAD2L1;NSF;STX5;CDKN1B;MDM4;SORL1;RNF41;AZIN1;PIN1;SNF8;SNX12;OAZ2;AREL1;DTL;SMURF1;HMGCR
prerank,organophosphate ester transport (GO:0015748),0.5775184271702857,1.3627607640575417,0.12112259970457903,0.7426599741031314,1.0,4/24,3.78%,TNFAIP8L3;PITPNC1;LDLR;PITPNA
prerank,regulation of interleukin-13 production (GO:0032656),-0.5438536523213453,-1.3620426572091286,0.1235632183908046,0.548548007945457,1.0,4/13,8.02%,LEF1;PRKCZ;TNFRSF21;IL18
prerank,protein hydroxylation (GO:0018126),0.6398203718061687,1.361835717782617,0.14626865671641792,0.7448239389474897,1.0,8/15,21.65%,PLOD2;EGLN3;P3H3;P3H1;JMJD4;ASPH;HIF1AN;P3H4
prerank,cellular component disassembly (GO:0022411),0.5190668344885907,1.361138771825957,0.08935128518971848,0.7461365224665373,1.0,10/53,8.49%,TLL1;BMP1;GSN;HTRA1;CAPN2;TIMP1;CD44;TIMP2;KIF9;MMP16
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.453025735057389,-1.3602495163662862,0.07722007722007722,0.5503844789967071,1.0,10/26,10.70%,SHANK3;NRXN1;APP;RIMS1;RIMS2;PRKCZ;GRIN1;CUX2;TMEM108;SLC8A3
prerank,sulfur compound biosynthetic process (GO:0044272),0.46528186752804906,1.3596536851236176,0.0457516339869281,0.7503148663284923,1.0,16/104,7.97%,SLC26A2;ST3GAL4;DSE;GCLC;UST;B3GNT2;PAPSS2;CHST13;BGN;GSTT1;CHST11;B4GALT1;SLC10A7;GSTA2;SLC35D2;CHST5
prerank,RNA biosynthetic process (GO:0032774),0.5434223738693276,1.359526261234162,0.11096256684491979,0.7490730783368822,1.0,18/31,26.45%,HELB;PRIM1;NCOA6;PRMT5;TAF4;PRIM2;SMARCA5;TAF5;POLA2;TTF1;TBP;TAF12;TAF13;GTF2B;TAF7;RSF1;SMN1;TTF2
prerank,extracellular matrix disassembly (GO:0022617),0.5184916856145929,1.3591675971957617,0.09024390243902439,0.7487999316938223,1.0,10/53,8.49%,TLL1;BMP1;GSN;HTRA1;CAPN2;TIMP1;CD44;TIMP2;KIF9;MMP16
prerank,Rac protein signal transduction (GO:0016601),-0.49472878924165953,-1.3591242185754302,0.12162162162162163,0.5503770723728109,1.0,7/18,12.18%,EPS8;ELMO1;CDH13;HACD3;RAC1;RHOH;HACE1
prerank,regulation of osteoblast differentiation (GO:0045667),0.4844285745187571,1.3588805605431271,0.058419243986254296,0.7481253648027476,1.0,19/82,9.62%,BMP4;CRIM1;SMOC1;DDR2;TWIST2;CCN1;DDX5;SMAD6;NELL1;BMPR1A;GDF10;NOG;TWIST1;SKI;BMP6;TRPM4;RUNX2;CHRD;TMEM119
prerank,hyaluronan catabolic process (GO:0030214),0.6059742498658438,1.3586682954844784,0.125,0.7471625502578036,1.0,7/18,11.45%,FGF2;SPAM1;HEXA;LYVE1;CD44;SLC9A1;CHP1
prerank,protein localization to nucleus (GO:0034504),0.47410058282501205,1.3565643986732543,0.06277533039647577,0.7542692385334079,1.0,23/102,16.18%,SIX1;BMP4;PRICKLE1;TBRG1;STAT3;LMNA;NUP93;ABCA7;E2F3;WRN;NUP214;NUP153;TNPO2;SIX4;TNPO3;IPO7;NUP155;NUTF2;MORC3;NUP88;TOR1B;DVL1;CSE1L
prerank,atrial septum development (GO:0003283),0.6501514971929059,1.3561038938585206,0.11024844720496894,0.7544176765952981,1.0,6/13,16.72%,ANK2;NOTCH2;GATA4;ZFPM1;MDM4;NPHP3
prerank,regulation of DNA metabolic process (GO:0051052),0.5223085656243437,1.3551984429885018,0.1169811320754717,0.7564429643631237,1.0,20/44,29.04%,GRHL2;HDAC8;SMG6;TICRR;HELB;USP1;KPNA1;TOM1L1;KPNA2;WDR18;YLPM1;XRCC5;WDR70;NBN;KDM1B;MPV17;UBE2V1;PDGFA;THOC1;UBE2N
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.47305848001222667,-1.3547672237289068,0.10461538461538461,0.5601471127143707,1.0,7/20,18.62%,RPS6KA5;PRKAA2;PPARGC1A;RPS6KA4;BRD7;SOX4;GLYR1
prerank,central nervous system neuron differentiation (GO:0021953),-0.4137216832481268,-1.3546104025108276,0.07964601769911504,0.5575363160682866,1.0,12/33,10.06%,GRID2;MDGA2;SPOCK1;MAP2;TOX;RYK;OPHN1;PROX1;FAIM2;NTRK2;MAPT;ZC4H2
prerank,type I interferon signaling pathway (GO:0060337),-0.41428849229774867,-1.3540165742613437,0.05759162303664921,0.5528802561319445,1.0,22/41,21.81%,IFNAR1;IFIT2;IFIT1;SAMHD1;IFITM1;OAS2;IFITM3;IFNAR2;BST2;STAT1;RNASEL;IFITM2;IRF2;IFIT3;ADAR;PSMB8;IRF9;IRF8;STAT2;XAF1;JAK1;IRF7
prerank,cellular response to type I interferon (GO:0071357),-0.41428849229774867,-1.3540165742613437,0.05759162303664921,0.5528802561319445,1.0,22/41,21.81%,IFNAR1;IFIT2;IFIT1;SAMHD1;IFITM1;OAS2;IFITM3;IFNAR2;BST2;STAT1;RNASEL;IFITM2;IRF2;IFIT3;ADAR;PSMB8;IRF9;IRF8;STAT2;XAF1;JAK1;IRF7
prerank,purine-containing compound catabolic process (GO:0072523),0.6497937016417232,1.3533421035435678,0.15055467511885895,0.7624617562055334,1.0,5/13,11.49%,NT5C1A;NT5E;DNPH1;XDH;NUDT15
prerank,ear morphogenesis (GO:0042471),0.6067268051394387,1.3523853680423077,0.1332378223495702,0.7645523654402911,1.0,5/20,5.17%,SIX1;ZIC1;NOG;TWIST1;NIPBL
prerank,signal release from synapse (GO:0099643),-0.40205224214699087,-1.3523482563374585,0.07476635514018691,0.55450425462157,1.0,9/43,7.00%,NRXN1;SYN2;RIMS1;LIN7A;SNAP25;SYT1;HSPA8;SYT10;PTPRN2
prerank,positive regulation of cytokinesis (GO:0032467),0.5445184899074327,1.3519058370098005,0.13132694938440492,0.7648147657518021,1.0,7/32,12.01%,CIT;PRKCE;GIPC1;CDC14A;CUL3;RHOA;DRD3
prerank,neuron projection development (GO:0031175),-0.3234935678888782,-1.351674595913181,0.0,0.5536114549824912,1.0,50/168,12.53%,DOCK10;PTPRM;GRM7;LYN;APOE;TNIK;CNTNAP2;SHANK3;FRYL;PAK1;EPHB1;MAP2;APP;CNTN4;RASGRF1;ADGRV1;RAPGEF2;MYO16;PAK3;GPM6A;RYK;EPB41L3;SH3GL2;PLP1;EPHA8;MAP4K4;EPHA4;BMP7;LAMB1;OPHN1;SGK1;DAB2IP;STMN1;NRK;BICDL1;LGI1;TMEM108;STMN4;MAPT;GPM6B;CAMSAP2;ATCAY;STMN3;MICALL1;VAPA;BTG2;UHMK1;FRY;WHRN;HMGB1
prerank,regulation of collagen biosynthetic process (GO:0032965),0.5983181968860719,1.3514519474876105,0.13865546218487396,0.76503255201833,1.0,4/19,10.84%,BMP4;TGFB3;EMILIN1;CREB3L1
prerank,L-serine metabolic process (GO:0006563),-0.5502229869368679,-1.3506434988814389,0.13333333333333333,0.5536239845565991,1.0,2/10,4.54%,SERINC3;SERINC5
prerank,regulation of amyloid-beta formation (GO:1902003),-0.4289350079332312,-1.3498339844815581,0.08085106382978724,0.5527876885238152,1.0,11/34,9.74%,IGF1;APOE;RTN1;PICALM;ROCK2;ABCG1;EPHA4;RTN4;LRRTM3;NTRK2;BIN1
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.5347811565270855,-1.3488140860994204,0.1309192200557103,0.5525266005730651,1.0,4/12,7.11%,SEMA6A;DCN;CADM4;DAB2IP
prerank,negative regulation of phagocytosis (GO:0050765),-0.5042945097187107,-1.3486488061205253,0.1301775147928994,0.5500570057086461,1.0,10/17,23.64%,DYSF;SIRPA;SYT11;CD300A;RACK1;HMGB1;SNX3;CD47;CD300LF;PRTN3
prerank,acidic amino acid transport (GO:0015800),-0.4952453739553255,-1.3484710521485006,0.09411764705882353,0.5475979810251448,1.0,7/17,5.34%,SLC1A3;SLC6A13;SLC6A1;SLC1A1;GJA1;SLC1A2;SLC25A13
prerank,pulmonary valve development (GO:0003177),0.6036392110099161,1.3478390361603598,0.142433234421365,0.7785934847716275,1.0,4/18,3.86%,SLIT2;BMP4;SMAD6;NOTCH2
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.5672696386877171,1.347830176406267,0.12696148359486448,0.7767900348440994,1.0,6/23,6.07%,UBASH3B;CAMK2D;ANK2;PTK2B;CACNG6;DIAPH1
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.5096010626575183,1.347826398811822,0.09737827715355805,0.7749640610164726,1.0,6/51,4.33%,THBS1;PGF;CMKLR1;VEGFA;ANO6;CCL1
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.5820944221008972,-1.3477985390639264,0.14049586776859505,0.54647558131374,1.0,2/10,3.85%,ANK3;KCNAB1
prerank,potassium ion export across plasma membrane (GO:0097623),0.6386713451368938,1.3477544111854474,0.1326219512195122,0.7734235142555469,1.0,1/13,0.18%,KCNK5
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.49312391706173975,1.3473179148297698,0.1044776119402985,0.7734803151389006,1.0,15/73,13.32%,THBS1;LBP;CD2;CCL3;PLCG2;TLR1;IL33;TWIST1;STAT3;TLR4;MAVS;IFIH1;EPHB2;CLU;TIRAP
prerank,activin receptor signaling pathway (GO:0032924),0.6320842530902135,1.347063677760874,0.1627565982404692,0.7727056957661282,1.0,5/15,15.32%,TGFBR1;INHBA;SMAD2;ACVR1;INHBB
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.5932322771674002,1.346980333038857,0.14032697547683923,0.7712192433872254,1.0,5/20,17.88%,FKBP5;NKTR;PPIC;PIN1;PPIL6
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.6323951015315391,1.3463114927949071,0.16118935837245696,0.7721411588211009,1.0,3/14,4.56%,WNT9A;TGFBR1;PTHLH
prerank,detection of calcium ion (GO:0005513),0.637067807430828,1.3457078688170305,0.136431784107946,0.7728111622949835,1.0,3/13,2.38%,KCNMB3;KCNMB2;CASR
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.658827105512565,1.3449462719040821,0.13819875776397517,0.7743390598966922,1.0,2/11,1.98%,KCNJ2;ATP1B1
prerank,myoblast differentiation (GO:0045445),0.6421076071659203,1.342974696026054,0.15328467153284672,0.7810045538621164,1.0,5/14,6.53%,TCF7L2;MBNL1;DDX5;DDX17;MAPK12
prerank,regulation of lipase activity (GO:0060191),0.6300826461541114,1.3429250747877937,0.15109034267912771,0.7793966652931874,1.0,3/13,11.46%,PCSK5;RHOA;ANGPTL3
prerank,positive regulation of catabolic process (GO:0009896),0.4963505485021942,1.3425036815470368,0.10368663594470046,0.7793544515629353,1.0,21/65,18.27%,WWP1;NEDD4;FZR1;GPC3;WWP2;GSK3B;DACT1;BARD1;VCP;IDE;ANGPTL3;NSF;STX5;CDKN1B;SORL1;RNF41;SNF8;OAZ2;AREL1;DTL;SMURF1
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.627034793985231,1.3424638076556108,0.16936671575846834,0.7776995579882671,1.0,5/15,6.58%,RSPO3;GPC3;SFRP4;DACT1;TIAM1
prerank,positive regulation of telomere maintenance (GO:0032206),0.5368039739952848,1.34217137670772,0.11155913978494623,0.7771289507956832,1.0,15/31,24.90%,NEK7;SLX4;SIRT6;DHX36;RAD50;ATRX;NAF1;MAP3K4;HNRNPA2B1;PML;NBN;TNKS2;ATM;MAPKAPK5;GNL3
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.5087106553449514,-1.3417509831548764,0.1339031339031339,0.5602465970044673,1.0,5/16,10.38%,AUTS2;ARHGAP24;RASGRF1;CADM4;STMN3
prerank,regulation of cell morphogenesis (GO:0022604),0.5464387451454827,1.3416199096253725,0.11973684210526316,0.7775701748098551,1.0,13/30,19.57%,FMNL2;EFNA5;CD44;ZMYM4;PDZD8;ZRANB1;MYO9A;MOV10;BCL9L;LARP4;SH3D19;FITM2;FERMT2
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.41274255692623657,-1.3413108375227807,0.0735930735930736,0.558421467271072,1.0,13/39,10.12%,ROBO1;ROBO2;MAML3;MAML2;TSPAN5;NOS3;EPN2;RBPJ;NOTCH1;NOTCH4;TSPAN14;JAG2;TM2D3
prerank,neuron projection regeneration (GO:0031102),-0.5706950068189867,-1.3410385250523753,0.15405405405405406,0.5563206002273944,1.0,2/10,7.28%,NREP;RTN4RL1
prerank,negative regulation of ATP metabolic process (GO:1903579),0.6127015908912722,1.3402581830584313,0.14222222222222222,0.7815137813767488,1.0,7/17,14.05%,HDAC4;PID1;PFKFB1;NCOR1;MLXIPL;PARP1;TIGAR
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.6125157891897343,1.339938613757434,0.16666666666666666,0.7810630576904238,1.0,13/16,31.68%,CELF3;DAZAP1;THRAP3;RBM3;CELF4;RBMX;CIRBP;NUP98;RBMXL1;TRA2A;TRA2B;PRDX6;SNW1
prerank,monoacylglycerol metabolic process (GO:0046462),0.6258217643261326,1.3396819587082833,0.167420814479638,0.7804093339540987,1.0,2/13,9.43%,MGLL;ABHD6
prerank,DNA replication (GO:0006260),0.4676980825604753,1.3389426004168499,0.08324084350721421,0.7817953467771184,1.0,44/105,25.29%,REV3L;EXO1;TBRG1;CDC45;MCM2;TICRR;BARD1;WRN;TOPBP1;HELB;TOP1;CLSPN;POLE2;KIN;RAD50;ORC3;RAD17;BRCA1;RNASEH2A;BRIP1;MCM7;PCLAF;FAM111A;CDK2;CDC7;POLG2;POLB;RECQL5;DONSON;MCM9;RMI2;POLA2;RFC1;ATR;BAZ1A;NAP1L1;NBN;CHEK1;ATM;CDK2AP1;RBBP8;RAD9A;CDC6;RAD9B
prerank,muscle tissue development (GO:0060537),0.6202077515270226,1.3387261886276198,0.15725190839694655,0.7808424741996626,1.0,4/13,5.44%,BMP4;CSRP3;SMO;NF1
prerank,tyrosine metabolic process (GO:0006570),0.6488779330311021,1.3385844148647368,0.16903633491311215,0.7797085750979921,1.0,1/11,1.78%,IYD
prerank,negative regulation of wound healing (GO:0061045),0.5464656621560565,1.337752237899926,0.15155615696887687,0.7814497736511155,1.0,5/28,4.29%,SLC12A2;FGF2;THBD;CD109;PHLDB2
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.4809787320522324,1.3374455919184376,0.07921928817451206,0.7809028026217903,1.0,14/77,12.19%,THBS1;BMP4;TCF7L2;TGFBR1;NDUFS3;NR4A2;MPV17L;GATA4;ITGAV;QARS1;MCL1;FXN;HERPUD1;CLU
prerank,protein localization to cell surface (GO:0034394),0.5618523658643075,1.3370248764678778,0.11605937921727395,0.7809469744735339,1.0,9/26,18.27%,PTPRU;ANK2;WNT11;RIC3;VCL;PIGU;USP4;PIGK;SMURF1
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.551416562161075,1.3365208374401856,0.11649214659685864,0.7813696618574817,1.0,17/29,23.98%,RAB6A;COG5;TRAPPC3L;COPG1;COPA;NSF;COG8;TRAPPC3;TRAPPC10;COPB2;GOSR2;COG3;VTI1A;RAB33B;VTI1B;COG2;COPZ1
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.4667461890003858,1.3365130291361573,0.07995618838992333,0.7796590280859664,1.0,17/113,7.31%,F3;BMP4;EGFR;TCF7L2;PGF;BMP5;FGF2;NRAS;NRP1;VEGFA;FZD7;NOTCH2;TGFBR1;NR4A3;BMP6;ERBB2;SRSF6
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.537344172930655,1.3364187278805424,0.12692307692307692,0.7783421118800381,1.0,8/33,13.24%,PKD1;TCIM;ID2;PLCG2;ATP2B4;TRIM39;CDKN1B;E2F1
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.49732297370232575,-1.3347515390103801,0.11824324324324324,0.5711672234248675,1.0,6/17,9.74%,IGF1;APOE;RTN1;RTN4;NTRK2;BIN1
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),-0.4716163866694343,-1.3346082098751197,0.11379310344827587,0.5685800700336424,1.0,4/21,5.77%,OSBPL8;PLA1A;OSBPL10;PLAAT3
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.636853362060112,1.3343901608175475,0.1437037037037037,0.7853699603260222,1.0,2/12,2.11%,GCLC;BDH2
prerank,negative regulation of transmembrane transport (GO:0034763),0.675194980389011,1.3343252964582437,0.1594896331738437,0.7839045828579114,1.0,1/10,0.19%,THBS1
prerank,DNA duplex unwinding (GO:0032508),0.5085953843608559,1.3336031228811105,0.10744810744810745,0.7853049178456512,1.0,27/50,31.10%,ANXA1;MCM2;RAD51;WRN;CHD1L;PARP1;RAD23B;RAD50;DDX11;MCM7;GTF2H3;RECQL5;MCM9;DHX9;CETN2;NBN;HMGA1;UBB;RECQL;UBA52;GTF2H4;RPS27A;DDB1;ERCC2;DDB2;XPA;GTF2H5
prerank,cellular response to sterol (GO:0036315),0.6294413700808719,1.333019337392182,0.14961832061068703,0.7859897369189988,1.0,5/13,9.97%,LRP6;SMO;RORA;GRAMD1A;GRAMD1C
prerank,cell-cell junction maintenance (GO:0045217),-0.5687759566897062,-1.3327531912084245,0.1235632183908046,0.57064155629389,1.0,1/11,0.05%,TJP1
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.4846280321584827,-1.3322051885970545,0.1232876712328767,0.5691832607115749,1.0,7/18,7.10%,SHANK3;NRXN1;RIMS1;RIMS2;PRKCZ;GRIN1;CUX2
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.6386099452077806,1.331426624327843,0.15846153846153846,0.7909647196865134,1.0,4/12,8.34%,ESR1;NCOR1;ZC3H12A;NCOR2
prerank,regulation of cholesterol efflux (GO:0010874),-0.41786392270956524,-1.3309779340608658,0.08949416342412451,0.5697650203775368,1.0,6/30,6.89%,PLTP;APOE;ABCA5;PTCH1;NR1H3;EEPD1
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.4954976611308911,1.330420330554012,0.10807600950118765,0.7936165636541956,1.0,22/63,17.54%,PLAGL1;CRADD;CNOT8;CHEK2;AURKA;WAC;CASP2;CCND1;CCNB1;FBXO31;TFDP1;CDKN1B;MDM4;E2F1;TNKS1BP1;PIDD1;PRKDC;CDK2;CDKN1A;CNOT4;PLK3;PCBP4
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.4746221525989075,1.3303708280357782,0.08256880733944955,0.7920669161242216,1.0,24/87,19.03%,FBXL7;FHL1;PSMB2;KLF4;DACT1;AURKA;FAM107A;PSMD11;CDKN2C;PSMC1;CUL1;PSMC6;FBXO5;DLG1;PSMD1;PSMD4;CDKN1A;USP47;RB1;PSMA6;PSMD14;PSMD12;PSMD7;WEE1
prerank,regulation of bone mineralization (GO:0030500),0.49191975342335775,1.3300064680439783,0.11003627569528417,0.7918924784831436,1.0,16/55,10.56%,BMP4;DDR2;CCN1;PTK2B;NELL1;TGFB3;BMPR1A;SGMS2;ANO6;TXLNG;CCL3;TWIST1;BMP6;TRPM4;TMEM119;BCOR
prerank,positive regulation of intracellular protein transport (GO:0090316),0.44867443288201087,1.3297403654233508,0.05863539445628998,0.7912806481020737,1.0,44/144,17.08%,TCF7L2;CDH1;ABLIM3;PRKCD;KCNB1;GSK3B;ZIC1;TMEM30B;BCAS3;HPS4;SEC16A;EMD;UBR5;ERBB2;BAG3;PCM1;NPEPPS;SAE1;TENM1;ZDHHC2;ZC3H12A;HSPA1L;MAVS;CIB1;MIEF1;C2CD5;XPO4;TM9SF4;PCNT;CHP1;TFDP1;JUP;SH3GLB1;ITGB1BP1;E2F1;SORL1;DMAP1;UBE2D3;PPP3CC;MIEF2;UBL5;VAMP2;PLK3;OAZ2
prerank,glucose import (GO:0046323),-0.5302027077375427,-1.329495838063816,0.16056338028169015,0.571326335402102,1.0,2/13,2.40%,SLC2A1;SORT1
prerank,regulation of lamellipodium assembly (GO:0010591),0.5228117562014105,1.3293566715903744,0.11957950065703023,0.791148445139689,1.0,2/34,0.50%,SLIT2;PLCE1
prerank,regulation of trophoblast cell migration (GO:1901163),0.6209658106332797,1.3287330761840588,0.1750380517503805,0.791970824610386,1.0,4/14,6.48%,ARHGDIB;VEGFA;TIMP1;AGO2
prerank,regulation of tumor necrosis factor production (GO:0032680),0.45989044809108487,1.3282057465579449,0.07019438444924406,0.792510412090085,1.0,17/112,9.54%,THBS1;FOXP1;LBP;CD2;RARA;CCL3;PLCG2;IRAK3;TLR1;IL33;TWIST1;STAT3;C5AR2;ZC3H12A;TLR4;MAVS;IFIH1
prerank,regulation of microtubule-based process (GO:0032886),0.5214537251575184,1.3279998563366313,0.12754409769335143,0.7916875903878923,1.0,14/36,17.52%,EFNA5;GSK3B;PHLDB2;DIAPH1;ERBB2;AURKA;FAM107A;PHLDB1;IGBP1;MARK2;MAP6;BICD1;CAMSAP3;MEMO1
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.6676312641134028,1.3279193360254362,0.1642512077294686,0.788643895462396,1.0,2/10,4.12%,WNK1;KLF4
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.6676312641134028,1.3279193360254362,0.1642512077294686,0.788643895462396,1.0,2/10,4.12%,WNK1;KLF4
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.6250553096478499,1.3278995435631564,0.15161290322580645,0.7870589203074838,1.0,7/14,18.57%,EHHADH;ACOX3;ABCD1;ACOT8;ACOX1;CROT;CRAT
prerank,negative regulation of chemotaxis (GO:0050922),0.5434026182460822,1.3272439027689074,0.1342281879194631,0.7881861066127747,1.0,6/31,5.77%,SLIT2;THBS1;SEMA3E;SEMA3C;PTPN2;SEMA3D
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.5709482588207666,1.3272335049712436,0.17158931082981715,0.7865742298034075,1.0,15/22,33.01%,CHD1L;PARP1;RAD23B;GTF2H3;CETN2;UBB;UBA52;GTF2H4;RPS27A;DDB1;ERCC2;DDB2;XPA;GTF2H5;GTF2H1
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.42886732415675793,1.3272314374149652,0.004004004004004004,0.7848870029938374,1.0,139/572,17.61%,FOXP2;FOXP1;KLF12;BMP4;ZFHX3;ZFPM2;TCF7L2;NFIB;HES1;HDAC4;FOXP4;NEDD4;CUX1;RARB;DDX5;USP2;PRDM6;EZR;HDAC9;SKIL;MDFI;SOX14;JDP2;VEGFA;ESR1;ID2;ID1;WWP2;ZNF148;FOXC2;GLIS1;RARA;KLF4;GLI3;HDAC8;KLF7;NOG;IL33;NR4A3;TWIST1;NIPBL;STAT3;FOXO3;KLF10;SKI;NFIX;FRK;ZBTB16;PER1;MEF2A;DACT1;NFIL3;NFATC4;BMP6;LCOR;BHLHE40;GLI2;TCF25;GLIS2;SIRT6;BAG3;NR4A2;MIER1;CREBBP;CRY2;NCOR1;PHF21A;NFATC3;SMAD2;CHD3;EED;MLX;CBX5;CCND1;NCOR2;NFIC;PER3;KDM1A;DNMT3A;RXRA;MXD4;FOXC1;MTA1;BRMS1L;BRMS1;NSD1;TBL1X;POU4F1;PARP1;BCOR;ERF;ZNF25;MECP2;IGBP1;ZFPM1;ZBTB1;PHF12;ZBTB32;NR2F1;MDM4;NR1D1;BATF3;GTF2IRD1;EZH1;DLG1;E2F1;HOXA7;MTDH;DMAP1;PRDM2;ATRX;SOX9;NR3C1;NKAP;THAP7;URI1;FOSB;UBE2D3;ZNF219;TRAF6;KMT5A;PAX6;MZF1;PRDM5;SMAD4;NCOA5;ZMYM5;PLK3;YAP1;E4F1;CHD8;ESR2;VPS72;HCFC1;RB1;SMAD7;ZBTB7B;TLE6;POU6F1
prerank,amino acid transport (GO:0006865),0.5018822030427451,1.3264906783582444,0.1161928306551298,0.7863140901427552,1.0,4/49,4.99%,SLC38A2;SLC38A1;SLC38A6;SLC7A9
prerank,dendrite self-avoidance (GO:0070593),-0.5109212621019817,-1.3259138184044803,0.14381270903010032,0.5783087721410375,1.0,6/16,13.46%,BSG;CNTN4;DSCAML1;ROBO4;NEXN;PALLD
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.5473691982897794,-1.3244489062488933,0.15649867374005305,0.5798413133808175,1.0,3/11,9.00%,NOS3;CALM1;GCH1
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.6081895002964931,1.324043517233961,0.17397881996974282,0.7946344689212491,1.0,2/14,2.28%,THBS1;CMKLR1
prerank,positive regulation of protein catabolic process (GO:0045732),0.4742386331631055,1.323358365792154,0.08651685393258426,0.7959206022900638,1.0,25/84,18.27%,WWP1;NEDD4;FZR1;ADAM9;EZR;GPC3;WWP2;GSK3B;DACT1;BARD1;RDX;VCP;IDE;NSF;STX5;CDKN1B;SORL1;RNF41;SNF8;PLK3;OAZ2;AREL1;DTL;SH3D19;SMURF1
prerank,pyroptosis (GO:0070269),-0.5032500387605885,-1.3225239814062884,0.1377245508982036,0.5826061171868709,1.0,8/15,25.39%,CASP4;GSDMD;AIM2;ZBP1;CASP1;APIP;TREM2;NLRC4
prerank,gonad development (GO:0008406),-0.39636644327654197,-1.322459006336306,0.08597285067873303,0.5798810341236553,1.0,8/41,10.09%,NR2F2;WNT4;KIT;WNT5A;MAMLD1;SALL1;GATA6;BASP1
prerank,cellular response to hormone stimulus (GO:0032870),0.4806405474514077,1.3224134293733207,0.09699769053117784,0.798203839019779,1.0,12/69,9.70%,SLIT3;SLIT2;RAMP1;RARA;BCAS3;NR4A3;SERPINB9;STAT3;KLF9;RDX;ATP1A3;ATP1A1
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.46534165620138535,1.3218541209952592,0.08826945412311266,0.7988963413860176,1.0,23/87,13.79%,ADAM9;SMAD6;COL3A1;SMAD9;TGFB3;ITGB5;BMPR1A;ID1;GDF10;TGFBR1;USP15;LTBP2;SKI;TGFBR2;ITGB1;SMAD2;NLK;RHOA;MAP3K7;COL1A2;PARD3;ACVR1;PARD6A
prerank,fatty acid oxidation (GO:0019395),0.48290206605673286,1.321712139815712,0.1116564417177914,0.7977944661518885,1.0,15/57,17.71%,ABCD3;EHHADH;ADH7;BDH2;AUH;ABCD1;ECHDC1;DECR1;PEX13;ADH5;ACOX1;ECHDC2;ACADL;PECR;CROT
prerank,early endosome to late endosome transport (GO:0045022),0.5801932085698088,1.3213336253765935,0.17221418234442837,0.7976572106316686,1.0,8/20,17.25%,KIF16B;EEA1;BECN1;WDR81;HOOK3;ANKRD27;SNF8;PTPN23
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.5939038653046972,1.321232904358711,0.16095380029806258,0.7963752873926275,1.0,5/17,12.02%,CD55;STAT3;TLR4;CD46;JAG1
prerank,thyroid hormone generation (GO:0006590),0.6587976793113737,1.3211397879905824,0.17973856209150327,0.7950754066599891,1.0,2/10,2.54%,IYD;CPQ
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),-0.5842860336551449,-1.3209697272267507,0.1510989010989011,0.5812920120590584,1.0,6/10,19.34%,PDE4D;MGRN1;PDE2A;RNF157;APLNR;CDC34
prerank,potassium ion transport (GO:0006813),0.45434939167458355,1.3209583386506174,0.06840390879478828,0.7941095604986085,1.0,10/120,3.07%,SLC9A2;KCNK5;KCNJ2;KCNB2;SLC24A3;KCNJ15;KCNMB3;KCNMB2;KCNB1;KCNS3
prerank,pulmonary valve morphogenesis (GO:0003184),0.6053384739435507,1.320773139950478,0.14499252615844543,0.7932852668609793,1.0,4/17,3.86%,SLIT2;BMP4;SMAD6;NOTCH2
prerank,cytosolic transport (GO:0016482),0.4556229910621841,1.3202799606987354,0.084070796460177,0.7936612887326607,1.0,46/108,27.06%,VPS13A;VPS13C;SNX2;ERC1;RNF126;GBF1;KIF16B;EEA1;RAB6A;PHETA2;BECN1;WDR81;RGP1;SNX32;HOOK3;GAK;DOP1B;STX5;ANKRD27;EVI5;GOSR2;UBE2O;SNF8;PTPN23;ANKFY1;MON2;TBC1D5;TBC1D17;AP2A1;VPS52;VTI1A;BET1L;VTI1B;STX8;TBC1D23;GCC2;TMEM87A;VPS54;RIC1;GGA1;RAB14;CCDC91;VPS26B;TBC1D10A;AP4M1;CLN3
prerank,global genome nucleotide-excision repair (GO:0070911),0.5537810655239018,1.3200034496472943,0.16066481994459833,0.7932057971642851,1.0,17/26,33.01%,CHD1L;PARP1;RAD23B;RNF111;GTF2H3;CETN2;ERCC4;UBB;UBA52;GTF2H4;RPS27A;DDB1;ERCC2;DDB2;XPA;GTF2H5;GTF2H1
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.6038503692886596,1.319948493541971,0.16593245227606462,0.7918062851964106,1.0,3/15,9.03%,BMP4;SFRP4;FOXC1
prerank,DNA repair (GO:0006281),0.42951571745878075,1.3183875427916696,0.02127659574468085,0.7966741499551279,1.0,115/284,26.95%,EXO1;MPG;ABL1;ERCC5;NABP1;HERC2;RAD51;CHEK2;FANCL;SMUG1;TICRR;SLX4;SETD2;MNAT1;APEX2;UBE2A;BARD1;APEX1;WRN;TOPBP1;CHD1L;SMARCAL1;UIMC1;VCP;TEX264;MTA1;MLH3;USP1;PARP3;NEIL3;CIB1;POLE2;PARP1;RAD23B;NSMCE1;WDR48;ZBTB1;RAD50;POLI;EYA3;KPNA2;RAD17;BRCA1;KMT5B;NUDT1;RNASEH2A;TNKS1BP1;HINFP;RNF8;COMMD1;PRIMPOL;BRIP1;BRCC3;UBE2B;SLC30A9;PRKDC;SMC1A;FAM111A;SMARCA5;PPP5C;USP47;FTO;GTF2H3;POLB;ASCC2;RECQL5;MDC1;TRRAP;ACTR5;BRCA2;APLF;PARP2;RMI2;CETN2;PRMT6;VCPIP1;ATR;PARP4;XRCC5;ERCC4;NBN;TDP2;CHEK1;DCLRE1A;KMT5C;SPRTN;RAD52;ALKBH1;ABRAXAS1;RAD51D;ATM;TP53;RBBP8;XRCC4;ASF1A;UBB;INO80;RECQL;RAD21;RAD9A;TDG;CSNK1E;RAD9B;ERCC8;RAD54L;UBE2V1;UBA52;POLK;POLQ;GTF2H4;MGME1;RPS27A;NEIL1;SUMO1;PARP9
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.5630415537255523,-1.318355454113572,0.14016172506738545,0.5856641295317178,1.0,7/11,26.07%,UQCRH;UQCR10;UQCRC1;CYCS;CYC1;UQCC3;UQCRQ
prerank,plasma membrane bounded cell projection organization (GO:0120036),-0.3179754177672189,-1.317547973357245,0.03896103896103896,0.5851199808990444,1.0,35/124,12.53%,PTPRM;LYN;APOE;CNTNAP2;FRYL;MAP2;APP;CNTN4;RASGRF1;RAPGEF2;GPM6A;RYK;SH3GL2;PLP1;EPHA8;LAMB1;OPHN1;STMN1;BICDL1;WDPCP;LGI1;ATP1B2;TMEM108;STMN4;RAC1;MAPT;GPM6B;ATCAY;STMN3;MICALL1;VAPA;BTG2;UHMK1;FRY;HMGB1
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.6401759024998919,1.3174534326220548,0.1704718417047184,0.7989574704655598,1.0,4/12,13.32%,FOXP1;KLF4;TLR4;TIRAP
prerank,adrenergic receptor signaling pathway (GO:0071875),0.5754187480476468,1.3173604685015345,0.16091954022988506,0.7977072307487195,1.0,4/20,5.20%,ADRA1B;ADRB2;AKAP13;ADCY9
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.6350663128939086,1.3172881364801867,0.16329704510108864,0.7947084076459611,1.0,5/12,13.71%,GSK3B;ATP2B4;RCAN1;CHP1;HOMER2
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.6350663128939086,1.3172881364801867,0.16329704510108864,0.7947084076459611,1.0,5/12,13.71%,GSK3B;ATP2B4;RCAN1;CHP1;HOMER2
prerank,supramolecular fiber organization (GO:0097435),0.43089223552633465,1.316999874463465,0.018145161290322582,0.7942511030405451,1.0,41/334,7.23%,COL25A1;COL8A1;COL12A1;COL6A2;COL8A2;TLL1;PLOD2;ADAMTS2;COL6A1;BMP1;DDR2;SNCAIP;COL5A2;CYP1B1;RHOBTB1;GSN;FGF13;NLRP5;LOXL1;MAP7D3;COL3A1;OPTC;DSP;COL6A3;CLIP4;COL11A1;ADAMTS3;TGFBR1;SHROOM4;KATNB1;SHROOM3;CLIP1;NF1;LTBP2;LTBP3;FAT1;EMILIN1;ARHGAP17;PCM1;FLII;KATNAL2
prerank,regulation of cellular biosynthetic process (GO:0031326),-0.42946892566674466,-1.3166981571350855,0.08833922261484099,0.584671085047319,1.0,15/28,26.03%,MITF;PRKAA2;SIRPA;FGFR4;RAC1;MED1;AVIL;PRKAG2;NOS1AP;CD47;PDK4;C3;NR1H4;MFSD12;SIRT5
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.4843743635884901,1.316479293759258,0.10772833723653395,0.794856428121673,1.0,8/63,9.87%,THBS1;BMP4;TCF7L2;TGFBR1;FGFR1;FEM1B;TMC8;ITGAV
prerank,respiratory tube development (GO:0030323),0.5519209137573988,1.3160840414324293,0.150066401062417,0.7948431466528899,1.0,5/28,6.46%,BMP4;PCSK5;FGF2;VEGFA;GLI2
prerank,response to estrogen (GO:0043627),0.5355034420588249,1.3158598455059427,0.15155440414507773,0.7941696693365792,1.0,8/31,17.23%,SLC34A2;ESR1;RARA;BCAS3;SERPINB9;BRCA1;SRA1;KMT2D
prerank,positive regulation of macrophage migration (GO:1905523),0.5678413540903019,1.315760920230964,0.16666666666666666,0.7929738855316887,1.0,3/19,4.13%,THBS1;CMKLR1;CCL3
prerank,sensory perception of light stimulus (GO:0050953),0.46230573087858184,1.3151511076185278,0.08294930875576037,0.7939631895360747,1.0,12/87,12.25%,SLC4A10;EYA4;CACNA1F;PITPNA;COL11A1;RDH12;TULP2;CRYBB3;SFRP5;ATF6;DHRS3;EYA3
prerank,positive regulation of vasculature development (GO:1904018),0.4599948998642762,1.3146145969130318,0.09232480533926585,0.7946080516538327,1.0,16/94,8.52%,SMOC2;F3;THBS1;PGF;CYP1B1;FGF2;PTGIS;ITGB8;VEGFA;HIPK1;TWIST1;AGO2;ITGB1;ZC3H12A;GATA4;ANXA3
prerank,positive regulation of cholesterol transport (GO:0032376),-0.43411149570967295,-1.3137203652355691,0.10996563573883161,0.5903591891902709,1.0,6/27,6.89%,PLTP;APOE;ABCA5;PTCH1;NR1H3;EEPD1
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.5759530986909424,1.3126289999491292,0.14502762430939226,0.8014450705012908,1.0,13/20,28.96%,PAICS;AMPD3;GMPR2;AK4;AK3;AMPD2;LHPP;ADSS2;GMPS;ADSL;PFAS;ATIC;NT5C2
prerank,negative regulation of cell death (GO:0060548),0.46714781546255896,1.311938133624116,0.10454545454545454,0.8027869650361483,1.0,19/88,14.05%,BMP4;CCN3;CCN5;CCN1;WNT11;FGF2;SRGAP2;GSK3B;SRSF6;IKBKG;AGR2;GATA4;BECN1;POU4F1;ATG5;CLU;TRAF2;SORL1;TIGAR
prerank,muscle organ development (GO:0007517),0.4940465612450503,1.3118606356095424,0.13186813186813187,0.8015022732850672,1.0,12/54,7.89%,FHL1;MKX;SGCD;COL6A3;MRAS;EMD;LARGE1;MEF2A;CTF1;MAPK12;EVC;COPRS
prerank,regulation of cell cycle (GO:0051726),0.43183743672126695,1.3117988735780373,0.03048780487804878,0.8001312375098497,1.0,78/271,22.80%,THBS1;BMP4;PLAGL1;TCF7L2;LRP6;PKD1;GRK5;TTC28;ID2;GADD45G;CDK10;NOTCH2;TXLNG;RARA;SON;TGFBR1;ABL1;TBRG1;GBF1;STAT3;NEK7;MAPK12;CDC14A;INHBA;BARD1;CDK11B;SMIM22;IRF1;MLXIPL;CCND1;EIF4G2;CDKN2C;PDCD4;CDC123;CCNB1;POU4F1;ANKRD17;GAS2L1;FBXO5;RPRM;CDKN1B;BRCA1;CDKN3;NR4A1;RRP8;PIM2;SOX9;SRA1;CDK7;PCLAF;CDKN1A;SIK1;E4F1;FAP;HCFC1;IQGAP1;RB1;RNF20;TSPYL2;DTL;TMEM8B;PRDM11;MED25;FBXL6;WDR12;LIN9;NEK6;GADD45GIP1;PML;PUM1;PES1;NBN;TARDBP;ZBTB17;CHEK1;RPS6KA2;PRCC;SRPK2
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.4795349072500491,-1.311058153032015,0.15064102564102563,0.5950452254177356,1.0,6/17,16.25%,CAMK1D;RIPOR2;DAPK2;RAC1;CD74;CCL19
prerank,protein K63-linked deubiquitination (GO:0070536),0.529963456153082,1.3109803581049029,0.1503957783641161,0.8018168251853774,1.0,14/31,23.91%,OTUD1;USP25;USP13;UIMC1;ZRANB1;BRCC3;ABRAXAS2;OTUD5;OTUD4;PSMD14;USP16;ABRAXAS1;USP7;USP33
prerank,positive regulation of mRNA processing (GO:0050685),0.5774526790848592,1.3105254596456526,0.17327459618208516,0.80216257519774,1.0,8/21,15.49%,CELF3;DAZAP1;THRAP3;DHX36;RBM3;CELF4;RBMX;CIRBP
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.5282976902622396,1.3104573506135193,0.15691489361702127,0.7991936662080745,1.0,10/29,20.97%,ACSM2A;ACSM2B;ACOT12;ACOT9;ACOT11;ACOT8;ACOT13;CROT;GLYAT;ACOT6
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.5282976902622396,1.3104573506135193,0.15691489361702127,0.7991936662080745,1.0,10/29,20.97%,ACSM2A;ACSM2B;ACOT12;ACOT9;ACOT11;ACOT8;ACOT13;CROT;GLYAT;ACOT6
prerank,integrin-mediated signaling pathway (GO:0007229),0.47491029810221846,1.3098801801712487,0.10545023696682465,0.7998768727549685,1.0,23/73,18.39%,ITGBL1;ADAM9;PTK2B;PLPP3;COL3A1;NRP1;ITGB8;ITGB5;ABL1;FN1;PTPRA;ITGB1;CUL3;ITGAV;ERBIN;ANGPTL3;ITGB1BP1;ITGB3;ADAM15;PTN;ADAMTS1;LAT;ITGA5
prerank,regulation of chromatin organization (GO:1902275),0.6235542846179082,1.3086599337350837,0.16567164179104477,0.8033006523069448,1.0,3/14,6.65%,MLLT3;TLK1;ALKBH4
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.5941876705545516,1.308486791534943,0.1791044776119403,0.8007832063866605,1.0,6/16,8.58%,THBS1;BCAS3;PHLDB2;FAM107A;DMTN;CORO1C
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.5941876705545516,1.308486791534943,0.1791044776119403,0.8007832063866605,1.0,6/16,8.58%,THBS1;BCAS3;PHLDB2;FAM107A;DMTN;CORO1C
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.5983015731282697,1.3081489398160777,0.18641618497109827,0.800646737681392,1.0,2/16,3.17%,BMP4;TGFB3
prerank,ganglion development (GO:0061548),0.6387924776547907,1.3080117418021535,0.18779342723004694,0.7995537733971415,1.0,2/11,3.10%,UNC5C;NRP1
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.567094867091453,-1.3078191646199016,0.17548746518105848,0.6014421501911515,1.0,2/10,1.41%,SOX5;SOX6
prerank,cardiac conduction system development (GO:0003161),0.558830007804946,1.3073765072610428,0.16115702479338842,0.8005047609847178,1.0,4/24,3.86%,BMP4;CACNA1G;BMPR1A;NOTCH2
prerank,cellular response to osmotic stress (GO:0071470),0.5714737784462769,1.3065791770859234,0.15159944367176634,0.8021570129116212,1.0,3/21,3.01%,STK39;LRRC8D;YBX3
prerank,negative regulation of protein polymerization (GO:0032272),0.5370218071104252,1.306544679051885,0.15706806282722513,0.8007087790095502,1.0,2/27,1.64%,SLIT2;PRKCD
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.5246541547773509,1.3064382960705931,0.14948453608247422,0.7995827406596788,1.0,10/37,13.32%,ENTPD6;SIDT2;NUDT5;ENTPD2;ENTPD5;NUDT15;ENTPD7;RNASE3;NUDT1;RNASEH2A
prerank,purine nucleotide biosynthetic process (GO:0006164),0.6201353418496096,1.3059038927106366,0.18902439024390244,0.8001293828852524,1.0,2/12,4.17%,PRPS2;ADA
prerank,negative regulation of cell migration (GO:0030336),0.442731214442305,1.3057717357268597,0.07066381156316917,0.7991251400182517,1.0,23/137,5.44%,SLIT2;TMEFF2;CLIC4;DPYSL3;CDH1;CYP1B1;PTPRU;WNT11;IGFBP5;FGF2;SLURP1;COL3A1;SRGAP2;SRGAP3;ARHGDIB;BMPR1A;PHLDB2;TIMP1;NOG;LRP1;HAS1;FOXO3;NF1
prerank,positive regulation of neutrophil migration (GO:1902624),-0.4728339526081537,-1.3055279866661407,0.1419141914191419,0.6052645208361359,1.0,6/18,16.25%,CAMK1D;RIPOR2;DAPK2;RAC1;CD74;CCL19
prerank,positive regulation of Rho protein signal transduction (GO:0035025),-0.4191180887402062,-1.3052144383886095,0.136,0.6033576005094861,1.0,6/30,9.24%,ROBO1;ARHGEF3;LPAR1;F11R;ADGRG1;RAC1
prerank,cell-cell junction assembly (GO:0007043),-0.35371951524168993,-1.3049477080784289,0.08280254777070063,0.6012798555740849,1.0,16/63,6.95%,TJP1;GJB6;TLN2;CDH2;CDH8;CLDN5;CDH10;GJB2;ARVCF;GJA1;ACTB;GJC1;GJD3;EPB41L3;JAM3;PKP4
prerank,cell junction organization (GO:0034330),-0.3617940967525444,-1.3047180903282156,0.05228758169934641,0.5991619672393882,1.0,20/71,11.59%,TJP1;OCLN;GRM5;PPFIBP2;PPFIBP1;PPFIA2;APP;SLC6A1;PAK3;VASP;ACTB;SDK2;OPHN1;FLNC;FBLIM1;CLDN1;MAPT;SLC8A3;C1QA;VMP1
prerank,regulation of autophagosome maturation (GO:1901096),0.6191954983372976,1.3046557704258106,0.18683001531393567,0.8019674894987635,1.0,3/13,5.21%,ADRB2;CLEC16A;TMEM39A
prerank,organophosphate biosynthetic process (GO:0090407),0.5245368935483687,1.304594867748688,0.14941022280471822,0.8006416906554439,1.0,11/37,12.65%,FGF2;PNPO;IP6K1;IP6K2;PPIP5K1;MBOAT1;TKT;LPCAT1;PIP5K1A;GNPAT;MOCOS
prerank,regulation of transferase activity (GO:0051338),0.5739416129433502,1.3042590859943721,0.1676470588235294,0.8005003166507147,1.0,6/17,23.47%,SMG6;FEM1B;SPTSSB;BAG5;PARP4;ATM
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.5369372185781296,1.3042491883667158,0.1519674355495251,0.7989694084244413,1.0,5/30,4.30%,KCNJ2;CACNA1C;CACNA1G;ANK2;SNTA1
prerank,retinol metabolic process (GO:0042572),0.6123851234056202,1.3041859963822093,0.18502202643171806,0.7976668845539661,1.0,4/14,11.77%,CYP1B1;ADH7;RDH12;DHRS3
prerank,clathrin coat assembly (GO:0048268),-0.49503254869447283,-1.3039619247306031,0.1936416184971098,0.5986371008267449,1.0,4/15,5.56%,SGIP1;PICALM;PIK3C2A;HIP1R
prerank,UV protection (GO:0009650),0.6497755898267445,1.302886492197481,0.18888888888888888,0.8014330210452996,1.0,2/10,4.67%,SCARA3;ERCC5
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.625589547685289,1.302412430927367,0.18373493975903615,0.8019384921447339,1.0,3/13,3.03%,CACNA1G;CLTRN;KCNB1
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.6049383604889834,1.302379550708972,0.17888563049853373,0.8005543547401444,1.0,4/14,9.03%,PGF;NRP1;VEGFA;FOXC1
prerank,superoxide anion generation (GO:0042554),-0.5178704408843361,-1.3022536500010211,0.1620879120879121,0.6007543909488995,1.0,9/13,37.27%,NOX1;ALOX12;NOX4;NCF2;TAFA4;NCF1;NOX3;NCF4;DUOX1
prerank,intracellular cholesterol transport (GO:0032367),0.5894436660888999,1.3020040310880683,0.16865671641791044,0.8004980412970306,1.0,8/15,24.55%,LRP6;LDLR;NPC1;STARD4;STAR;SERAC1;RELCH;OSBP
prerank,activation of protein kinase B activity (GO:0032148),-0.42903789002278786,-1.3015828502221156,0.0967741935483871,0.5998474848778429,1.0,12/29,17.34%,IGF1;OSBPL8;WNT5A;FGF1;INSR;IL18;GAS6;PINK1;ADRA2A;CCDC88A;MT3;NTF3
prerank,regulation of DNA repair (GO:0006282),0.5125122627930804,1.3014038512732857,0.1414141414141414,0.8013367352304612,1.0,12/44,14.62%,EGFR;EYA2;EYA4;UBR5;UIMC1;USP1;EYA3;BRCA1;TRIP12;TIGAR;RNF8;BRCC3
prerank,cell cycle G1/S phase transition (GO:0044843),0.4857384418790036,1.3013666550029335,0.1380952380952381,0.7999424165085566,1.0,23/61,17.24%,CCNA2;MNAT1;INHBA;E2F3;CCND1;CUL3;CDKN2C;CUL1;GSPT1;CDKN1B;CDKN3;E2F1;ACVR1;HINFP;PIM2;KHDRBS1;CDK7;CDK2;CDKN1A;CDC7;PLK3;RPS6KB1;RB1
prerank,keratinocyte differentiation (GO:0030216),0.5353699050117308,1.3005602128738223,0.17177097203728361,0.8017300163410145,1.0,7/29,12.38%,CLIC4;ADAM9;DSP;ANXA1;BCR;JAG1;PIP5K1A
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.39111439559683875,-1.3005467870298666,0.10638297872340426,0.5997899488550248,1.0,8/39,7.95%,MYO1B;PPFIA2;FNBP1L;MYO5A;BICDL1;SYT4;ACTN4;KIF1A
prerank,eye morphogenesis (GO:0048592),0.5730761655772755,1.3004628251477033,0.19690576652601968,0.8005939108589041,1.0,7/19,5.65%,MFAP5;COL5A2;VEGFA;NIPBL;STAT3;NF1;SKI
prerank,double-strand break repair via homologous recombination (GO:0000724),0.45826033079751377,1.3004388718141833,0.08529741863075196,0.7991456848707278,1.0,39/95,25.86%,REV3L;ERCC5;NIPBL;NABP1;CDC45;MCM2;RAD51;SLX4;SPIDR;WRN;SMC6;SMC5;PARP1;NSMCE1;RAD50;RNF138;BRCA1;MCM7;MORF4L1;CDC7;RECQL5;RAD21L1;REC8;MCM9;BRCA2;PSMD14;ERCC4;YY1;NBN;AP5Z1;RAD52;RAD51D;RBBP8;INO80;RECQL;RAD21;KDM4D;RAD54L;POLQ
prerank,protein targeting to peroxisome (GO:0006625),0.529395288577362,1.3003400726828744,0.15363881401617252,0.7979996701218264,1.0,7/29,10.07%,ABCD3;PXMP2;ABCD1;ZFAND6;LONP2;ACBD5;PEX13
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.4686395033925279,-1.299977034560645,0.12927756653992395,0.5985823349837084,1.0,6/19,9.75%,GRM5;RYR2;VCAM1;KDR;PTGFR;PTPRJ
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.44305749509897174,1.2999608817238215,0.0894396551724138,0.7980158229735954,1.0,19/122,12.21%,SMOC2;THBS1;EGFR;SAMD4A;FGF2;NIBAN1;IRS1;KLF4;IL33;GLI2;ERBB2;NLRP12;TLR4;EIF3E;STN1;EIF6;RBM3;BCAR3;NAT10
prerank,T cell differentiation (GO:0030217),-0.3859771049141815,-1.2993644168802887,0.08629441624365482,0.5976397316256438,1.0,10/40,13.51%,LEPR;KIT;CHD7;SOX13;TCF7;RHOH;JAG2;LFNG;MR1;PTPN22
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.5033863368993854,1.2982849295988967,0.15701415701415702,0.80315404377575,1.0,10/45,10.68%,EGFR;PLCE1;REPS2;PTK2B;SHC1;KIF16B;NCK2;AAMP;ERBIN;GAREM1
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.6042794337275237,1.2981378691923968,0.1791277258566978,0.8022353550883625,1.0,2/15,4.18%,CD55;GLI3
prerank,regulation of DNA biosynthetic process (GO:2000278),0.5318101940410306,1.2969937257587523,0.15127175368139223,0.805296365885169,1.0,3/27,4.76%,SMOC2;FGF2;SMG6
prerank,cytoplasmic sequestering of protein (GO:0051220),0.6213952692274448,1.2969493328751116,0.1895734597156398,0.8039239113494644,1.0,5/13,16.18%,PKD1;MDFI;KEAP1;DBN1;GOPC
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.4967126098188005,1.2956090323037346,0.1444582814445828,0.807818140968242,1.0,8/45,6.78%,BMP4;BMP5;TGFB3;BMPR1A;GDF10;TGFBR1;BMP6;INHBA
prerank,blood vessel morphogenesis (GO:0048514),-0.36151790476995327,-1.2951747642580982,0.06666666666666667,0.6067056181272507,1.0,16/54,8.55%,FLT1;EFNB2;ENG;LAMA1;CDH2;TGFBR3;CCBE1;KDR;SLC1A1;RASIP1;RBPJ;TBX1;SOX17;COL4A1;PROX1;HEY2
prerank,visual system development (GO:0150063),0.5192119653480763,1.2949796733598449,0.16120576671035386,0.808792347176251,1.0,7/37,12.36%,PBX3;SMOC1;PBX1;HIPK1;FOXC1;ATF6;SCO2
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.44475283225541257,-1.294728808106995,0.14429530201342283,0.6053860074920395,1.0,8/22,23.98%,APOD;CCDC3;ALK;ADRA2A;PPP2R5A;ASXL3;GPER1;APOC1
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.5982347880306422,1.2941064842472132,0.17455621301775148,0.8108546359280236,1.0,2/15,1.98%,KCNJ2;ATP1B1
prerank,apoptotic mitochondrial changes (GO:0008637),-0.40245354195551447,-1.293948288692627,0.13168724279835392,0.6048036956268642,1.0,13/32,22.53%,BCL2;ERBB4;BCL2L1;IFIT2;THEM4;BOK;CAMK2A;HK2;FIS1;HSPD1;BIK;SFN;MFF
prerank,protein localization to Golgi apparatus (GO:0034067),0.5388247104086875,1.2934507285956214,0.16643741403026135,0.8119813784291484,1.0,14/27,24.51%,VPS13A;VPS13C;GBF1;RAB6A;GAK;VPS13D;ZDHHC15;SORL1;GOLPH3;RAB33B;BICD2;PAQR3;GCC2;ARL5C
prerank,regulation of catecholamine secretion (GO:0050433),-0.40224859272472907,-1.2931680268704369,0.10121457489878542,0.6042309600961032,1.0,15/29,22.09%,SYT1;SYT7;SYT10;SYT4;SYT11;SYT12;SYT6;GRK2;CHGA;SYT13;SYT2;KCNA2;SYT15;SNCA;CHRNA4
prerank,DNA alkylation (GO:0006305),0.5654881469525949,1.2924733289719175,0.16944444444444445,0.8130241411848576,1.0,9/19,26.10%,TEX15;EHMT1;DNMT3A;DMAP1;ATF7IP;ATRX;KMT2E;PPM1D;BAZ2A
prerank,DNA methylation or demethylation (GO:0044728),0.5654881469525949,1.2924733289719175,0.16944444444444445,0.8130241411848576,1.0,9/19,26.10%,TEX15;EHMT1;DNMT3A;DMAP1;ATF7IP;ATRX;KMT2E;PPM1D;BAZ2A
prerank,regulation of protein kinase activity (GO:0045859),0.4531254552806719,1.291512046596547,0.09161147902869757,0.8153458317659237,1.0,27/106,19.72%,RASSF2;PLCE1;LRP6;UBASH3B;DDR2;CCN1;PTK2B;NF1;CEP43;DUSP19;QARS1;TAB2;RAP1A;CHP1;ITGB1BP1;RAP2C;DVL1;CDKN1A;CEP85;IQGAP1;RB1;TSPYL2;TRAF4;LAT;RAP2B;XRCC5;ANKRD54
prerank,oligosaccharide biosynthetic process (GO:0009312),0.5524063027876455,1.291442282932073,0.17655571635311143,0.814124547368508,1.0,3/20,7.09%,ST3GAL4;FUT8;B4GALT1
prerank,regulation of actin nucleation (GO:0051125),0.6145638826757793,1.2913576652874057,0.20221169036334913,0.8129599949261687,1.0,4/12,16.38%,GSN;ARFIP2;WASHC5;ARPIN
prerank,regulation of DNA recombination (GO:0000018),0.51455404404553,1.2906829952184173,0.15572715572715573,0.8142024911889162,1.0,9/32,16.00%,RAD51;SETD2;SIRT6;SPIDR;KDM1A;KPNA1;RAD50;KPNA2;PPP4R2
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),-0.555942759908059,-1.2903934135645712,0.1761786600496278,0.6095200206138983,1.0,4/10,18.05%,TGFA;ADRA2A;HBEGF;FBXW7
prerank,positive regulation of filopodium assembly (GO:0051491),0.5489961348881155,1.2903574512749518,0.16905444126074498,0.813978380676652,1.0,8/24,7.71%,DPYSL3;ARAP1;NRP1;TGFB3;PALM;BCAS3;TENM1;RHOQ
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),-0.5373955496715693,-1.289318907486828,0.17066666666666666,0.6099119600229989,1.0,3/11,5.74%,LYN;ANK3;PRKCQ
prerank,negative regulation of hemostasis (GO:1900047),-0.5194275327491608,-1.2892727890095002,0.1781609195402299,0.6073417435903806,1.0,5/12,11.41%,VTN;APOE;CD34;EDN1;TFPI
prerank,calcium ion transmembrane import into cytosol (GO:0097553),-0.3832908342789717,-1.2891291183085107,0.09947643979057591,0.6050262907213705,1.0,10/41,7.67%,ITPR1;SLC24A2;SLC8A1;RYR2;HTR2C;GRIN2A;GRIN2B;GRIN1;CACNA2D1;TRPV2
prerank,oligodendrocyte differentiation (GO:0048709),-0.47301323273016965,-1.2888121373229626,0.16993464052287582,0.6033476034918263,1.0,5/19,17.15%,SOX6;SOX13;SLC8A3;EIF2B1;NSUN5
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.46228614631006704,-1.2886284791403353,0.1513157894736842,0.6012998493422681,1.0,6/19,16.25%,CAMK1D;RIPOR2;DAPK2;RAC1;CD74;CCL19
prerank,epidermal cell differentiation (GO:0009913),0.5007485895191172,1.288308477553867,0.15384615384615385,0.8208162474125338,1.0,6/41,6.23%,CLIC4;ADAM9;PITX2;DSP;ANXA1;BCR
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.4714093029358454,1.2876962669699283,0.1502403846153846,0.8216931853423157,1.0,17/62,19.87%,MLLT3;ELOF1;CDK12;AFF4;SETD2;MNAT1;ADRM1;CDK13;ELOA;NELFE;CDK7;CCNT2;GTF2H3;PCID2;POLR2C;ELP4;CCNT1
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.5559523032622329,-1.2875360135678549,0.1867816091954023,0.6016679565958901,1.0,9/10,43.91%,UBAC2;ERLEC1;UBE2J1;SVIP;DERL2;DERL3;INSIG1;OS9;YOD1
prerank,response to calcium ion (GO:0051592),0.4508235944479053,1.28741786642745,0.10284463894967177,0.8213678845858381,1.0,13/102,7.87%,THBS1;CLIC4;NEDD4;ADAM9;PPP3CA;KCNMB3;KCNMB2;CAMK2D;CASR;PLCG2;MEF2A;SEC31A;DMTN
prerank,protein kinase B signaling (GO:0043491),-0.43846257778281184,-1.2871399402564547,0.15034965034965034,0.6001649162486891,1.0,13/23,23.81%,IGF1;KDR;GAS6;SIRT2;THEM4;TSC2;TYRO3;MT3;ZFP36L1;EPHA2;AKT1;CCL2;PAX2
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.6055187419948679,1.2869248272331695,0.19280575539568345,0.8219141932668993,1.0,6/15,13.65%,ENTPD6;ENTPD2;ENTPD5;ENTPD7;AK4;AK1
prerank,positive chemotaxis (GO:0050918),0.5864916673169117,1.2865238369386645,0.2,0.8220424985178193,1.0,3/17,3.16%,MET;NRP1;VEGFA
prerank,regulation of actin filament polymerization (GO:0030833),0.46880067896324135,1.2864384964328008,0.14084507042253522,0.8208841727757406,1.0,19/69,16.45%,SLIT2;CDC42EP5;BAIAP2L1;PRKCD;PRKCE;PTK2B;ARHGAP40;NCK2;TENM1;KANK4;WASHC5;CTTN;DBN1;GBA2;NCK1;FCHSD2;CDC42EP2;ARFGEF1;PLEKHG2
prerank,regulation of endopeptidase activity (GO:0052548),-0.35822775393597206,-1.286249414021901,0.09202453987730061,0.5999834804559883,1.0,12/59,13.60%,VTN;SPOCK3;SPOCK2;SPOCK1;TIMP3;PICALM;SERPINI1;SERPIND1;BIRC2;GAPDH;APH1B;PSMB8
prerank,proteolysis (GO:0006508),0.4251974938679009,1.2859524943108804,0.04480651731160896,0.8213366758136942,1.0,55/252,17.77%,F3;CAPN5;HTRA3;PCSK5;TRABD2B;BMP1;CASP6;HTRA4;CPQ;CNDP1;ASPRV1;HTRA1;CAPN2;ADAMTS3;CAPN12;USP25;ECE1;XPNPEP3;XPNPEP1;BACE2;SPPL2A;NPEPPS;CASP2;PHEX;TINAGL1;MMP16;LONP2;TASP1;DESI1;DESI2;TBL1X;IDE;MMEL1;DDI2;PCSK7;ECE2;CTRC;CPNE1;RNF123;CLPP;RET;ATG4C;TYSND1;CTSE;ATG4B;PGPEP1;YME1L1;NLN;FAM111A;DPP3;ATG4A;FAP;CPZ;PSMA6;APEH
prerank,positive regulation of nuclear division (GO:0051785),-0.43957441570273936,-1.2857143296758191,0.16778523489932887,0.598781219569436,1.0,4/25,3.89%,IGF1;TGFA;PDGFRB;INSR
prerank,response to organophosphorus (GO:0046683),-0.47942766868579195,-1.285710882988339,0.16257668711656442,0.5962457310841848,1.0,4/16,10.41%,ABCC9;TRPC3;STAT1;P2RX7
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.5198807534656092,1.2851295867481067,0.15191545574636725,0.8234351579478614,1.0,9/35,4.52%,NTRK3;BAIAP2L1;SEMA3E;PTK2B;NRP1;ARHGDIB;NOTCH2;BCAS3;ABL1
prerank,relaxation of muscle (GO:0090075),0.607365667025496,1.2850716248625236,0.20176730486008837,0.8221874154222736,1.0,4/13,1.98%,KCNJ2;CAMK2D;GSN;ATP1B1
prerank,cellular defense response (GO:0006968),0.5013374795604607,1.284957480204588,0.17193426042983564,0.8211247757427736,1.0,8/40,10.89%,LBP;PTK2B;ZNF148;TCIRG1;CLEC5A;ITGB1;BECN1;TRAT1
prerank,lung development (GO:0030324),0.5220878299321127,1.2846835799636602,0.1806615776081425,0.820732378329126,1.0,6/33,6.46%,BMP4;PKD1;WNT11;FGF2;VEGFA;GLI2
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.5139776644085712,-1.2846483019724328,0.1608187134502924,0.5966108369872818,1.0,4/13,5.98%,ADCY1;SHANK3;APP;LGMN
prerank,positive regulation of collagen metabolic process (GO:0010714),0.584733566104962,1.2845553588167524,0.2019914651493599,0.8198052421071982,1.0,2/17,3.17%,BMP4;TGFB3
prerank,epithelial to mesenchymal transition (GO:0001837),-0.36375609064335185,-1.2838644411528302,0.11320754716981132,0.5961909639007712,1.0,14/47,8.78%,LEF1;WNT4;ENG;TGFBR3;WNT5A;ROCK2;TBX3;RBPJ;BMP7;NOTCH1;LOXL3;NOTCH4;HEY2;BMP2
prerank,telomere maintenance via telomere trimming (GO:0090737),0.6403781658744858,1.282429206111363,0.21394611727416799,0.8241281331281135,1.0,4/10,8.80%,EXO1;SLX4;WRN;SMARCAL1
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.6403781658744858,1.282429206111363,0.21394611727416799,0.8241281331281135,1.0,4/10,8.80%,EXO1;SLX4;WRN;SMARCAL1
prerank,t-circle formation (GO:0090656),0.6403781658744858,1.282429206111363,0.21394611727416799,0.8241281331281135,1.0,4/10,8.80%,EXO1;SLX4;WRN;SMARCAL1
prerank,response to interleukin-6 (GO:0070741),0.6284268998997962,1.2822609415344568,0.1993517017828201,0.8233152376512003,1.0,2/10,2.55%,PID1;PTGIS
prerank,chondrocyte differentiation (GO:0002062),0.5119955154952638,1.2819010090649465,0.16666666666666666,0.8232833773715514,1.0,6/32,8.72%,BMP4;CCN3;NFIB;SLC39A14;SULF1;RUNX2
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.4698329158590903,1.281385079852862,0.13716295427901523,0.8237640617319155,1.0,21/65,18.27%,HTRA3;SMAD6;SKIL;HTRA4;PMEPA1;CD109;TGFBR1;SPRED2;SKI;EMILIN1;TGFBR2;IL17RD;SMAD2;TGFB1I1;LDLRAD4;WFIKKN1;FAM89B;PIN1;BCL9L;SMAD7;SMURF1
prerank,response to ionizing radiation (GO:0010212),0.4696933778282716,1.2813800506629385,0.11525029103608847,0.8223136245751147,1.0,31/70,26.12%,TANK;CLK2;ANXA1;NABP1;RAD51;TICRR;SPIDR;TOPBP1;UIMC1;MTA1;EYA3;BRAT1;BRCA1;COP1;TNKS1BP1;RNF8;BRCC3;USP28;CDKN1A;INTS7;ABRAXAS1;ATM;TP53;XRCC4;INO80;AEN;RAD9A;RAD9B;KDM4D;IKBIP;MRNIP
prerank,regulation of protein phosphorylation (GO:0001932),0.4200347617491863,1.2811883155505337,0.0449438202247191,0.8216244061760786,1.0,35/256,10.33%,SLIT2;BMPER;BMP4;CARD14;EGFR;SLCO3A1;PLCE1;LRP6;PGF;NTRK3;PID1;CCN1;PLPP3;EFNA5;FGF2;NIBAN1;KRAS;KLHL31;VEGFA;ABL1;IBTK;FAM20A;ERBB2;LIMK2;FN1;ZC3H12A;CCND1;CORO1C;MAVS;PPP2R5C;CIB1;TMEM119;PIK3R3;NSD1;XDH
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.5650975339127584,1.2807911177421887,0.19014084507042253,0.8216816197740023,1.0,8/18,10.83%,RHOJ;HDAC9;FGF2;VEGFA;FOXC2;ANXA1;CIB1;MAP3K3
prerank,negative regulation of cell differentiation (GO:0045596),0.4254729444828349,1.280564976362905,0.0734229576008273,0.8211155778181141,1.0,40/181,14.65%,BMP4;EGFR;CRIM1;ZFPM2;WNT9A;HES1;TWIST2;COL5A2;SMAD6;BMP5;PTK2B;ID2;GDF10;TGFBR1;PTHLH;NOG;TWIST1;SPRED2;SKI;ZBTB16;TSKU;RORA;IL17RD;TRPM4;CHRD;PDCD4;HES3;ITGAV;XDH;NEPRO;ZFPM1;LDLRAD4;JAG1;TRIO;E2F1;LRP5;ITGB3;NBR1;SOX9;SRA1
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.5554360143389924,1.2803803675825156,0.1934566145092461,0.8189968442175731,1.0,13/21,33.98%,ERCC5;CHD1L;PARP1;GTF2H3;ERCC4;GTF2H4;DDB1;ERCC2;DDB2;XPA;GTF2H5;GTF2H1;RPA1
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.5554360143389924,1.2803803675825156,0.1934566145092461,0.8189968442175731,1.0,13/21,33.98%,ERCC5;CHD1L;PARP1;GTF2H3;ERCC4;GTF2H4;DDB1;ERCC2;DDB2;XPA;GTF2H5;GTF2H1;RPA1
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.5541012793928308,1.2802883665603493,0.16907514450867053,0.817916445451255,1.0,15/22,33.50%,CDK12;SCAF8;CDK13;CCNT2;BRD4;CCNT1;TCERG1;HMGN1;EAPP;SUPT4H1;ELL;THOC1;THOC5;DDX39B;ALYREF
prerank,striated muscle contraction (GO:0006941),-0.3588775372056046,-1.2796811121922296,0.09090909090909091,0.6051838851579512,1.0,5/53,2.92%,ATP1A2;DTNA;SLC8A1;RYR2;RCSD1
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.6169481936980548,1.2792607826002547,0.19076923076923077,0.8206865643537459,1.0,5/11,17.25%,EZR;RDX;SORL1;RAB21;PTPN23
prerank,regulation of cellular protein catabolic process (GO:1903362),0.569602252710809,1.2789135829695963,0.19849624060150375,0.8206174142952817,1.0,5/18,9.13%,EZR;NELL1;DACT1;RDX;RGP1
prerank,actin crosslink formation (GO:0051764),0.6289451557800877,1.2787402692985597,0.19906687402799378,0.8198224921859578,1.0,3/12,3.04%,DPYSL3;BAIAP2L1;GAS2
prerank,primary miRNA processing (GO:0031053),0.6273338461859655,1.2782672769416443,0.1941747572815534,0.8203176111767739,1.0,8/10,34.16%,DGCR8;SMAD2;HNRNPA2B1;MRPL44;DROSHA;SMAD1;PUS10;SRRT
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.49858464868013896,1.2780598224995394,0.17532467532467533,0.8197178634557246,1.0,9/39,12.02%,FXYD5;CDH1;WNK1;VEGFA;KLF4;BMP6;RDX;MIA3;JAG1
prerank,cell junction assembly (GO:0034329),-0.317474964376727,-1.2768815841561785,0.022988505747126436,0.6107827049009198,1.0,32/100,11.65%,TJP1;TLN2;SPOCK2;CDH2;DNM3;CDH8;SHANK3;ITGA6;CLDN5;ADGRL3;NRXN1;CDH10;KIRREL3;VASP;ARVCF;GPM6A;RYK;ACTB;GJC1;SDK2;PLXND1;OPHN1;PKP4;FLNC;FBLIM1;SHANK2;CDH7;CDH19;CDH20;DNER;VMP1;CDH5
prerank,regulation of angiogenesis (GO:0045765),0.4268225262034522,1.2767853241832552,0.07684319833852545,0.8234921490801738,1.0,41/192,14.07%,BMPER;SMOC2;F3;THBS1;RHOJ;PGF;HOXA5;SEMA3E;CYP1B1;FGF2;PTGIS;ISM1;ITGB8;VEGFA;KLF4;HIPK1;TWIST1;NF1;EMILIN1;ATP2B4;PROK2;AGO2;ERBB2;ITGB1;SULF1;ZC3H12A;GATA4;ANXA3;KRIT1;FOXC1;ADAM12;MECP2;ANGPTL3;JUP;NIBAN2;SYNJ2BP;BRCA1;MTDH;EFNA3;CD160;HTATIP2
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.4495822839997364,1.2766809493227345,0.11237230419977298,0.8224241109640443,1.0,21/93,15.53%,RASSF2;EGFR;NTRK3;NGF;VEGFA;DOCK7;ATP2B4;NCK2;CD44;TENM1;DMTN;MLXIPL;AKAP9;RIPK2;NSD1;BCAR3;RAF1;TNKS1BP1;DMD;NCK1;CAPRIN2
prerank,action potential (GO:0001508),0.4971145537761695,1.2765400392561534,0.17125,0.8215401509156158,1.0,5/44,3.03%,KCNJ2;CACNA1G;KCNMB3;KCNMB2;KCNB1
prerank,regulation of interleukin-4 production (GO:0032673),-0.4419113318718914,-1.276536739149558,0.1482758620689655,0.6091855696363536,1.0,4/21,5.74%,LEF1;SLC7A5;PRKCZ;PRKCQ
prerank,cation transmembrane transport (GO:0098655),-0.37373532370612883,-1.2762908567032634,0.11442786069651742,0.6073942021577922,1.0,6/44,6.71%,ATP1A2;TRPM3;ABCC9;SLC7A5;SLC6A9;SLC38A5
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.4293835180139004,1.2762436046030963,0.10425531914893617,0.8211889218882371,1.0,19/150,7.67%,F3;THBS1;EGFR;TNFAIP8L3;TCF7L2;MET;FGF2;GAB2;PIK3AP1;IRS1;ESR1;CCL3;TGFBR1;FGFR1;MYOC;ERBB2;STRN;ITGB1;KITLG
prerank,cellular response to ketone (GO:1901655),-0.3921129071942612,-1.275896706109604,0.1111111111111111,0.6060187428512376,1.0,10/35,15.06%,ADCY5;ADCY1;ROCK2;AHR;GNG2;PTGFR;SPP1;PCK2;GNAI1;MSN
prerank,histone mRNA catabolic process (GO:0071044),0.5846411584643793,1.2756353243955896,0.21925925925925926,0.8221598971715793,1.0,8/15,25.44%,TUT7;TUT4;TENT2;ERI1;SSB;TENT4B;ATM;LSM1
prerank,integrated stress response signaling (GO:0140467),0.5849392430794432,1.2754571354425377,0.20150375939849624,0.8214708613388838,1.0,4/14,11.99%,NFE2L2;EIF2AK1;EIF2S1;HERPUD1
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.46612433214886695,1.2751176207169301,0.1334120425029516,0.8213650319857558,1.0,22/66,19.43%,FHL1;EGFR;PKD1;ID2;KLF4;ANXA1;DACT1;LSM11;FAM107A;CCND1;RDX;CDKN2C;ANKRD17;TFDP1;DLG1;E2F1;CDKN1A;ADAMTS1;RB1;KMT2E;WEE1;EIF4G1
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.6092574069508992,1.2750315921672102,0.22432859399684044,0.8202960859570424,1.0,1/12,0.19%,F3
prerank,regulation of platelet activation (GO:0010543),-0.4505969565374821,-1.2749901663994723,0.17041800643086816,0.6060345322263696,1.0,5/21,5.74%,LYN;APOE;NOS3;TEC;PRKCQ
prerank,macrophage differentiation (GO:0030225),0.6028116958853841,1.2739524226485914,0.21517027863777088,0.8230469184895359,1.0,2/13,3.16%,BMP4;VEGFA
prerank,calcium ion import across plasma membrane (GO:0098703),-0.49486235662914513,-1.2736136577661044,0.18181818181818182,0.607392318039447,1.0,7/14,19.55%,SLC24A2;SLC8A1;CACNA2D1;TRPV2;SLC8A3;TRPV4;SLC8A2
prerank,positive regulation of DNA repair (GO:0045739),0.49192820575420754,1.2733387670453342,0.17224287484510534,0.824137842457428,1.0,12/46,14.62%,EGFR;EYA2;EYA4;SPIDR;UIMC1;PARP1;EYA3;BRCA1;DDX11;TIGAR;RNF8;BRCC3
prerank,positive regulation of calcium ion transport (GO:0051928),-0.4004316972165215,-1.272829088842745,0.12448132780082988,0.6072262867542069,1.0,13/36,13.22%,MYLK;PDGFRB;CACNA1D;CXCL12;TRPC3;CACNB2;GRIN1;TRPC6;WFS1;P2RX7;ATP2B1;WNK3;ORAI1
prerank,negative regulation of potassium ion transport (GO:0043267),0.5947485727960015,1.27237500035509,0.21450617283950618,0.8265445052812928,1.0,2/13,2.10%,STK39;PTK2B
prerank,triglyceride biosynthetic process (GO:0019432),-0.44418703312182767,-1.2722596840948108,0.15960912052117263,0.606439840569492,1.0,6/18,11.56%,LPGAT1;GK;LPIN3;GPAM;PCK2;DGAT1
prerank,positive regulation of T cell migration (GO:2000406),0.5580864180517773,1.2721117786970575,0.17597765363128492,0.8260567618510897,1.0,2/20,1.59%,STK39;WNK1
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.41447679435560103,1.272073474542733,0.02920443101711984,0.8247944403878731,1.0,101/417,16.53%,FOXP2;FOXP1;WWP1;BMP4;ZFPM2;TCF7L2;FOXD1;HES1;HDAC4;TWIST2;RBFOX2;WNT11;SAMD7;FOXN3;GCLC;HDAC9;PRICKLE1;DMBX1;SOX14;ZNF423;ID2;ID1;WWP2;ZNF148;RARA;KLF4;GLI3;PHC2;LIMS1;TLE2;MDFIC;TWIST1;RCOR3;NIPBL;SHC1;KLF10;SPINDOC;ZBTB16;PER1;NFIL3;BHLHE40;L3MBTL3;GLIS2;MBD1;EHMT1;CRY2;NCOR1;DKK3;IRF1;SMAD2;EED;BTAF1;MLX;MLXIPL;CBX5;NCOR2;CIPC;KDM1A;RUNX2;UIMC1;ELF3;PDCD4;SIX4;BRMS1;QARS1;BCOR;ARID4A;CREB3L1;RCOR1;MECP2;SCMH1;ATOH8;PHF12;CDKN1C;NIBAN2;CDKN1B;BRCA1;NR1D1;E2F1;HOXA7;PATZ1;DMAP1;HINFP;SP3;ATF7IP;KHDRBS1;SOX9;NR3C1;NKAP;THAP7;POU2F1;MBTD1;KAT6B;ZNF219;TRAF6;KMT5A;MAP3K10;PRDM5;SMAD4;FOXK1;USP47
prerank,protein K11-linked ubiquitination (GO:0070979),0.5309476912084331,1.2719564603122988,0.1816958277254374,0.8237769791254392,1.0,9/27,17.68%,FZR1;ANAPC5;UBE2A;ANAPC10;CDC16;ANAPC11;UBE2B;UBE2D3;UBE2S
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.4259479644130267,1.2718278148321172,0.081419624217119,0.822816158841713,1.0,39/166,17.75%,SMOC2;THBS1;EGFR;SAMD4A;FGF2;NIBAN1;IRS1;GIPC1;LDLR;KLF4;PTPN2;NNMT;GLI2;ERBB2;MLXIPL;TLR4;EGR1;EIF3E;STN1;ARNT;EIF6;CHP1;RBM3;BCAR3;CLU;NAT10;STARD4;NR1D1;SREBF1;PAOX;NMD3;ELOVL5;CIRBP;PRKDC;ARPP19;RPS6KB1;SLC25A37;LARP4;P2RX4
prerank,postsynaptic membrane organization (GO:0001941),-0.47673806785791895,-1.2716799567722896,0.17592592592592593,0.6055684630619617,1.0,3/17,2.68%,APOE;SHANK3;NRXN1
prerank,bone morphogenesis (GO:0060349),0.5845260528295094,1.2710775467850226,0.20588235294117646,0.82433642601835,1.0,3/14,5.65%,LRP6;SFRP4;SKI
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.5442041121934101,1.2710117101641998,0.19386331938633194,0.823205261327717,1.0,5/22,12.33%,BMP4;INHBA;CDKN2C;CDKN1C;CDKN1B
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.47489355365206987,-1.271010419739696,0.14576271186440679,0.604941324529122,1.0,6/17,4.94%,ATP1A2;SLC8A1;RYR2;GJA1;GJC1;GJD3
prerank,response to X-ray (GO:0010165),0.5901429430799869,1.2706896969934487,0.203240058910162,0.8230865193494348,1.0,7/14,25.68%,NIPBL;ANXA1;BRCC3;XRCC5;ATM;XRCC4;IKBIP
prerank,negative regulation of peptidase activity (GO:0010466),-0.3727614451575751,-1.2705214197071084,0.105,0.6036852613911899,1.0,7/47,3.61%,VTN;SPOCK3;SPOCK2;SPOCK1;TIMP3;SERPINI1;CST3
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.4912110563433108,1.2699888168434899,0.15994962216624686,0.8243345397884747,1.0,19/42,28.74%,RAD51;SETD2;SIRT6;SPIDR;KDM1A;HELB;PARP1;CGAS;WDR48;FUS;PPP4R2;ACTR2;RMI2;CHEK1;POLQ;KLHL15;MRNIP;SMCHD1;PPP4C
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.47625600107072064,1.2699716782692243,0.16786570743405277,0.8230016112730939,1.0,10/50,13.46%,THBS1;NGF;VEGFA;KLF4;CD44;IGBP1;RPS6KA3;RAF1;DPEP1;CARD16
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.5358113936692926,1.2699014647600597,0.1927877947295423,0.8218803276507708,1.0,4/26,8.86%,ST3GAL4;LARGE1;GAL3ST4;TKT
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.46489151790991096,1.269266941131405,0.15702479338842976,0.8229749079262342,1.0,13/67,9.61%,DOCK5;VIT;PTK2B;NRP1;GSK3B;LIMS1;ABL1;MYOC;FN1;AGR2;DMTN;S100A10;CIB1
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.46110778580294776,1.269248940483016,0.15721040189125296,0.821657754106845,1.0,17/64,19.87%,MLLT3;ELOF1;CDK12;AFF4;SETD2;MNAT1;ADRM1;CDK13;ELOA;NELFE;CDK7;CCNT2;GTF2H3;PCID2;POLR2C;ELP4;CCNT1
prerank,T cell proliferation (GO:0042098),-0.512105096169196,-1.2691019140008009,0.1836734693877551,0.6051767334566495,1.0,6/13,22.72%,CADM1;DOCK8;MSN;PPP3CB;CTPS1;PIK3CG
prerank,protein depolymerization (GO:0051261),0.527980391226998,1.269089342247134,0.1771117166212534,0.8208957642710628,1.0,3/27,4.74%,MICAL2;GSN;KATNB1
prerank,sodium ion transmembrane transport (GO:0035725),0.45259335799898504,1.2685035219681902,0.1417233560090703,0.8217891647582249,1.0,14/84,9.77%,SLC4A4;SLC9A2;SLC12A2;SLC24A3;ATP1B1;ANO6;SLC6A7;TRPM4;SLC6A2;ATP12A;ATP1A3;ATP1A4;ATP1A1;SLC9A1
prerank,cellular potassium ion homeostasis (GO:0030007),0.6063102485099738,1.2683113236713828,0.215311004784689,0.8211019048239755,1.0,7/13,9.70%,KCNJ2;SLC12A2;ATP1B1;ATP12A;ATP1A3;ATP1A4;ATP1A1
prerank,regulation of protein localization to membrane (GO:1905475),0.5296661508172783,1.267696394131788,0.17928286852589642,0.8220474491405241,1.0,4/28,7.40%,GPC6;GSN;GPC3;ZDHHC2
prerank,positive regulation of protein sumoylation (GO:0033235),0.6331890103810875,1.2670611614396001,0.21262458471760798,0.8231106674438835,1.0,2/10,7.22%,HDAC4;SAE1
prerank,calcium ion import into cytosol (GO:1902656),-0.4809572482556179,-1.266985253474172,0.153125,0.6085938339858148,1.0,7/15,19.55%,SLC24A2;SLC8A1;CACNA2D1;TRPV2;SLC8A3;TRPV4;SLC8A2
prerank,"base-excision repair, AP site formation (GO:0006285)",0.5675287537239867,1.2669418107788284,0.18992805755395684,0.8222269486731469,1.0,4/17,9.58%,MPG;ERCC5;SMUG1;NEIL3
prerank,regulation of synapse maturation (GO:0090128),-0.5255658095933798,-1.2667345291415597,0.20320855614973263,0.6069335893454868,1.0,5/10,15.97%,NRXN1;ARHGEF15;DAB2IP;CAMK2B;RELN
prerank,positive regulation of developmental growth (GO:0048639),-0.3647951693941311,-1.2662682359038222,0.08333333333333333,0.6057825198518973,1.0,13/49,9.60%,PLCB1;NEDD4L;SEMA7A;RIMS1;RIMS2;INSR;SYT1;GHR;SYT4;RNF157;TWF2;MAPT;RUFY3
prerank,regulation of chromatin binding (GO:0035561),0.633621425042803,1.265490018091463,0.21129032258064517,0.8262083004532247,1.0,7/10,29.80%,BTAF1;DDX11;MED25;WAPL;KDM4D;PARP9;DTX3L
prerank,positive regulation of vasoconstriction (GO:0045907),0.5958855863739807,1.265450341569448,0.21341463414634146,0.8250017765790281,1.0,2/13,8.50%,ADRA1B;TRPM4
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),-0.31665666168827267,-1.264938807491059,0.0784313725490196,0.6070839815668064,1.0,19/100,7.11%,FLT1;IGF1R;IGF1;PDGFD;LYN;TEK;PIP5K1B;PDGFRB;PPP1R16B;KIT;PIK3R1;DCN;KDR;INSR;ROR2;IER3;PTPN13;MAPK1;DAB2IP
prerank,positive regulation of binding (GO:0051099),0.453355592217272,1.264909717794115,0.14576271186440679,0.8257013206532035,1.0,31/84,19.85%,BMP4;TCF7L2;MET;PKD1;HES1;NGF;GSK3B;RARA;LRP1;SKI;DACT1;TIAM1;FOXC1;DPH3;RIPK2;IDE;DDX11;NMD3;MARK3;CAPRIN2;FLOT1;ADD1;PIN1;LRRK2;STK3;RALB;DHX9;PPARG;MED25;CEBPG;GPSM1
prerank,negative regulation of signal transduction (GO:0009968),0.4184536013784558,1.2648328173487031,0.059003051881993895,0.8246311003823199,1.0,40/249,9.11%,THBS1;EGFR;NXN;NTN1;TRABD2B;UBASH3B;NEDD4;PID1;TCIM;PRKCD;BMP5;IGFBP5;GPC3;FGF2;MDFI;SFRP4;IRS1;SRMS;WWP2;PALM;GRB10;GLI3;IRAK3;PTPN2;NOG;LRP1;EMILIN1;DACT1;TSKU;ERBB2;GLIS2;NR4A2;NLRP12;PALM3;DKK3;SULF1;GATA4;NLK;SFRP5;VCP
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.511093296126688,1.264440981531464,0.18659658344283836,0.8248471063406819,1.0,12/31,14.64%,CRIM1;TWIST2;SMAD6;GDF10;NOG;TWIST1;SKI;TRPM4;CHRD;LRP5;NBR1;SOX9
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.5909155883337984,1.2636936870113802,0.2006172839506173,0.826410991691478,1.0,4/13,16.13%,LARGE1;RENBP;CHST5;OGA
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.49815388235080305,-1.2632423525036904,0.1746031746031746,0.6093903159236224,1.0,4/14,6.97%,ZEB1;SPRED1;OSR1;NOTCH4
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.4678909037462002,1.262668220536403,0.13892215568862276,0.8289617098607235,1.0,8/60,7.79%,SMOC2;FGF2;GRHL2;KLF4;CHTF18;NEK7;CHTF8;DSCC1
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.5052933314831476,-1.2625199534734506,0.16666666666666666,0.6090397750199716,1.0,5/14,12.19%,NOS3;ACE;ENPEP;EDN1;ACE2
prerank,negative regulation of protein catabolic process (GO:0042177),0.49521751855203217,1.262048327621068,0.16645489199491742,0.8300458088589476,1.0,14/40,18.62%,EGFR;PTPN3;NELL1;TIMP1;IRAK3;TIMP2;RGP1;MAD2L1;MDM4;AZIN1;SNRNP70;PIN1;SNX12;HMGCR
prerank,acylglycerol biosynthetic process (GO:0046463),0.5356550510435041,1.2620110677176288,0.208731241473397,0.828846839343298,1.0,7/23,14.40%,PLCE1;PLA2G15;PNPLA3;LPIN2;AGMO;PNPLA2;MOGAT1
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.4796181418295278,-1.261617424330933,0.1781609195402299,0.6093634158798152,1.0,5/16,8.98%,ST6GALNAC3;ST8SIA4;ST8SIA1;ST8SIA6;B4GALT6
prerank,regulation of focal adhesion assembly (GO:0051893),0.4736936523067741,1.2615326626311043,0.16605616605616605,0.8293178457918607,1.0,17/54,10.42%,THBS1;EFNA5;NRP1;VEGFA;BCAS3;PHLDB2;LIMS1;ABL1;MYOC;PTPRA;VCL;FAM107A;DMTN;CORO1C;S100A10;SLC9A1;RHOA
prerank,calcium-ion regulated exocytosis (GO:0017156),-0.40969520576491475,-1.2608430050488633,0.14285714285714285,0.6092323132204434,1.0,14/27,20.91%,RIMS1;RIMS2;SYT1;SYT7;SYT10;SYT4;SYT11;SYT12;SYT6;SYT13;SDF4;PPP3CB;SYT2;SYT15
prerank,regulation of protein binding (GO:0043393),0.43312038988967766,1.2606257263663903,0.14021739130434782,0.8315411297803285,1.0,34/114,18.20%,BMP4;TCF7L2;PKD1;HDAC4;PRKCD;GSK3B;LRP1;DACT1;PRMT8;TIAM1;AURKA;KDM1A;TMC8;RIPK2;IDE;ZFPM1;MARK2;ITGB1BP1;DISC1;CARD16;SORL1;DDX11;NMD3;MARK3;DVL1;CAPRIN2;FLOT1;ADD1;CDKN1A;PSME3IP1;PIN1;LRRK2;STK3;RALB
prerank,glycerolipid catabolic process (GO:0046503),0.5456898920315791,1.260567532791245,0.19635343618513323,0.830439213842485,1.0,4/19,9.43%,MGLL;PLA2G4F;LYPLA2;ABHD6
prerank,metal ion homeostasis (GO:0055065),0.49716035969263794,1.2605022663182999,0.16750629722921914,0.8293408872073705,1.0,4/40,6.19%,SLC12A7;SLC12A2;CNNM2;FAM20A
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.3557992934034241,-1.2604294685728865,0.08860759493670886,0.6079703230203619,1.0,21/57,16.08%,GRIA4;ACTN2;APP;DLGAP1;GRIN2A;LRRC7;GRIN2B;MEF2C;GRIA1;GRIN1;CACNG7;CACNG4;GRIA3;CACNG3;CACNG2;NETO1;OPRM1;CAMK2B;CAMK2A;RELN;GSG1L
prerank,telomere maintenance via recombination (GO:0000722),0.6042818278323707,1.2604259417437673,0.22677165354330708,0.8282592300140178,1.0,6/11,23.41%,RAD51;SMC6;SMC5;RAD50;ERCC4;RAD51D
prerank,T-helper cell differentiation (GO:0042093),0.5801640018851438,1.2599019288709978,0.2118003025718608,0.828912071213472,1.0,1/14,0.23%,FOXP1
prerank,regulation of mast cell activation (GO:0033003),-0.5395443986173994,-1.2598748900800796,0.19289340101522842,0.6071290858004859,1.0,6/10,23.09%,LYN;NECTIN2;CD84;CRLF2;MILR1;CD300LF
prerank,regulation of cellular metabolic process (GO:0031323),0.48970734350768746,1.2588383838304167,0.16441717791411042,0.8315553449004498,1.0,12/45,16.22%,PID1;CYP1B1;CNDP1;COQ7;KIF16B;NCOR2;ACACA;EIF6;PDK3;ARF4;RNF41;FLOT1
prerank,blood vessel endothelial cell migration (GO:0043534),0.5434104117623748,1.2585636278771313,0.212707182320442,0.8312948721686613,1.0,5/22,3.37%,SLIT2;FGF2;NRP1;VEGFA;ID1
prerank,inflammatory response (GO:0006954),0.41985871515964446,1.258126256787157,0.07987551867219916,0.8316013069795885,1.0,30/195,9.99%,THBS1;MGLL;HDAC4;PTGDR;HDAC9;CMKLR1;CXCL2;VNN1;CCL3;CCL1;TRAF3IP2;ABCF1;TLR1;FOLR2;STAT3;ANXA1;C5AR2;PROK2;NFATC4;PRDX5;REL;CD44;PTGER1;IKBKG;NFATC3;AOC3;TLR4;ELF3;CCL7;RIPK2
prerank,protein import into peroxisome membrane (GO:0045046),0.5359407225466423,1.257877293279437,0.2,0.8311824480850126,1.0,5/22,10.07%,ABCD3;PXMP2;ABCD1;ACBD5;PEX13
prerank,exit from mitosis (GO:0010458),-0.5049084427091198,-1.257620434054656,0.20765027322404372,0.6111403215869928,1.0,2/12,2.71%,EPS8;CLASP2
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.45047806699476634,1.257113038766834,0.14689265536723164,0.8328062651142745,1.0,27/84,18.97%,FZR1;ECRG4;PSMB2;ANAPC5;AURKA;PSMD11;CUL3;ANAPC10;PSMC1;CDC16;ANAPC11;CDC20;CCNB1;PSMC6;MAD2L1;FBXO5;FBXO31;ANAPC16;PSMD1;PSMD4;CDK2;RB1;PSMA6;UBE2S;PSMD14;PSMD12;PSMD7
prerank,negative regulation of cell motility (GO:2000146),0.43583115219855695,1.256095515939746,0.12472406181015452,0.8354317425435743,1.0,15/108,5.44%,SLIT2;TMEFF2;CLIC4;DPYSL3;CDH1;CYP1B1;PTPRU;WNT11;IGFBP5;SLURP1;SRGAP2;SRGAP3;NOG;FOXO3;NF1
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.6321543772409013,1.2559960997817052,0.2259083728278041,0.8344915738650318,1.0,2/10,3.79%,LRP6;FZD1
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.6160013345292461,1.2559321162052128,0.21528861154446177,0.8334124224137505,1.0,6/12,11.40%,NFIB;TSKU;GLI2;PAFAH1B1;SZT2;EPHB2
prerank,relaxation of cardiac muscle (GO:0055119),0.5980120064569903,1.2559073087038783,0.22304283604135894,0.8321756231788476,1.0,4/13,1.98%,KCNJ2;CAMK2D;GSN;ATP1B1
prerank,NAD biosynthetic process (GO:0009435),0.5487545259702034,1.255896479374619,0.21128798842257598,0.8308816547662402,1.0,5/20,8.85%,PTGIS;NMNAT2;NNMT;NMNAT1;NUDT12
prerank,ERK1 and ERK2 cascade (GO:0070371),-0.43911170219035073,-1.2558547026810218,0.16610169491525423,0.6136539667569606,1.0,5/21,10.31%,IGF1;KDR;CTSH;MAPK1;MAP2K1
prerank,sodium ion export across plasma membrane (GO:0036376),0.5922635154261233,1.2554184227484635,0.2306525037936267,0.8314192960583592,1.0,7/13,9.77%,SLC4A4;ATP1B1;ATP12A;ATP1A3;ATP1A4;ATP1A1;SLC9A1
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),-0.5260446416735598,-1.2547569630571918,0.21098265895953758,0.6142397389926452,1.0,3/12,3.31%,APOE;PICALM;ROCK2
prerank,double-strand break repair (GO:0006302),0.4251709031791924,1.2546416456780531,0.09302325581395349,0.8330422725323107,1.0,76/158,30.15%,REV3L;ERCC5;NABP1;HERC2;RAD51;CHEK2;SLX4;BARD1;SPIDR;WRN;SMARCAL1;UIMC1;VCP;SMC6;MTA1;PARP3;CIB1;SMC5;PARP1;NSMCE1;RAD50;RNF138;EYA3;KPNA2;BRCA1;TNKS1BP1;RNF8;BRIP1;BRCC3;MORF4L1;PRKDC;SMARCA5;PPP5C;POLB;RECQL5;MDC1;MCM9;ACTR5;BRCA2;APLF;PARP2;PSMD14;KDM2A;XRCC5;ERCC4;YY1;NBN;AP5Z1;TDP2;DCLRE1A;RAD52;ABRAXAS1;RAD51D;ATM;RBBP8;XRCC4;POLM;INO80;RECQL;RAD21;KDM4D;POLQ;SUMO1;PARP9;SETMAR;RAD51B;PALB2;UBE2N;PAXIP1;PIAS4;RNF168;DTX3L;MAPK8;MMS22L;POLA1;GEN1
prerank,apoptotic cell clearance (GO:0043277),0.5134138550637998,1.2543185835957231,0.2,0.8330145012851911,1.0,5/30,5.34%,THBS1;RHOBTB1;RARA;LRP1;ANXA1
prerank,regulation of protein sumoylation (GO:0033233),0.5559971622675712,1.2541890711543975,0.22470238095238096,0.8322196702566393,1.0,3/17,8.34%,HDAC4;SAE1;EGR1
prerank,nuclear export (GO:0051168),0.45287703949601954,1.2541876715456584,0.13948256467941508,0.8309087585896451,1.0,26/80,19.30%,PKD1;SRSF11;U2AF2;THOC2;SRSF5;STRADA;SRSF6;NUP214;WASHC4;RANBP3;NUP153;XPO1;DESI1;XPO4;CHP1;CDC40;SRSF2;NUP155;NUTF2;SRSF1;XPO7;RNPS1;CSE1L;CHTOP;SMURF1;SARNP
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.6016165851935236,1.2539956019350798,0.22700296735905046,0.8290183349205098,1.0,2/11,5.33%,PTK2B;SHC1
prerank,cellular response to interleukin-2 (GO:0071352),0.6016165851935236,1.2539956019350798,0.22700296735905046,0.8290183349205098,1.0,2/11,5.33%,PTK2B;SHC1
prerank,negative regulation of mRNA processing (GO:0050686),0.5840316521818885,1.253548404312884,0.21122599704579026,0.8294465736234565,1.0,6/15,17.54%,U2AF2;BARD1;SRSF6;RBMX;RNPS1;PCBP4
prerank,nucleoside catabolic process (GO:0009164),0.6154775356237316,1.2532960594323614,0.234375,0.8291567540661576,1.0,4/11,12.29%,NT5C1A;NT5E;DERA;UPP2
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.5027304965382093,1.253074048931494,0.18518518518518517,0.8287459435497577,1.0,11/32,13.41%,THBS1;SEMA3E;BCAS3;PHLDB2;MYOC;FAM107A;DMTN;CORO1C;JAG1;ITGB1BP1;HOXA7
prerank,protein localization to centrosome (GO:0071539),0.5685112889099737,1.2529071488858492,0.20930232558139536,0.828093000918487,1.0,10/17,32.28%,PCM1;GOLGB1;HOOK3;NUDCD3;C2CD3;PIBF1;CCDC14;BBS4;CEP131;CSNK1D
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.5701964661792643,1.2528438431862725,0.2132564841498559,0.8270317771733153,1.0,10/16,27.04%,PAICS;AMPD3;AMPD2;NUDT2;LHPP;ADSS2;GMPS;ADSL;PFAS;ATIC
prerank,response to fatty acid (GO:0070542),0.5598103203748337,1.2526762335159825,0.2222222222222222,0.8263378650318974,1.0,7/17,18.40%,PID1;IRS1;FOXO3;PDK3;SOX9;PPP5C;SCD
prerank,monocyte differentiation (GO:0030224),0.6264390565797909,1.2516990659015623,0.24311183144246354,0.8288539834576533,1.0,2/10,3.16%,BMP4;VEGFA
prerank,positive regulation of glycolytic process (GO:0045821),0.5441802931189441,1.2513315033928212,0.21030640668523676,0.8276222344805324,1.0,5/20,9.51%,SLC4A4;PFKFB1;ENTPD5;MLXIPL;ARNT
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.5441802931189441,1.2513315033928212,0.21030640668523676,0.8276222344805324,1.0,5/20,9.51%,SLC4A4;PFKFB1;ENTPD5;MLXIPL;ARNT
prerank,camera-type eye development (GO:0043010),0.5267348322454508,1.2512977293446512,0.21825962910128388,0.8264400242750202,1.0,7/25,6.02%,CACNA1C;CYP1B1;PITX2;VEGFA;NF1;SKI;TSKU
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.4962898096801974,-1.251217786772211,0.1871508379888268,0.6214429949356801,1.0,3/13,9.00%,NOS3;CALM1;GCH1
prerank,protein maturation (GO:0051604),0.43589460853181494,1.2512174362199833,0.1403118040089087,0.8254553571569563,1.0,27/95,19.23%,F3;PCSK5;ASPRV1;ADAMTS3;ECE1;XPNPEP3;CASP2;GLRX3;PHEX;TSPAN17;MMP16;LONP2;TASP1;MMEL1;DDI2;PCSK7;NAA15;ECE2;SORL1;TYSND1;NAA40;CCS;ISCA1;CPZ;NFU1;NDUFAB1;NAA60
prerank,mitochondrion localization (GO:0051646),0.561279895635146,1.2510029376276672,0.21171171171171171,0.824990453091932,1.0,6/19,17.77%,MARK1;MEF2A;BRAT1;MARK2;TLE6;LRRK2
prerank,acyl-CoA metabolic process (GO:0006637),0.4898240993872502,1.250836082446999,0.2095115681233933,0.8243399515144167,1.0,13/35,21.18%,ACSM2A;ACSM2B;ACOT12;ACOT9;ACOT11;ACACA;ACOT8;SUCLA2;ACOT13;HMGCS2;GLYAT;ACOT6;OGDH
prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.39426694617196933,-1.2493049512190895,0.13178294573643412,0.6245922879360281,1.0,12/32,15.30%,ITGA1;PDGFRB;PPP1R16B;PPP1R15B;CALM1;HSP90AB1;CD300A;MAGI2;ANKLE2;CDH5;SMPD1;PPP2R5A
prerank,PERK-mediated unfolded protein response (GO:0036499),0.6112026956768736,1.2487962954696739,0.23208722741433022,0.8308890307061513,1.0,3/10,11.99%,NFE2L2;EIF2S1;HERPUD1
prerank,positive regulation of ATP metabolic process (GO:1903580),0.49909500227074827,1.2485712317001272,0.18961038961038962,0.8304769392064955,1.0,7/32,9.51%,SLC4A4;PID1;PFKFB1;ENTPD5;MLXIPL;VCP;ARNT
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.4988373740175285,-1.2485064842892764,0.19174041297935104,0.6244152488088957,1.0,6/13,26.59%,ADHFE1;GOT2;GPT2;PHYH;GOT1;IDH2
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.44879140731075884,1.2479501488267968,0.168141592920354,0.8314903354759808,1.0,36/80,24.22%,PLPP3;GBF1;TMED3;RAB6A;ARFGAP3;ARFGAP1;COPG1;ERGIC1;COPA;ERGIC2;KIF3B;NSF;ZW10;ARF4;ATP9B;KIF1C;ARCN1;COPB2;BNIP1;KLC1;GOLPH3;RAB1A;KDELR2;SURF4;COG3;RER1;TMED2;BICD2;GOLPH3L;KDELR3;ARF3;KIF23;KIF15;RAB1B;COPZ1;KIFAP3
prerank,regulation of cholesterol transport (GO:0032374),-0.4427269422588239,-1.2477898455012288,0.19936708860759494,0.624063270616923,1.0,8/20,17.62%,ABCA5;NUS1;NR1H3;ARV1;NR1H2;ABCB4;ABCA2;YJEFN3
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.40065338767304826,1.247751782002486,0.006,0.8309748006007763,1.0,198/834,17.36%,MICAL2;SIX1;BMP4;EGFR;PLAGL1;ZFHX3;KLF5;ZFPM2;TCF7L2;LRP6;NFIB;MET;PKD1;HES1;HDAC4;PID1;RARB;HOXA5;PPP3CA;CCN1;CSRP3;MEOX2;BMP5;NFAT5;TCF20;NFIA;FGF2;PBX1;SMAD9;EHF;GRHL2;PITX2;VEGFA;TGFB3;ESR1;NFE2L2;BMPR1A;GRHL1;DDX17;DCAF6;FOXC2;GLIS1;MLXIP;HOXC4;RARA;ELF1;BCAS3;KLF4;GLI3;CDK12;ABL1;RBM14;HDAC8;KLF7;HOXB3;IL33;MLLT10;MED13;NR4A3;TWIST1;KMT2C;STAT3;FOXO3;KLF10;SKI;NFIX;MRTFA;PER1;MEF2A;BMP6;MYSM1;GLI2;AGO2;HOXB4;GLIS2;REL;NR4A2;NCK2;INHBA;NRF1;CREBBP;RORA;APEX1;E2F3;IKBKG;MED24;NFATC3;RHOQ;IRF1;SMAD2;KANSL3;ZC3H12A;MLX;MLXIPL;TLR4;EGR1;NFIC;GATA4;THRAP3;KDM1A;RUNX2;RXRA;GABPB1;GABPB2;FOXC1;ELF3;PPRC1;MAVS;ZFP64;ARNT;SLC9A1;RIPK2;ATF6;CDK13;TBL1X;POU4F1;PARP1;DHX36;CRTC2;LPIN2;POGZ;ZFPM1;ATOH8;TEAD1;TFDP1;JUP;RXRB;ARF4;JAG1;THAP3;CRTC1;RPS6KA3;NCOA6;NR2F1;HSF2;BRCA1;NR1D1;ITGB1BP1;LMX1A;SREBF1;NR4A1;RRP1B;E2F1;LRP5;HOXA7;PAXBP1;SSBP3;NFATC1;RBMX;ACVR1;AATF;PRDM2;COPS5;HTATIP2;METTL23;RFXANK;HINFP;SP3;PPP1R12A;ATRX;SOX9;NR3C1;AKIRIN2;BCL11B;POU2F1;CDK7;CCNT2;PLSCR1;DVL1;E2F2;MEF2D;NCK1;SLC30A9;KAT6B;CAPRIN2;PRKDC;RNF111;HOXD3;TRAF6;TNIP1;PAX6;SMARCA5;MZF1;GDNF;ATF1;SMAD4;PIN1;IKBKB;ACTR2;PRDM10;YAP1;E4F1;CHD8;BCL9L;HCFC1;KMT2D;SMAD7;CAMTA2
prerank,regulation of endothelial cell proliferation (GO:0001936),0.4419504778788799,1.2472652397561177,0.13919821826280623,0.8314986646115763,1.0,19/88,13.73%,F3;THBS1;BMP4;PGF;FGF2;NRAS;NRP1;VEGFA;TGFBR1;NF1;SULF1;KRIT1;ARNT;XDH;ATOH8;SYNJ2BP;NRARP;NR4A1;ITGB3
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.5398088109842546,1.2466106786938094,0.20863309352517986,0.8327143110530488,1.0,5/21,7.75%,EXT1;HS3ST4;HS6ST2;XYLT1;SULF1
prerank,regulation of protein export from nucleus (GO:0046825),0.532661170065161,1.2463710897741975,0.21794871794871795,0.8323657989192343,1.0,6/23,10.49%,TCF7L2;GSK3B;EMD;BAG3;BARD1;XPO4
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.4477546802623789,1.2463652163692378,0.16493656286043828,0.8311146223818552,1.0,10/75,6.64%,F3;BMP4;PGF;FGF2;NRAS;NRP1;VEGFA;TGFBR1;FGFR1;SIRT6
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.4773827811526809,1.2462231946819098,0.18727050183598531,0.8304068318316243,1.0,10/47,9.61%,DOCK5;EFNA5;NRP1;LIMS1;ABL1;MYOC;DMTN;CORO1C;S100A10;CIB1
prerank,actin filament bundle assembly (GO:0051017),0.506680670438136,1.2459801186990553,0.19086021505376344,0.8300511519572757,1.0,9/33,7.87%,DPYSL3;BAIAP2L1;EZR;PAWR;CALD1;PLS1;LIMA1;FAM107A;DMTN
prerank,regulation of smooth muscle cell migration (GO:0014910),0.5617270912286063,1.2457787709446309,0.2373134328358209,0.829618395057416,1.0,5/20,5.02%,SLIT2;IGFBP5;NRP1;BMPR1A;LRP1
prerank,peptide biosynthetic process (GO:0043043),-0.2981809657259549,-1.2456416156277512,0.0,0.6277419160364407,1.0,52/153,17.53%,EEF1A1;RPL37;RPL27A;RPL19;RPS13;EIF4EBP2;RPS9;RPS3;GGT5;RPS14;RPL18A;RPL38;RPS19;RPS8;RPS11;RPL34;RPL18;RPL7;RPS25;RPL21;RPL23A;RPLP2;RPS21;RPL26;RPS4X;RPL41;RPS29;RPL35A;RPL10A;RPL11;RPS5;RPS16;MRPL3;CARNS1;RPL4;RPS7;RPS23;RPS15;MRPS14;RPL36;MRPS33;RPS18;RPL37A;RPL32;RPS20;RPL29;RPL13;RPL36A;MRPL51;HARS1;RPL23;RPL17
prerank,embryonic organ development (GO:0048568),0.46375233719679065,1.2453998068102057,0.17577197149643706,0.8298158720221561,1.0,10/61,7.67%,PBX3;PCSK5;RARB;COBL;PBX1;BMPR1A;GLI3;GLI2;TGFBR2;KITLG
prerank,regulation of mitochondrial membrane permeability (GO:0046902),-0.4539068272816005,-1.2453550270297449,0.20447284345047922,0.6260643830107462,1.0,4/18,15.60%,BCL2;BCL2L1;THEM4;CAMK2A
prerank,O-glycan processing (GO:0016266),0.458107543486676,1.2452503384311673,0.18316831683168316,0.8291235157702873,1.0,5/54,5.26%,ST3GAL4;GXYLT2;B3GNT2;GALNT15;GALNT13
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.47749614152244085,1.2450683717233064,0.17967781908302355,0.8285202155306508,1.0,4/48,5.20%,SLC26A2;GUCY2C;PAPSS2;ADCY9
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.3996435974462839,1.2447917115027713,0.0,0.8282569067171832,1.0,378/1667,17.61%,FOXP2;TBX15;FOXP1;KLF12;ZBTB7C;SIX1;BMP4;PBX3;EGFR;NR3C2;PLAGL1;ZFHX3;TCF7L1;KLF5;ZFPM2;TCF7L2;TFCP2L1;LRP6;ZFHX4;PRRX2;NFIB;SLTM;MET;MKX;PKD1;FOXD1;HES1;HDAC4;FOXP4;PID1;ZIC4;CUX1;RARB;TWIST2;HOXA5;PPP3CA;CCN1;CSRP3;KLF3;MEOX2;DDX5;CAMK2D;SMAD6;USP2;BMP5;NFAT5;PRDM6;TCF20;EZR;ANXA4;HOXA3;NFIA;HDAC9;FGF2;SKIL;JMJD1C;HOXB6;PBX1;MDFI;PURG;FOXL1;SMAD9;EHF;PRRX1;DMRT3;DMBX1;SOX14;SP8;GRHL2;PITX2;ELP3;JDP2;VEGFA;TGFB3;ESR1;HOXC6;NFE2L2;BMPR1A;ID2;GRHL1;DDX17;ID1;DCAF6;WWP2;ZNF148;FOXC2;ZIC1;GLIS1;BRD3;MLXIP;HOXC4;RARA;ELF1;BCAS3;KLF4;GLI3;SP110;CDK12;ABL1;ATOH7;RBM14;HDAC8;HOXA6;KLF7;HOXB3;NOG;IL33;MLLT10;MED13;NR4A3;TWIST1;ARID4B;RCOR3;NIPBL;KMT2C;STAT3;FOXO3;KLF10;CC2D1B;CCNL1;SKI;NFIX;MRTFA;FRK;ZBTB16;PER1;MEF2A;DACT1;ATP2B4;NFIL3;SRCAP;NFATC4;BMP6;LCOR;BHLHE40;MYSM1;KLF9;GLI2;CCNL2;TCF25;AGO2;MNAT1;HOXB4;ERBB2;GLIS2;REL;SIRT6;NR4A2;NCK2;INHBA;MIER1;NFE2L1;NRF1;CREBBP;RORA;CRY2;NCOR1;ZNF691;APEX1;E2F3;POU3F4;IKBKG;MED24;PHF21A;NFATC3;RHOQ;IRF1;SMAD2;FOXO6;CHD3;KANSL3;EED;ZC3H12A;MLX;MLXIPL;CBX5;CCND1;TLR4;EGR1;NCOR2;NFIC;GATA4;PER3;THRAP3;KDM1A;DNMT3A;RUNX2;RXRA;HOXA2;HIF3A;SMARCAL1;GABPB1;GABPB2;MED27;MXD4;IFRD1;FOXC1;ELF3;PPRC1;MAVS;MTA1;TADA3;ZFP64;ARNT;HES3;SIX4;BRMS1L;BRMS1;SLC9A1;SMARCC1;ATF7;RIPK2;ATF6;HDGFL3;CDK13;NSD1;TBL1X;CCNB1;POU4F1;PARP1;DHX36;BCOR;CRTC2;ARID4A;LPIN2;ERF;ZNF25;CREB3L1;RCOR1;MECP2;IGBP1;RFX2;POGZ;ZFPM1;ATOH8;HOXB5;TEAD1;ZBTB1;TFDP1;PHF12;JUP;RXRB;ZBTB32;MYNN;ARF4;JAG1;ZBTB8B;THAP3;CRTC1;RPS6KA3;NCOA6;NR2F1;ETV3;MDM4;HSF2;BRCA1;NR1D1;CEBPD;ZBTB8A;FUS;ZFP3;BATF3;ITGB1BP1;GTF2IRD1;EZH1;LMX1A;ELOA;SREBF1;NR4A1;ZBTB24;DLG1;RRP1B;E2F1;LRP5;HOXA7;PAXBP1;MTDH;NFYA;SSBP3;HIRA;NFATC1;PATZ1;DMAP1;RBMX;ACVR1;AATF;MED15;PRDM2;COPS5;HTATIP2;METTL23;RFX7;HR;RFXANK;HINFP;SP3;PPP1R12A;BRIP1;MED31;ZBTB34;ATRX;SOX9;SRA1;NR3C1;SP140;AKIRIN2;BCL11B;NKAP;CHD1;TARBP1;THAP7;POU2F1;CDK7;CCNT2;URI1;PLSCR1;FOSB;GMEB1;DVL1;E2F2;MEF2D;NCK1;ZNF394;UBE2D3;SLC30A9;KAT6B;CAPRIN2;PRKDC;TOX4;ZNF219;RNF111;HOXD3;TRAF6;KMT5A;TNIP1;HIVEP3;KDM5B;PAX6;SSU72;SMARCA5;ZBTB3;MZF1;CDKN1A;MOV10;GDNF;ATF1;PRDM5;SMAD4;FOXK1;NCOA5;PIN1;ZFP1;ZMYM5;IKBKB;ACTR2;TSHZ2;SNF8;PHF20L1;PRDM10;PLK3;GTF2H3;YAP1;E4F1;CHD8;ESR2;VPS72;BCL9L;HCFC1;KMT2D;RB1;SMAD7;ZBTB7B;CAMTA2;TLE6;RNF14;KDM3B;MED20;POU6F1
prerank,positive regulation of transporter activity (GO:0032411),0.5804604738743121,1.2446499927603842,0.21752738654147105,0.8275715639331954,1.0,3/13,11.00%,STK39;RXRA;SYNGR3
prerank,carbohydrate biosynthetic process (GO:0016051),0.5303353626203939,1.244581991726099,0.20953757225433525,0.8265815161520476,1.0,3/21,7.09%,ST3GAL4;FUT8;B4GALT1
prerank,actin filament bundle organization (GO:0061572),0.505923920716119,1.2439886411162882,0.19448275862068964,0.8275596893776959,1.0,9/33,7.87%,DPYSL3;BAIAP2L1;EZR;PAWR;CALD1;PLS1;LIMA1;FAM107A;DMTN
prerank,fat cell differentiation (GO:0045444),0.46483233332631824,1.24379334539914,0.19952210274790919,0.8270420104535137,1.0,8/57,6.71%,TCF7L2;BBS9;PID1;SMAD6;TMEM120A;KLF4;NR4A3;NR4A2
prerank,amino acid import (GO:0043090),0.5379608813896855,1.243530616519152,0.19637883008356546,0.8267617322791921,1.0,2/21,3.80%,SLC47A1;SFXN3
prerank,digestive tract morphogenesis (GO:0048546),0.5739856312054246,1.243514244875072,0.23520710059171598,0.8255901399900925,1.0,4/14,7.51%,ID2;EPHB3;NIPBL;AGR2
prerank,regulation of response to biotic stimulus (GO:0002831),0.5193709238685972,1.2431155265753184,0.2247191011235955,0.825866056429762,1.0,2/28,1.19%,FOXP1;CD55
prerank,response to interferon-beta (GO:0035456),-0.42129211023902446,-1.2428884402524456,0.17105263157894737,0.6304927478203255,1.0,11/22,19.63%,IFITM1;IFITM3;IFNAR2;NDUFA13;BST2;STAT1;AIM2;IFITM2;SHFL;CDC34;XAF1
prerank,protein localization to synapse (GO:0035418),0.6058113357474026,1.2427998316045046,0.23397913561847988,0.825799500562285,1.0,7/12,14.20%,SHANK1;BSN;PCLO;ZDHHC12;NLGN1;ZDHHC15;NRXN2
prerank,chromatin assembly or disassembly (GO:0006333),0.6200871583225411,1.2425739453242772,0.2365079365079365,0.8254130451643699,1.0,3/11,8.07%,CHAF1B;HDAC8;CHAF1A
prerank,regulation of cartilage development (GO:0061035),0.5557249115450038,1.2425596818335447,0.2324561403508772,0.8242414435849742,1.0,5/18,5.84%,BMP4;BMP1;WNT11;PTHLH;ZBTB16
prerank,protein stabilization (GO:0050821),0.4186802759971334,1.2423326800747523,0.12289915966386554,0.82389741362064,1.0,52/168,20.01%,RASSF2;PRKCD;USP2;ANK2;ATP1B1;PLPP3;TELO2;HPS4;SEC16A;TBRG1;IFT46;PARVA;CHEK2;USP13;BAG3;TRIM39;PER3;NLK;P3H1;WDR81;TBL1X;AAK1;CHP1;TRIM44;NAA15;CLU;STX12;MDM4;COA8;RAB21;MORC3;PIM2;ATF7IP;SEL1L;CDK7;UBE2B;DVL1;CCT5;FLOT1;CDKN1A;PIN1;HCFC1;SMAD7;GOLGA7;STK3;BAG5;COG3;OTUD3;FKBPL;CREBL2;USP19;BAG2
prerank,spliceosomal complex assembly (GO:0000245),0.48070407461930953,1.2416031673143029,0.18678526048284624,0.82543202342471,1.0,24/46,32.07%,CELF3;LUC7L2;SRSF5;SRSF6;CELF4;CELF1;SCAF11;SRSF1;LUC7L3;SRPK2;KHDC4;YTHDC1;USP39;SMN1;SNRNP200;CELF6;RBM5;GCFC2;ZRSR2;SRPK1;TXNL4A;SF3B1;NOL3;DDX39B
prerank,toll-like receptor signaling pathway (GO:0002224),0.4366919381907196,1.2409752082767609,0.16647919010123735,0.8265124186823668,1.0,27/84,19.76%,SCARA3;LBP;PIK3AP1;PLCG2;IRAK3;TLR1;TAB3;IRAK4;IKBKG;TLR4;RIPK2;MAP3K7;TAB2;TLR8;MAP3K1;MYD88;RPS6KA3;TIRAP;UBE2D3;TRAF6;TNIP1;IKBKB;SCIMP;MAPKAPK2;TICAM1;COLEC12;CHUK
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.46877908231161913,-1.240870005845841,0.1933534743202417,0.6337921801254932,1.0,4/15,11.91%,ARPC4;ARPC5;IQGAP2;ARPC3
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.4752183165249889,1.2408538027661165,0.18681318681318682,0.8257324754541625,1.0,10/48,10.24%,DOCK5;CUX1;NRP1;LIMS1;ABL1;MYOC;DMTN;S100A10;CIB1;FBXW8
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.5263929368089703,1.2406579620240759,0.22330097087378642,0.8252140075191464,1.0,5/23,9.51%,SLC4A4;PFKFB1;ENTPD5;MLXIPL;ARNT
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.4569386457365181,-1.2403617822128237,0.20261437908496732,0.6327921917458238,1.0,9/18,18.29%,ACSL1;ELOVL7;ACSL4;HACD1;HACD2;ACSBG1;ACSL5;ELOVL6;HSD17B12
prerank,stabilization of membrane potential (GO:0030322),0.5681155464423115,1.2401295531984762,0.23053435114503817,0.8259686869540176,1.0,1/16,0.18%,KCNK5
prerank,cellular response to hydroxyurea (GO:0072711),0.6137605574809445,1.2400687688700562,0.21955128205128205,0.824996966705303,1.0,7/10,22.06%,SPIDR;DDI2;DDX11;RTF2;ATRX;DDI1;FMR1
prerank,epithelial cell morphogenesis (GO:0003382),0.5565844354704516,1.2398880371719532,0.2298507462686567,0.8244433176052804,1.0,3/17,3.31%,MET;GRHL2;RAB25
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.6010042392002927,1.2392205267650251,0.24758842443729903,0.8246227863777229,1.0,1/10,0.77%,CDC42EP5
prerank,regulation of pseudopodium assembly (GO:0031272),0.6010042392002927,1.2392205267650251,0.24758842443729903,0.8246227863777229,1.0,1/10,0.77%,CDC42EP5
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.41958278946301286,-1.2388483136044024,0.1906474820143885,0.6345218742893761,1.0,5/26,3.89%,IGF1;OSBPL8;OCLN;PIK3R1;INSR
prerank,lipid catabolic process (GO:0016042),-0.457547230789356,-1.2387481716088589,0.1880597014925373,0.6324744792678283,1.0,8/18,26.92%,PLA1A;PLAAT3;SIRT2;LPL;MT3;LIPE;LIPH;PPT1
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.46060712285054034,1.2383952313631938,0.17753623188405798,0.8265878491613591,1.0,26/59,26.46%,TANK;ERC1;TAB3;REL;IKBKG;TLR4;RIPK2;MAP3K7;TAB2;IRAK1BP1;TLR8;TRAF2;TRAF6;IKBKB;MAP3K14;RBCK1;FAIM;TICAM1;CHUK;RELB;TRADD;UBB;NLRC3;UBA52;SHARPIN;RPS27A
prerank,negative regulation of transposition (GO:0010529),0.5646113788244523,1.2382605051109454,0.2441860465116279,0.8258464150823202,1.0,4/16,16.34%,TEX15;TUT7;TUT4;MOV10
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.39771436282948097,1.237342284698967,0.0,0.8279894213410838,1.0,411/1645,20.29%,FOXP2;BNC2;TBX15;FOXP1;WWP1;KLF12;ZBTB7C;VSX1;SIX1;BMP4;PBX3;EGFR;NR3C2;PLAGL1;ZFHX3;TCF7L1;KLF5;ZFPM2;TCF7L2;TFCP2L1;LRP6;ZFHX4;PRRX2;NFIB;SLTM;MKX;MAP3K5;FOXD1;HES1;HDAC4;FOXP4;CDH1;ZIC4;CUX1;TWIST2;HOXA5;TCIM;MLLT3;KLF3;MEOX2;DDX5;CAMK2D;RBFOX2;SMAD6;WNT11;SAMD7;NFAT5;TCF20;FOXN3;GCLC;ANXA4;HOXA3;NFIA;HDAC9;FGF2;JMJD1C;PRICKLE1;HOXB6;PBX1;PURG;FOXL1;SMAD9;EHF;PRRX1;ERC1;DMRT3;DMBX1;SOX14;SP8;GRHL2;PITX2;ELP3;JDP2;VEGFA;TGFB3;ZNF423;ESR1;HOXC6;NFE2L2;ID2;GRHL1;DDX17;ID1;WWP2;ZNF148;FZD1;FZD7;FOXC2;ZIC1;GLIS1;BRD3;MLXIP;HOXC4;RARA;ELF1;KLF4;GLI3;PHC2;SP110;LIMS1;TLE2;TGFBR1;ABL1;ATOH7;MDFIC;HOXA6;KLF7;HOXB3;MED13;NR4A3;TWIST1;ARID4B;RCOR3;NIPBL;STAT3;SHC1;FOXO3;CDC45;KLF10;CC2D1B;SPINDOC;CCNL1;NFIX;CHEK2;USP13;ZBTB16;PER1;MEF2A;ATP2B4;NFIL3;SRCAP;NFATC4;LCOR;BHLHE40;HMG20A;KLF9;GLI2;CCNL2;MNAT1;HOXB4;ERBB2;L3MBTL3;GLIS2;REL;NR4A2;MBD1;INHBA;NFE2L1;NRF1;WAC;CREBBP;EHMT1;RORA;CRY2;NCOR1;ZNF691;TENM1;SERTAD3;CDK11B;E2F3;POU3F4;MED24;NFATC3;DKK3;IRF1;SMAD2;FOXO6;CHD3;EED;BTAF1;MLX;MLXIPL;GPBP1;CBX5;EGR1;NCOR2;NFIC;GATA4;THRAP3;CIPC;KDM1A;RUNX2;RXRA;NLK;HOXA2;HIF3A;SMARCAL1;MED27;MXD4;UIMC1;IFRD1;CD80;FOXC1;ELF3;PDCD4;ILF2;TADA3;ARNT;HES3;SIX4;GPATCH3;BRMS1;SMARCC1;ATF7;CDK16;TASP1;ATF6;HDGFL3;NSD1;TBL1X;POU4F1;TGFB1I1;QARS1;DHX36;BCOR;ARID4A;ERF;ZNF25;CREB3L1;RCOR1;DENND4A;MECP2;SCMH1;RFX2;ATOH8;HOXB5;TRIM44;TEAD1;ZBTB1;NAA15;FBXO5;POLR3F;TP53INP2;TFDP1;PHF12;CDKN1C;RXRB;ZBTB32;MYNN;ZBTB8B;NIBAN2;CDKN1B;RPS6KA3;NCOA6;NFXL1;NR2F1;APBB3;ETV3;MDM4;HSF2;BRCA1;POFUT1;NR1D1;CEBPD;ZBTB8A;FUS;ZFP3;BATF3;GTF2IRD1;RET;LMX1A;ELOA;SREBF1;NR4A1;ZBTB24;E2F1;PRMT5;LRP5;HOXA7;RRP8;MTDH;NFYA;HIRA;NFATC1;PATZ1;DMAP1;ACVR1;AATF;PRDM2;HTATIP2;RFX7;HR;RFXANK;HINFP;SP3;PIM2;ATF7IP;BRIP1;KHDRBS1;MED31;MSL3;PITHD1;ZBTB34;ATRX;SOX9;SRA1;NR3C1;SP140;BCL11B;NKAP;CHD1;TARBP1;THAP7;POU2F1;CCNT2;URI1;FOSB;GMEB1;DVL1;E2F2;MEF2D;MBTD1;ZNF394;KAT6B;TOX4;ZNF219;RNF111;HOXD3;TRAF6;KMT5A;EFEMP1;HIVEP3;KDM5B;PAX6;SMARCA5;ZBTB3;MZF1;CDKN1A;ATF1;MAP3K10;PRDM5;SMAD4;FOXK1;USP47;ZFP1;IKBKB;TSHZ2;SNF8;PHF20L1;YAP1;E4F1;CHD8;ESR2;ERN2;HCFC1;KMT2D;RB1;SMAD7;ASCC2;ZBTB7B;NEK4;CAMTA2;RNF20;PCID2;RNF14;KDM3B;MED20;POU6F1;PRDM15;UBP1;NUP35;TAF5;TRRAP;DEK;ACTR5;ATF2;BRCA2;RGMB;KMT2E;DHX9;KDM2A;PRDM11;NONO;PIAS2;PHF20;GON4L;MED16;NFX1;PPARG;PRMT6;COMMD7;BRD4;ZBTB2;ZNF260;USP21;USP16;ELP4;HDAC2;CARF;EPC1;MAFF;CEBPG;HEXIM1;XRCC5;CHUK;SATB2;CREBL2;LIN9;CCNT1;ZBTB25;NR1D2;ZBTB7A;TCF12;IKZF2;BRD9;PHF14;FOXK2;E2F5;BCL7A;PCGF1;ZBTB48
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.51155210454661,-1.2372048382503202,0.18994413407821228,0.6343353521914886,1.0,3/11,8.56%,NOVA1;NOVA2;PCBP3
prerank,amino acid import across plasma membrane (GO:0089718),0.5193184437990225,1.2361959964475997,0.21208053691275167,0.8309346157891105,1.0,1/24,0.01%,SLC47A1
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.4688518413092939,-1.2361350763844787,0.19463087248322147,0.6349749087871522,1.0,6/16,8.07%,PLCB1;RANBP3L;IGFBP3;RIPOR2;MEF2C;BTG1
prerank,regulation of striated muscle contraction (GO:0006942),-0.4002521847723278,-1.23596187291395,0.1423076923076923,0.6331144144297016,1.0,5/27,12.14%,ATP1A2;RYR2;CALM1;SLC8A3;GRK2
prerank,negative regulation of response to stimulus (GO:0048585),0.45628052860401325,1.2358456120218582,0.18137847642079807,0.8310311128126009,1.0,9/60,6.93%,SLIT2;UBASH3B;VPS13C;COL3A1;SRMS;KLF4;KLF7;TWIST1;NLRP12
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.5981076329411408,1.2357373153852171,0.23316912972085385,0.8302303688169318,1.0,3/12,11.50%,SOAT1;ACSL3;SOAT2
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.43244017468224577,-1.235724535033981,0.1875,0.6314824451607459,1.0,6/21,11.17%,PLTP;APOE;PTCH1;NR1H3;EEPD1;NR1H2
prerank,positive regulation of lymphocyte activation (GO:0051251),-0.40061273118301255,-1.235476781198319,0.16917293233082706,0.62986920309213,1.0,13/28,24.36%,SIRPA;SH3KBP1;PRKCQ;TNIP2;TYROBP;CD47;NOD2;THY1;PYCARD;HSPD1;FGF10;CCL2;CYRIB
prerank,mesenchymal cell differentiation (GO:0048762),-0.3462021515760256,-1.2349431968152211,0.135678391959799,0.6291148948711105,1.0,15/51,8.78%,RANBP3L;LEF1;WNT4;ENG;TGFBR3;WNT5A;ROCK2;RBPJ;MEF2C;BMP7;NOTCH1;LOXL3;NOTCH4;HEY2;BMP2
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.42816912632405696,1.234700674860254,0.1511111111111111,0.8328067623712161,1.0,15/101,12.21%,THBS1;PERP;SAMD4A;CYFIP2;EZR;NIBAN1;KLF4;DACT1;ERBB2;INHBA;EIF3E;RDX;EIF6;RBM3;NAT10
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.6092310017774459,1.2337586052843466,0.2319277108433735,0.8350965562341351,1.0,4/11,13.02%,LRP6;FZD1;NR4A2;LMX1A
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.588452264849445,1.2336070346183063,0.23692307692307693,0.8344218156821059,1.0,4/12,7.52%,IRS1;NR4A3;TWIST1;ABCD1
prerank,regulation of epidermal cell differentiation (GO:0045604),0.5357674278490598,1.2334846841018896,0.22657342657342658,0.8336543141635373,1.0,3/21,4.71%,BMP4;SFRP4;KLF7
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.5396163727455776,1.2331676187437932,0.23295454545454544,0.8336325518643474,1.0,5/19,4.73%,ZFPM2;FGF2;BMPR1A;TGFBR1;NOG
prerank,central nervous system development (GO:0007417),0.40706981620393773,1.2330983789913925,0.09257375381485249,0.8326562762362009,1.0,29/250,6.71%,SLC23A1;WWP1;PBX3;DCLK1;ZFHX3;VIT;NFIB;PKD1;ADGRL2;ZIC4;GSN;PBX1;ECRG4;DMBX1;GRHL2;ELP3;SMO;ZIC1;S100B;SHROOM4;PDGFC;NIPBL;STAT3;NF1;ZBTB16;SNTG2;GLIS2;TGFBR2;NR4A2
prerank,negative regulation of ion transport (GO:0043271),0.5181063744334591,1.2329683940907286,0.23404255319148937,0.8319338090825766,1.0,3/24,2.10%,NEDD4;WNK1;PTK2B
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.586768217100774,1.2327232046704402,0.23299565846599132,0.8316900599230935,1.0,5/13,13.58%,TMEM30B;SEC16A;TM9SF4;BCAP31;SORL1
prerank,negative regulation of epithelial cell proliferation (GO:0050680),-0.33645625226656967,-1.2322540769584338,0.11464968152866242,0.6344372251802681,1.0,9/66,3.88%,ROBO1;MCC;MTSS1;PTPRM;NR2F2;APOE;TGFBR3;B2M;CDK6
prerank,angiogenesis involved in wound healing (GO:0060055),-0.5061914909520184,-1.232072500587281,0.21680216802168023,0.6326985465492568,1.0,6/11,8.91%,KDR;NDNF;GATA2;PRCP;CD34;MCAM
prerank,positive regulation of cell adhesion (GO:0045785),0.44745445604647216,1.231518156028549,0.18566392479435959,0.8349421636790242,1.0,12/74,9.87%,ZFHX3;VIT;ADAM9;PPP3CA;VEGFA;FOXC2;LIMS1;ERBB2;AGR2;CHRD;CIB1;ITGAV
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.5146701423296325,1.231351117817848,0.22443181818181818,0.8344159912485618,1.0,4/25,1.98%,STK39;WNK1;ANK2;ATP1B1
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.5354538515025481,1.2311540818599613,0.2185792349726776,0.833938929763931,1.0,7/21,17.26%,RASSF2;NCK2;DMTN;MLXIPL;DMD;NCK1;SMAD7
prerank,regulation of viral life cycle (GO:1903900),-0.4441937649912598,-1.2309952568366354,0.19202898550724637,0.6334909025896579,1.0,6/21,16.32%,HS3ST5;TRIM14;AXL;TRIM62;NECTIN2;TYRO3
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.5750634968176376,1.2308861615939048,0.23493975903614459,0.8338118246294017,1.0,8/14,27.04%,RFK;PAICS;LHPP;ADSS2;GMPS;ADSL;PFAS;ATIC
prerank,response to organic cyclic compound (GO:0014070),0.4590924914619789,1.230773565371173,0.18726591760299627,0.833030609562571,1.0,7/52,5.34%,ALPL;CYP1B1;IGFBP5;ESR1;CCL3;STAT3;ANXA1
prerank,protein localization to chromatin (GO:0071168),0.5518052186223195,1.2305562347582955,0.23795620437956205,0.8326380016300557,1.0,11/18,27.83%,ESR1;NIPBL;LEMD2;MCM9;TASOR;WAPL;PPHLN1;RAD21;SGF29;MRNIP;PLK1
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.4457666107281593,-1.2305470842061992,0.17391304347826086,0.632510061434786,1.0,9/19,7.11%,ROBO1;SEMA6A;JCAD;CCBE1;DCN;CD63;TSPAN12;CADM4;DAB2IP
prerank,dicarboxylic acid transport (GO:0006835),0.5149200687445327,1.2305071749410845,0.21359223300970873,0.8316469730066876,1.0,4/28,4.89%,SLC26A7;SLC26A6;GIPC1;FOLR2
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.6120703183421484,1.2302385118333443,0.2369281045751634,0.8314035411530346,1.0,4/10,11.85%,RARB;RARA;RXRA;RXRB
prerank,cellular zinc ion homeostasis (GO:0006882),-0.4168393472220249,-1.2296590521858046,0.18352059925093633,0.6327470762277432,1.0,16/26,20.31%,SLC30A10;SLC39A10;SLC39A8;SLC30A1;SLC39A12;ATP13A2;MT3;MT2A;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B
prerank,regulation of dendritic spine development (GO:0060998),-0.4370723377894836,-1.229532547971946,0.1792452830188679,0.630877497352286,1.0,6/19,7.95%,APOE;SHANK3;PPFIA2;MEF2C;CPEB3;KIF1A
prerank,regulation of Ras protein signal transduction (GO:0046578),0.43882445723757657,1.229456014676274,0.15885714285714286,0.8331430991680705,1.0,18/86,12.55%,ARHGEF28;PLCE1;AKAP13;NGF;ARHGDIB;NOTCH2;ARHGAP44;SHOC2;SHC1;BCR;ARHGAP17;STARD13;ARFGAP1;RDX;ERBIN;DENND4A;EPHB2;RAF1
prerank,endoplasmic reticulum organization (GO:0007029),0.4442831332428264,1.229324812774588,0.16904761904761906,0.8324526370370107,1.0,23/72,19.10%,ATL3;TRAM2;ATL2;SEC16A;EMD;LMAN2L;SEC31A;SEC61A1;SHTN1;MIA3;GAK;DOP1B;STX5;RTN3;SPTSSB;TMEM33;TOR1B;ATL1;BNIP1;VAMP2;TLE6;LRRK2;VCPIP1
prerank,regulation of epithelial cell migration (GO:0010632),0.4597661297278306,1.2293165806746063,0.20525657071339173,0.8313134586374488,1.0,6/51,4.45%,BMPER;DOCK5;RHOJ;PRKCE;RAB25;PLCG2
prerank,inositol lipid-mediated signaling (GO:0048017),0.4621694249521197,1.2290438078596602,0.21303258145363407,0.8311445079822307,1.0,10/50,5.14%,PLCE1;TNFAIP8L3;PLCZ1;EZR;PIK3C2B;GAB2;NGF;PLCB3;IRS1;FGFR1
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.4545595865073639,1.228742415788617,0.18257756563245822,0.8310258098128791,1.0,33/58,30.61%,HERC2;BARD1;SMARCAL1;UIMC1;SMC5;RAD50;BRCA1;RNF8;BRCC3;PRKDC;POLB;MDC1;PSMD14;KDM2A;XRCC5;ZBTB7A;ERCC4;NBN;DCLRE1A;ABRAXAS1;ATM;XRCC4;POLM;ERCC8;POLQ;SUMO1;SETMAR;UBE2N;PAXIP1;PIAS4;RNF168;POLA1;XRCC6
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.5198295199486684,1.2282676987938212,0.24617524339360222,0.8315635527309114,1.0,4/22,7.88%,ADAM9;PTPN3;TIMP1;TIMP2
prerank,macrophage activation (GO:0042116),0.48770330028416137,1.228211910872935,0.22007722007722008,0.8305752769331061,1.0,7/34,12.19%,FOXP1;LBP;PLCG2;TLR1;TLR4;IFI35;CLU
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.3987566144905572,1.2277209751818228,0.04008016032064128,0.8312240166155545,1.0,145/497,21.27%,FOXP2;FOXP1;WWP1;BMP4;ZFPM2;TCF7L2;FOXD1;HES1;HDAC4;TWIST2;RBFOX2;SAMD4A;WNT11;SAMD7;IGFBP5;FOXN3;GCLC;HDAC9;PRICKLE1;DMBX1;SOX14;ZNF423;ID2;ID1;WWP2;ZNF148;GSK3B;RARA;KLF4;GLI3;PHC2;LIMS1;TLE2;MDFIC;PAIP2;TWIST1;RCOR3;NIPBL;SHC1;KLF10;SPINDOC;CNOT8;ZBTB16;PER1;NFIL3;BHLHE40;L3MBTL3;GLIS2;MBD1;EHMT1;CRY2;NCOR1;DKK3;IRF1;SMAD2;EED;BTAF1;MLX;MLXIPL;CBX5;NCOR2;CIPC;KDM1A;RUNX2;UIMC1;ELF3;EPRS1;PDCD4;SIX4;BRMS1;QARS1;DHX36;BCOR;ARID4A;EIF2AK2;EIF2AK1;CREB3L1;RCOR1;MECP2;SCMH1;ATOH8;PHF12;CDKN1C;NIBAN2;CDKN1B;RAD17;BRCA1;NR1D1;E2F1;HOXA7;PATZ1;DMAP1;HINFP;SP3;ATF7IP;KHDRBS1;SOX9;NR3C1;NKAP;THAP7;POU2F1;MBTD1;KAT6B;ZNF219;TRAF6;KMT5A;CDKN1A;MAP3K10;PRDM5;SMAD4;FOXK1;USP47;CHD8;ERN2;RB1;TSPYL2;TOB1;PRDM11;NONO;SYNCRIP;ENC1;DAPK1;IGF2BP3;PPARG;PRMT6;COMMD7;ATR;HDAC2;EPC1;HEXIM1;XRCC5;S100A11;NR1D2;ZBTB7A;FOXK2;BCL7A;WAPL;CAPRIN1;NKX2-1;PML;CBFA2T2;NPAS1;ID3;SAMD4B;DAP
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.6116931180309102,1.2274632671882102,0.24807395993836673,0.8309602151756246,1.0,3/10,7.06%,KLF4;IRAK3;PALM3
prerank,generation of neurons (GO:0048699),0.40963376010638597,1.2273407676638353,0.102803738317757,0.8302212503105131,1.0,33/190,10.21%,SIX1;WNT9A;MET;HES1;MARK1;CIT;WNT11;FGF13;NRP1;ELP3;FZD1;FZD7;ITM2C;ATOH7;FGFR1;THOC2;DNAAF4;DOCK7;ACSL3;CTF1;BHLHE40;ERBB2;NRBP2;NR4A2;PAFAH1B1;RUNX2;SDCCAG8;MAP1B;HES3;SIX4;LRP12;PEX13;NAV1
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.5274184104712617,-1.2270815260201728,0.21671018276762402,0.6354162414449358,1.0,4/10,13.35%,ST6GAL1;ST3GAL1;NPL;GNPDA2
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.5909018039383767,1.2268886301586486,0.23099850968703428,0.8306731526486986,1.0,6/12,13.18%,CACNA1C;DSP;DSG2;TRPM4;JUP;DLG1
prerank,camera-type eye morphogenesis (GO:0048593),0.6215742677127317,1.2262268657041777,0.25732899022801303,0.8319532361097876,1.0,4/10,5.65%,LRP6;VEGFA;NF1;SKI
prerank,negative regulation of interleukin-8 production (GO:0032717),0.5417073781855706,1.2258933208819223,0.2602739726027397,0.8319669230449515,1.0,3/17,5.34%,ANXA4;KLF4;ANXA1
prerank,somite development (GO:0061053),0.5955078987681085,1.2256877732127007,0.2375776397515528,0.831567708185404,1.0,2/11,3.50%,MEOX2;SMO
prerank,sphingosine metabolic process (GO:0006670),0.5598846005279574,1.224580689791102,0.2440828402366864,0.8343781642254605,1.0,2/17,2.14%,ACER3;PLPP3
prerank,gliogenesis (GO:0042063),0.5615298622308605,1.224493929349391,0.24511278195488723,0.8335271804790297,1.0,3/15,5.34%,NFIB;CD9;ANXA1
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.5046471568757451,1.2243424250807418,0.21324503311258278,0.8329148980809995,1.0,12/28,24.39%,EGFR;TCIM;WWP2;NIBAN2;NRARP;ZBTB7A;HIF1AN;DLK2;EGF;DLK1;MMP14;RITA1
prerank,regulation of smoothened signaling pathway (GO:0008589),0.46051074766456496,1.2243242674051393,0.199252801992528,0.8318197261170818,1.0,16/50,16.29%,GPC3;SMO;ZIC1;GLI3;GAS1;GLIS2;TEDC2;CREBBP;RORA;EVC;VCP;ULK3;KIF7;MEGF8;HHIP;DLG5
prerank,positive regulation of cell junction assembly (GO:1901890),-0.34154359665689676,-1.2240635623089455,0.12418300653594772,0.6415507829234304,1.0,17/56,12.19%,IL1RAPL1;TEK;GRID2;CNTNAP2;CLDN5;EPHB1;NRXN1;KDR;SYNDIG1;MAP4K4;CUX2;RAC1;SRPX2;LRRC4B;PTPRJ;PTPRD;ACE2
prerank,substrate-dependent cell migration (GO:0006929),0.5601567253417147,1.2239342017052055,0.23227752639517346,0.8321207662569183,1.0,4/14,12.96%,NTN1;NRP1;SHTN1;ITGB1BP1
prerank,inorganic cation transmembrane transport (GO:0098662),0.4045714777192528,1.2233988706244656,0.10050761421319797,0.8329139696516064,1.0,40/268,11.37%,SLC4A4;SLC9A2;KCNK5;KCNJ2;KCNB2;SLC12A2;SLC24A3;CACNA1C;PKD1;SCARA5;CACNA1G;ATP2C2;ATP1B1;KCNB1;KCNS3;SLC39A14;ANO6;TRPM7;TRPM6;SLC6A7;ATP2B4;ATP6V0A4;SLC39A13;SLC39A11;SLC30A3;TRPM4;SLC6A2;ATP12A;ATP1A3;ATP1A4;ATP1A1;SLC9A1;ITGAV;COX15;KCNG4;TRPM8;TRPC4AP;SLC9A8;NALCN;RHCG
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.5449235845183122,1.2227970873358205,0.24390243902439024,0.8338551796958663,1.0,3/17,3.03%,CACNA1G;CLTRN;KCNB1
prerank,ncRNA 3'-end processing (GO:0043628),0.573937353568302,1.2223090198993256,0.24357034795763993,0.8344077062557125,1.0,9/14,24.95%,INTS5;INTS6;ERI1;SSB;INTS7;PTCD1;INTS14;INTS8;INTS2
prerank,regulation of cellular protein localization (GO:1903827),0.4636962648427259,1.222249860939863,0.21473158551810237,0.8335010899845825,1.0,16/45,19.10%,GPC6;GPC3;NDEL1;GBF1;SETD2;SPIDR;KDM1A;VCP;PARP1;RAB11B;GPC4;DVL1;CCDC66;PIN1;RALB;VCPIP1
prerank,"wound healing, spreading of cells (GO:0044319)",0.5187592478311207,1.2221873512294175,0.23462088698140202,0.8325858879901088,1.0,5/24,10.42%,TMEFF2;CCN1;MRTFA;CD44;RHOA
prerank,positive regulation of histone methylation (GO:0031062),-0.41775694274282604,-1.2212501341326167,0.15699658703071673,0.6473307472414536,1.0,2/24,2.65%,AUTS2;JARID2
prerank,peptidyl-lysine monomethylation (GO:0018026),0.6146853291029704,1.2211949301057055,0.26366559485530544,0.8349621626866855,1.0,6/10,26.83%,SETD2;EHMT1;KMT5A;SETD6;SMYD2;SETD7
prerank,cardiac muscle cell action potential (GO:0086001),0.5027650282110352,1.221082606362141,0.22462787550744248,0.8342422139812321,1.0,5/30,1.98%,KCNJ2;CACNA1C;CACNA1G;ANK2;ATP1B1
prerank,microglial cell activation (GO:0001774),-0.41744190093172134,-1.2210000027983805,0.17320261437908496,0.6457612382336557,1.0,10/21,24.12%,APP;MAPT;C1QA;IFNGR1;CX3CL1;TYROBP;GRN;SNCA;AGER;TREM2
prerank,cellular response to tumor necrosis factor (GO:0071356),0.41037691437862617,1.2206862652090231,0.1261730969760167,0.8344538791764351,1.0,46/175,21.82%,CARD14;PID1;TANK;TNFRSF11B;PTK2B;EDA;YBX3;NFE2L2;PSMB2;CCL3;LIMS1;CCL1;FOXO3;ZFAND6;PSMD11;ZC3H12A;PSMC1;CIB1;CCL7;ERBIN;PSMC6;TRAF2;BRCA1;NR1D1;PSMD1;GSDME;TRAF6;PSMD4;TRAF5;IKBKB;TNFRSF12A;MAP3K14;PSMA6;TNFSF13B;PSMD14;DHX9;PSMD12;PSMD7;JAK2;COMMD7;CHUK;CDIP1;TRAF3;PSME3;TXNDC17;TRADD
prerank,regulation of leukocyte activation (GO:0002694),-0.4801393449985823,-1.2203826080353306,0.22580645161290322,0.6453009179756752,1.0,5/14,15.87%,LYN;MFHAS1;CD200;MIF;CD74
prerank,regulation of phosphorylation (GO:0042325),0.41946408144219094,1.2201608449116785,0.1664841182913472,0.835184246234443,1.0,28/120,18.04%,THBS1;BMP4;EGFR;NRP1;FZD7;NUP93;INHBA;BARD1;FN1;NUP214;CORO1C;NUP153;CDKN2C;EIF6;CDKN1C;CDKN1B;NUP155;RAD17;RANBP2;ROPN1;NUP88;MCM7;CDKN1A;PIN1;IKBKB;GLMN;NUP35;NCKAP1L
prerank,mRNA splice site selection (GO:0006376),0.4990186941577158,1.220138660139751,0.2125340599455041,0.8341395706485571,1.0,13/30,27.87%,CELF3;LUC7L2;SRSF5;SRSF6;CELF4;CELF1;SRSF1;LUC7L3;KHDC4;YTHDC1;PRPF39;SFSWAP;CELF6
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.593269676033469,1.2199271979055089,0.2419871794871795,0.8337831942547927,1.0,7/11,32.75%,SIRT6;ATF7IP;TASOR;PPHLN1;RESF1;SETDB1;TPR
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.5839387724724016,1.2191335894458235,0.258160237388724,0.8355156280308691,1.0,5/13,18.04%,GLI3;TGFBR2;NKAP;ZBTB7B;NCKAP1L
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.5650458431234691,1.218801446589818,0.24926253687315633,0.8356227476694756,1.0,4/15,9.03%,LRP6;EDA;GLI2;FOXC1
prerank,positive regulation of actin filament polymerization (GO:0030838),0.47387526616960585,1.2186664221832657,0.20558375634517767,0.8349785191018823,1.0,7/44,7.25%,CDC42EP5;BAIAP2L1;PRKCE;GSN;PTK2B;NCK2;TENM1
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.5553256608889157,1.217766281915828,0.25722543352601157,0.8370028407242132,1.0,4/17,3.16%,SLIT2;FGF2;NRP1;VEGFA
prerank,negative regulation of cell adhesion (GO:0007162),-0.3226149152340373,-1.2174316672367196,0.125,0.6511597567972082,1.0,19/72,10.23%,SEMA6A;FBLN1;SPOCK1;ACER2;CDH13;RIPOR2;CORO2B;PODXL;NEXMIF;SIPA1;PLXND1;NOTCH1;JAM3;PLXNC1;ADAM22;PTPRO;NF2;ARHGDIA;SEMA5A
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.4132498656565192,1.217389982318678,0.1511879049676026,0.8372125637740576,1.0,16/142,6.83%,PLCE1;SLC35G1;CACNA1C;CD55;PTGDR;ADRA1B;PLCZ1;EDNRA;CMKLR1;ESR1;CCL1;ABL1;C5AR2;ATP2B4;PROK2;PTGER1
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.4620840516449111,-1.2170243390879483,0.22318840579710145,0.6500249263405717,1.0,4/16,17.64%,CLDN5;CLDN1;CLDN14;CLDN10
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.4939526088413362,-1.2169975978939744,0.23809523809523808,0.6478773212455049,1.0,5/12,11.17%,PPARA;ABCA5;ABCG1;NR1H3;NR1H2
prerank,regulation of postsynapse organization (GO:0099175),-0.3970684519754783,-1.216953103577517,0.17753623188405798,0.6458173963677821,1.0,8/28,7.95%,IL1RAPL1;SHANK3;PPFIA2;WNT5A;ARHGAP22;EPHA4;CFL1;KIF1A
prerank,proteoglycan metabolic process (GO:0006029),0.5022639590938935,1.2166093915368685,0.22795115332428764,0.8390199224945677,1.0,8/26,11.16%,HS3ST4;FOXL1;CHST13;XYLT1;CHST11;GAL3ST4;SULF1;B3GALT6
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.5736514472469391,1.2161128650389794,0.2417910447761194,0.8396073351952156,1.0,5/13,17.77%,RHOQ;ENTPD7;AK4;AK3;LRRK2
prerank,purine ribonucleotide catabolic process (GO:0009154),0.5253545734086826,1.2158862272908664,0.2538569424964937,0.8393058564515183,1.0,4/21,10.33%,NT5C1A;NT5E;AMPD3;XDH
prerank,cellular response to DNA damage stimulus (GO:0006974),0.3967114760174617,1.2158426260350443,0.06161616161616162,0.8383226276729527,1.0,133/336,26.18%,FOXP1;TANK;EXO1;DCUN1D5;ABL1;NIPBL;NABP1;HERC2;UBR5;RAD51;CHEK2;FANCL;TICRR;SLX4;MAPK12;MNAT1;UBE2A;WAC;CASP2;BARD1;SPIDR;APEX1;IKBKG;WRN;TOPBP1;IKBKE;ZC3H12A;CBX5;CCND1;CHD1L;HELB;SMARCAL1;VCP;SMC6;PARP3;ALKBH8;CIB1;POLE2;SMC5;CEP63;PARP1;KIN;CGAS;WDR48;MCL1;ZBTB1;FBXO31;RAD50;SUSD6;POLI;NCOA6;BRAT1;RAD17;BRCA1;KMT5B;NUDT1;E2F1;TRIP12;DDX11;AATF;TIGAR;HINFP;RNF8;FBXO45;PIDD1;MCM7;UBE2B;USP28;PRKDC;SMC1A;PCLAF;FAM111A;CDKN1A;USP47;PLK3;GTF2H3;YAP1;POLB;NEK4;RECQL5;DTL;TRRAP;MCM9;MAPKAPK2;ATF2;APLF;PARP2;RMI2;VCPIP1;ATR;USP16;TLK2;PARP4;XRCC5;USP10;ERCC4;CDKN2AIP;PML;YY1;IRF3;NBN;FMR1;SPDYA;CHEK1;TAOK1;KMT5C;SPRTN;RAD52;WDR76;BOD1L1;ALKBH1;RAD51D;ATM;TP53;RBBP8;DDIT3;SLF1;ASF1A;INO80;RECQL;RAD9A;BID;CSNK1E;RAD9B;ALKBH7;ERCC8;RAD54L;MACROD2;POLK;POLQ;GTF2H4;MRNIP;TOPORS
prerank,tRNA wobble uridine modification (GO:0002098),0.5695747729030605,1.2153017016837508,0.25609756097560976,0.839045477932231,1.0,4/14,9.90%,ELP3;DPH3;ALKBH8;MTO1
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.5251825782929239,1.2152551596694983,0.24147727272727273,0.8380733622264294,1.0,2/20,6.89%,ADAM9;SPPL2A
prerank,cellular response to misfolded protein (GO:0071218),0.5360765327271481,1.2149565343266708,0.24061196105702365,0.8380850590423276,1.0,4/20,9.11%,RNF126;RNF185;CUL3;VCP
prerank,negative regulation of cell projection organization (GO:0031345),-0.35211307604264536,-1.2141981460197457,0.14427860696517414,0.6510454557524763,1.0,14/48,9.42%,EFNB2;APOE;LPAR1;SPOCK1;RAPGEF2;DCC;GRIN2B;EPHA4;MAG;RTN4RL1;PTPRO;DENND5A;YWHAH;CRMP1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.46412847216015274,1.2135409695652024,0.21189591078066913,0.842099956473963,1.0,17/54,17.54%,PLAGL1;CRADD;CNOT8;CHEK2;AURKA;CASP2;CCNB1;TFDP1;CDKN1B;MDM4;E2F1;TNKS1BP1;PIDD1;CDKN1A;CNOT4;PLK3;PCBP4
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.5576274940757168,1.2134956855058507,0.2545454545454545,0.841155961763858,1.0,5/15,18.55%,LARGE1;RENBP;CHST5;OGA;GNPDA1
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.457082345435829,1.2131000643549403,0.2140221402214022,0.8414165570626798,1.0,8/48,5.34%,THBS1;RHOJ;HDAC9;FGF2;VEGFA;FOXC2;FGFR1;ANXA1
prerank,myelination in peripheral nervous system (GO:0022011),0.5691782541751255,1.2129019829962744,0.2406832298136646,0.8410069944635387,1.0,4/13,12.45%,NF1;SKI;MYOC;PARD3
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.39151837847780546,1.2127525922775861,0.016016016016016016,0.8404213128562369,1.0,185/807,17.32%,FOXP2;FOXP1;WWP1;KLF12;BMP4;ZFHX3;ZFPM2;TCF7L2;FOXD1;HES1;HDAC4;FOXP4;CUX1;RARB;TWIST2;DDX5;RBFOX2;USP2;WNT11;SAMD7;PRDM6;FOXN3;GCLC;EZR;HDAC9;SKIL;PRICKLE1;MDFI;DMBX1;SOX14;JDP2;VEGFA;ZNF423;ESR1;ID2;ID1;WWP2;ZNF148;FOXC2;GLIS1;RARA;KLF4;GLI3;PHC2;LIMS1;TLE2;MDFIC;HDAC8;KLF7;NOG;IL33;NR4A3;TWIST1;RCOR3;NIPBL;STAT3;SHC1;FOXO3;KLF10;SPINDOC;SKI;NFIX;FRK;ZBTB16;PER1;MEF2A;DACT1;NFIL3;BMP6;PRDX5;LCOR;BHLHE40;GLI2;TCF25;L3MBTL3;GLIS2;SIRT6;NR4A2;MBD1;MIER1;CREBBP;EHMT1;CRY2;NCOR1;PHF21A;DKK3;IRF1;SMAD2;CHD3;EED;BTAF1;MLX;MLXIPL;CBX5;CCND1;NCOR2;NFIC;PER3;CIPC;KDM1A;DNMT3A;RUNX2;RXRA;MXD4;UIMC1;FOXC1;ELF3;MTA1;PDCD4;SIX4;BRMS1L;BRMS1;NSD1;TBL1X;POU4F1;PARP1;QARS1;BCOR;ARID4A;ERF;ZNF25;CREB3L1;RCOR1;MECP2;SCMH1;IGBP1;ZFPM1;ATOH8;ZBTB1;PHF12;CDKN1C;ZBTB32;NIBAN2;CDKN1B;NR2F1;MDM4;BRCA1;NR1D1;BATF3;GTF2IRD1;EZH1;DLG1;E2F1;HOXA7;MTDH;PATZ1;DMAP1;PRDM2;HINFP;SP3;ATF7IP;KHDRBS1;SOX9;NR3C1;NKAP;THAP7;POU2F1;URI1;FOSB;MBTD1;UBE2D3;KAT6B;ZNF219;TRAF6;KMT5A;PAX6;MZF1;MAP3K10;PRDM5;SMAD4;FOXK1;NCOA5;USP47;ZMYM5;PLK3;YAP1;E4F1;CHD8;ESR2;VPS72;ERN2;HCFC1;RB1;SMAD7;ZBTB7B
prerank,regulation of T cell cytokine production (GO:0002724),0.5683370275825695,1.2125350154322685,0.2481536189069424,0.8400865651438393,1.0,6/15,17.26%,CD55;TRPM4;MAP3K7;TRAF2;TRAF6;SMAD7
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.4119130636863173,-1.2124053427341026,0.21052631578947367,0.653963738986547,1.0,3/23,1.78%,ENG;NREP;TGFBR3
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.44136536666349296,1.2121951295959918,0.19134396355353075,0.8401758122522519,1.0,24/78,17.77%,FZR1;RNF144A;PRICKLE1;NFE2L2;GSK3B;ZYG11B;SIRT6;CSNK1A1;ARIH1;VCP;CDC20;ANKIB1;DDA1;DET1;KEAP1;HERPUD1;CLU;BCAP31;COP1;DVL1;PLK3;SMAD7;RNF14;LRRK2
prerank,double-strand break repair via break-induced replication (GO:0000727),0.5831714054764203,1.2121113564183834,0.25116279069767444,0.8393876451852259,1.0,4/12,16.33%,CDC45;MCM2;MCM7;CDC7
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.5074995146662553,1.212091408159872,0.25884016973125884,0.8383304852186932,1.0,8/26,13.41%,RARA;CCL3;PTPN2;INHBA;TLR4;TCTA;ZFPM1;HOXA7
prerank,positive regulation of DNA binding (GO:0043388),0.49179927458879025,1.2110783039206405,0.2404227212681638,0.8407915430264749,1.0,12/31,21.00%,HES1;NGF;TWIST1;SKI;FOXC1;POU4F1;NIBAN2;TRAF6;RB1;PPARG;CEBPG;EGF
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.5870161884384493,1.2110343670852415,0.270935960591133,0.839877831157157,1.0,3/12,5.87%,DSE;UST;BGN
prerank,negative regulation of axon extension (GO:0030517),-0.38420844845252167,-1.2109193372214055,0.1879432624113475,0.6559411845815583,1.0,17/30,20.81%,SEMA6A;MAP2;SEMA7A;SEMA6D;RTN4;MAG;SEMA3B;SEMA5A;SEMA3G;SEMA5B;MT3;SEMA6B;TRIM46;SEMA4G;SEMA3A;SEMA3F;SEMA4D
prerank,neuron development (GO:0048666),-0.29238413986301215,-1.2106834604215917,0.06349206349206349,0.6543081413405443,1.0,45/141,13.25%,PTPRM;LYN;APOE;CNTNAP2;FRYL;TENM3;MAP2;APP;CNTN4;TENM2;RASGRF1;MYT1L;RAPGEF2;UGCG;GPM6A;EPHA5;RYK;SH3GL2;PLP1;EPHA8;MEF2C;DCX;LAMB1;OPHN1;TENM4;STMN1;BICDL1;LGI1;TMEM108;B4GALT6;STMN4;NTRK2;MAPT;ALK;GPM6B;ATCAY;STMN3;MICALL1;VAPA;BTG2;UHMK1;FRY;HMGB1;ATP8A2;ATXN10
prerank,regulation of cell-matrix adhesion (GO:0001952),0.4383041225778138,1.2106363811121177,0.1960093896713615,0.8402101718524564,1.0,16/64,13.41%,THBS1;SEMA3E;PTK2B;EFNA5;GSK3B;NF1;MYOC;PTPRA;VCL;CORO1C;CIB1;SLC9A1;RHOA;JUP;JAG1;HOXA7
prerank,regulation of RNA export from nucleus (GO:0046831),0.5947434201014545,1.210121801001768,0.2665639445300462,0.8408272287470844,1.0,5/11,24.47%,SETD2;NUP153;KHDRBS1;DHX9;AKAP8L
prerank,positive regulation of glucose metabolic process (GO:0010907),0.5583796146210263,1.2099708317343116,0.2543859649122807,0.8402752606229384,1.0,3/14,5.71%,IRS1;PTPN2;NNMT
prerank,endothelial cell development (GO:0001885),-0.41059499616570044,-1.2096342490904792,0.2074074074074074,0.6552025380125431,1.0,9/25,7.74%,COL22A1;PECAM1;PPP1R16B;COL18A1;RAPGEF3;RAPGEF2;PDE4D;ROBO4;PDE2A
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.5108098674637466,1.2095289377038805,0.2348804500703235,0.8408495378668611,1.0,15/25,33.50%,SCAF8;WDR43;CCNT2;CCNT1;TSFM;SETD5;HMGN1;SUPT4H1;ELL;THOC1;EAF1;THOC5;HTATSF1;DDX39B;ALYREF
prerank,response to molecule of bacterial origin (GO:0002237),0.4380705450329109,1.2091361858901164,0.19444444444444445,0.8411656237838981,1.0,17/69,20.79%,FOXP1;LBP;SMAD6;CXCL2;IRAK3;PALM3;TLR4;ERBIN;TAB2;RPS6KA3;TIRAP;OTUD5;MAPKAPK2;SRR;JAK2;SLPI;FER
prerank,wound healing (GO:0042060),0.44416212125098387,1.2089811640413313,0.19953863898500576,0.8405559231582902,1.0,14/62,9.50%,AHNAK2;PPP3CA;FGF2;COL3A1;DSP;SYTL4;FZD7;TGFBR1;NOG;NF1;TSKU;ERBB2;GATA4;MIA3
prerank,regulation of muscle contraction (GO:0006937),0.5055571979153557,1.2087739418878851,0.23473541383989144,0.8401550034297814,1.0,3/26,4.22%,KCNB2;PLCE1;PPP1R12B
prerank,modification-dependent protein catabolic process (GO:0019941),0.40936775141360743,1.208706673364993,0.13043478260869565,0.8393281310523452,1.0,55/193,19.05%,FBXL7;NEDD4;FZR1;RNF144A;FBXO10;CBLC;RNF126;UBE4B;RNF114;ANAPC5;SPSB2;UBE2A;AURKA;ADRM1;PSMD11;RNF185;ARIH1;WDR81;CUL3;ANAPC10;CDC16;UBE4A;ANAPC11;CDC20;ANKIB1;UBR4;TRPC4AP;UBE3C;MAD2L1;KEAP1;ANAPC16;HERPUD1;RNF130;RNF146;UBE2K;UBR3;TRIP12;MIB1;RNF8;FBXO45;UBE2B;RNF111;NTAN1;RNF11;CNOT4;RNF20;AREL1;RNF14;UBE2S;DTL;SMURF1;PSMD14;CHFR;COPS3;PCYOX1L
prerank,adherens junction organization (GO:0034332),-0.35199990480159943,-1.2084666302233713,0.19662921348314608,0.6564623346081353,1.0,19/48,15.16%,TJP1;CADM1;CDH2;CDH8;CDH13;CADM2;CDH4;CDH10;ACTB;JAM3;CADM3;CDH7;CDH19;CDH20;CDH5;CDH12;CDH22;NECTIN2;CTNNB1
prerank,regulation of protein kinase B signaling (GO:0051896),0.400722735807505,1.2084326161309067,0.13664596273291926,0.839207579513821,1.0,34/193,13.45%,F3;THBS1;EGFR;TNFAIP8L3;TCF7L2;MET;NTRK3;FGF2;GAB2;PIK3AP1;IRS1;ESR1;PHLPP2;CCL3;TGFBR1;FGFR1;MYOC;ERBB2;STRN;ITGB1;KITLG;GATA4;CD80;SFRP5;PPP2R5C;CIB1;MYORG;XDH;TRAT1;DRD3;CPNE1;ITGB1BP1;RET;MTDH
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.6002849445348453,1.2077928866094074,0.2659235668789809,0.8403610611969153,1.0,2/10,2.99%,NT5C1A;NT5E
prerank,"DNA-templated transcription, termination (GO:0006353)",0.44443999725140426,1.2076429979960128,0.19689737470167065,0.8398049559921046,1.0,36/68,34.15%,POLR1G;POLR1A;MNAT1;LSM11;SCAF8;TAF1D;PRMT5;POLR3K;CDK7;SSU72;GTF2H3;CPSF3;POLR1F;UBTF;MTERF2;CSTF3;CLP1;TTF1;TBP;MAZ;FIP1L1;SMN1;GTF2H4;TTF2;CSTF1;WDR33;SNRPB;ERCC2;CSTF2T;GTF2H5;NUDT21;TAF1C;GTF2H1;MED18;SNRPF;TAF1A
prerank,response to tumor necrosis factor (GO:0034612),0.42789633650144654,1.207358130400465,0.20501138952164008,0.8397629171232095,1.0,16/91,12.71%,PID1;ADAM9;TANK;AFF3;YBX3;NFE2L2;CCL3;CCL1;ZFAND6;ZC3H12A;CIB1;CCL7;ERBIN;IGBP1;BRCA1;NR1D1
prerank,mesonephros development (GO:0001823),0.5896579164409509,1.2067012038387805,0.26791277258566976,0.8409308168069428,1.0,2/11,5.84%,BMP4;ZBTB16
prerank,positive regulation of gene expression (GO:0010628),0.3905497891899619,1.2064357326732842,0.07228915662650602,0.8407566611189011,1.0,94/442,17.50%,SLC38A2;F3;THBS1;BMP4;EGFR;SLC24A3;FOXD1;NTRK3;PID1;HOXA5;DDX5;SAMD4A;ANK2;WNT11;GSN;EZR;FGF2;NIBAN1;KRAS;PKP1;NGF;SFRP4;ITGB8;VEGFA;NFE2L2;ID2;SMO;GSK3B;KLF4;CCL3;LIMS1;U2AF2;PLCG2;TGFBR1;NOG;IL33;POLR1G;SERPINB9;TWIST1;STAT3;UBR5;EMILIN1;BMP6;POLR1A;AGO2;ERBB2;INHBA;FN1;AGR2;ZC3H12A;TLR4;EGR1;EIF3E;RDX;TADA3;TMEM119;PIK3R3;EIF6;POU4F1;DHX36;EIF2AK2;EPHB2;RBM3;CD46;TAF1D;CLU;NAT10;MYD88;BRCA1;CELF1;E2F1;DDX21;HINFP;SOX9;CNTF;AFDN;PLSCR1;CIRBP;PRKDC;HOXD3;PAX6;RBMS3;SMARCA5;FLOT1;MOV10;SNF8;YAP1;GLMN;HCFC1;RPS6KB1;TENT4B;POLR1F;ZBTB7B;LARP4
prerank,positive regulation of MAP kinase activity (GO:0043406),-0.3282317853100277,-1.2060654837531675,0.08633093525179857,0.6609733811573456,1.0,13/66,7.11%,ROBO1;FLT1;IL34;SASH1;PDGFD;PDGFRB;KIT;PAK1;FGF1;RPS3;TNFRSF11A;PIK3R6;DAB2IP
prerank,epithelial cell-cell adhesion (GO:0090136),0.5797367355173416,1.2057621824846425,0.249597423510467,0.8420678138325947,1.0,5/11,11.81%,CCN3;ITGB5;DSP;VCL;JUP
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.5648588441809599,1.2054588069147725,0.2737341772151899,0.8420543636397037,1.0,5/12,14.79%,NIN;PCM1;HOOK3;BICD1;CEP19
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.5411032757171832,1.2053696000545058,0.25773195876288657,0.8413258408205508,1.0,2/17,2.18%,PCSK5;HDAC9
prerank,response to retinoic acid (GO:0032526),-0.3253907989056927,-1.204534316176598,0.13636363636363635,0.6631248098134971,1.0,15/59,9.28%,LYN;PTK7;WNT5B;WNT6;ACER2;RBP4;WNT5A;BRINP3;RORB;CTSH;TBX1;NDUFA13;TWF2;GATA6;BRINP1
prerank,regulation of glycolytic process (GO:0006110),0.4417091625077179,1.2044519180150435,0.20441347270615565,0.8434728459980116,1.0,15/68,14.40%,SLC4A4;HDAC4;PFKFB1;NUP93;NCOR1;ENTPD5;NUP214;MLXIPL;NUP153;ARNT;EIF6;NUP155;RANBP2;TIGAR;NUP88
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.545122984879502,1.2041319736865748,0.2716236722306525,0.8434836189689222,1.0,4/17,1.84%,KCNJ2;CACNA1C;CACNA1G;ANK2
prerank,positive regulation of axon extension (GO:0045773),0.5123529650994487,1.2040764800626986,0.2610497237569061,0.8425731193414182,1.0,7/22,17.38%,NTN1;NRP1;VEGFA;SHTN1;DBN1;MEGF8;GOLGA4
prerank,regulation of histone deacetylation (GO:0031063),0.5711240121089299,1.2040487646567226,0.2545454545454545,0.8415910994355167,1.0,5/13,19.08%,CAMK2D;NIPBL;SAP30BP;ZBTB7B;PRMT6
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.5644135039158746,1.2036972351153052,0.2559880239520958,0.8417867306892794,1.0,3/13,3.27%,ZFPM2;FGF2;BMPR1A
prerank,positive regulation of lymphocyte migration (GO:2000403),-0.482656258162254,-1.203692607111585,0.23054755043227665,0.6633043592241106,1.0,4/12,11.26%,APP;CXCL12;JAM2;DOCK8
prerank,purine-containing compound biosynthetic process (GO:0072522),0.5079963974764041,1.203479252940928,0.24,0.8414209012111066,1.0,9/25,23.14%,PRPS2;ADA;PAICS;AMPD3;DGUOK;GMPR2;AMPD2;GMPS;ADSL
prerank,DNA geometric change (GO:0032392),0.5082415755291907,1.2030708873225902,0.25500667556742324,0.8417324277041207,1.0,11/24,24.42%,ANXA1;WRN;DHX36;RAD50;DDX11;RECQL5;HNRNPA2B1;MCM9;DHX9;NBN;RECQL
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.4604625032280067,1.202746085680293,0.22632226322263221,0.8417827337724598,1.0,13/49,19.08%,THBS1;RAB7B;NR4A3;KMT2C;CIB1;EIF6;ZFPM1;PITHD1;MOV10;CNOT4;KMT2D;KMT2E;PRMT6
prerank,superoxide metabolic process (GO:0006801),0.49243293597811766,1.2024527295802387,0.23915900131406045,0.8417273302377006,1.0,1/29,0.13%,SH3PXD2A
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.5174566964455432,1.2022507549597676,0.254421768707483,0.8413621595547867,1.0,8/26,17.21%,EGFR;ERBB2;KNSTRN;FOXC1;SYAP1;GAREM1;SOX9;IQGAP1
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.5408321648699916,1.2020716032413035,0.27180232558139533,0.8409337060370929,1.0,6/16,19.64%,RAET1E;PLEKHM2;LYST;KIF5B;VAMP2;CEBPG
prerank,DNA replication checkpoint signaling (GO:0000076),0.5505604742065641,1.2018420689251224,0.2816691505216095,0.8405897164888494,1.0,5/16,12.64%,CDC45;TICRR;TOPBP1;CLSPN;RAD17
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.4083963983400965,1.2017253531347234,0.15918803418803418,0.8399737449838222,1.0,38/146,20.40%,FBXL7;FHL1;PSMB2;PCM1;AURKA;PAFAH1B1;PSMD11;CEP43;CCND1;AKAP9;PSMC1;SDCCAG8;CUL1;HAUS2;CCNB1;CEP63;PLK4;MECP2;PSMC6;PCNT;FBXO5;PSMD1;OFD1;PSMD4;CDK2;CDC7;USP47;CENPJ;PSMA6;DTL;CEP164;PSMD14;PSMD12;CETN2;PSMD7;BRD4;RAB11A;SFI1
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.5783845782908876,1.2015704663698288,0.26489028213166144,0.8394220290635043,1.0,2/13,1.74%,PERP;CYFIP2
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.5307119709527087,1.2015169536233403,0.26173541963015645,0.8385599378928512,1.0,8/20,9.77%,KCNJ2;SLC12A2;ATP1B1;ATP12A;ATP1A3;ATP1A4;ATP1A1;SLC9A1
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.5120861555777271,1.201372701820405,0.24005486968449932,0.8379692994675927,1.0,11/24,19.28%,ABCG2;NFE2L1;UROS;RSAD1;COX15;FXN;SUCLA2;TSPO;PPOX;ATP5IF1;FLVCR1
prerank,sensory perception (GO:0007600),-0.35288047971316294,-1.2012892979760785,0.17676767676767677,0.6678900475555801,1.0,24/45,28.94%,RETREG1;ADGRV1;PCDH15;MME;ADORA2A;TRPV2;P2RX7;TMEM150C;SCN9A;WHRN;OPRM1;TTC8;TRPA1;USH2A;KCNA2;PENK;CHRNA4;NTSR2;CCL2;KCNK4;CHRNB2;ALOXE3;CLRN1;PNOC
prerank,protein neddylation (GO:0045116),0.5598384744215474,1.20115334572628,0.26843657817109146,0.8376516320220546,1.0,6/13,19.53%,DCUN1D5;UBE2M;DCUN1D2;DCUN1D1;UBA3;UBE2F
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.5854352297962135,1.2011364509138003,0.2723076923076923,0.8366550271802522,1.0,10/13,29.52%,NELFE;RNF8;RECQL5;HEXIM1;TCERG1;LARP7;EAPP;SUPT4H1;NELFA;RNF168
prerank,calcium-mediated signaling (GO:0019722),0.4198186615896464,1.2010522550093765,0.19063545150501673,0.8358834191857969,1.0,16/93,12.45%,EGFR;PLCE1;CACNA1C;PPP3CA;ANK2;ATP1B1;CCL3;PLCG2;DMTN;TRPM4;SLC9A1;RCAN1;SAMD14;MCU;NMUR2;BCAP31
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.5581902250878416,1.2009978330160687,0.27165932452276065,0.8350071014248216,1.0,4/15,4.52%,EGFR;PTK2B;SRMS;ABL1
prerank,clathrin-dependent endocytosis (GO:0072583),-0.40349690988931797,-1.2008788347113144,0.18556701030927836,0.6668897380565599,1.0,5/26,6.04%,DNAJC6;SGIP1;PICALM;FNBP1L;SNAP91
prerank,steroid catabolic process (GO:0006706),-0.5176244407128844,-1.2007312096633742,0.24093264248704663,0.6651518060898347,1.0,2/10,9.37%,YWHAH;SPP1
prerank,phosphate ion homeostasis (GO:0055062),0.5949090038471985,1.200564735464399,0.27001569858712715,0.8354936762010973,1.0,2/10,3.07%,SLC34A2;SFRP4
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),-0.4424388647039514,-1.2000789140057215,0.23636363636363636,0.664864038553635,1.0,4/18,5.75%,FLT1;COL4A3;AKT3;MEF2C
prerank,myotube cell development (GO:0014904),0.6004798939202838,1.1997182197506004,0.2889983579638752,0.8374329893613385,1.0,3/10,9.94%,SIX1;SKI;MYORG
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.4778414560123792,1.1997096998846501,0.22617534942820838,0.8364239453759678,1.0,7/38,12.66%,THBS1;BMP5;GSK3B;FEM1B;TMC8;TRAF2;BRCA1
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.5695999561133409,1.1991591459370305,0.27300613496932513,0.8372707527176112,1.0,4/12,17.68%,FZR1;CDC20;RAB1A;UBE2S
prerank,homeostasis of number of cells (GO:0048872),0.5770895799098058,1.1989990825176902,0.2787136294027565,0.8367590495115201,1.0,1/12,0.43%,CCN3
prerank,response to ATP (GO:0033198),-0.4252948354704621,-1.1989979934072073,0.20915032679738563,0.6656474544161951,1.0,7/18,21.55%,ABCC9;TRPC3;P2RY1;P2RX7;CIB2;TAF1;HSP90B1
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.483837129727913,-1.1987319182494383,0.24471299093655588,0.6642371423586703,1.0,4/13,7.27%,ERRFI1;CBLB;SNX6;ZFYVE28
prerank,nucleic acid metabolic process (GO:0090304),0.43977240131099626,1.1984979400919191,0.22800925925925927,0.8373928681687818,1.0,18/69,18.58%,RBFOX2;NT5E;DDX24;WRN;TOPBP1;DUSP11;ATXN2;RAD50;KPNA2;HNRNPH1;WTAP;RBMX;DNASE2;HNRNPM;LSM8;RECQL5;HNRNPA2B1;POLR2C
prerank,catecholamine metabolic process (GO:0006584),0.5625708941618699,1.198479532085544,0.2633181126331811,0.8364140915967454,1.0,3/14,14.55%,SNCAIP;DRD3;LRTOMT
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.38912053455578705,1.19837726005149,0.09109311740890688,0.835710534596468,1.0,58/348,12.68%,SLC38A2;F3;BMP4;SLC24A3;FOXD1;NTRK3;PID1;HOXA5;ANXA2;ANK2;WNT11;GSN;EZR;FGF2;KRAS;PKP1;NGF;SFRP4;ITGB8;VEGFA;NFE2L2;ID2;SMO;GSK3B;KLF4;CCL3;LIMS1;PLCG2;TGFBR1;NOG;IL33;SERPINB9;TWIST1;STAT3;UBR5;EMILIN1;BMP6;ECE1;AGO2;INHBA;FN1;AGR2;ZC3H12A;TLR4;EGR1;RDX;TADA3;TMEM119;PIK3R3;POU4F1;DHX36;EPHB2;CD46;NSF;CLU;MYD88;BRCA1;CELF1
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.4014038677619654,-1.1983236148324161,0.18088737201365188,0.6631354018962249,1.0,11/25,20.61%,EPHA4;OPHN1;HSP90AB1;RPL11;RPS7;HIPK2;SGTA;RPL23;GABARAPL2;TAF1;ALAD
prerank,regulation of macrophage migration (GO:1905521),0.5991814160622418,1.1981235251249187,0.2616822429906542,0.8355711797223055,1.0,3/10,5.81%,PTK2B;MTUS1;EMILIN1
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.488819742669461,1.197730406021341,0.2549019607843137,0.8358584979238746,1.0,4/29,13.01%,THBS1;INHBA;TRAF2;RET
prerank,positive regulation of phospholipase C activity (GO:0010863),0.45960272389363227,1.1977172119334942,0.24494949494949494,0.8348827422865435,1.0,6/40,5.14%,EGFR;NTRK3;EDNRA;FGF2;ESR1;FGFR1
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.3658708819148402,-1.1976972218765094,0.16996047430830039,0.6626849463456743,1.0,3/33,3.58%,IL34;LEF1;CSF1
prerank,neutrophil activation (GO:0042119),0.5842692496810301,1.1976448166715508,0.2616822429906542,0.8340957778058545,1.0,1/12,1.64%,PRKCD
prerank,microtubule anchoring at centrosome (GO:0034454),0.5817469119046196,1.1974893073693544,0.28503184713375795,0.8335781019204092,1.0,4/10,14.79%,NIN;PCM1;HOOK3;CEP19
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.5919694933443997,1.1974471099085933,0.2731629392971246,0.8327036234458309,1.0,8/12,27.11%,WAC;CCND1;FBXO31;PRKDC;CDK2;PLK3;TP53;RPS27L
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.5689183901793577,1.1969636071353276,0.2957074721780604,0.833327924489343,1.0,5/13,19.18%,SAE1;DESI1;DESI2;UBA5;UBA3
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.5188736242502175,1.1968459807794012,0.24719101123595505,0.8327073264017429,1.0,15/23,31.91%,PARP1;RAD23B;COPS7B;COPS5;COPS8;CETN2;COPS3;COPS2;UBB;UBA52;RPS27A;DDB1;DDB2;XPA;COPS7A
prerank,cellular response to estrogen stimulus (GO:0071391),0.5578894526811131,1.196823461796,0.26323529411764707,0.8317650640675303,1.0,3/14,4.97%,RARA;BCAS3;SERPINB9
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.5663400848734799,1.196465383721904,0.27358490566037735,0.8319499525640475,1.0,2/14,6.60%,CD55;TGFBR2
prerank,low-density lipoprotein particle remodeling (GO:0034374),-0.5121751969434786,-1.1964621833912954,0.22911051212938005,0.6640730191199945,1.0,4/11,26.84%,ABCG1;PLA2G7;AGT;PLA2G5
prerank,calcium ion transport (GO:0006816),0.4166883295638688,1.1963254392519325,0.18271334792122537,0.8313705443982307,1.0,22/113,11.25%,SLC24A3;RAMP1;CACNA1C;PKD1;CACNA1G;ATP2C2;ANK2;CASR;CACNG6;CACNA1F;ANO6;CCL3;ORAI3;TRPM7;TRPM6;ATP2B4;CRACR2A;TRPM4;ITGAV;TRPM8;TRPC4AP;NALCN
prerank,regulation of gene expression (GO:0010468),0.3853026319981044,1.196194790963536,0.018018018018018018,0.8307999924518374,1.0,207/903,19.03%,SLC38A2;BNC2;F3;FOXP1;VSX1;SIX1;BMP4;ZFHX3;TCF7L1;SLC24A3;PRRX2;AHNAK2;MBNL1;FOXD1;HDAC4;NTRK3;CDH1;PID1;HOXA5;AFF3;ANK2;WNT11;PRDM6;GSN;ATP1B1;FOXN3;EZR;NFIA;AHNAK;FGF2;JMJD1C;ERC1;KRAS;PKP1;NGF;SOX14;YBX3;SFRP4;NELL1;ITGB8;VEGFA;ZNF423;ESR1;NFE2L2;BMPR1A;ID2;WWP2;SMO;ZNF148;CLK2;COQ7;CLK1;GSK3B;FZD7;NOTCH2;KLF4;CCL3;LIMS1;PLCG2;SON;TGFBR1;ABL1;PTHLH;NOG;IL33;SERPINB9;TWIST1;AFF4;C1D;STAT3;ZC3H7A;UBR5;CHEK2;EMILIN1;USP13;PER1;ATP2B4;NFIL3;TSKU;BMP6;BHLHE40;HMG20A;AGO2;TCF19;REL;INHBA;AURKA;CREBBP;RORA;SERTAD3;TDRD7;CDK11B;FN1;AGR2;TRIM39;CHD3;ZC3H12A;MLX;MLXIPL;GPBP1;TLR4;EGR1;GATA4;NLK;RDX;FOXC1;MTA1;TADA3;ZFP64;TMEM119;PIK3R3;ANXA7;ATF7;NSD1;XDH;POU4F1;ANKRA2;DHX36;CREB3L1;DENND4A;MECP2;POGZ;ATOH8;EPHB2;TRIM44;CD46;PHF12;CLK4;CLU;MYD88;NFXL1;APBB3;BRCA1;POFUT1;CELF1;HMG20B;FUS;CPNE1;HNRNPH1;GTF2IRD1;RRP1B;E2F1;PRMT5;NFYA;PATZ1;PRDM2;RFXANK;HINFP;SP3;MSL3;ATRX;SOX9;CNTF;NR3C1;NKAP;THAP7;AFDN;PLSCR1;DVL1;SNRNP70;TOB2;KAT6B;ZNF219;HOXD3;MEGF8;EFEMP1;PAX6;RBMS3;CDK2;MZF1;MOV10;GDNF;PRDM5;PIN1;MBNL2;SNF8;PRDM10;YAP1;ESR2;GLMN;SNX12;HCFC1;KMT2D;RB1;ASCC2;ZBTB7B;RNF20;LARP4;PCBP4;RNF14;NUP35;TAF5;TRRAP;TOB1;ACTR5;ATF2;PRDM4;BRCA2;TICAM1;CCN4;PUM2;PRDM11;NONO;GON4L;IGF2BP3;NFX1;ZUP1
prerank,fatty acid catabolic process (GO:0009062),0.43172865346101286,1.1960601414630707,0.2097735399284863,0.8302531075497597,1.0,19/67,18.73%,ABCD3;EHHADH;BDH2;PLA2G15;AUH;ABCD1;ECHDC1;ACBD5;DECR1;PEX13;LPIN2;ACOT8;ACOX1;ECHDC2;ACADL;CEL;PECR;CROT;PCCB
prerank,regulation of receptor recycling (GO:0001919),0.5465426219345046,1.1959426301629634,0.2582089552238806,0.8296297321251968,1.0,6/16,16.29%,ANXA2;KIF16B;ECE1;TRAT1;NSF;SCRIB
prerank,dorsal/ventral pattern formation (GO:0009953),0.5272543453935169,1.1959118031959333,0.2627840909090909,0.8287154446828409,1.0,5/20,6.46%,MDFI;BMPR1A;NOG;NBL1;GLI2
prerank,neuronal action potential (GO:0019228),0.5207570200312013,1.1957662362938668,0.24347826086956523,0.8282014648983133,1.0,3/22,1.57%,CACNA1G;KCNMB3;KCNMB2
prerank,DNA modification (GO:0006304),0.5078534114268222,1.1956295263952155,0.24050632911392406,0.8276862799746848,1.0,6/22,11.96%,MPG;SMUG1;PARP3;NEIL3;PARP1;EXOSC3
prerank,miRNA metabolic process (GO:0010586),0.5295247157306269,1.1953302850935867,0.26944444444444443,0.8276948497304553,1.0,12/20,29.56%,DDX17;AGO2;TUT7;DGCR8;TUT4;TENT4B;TRIM71;PARN;DICER1;PRKRA;DROSHA;SND1
prerank,regulation of cation channel activity (GO:2001257),-0.3029590771232763,-1.1952717440668141,0.09649122807017543,0.6652118156704585,1.0,33/89,16.08%,FGF14;GRIA4;ANK3;ACTN2;APP;FGF12;GRIN2A;KCNAB1;LRRC7;GRIN2B;CACNB4;CACNB2;PDE4D;MEF2C;GRIA1;GRIN1;CACNG7;JPH1;CALM1;CACNG4;CACNB1;GRIA3;CACNG3;JPH2;CACNG2;FGF11;NETO1;OPRM1;CTSS;CAMK2B;CAMK2A;RELN;GSG1L
prerank,microtubule polymerization (GO:0046785),0.4910191190373111,1.1950976153002912,0.2661179698216735,0.8274615014010872,1.0,9/29,17.14%,FGF13;MAP7D3;NDEL1;AKAP9;HDGFL3;TUBGCP6;TUBGCP2;PIN1;CENPJ
prerank,stem cell development (GO:0048864),-0.4504092952347722,-1.1949170313949014,0.24620060790273557,0.6640773946875033,1.0,9/16,33.53%,CDH2;TAPT1;SNAI2;NRG1;SHH;WNT7A;NOLC1;CYP26C1;TCOF1
prerank,negative regulation of endothelial cell migration (GO:0010596),0.48511377518272947,1.1946055946341125,0.2351421188630491,0.8282858859608047,1.0,8/36,12.62%,SLIT2;THBS1;FGF2;ATP2B4;KRIT1;MECP2;JUP;SYNJ2BP
prerank,negative regulation of secretion by cell (GO:1903531),-0.36385853447916905,-1.1945656955049484,0.16666666666666666,0.6630060034361251,1.0,9/38,13.14%,GRM7;IL1RAPL1;APOE;NOTCH1;SYT4;SYT11;SLC30A1;CHGA;RHBDF2
prerank,telomere maintenance (GO:0000723),0.4550496884885683,1.1944859394371266,0.23891625615763548,0.8277020601386189,1.0,18/50,23.47%,RAD51;TEN1;APEX1;WRN;STN1;SMC6;PARP3;SMC5;PARP1;RAD50;PRKDC;ATR;XRCC5;ERCC4;ZBTB48;NBN;RAD51D;ATM
prerank,protein localization to kinetochore (GO:0034501),0.5603200251795853,1.1941291709627164,0.27586206896551724,0.8279393502034395,1.0,8/14,27.57%,TTK;CENPT;ZW10;ZWILCH;SPDL1;BUB3;MTBP;MIS12
prerank,cilium organization (GO:0044782),0.39644179178236705,1.1939435549377322,0.15631469979296067,0.827544319386024,1.0,68/210,22.22%,PKD1;BBS9;ABLIM3;EXOC4;GSN;PTPDC1;IFT46;PDE6D;GBF1;FAM161A;PARVA;DZIP1;WDR35;CDC14A;PCM1;RAB11FIP3;CFAP43;EHD2;IFT52;MAK;DYNC2I2;TSGA10IP;ARL3;PLK4;RFX2;PCNT;GALNT11;KIF3B;ARF4;OCRL;DISC1;EXOC7;EHD1;DYNC2I1;ROPN1;TMEM231;CEP19;TRAPPC14;OFD1;ATAT1;RAB1A;CCDC66;IFT43;NPHP3;ACTR2;CPLANE2;CEP20;CENPJ;PTPN23;CEP164;MKKS;ATP6V0D1;CLUAP1;IQCB1;NUDCD3;RAB11A;LZTFL1;HYLS1;EXOC2;TXNDC15;PIBF1;CEP89;ACTR3;EXOC5;TEKT2;DYNC2H1;TCTN1;ARMC2
prerank,SNARE complex assembly (GO:0035493),0.6058549615708301,1.1936619197771456,0.2707993474714519,0.8275017394589268,1.0,4/10,17.26%,CLTRN;STXBP6;VAMP2;STXBP1
prerank,carnitine metabolic process (GO:0009437),0.5714872489040435,1.1931495192825274,0.2639751552795031,0.8282564788737056,1.0,9/12,27.11%,TMLHE;CPT1B;CPT1C;ACADL;CROT;CRAT;ACADM;SHMT1;CPT1A
prerank,NIK/NF-kappaB signaling (GO:0038061),0.43489324003541663,1.1931040527670973,0.22388059701492538,0.8274156710169284,1.0,23/72,21.15%,CARD14;PSMB2;REL;PSMD11;PSMC1;CUL1;MAP3K7;PSMC6;TRAF2;TIRAP;PSMD1;TRAF6;PSMD4;MAP3K14;PSMA6;COPS8;PSMD14;PSMD12;PSMD7;CHUK;RELB;PSME3;NFKB2
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.4332609849188236,1.1924637805532257,0.20372526193247964,0.8286551076059537,1.0,11/76,7.25%,CDC42EP5;NTRK3;BAIAP2L1;SORBS3;PRKCE;PTK2B;NRP1;BCAS3;ABL1;NCK2;TENM1
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.5850029533335805,1.1923945406138783,0.2902155887230514,0.8279117987111035,1.0,3/10,9.13%,ANXA2;NELL1;RGP1
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.4263184509727215,1.1923074307360182,0.20761245674740483,0.8272297233342606,1.0,16/78,16.26%,EGFR;PKD1;CCNA2;MNAT1;CCND1;CDKN2C;CCNB1;CCNYL1;CDKN1C;IPO7;CDKN1B;CDKN3;CCNG1;CDK7;CCNT2;CDKN1A
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.3936286107004374,1.1921988067824152,0.09356136820925554,0.8265880623550191,1.0,89/341,18.97%,WWP1;FBXL7;NEDD4;FZR1;RNF144A;FBXO10;CBLC;NFE2L2;WWP2;RNF126;PSMB2;UBE4B;RNF114;ANAPC5;SPSB2;UBE2A;RNF115;AURKA;MVB12B;ADRM1;PSMD11;FEM1B;RNF185;ARIH1;WDR81;CUL3;ANAPC10;PSMC1;VCP;MTA1;CDC16;UBE4A;PPP2R5C;ANAPC11;CDC20;KLHL22;ANKIB1;TBL1X;UBR4;TGFB1I1;RAD23B;TRPC4AP;TOM1L1;UBE3C;PSMC6;MAD2L1;KEAP1;ANAPC16;VPS37A;HERPUD1;RNF130;RNF146;UBE2K;VPS37B;UBR3;TRIP12;COP1;SPOPL;MIB1;ZRANB1;RNF122;RNF8;FBXO45;PSMD1;UBE2B;NHLRC1;UBE2D3;RNF111;PSMD4;NTAN1;RNF11;CNOT4;PTPN23;RNF20;AREL1;RNF14;PSMA6;UBE2S;DTL;RBCK1;SMURF1;UBXN2B;PSMD14;SPOP;PSMD12;CHFR;COPS3;RMND5A;PSMD7
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.5966643167160166,1.1920810326444327,0.29545454545454547,0.8259866700483876,1.0,4/10,1.91%,STK39;NEDD4;CAMK2D;PRKCE
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.40427550422658054,1.1917441023746147,0.1619644723092999,0.8261446025867486,1.0,57/173,22.55%,CD55;ANK2;ATL3;ATL2;SEC16A;SPTAN1;TMED5;GBF1;TMED3;RANGRF;COG5;LMAN2L;NRBP2;TRAPPC3L;GOLGB1;SEC31A;SEC24B;SEC23A;ARFGAP3;ARFGAP1;COPG1;CUL3;ERGIC1;COPA;MIA3;ERGIC2;SEC24D;DCTN5;DCTN4;NSF;STX5;ZW10;ARF4;BCAP31;TRAPPC11;COG8;ARCN1;TRAPPC3;COPB2;CAPZA1;GOSR2;RAB1A;GOPC;KDELR2;PROZ;COG3;VTI1A;BET1L;SPTBN1;TMED2;MPPE1;STX17;VTI1B;KDELR3;COG2;MCFD2;BET1
prerank,cAMP biosynthetic process (GO:0006171),-0.5182164562595469,-1.191438702577896,0.239247311827957,0.6696367100602549,1.0,3/10,5.92%,ADCY5;ADCY1;ADCY7
prerank,DNA metabolic process (GO:0006259),0.3906051159419028,1.1908625785731635,0.12321792260692464,0.8281106800730219,1.0,91/270,26.52%,TCF7L2;NT5E;EXO1;MPG;ERCC5;NABP1;CDC45;MCM2;RAD51;FANCL;SMUG1;TICRR;SLX4;MNAT1;UBE2A;BARD1;APEX1;WRN;TOPBP1;CHD1L;HELB;SMARCAL1;STN1;VCP;TOP1;PARP3;PRIM1;NEIL3;POLE2;PARP1;NUDT15;ZBTB1;RAD50;ORC3;POLI;KPNA2;RAD17;BRCA1;KMT5B;NUDT1;RNASEH2A;DDX21;HINFP;PRIMPOL;PRIM2;MCM7;UBE2B;DNASE2;PRKDC;SMC1A;CDK2;CDC7;GTF2H3;POLB;RECQL5;TRRAP;PARP2;RMI2;POLA2;RFC1;ATR;PARP4;XRCC5;ERCC4;NBN;CHEK1;KMT5C;SRPK2;RAD52;ALKBH1;RAD51D;ATM;RBBP8;USP7;ASF1A;UBB;INO80;RECQL;RAD21;RAD9A;TDG;CSNK1E;CDC6;RAD9B;RAD54L;UBA52;POLK;POLQ;GTF2H4;RPS27A;NEIL1
prerank,anion transmembrane transport (GO:0098656),0.4388955073855744,1.1908324055625232,0.22520420070011668,0.8272178101537562,1.0,4/67,1.13%,SLC23A1;SLC23A2;SLC5A6;LRRC8D
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.39616462333247554,-1.1905955683053593,0.2,0.6701177854208713,1.0,6/26,7.27%,ERRFI1;TGFA;APP;CBLB;SNX6;ZFYVE28
prerank,central nervous system neuron axonogenesis (GO:0021955),-0.4755316747497784,-1.1904909058614757,0.2693333333333333,0.66829987297886,1.0,4/12,11.67%,EPHB1;B4GALT6;HSP90AB1;SPTBN4
prerank,cell differentiation in hindbrain (GO:0021533),-0.4827536066057083,-1.1899139053509389,0.2727272727272727,0.6677403643572276,1.0,5/11,12.75%,GRID2;OPHN1;PROX1;FAIM2;KNDC1
prerank,organelle disassembly (GO:1903008),0.4952424434281865,1.189855744651868,0.26104417670682734,0.8296187121987828,1.0,16/33,22.73%,ULK2;GBF1;MTIF3;KIF9;VCP;TEX264;RB1CC1;STX5;UBA5;KLC1;KIF5B;PLK3;EIF2D;MRRF;ZFAND1;MTIF2
prerank,barbed-end actin filament capping (GO:0051016),0.537336797505658,1.1896077801792309,0.26814814814814814,0.82844494153129,1.0,4/18,7.03%,VILL;GSN;ADD3;FLII
prerank,actin filament capping (GO:0051693),0.537336797505658,1.1896077801792309,0.26814814814814814,0.82844494153129,1.0,4/18,7.03%,VILL;GSN;ADD3;FLII
prerank,regulation of signal transduction (GO:0009966),0.39708557697607594,1.189095262392125,0.1549738219895288,0.8292060638928649,1.0,34/190,12.96%,RSPO3;PLCE1;TCF7L1;UBASH3B;MGLL;CD55;GRK5;IGFBP5;FOXL1;LRIT3;SRMS;ESR1;ZIC1;ELF1;TIMP1;GAS1;MDFIC;PTPN2;NCK2;NLRP12;CREBBP;RORA;SULF1;GRK4;CD80;RGS6;GALNT11;CD46;DHRS3;CLU;SYNJ2BP;POFUT1;IGFBP6;ITGB1BP1
prerank,positive regulation of phosphorylation (GO:0042327),0.3926520677901318,1.1890055339464807,0.1403688524590164,0.8285233756571252,1.0,35/240,9.82%,SLC4A4;THBS1;BMP4;CARD14;EGFR;SLCO3A1;MET;PGF;NTRK3;DDR2;CCN1;LMO4;EFNA5;FGF2;NIBAN1;KRAS;NRP1;VEGFA;FZD7;ABL1;EPHB3;FGFR1;PFKFB1;FAM20A;ERBB2;ROR1;LIMK2;ENTPD5;MLXIPL;CCND1;MAVS;ARNT;CIB1;TMEM119;PIK3R3
prerank,protein export from nucleus (GO:0006611),0.493707338831531,1.1886808389024277,0.25371120107962214,0.8286444639966924,1.0,12/27,18.27%,PKD1;STRADA;NUP214;RANBP3;XPO1;DESI1;XPO4;CHP1;NUTF2;XPO7;CSE1L;SMURF1
prerank,regulation of transmembrane transport (GO:0034762),0.491507035493839,1.188663686744854,0.25375170532060026,0.8277201167518424,1.0,5/31,3.49%,KCNJ2;NEDD4;KCNJ15;CLTRN;WWP2
prerank,regulation of mRNA metabolic process (GO:1903311),0.590664665281058,1.1885265331113652,0.2886435331230284,0.8272004762917183,1.0,2/11,7.35%,SLTM;CDK11B
prerank,error-prone translesion synthesis (GO:0042276),0.5122521076383371,1.18812100329372,0.265625,0.8276042467521841,1.0,9/21,26.46%,REV3L;POLE2;POLI;PRIMPOL;RFC1;UBB;UBA52;POLK;RPS27A
prerank,chloride transmembrane transport (GO:1902476),0.4570641902580571,1.1880835629550657,0.24078624078624078,0.8267654394043659,1.0,6/48,4.12%,SLC12A7;SLC12A2;ANO9;GABRA3;ANO6;GLRB
prerank,regulation of trans-synaptic signaling (GO:0099177),-0.37376589868242593,-1.1879905695995803,0.2015810276679842,0.6707458185871193,1.0,14/33,18.15%,LRRC4C;GRID2;GRIK2;NRG3;EIF4EBP2;CACNA1B;ABR;LRP8;IQSEC2;FABP5;GRIK1;RELN;NTF3;BDNF
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.4212807392068192,1.1879724724455867,0.22540045766590389,0.8262071142398029,1.0,30/80,24.03%,SGSM2;SNX2;ERC1;RNF126;RAB7B;GBF1;RAB6A;PHETA2;RGP1;SNX32;STX5;EVI5;TRAPPC10;GOSR2;SNX8;UBE2O;SNX12;ANKFY1;SURF4;TBC1D5;TBC1D17;VPS52;VTI1A;BET1L;VTI1B;TBC1D23;GCC2;TMEM87A;VPS54;RIC1
prerank,apical protein localization (GO:0045176),-0.5061688327572962,-1.187493559089421,0.2563380281690141,0.6698990083506959,1.0,4/10,6.49%,SHROOM2;ACTB;JAM3;MAL
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.47026191314467475,1.1874359287513974,0.2529960053262317,0.8269708223610697,1.0,9/31,19.03%,FHL1;KLF4;DACT1;FAM107A;CDKN2C;DLG1;CDKN1A;RB1;WEE1
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.4975868005524001,-1.187411561201923,0.25280898876404495,0.6680314334398145,1.0,2/11,1.42%,LYN;MFHAS1
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.5283066391788808,1.1873700611831746,0.26580459770114945,0.8262235941294157,1.0,7/18,25.01%,THOC2;NUP93;PCID2;DDX19B;SARNP;ZC3H11A;ENY2
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.4029845253230452,1.1873375303231828,0.19402985074626866,0.8253713895792272,1.0,17/140,8.88%,PLCE1;CACNA1C;CD55;PTGDR;ADRA1B;PLCZ1;EDNRA;CMKLR1;ESR1;CCL1;ABL1;C5AR2;PROK2;GPR65;PTGER1;TRPM4;GPR4
prerank,ceramide catabolic process (GO:0046514),0.5575512148262949,1.1872940881397116,0.27342549923195086,0.8245436969831054,1.0,2/14,3.41%,ACER3;HEXA
prerank,establishment of apical/basal cell polarity (GO:0035089),0.5549940659935715,1.186646347172303,0.27134146341463417,0.8257695745544568,1.0,7/14,16.49%,EZR;SYNE4;PATJ;RHOA;MYO9A;SCRIB;CAMSAP3
prerank,GTP metabolic process (GO:0046039),0.5442848142700856,1.1863094818394198,0.28075253256150506,0.8259325124320217,1.0,5/15,17.77%,RHOQ;ENTPD7;AK4;AK3;LRRK2
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.4891794916769595,1.185783320485353,0.2513089005235602,0.8267206805708692,1.0,6/29,13.51%,SLC4A10;ACP4;ZDHHC2;EPHB2;NSMF;DBN1
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.48081579509132166,-1.1853906143859254,0.24853801169590642,0.6693809633048943,1.0,2/12,2.09%,IGF1;AKAP6
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.48081579509132166,-1.1853906143859254,0.24853801169590642,0.6693809633048943,1.0,2/12,2.09%,IGF1;AKAP6
prerank,regulation of macrophage activation (GO:0043030),0.47905129712317396,1.1851509753986917,0.27628032345013476,0.8279774312070349,1.0,5/30,8.33%,THBS1;LBP;IL33;ZC3H12A;TLR4
prerank,RNA 3'-end processing (GO:0031123),0.4332199003805134,1.1849261547310537,0.21749136939010358,0.8277639033982999,1.0,23/69,23.79%,SRSF11;U2AF2;THOC2;SRSF5;TUT7;SRSF6;TUT4;CDC40;SRSF2;TENT2;SRSF1;RNPS1;CPSF3;CHTOP;TENT4B;CSTF3;SARNP;CLP1;DHX38;SRSF3;SRRM1;ZC3H11A;FIP1L1
prerank,response to nitric oxide (GO:0071731),-0.47134489040904154,-1.1848003131899365,0.25449101796407186,0.6689306943074084,1.0,8/13,28.11%,GUCY1B1;FOXO1;KCNC2;CCL19;MT3;EGLN1;MMP3;AQP1
prerank,heart trabecula morphogenesis (GO:0061384),-0.4352502692593823,-1.1847655136313278,0.2088607594936709,0.6669689897529428,1.0,7/18,6.27%,ENG;TEK;TGFBR3;RBP4;RBPJ;BMP7;NOTCH1
prerank,regulation of actin filament depolymerization (GO:0030834),-0.49205200609812194,-1.1847583680550604,0.2591549295774648,0.6649594617397563,1.0,6/12,16.14%,PLEKHH2;SEMA5A;PIK3CA;CFL2;MTPN;PLEK
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.4984747916575457,1.1837945680626174,0.2579310344827586,0.8307373726896674,1.0,10/24,24.68%,SLX4;TEN1;STN1;PARP1;NAT10;TENT4B;ERCC4;TNKS2;GNL3L;SRC
prerank,ameboidal-type cell migration (GO:0001667),0.4441984190917605,1.1836237610958604,0.25830258302583026,0.8303413643880573,1.0,9/51,8.58%,CCN3;FAT2;SEMA3E;GPC3;SRGAP2;SEMA3C;SEMA3D;PDXDC1;CORO1C
prerank,protein trimerization (GO:0070206),0.5535015477624338,1.1834312268622722,0.30368098159509205,0.8290961453140444,1.0,2/14,2.21%,SCARA5;DISP1
prerank,protein homotrimerization (GO:0070207),0.5535015477624338,1.1834312268622722,0.30368098159509205,0.8290961453140444,1.0,2/14,2.21%,SCARA5;DISP1
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.514948140618302,1.1832859053181681,0.2705718270571827,0.8286027386730014,1.0,11/21,25.90%,SAMD4A;CNOT8;TUT7;TUT4;TNKS1BP1;CNOT4;SAMD4B;CNOT1;CNOT11;PAN3;PARN
prerank,ERBB signaling pathway (GO:0038127),0.4348931601103809,1.1825142053254039,0.2476303317535545,0.8301371052711369,1.0,11/64,10.68%,EGFR;PLCE1;REPS2;PTK2B;SHC1;KIF16B;ERBB2;NCK2;AAMP;ERBIN;GAREM1
prerank,base-excision repair (GO:0006284),0.44416388107718024,1.1821010800666183,0.2583547557840617,0.8306388367296749,1.0,12/48,19.19%,MPG;ERCC5;SMUG1;APEX2;APEX1;WRN;NEIL3;PARP1;USP47;POLB;PRMT6;RFC1
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.3682258513342507,-1.1820690038417616,0.20161290322580644,0.6702814416121277,1.0,17/36,26.49%,WNT5A;CSF1;CASP4;PARP14;AXL;EDN1;GAS6;CD74;NLRC5;HIF1A;HSPA1A;ZBP1;CASP1;IL7;CD300LF;FADD;C1QTNF4
prerank,positive regulation of ossification (GO:0045778),0.46180570047807307,1.1819354441818455,0.2599231754161332,0.8302655301363764,1.0,8/39,6.10%,BMP4;CCN1;NELL1;TGFB3;BMPR1A;ANO6;ZBTB16;BMP6
prerank,regulation of cytokinesis (GO:0032465),0.4238716346781701,1.1819196688254054,0.22170900692840648,0.8293523549264303,1.0,28/78,25.26%,CIT;PRKCE;GIPC1;KIF13A;SETD2;CDC14A;AURKA;RAB11FIP3;BECN1;CUL3;AHCTF1;RHOA;PLK4;DRD3;SH3GLB1;ZFYVE19;PIN1;CXCR5;PLK3;CETN2;RAB11A;BIRC6;KIF23;CALM2;ENTR1;PKN2;PDXP;CDC6
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.4179196616561816,1.1817181833399124,0.2222222222222222,0.8290687006114431,1.0,47/96,33.50%,SRSF11;U2AF2;SMG6;THOC2;SRSF5;NUP93;SRSF6;NUP214;NUP153;CDC40;SRSF2;NUP155;FYTTD1;RANBP2;NUP88;SRSF1;RNPS1;CPSF3;CHTOP;UPF2;HNRNPA2B1;NUP35;DDX19B;SARNP;DHX38;SRSF3;SRRM1;ZC3H11A;FIP1L1;YTHDC1;NUP98;POM121;WDR33;THOC1;ALKBH5;SEC13;UPF3B;THOC5;SEH1L;DDX39A;DDX39B;NUP54;SRSF7;TPR;AAAS;NXT1;ALYREF
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.5951098123169702,1.1815890984840696,0.3016129032258065,0.8285508398414267,1.0,4/10,18.04%,CD55;TGFBR2;ZBTB7B;NCKAP1L
prerank,response to hydroxyurea (GO:0072710),0.5765791232020527,1.1813006253849303,0.27053140096618356,0.828571874040076,1.0,7/11,22.06%,SPIDR;DDI2;DDX11;RTF2;ATRX;DDI1;FMR1
prerank,positive regulation of protein modification process (GO:0031401),0.3947085904024593,1.1812370441676416,0.16475495307612095,0.8278179784824977,1.0,28/203,9.82%,BMP4;CARD14;EGFR;SLCO3A1;RAMP1;PGF;TRABD2B;NTRK3;CCN1;PRKCD;EFNA5;FGF2;NIBAN1;KRAS;VEGFA;ABL1;FAM161A;NNMT;FAM20A;ERBB2;LIMK2;CCND1;MAVS;PTPA;CIB1;TMEM119;BRMS1;PIK3R3
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),-0.365947384045309,-1.181102510023592,0.2183406113537118,0.6707935789186675,1.0,13/33,16.32%,IGF1R;IGF1;PIK3R1;MYO16;PIK3C2A;EDN1;PIK3CA;SIRT2;ERBB3;HTR2A;PIK3R5;NYAP2;TYRO3
prerank,regulation of feeding behavior (GO:0060259),-0.48788458520965694,-1.1808354034102613,0.29508196721311475,0.6695401361472536,1.0,2/11,1.21%,LEPR;SGIP1
prerank,synaptic vesicle transport (GO:0048489),0.5827953498589448,1.1807061583277965,0.28548123980424145,0.8286392878823632,1.0,4/11,17.62%,TMEM230;SPG11;KIF5B;SYNJ1
prerank,lipid transport (GO:0006869),0.4147780136976275,1.1806203913371893,0.22430939226519336,0.8279726907401247,1.0,14/97,8.75%,SLCO3A1;TNFAIP8L3;ABCD3;SLCO2A1;LBP;PITPNC1;SLC10A2;LDLR;PITPNA;SLC27A3;ABCA7;ABCD1;SLC51A;RXRA
prerank,peptidyl-serine modification (GO:0018209),0.39631173387688823,1.1802882084412634,0.18604651162790697,0.8281642250751411,1.0,50/166,20.09%,STK39;PKD1;MARK1;WNK1;PRKCD;CAMK2D;ULK2;PRKCE;TLK1;GSK3B;MBOAT4;HIPK1;TGFBR1;GALNT13;VRK3;MAPK12;TGFBR2;AURKA;IKBKE;CSNK1A1;MAST2;TOP1;CLSPN;TTK;PARP1;PDK3;CSNK1G3;POGLUT3;CAB39;ULK3;SGK3;RPS6KA3;MARK2;CSNK1G1;MORC3;PRKCA;MARK3;PRKDC;CDK2;CDC7;MAP3K10;IKBKB;RPS6KB1;LRRK2;MAPKAPK2;PARP2;ATR;TLK2;CHUK;NEK6
prerank,regulation of ERBB signaling pathway (GO:1901184),0.5385942102399478,1.1801050640447914,0.2852807283763278,0.8277941452318014,1.0,3/15,7.40%,EGFR;ERBB2;MVB12B
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.46778182571241356,1.17990684740307,0.2623574144486692,0.8274860412058154,1.0,8/39,6.83%,EGFR;PTPN3;CBLC;RNF126;PTPN2;ACP4;ERBB2;RNF115
prerank,natural killer cell mediated immunity (GO:0002228),0.5374617190842558,1.1797892751227634,0.2750759878419453,0.8269056090913667,1.0,5/15,19.64%,RAET1E;PLEKHM2;LYST;KIF5B;CEBPG
prerank,regulation of cell cycle phase transition (GO:1901987),0.4255041371652371,1.1795289878427133,0.21404303510758776,0.8268915081397393,1.0,27/91,18.97%,FZR1;TCIM;PSMB2;ANAPC5;ATP2B4;TRIM39;PSMD11;ANAPC10;PSMC1;CDC16;CUL1;ANAPC11;CDC20;CCNB1;PSMC6;MAD2L1;FBXO5;ANAPC16;CDKN1B;PSMD1;PSMD4;CDKN1A;PSMA6;UBE2S;PSMD14;PSMD12;PSMD7
prerank,estrogen metabolic process (GO:0008210),0.5398769014255994,1.1794629322654393,0.2954898911353033,0.8261625074153051,1.0,4/15,26.31%,CYP1B1;SULT1A1;HSD17B2;HSD17B4
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.5526015272486732,1.1790080823124922,0.2719033232628399,0.8267313714735359,1.0,6/14,16.62%,WNK1;ATP1B1;SLC9A1;CHP1;DMD;FXYD2
prerank,regulation of complement activation (GO:0030449),0.45782953719766106,1.1786270982467475,0.2613784135240572,0.8270191229381205,1.0,8/40,15.67%,CFH;CD55;C5AR2;SERPING1;CD46;CLU;CR1L;C3AR1
prerank,bone development (GO:0060348),0.4580639496613822,1.1782206275959093,0.2601307189542484,0.8274585692378206,1.0,9/39,8.79%,LRP6;GNAS;AKAP13;SFRP4;SKI;MYOC;SLC10A7;SULF1;P3H1
prerank,activation of phospholipase C activity (GO:0007202),0.4748892544055565,1.1782034182278551,0.2802631578947368,0.8265686194929742,1.0,2/29,1.94%,EGFR;EDNRA
prerank,hemidesmosome assembly (GO:0031581),-0.4886760867369496,-1.1781951558791446,0.26287262872628725,0.6746378005110695,1.0,6/11,19.00%,ITGA6;DST;LAMC2;LAMC1;CD151;LAMB3
prerank,negative regulation of RNA metabolic process (GO:0051253),0.5102956578984491,1.1781549676270822,0.26308139534883723,0.8257904070244604,1.0,4/18,8.34%,ESR1;NCOR1;ZC3H12A;NCOR2
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.43946951831091186,-1.1776317137432823,0.2326388888888889,0.6741753215899178,1.0,3/18,1.73%,PRKCB;SLC2A1;OCLN
prerank,Golgi localization (GO:0051645),0.5665937187541014,1.1774991480011567,0.29082426127527217,0.8270836604343145,1.0,4/11,14.21%,ARHGAP21;COPG1;HOOK3;ARCN1
prerank,positive regulation of protein binding (GO:0032092),0.4378376732882063,1.177358874143749,0.2589928057553957,0.8266122267578058,1.0,19/56,18.20%,BMP4;TCF7L2;PKD1;GSK3B;ABL1;LRP1;DACT1;TIAM1;RIPK2;IDE;NMD3;MARK3;CAPRIN2;FLOT1;ADD1;PIN1;LRRK2;STK3;RALB
prerank,mitotic recombination (GO:0006312),0.5448938495773933,1.1769485135559272,0.29210134128166915,0.8270564818298382,1.0,6/15,23.41%,RAD51;SMC6;SMC5;RAD50;RAD52;RAD51D
prerank,epithelium development (GO:0060429),0.4118579482266997,1.1768437112291987,0.22580645161290322,0.82643937844674,1.0,15/107,7.96%,SIX1;PKD1;MEOX2;CASP6;ANXA4;BDH2;EHF;GRHL2;VEGFA;SMO;RIPK4;DACT1;VCL;GSTA2;DNPH1
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.5051786883072548,1.1762751792252495,0.2847124824684432,0.8273294448473211,1.0,3/24,2.10%,HES1;CYP1B1;PTK2B
prerank,mRNA export from nucleus (GO:0006406),0.4138690952797895,1.1760938276844675,0.21645021645021645,0.8270028894589206,1.0,49/102,33.50%,SRSF11;U2AF2;SMG6;THOC2;SRSF5;NUP93;SRSF6;NUP214;NUP153;CDC40;SRSF2;NUP155;FYTTD1;RANBP2;NUP88;SRSF1;RNPS1;CPSF3;CHTOP;PCID2;UPF2;HNRNPA2B1;NUP35;DDX19B;SARNP;DHX38;SRSF3;SRRM1;ZC3H11A;FIP1L1;YTHDC1;ENY2;NUP98;POM121;WDR33;THOC1;ALKBH5;SEC13;UPF3B;THOC5;SEH1L;DDX39A;DDX39B;NUP54;SRSF7;TPR;AAAS;NXT1;ALYREF
prerank,mitochondrion morphogenesis (GO:0070584),0.5838949128238997,1.1759033324353252,0.29256965944272445,0.8267054164496794,1.0,1/11,1.27%,PID1
prerank,organelle transport along microtubule (GO:0072384),0.4759494174784287,1.1758094258287308,0.2757255936675462,0.8261141365901421,1.0,14/31,27.06%,ARHGAP21;NDEL1;RAB6A;PAFAH1B1;COPG1;MAP1S;BICD1;KIF5B;RAB1A;BICD2;UBB;FBXW11;RHOT1;CLN3
prerank,recombinational repair (GO:0000725),0.4250738267475813,1.1754837368635154,0.23897911832946636,0.8262323966062319,1.0,30/77,25.86%,REV3L;ERCC5;NABP1;RAD51;SLX4;SPIDR;WRN;SMC6;SMC5;PARP1;NSMCE1;RAD50;RNF138;BRCA1;MORF4L1;RECQL5;MCM9;BRCA2;PSMD14;ERCC4;YY1;NBN;AP5Z1;RAD52;RAD51D;RBBP8;INO80;RECQL;KDM4D;POLQ
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.577301942415542,1.1751385636796448,0.31852986217457885,0.8263583015737292,1.0,9/12,29.52%,NELFE;RNF8;RECQL5;HEXIM1;TCERG1;LARP7;EAPP;NELFA;RNF168
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.40015320257243703,-1.1748146962541866,0.21107266435986158,0.6798744051905392,1.0,9/23,15.81%,CEMIP;APP;BMP7;MAPK1;CALM1;SPHK1;WNK3;PRKAG2;STOX1
prerank,cellular response to exogenous dsRNA (GO:0071360),0.5709511757668095,1.1748050095156963,0.3050847457627119,0.8265065000654401,1.0,7/12,19.69%,MAVS;IFIH1;CGAS;FLOT1;RALB;DHX9;COLEC12
prerank,positive regulation of cellular component movement (GO:0051272),0.49590280868134734,1.1744659457323472,0.289875173370319,0.8266960851473556,1.0,5/24,4.98%,NTN1;VEGFA;TGFBR1;CCDC25;TWIST1
prerank,termination of RNA polymerase I transcription (GO:0006363),0.4793767968834673,1.1741620645582675,0.2726045883940621,0.8267669881865274,1.0,10/30,22.37%,POLR1G;POLR1A;MNAT1;TAF1D;CDK7;GTF2H3;POLR1F;UBTF;TTF1;TBP
prerank,positive regulation of ERAD pathway (GO:1904294),0.5553096664357969,1.1740544646955566,0.2887218045112782,0.8262167286652586,1.0,5/13,12.45%,NFE2L2;USP13;RNF185;HERPUD1;BCAP31
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.4664473926002226,-1.1737912282943417,0.2602739726027397,0.6784538065305448,1.0,2/13,3.72%,PLCB1;IL15RA
prerank,cellular response to interleukin-15 (GO:0071350),-0.4664473926002226,-1.1737912282943417,0.2602739726027397,0.6784538065305448,1.0,2/13,3.72%,PLCB1;IL15RA
prerank,regulation of synapse assembly (GO:0051963),-0.3452669957863341,-1.1736706236822774,0.2,0.6768537283964563,1.0,14/46,11.90%,IL1RAPL1;ROBO2;GRID2;EPHB1;NRXN1;APP;SYNDIG1;LRFN5;MEF2C;CUX2;SRPX2;LRRC4B;PTPRD;IL1RAPL2
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.4668216605764798,1.1735315283592027,0.28891820580474936,0.8269734970762674,1.0,5/31,4.73%,ZFPM2;BMPR1A;DSP;TGFBR1;NOG
prerank,endochondral bone morphogenesis (GO:0060350),0.5651934760505114,1.1733269489231652,0.2786377708978328,0.8267587389483065,1.0,5/11,16.78%,BMP4;FOXC1;TMEM119;INPPL1;FGFR3
prerank,myeloid cell development (GO:0061515),0.5252328392140561,1.173199597267442,0.26055312954876275,0.8262809655889882,1.0,2/18,1.69%,FOXP1;ANXA2
prerank,blood circulation (GO:0008015),-0.3400864431759992,-1.1727482588769922,0.19337016574585636,0.6772675807493233,1.0,17/49,12.71%,COL4A3;NOS3;GUCY1B1;ROCK2;SGCZ;CXCL12;NPR1;ACE;TBC1D8;GUCY1A1;ADORA2A;BDKRB2;MYOF;STAT1;F5;ACE2;CYB5R3
prerank,Golgi organization (GO:0007030),0.4072350418884876,1.172743898688835,0.22604951560818085,0.8269186569849477,1.0,42/112,22.55%,ATL3;ARHGAP21;GORASP2;BCAS3;ATL2;SEC16A;RAB30;TMED5;GBF1;TMED3;RAB43;LMAN2L;GOLGB1;CSNK1A1;PLEKHM2;GAK;FBXW8;SEC23IP;STX5;ZW10;TRAPPC11;PRMT5;GOSR2;GOLPH3;ARFGEF1;RAB1A;PLK3;SURF4;LRRK2;BAG5;COG3;UBXN2B;ATP8B4;VCPIP1;VTI1A;TMED2;STX17;GOLPH3L;VTI1B;DYNC2H1;COG2;BET1
prerank,regulation of vacuole organization (GO:0044088),0.5154295161152398,1.1727346311697238,0.2678311499272198,0.8260289461700678,1.0,3/20,4.86%,ANXA2;NPRL3;SCARB2
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.4750143172662793,1.1727297110255988,0.2658064516129032,0.8251244475599381,1.0,3/35,3.02%,PCDHB16;CDH11;PCDHB9
prerank,positive regulation of lipid localization (GO:1905954),0.5689038787976958,1.172707290176052,0.3106796116504854,0.8242744194997235,1.0,3/11,8.14%,LRP1;IKBKE;ZC3H12A
prerank,positive regulation of fatty acid metabolic process (GO:0045923),-0.4407632353212081,-1.1725801993304497,0.2692307692307692,0.6758077011105211,1.0,7/15,15.43%,LPGAT1;PPARA;NR1H3;PPARGC1A;PPARD;NR1H2;MID1IP1
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.4170192895646361,1.1712653113084932,0.2335928809788654,0.827893126824689,1.0,18/87,8.69%,SEMA3E;PRKCD;RHOBTB1;EZR;PTK2B;EFNA5;ARHGDIB;CDK10;NOTCH2;ABL1;ARHGAP44;LRP1;ARHGAP17;SMIM22;RHOQ;FAM107A;DMTN;RND3
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.5657341844762659,1.1712039659391995,0.3089430894308943,0.8271544111828353,1.0,5/11,7.32%,SOAT1;ITM2C;AGO2;BACE2;ABCA7
prerank,regulation of immune effector process (GO:0002697),0.4551144591589136,1.1702936465616247,0.2649350649350649,0.8293167022599406,1.0,8/41,15.67%,CFH;CD55;C5AR2;SERPING1;CD46;CLU;CR1L;C3AR1
prerank,endocardial cushion morphogenesis (GO:0003203),0.5178378780279094,1.1701309151622028,0.27786032689450224,0.8289470137400506,1.0,7/18,14.64%,BMP4;BMPR1A;NOG;TGFBR2;MDM4;ACVR1;SOX9
prerank,aromatic amino acid family metabolic process (GO:0009072),0.5926578298553143,1.1696428924664743,0.29952456418383516,0.8295772512246077,1.0,1/10,1.78%,IYD
prerank,dermatan sulfate metabolic process (GO:0030205),0.5535572912207821,1.1695697246732948,0.3004769475357711,0.8289175581108745,1.0,5/13,16.84%,DSE;UST;BGN;IDUA;CHST12
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.5069009945311171,1.16946872903951,0.3124087591240876,0.8283379617906182,1.0,4/20,8.33%,LBP;PRKCE;CCL3;TLR4
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.5123423113076447,1.1694314256815486,0.2883008356545961,0.8275516241928108,1.0,5/22,11.07%,ESR1;MED13;MED24;DHX36;PSMC6
prerank,purine ribonucleotide metabolic process (GO:0009150),0.4251180035041506,1.1691292067858863,0.23696682464454977,0.8276136335099503,1.0,23/68,23.57%,PTHLH;ACSM2A;ACSM2B;ACOT12;RHOQ;ACOT9;ACOT11;AMPD3;ENTPD7;ACOT8;ACOT13;GMPR2;AK4;AK3;SULT1A1;CROT;LRRK2;GLYAT;AMPD2;ADSS2;ACOT6;ABHD14B;SULT6B1
prerank,regulation of mitochondrial fusion (GO:0010635),0.569016700632241,1.168713185729833,0.296998420221169,0.8279978856241843,1.0,1/11,1.27%,PID1
prerank,cellular metal ion homeostasis (GO:0006875),0.40889994837956595,1.1685605862779613,0.2215973003374578,0.8276093166235335,1.0,22/102,13.14%,KCNJ2;SLC12A2;SLC24A3;CSRP3;ATP2C2;ANK2;ATP1B1;CASR;CCL3;CCL1;ATP2B4;SLC10A7;ATP12A;ATP1A3;ATP1A4;ATP1A1;SLC9A1;CCL7;DRD3;SLC8B1;CTRC;NPTN
prerank,ether lipid metabolic process (GO:0046485),0.5547382411421068,1.168454153595568,0.29096477794793263,0.8270772855204307,1.0,6/14,13.44%,NCEH1;AGPS;PAFAH1B1;AGMO;GNPAT;PEDS1
prerank,phospholipid biosynthetic process (GO:0008654),0.46935537223386103,1.168379260203717,0.2906208718626156,0.8263901580939623,1.0,10/36,12.85%,DHDDS;SGMS2;MBOAT1;LPCAT1;DPAGT1;HDHD5;PIP5K1A;AGK;GNPAT;CPNE1
prerank,positive regulation of translation (GO:0045727),0.4130221071077837,1.1680333162379075,0.23535911602209944,0.8266091855525853,1.0,24/94,20.27%,THBS1;SAMD4A;NIBAN1;YBX3;AGO2;ERBB2;EIF3E;MRPS27;CDC123;RPUSD4;EIF6;DHX36;JMJD4;RBM3;NAT10;KHDRBS1;CIRBP;PRKDC;RPS6KB1;LARP4;DHX9;USP16;FASTKD3;LARP4B
prerank,positive regulation of vacuole organization (GO:0044090),0.5813438945769499,1.167617087003536,0.30615640599001664,0.8270100061446958,1.0,6/10,24.14%,ANXA2;SH3GLB1;PIP4K2A;RALB;LRSAM1;RAB3GAP1
prerank,positive regulation of bone mineralization (GO:0030501),0.46402600281143613,1.167022816058584,0.27586206896551724,0.8280680460884529,1.0,7/35,6.10%,BMP4;CCN1;NELL1;TGFB3;BMPR1A;ANO6;BMP6
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.4933874558403759,1.16671818110746,0.2661971830985915,0.8281881175536955,1.0,6/24,12.66%,CYP1B1;RORA;SULF1;GATA4;ARNT;BRCA1
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.314849976985309,-1.1667015107466836,0.1111111111111111,0.689761404303084,1.0,20/75,12.24%,DCDC2;ANK3;CTNNA2;MAP2;APP;CNTN4;DCC;PAK3;DSCAML1;BAIAP2;RYK;ACTB;MEF2C;ZDHHC17;OPHN1;LMTK2;PLPPR4;SPTBN4;MAP1A;SLITRK5
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.46112028004712113,1.1656552234185547,0.27860026917900405,0.8306762888073735,1.0,10/33,19.03%,FHL1;KLF4;DACT1;FAM107A;CDKN2C;DLG1;CDKN1A;PLK3;RB1;WEE1
prerank,protein targeting to lysosome (GO:0006622),0.5169352015369745,1.165395670971294,0.27982954545454547,0.8306325600640189,1.0,6/20,17.13%,NEDD4;SCARB2;CLU;AP3M1;SORL1;GNPTAB
prerank,peptidyl-serine phosphorylation (GO:0018105),0.3935443224636542,1.1652993982386035,0.20903361344537816,0.8300636440874899,1.0,42/153,18.03%,STK39;PKD1;MARK1;WNK1;PRKCD;CAMK2D;ULK2;PRKCE;TLK1;GSK3B;HIPK1;TGFBR1;VRK3;MAPK12;TGFBR2;AURKA;IKBKE;CSNK1A1;NLK;MAST2;TOP1;CLSPN;TTK;PDK3;CSNK1G3;CAB39;ULK3;SGK3;RPS6KA3;MARK2;CSNK1G1;MORC3;PRKCA;MARK3;PRKDC;CDK2;CDC7;MAP3K10;IKBKB;RPS6KB1;LRRK2;MAPKAPK2
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.4419531250582835,1.1651660514156332,0.254320987654321,0.8295854129749255,1.0,14/52,14.13%,EGFR;PRKCE;LRP1;RANGRF;ACSL3;ATP2B4;PLS1;ZDHHC2;AGR2;ITGB1;CIB1;EPHB2;DLG1;PTPN9
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.5433347621364933,1.1648937759765428,0.3106646058732612,0.8295811462670095,1.0,1/13,0.35%,SIX1
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.516997294961989,1.1645583898855687,0.28939828080229224,0.8297826192026662,1.0,9/19,16.29%,CLIC4;DLG2;ERBIN;PATJ;PARD3;SYNJ2BP;MARK2;DLG1;SCRIB
prerank,cell projection assembly (GO:0030031),0.4985917950722598,1.1643677936913537,0.3087621696801113,0.8295291466883065,1.0,4/22,7.71%,RHOJ;GSN;PARVA;RHOQ
prerank,arachidonic acid metabolic process (GO:0019369),0.4677025110830195,1.1642300788290363,0.27146464646464646,0.8290611589345189,1.0,5/35,5.09%,MGLL;CYP1B1;PTGIS;CYP2S1;PTGES2
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.3964415172273971,1.164117566589688,0.21063829787234042,0.8285214846539762,1.0,33/140,14.62%,SLIT2;PLCE1;RHOJ;ARHGAP20;VAV2;ARAP1;ARHGAP21;ARHGAP10;SRGAP2;SRGAP3;AKAP13;ARHGDIB;ARHGAP44;ARHGAP40;BCR;ARHGAP17;TIAM1;SOS2;RHOQ;TIAM2;ARHGAP31;STARD13;ARHGAP5;ITGAV;RHOA;FGD1;TRIO;OCRL;FGD3;TRIP10;MYO9A;GNA13;DEPDC1B
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.48973826182060975,-1.1636582442799057,0.30179028132992325,0.6962955178714811,1.0,4/10,16.14%,ACTN2;SEMA5A;CFL2;PLEK
prerank,protein import into nucleus (GO:0006606),0.4305010325029569,1.1635737672681155,0.2611683848797251,0.8294363934487418,1.0,19/66,17.82%,PRICKLE1;STAT3;NUP93;E2F3;NUP214;NUP153;TNPO2;RGPD1;KPNA1;TNPO3;IPO7;NUP155;KPNA2;RANBP2;NUTF2;NUP88;KPNA4;CSE1L;NUP35
prerank,positive regulation of cell division (GO:0051781),0.45197165529194083,1.163261668271272,0.28218465539661897,0.8295459946933237,1.0,7/38,12.01%,CIT;PRKCE;GIPC1;CDC14A;CUL3;RHOA;DRD3
prerank,negative regulation of endopeptidase activity (GO:0010951),-0.34227260782221314,-1.1626265011525079,0.21714285714285714,0.6971321863245672,1.0,9/47,10.21%,VTN;SPOCK3;SPOCK2;SPOCK1;TIMP3;SERPINI1;SERPIND1;BIN1;GAPDH
prerank,protein processing (GO:0016485),0.40619473445803,1.1625649176850552,0.23404255319148937,0.8308093269223377,1.0,20/102,15.95%,F3;PCSK5;ASPRV1;PRSS12;ADAMTS3;ECE1;XPNPEP3;CASP2;PHEX;MMP16;LONP2;MMEL1;DDI2;PCSK7;FXN;ECE2;TYSND1;PIDD1;YME1L1;FAM111A
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.541326150391678,1.1624211826765194,0.29420505200594355,0.830374886602922,1.0,5/14,17.54%,U2AF2;SRSF6;RBMX;RNPS1;PCBP4
prerank,amide transport (GO:0042886),0.488375968762291,1.1621067156349922,0.2987721691678035,0.8304971589781671,1.0,5/26,8.48%,SLC5A6;ABCG2;DISP1;FOLR2;SLC25A32
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.38336130385922795,1.161996565611181,0.17959183673469387,0.8299680383368674,1.0,88/260,21.37%,NTN1;FXYD5;PKD1;BBS9;ABLIM3;EXOC4;GSN;EZR;SRGAP2;NRP1;PTPDC1;ANO6;EMP1;PMP22;IFT46;PDE6D;GBF1;FAM161A;PARVA;DZIP1;WDR35;CDC14A;PCM1;RAB11FIP3;ARFIP2;VCL;ITGB1;DMTN;ABLIM2;SHTN1;CFAP43;EHD2;IFT52;MAK;DYNC2I2;ARL3;PLK4;RAP1A;RFX2;PCNT;GALNT11;KIF3B;FGD1;ARF4;PIP5K1A;OCRL;DISC1;EXOC7;EHD1;FGD3;EMP3;DYNC2I1;TMEM231;RAP2C;CYFIP1;FGD6;CEP19;TRAPPC14;OFD1;ATAT1;GOLPH3;RAB1A;CCDC66;IFT43;NPHP3;ACTR2;CPLANE2;CEP20;CENPJ;PTPN23;S1PR2;CEP164;MKKS;ATP6V0D1;RAP2B;CLUAP1;IQCB1;NUDCD3;RAB11A;LZTFL1;HYLS1;EXOC2;TXNDC15;PIBF1;CEP89;ACTR3;EXOC5;TEKT2
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.5527688415267937,1.1618681701936622,0.29901960784313725,0.8295423529902899,1.0,2/11,2.88%,CAMK2D;CACNG6
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.5893948319628752,1.1618531129134415,0.30917874396135264,0.8286969674675577,1.0,6/10,26.46%,TUT7;TUT4;CHFR;UBB;UBA52;RPS27A
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.48949293296174207,-1.161417645103516,0.2727272727272727,0.6985499745289073,1.0,5/11,27.42%,AKAP6;NOS1AP;LRRC55;TREM2;RNF207
prerank,mitotic sister chromatid cohesion (GO:0007064),0.5385768143614954,1.1613677009355774,0.3028485757121439,0.829404005669975,1.0,7/16,17.63%,NIPBL;DSCC1;POGZ;SMC1A;RB1;RAD21L1;REC8
prerank,peptidyl-proline hydroxylation (GO:0019511),0.5620659803763005,1.1612688284977473,0.29984301412872844,0.8288944083346702,1.0,2/11,13.54%,EGLN3;P4HA1
prerank,regulation of hippo signaling (GO:0035330),0.5231977166651256,1.1612639183978004,0.2925764192139738,0.828029895640494,1.0,2/17,1.26%,CIT;MOB3B
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.4544008444172186,1.1611234684015732,0.2716688227684347,0.8276010383765683,1.0,11/39,13.41%,THBS1;SEMA3E;EFNA5;FZD7;MYOC;DMTN;CORO1C;RHOA;JAG1;ITGB1BP1;HOXA7
prerank,nucleoside phosphate catabolic process (GO:1901292),0.5532663080598315,1.1610270761434862,0.30802919708029197,0.8270457611285887,1.0,6/13,11.57%,ENTPD6;ENTPD2;ENTPD5;SMPDL3A;NUDT15;ENTPD7
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.5518580056619812,1.1610075629655243,0.3160377358490566,0.8262212370550265,1.0,3/12,12.08%,DPYSL3;DPYSL2;CTPS2
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.40389388366899437,1.161003395142635,0.23026315789473684,0.8253589552148796,1.0,31/114,21.82%,CARD14;TNFRSF11B;PTK2B;EDA;PSMB2;LIMS1;FOXO3;PSMD11;PSMC1;PSMC6;TRAF2;PSMD1;TRAF6;PSMD4;TRAF5;IKBKB;TNFRSF12A;MAP3K14;PSMA6;TNFSF13B;PSMD14;PSMD12;PSMD7;JAK2;COMMD7;CHUK;CDIP1;TRAF3;PSME3;TXNDC17;TRADD
prerank,cellular copper ion homeostasis (GO:0006878),-0.4539351390290489,-1.160995755038572,0.26878612716763006,0.6976935960376304,1.0,6/14,19.92%,APP;ATOX1;SLC31A1;COX19;MT2A;PRNP
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.48748007669164545,1.1609402901804557,0.2707482993197279,0.8246851573335207,1.0,7/26,13.01%,EYA2;EYA4;FGFR1;INHBA;MCL1;EYA3;RET
prerank,mitochondrial RNA metabolic process (GO:0000959),0.5426093209483009,1.1606319828280762,0.29583975346687214,0.8248278801700527,1.0,5/14,18.35%,FASTKD1;FOXO3;EARS2;FASTKD5;MTERF2
prerank,mitochondrion disassembly (GO:0061726),0.46470617774337203,1.1604457104314767,0.2751322751322751,0.8244966624233011,1.0,9/34,13.98%,ULK2;CISD2;BECN1;WDR45B;ATG3;RB1CC1;ATG5;MARK2;WIPI2
prerank,regulation of nuclear division (GO:0051783),0.5108991848272956,1.159923233233573,0.28995756718529,0.8253495225452034,1.0,9/20,27.65%,CCDC8;CDK13;FBXO5;PRMT5;PIN1;BORA;PDXP;CUL7;KIF20B
prerank,sensory organ development (GO:0007423),0.44378565363330325,1.1597789429308454,0.2779827798277983,0.82495047818011,1.0,9/51,12.36%,PBX3;SMOC1;PBX1;HIPK1;ECE1;FOXC1;SIX4;ATF6;SCO2
prerank,peroxisomal membrane transport (GO:0015919),0.4749404212510477,1.1596590961703228,0.2706359945872801,0.8244822493029732,1.0,5/27,10.07%,ABCD3;PXMP2;ABCD1;ACBD5;PEX13
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.5220005286337644,1.159500200513543,0.30132939438700146,0.8241506702283276,1.0,7/17,24.12%,DHDDS;ALG13;ALG12;DPAGT1;ALG14;ALG8;MVD
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.37899184554830817,1.1585393198414509,0.13253012048192772,0.8263343457701019,1.0,109/366,23.55%,BNC2;VSX1;SIX1;ZFHX3;TCF7L1;PRRX2;CCNA2;FOXN3;NFIA;JMJD1C;ERC1;SOX14;ZNF423;ESR1;FZD7;TGFBR1;ABL1;STAT3;FOXO3;CHEK2;USP13;NFIL3;BHLHE40;HMG20A;CREBBP;RORA;SERTAD3;CDK11B;DSCC1;CHD3;MLX;MLXIPL;GPBP1;GATA4;NLK;FOXC1;ATXN2;ATF7;NSD1;TOM1L1;DENND4A;ANKRD17;RBM3;FBXO5;PHF12;ESCO1;ORC3;NFXL1;APBB3;POFUT1;FUS;GTF2IRD1;E2F1;PRMT5;NFYA;PATZ1;PRDM2;HINFP;SP3;MSL3;ATRX;CYFIP1;NR3C1;THAP7;DVL1;KAT6B;ZNF219;EFEMP1;MZF1;ESR2;HCFC1;KMT2D;RB1;ASCC2;RNF20;RNF14;NUP35;TAF5;TRRAP;ACTR5;ATF2;BRCA2;NONO;GON4L;NFX1;GEMIN5;CREBL2;NR1D2;FOXK2;PCGF1;UTP4;PUM3;ZKSCAN5;PML;NFKB2;IGF2;POU6F2;HOXB7;WWC2;ATXN1L;ZNF35;RPL10;SBNO1;CCAR1;RABL3;HMGA1;MYCBP;MAPKAPK5;TP53
prerank,glycogen catabolic process (GO:0005980),0.5344028056266926,1.1581850123580082,0.30058651026392963,0.8266604330255414,1.0,5/15,15.09%,PYGB;PHKA2;PHKB;RB1CC1;PGM2
prerank,regulation of phospholipase activity (GO:0010517),0.5749607854607802,1.1580220820883087,0.3106796116504854,0.8263519125364828,1.0,4/10,16.78%,LRP1;FGFR1;ANGPTL3;FGFR3
prerank,homotypic cell-cell adhesion (GO:0034109),0.4517023150486485,1.1578082876471478,0.29329962073324906,0.8261696351926031,1.0,7/39,7.44%,UBASH3B;PLPP3;GNAS;CLIC1;CEACAM5;FN1;VCL
prerank,RNA export from nucleus (GO:0006405),0.4093756654371049,1.1577976906878469,0.2570806100217865,0.8253308942572354,1.0,47/100,33.50%,SRSF11;U2AF2;SMG6;THOC2;SRSF5;NUP93;SRSF6;NUP214;NUP153;CDC40;SRSF2;NUP155;FYTTD1;RANBP2;NUP88;SRSF1;RNPS1;CPSF3;CHTOP;UPF2;HNRNPA2B1;NUP35;DDX19B;SARNP;DHX38;SRSF3;SRRM1;ZC3H11A;FIP1L1;YTHDC1;NUP98;POM121;WDR33;THOC1;ALKBH5;SEC13;UPF3B;THOC5;SEH1L;DDX39A;DDX39B;NUP54;SRSF7;TPR;AAAS;NXT1;ALYREF
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.43755771315943953,-1.1577360483140082,0.26688102893890675,0.7049446015776588,1.0,11/16,35.88%,CXCL12;BCL2L1;RPS3;TPT1;CDKN2D;SNAI2;CCAR2;DDIAS;SFRP2;ACKR3;NACC2
prerank,positive regulation of axonogenesis (GO:0050772),0.4437347295411518,1.1568980612791975,0.2662420382165605,0.827414496806436,1.0,10/43,13.51%,SLIT2;NTN1;NGF;TIAM1;TIAM2;SHTN1;RHOA;MAP6;PLXNB1;DBN1
prerank,negative regulation of cell junction assembly (GO:1901889),0.49038765264349066,1.1567068155951732,0.28851540616246496,0.8271906477408968,1.0,7/25,8.58%,THBS1;SLIT1;BCAS3;PHLDB2;FAM107A;DMTN;CORO1C
prerank,tRNA wobble base modification (GO:0002097),0.5470219106693638,1.1555792173705082,0.28396946564885495,0.8299763497592898,1.0,4/14,9.90%,ELP3;DPH3;ALKBH8;MTO1
prerank,negative regulation of catabolic process (GO:0009895),0.44498373472905184,1.1555581436015796,0.2736077481840194,0.8291843845534574,1.0,12/47,18.62%,EGFR;HDAC4;IRAK3;PFKFB1;NCOR1;MAD2L1;MDM4;TIGAR;AZIN1;PIN1;SNX12;HMGCR
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.4829250332498116,1.1554635893487477,0.28372739916550765,0.8286541803749411,1.0,6/26,12.66%,CYP1B1;RORA;SULF1;GATA4;ARNT;BRCA1
prerank,protein localization to cell-cell junction (GO:0150105),-0.4436849287595514,-1.1547821635426663,0.29737609329446063,0.7111363799496213,1.0,4/15,4.83%,TJP1;F11R;CGNL1;ACTB
prerank,positive regulation of cell population proliferation (GO:0008284),0.37177742381201895,1.154770174854616,0.13440320962888666,0.8300173047254611,1.0,61/423,10.17%,THBS1;FOXP1;BMP4;EGFR;ZFPM2;TCF7L2;ACER3;PGF;HES1;HDAC4;NTRK3;PID1;GRK5;DDR2;CCN1;BMP5;PTK2B;FGF2;GAB2;KRAS;IRS1;VEGFA;TGFB3;BMPR1A;ID2;RAB25;CLCF1;RARA;TIMP1;S100B;TGFBR1;PTHLH;FOLR2;NR4A3;PDGFC;FGFR1;SHC1;TCIRG1;CNOT8;PROK2;BMP6;CTF1;ERBB2;TIAM1;TGFBR2;SIRT6;UBE2A;FN1;KITLG;CEP43;MLXIPL;TRPM4;KDM1A;CUL3;CHRD;CIB1;TMEM119;CDC123;ITGAV;CDK13;TTK
prerank,mitotic DNA replication (GO:1902969),0.5665833423295934,1.1545512618939926,0.32558139534883723,0.8298704125862818,1.0,2/10,5.63%,CDC45;MCM2
prerank,protein insertion into membrane (GO:0051205),0.465600237677287,1.1536069067775472,0.2826666666666667,0.8319906162511272,1.0,3/32,4.58%,EGFR;TRAM2;EMD
prerank,ephrin receptor signaling pathway (GO:0048013),-0.3045885475794595,-1.153462790285248,0.17475728155339806,0.7129128266692142,1.0,19/82,6.57%,EFNB2;LYN;PAK1;EPHB1;EPHA6;ROCK2;EPHA7;PAK3;ARPC4;GRIN2B;EPHA5;DNM1;ACTB;EPHA8;ARPC5;EPHA4;VAV3;GRIN1;NGEF
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.2686767340244575,-1.1533937488887887,0.0625,0.7110783533556926,1.0,57/168,18.17%,RPL37;RPL27A;RPL19;RPS13;RPS9;RPS3;RPS14;RPL18A;RPL38;RPS19;RPS8;RPS11;RPL34;RPL18;RPL7;RPS25;RPL21;RPL23A;RPLP2;RPS21;RPL26;RPS4X;RPL41;DCP2;RPS29;RPL35A;RPL10A;PAN2;RPL11;MAGOH;RPS5;CNOT6L;CTIF;RPS16;EXOSC5;RPL4;SMG7;POLR2G;RPS7;RPS23;RPS15;RPL36;RPS18;EXOSC9;RPL37A;RPL32;RPS20;RPL29;RPL13;RPL36A;PELO;PDE12;HELZ2;RPL23;RPL17;RPL9;CNOT9
prerank,negative regulation of neuron projection development (GO:0010977),-0.3323190927722431,-1.1528719979520792,0.17073170731707318,0.7104568093344696,1.0,26/56,19.25%,EFNB2;APOE;LPAR1;SPOCK1;DCC;EPHA4;RTN4;NGEF;MAG;RTN4RL1;PTPRO;DENND5A;CRMP1;RUFY3;ARHGDIA;FKBP4;STMN2;MCF2;TRPV4;MT3;PRAG1;THY1;MYLIP;LINGO1;BCL11A;SEMA3A
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.4759998892805679,1.1528524380888694,0.30604026845637583,0.8335288220170907,1.0,6/29,10.26%,TCF7L1;TCF7L2;TLE2;PYGO2;CREBBP;PYGO1
prerank,glycosaminoglycan catabolic process (GO:0006027),0.4303503754774823,1.1522771818142998,0.26625766871165646,0.8344826656012602,1.0,14/55,15.34%,GPC6;GPC3;FGF2;SPAM1;HEXA;BGN;LYVE1;CD44;ARSB;SLC9A1;CHP1;GPC4;NAGLU;IDUA
prerank,positive regulation of protein polymerization (GO:0032273),0.4247127281395356,1.1520323125472904,0.2755344418052256,0.8343859598542831,1.0,10/65,8.37%,CDC42EP5;MET;BAIAP2L1;PRKCE;PTK2B;CLIP1;NCK2;TENM1;TOGARAM1;AKAP9
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.5574250960041288,1.1510969877358075,0.33387888707037644,0.8355952929208851,1.0,1/10,2.89%,CACNA1F
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.5574250960041288,1.1510969877358075,0.33387888707037644,0.8355952929208851,1.0,1/10,2.89%,CACNA1F
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.28273102408589973,-1.1509102550449437,0.16455696202531644,0.7139344018817194,1.0,34/121,15.97%,IGF1;IL34;VTN;LYN;IL31RA;ENPP2;PECAM1;KIT;GRM5;NEDD9;TEC;ERBB4;IL6R;ACE;PARP14;EPHA4;GHR;GPRC5B;IL18;LRP8;PTPRJ;TNK2;FLT3;GAS6;CD81;NOX4;ERBB3;ARL2BP;MIF;CD40;FGF7;CSF1R;CD74;RELN
prerank,embryonic axis specification (GO:0000578),0.534550105504057,1.1506359490573064,0.30409356725146197,0.8362500421004534,1.0,3/15,7.92%,COBL;SMAD6;SMAD2
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.4328537738977588,1.1501362818081995,0.2717391304347826,0.8370363081421387,1.0,22/56,20.16%,EGFR;ANXA1;ANAPC5;LSM11;CCND1;RDX;CUL3;CDC16;ANAPC11;CCNB1;ANKRD17;MECP2;FBXO5;TFDP1;ADAMTS1;CDC7;RB1;DTL;KMT2E;BRD4;EIF4G1;RAB11A
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.4592480978192852,1.149814623558924,0.2845953002610966,0.8372133000390187,1.0,11/38,18.67%,ABLIM3;HPS4;NPEPPS;SAE1;HSPA1L;SH3GLB1;SREBF1;UBE2D3;UBL5;LRRK2;ATP5IF1
prerank,cardiac muscle tissue morphogenesis (GO:0055008),-0.3803705338293265,-1.1498009490705179,0.2766798418972332,0.715154684448773,1.0,5/29,8.78%,ENG;TGFBR3;NOTCH1;PROX1;BMP2
prerank,regulation of integrin activation (GO:0033623),-0.4503760086055088,-1.1496452147115956,0.29329608938547486,0.7135575237765925,1.0,9/15,28.24%,RASIP1;PIEZO1;JAM3;FBLIM1;PLEK;KIF14;SELP;PTGER4;RAP1B
prerank,bile acid biosynthetic process (GO:0006699),-0.39542872869934886,-1.1495424892023292,0.2768166089965398,0.7118694203704731,1.0,8/24,21.98%,CYP7B1;CYP27A1;OSBPL1A;SCP2;OSBPL9;OSBPL3;OSBPL7;CH25H
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.37693801992967463,1.149352968763766,0.1595959595959596,0.8378239641979632,1.0,85/327,21.37%,BNC2;VSX1;SIX1;ZFHX3;TCF7L1;PRRX2;FOXN3;NFIA;JMJD1C;ERC1;SOX14;ZNF423;ESR1;FZD7;TGFBR1;ABL1;STAT3;CHEK2;USP13;NFIL3;BHLHE40;HMG20A;CREBBP;RORA;SERTAD3;CDK11B;CHD3;MLX;MLXIPL;GPBP1;GATA4;NLK;FOXC1;ATF7;NSD1;DENND4A;PHF12;NFXL1;APBB3;POFUT1;FUS;GTF2IRD1;E2F1;PRMT5;NFYA;PATZ1;PRDM2;HINFP;SP3;MSL3;ATRX;NR3C1;THAP7;DVL1;KAT6B;ZNF219;EFEMP1;MZF1;ESR2;HCFC1;KMT2D;RB1;ASCC2;RNF20;RNF14;NUP35;TAF5;TRRAP;ACTR5;ATF2;BRCA2;NONO;GON4L;NFX1;COPS2;CREBL2;NR1D2;FOXK2;PCGF1;UTP4;ZKSCAN5;PML;NFKB2;IGF2;POU6F2
prerank,synapse assembly (GO:0007416),-0.30824417421552747,-1.149168676952742,0.17880794701986755,0.7109359046192141,1.0,16/67,5.97%,SPOCK2;CDH2;DNM3;GRID2;SHANK3;ADGRL3;NRXN1;WNT5A;KIRREL3;GABRB3;GPM6A;RYK;GABRA2;SDK2;GABRB2;PLXND1
prerank,protein import (GO:0017038),0.41411802459286445,1.1490580428021067,0.2588369441277081,0.8379190666697364,1.0,18/84,14.40%,ABCD3;PRICKLE1;PXMP2;STAT3;NUP93;E2F3;ABCD1;NUP214;NUP153;TNPO2;ACBD5;PEX13;TNPO3;CLU;IPO7;NUP155;NUTF2;NUP88
prerank,protein localization to microtubule organizing center (GO:1905508),0.5314992807631406,1.1490540986255082,0.3205882352941177,0.8370773878232375,1.0,8/15,32.28%,PCM1;HOOK3;C2CD3;PIBF1;CCDC14;BBS4;CEP131;CSNK1D
prerank,histone H2A acetylation (GO:0043968),0.5265277065973519,1.1488432907819321,0.3333333333333333,0.8369303766308221,1.0,7/16,19.60%,EP400;DMAP1;MSL3;MORF4L1;NAA40;TRRAP;EPC1
prerank,negative regulation of MAP kinase activity (GO:0043407),0.44216239257117024,1.1485611204368333,0.29448621553884713,0.8369569823892916,1.0,7/44,10.44%,BMP4;PRKCD;CBLC;IRAK3;NF1;PDCD4;DUSP19
prerank,regulation of calcium ion transport (GO:0051924),-0.32635621290347844,-1.1483944241164348,0.18333333333333332,0.7112753610888574,1.0,18/54,15.60%,MYLK;EPB41;BCL2;CACNA1D;CACNB2;CACNA2D1;TRPC6;WFS1;PLPP4;ADRA2A;ATP2B1;WNK3;ORAI1;CAMK2G;CD84;CAMK2B;CTNNB1;CAMK2A
prerank,protein localization to condensed chromosome (GO:1903083),0.5560057653239161,1.1481764030545154,0.3250388802488336,0.8373205350226339,1.0,7/12,27.57%,TTK;ZW10;ZWILCH;SPDL1;BUB3;MTBP;MIS12
prerank,cognition (GO:0050890),0.450147724947504,1.1481593218363517,0.2807017543859649,0.8365107079678558,1.0,12/42,16.94%,ST3GAL4;SOBP;SHROOM4;CBR3;NIPBL;NF1;FAM107A;DOP1B;METTL23;CYFIP1;CHMP2B;STRA6
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.5370992032443278,1.1477963729120042,0.3164933135215453,0.836824606718333,1.0,7/15,27.06%,USP46;ZDHHC12;NLGN1;STXBP1;ZDHHC3;NLGN2;CLN3
prerank,response to metal ion (GO:0010038),0.4253423184352667,1.1476113512944583,0.27357392316647267,0.8365532570284837,1.0,7/67,8.44%,THBS1;NEDD4;ADAM9;PPP3CA;NDRG1;SEC31A;SLC30A3
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.5351792413650331,1.1472023189540854,0.3491827637444279,0.8369865592546056,1.0,2/14,2.99%,NT5C1A;NT5E
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.44354666572252255,-1.1471945835404995,0.32409972299168976,0.7125107613653597,1.0,3/14,6.47%,LYN;PIK3R1;GHR
prerank,adipose tissue development (GO:0060612),-0.4638517851209436,-1.1471655846624738,0.3045977011494253,0.710583593628935,1.0,6/11,25.43%,ARID5B;SPTLC2;XBP1;DYRK1B;RORC;NAMPT
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.5711855126393058,1.146384498707871,0.34728682170542635,0.8386688657163648,1.0,2/10,1.65%,WNK1;CYP1B1
prerank,lymphocyte chemotaxis (GO:0048247),0.46804950491209035,1.1462148012181868,0.3220108695652174,0.8383790549904707,1.0,3/34,4.33%,SLC12A2;CCL3;CCL1
prerank,atrial septum morphogenesis (GO:0060413),0.574583899580833,1.1459179999751947,0.3258064516129032,0.8385175533726007,1.0,4/10,13.64%,NOTCH2;GATA4;ZFPM1;ACVR1
prerank,regulation of glucose import (GO:0046324),-0.37037266037586025,-1.1457624686442596,0.24372759856630824,0.7123809473379797,1.0,6/30,3.89%,IGF1;OSBPL8;OCLN;PIK3R1;ENPP1;INSR
prerank,cAMP metabolic process (GO:0046058),-0.45417589917576695,-1.14572768838788,0.2914285714285714,0.7104648775110265,1.0,4/13,5.92%,ADCY5;ADCY1;PDE4D;ADCY7
prerank,regulation of interferon-alpha production (GO:0032647),0.49647869209425743,1.1449944567760137,0.3347517730496454,0.8406276230821534,1.0,13/23,26.18%,SETD2;TLR4;MAVS;IFIH1;RIPK2;DHX36;TLR8;PTPRS;DHX9;CHUK;IRF3;NLRC3;IRF5
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.4090147605530083,1.1449704382752475,0.2818181818181818,0.839855732645413,1.0,38/84,26.48%,MBNL1;DDX5;RBFOX2;DDX17;CELF3;U2AF2;SON;RBM39;SRSF6;DAZAP1;THRAP3;RBM3;CELF4;RBM25;CELF1;TIA1;WTAP;RBMX;KHDRBS1;CIRBP;RNPS1;MBNL2;PCBP4;ZBTB7A;FMR1;SRSF3;SRPK2;JMJD6;LARP7;REST;YTHDC1;NUP98;RBM11;RBM4;SFSWAP;ZC3H10;RBMXL1;METTL16
prerank,regulation of calcium ion import (GO:0090279),-0.4017451697567698,-1.144849317924694,0.28774928774928776,0.7109861285831583,1.0,10/21,26.30%,PDGFRB;CXCL12;PLPP4;SLC30A1;WNK3;CTNNB1;PRNP;STC1;CCL2;SPHK2
prerank,positive regulation of neuron differentiation (GO:0045666),-0.34476736525432905,-1.1444760925976394,0.25925925925925924,0.7100840250279106,1.0,10/40,10.06%,TCF4;ZEB1;BRINP3;MEF2C;GPRC5B;PROX1;BMP2;BRINP1;MMD2;ZC4H2
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.5207370159701777,1.1441789235407045,0.3022556390977444,0.8415296702513771,1.0,6/16,24.13%,NCOR1;BRCA1;SOX9;ACADL;ACADVL;APPL2
prerank,response to lipid (GO:0033993),0.3961185007931459,1.1440112244074816,0.2633333333333333,0.8412078572975425,1.0,27/105,19.05%,FOXP1;ALPL;LBP;SMAD6;ESR1;RARA;IRAK3;STAT3;ANXA1;FOXO3;PALM3;TLR4;RXRA;ERBIN;TAB2;RXRB;RPS6KA3;STRN3;TIRAP;SOX9;OTUD5;MAPKAPK2;SCD;OVCA2;SRR;PPARG;JAK2
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.4961812972089947,1.143758098579677,0.3091168091168091,0.8411707396052811,1.0,7/22,14.37%,RASSF2;VEGFA;PDGFC;TOM1L1;RAD50;TNKS1BP1;RAP2C
prerank,regulation of cellular component biogenesis (GO:0044087),-0.342328569577518,-1.1437440840888593,0.2556053811659193,0.7102405100128155,1.0,9/39,7.73%,TJP1;APOE;TIE1;RAPGEF2;ROCK2;NOTCH1;HSPA8;DAB2IP;GFAP
prerank,positive regulation of secretion by cell (GO:1903532),0.4173491684195152,1.143655469542759,0.2759022118742724,0.8406505971038994,1.0,8/70,6.10%,SLC12A2;ADAM9;EZR;UNC13B;KCNB1;TGFB3;SYTL4;BMP6
prerank,negative regulation of dephosphorylation (GO:0035305),-0.41144765886615525,-1.143639014344609,0.2736156351791531,0.7085945434439759,1.0,4/18,9.55%,MFHAS1;PPP1R16B;YWHAB;SH3RF2
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.4555014199928772,-1.143319156545431,0.2987012987012987,0.7075394410830681,1.0,2/15,4.44%,IGF1;BCL2L1
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.4115303782881064,1.1429921479692027,0.2794811320754717,0.8418902451850611,1.0,14/73,15.53%,EGFR;NTRK3;NGF;VEGFA;DOCK7;ATP2B4;CD44;TENM1;AKAP9;RIPK2;BCAR3;RAF1;TNKS1BP1;CAPRIN2
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.5148204776908664,1.1429044018739525,0.3277439024390244,0.8413328709874968,1.0,5/17,5.43%,DOCK5;IGFBP5;NRP1;NR4A3;DOCK7
prerank,regulation of cell communication (GO:0010646),0.4593951554632469,1.1428795721126968,0.2903225806451613,0.8405717955308286,1.0,6/35,8.04%,MGLL;GRK5;CAMK2D;ANK2;ANXA1;GRK4
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.4915259371191444,1.1428504547738247,0.3153409090909091,0.8398396013178056,1.0,9/21,23.47%,CDC20;KLHL22;TTK;MAD2L1;FBXO5;ZW10;MAD1L1;BUB3;ATM
prerank,glial cell development (GO:0021782),-0.37853056352531333,-1.1425762071749015,0.27238805970149255,0.7077284736865341,1.0,8/25,17.25%,APP;CDK6;NRROS;CSPG5;EIF2B1;SOX4;NSUN5;MT3
prerank,lipoprotein biosynthetic process (GO:0042158),-0.4811276854304409,-1.1422639895318012,0.2970027247956403,0.7066815032231107,1.0,2/11,3.64%,APOE;UGCG
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.47487110928555415,1.1422075486448269,0.3076923076923077,0.8409698390563428,1.0,8/26,10.55%,ALPK1;TAB3;IKBKG;IFIH1;AAMP;RIPK2;MAP3K7;TAB2
prerank,calcium ion import (GO:0070509),0.47024404294300765,1.1419500973534549,0.3203230148048452,0.8409544506384757,1.0,4/28,2.89%,CACNA1C;CACNA1G;CASR;CACNA1F
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.3767657719399888,1.1412983741175458,0.1846619576185671,0.8421237191750289,1.0,99/314,26.23%,WWP1;FBXL7;NEDD4;FZR1;ECRG4;NFE2L2;WWP2;RNF126;PSMB2;UBE4B;ANAPC5;SPSB2;AMN1;UBE2A;AURKA;FBXL20;PSMD11;FEM1B;RNF185;CUL3;ANAPC10;PSMC1;MAN1B1;VCP;MTA1;CDC16;UBE4A;PPP2R5C;CUL1;ANAPC11;CDC20;KLHL22;TBL1X;CCNB1;FBXO27;RAD23B;PSMC6;MAD2L1;FBXO5;FBXO31;ANAPC16;HERPUD1;UBE2K;UBR3;FBXO48;COP1;SPOPL;RNF122;FBXO45;SEL1L;PSMD1;UBE2B;NHLRC1;UBE2D3;PSMD4;CDK2;FBXO17;TMEM129;RB1;AREL1;PSMA6;UBE2S;RBCK1;SMURF1;UBXN2B;PSMD14;SPOP;PSMD12;RMND5A;PSMD7;FBXL6;ANKZF1;USP19;UBXN4;DNAJB2;PML;PSME3;BUB3;ANKRD9;RHBDD2;FBXL8;TRIM71;PSMD3;DDIT3;FBXW4;PSMB6;SEC61B;UBB;FBXW11;APPBP2;LTN1;HECTD3;ERCC8;UBA52;SHARPIN;KLHL15;RNF103-CHMP3;TOPORS;ANAPC4
prerank,regulation of intracellular protein transport (GO:0033157),0.45224788268934984,1.14128792839852,0.29010695187165775,0.8413121926163898,1.0,9/32,17.08%,BMP4;BCAS3;NDEL1;PCM1;TENM1;PCNT;VAMP2;PLK3;OAZ2
prerank,polarized epithelial cell differentiation (GO:0030859),0.5450777516362191,1.1408168864256027,0.3333333333333333,0.8419496201526456,1.0,6/13,16.49%,EZR;SYNE4;RHOA;MYO9A;SCRIB;CAMSAP3
prerank,positive regulation of interferon-alpha production (GO:0032727),0.5136242797399001,1.1407397586103831,0.3260553129548763,0.841382549230221,1.0,10/19,21.44%,SETD2;TLR4;MAVS;IFIH1;RIPK2;DHX36;TLR8;DHX9;CHUK;IRF3
prerank,androgen metabolic process (GO:0008209),-0.41214365558238014,-1.1401097332806642,0.2956810631229236,0.7108445043907128,1.0,12/18,46.50%,SPP1;MED1;SRD5A1;SHH;HSD17B7;SRD5A2;HSD3B2;CYP19A1;DHRS9;HSD17B6;HSD17B3;AKR1D1
prerank,myeloid leukocyte differentiation (GO:0002573),0.41279166743360984,1.1400027840064997,0.27809965237543455,0.8428786567083922,1.0,15/65,19.02%,FOXP1;BMP4;GAB2;VEGFA;RARA;TGFBR2;RXRA;PARP1;BATF3;E2F1;CDK2;CDKN1A;FARP2;DEK;PPARG
prerank,cellular senescence (GO:0090398),0.46949963265199235,1.1399014491413981,0.3112313937753721,0.8423419366398488,1.0,11/27,23.61%,PRKCD;ECRG4;ID2;SMC6;SMC5;ULK3;CDKN1A;PML;HMGA1;MAPKAPK5;KAT6A
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.5028110783068427,1.139556286694,0.3022598870056497,0.8425411196894027,1.0,2/20,1.99%,PLOD2;GCLC
prerank,translesion synthesis (GO:0019985),0.4356879103738872,1.139554555707092,0.2945638432364096,0.841709958268809,1.0,15/42,26.46%,REV3L;VCP;POLE2;ZBTB1;POLI;PRIMPOL;PCLAF;DTL;RFC1;USP10;SPRTN;UBB;UBA52;POLK;RPS27A
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.5599163580019376,1.1391105017693077,0.34340222575516693,0.8422269672922663,1.0,3/10,13.00%,VEGFA;KDM1A;DISC1
prerank,aminoglycan metabolic process (GO:0006022),0.5608948069827527,1.1385385398592083,0.32263242375601925,0.8432233691454948,1.0,2/10,11.16%,XYLT1;B3GALT6
prerank,negative regulation of programmed cell death (GO:0043069),0.3702619034947244,1.138487295289411,0.17051153460381144,0.8425309902715822,1.0,75/355,17.51%,THBS1;BMP4;CARD14;EGFR;MET;FSTL1;GRK5;TCIM;SMAD6;WNT11;GCLC;ANXA4;PTK2B;ARHGAP10;ERC1;NGF;VEGFA;NTSR1;GSK3B;NOTCH2;KRT18;SON;ERCC5;SERPINB9;TAX1BP1;SHC1;ANXA1;PROK2;CEACAM5;CLEC5A;PRDX5;BAG3;CD44;CASP2;BARD1;ZFAND6;SIX4;CIB1;RIPK2;POU4F1;DNAJC3;MCL1;MAD2L1;NAA15;FXN;ARF4;NIBAN2;MYD88;RPS6KA3;RAF1;DPEP1;TMBIM4;MTDH;AATF;COPS5;TIGAR;HTATIP2;PIM2;SOX9;PIDD1;BNIP1;NAA38;YME1L1;PRKDC;TRAF6;GOLPH3;FFAR4;UBE2O;GDNF;USP47;IKBKB;PLK3;RPS6KB1;AREL1;PCID2
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.4103878964248872,1.1382057364492382,0.2761795166858458,0.8426031375471891,1.0,13/76,11.45%,CYP1B1;ANXA4;CMKLR1;PTGIS;KLF4;IRAK3;TAX1BP1;G3BP2;NLRP12;ZC3H12A;BRMS1;ERBIN;CHP1
prerank,mRNA transport (GO:0051028),0.40234903312060255,1.1379707576333962,0.2724288840262582,0.8425394273375859,1.0,48/101,33.50%,SRSF11;U2AF2;SMG6;THOC2;SRSF5;NUP93;SRSF6;NUP214;NUP153;CDC40;SRSF2;NUP155;FYTTD1;RANBP2;NUP88;SRSF1;RNPS1;CPSF3;CHTOP;UPF2;HNRNPA2B1;NUP35;DDX19B;SARNP;FMR1;DHX38;SRSF3;SRRM1;ZC3H11A;FIP1L1;YTHDC1;NUP98;POM121;WDR33;THOC1;ALKBH5;SEC13;UPF3B;THOC5;SEH1L;DDX39A;DDX39B;NUP54;SRSF7;TPR;AAAS;NXT1;ALYREF
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.5345301354503958,1.137970294285011,0.31825037707390647,0.8417062267973277,1.0,5/13,21.51%,ALG13;ALG12;DPAGT1;ALG14;ALG8
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.4432282209939017,1.1378999837963206,0.31776913099870296,0.8410907905744931,1.0,9/36,13.18%,EZR;KLHL31;PER1;DACT1;NCOR1;DUSP19;QARS1;IGBP1;DLG1
prerank,heterochromatin organization (GO:0070828),-0.44204972743089355,-1.137665651094063,0.2861111111111111,0.7156536285677189,1.0,3/14,13.17%,MECOM;PRDM16;HP1BP3
prerank,positive regulation of vascular permeability (GO:0043117),-0.45182147243161447,-1.1376470023561174,0.2949438202247191,0.7137726443545985,1.0,2/12,1.73%,TJP1;OCLN
prerank,positive regulation of programmed cell death (GO:0043068),0.3771484765637811,1.1376368670833186,0.20651068158697863,0.8410765208768282,1.0,47/272,16.83%,SLIT2;RASSF2;BMP4;MAP3K5;HOXA5;CYP1B1;VAV2;UNC13B;CRADD;AKAP13;NGF;SFRP4;PAWR;TGFB3;ANO6;GADD45G;ABL1;FOXO3;NF1;TIAM1;SOS2;CASP2;BARD1;IP6K2;ITGB1;TIAM2;PTPA;ATF6;PDCD2;FGD1;CLU;TRIO;ARL6IP5;FGD3;RRP1B;E2F1;HTATIP2;RNF122;GNA13;PIDD1;RNPS1;TRAF6;MTCH1;SCRIB;MAP3K10;PLEKHG2;TNFRSF12A
prerank,regulation of humoral immune response (GO:0002920),0.43863546894326605,1.137570410425192,0.29987129987129985,0.8404480119523315,1.0,8/44,15.67%,CFH;CD55;C5AR2;SERPING1;CD46;CLU;CR1L;C3AR1
prerank,response to growth factor (GO:0070848),0.44264084979361523,1.1368476890883665,0.30641025641025643,0.8418285481639832,1.0,12/41,17.19%,BMPR1A;KLF4;TGFBR1;EMD;SHC1;ERBB2;TGFBR2;CIB1;ACVR1;URI1;CPNE3;RPS6KB1
prerank,intestinal lipid absorption (GO:0098856),0.5618181269234227,1.1366918589939397,0.3267175572519084,0.8414604411999267,1.0,4/11,16.98%,LDLR;LIMA1;SOAT2;CEL
prerank,positive regulation of apoptotic process (GO:0043065),0.3760807039127189,1.1365331364946645,0.20612244897959184,0.8411326998667702,1.0,54/293,16.99%,SLIT2;RASSF2;BMP4;MAP3K5;HOXA5;CYP1B1;VAV2;UNC13B;CRADD;PTGIS;AKAP13;NGF;SFRP4;PAWR;TGFB3;ANO6;GADD45G;CCL3;TGFBR1;ABL1;FOXO3;NF1;TIAM1;SOS2;CASP2;BARD1;IP6K2;ITGB1;TIAM2;TRIM39;ZC3H12A;PTPA;BRMS1;ATF6;PDCD2;FGD1;CLU;TRIO;ARL6IP5;FGD3;RRP1B;E2F1;RNF122;GNA13;PIDD1;RNPS1;TRAF6;MTCH1;SCRIB;MAP3K10;PLEKHG2;SIK1;TNFRSF12A;FAP
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.5159584866302196,1.13600733323917,0.3257918552036199,0.8419659426119924,1.0,2/15,4.61%,TGFB3;IRAK3
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.4580631950524744,-1.1355849916889842,0.3125,0.7176601318475363,1.0,4/12,5.53%,NKD1;PROM1;RORB;SDK2
prerank,nucleotide-excision repair (GO:0006289),0.39888214423372326,1.1352242559034538,0.26918798665183535,0.8435898000306074,1.0,43/101,31.91%,ERCC5;SLX4;MNAT1;UVSSA;CHD1L;PARP1;RAD23B;COPS7B;COPS5;COMMD1;BRIP1;CDK7;SLC30A9;RNF111;GTF2H3;POLB;COPS8;BRCA2;POLR2C;CETN2;COPS3;RFC1;COPS2;ERCC4;TP53;USP7;UBB;HMGN1;ERCC8;UBA52;POLK;GTF2H4;RPS27A;DDB1;ERCC2;POLA1;DDB2;POLD1;XPA;HUS1;GTF2H5;ATXN3;COPS7A
prerank,histone H4 acetylation (GO:0043967),0.43537929047016705,1.1345473071877001,0.2941903584672435,0.8448715493727438,1.0,19/47,20.09%,EP400;PER1;KANSL3;TADA3;KANSL2;ZZZ3;JADE2;DMAP1;MSL3;MORF4L1;NAA40;HCFC1;TRRAP;ATF2;BRCA2;PHF20;NAA60;EPC1;KANSL1
prerank,regulation of cholesterol esterification (GO:0010872),-0.49401743220709693,-1.1345116951295813,0.3156498673740053,0.7187305904622877,1.0,2/10,4.23%,APOE;ABCG1
prerank,skeletal muscle contraction (GO:0003009),-0.4014011898287365,-1.1337730564670931,0.27,0.7188227258026174,1.0,7/19,30.40%,RCSD1;STAC;STAC2;MYH14;STAC3;CCDC78;TCAP
prerank,regulation of actin polymerization or depolymerization (GO:0008064),-0.363736358058742,-1.1334863367308265,0.2777777777777778,0.7176815444421882,1.0,4/28,4.20%,ARHGAP28;ESAM;CXCL12;PAK3
prerank,regulation of cellular senescence (GO:2000772),-0.3734757111358327,-1.1330592484828115,0.291970802919708,0.7170419464278863,1.0,9/28,15.84%,AKT3;SLC30A10;B2M;CDK6;NUAK1;YPEL3;RBL1;ABI3;TERT
prerank,long-chain fatty acid biosynthetic process (GO:0042759),-0.3910471728739492,-1.1330116204731653,0.2952029520295203,0.7152684083959691,1.0,11/23,30.45%,LTA4H;GSTM1;ACSBG1;ALOX12;GPX4;ELOVL6;PTGS2;GSTM2;ALOXE3;ACOT7;CYP2E1
prerank,oligodendrocyte development (GO:0014003),-0.43524244985029586,-1.1328366739051203,0.3072463768115942,0.7138876281494213,1.0,4/15,17.15%,PLP1;B4GALT6;EIF2B1;NSUN5
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.44134559758827574,-1.1328010225510758,0.2807017543859649,0.7121162613198156,1.0,1/14,0.16%,AUTS2
prerank,regulation of tau-protein kinase activity (GO:1902947),0.5608829763642391,1.1322891324947377,0.36012861736334406,0.8509749332787531,1.0,4/10,17.24%,EGR1;CLU;SORL1;RB1
prerank,antigen receptor-mediated signaling pathway (GO:0050851),-0.2625180629649958,-1.1322876551908736,0.058823529411764705,0.7115085299084066,1.0,34/163,14.35%,PRKCB;PDE4B;BCL2;RFTN1;PAK1;PIK3R1;TEC;FYB1;INPP5D;PAK3;TNFRSF21;PDE4D;PRKCQ;MEF2C;VAV3;THEMIS;CD38;BTRC;PSMD8;PSMC3;PSMB4;BMX;PTPRJ;PAG1;NFATC2;MOG;PSMB3;SH2B2;PIK3CA;ICOSLG;PTPN22;PSMB8;BLNK;BTN3A3
prerank,microtubule depolymerization (GO:0007019),-0.41752503022692916,-1.1322264266625683,0.30491803278688523,0.7098433331662592,1.0,10/17,26.35%,STMN1;STMN4;STMN3;NCKAP5;STMN2;CKAP5;KIF2A;NCKAP5L;KIF14;KIF19
prerank,phosphatidylserine metabolic process (GO:0006658),-0.3661808076732336,-1.1321687982029274,0.29296875,0.7081352966607299,1.0,5/32,5.77%,OSBPL8;PLA1A;OSBPL10;SERINC5;PLAAT3
prerank,regulation of cellular response to stress (GO:0080135),0.3919181301188999,1.1321674325702071,0.2786885245901639,0.8505014140610272,1.0,29/115,20.09%,SLC38A2;CAMK2D;GSK3B;ABL1;HSPB8;NUP93;BAG3;CREBBP;ABCD1;NUP214;HSPA1L;NUP153;MCL1;CHORDC1;NUP155;RANBP2;NUP88;ALOX5;MLST8;ADCY8;NEK4;NUP35;BAG5;MAPKAPK2;ATR;EIF4G1;USP19;BAG2;NEK6
prerank,Rap protein signal transduction (GO:0032486),-0.47917141313195166,-1.131911946419443,0.3112391930835735,0.7069637784874773,1.0,4/10,11.28%,RAPGEF3;RAPGEF2;RAP2A;PLK2
prerank,regulation of cell development (GO:0060284),0.4530380366317895,1.1316905443269694,0.32100396301188905,0.8511224013986118,1.0,6/36,9.52%,HES1;HDAC9;NOTCH2;DOCK7;BHLHE40;HES3
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.5090565598652554,1.1315789362675004,0.32994186046511625,0.8506762383642538,1.0,3/17,4.65%,EZR;UBASH3A;PTPN2
prerank,regulation of protein localization to centrosome (GO:1904779),0.5527185540567421,1.1314589533163064,0.344391785150079,0.8502496291169325,1.0,4/10,18.39%,GSK3B;PARD6A;BICD1;UBXN2B
prerank,anterograde axonal transport (GO:0008089),0.4462168153770225,1.1313138472847568,0.3087855297157623,0.8499004735176832,1.0,11/37,18.54%,DLG2;KIF1B;AP3B1;KIF3B;AP3M1;KIF1C;RAB21;AP3D1;KIF5B;BLOC1S5;AP3S1
prerank,peptidyl-lysine modification (GO:0018205),0.3967835527136188,1.1311976255115626,0.3003337041156841,0.849463675579544,1.0,19/99,14.40%,PLOD2;HDAC4;HDAC9;LOXL1;NUP93;SAE1;NUP214;P3H3;TRPM4;NUP153;SENP5;IFIH1;ETFBKMT;LOX;ESCO1;NUP155;RANBP2;SIRT3;NUP88
prerank,negative regulation of cell aging (GO:0090344),-0.43064412504935246,-1.1309449952544308,0.2878787878787879,0.7078722785879163,1.0,6/16,15.84%,AKT3;SLC30A10;CDK6;RBL1;MIF;TERT
prerank,regulation of cytoskeleton organization (GO:0051493),0.39065774445858265,1.130721326093777,0.2717391304347826,0.8501101015624454,1.0,22/108,10.42%,CLIC4;PRKCD;SORBS3;RHOBTB1;EZR;EFNA5;GSK3B;CDK10;CAPN2;PHLDB2;ABL1;ARHGAP44;LRP1;DIAPH1;ARHGAP17;SMIM22;RHOQ;FAM107A;DMTN;RND3;PHLDB1;RHOA
prerank,iron-sulfur cluster assembly (GO:0016226),0.4774058502783189,1.1301947413149984,0.31520223152022314,0.8509736887923594,1.0,8/24,20.90%,GLRX3;HSCB;FXN;NUBP2;NUBPL;ISCA1;NFU1;IBA57
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.42413291928366853,1.1300442876369445,0.30419161676646705,0.8505977886603358,1.0,15/52,16.76%,MBNL1;DDX5;RBFOX2;DDX17;CELF3;SRSF6;THRAP3;CELF4;RBM25;CELF1;WTAP;RBMX;KHDRBS1;RNPS1;MBNL2
prerank,calcium ion transmembrane transport (GO:0070588),0.4072185179696317,1.1293928647118534,0.29896907216494845,0.8517378287215994,1.0,17/86,12.50%,SLC35G1;SLC24A3;CACNA1C;PKD1;CACNA1G;ATP2C2;ANO6;TRPM7;TRPM6;ATP2B4;TRPM4;ITGAV;TRPM8;TRPC4AP;NALCN;MCU;SLC8B1
prerank,regulation of neuroblast proliferation (GO:1902692),0.5255848550775092,1.1291184892305997,0.3516819571865443,0.8517427932978511,1.0,7/15,19.29%,VEGFA;NF1;KDM1A;DISC1;PTN;LRRK2;TAFA3
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.3622628624469182,1.1290665515276808,0.054,0.8510872260676583,1.0,244/1082,17.72%,SIX1;BMP4;EGFR;PLAGL1;ZFHX3;KLF5;ZFPM2;TCF7L2;LRP6;NFIB;MET;MAP3K5;PKD1;HES1;HDAC4;CDH1;PID1;RARB;HOXA5;MLLT3;PPP3CA;CCN1;CSRP3;MEOX2;BMP5;WNT11;NFAT5;TCF20;NFIA;FGF2;PBX1;EHF;GRHL2;PITX2;VEGFA;TGFB3;ZNF423;ESR1;NFE2L2;BMPR1A;ID2;GRHL1;DDX17;DCAF6;FZD1;FZD7;FOXC2;ZIC1;GLIS1;MLXIP;HOXC4;RARA;ELOF1;ELF1;BCAS3;KLF4;GLI3;TGFBR1;ABL1;RBM14;MDFIC;HDAC8;KLF7;HOXB3;IL33;MLLT10;MED13;NR4A3;TWIST1;KMT2C;STAT3;SHC1;FOXO3;KLF10;SKI;NFIX;MRTFA;CHEK2;ZBTB16;PER1;MEF2A;NFIL3;BMP6;MYSM1;GLI2;AGO2;HOXB4;ERBB2;GLIS2;REL;NR4A2;NCK2;INHBA;NRF1;WAC;CREBBP;RORA;SERTAD3;APEX1;E2F3;IKBKG;MED24;NFATC3;RHOQ;IRF1;SMAD2;KANSL3;ZC3H12A;MLX;MLXIPL;TLR4;EGR1;NFIC;GATA4;THRAP3;KDM1A;RUNX2;RXRA;GABPB1;GABPB2;CD80;FOXC1;ELF3;PPRC1;MAVS;ILF2;TADA3;ZFP64;ARNT;SIX4;GPATCH3;SLC9A1;SMARCC1;SCAF8;TASP1;RIPK2;ATF6;NSD1;TBL1X;POU4F1;TGFB1I1;PARP1;DHX36;CRTC2;WDR43;LPIN2;POGZ;ZFPM1;ATOH8;TRIM44;TEAD1;NAA15;TP53INP2;TFDP1;CDKN1C;JUP;RXRB;ARF4;JAG1;THAP3;NIBAN2;CRTC1;RPS6KA3;NCOA6;NR2F1;HSF2;BRCA1;NR1D1;ITGB1BP1;RET;LMX1A;SREBF1;NR4A1;RRP1B;E2F1;LRP5;HOXA7;PAXBP1;NFYA;SSBP3;NFATC1;RBMX;ACVR1;AATF;PRDM2;COPS5;HTATIP2;METTL23;RFXANK;HINFP;SP3;PIM2;ATF7IP;PPP1R12A;PITHD1;ATRX;SOX9;NR3C1;AKIRIN2;BCL11B;POU2F1;CDK7;CCNT2;PLSCR1;DVL1;E2F2;MEF2D;NCK1;SLC30A9;KAT6B;CAPRIN2;PRKDC;RNF111;HOXD3;TRAF6;TNIP1;HIVEP3;PAX6;SMARCA5;MZF1;GDNF;ATF1;SMAD4;FOXK1;PIN1;IKBKB;ACTR2;PRDM10;YAP1;E4F1;CHD8;ESR2;BCL9L;HCFC1;KMT2D;SMAD7;NEK4;CAMTA2;UBTF;RNF20;PCID2;RNF14;PRDM15;UBP1
prerank,regulation of chromosome organization (GO:0033044),0.4762162786654222,1.1286458898339553,0.32918395573997233,0.8515733458618135,1.0,7/22,20.35%,HDAC8;SMG6;YLPM1;RB1;RMI2;XRCC5;WAPL
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.4988123317827751,1.1283930573707401,0.3430232558139535,0.8515190549321222,1.0,4/20,9.61%,HOXA5;PTK2B;ZBTB16;CIB1
prerank,sphingolipid biosynthetic process (GO:0030148),-0.30560199989042247,-1.1283296344782061,0.20134228187919462,0.7133404921165827,1.0,25/71,16.94%,PRKD1;CERS4;ACER2;CERT1;SGMS1;ELOVL7;DEGS2;ST8SIA1;HACD3;HACD1;B4GALT6;SPHK1;CSNK1G2;ASAH1;HACD2;VAPA;CERS2;SPNS2;ALDH3B1;CERS1;SMPD1;SPTLC2;ELOVL6;CLN8;ST8SIA5
prerank,regulation of protein transport (GO:0051223),0.4708988157422243,1.1282396619783623,0.3125845737483085,0.851192475801846,1.0,9/27,19.09%,DISP1;WWP2;NDEL1;DNAJC1;P3H1;CHP1;GAPVD1;SNX12;STXBP5
prerank,glycoprotein metabolic process (GO:0009100),0.4167615727502597,1.128229408810206,0.31757575757575757,0.8504000182482725,1.0,14/53,16.72%,ST3GAL4;FUT8;LARGE1;MAN2A1;ST8SIA2;GAL3ST4;MAN1B1;FBXO27;GANAB;MAN2B1;TNIP1;GOLPH3;OGA;FBXO17
prerank,transcription by RNA polymerase II (GO:0006366),0.36815596220029256,1.1277939020839205,0.20689655172413793,0.850902402843607,1.0,81/305,19.88%,NR3C2;RNMT;RARB;MLLT3;DDX5;HDAC9;PRRX1;ESR1;NOTCH2;RARA;ELOF1;CDK12;NR4A3;AFF4;NABP1;NFIX;SETD2;MNAT1;NR4A2;MBD1;CREBBP;RORA;SNAPC2;NCOR1;E2F3;LSM11;ADRM1;INTS5;NCOR2;NFIC;RXRA;MED27;SCAF8;CDK13;TBL1X;PARP1;TEAD1;ZBTB1;TFDP1;RXRB;NR2F1;NR1D1;CEBPD;GTF2E1;INTS6;ELOA;NR4A1;NFYA;RBMX;NELFE;DDX21;GTF2A2;TAF4;NR3C1;POU2F1;CDK7;CCNT2;E2F2;SSU72;HSF2BP;GTF2H3;YAP1;ESR2;CPSF3;ZBTB7B;PCID2;INTS7;MED20;TAF5;DEK;ELL2;POLR2C;MED16;NFX1;PPARG;CSTF3;ELP4;CLP1;COPS2;CCNT1;NR1D2
prerank,negative regulation of cell cycle process (GO:0010948),0.41339136079699795,1.1277871244342814,0.3145539906103286,0.8500991413654371,1.0,21/61,23.71%,BMP4;RAD51;EHMT1;EED;CBX5;RBBP7;TOM1L1;FBXO5;TFDP1;BRCA1;E2F1;CDC7;ZFYVE19;EPC1;SUZ12;WAPL;AURKAIP1;CHEK1;PCGF6;APAF1;RBBP8
prerank,regulation of cell differentiation (GO:0045595),0.38054174606940555,1.127571892629568,0.271474019088017,0.8499631890641884,1.0,26/148,12.72%,SIX1;ZFHX3;SMOC1;DDX5;NGF;ID2;DDX17;KLF4;PHLDB2;TGFBR1;PTHLH;FGFR1;NF1;TIAM1;CREBBP;LTBP4;RUNX2;ST7;PHLDB1;EIF2AK2;PDCD2;NLGN1;RPS6KA3;RAF1;NR1D1;CEBPD
prerank,positive regulation of dendrite development (GO:1900006),0.5643747511172721,1.1274316094281176,0.3415032679738562,0.8495999816769664,1.0,2/10,1.82%,COBL;BMP5
prerank,7-methylguanosine RNA capping (GO:0009452),0.45748504531064976,1.1274308229515075,0.33687002652519893,0.8479712041337796,1.0,11/31,29.40%,RNMT;MNAT1;CDK7;GTF2H3;POLR2C;RNGTT;GTF2H4;CMTR2;RAMAC;CMTR1;ERCC2
prerank,7-methylguanosine mRNA capping (GO:0006370),0.45748504531064976,1.1274308229515075,0.33687002652519893,0.8479712041337796,1.0,11/31,29.40%,RNMT;MNAT1;CDK7;GTF2H3;POLR2C;RNGTT;GTF2H4;CMTR2;RAMAC;CMTR1;ERCC2
prerank,protein methylation (GO:0006479),0.43974635066746004,1.1271842751352534,0.31341301460823373,0.8479546232892066,1.0,10/40,13.29%,PCMT1;RAB6A;PRMT8;EHMT1;GSPT1;ETFBKMT;NSD1;ETF1;EEF2KMT;PRMT5
prerank,positive regulation of phospholipid transport (GO:2001140),-0.4732042497977239,-1.1271560113144878,0.33516483516483514,0.7147561918214834,1.0,4/10,14.65%,APOE;DBI;TMEM30A;ABCB4
prerank,positive regulation of cell migration (GO:0030335),0.36861306087677354,1.126898970757481,0.24407826982492276,0.848016194338789,1.0,42/253,9.92%,F3;THBS1;EGFR;DOCK5;NTRK3;ADAM9;DDR2;TWIST2;PPP3CA;CCN1;SEMA3E;WNT11;PRKCE;PTK2B;NRP1;ELP3;VEGFA;RAB25;SMO;CCL3;SEMA3C;PLCG2;TGFBR1;PDGFC;NIPBL;STAT3;SEMA3D;MYOC;AGO2;TIAM1;FN1;SMIM22;ITGB1;FAM107A;DMTN;CEP43;SHTN1;RDX;MIA3;CIB1;PIK3R3;CCL7
prerank,cellular response to alcohol (GO:0097306),0.442299223965684,1.1266965485357927,0.31512071156289706,0.8478358032420169,1.0,15/42,16.93%,LRP6;CDH1;SMO;CTNNA1;RAD51;KLF9;SPIDR;GRAMD1A;GRAMD1C;JUP;BRCA1;ADAM15;GOLPH3;ADCY8;ADCY3
prerank,aminoglycan catabolic process (GO:0006026),0.46904459114988156,1.126523393918671,0.31420765027322406,0.8475748984945317,1.0,2/28,2.08%,GPC6;GPC3
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.4530894725297265,1.126467125541016,0.324,0.8469394359204923,1.0,8/32,17.38%,POLR1G;POLR1A;MNAT1;TAF1D;CDK7;GTF2H3;POLR1F;UBTF
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.4025532290562771,1.1263519714552341,0.29849012775842043,0.8465223189419426,1.0,19/76,18.27%,HDAC4;TANK;PRICKLE1;DCUN1D5;SAE1;FAM107A;ZC3H12A;CUL3;RIPK2;WDR48;BRCA1;COMMD1;DCUN1D2;TRAF6;TNIP1;SMAD7;DCUN1D1;LRRK2;MYCBP2
prerank,negative regulation of lipid storage (GO:0010888),-0.4008325607893461,-1.1259835790804695,0.28869047619047616,0.7160804965126197,1.0,6/19,11.17%,OSBPL8;PPARA;ABCG1;NR1H3;PPARD;NR1H2
prerank,prostanoid biosynthetic process (GO:0046457),-0.42572167581038656,-1.1254061697019373,0.30094043887147337,0.715802762288053,1.0,9/15,24.50%,PTGDS;PTGS1;EDN1;TBXAS1;MIF;CD74;PNPLA8;PTGS2;PRXL2B
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.5325860740509466,1.1252528235711932,0.34615384615384615,0.849261021129395,1.0,5/14,13.74%,IRS1;TWIST1;ABCD1;LONP2;TYSND1
prerank,anterograde synaptic vesicle transport (GO:0048490),0.5189220466970352,1.1251550524796976,0.34911242603550297,0.8479505294192102,1.0,5/15,18.54%,AP3B1;AP3M1;AP3D1;BLOC1S5;AP3S1
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.5189220466970352,1.1251550524796976,0.34911242603550297,0.8479505294192102,1.0,5/15,18.54%,AP3B1;AP3M1;AP3D1;BLOC1S5;AP3S1
prerank,muscle contraction (GO:0006936),-0.2773615837230149,-1.1246923510376468,0.14285714285714285,0.7157772826141777,1.0,20/126,10.51%,ITGA1;MYLK;DTNA;SNTB1;SLC8A1;ACTN2;ROCK2;DYSF;GJC1;MYH11;MYL9;BDKRB2;LMOD1;ACTA2;TPM2;MYOF;CALM1;DES;GLRA1;TMOD1
prerank,glycolipid biosynthetic process (GO:0009247),0.4443578805514001,1.124674986642734,0.3301759133964817,0.8486136594992985,1.0,13/38,25.83%,ST3GAL4;LARGE1;PGAP2;PIGU;ST6GALNAC5;PIGO;DPM1;MPPE1;PIGG;PGAP3;PIGB;ST3GAL2;PIGQ
prerank,regulation of brown fat cell differentiation (GO:0090335),0.5046453727943155,1.1246265195415086,0.3338235294117647,0.8479607510555818,1.0,1/16,0.35%,SIX1
prerank,protein O-linked glycosylation (GO:0006493),0.3925356956624345,1.1242395282651354,0.2870159453302961,0.8483474879623546,1.0,8/96,5.26%,ST3GAL4;PLOD2;TMTC1;GXYLT2;B3GNT2;LARGE1;GALNT15;GALNT13
prerank,positive regulation of tissue remodeling (GO:0034105),-0.47810379394571767,-1.1238129238067494,0.3178294573643411,0.7164620206838537,1.0,2/10,8.02%,ROCK2;IL18
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.35747685639253657,-1.1236067093532887,0.2601626016260163,0.7151394393627251,1.0,15/34,18.96%,GRID2;GABRG3;GRIN2A;GRIN2B;GABRA2;MEF2C;GRIN1;GLRA1;GABRG1;GABRA5;GABRA1;GABRG2;GSK3A;ARRB2;GABRA4
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.42418976823239235,1.1233020991302665,0.31467661691542287,0.850461892397674,1.0,13/52,14.13%,EGFR;PRKCE;EPB41L2;LRP1;RANGRF;ATP2B4;PLS1;AGR2;ITGB1;CIB1;EPHB2;DLG1;PTPN9
prerank,cytoplasmic microtubule organization (GO:0031122),0.4270305843125283,1.1230891667625105,0.2998745294855709,0.8503106224524,1.0,17/54,16.88%,EZR;CLIP4;CLIP1;PCM1;KATNAL2;LIMK2;HOOK3;CIB1;RHOA;CHP1;TUBGCP6;DLG1;FIGNL2;TUBGCP2;CAMSAP3;CRIPT;PLK3
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.5542008810917087,1.1230540637066158,0.34335443037974683,0.8496147604738633,1.0,6/10,26.36%,ETFDH;ETFA;ACADL;ACADS;ACADVL;ACADM
prerank,eosinophil migration (GO:0072677),0.5273619121574064,1.1226203662870757,0.34915773353751917,0.8493774293408024,1.0,3/14,9.92%,CCL3;CCL1;CCL7
prerank,eosinophil chemotaxis (GO:0048245),0.5273619121574064,1.1226203662870757,0.34915773353751917,0.8493774293408024,1.0,3/14,9.92%,CCL3;CCL1;CCL7
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.46020357994585404,1.1221565636416098,0.3390957446808511,0.8499401695845213,1.0,8/30,16.60%,ABLIM3;HPS4;NPEPPS;SAE1;HSPA1L;SH3GLB1;UBE2D3;UBL5
prerank,response to interleukin-1 (GO:0070555),0.4033273867690525,1.1218208267377465,0.30997624703087884,0.8502465699116437,1.0,16/73,15.75%,HDAC4;TANK;PTGIS;CCL3;CCL1;IRAK3;ANXA1;ZC3H12A;CCL7;IGBP1;MYD88;NR1D1;RBMX;SOX9;PRKCA;TRAF6
prerank,cytosolic calcium ion transport (GO:0060401),0.4620995568567272,1.1217304514126527,0.3257676902536716,0.8497313390404224,1.0,2/28,0.97%,SLC35G1;CACNA1C
prerank,sensory perception of pain (GO:0019233),-0.387738244680671,-1.1211466949879807,0.3028169014084507,0.7200333166402196,1.0,12/21,27.60%,RETREG1;MME;P2RX7;SCN9A;OPRM1;TRPA1;KCNA2;CHRNA4;CCL2;KCNK4;CHRNB2;ALOXE3
prerank,negative regulation of protein secretion (GO:0050709),0.4453796863742811,1.1205856318916156,0.33375,0.8523750676910493,1.0,7/38,12.01%,CCN3;KCNB1;IRS1;RAB11FIP3;DPH3;SERGEF;DRD3
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.5262232841206105,1.1205742593031895,0.3384853168469861,0.8516070844119064,1.0,1/13,2.25%,GAB2
prerank,limb development (GO:0060173),0.46362306952285176,1.120494603347321,0.32916666666666666,0.8510712279831516,1.0,4/28,4.73%,PCSK5;SMOC1;GLI3;NOG
prerank,mRNA 3'-end processing (GO:0031124),0.4022034750183531,1.1204551891986032,0.29537767756482525,0.8503833611240389,1.0,26/78,23.87%,SRSF11;U2AF2;THOC2;SRSF5;SRSF6;LSM11;SCAF8;PABPC1;CDC40;SRSF2;TENT2;SRSF1;RNPS1;SSU72;CPSF3;CHTOP;TENT4B;CSTF3;SARNP;CLP1;DHX38;SRSF3;SRRM1;ZC3H11A;FIP1L1;PAPOLG
prerank,central nervous system myelination (GO:0022010),-0.47412259178678084,-1.1203073049163923,0.34210526315789475,0.7206342105204996,1.0,4/11,16.62%,PLP1;TENM4;B4GALT6;ABCA2
prerank,cellular response to cadmium ion (GO:0071276),0.47432891246000886,1.1203000885499346,0.32905982905982906,0.8500855701641785,1.0,1/24,0.41%,EGFR
prerank,protein localization to chromosome (GO:0034502),0.4546565229201317,1.120237886388041,0.3311772315653299,0.8494819356060084,1.0,15/34,27.83%,ESR1;PARP3;LEMD2;ATRX;RB1;MCM9;ATR;XRCC5;WAPL;TNKS2;XRCC4;SLF1;RAD21;MRNIP;PLK1
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.5582158844043557,1.1198292515527635,0.3501577287066246,0.8491249611778388,1.0,3/10,18.59%,AP2A2;AP2B1;AP2A1
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.5582158844043557,1.1198292515527635,0.3501577287066246,0.8491249611778388,1.0,3/10,18.59%,AP2A2;AP2B1;AP2A1
prerank,cellular response to light stimulus (GO:0071482),0.405960782398285,1.1196611047755962,0.29739336492890994,0.848869883080613,1.0,19/66,24.41%,NEDD4;PRKCD;PDE6A;CREBBP;KDM1A;PARP1;DHX36;EIF2S1;ZBTB1;PDE6B;USP28;USP47;ATR;ERCC4;YY1;FMR1;TP53;CNGB1;INO80
prerank,negative regulation of cellular process (GO:0048523),0.36305138075612475,1.1174717947953345,0.1757028112449799,0.8547805526343075,1.0,78/521,13.11%,SLIT3;SLIT2;ZBTB7C;FHL1;BMP4;CCN3;WNT9A;CCN5;NDRG3;OSGIN2;CCN1;CYP1B1;SMAD6;PTPRU;BMP5;WNT11;ABI1;VPS13C;PTK2B;FGF2;SLURP1;SRGAP2;TES;NGF;CLMN;CD9;SFRP4;ARHGDIB;TGFB3;CDK10;KLF4;PTHLH;TBRG1;PTPN2;KLF10;TEX15;NDUFS3;SKI;FRK;EMILIN1;LMNA;NCK2;INHBA;STRN;TENM1;SERTAD3;SRSF6;AGR2;IP6K2;IRF1;P3H3;BECN1;P3H1;CDKN2C;SFRP5;PDCD4;MIA3;PPP2R5C;CIB1;RBBP7;TGFB1I1;EIF2AK2;BTG3;EPHB2;FBXO5;ATG5;GNRH1;IFI35;NIBAN2;CLU;CDKN1B;RAF1;MDM4;CELF1;CDKN3;IGFBP6;ITGB1BP1;NR4A1
prerank,endocardial cushion development (GO:0003197),0.48094515491578194,1.1173016931392743,0.32571428571428573,0.8544840823463534,1.0,7/21,14.64%,BMP4;BMPR1A;NOG;GATA4;MDM4;ACVR1;SOX9
prerank,purine-containing compound salvage (GO:0043101),0.5445378092195873,1.1172968414454867,0.3368421052631579,0.8537072234554659,1.0,5/12,18.91%,ADA;AMPD3;DGUOK;GMPR2;AMPD2
prerank,positive regulation of T cell proliferation (GO:0042102),-0.3195513828386243,-1.1172626798371392,0.2736842105263158,0.7271874248400051,1.0,17/55,21.91%,IGF1;IGFBP2;VCAM1;TFRC;RPS3;IL18;HMGB1;ICOSLG;CD24;CCL19;CD86;SLC7A1;JAK3;PYCARD;CD276;AGER;CD274
prerank,negative regulation of epithelial cell migration (GO:0010633),0.44915761975647406,1.1170100246380787,0.33243606998654107,0.8537719706871321,1.0,2/33,0.19%,SLIT2;THBS1
prerank,zinc ion homeostasis (GO:0055069),-0.3711444092463337,-1.116796451856873,0.28174603174603174,0.7266743135698267,1.0,16/28,20.31%,SLC30A10;SLC39A10;SLC39A8;SLC30A1;SLC39A12;ATP13A2;MT3;MT2A;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B
prerank,DNA double-strand break processing (GO:0000729),0.504575389481005,1.1167559664292102,0.3540740740740741,0.8537467642613423,1.0,11/18,29.04%,SLX4;BARD1;RAD50;RNF138;BRCA1;NBN;RAD52;ATM;RBBP8;SETMAR;UBE2N
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.392311667844711,1.1166100481674628,0.31755196304849886,0.8534355268418607,1.0,11/80,7.71%,PLCE1;CDC42EP5;DPYSL3;ARAP1;NRP1;TGFB3;PALM;BCAS3;NDEL1;TENM1;RHOQ
prerank,regulation of mRNA catabolic process (GO:0061013),0.38789249819435756,1.1165297963191338,0.28864864864864864,0.8528605370664832,1.0,45/121,24.31%,PRKCD;SAMD4A;PKP1;PSMB2;CNOT8;ZC3H14;APEX1;NUP214;PSMD11;ZC3H12A;XPO1;PSMC1;PABPC1;DHX36;PSMC6;EXOSC3;DCP1A;PRKCA;PSMD1;PSMD4;MOV10;EXOSC1;PCID2;PCBP4;PSMA6;MAPKAPK2;PSMD14;PSMD12;DIS3;PUM2;SERBP1;IGF2BP3;PSMD7;EIF4G1;EXOSC2;EXOSC7;PSME3;SAMD4B;PUM1;FMR1;CNOT1;PSMD3;PSMB6;UBB;EXOSC8
prerank,epithelial cell migration (GO:0010631),0.44726032652396724,1.1158007573468718,0.3324742268041237,0.8542994432652532,1.0,9/37,12.15%,FAT2;FSTL1;CYP1B1;NRP1;GIPC1;ABL1;STARD13;RHOA;S100A2
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.3146375184385618,-1.1156537545878868,0.27074235807860264,0.7280326822021136,1.0,9/49,8.02%,IGF1;LYN;IL31RA;KIT;ERBB4;IL6R;PARP14;GHR;IL18
prerank,regulation of macromolecule metabolic process (GO:0060255),0.37740587813281246,1.1153739430129044,0.2787750791974657,0.8548378819945597,1.0,43/170,19.46%,FOXP1;CDH1;AFF3;PRDM6;ATP1B1;YBX3;NELL1;LDLR;COQ7;PTHLH;SCARB2;AFF4;C1D;KIF16B;TSKU;HMG20A;TCF19;TRIM39;ZC3H12A;ZFP64;ANKRA2;POGZ;TRIM44;HMG20B;PRDM2;RFXANK;HINFP;NKAP;TOB2;MEGF8;CDK2;FLOT1;GDNF;PRDM5;PIN1;PRDM10;PCBP4;TOB1;PRDM4;PRDM11;IGF2BP3;ZUP1;EDN3
prerank,membrane raft organization (GO:0031579),0.5253727759097542,1.1153586079270064,0.3560606060606061,0.854082492190414,1.0,5/15,16.22%,ANXA2;ABCA7;S100A10;NPC1;FLOT1
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.37097657530352257,-1.1152210085122662,0.2936802973977695,0.7273512384079917,1.0,9/26,16.59%,SHANK3;ROCK2;SYNPO2;FHOD1;RAC1;SYNPO;CX3CL1;PLEK;ALMS1
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.483128255058477,1.1151467023338137,0.3528550512445095,0.8539296498379596,1.0,4/21,4.96%,IGFBP5;FGF2;BMPR1A;NR4A3
prerank,neuron projection morphogenesis (GO:0048812),-0.274750809277812,-1.1151181407229276,0.16901408450704225,0.7257917989675386,1.0,28/137,8.14%,DOCK10;TNIK;CNTNAP2;DCDC2;SHANK3;ANK3;PAK1;EPHB1;CTNNA2;MAP2;APP;CNTN4;DCC;MYO16;PAK3;GPM6A;DSCAML1;BAIAP2;RYK;ACTB;EPB41L3;MAP4K4;BMP7;ZDHHC17;SGK1;DAB2IP;NRK;LMTK2
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.5394537905887214,1.115015408115578,0.3562300319488818,0.8535520986387404,1.0,1/11,0.32%,STK39
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.4890931788674861,1.1134787718028842,0.35745296671490595,0.8574191945641108,1.0,2/19,2.28%,THBS1;CMKLR1
prerank,lipid droplet formation (GO:0140042),0.5413007628718478,1.1132680492402496,0.365625,0.8572432834815156,1.0,5/10,19.00%,ZFYVE1;SMIM22;SQLE;CDS1;FITM2
prerank,DNA damage checkpoint signaling (GO:0000077),0.464147002333153,1.1131714978364344,0.33201581027667987,0.8567329962818775,1.0,15/28,24.90%,CHEK2;CLSPN;CEP63;RAD17;E2F1;HINFP;BRIP1;USP28;INTS7;DONSON;ATR;NBN;CHEK1;ATM;RAD9A
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.5403819667722939,1.113087435716158,0.34307692307692306,0.8561977117385896,1.0,7/12,27.04%,PAICS;LHPP;ADSS2;GMPS;ADSL;PFAS;ATIC
prerank,regulation of Notch signaling pathway (GO:0008593),0.402013321156036,1.1128662559376206,0.32712456344586727,0.8560595006573393,1.0,17/76,12.96%,EGFR;CCN3;TCIM;WWP2;STAT3;CREBBP;ELF3;AAK1;NEPRO;GALNT11;CD46;JAG1;NIBAN2;SYNJ2BP;POFUT1;NRARP;ITGB1BP1
prerank,cellular response to organonitrogen compound (GO:0071417),0.389927381866291,1.1127366463467885,0.3108407079646018,0.8556811492512323,1.0,16/99,12.66%,SLIT2;CDH1;IGFBP5;EZR;SLC26A6;CAPN2;CTNNA1;RRAGB;DIAPH1;DMTN;EGR1;AKAP9;RAP1A;JUP;NSMF;BRCA1
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.48301881287542153,1.112551968040351,0.33666191155492153,0.8554411300218541,1.0,7/22,13.14%,NTRK3;NGF;KIDINS220;CIB1;RAB35;RAP1A;EHD1
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.4766341805158255,1.112474958192217,0.3399715504978663,0.8548988402594919,1.0,4/24,5.50%,PPP1R3B;IRS1;GSK3B;PPP1R3C
prerank,regulation of neural precursor cell proliferation (GO:2000177),-0.38850053235676757,-1.1123604339769981,0.31290322580645163,0.7315974840498637,1.0,6/22,8.39%,SLC16A2;TOX;NES;TAFA1;GATA2;PROX1
prerank,endomembrane system organization (GO:0010256),0.3730015878720744,1.1122642626662174,0.2971014492753623,0.8547346633041613,1.0,50/178,18.41%,ATL3;ARHGAP21;GORASP2;BCAS3;ATL2;SEC16A;RAB30;TMED5;GBF1;TMED3;RAB43;NUP93;LMAN2L;GOLGB1;SEC31A;SEC61A1;CSNK1A1;PLEKHM2;WASHC4;PHETA2;HOOK3;MIA3;GAK;TLCD1;LEMD2;FBXW8;PLEKHF1;SEC23IP;WASHC5;DOP1B;ZW10;NUP155;SPTSSB;TRAPPC11;AP3D1;TOR1B;ATL1;ANXA8;ANXA8L1;BNIP1;CHMP2B;GOLPH3;ARFGEF1;RAB1A;SURF4;LRRK2;BAG5;COG3;UBXN2B;ATP8B4
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.36124186289025734,-1.1119635182258412,0.2608695652173913,0.7308801944070346,1.0,6/28,5.98%,APOE;ADCY1;SHANK3;APP;EPHA4;LGMN
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.43765317638103707,-1.1118505932614466,0.31952662721893493,0.7293850688557647,1.0,7/15,23.23%,GGT5;GOT2;CHAC2;ALDH4A1;SARDH;GGT1;ABHD12
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.44351951232119463,1.1116429753283064,0.34172185430463575,0.8557766496321406,1.0,11/33,22.26%,TELO2;RAD51;STN1;ANKRD28;PPP6R3;RAD50;TNKS1BP1;CDK2;RFC1;ZBTB48;PPP6C
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.29863122167268774,-1.1112170577391303,0.26119402985074625,0.7293852900155795,1.0,29/69,26.07%,COX7B;NDUFB9;NDUFA4;UQCRH;NDUFA13;COX4I1;AFG1L;COX5B;NDUFC1;NDUFV3;UQCR10;SDHA;NDUFB11;UQCRC1;CYCS;COX7C;CYC1;SDHC;NDUFA7;COX6C;COX6B1;NDUFA11;NDUFB6;NDUFB8;NDUFA3;COX4I2;UQCC3;NDUFA1;UQCRQ
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.4477950078864734,-1.1110635043397767,0.32608695652173914,0.7280040425515659,1.0,2/13,3.89%,IGF1;INSR
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.3595822493535655,-1.1109122779920675,0.3170731707317073,0.7266735688391455,1.0,11/29,19.42%,WNT5A;SAMHD1;IFNAR2;RNASEL;HSP90AB1;USP18;NLRC5;PTPN6;CACTIN;ZBP1;STAT2
prerank,establishment of vesicle localization (GO:0051650),0.501543424592765,1.1108269538117264,0.3395638629283489,0.8574775546723553,1.0,7/18,20.16%,LIMK2;IKBKG;TMEM230;SPG11;KIF5B;SYNJ1;RAB11A
prerank,metanephric mesenchyme development (GO:0072075),0.5321961154887461,1.1103117906379836,0.3610648918469218,0.8582585849712824,1.0,1/10,0.35%,SIX1
prerank,response to cadmium ion (GO:0046686),0.4655283648221573,1.1096015870510043,0.3319327731092437,0.8595747036265703,1.0,1/26,0.41%,EGFR
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.3351004152230095,-1.108999187237902,0.27601809954751133,0.7303883185560951,1.0,5/35,1.46%,FLT1;PTPRM;NR2F2;COL4A3;APOE
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.429526632784704,1.1087575232475533,0.33034571062740076,0.8613115517400434,1.0,11/43,13.64%,BMP4;DDR2;CCN1;NELL1;BMPR1A;BMP6;RUNX2;TMEM119;FBXO5;LRP5;ACVR1
prerank,regulation of translation (GO:0006417),0.3771153903859307,1.1085706680393457,0.28854166666666664,0.8610929127990222,1.0,54/173,25.56%,THBS1;SAMD4A;IGFBP5;NIBAN1;EIF4G3;PAIP2;FOXO3;CNOT8;ERBB2;EIF4G2;EIF3E;EPRS1;ATXN2;GSPT1;EIF6;DHX36;EIF2AK2;ETF1;RBM3;NAT10;EIF5B;RPS6KA3;CYFIP1;CIRBP;PRKDC;RPS6KB1;LARP4;EIF4B;TOB1;DHX9;SYNCRIP;ENC1;DAPK1;IGF2BP3;EIF4G1;GEMIN5;LARP4B;PUM3;CAPRIN1;SAMD4B;FMR1;MALSU1;RPL10;MTIF2;TSFM;ALKBH1;CNOT1;MAPKAPK5;TRIM71;MTOR;LTN1;DDX6;TSC1;RBM4
prerank,cholesterol transport (GO:0030301),0.42630907751240515,1.1083610936240667,0.3308270676691729,0.8609397205158035,1.0,17/45,24.55%,SOAT1;LDLR;TSKU;LIMA1;ABCA7;NPC1;SOAT2;CLU;STX12;STARD4;LCAT;CEL;STAR;STARD5;SERAC1;RELCH;OSBP
prerank,transcription by RNA polymerase I (GO:0006360),0.44109072955169076,1.1081851128736215,0.34120734908136485,0.8606696423507249,1.0,10/34,22.37%,POLR1G;POLR1A;MNAT1;TAF1D;CDK7;GTF2H3;POLR1F;UBTF;TTF1;TBP
prerank,DNA packaging (GO:0006323),0.5045020810353973,1.1081253211646274,0.36874051593323215,0.8600607695028937,1.0,6/16,27.27%,CHAF1B;CHAF1A;AIFM1;TP53;KAT6A;HAT1
prerank,regulation of vasoconstriction (GO:0019229),0.46480405031676497,1.1080380585432046,0.3342579750346741,0.8595489386893137,1.0,4/27,8.50%,KCNMB2;ADRA1B;ECE1;TRPM4
prerank,positive regulation of B cell proliferation (GO:0030890),-0.3506355898419584,-1.108034106268458,0.3015267175572519,0.7313082833631349,1.0,10/29,15.87%,BCL2;TFRC;MEF2C;VAV3;CD38;NFATC2;CD81;MIF;CD40;CD74
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.41761040855503334,1.1079587157338622,0.32138442521631644,0.8590161273692855,1.0,5/48,6.07%,UBASH3B;CAMK2D;ANK2;PTK2B;DIAPH1
prerank,response to acidic pH (GO:0010447),0.5301933139073309,1.1077018722603476,0.38304552590266877,0.859027851467671,1.0,5/13,14.80%,GPR65;GPR4;SLC9A1;CHP1;RAB11B
prerank,positive regulation of cell motility (GO:2000147),0.36538021612138355,1.107696802063962,0.2903225806451613,0.8582677635947198,1.0,33/205,9.92%,F3;THBS1;EGFR;NTN1;NTRK3;ADAM9;TWIST2;PPP3CA;CCN1;SEMA3E;WNT11;PTK2B;ELP3;VEGFA;SMO;CCL3;SEMA3C;TGFBR1;CCDC25;TWIST1;PDGFC;STAT3;SEMA3D;MYOC;TIAM1;SMIM22;ITGB1;FAM107A;CEP43;RDX;CIB1;PIK3R3;CCL7
prerank,negative regulation of protein metabolic process (GO:0051248),0.4260559747410315,1.1072914852099358,0.3371069182389937,0.8586952769879828,1.0,16/48,21.26%,EGFR;LDLR;IRAK3;ITGAV;EIF2AK1;MAD2L1;CLU;MDM4;ITGB3;AZIN1;INHBB;PIN1;SNX12;HMGCR;SF3B3;IAPP
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.3982882462509036,1.1069712829504779,0.3145809414466131,0.8588828040147167,1.0,14/80,13.46%,THBS1;MAP3K5;NGF;VEGFA;KLF4;CD44;NLRP12;IGBP1;RPS6KA3;BCAP31;RAF1;DPEP1;ARL6IP5;CARD16
prerank,keratan sulfate metabolic process (GO:0042339),0.44786780461846354,1.1069117603649057,0.33936022253129344,0.8582948390520605,1.0,7/31,10.81%,ST3GAL4;B3GNT2;HEXA;B4GALT1;SLC35D2;CHST5;B4GAT1
prerank,positive regulation of proteolysis (GO:0045862),0.41166969845911816,1.1068622418085423,0.3141104294478528,0.8576634464318472,1.0,7/55,8.14%,PERP;ADAM9;TANK;CYFIP2;TNP2;MAPK12;ZC3H12A
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.5434668020165735,1.106806391652576,0.3645320197044335,0.8570331914559948,1.0,2/10,3.77%,DSE;XYLT1
prerank,autonomic nervous system development (GO:0048483),0.5080086490820177,1.1067187375467205,0.3602941176470588,0.8565209817062814,1.0,3/17,7.37%,NRP1;NF1;FN1
prerank,regulation of membrane repolarization (GO:0060306),0.5199772120349234,1.1067112684665872,0.3713850837138508,0.8557751766915006,1.0,1/13,0.23%,KCNJ2
prerank,negative regulation of binding (GO:0051100),0.392538658285275,1.106612895261389,0.3233601841196778,0.8552975852478282,1.0,36/81,25.27%,PRKCD;MDFI;SMO;GSK3B;DACT1;AURKA;BTAF1;KDM1A;TMC8;ZFPM1;CPNE1;ITGB1BP1;DISC1;E2F1;CARD16;SORL1;DDX11;DVL1;CDKN1A;PSME3IP1;PIN1;LRRK2;RALB;JAK2;BAG2;WAPL;SLPI;DNAJB2;GTPBP4;STYX;DAB2;GNL3L;USP33;RSF1;CSNK1E;JUN
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.466704203430697,1.106576876959094,0.33604336043360433,0.8546283325705465,1.0,8/26,11.71%,EGFR;CDK10;ANXA1;LSM11;CCND1;RDX;ANKRD17;TFDP1
prerank,regulation of DNA binding (GO:0051101),0.427750172050008,1.1061158358591128,0.3376792698826597,0.8551802777861089,1.0,15/44,21.00%,HES1;MDFI;NGF;SMO;SKI;KDM1A;FOXC1;HJURP;CPNE1;E2F1;PPARG;JAK2;CEBPG;ZBTB7A;EGF
prerank,synaptic membrane adhesion (GO:0099560),0.5172516520999825,1.1060299217160925,0.3537313432835821,0.8546792409896499,1.0,5/14,14.92%,GPC6;PTPRF;SLITRK2;PTPRS;GPC4
prerank,regulation of gastrulation (GO:0010470),-0.42445165072096647,-1.1059317426129078,0.3256484149855908,0.7354338534961925,1.0,5/14,11.14%,CLASP2;DAG1;OSR1;TENM4;RACK1
prerank,positive regulation of macrophage differentiation (GO:0045651),-0.4645280015647627,-1.1059176006977032,0.34025974025974026,0.7336683243703174,1.0,2/11,3.58%,IL34;CSF1
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.43443858067441293,1.1058696273602824,0.32129032258064516,0.8543557788415509,1.0,5/39,9.27%,THBS1;NFE2L2;ANO6;KRIT1;PDCD4
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.4666081651945765,1.1053741150468936,0.3472409152086137,0.8550812050619024,1.0,5/27,4.65%,PID1;PRKCD;IRS1;GRB10;PTPN2
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.46122175500299856,1.1050659721358593,0.3483606557377049,0.8552465558813191,1.0,16/29,29.09%,ZC3H7A;AGO2;TUT7;DGCR8;TUT4;SMAD2;HNRNPA2B1;PUM2;MRPL44;PUM1;TRIM71;DICER1;PRKRA;DROSHA;AGO1;SMAD1
prerank,heme biosynthetic process (GO:0006783),0.4733261050775654,1.104940813721797,0.34206896551724136,0.8548263614568571,1.0,9/22,19.28%,ABCG2;NFE2L1;UROS;COX15;FXN;TSPO;PPOX;ATP5IF1;FLVCR1
prerank,aerobic electron transport chain (GO:0019646),-0.2988072296952342,-1.1046349774180244,0.28888888888888886,0.7353033851941658,1.0,29/68,26.07%,COX7B;NDUFB9;NDUFA4;UQCRH;NDUFA13;COX4I1;AFG1L;COX5B;NDUFC1;NDUFV3;UQCR10;SDHA;NDUFB11;UQCRC1;CYCS;COX7C;CYC1;SDHC;NDUFA7;COX6C;COX6B1;NDUFA11;NDUFB6;NDUFB8;NDUFA3;COX4I2;UQCC3;NDUFA1;UQCRQ
prerank,intraciliary retrograde transport (GO:0035721),0.5377833305503622,1.1045529277197506,0.34285714285714286,0.8552081106937949,1.0,5/12,21.80%,WDR35;DYNC2I2;DYNC2I1;IFT43;DYNC2H1
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.5544011361927326,1.1045057689356614,0.3646496815286624,0.8538311788076932,1.0,4/10,14.05%,HDAC4;PFKFB1;NCOR1;TIGAR
prerank,negative regulation of glycolytic process (GO:0045820),0.5544011361927326,1.1045057689356614,0.3646496815286624,0.8538311788076932,1.0,4/10,14.05%,HDAC4;PFKFB1;NCOR1;TIGAR
prerank,mitotic chromosome condensation (GO:0007076),0.4591925453793808,1.1044693390653024,0.3545706371191136,0.8531906842206719,1.0,8/26,24.47%,SMC4;CCNB1;KMT5A;RB1;NCAPH2;SMC2;PHF8;AKAP8L
prerank,long-chain fatty acid import into cell (GO:0044539),-0.47065311250416714,-1.1036586014920353,0.3474576271186441,0.7362142996336226,1.0,2/10,1.44%,ACSL1;SLC2A1
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.43591739048728906,-1.1033549328121666,0.35311572700296734,0.7352197406124301,1.0,4/13,8.55%,RYR2;RBPJ;NOTCH1;HEY2
prerank,regulation of tissue remodeling (GO:0034103),-0.40463381930195597,-1.1030072496385066,0.3363914373088685,0.734395039896986,1.0,4/18,8.02%,LEPR;CST3;SYT7;IL18
prerank,positive regulation of cellular catabolic process (GO:0031331),0.3790241182379773,1.102705118922081,0.32397408207343414,0.8576797122971457,1.0,21/132,10.45%,SLC4A4;ADAM9;PRKCD;EZR;IRS1;GSK3B;TPCN1;TWIST1;ZC3H18;FOXO3;CNOT8;DACT1;PFKFB1;ENTPD5;ABCD1;ZC3H12A;MLXIPL;RDX;ARNT;ATF6;PLEKHF1
prerank,histone mRNA metabolic process (GO:0008334),0.45580689663114793,1.102591267020066,0.3351063829787234,0.8572676439341588,1.0,8/27,17.28%,TUT7;LSM11;TUT4;TENT2;ERI1;SSB;CPSF3;TENT4B
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.4052211541051462,-1.1022533937967594,0.31470588235294117,0.7347146616553607,1.0,7/16,23.83%,TNFRSF21;TRIB2;TYROBP;JAK3;AGER;CD274;VSIR
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.3684617649646843,1.1021715493620596,0.29914529914529914,0.8578060097850272,1.0,41/166,19.02%,NR3C2;RARB;HDAC9;ESR1;NOTCH2;RARA;POLR1G;NR4A3;POLR1A;MNAT1;NR4A2;CREBBP;RORA;NCOR1;E2F3;NCOR2;RXRA;MED27;TBL1X;TEAD1;RXRB;TAF1D;NCOA6;NR2F1;NR1D1;GTF2E1;NR4A1;GTF2A2;TAF4;NR3C1;CDK7;E2F2;SMARCA5;GTF2H3;YAP1;ESR2;POLR1F;UBTF;TAF5;POLR2C;PPARG
prerank,DNA-dependent DNA replication (GO:0006261),0.3803407508684406,1.1020893751492262,0.31947483588621445,0.8572820892482627,1.0,44/128,26.46%,REV3L;PSMB2;CDC45;MCM2;RAD51;WRN;TOPBP1;PSMD11;HELB;PSMC1;PRIM1;POLE2;PSMC6;ORC3;DDX21;PRIMPOL;PRIM2;PSMD1;MCM7;PSMD4;CDK2;CDC7;POLG2;POLB;RECQL5;PSMA6;PSMD14;PSMD12;POLA2;PSMD7;RFC1;BAZ1A;PSME3;SRPK2;HMGA1;CDK2AP1;PSMD3;PSMB6;UBB;RECQL;CDC6;UBA52;MGME1;RPS27A
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.4485244831017278,-1.1015172918807263,0.3546511627906977,0.7349399198810239,1.0,6/13,15.51%,ELOVL7;HACD3;HACD1;HACD2;TECRL;ELOVL6
prerank,regulation of B cell differentiation (GO:0045577),0.5000655207003815,1.100887753509871,0.36376811594202896,0.8600990187736443,1.0,3/17,6.78%,ID2;PPP2R3C;INHBA
prerank,iron ion transmembrane transport (GO:0034755),0.5553289877602601,1.1002556727321315,0.3836477987421384,0.8612732205284499,1.0,2/10,3.32%,SCARA5;SLC39A14
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.4436797410965945,-1.0998954271144437,0.3423180592991914,0.7377897665593179,1.0,3/12,9.60%,IGF1R;INSR;FYCO1
prerank,positive regulation of metabolic process (GO:0009893),-0.2771550342168452,-1.0998003606044668,0.25287356321839083,0.7362492320222275,1.0,15/103,8.02%,IGF1R;CAMK1D;LEPR;ACSL1;PPARGC1B;EBF2;ESRRG;GATM;INSR;GJA1;ACACB;PRDM16;PPARGC1A;TRPV2;IL18
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.5407934533843158,1.0996720402115157,0.3859375,0.8622557209564317,1.0,6/11,15.90%,THBS1;CREB3L1;SYNJ2BP;EPN1;E2F2;ALOX5
prerank,chromosome organization (GO:0051276),0.3864925791320184,1.0994719538434525,0.32083792723263505,0.8621015199530765,1.0,19/99,19.89%,TCF7L1;TCF7L2;ABL1;HDAC8;HMG20A;EHMT1;PARP1;RAD23B;CENPT;NUP155;COPS7B;EZH1;COPS5;COPS8;CETN2;COPS3;HDAC2;COPS2;ZBTB7A
prerank,ERBB2 signaling pathway (GO:0038128),0.44668876055701306,1.0992558587985717,0.3394980184940555,0.8619938028413303,1.0,5/31,10.04%,EGFR;SHC1;MYOC;ERBB2;ERBIN
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.3626514308491808,1.0992231453194956,0.28336755646817247,0.8613251211921721,1.0,56/234,18.46%,CARD14;SLCO3A1;LRP6;HDAC4;DDR2;PLPP3;EDA;ERC1;VEGFA;ESR1;SMO;FZD1;RAB7B;RIPK4;PLCG2;IRAK3;STAT3;TAB3;ROR1;IKBKG;IKBKE;TLR4;ANXA3;KDM1A;PPRC1;MAVS;CIB1;RIPK2;MAP3K7;TAB2;CRTC2;EIF2AK2;TRIM41;TFDP1;JUP;CLU;MYD88;CRTC1;TRAF2;TIRAP;MTDH;CARD16;COPS5;PIDD1;TRAF6;FLOT1;TRAF5;IKBKB;ADCY8;ESR2;PSMA6;STK3;RBCK1;ATF2;TICAM1;DHX9
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.47576499539018285,1.0992044565272687,0.35805991440798857,0.86062656862197,1.0,13/22,27.87%,ERI3;URB1;EXOSC3;ERI1;KRI1;WDR12;EXOSC2;EXOSC7;PES1;NOP14;EXOSC8;FTSJ3;ERI2
prerank,metallo-sulfur cluster assembly (GO:0031163),0.4718534319997317,1.0985556606883529,0.3488700564971751,0.8617932178749678,1.0,7/22,20.90%,HSCB;FXN;NUBP2;NUBPL;ISCA1;NFU1;IBA57
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.4873364625783494,1.0984249061728164,0.3718518518518519,0.8614302240402405,1.0,8/18,20.16%,CCND1;CCNB1;MECP2;FBXO5;CDC7;DTL;BRD4;RAB11A
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.49112003367131146,1.0981159403808458,0.37209302325581395,0.8616190872109863,1.0,4/17,13.48%,ANK2;SNTA1;AKAP9;SCN1B
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.4558598585048686,1.0977629699779068,0.3447802197802198,0.8618880632054673,1.0,3/27,2.15%,CAMK2D;ANK2;AHNAK
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.39556738587713935,1.0976421745843061,0.33631284916201115,0.8614817799429687,1.0,25/88,24.34%,FBXL7;PSMB2;AMN1;FBXL20;PSMD11;PSMC1;CUL1;FBXO27;PSMC6;FBXO31;FBXO48;PSMD1;PSMD4;FBXO17;PSMA6;PSMD14;PSMD12;PSMD7;FBXL6;PSME3;FBXL8;PSMD3;FBXW4;PSMB6;FBXW11
prerank,protein heterooligomerization (GO:0051291),0.493182836765783,1.097522174075776,0.3816568047337278,0.8610815035661714,1.0,2/17,2.72%,PKD1;TMEM120A
prerank,protein K63-linked ubiquitination (GO:0070534),0.42811547450334175,1.0973344423874714,0.33578431372549017,0.8608829518610305,1.0,12/41,17.68%,NEDD4;WWP2;RNF126;TRAF3IP2;RNF115;TRAF2;RNF8;UBE2B;TRAF6;UBE2O;TRAF5;UBE2S
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.42549729374964385,1.0972887735304688,0.356234096692112,0.8602804092668466,1.0,20/40,33.96%,RAD51;WRN;SMARCAL1;DDX11;PRIMPOL;ATRX;FAM111A;DONSON;MCM9;ATR;BOD1L1;SETMAR;THOC1;MMS22L;TIPIN;GEN1;POLD1;ALYREF;RFWD3;ZRANB3
prerank,respiratory system development (GO:0060541),0.4541993714627453,1.0971051555022804,0.3616734143049933,0.860082904937326,1.0,5/32,6.46%,BMP4;DISP1;FGF2;VEGFA;GLI2
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.48405346273542194,1.097058066471549,0.3492957746478873,0.8594513355077088,1.0,9/19,27.62%,PRDX5;TENM1;DHX36;POLR3F;CHD8;ICE2;MTOR;ELL;ZNF76
prerank,regulation of neuron death (GO:1901214),-0.29081669907693297,-1.096989318580836,0.24812030075187969,0.7424772324980239,1.0,24/82,16.92%,EFNB2;GRID2;EPHB1;WNT5A;PICALM;DCC;CSF1;GRIN2B;TRIM2;RRAS2;MEF2C;PPARGC1A;CD34;FAIM2;CD200;MAPT;C1QA;CHGA;SARM1;BTBD10;TYROBP;CTSZ;CD200R1;ATP13A2
prerank,regulation of stem cell proliferation (GO:0072091),-0.40333349963576776,-1.096731723781332,0.3474320241691843,0.7413500097631562,1.0,3/17,4.44%,FBLN1;GJA1;ACE
prerank,manganese ion transport (GO:0006828),-0.4146230771006624,-1.0965589691654367,0.30368098159509205,0.7399601497983707,1.0,7/14,8.38%,SLC30A10;TRPC3;ATP2C1;SLC39A8;TRPC4;TRPC6;TRPC1
prerank,phospholipid metabolic process (GO:0006644),0.393217788035036,1.0963502725644583,0.3474676089517079,0.8607221701681005,1.0,13/71,13.81%,TNFAIP8L3;PLPP3;PLPPR2;PLA2G4F;PLA2G15;PLA2G2C;MBOAT1;PNPLA3;LPCAT1;ANGPTL3;PIP5K1A;GNPAT;PIP4K2A
prerank,epidermis development (GO:0008544),0.4098512414868153,1.0962225946406592,0.3446601941747573,0.860364152678387,1.0,8/56,8.83%,KRTDAP;GRHL2;GRHL1;DSP;EMP1;PTHLH;COL17A1;TGM5
prerank,regulation of neuron differentiation (GO:0045664),0.39501582021607634,1.096210931722395,0.33797909407665505,0.8596471583137164,1.0,13/76,11.39%,SIX1;ZFHX3;VWC2;HES1;NGF;ID2;FGFR1;NBL1;TIAM1;HES3;RHOA;NEPRO;NLGN1
prerank,protein-containing complex assembly (GO:0065003),0.3611291575483393,1.0960730398976315,0.2969387755102041,0.8592845654324426,1.0,63/259,18.09%,FBXL7;TCF7L1;TCF7L2;HES1;REPS2;PTK2B;ANO6;GSK3B;TLE2;SEC16A;SLC7A9;MNAT1;TIAM1;PYGO2;CREBBP;SHANK1;SEC31A;FN1;SEC24B;IKBKG;DMTN;CSNK1A1;ZC3H12A;SEC23A;CUL3;EPRS1;ANKRD28;CUL1;SLC9A1;CDC123;SEC24D;PYGO1;SEC23IP;PPP6R3;DET1;TEAD1;MCU;NSF;STX5;ZW10;TRAF2;PARD3;MDM4;ITGB1BP1;DMD;TRAPPC3;TRAPPC10;SOX9;CAPZA1;GOSR2;AFDN;RAB1A;TUBGCP2;VAMP2;YAP1;ADCY8;BCL9L;KMT2D;FARP2;LRRK2;TRRAP;NCKAP1L;TRAPPC9
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.3851336147446626,-1.0959944614699364,0.3231292517006803,0.7398083979403465,1.0,9/22,14.42%,AEBP1;APOE;MAP2;HSPA8;MAPT;CAMSAP2;MAP1A;PIK3CA;EFEMP2
prerank,glucan catabolic process (GO:0009251),0.4991367747109973,1.0954875086935052,0.361671469740634,0.8602087850457558,1.0,4/15,15.09%,PYGB;PHKA2;PHKB;PGM2
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.3940055373154371,1.0950073834363452,0.33716915995397007,0.8608899570639478,1.0,16/80,17.50%,THBS1;SLC2A13;PRKCD;SAMD4A;NIBAN1;ERBB2;EIF3E;EIF6;RBM3;CLU;NAT10;SIRT3;CIRBP;PRKDC;RPS6KB1;LARP4
prerank,L-amino acid transport (GO:0015807),0.457401169728718,1.0942929805116741,0.35190217391304346,0.8623050050769611,1.0,3/28,8.53%,SLC38A2;SLC7A9;SLC38A3
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.45670464798520505,1.0942503602046056,0.36538461538461536,0.8616942292037248,1.0,15/29,29.80%,DCUN1D5;ABL1;FEM1B;FBXO5;DCUN1D2;PIN1;SMAD7;DCUN1D1;BAG5;AXIN1;TOPORS;PLK1;ARRDC3;UBE2N;DTX3L
prerank,negative regulation of cellular senescence (GO:2000773),-0.4398503642235047,-1.093832057721116,0.3371757925072046,0.744211080929622,1.0,3/13,3.88%,AKT3;SLC30A10;CDK6
prerank,DNA integrity checkpoint signaling (GO:0031570),0.43964598176911823,1.0937285739774723,0.36363636363636365,0.8624648297292941,1.0,18/36,25.29%,CDC45;CHEK2;CLSPN;CEP63;RAD17;E2F1;HINFP;BRIP1;USP28;INTS7;DONSON;ATR;NBN;CHEK1;ATM;RAD9A;CDC6;RAD9B
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.3278261239886075,-1.0937119813250342,0.29838709677419356,0.7427379612675138,1.0,10/34,10.26%,FLT1;SEMA6A;PRKD1;KDR;NUS1;NOTCH1;VEGFC;DAB2IP;SPHK1;HSPB1
prerank,regulation of dendrite morphogenesis (GO:0048814),-0.34603436558931433,-1.093412495092945,0.2590909090909091,0.7417585840083138,1.0,13/32,13.13%,IL1RAPL1;TNIK;NEDD4L;ADGRB3;HECW2;RAPGEF2;RAP2A;HECW1;CUX2;YWHAH;PTPRD;KNDC1;SARM1
prerank,cholesterol efflux (GO:0033344),0.4738800950011392,1.093074657009334,0.36142857142857143,0.8636516684557887,1.0,6/20,12.35%,SOAT1;TSKU;ABCA7;NPC1;SOAT2;STX12
prerank,regulation of protein modification process (GO:0031399),-0.3153232214541447,-1.0928423738856161,0.25462962962962965,0.7416040088640864,1.0,16/50,19.79%,LYN;PPP1R16B;GRM5;SPRED1;CADM4;HSPB1;CDH5;PTK2;FNIP2;CCDC88A;ABCA2;MT3;CCDC88C;STAT2;PPIB;FNIP1
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.43100566682380026,1.0928374533242449,0.37694300518134716,0.863617046953238,1.0,18/40,24.23%,TCF7L2;TGFB3;TGFBR1;TWIST1;TIAM1;TGFBR2;SMAD2;FOXC1;TGFB1I1;JAG1;SMAD4;BCL9L;FERMT2;GCNT2;SNAI1;CRB2;DAB2;MTOR
prerank,glycogen metabolic process (GO:0005977),0.45376974268014636,1.0926708156442757,0.3468286099865047,0.8633344634499591,1.0,8/27,15.40%,PYGB;GSK3B;PHKA2;PPP1R3C;PHKB;NR1D1;PGM2;NHLRC1
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.36915104293725864,-1.0925517527030133,0.31756756756756754,0.7389614800865054,1.0,5/23,8.94%,BCL2;TFDP2;YWHAB;PPP1R13B;YWHAH
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.36915104293725864,-1.0925517527030133,0.31756756756756754,0.7389614800865054,1.0,5/23,8.94%,BCL2;TFDP2;YWHAB;PPP1R13B;YWHAH
prerank,protein localization to plasma membrane (GO:0072659),0.37567892841829953,1.092459905593181,0.33190578158458245,0.863203661102764,1.0,29/129,13.18%,KCNB2;LRP6;RAMP1;CDH1;ANK2;ATP1B1;EZR;FGF13;SLMAP;KCNB1;NECTIN3;GORASP2;SEC16A;TTC7A;ZDHHC2;FCHO2;TSPAN17;RDX;EHD2;S100A10;GAK;C2CD5;PLEKHF1;RAP1A;JUP;PIP5K1A;ITGB1BP1;EHD1;DLG1
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.5290225442161525,1.0923656351964253,0.3855421686746988,0.8627368780789748,1.0,5/11,17.26%,TGFBR1;USP15;TGFBR2;ACVR1;SMAD7
prerank,positive regulation of cartilage development (GO:0061036),0.4941281606260708,1.0920805661471433,0.3760932944606414,0.8628264207785559,1.0,3/17,5.84%,BMP4;BMP1;ZBTB16
prerank,organelle assembly (GO:0070925),0.3554207420419563,1.0920732510431546,0.27867203219315895,0.8620997233893035,1.0,107/385,21.37%,PKD1;BBS9;ABLIM3;EXOC4;ULK2;GSN;PTPDC1;GORASP2;HPS4;RBM14;IFT46;PDE6D;GBF1;FAM161A;RAB43;PARVA;DZIP1;NEK7;WDR35;CDC14A;PCM1;FLII;RAB11FIP3;ZFYVE1;NCOR1;SMIM22;BECN1;CFAP43;EHD2;WDR45B;ATXN2;IFT52;MAK;DYNC2I2;HAUS2;ARL3;CEP63;PLK4;ATG3;CENPT;RFX2;POGZ;PCNT;GALNT11;EIF2S1;KIF3B;TP53INP2;UBAP2L;TUBGCP6;RB1CC1;ATG5;VPS37A;ARF4;STX12;OCRL;VTA1;VPS37B;DISC1;EXOC7;EHD1;PDCD6IP;DYNC2I1;WIPI2;TMEM231;BICD1;CEP19;TRAPPC14;CIRBP;OFD1;ATAT1;CHMP2B;RAB1A;CCDC66;TUBGCP2;IFT43;SQLE;NPHP3;ACTR2;SNF8;CPLANE2;CEP20;CENPJ;PTPN23;FARP2;UBXN2B;CEP164;CDS1;MKKS;ATP6V0D1;FITM2;CLUAP1;IQCB1;NUDCD3;NEK6;RAB11A;LZTFL1;HYLS1;CCDC61;EXOC2;TXNDC15;PIBF1;TMOD3;LSM4;CEP89;ACTR3;EXOC5;TEKT2
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.3790488754440592,-1.0920598486380055,0.33447098976109213,0.738632324448761,1.0,6/22,8.01%,LYN;PICALM;ROCK2;ABCG1;EPHA4;LRRTM3
prerank,positive regulation of biomineral tissue development (GO:0070169),0.42490414010746635,1.0920173315396875,0.3496774193548387,0.861519850024541,1.0,7/40,6.10%,BMP4;CCN1;NELL1;TGFB3;BMPR1A;ANO6;BMP6
prerank,response to endoplasmic reticulum stress (GO:0034976),0.3809388773938749,1.0917103995605646,0.33114754098360655,0.861703710541005,1.0,23/107,16.22%,THBS1;MAP3K5;TMEM117;NIBAN1;GSK3B;ERP27;GORASP2;SEC16A;AGR2;RNF185;VCP;ATF6;CREB3L1;EIF2S1;HERPUD1;TRAF2;BCAP31;UBA5;TMEM33;SEL1L;NCK1;TMTC3;FLOT1
prerank,smooth muscle cell differentiation (GO:0051145),0.5248283688075327,1.0915428802758533,0.3792,0.8614521507787812,1.0,2/12,5.73%,BMP4;MRTFA
prerank,protein polymerization (GO:0051258),0.41052294323819283,1.0914987556385014,0.35406698564593303,0.8608518553274193,1.0,14/56,19.05%,COBL;GSN;FGF13;MAP7D3;PSTPIP1;DIAPH1;FAM107A;HDGFL3;WASHC5;UBE2K;PIN1;CENPJ;UBE2S;JAK2
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.38559542604402713,1.09129315143625,0.3396017699115044,0.8606999006131177,1.0,36/100,24.15%,RNF144A;PRICKLE1;FHIT;GIPC1;GSK3B;ZYG11B;WAC;TRIM39;CSNK1A1;XPO1;ARIH1;VCP;DESI1;ANKIB1;RAD23B;DDA1;DET1;KEAP1;HERPUD1;CLU;COP1;COMMD1;DVL1;GLMN;SMAD7;RNF14;LRRK2;BAG5;TLK2;BAG2;DNAJB2;PIAS1;DAB2;OGT;USP7;ARIH2
prerank,positive regulation of superoxide anion generation (GO:0032930),0.5061415477296088,1.0909257219645063,0.375609756097561,0.8610805507865004,1.0,1/13,1.64%,PRKCD
prerank,negative regulation of stem cell differentiation (GO:2000737),0.5454625771502807,1.0901769008109208,0.3798449612403101,0.8624941545814305,1.0,2/12,12.02%,HES1;JAG1
prerank,autophagy of mitochondrion (GO:0000422),0.4256175954043757,1.0899834729206777,0.37435897435897436,0.8623075935193951,1.0,9/38,13.98%,ULK2;CISD2;BECN1;WDR45B;ATG3;RB1CC1;ATG5;MARK2;WIPI2
prerank,cGMP biosynthetic process (GO:0006182),0.5378275986025759,1.089971370607571,0.38176197836166925,0.8615972565437173,1.0,1/10,0.83%,GUCY2C
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.46919184092647326,1.0890408317464428,0.36629526462395545,0.8637256302485924,1.0,7/23,17.53%,SEC16A;RANGRF;VCP;HERPUD1;SEL1L;TMEM129;SURF4
prerank,positive regulation of interleukin-6 production (GO:0032755),0.40159181863044624,1.088920631972094,0.32909930715935337,0.863353786462186,1.0,14/68,13.32%,LBP;RAB7B;PLCG2;TLR1;IL33;TWIST1;STAT3;IL17RA;TLR4;MAVS;IFIH1;TLR8;MYD88;TIRAP
prerank,regulation of actin filament-based process (GO:0032970),0.3937205409369716,1.0888327195980159,0.36104783599088835,0.8628890130805681,1.0,16/70,11.66%,PRKCD;RHOBTB1;EZR;EFNA5;CDK10;ABL1;ARHGAP44;LRP1;ARHGAP17;SMIM22;RHOQ;FAM107A;DMTN;RND3;RHOA;ABRACL
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.4560816012364642,1.088335059622115,0.37532467532467534,0.8636857776984839,1.0,16/27,29.25%,CREBBP;MSL3;MORF4L1;KAT6B;ATAT1;PHF20L1;TRRAP;PHF20;KAT6A;MRGBP;CPA4;SGF29;KAT8;KAT2B;NAA50;BRD8
prerank,postreplication repair (GO:0006301),0.41384865591857223,1.0878462908661293,0.3383838383838384,0.8643723572081684,1.0,20/45,29.04%,UBE2A;VCP;NSMCE1;ZBTB1;POLI;BRCA1;PRIMPOL;UBE2B;PCLAF;DTL;RFC1;USP10;SPRTN;UBB;UBE2V1;UBA52;POLK;RPS27A;WDR33;UBE2N
prerank,regulation of establishment of cell polarity (GO:2000114),0.505064590761853,1.0875356050327933,0.37175792507204614,0.8645791577924518,1.0,5/16,8.90%,GSN;PTK2B;BCAS3;SHTN1;KRIT1
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.41201321996434426,1.0872131499108595,0.3572327044025157,0.8648155482301882,1.0,22/45,26.95%,ZC3H7A;FOXO3;PER1;TDRD7;ATXN2;RBM3;CYFIP1;MEX3D;LARP4;PUM2;GEMIN5;PUM3;GCNT2;PUM1;RPL10;MAPKAPK5;TRIM71;YTHDC1;TSC1;ZC3H10;METTL16;PARP9
prerank,B cell differentiation (GO:0030183),0.420043729902435,1.0870455267130517,0.34491634491634493,0.8645566438702498,1.0,6/46,7.66%,HDAC4;HDAC9;CLCF1;PLCG2;PTPN2;ITGB1
prerank,histone H4-K16 acetylation (GO:0043984),0.4803307821295109,1.0868015612013322,0.3559077809798271,0.8645560907190227,1.0,10/19,27.20%,KANSL3;KANSL2;JADE2;MSL3;HCFC1;PHF20;KANSL1;OGT;MCRS1;KAT8
prerank,neuron migration (GO:0001764),0.41444335526922926,1.0867998745185514,0.35599505562422745,0.863826829224097,1.0,16/48,13.00%,MARK1;FGF13;NRP1;ELP3;VEGFA;FGFR1;DNAAF4;NR4A2;PAFAH1B1;SDCCAG8;MAP1B;LRP12;PEX13;NAV1;MARK2;DISC1
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.3971422267552626,1.086592063901891,0.3584018801410106,0.8637484588050429,1.0,26/72,23.55%,PLAGL1;CRADD;NDRG1;CNOT8;CHEK2;AURKA;CASP2;CCNB1;TFDP1;CDKN1B;MDM4;E2F1;TNKS1BP1;ATRX;PIDD1;CDKN1A;CNOT4;PLK3;PCBP4;USP10;PML;NBN;CNOT1;ATM;CNOT11;TP53
prerank,cellular response to ionizing radiation (GO:0071479),0.4211156472488625,1.0865524921445586,0.37267080745341613,0.8631131138718624,1.0,19/47,25.37%,TANK;NIPBL;RAD51;SPIDR;WRN;KDM1A;TNKS1BP1;CDKN1A;YAP1;INTS7;ATR;TLK2;XRCC5;ATM;TP53;INO80;RAD9A;RAD9B;KDM4D
prerank,keratan sulfate biosynthetic process (GO:0018146),0.44880885311701724,1.0865239627442904,0.35319148936170214,0.8624575649217335,1.0,6/26,10.81%,ST3GAL4;B3GNT2;B4GALT1;SLC35D2;CHST5;B4GAT1
prerank,cellular response to peptide hormone stimulus (GO:0071375),-0.2719008162567739,-1.086299635655708,0.2736842105263158,0.7528852546487692,1.0,18/102,8.10%,TBC1D4;ADCY5;ADCY1;SLC30A10;PIK3R1;CPEB2;FOXO1;ENPP1;INSR;PRKAR2B;INSIG2;PRKAR1B;ADCY7;PRKAR1A;SLC25A33;MYO5A;LPIN3;RAB31
prerank,cell part morphogenesis (GO:0032990),0.5224061852844395,1.0861079654631003,0.38266068759342303,0.8629044001516504,1.0,1/13,1.27%,PID1
prerank,protein autoubiquitination (GO:0051865),0.4055987391830077,1.0860989143212658,0.34251497005988024,0.8622059499056853,1.0,20/61,19.40%,SH3RF3;WWP2;UBE2A;RNF115;RNF185;CUL3;RNF146;TRAF2;BRCA1;RNF122;RNF8;RNF41;UBE2B;UBE2D3;TRAF6;RNF141;RNF11;CNOT4;NFX1;LRSAM1
prerank,neural crest cell development (GO:0014032),-0.3136697087818556,-1.0860581551523747,0.29411764705882354,0.7518201005494861,1.0,20/44,24.14%,SEMA6A;CDH2;SEMA7A;RADIL;ERBB4;TBX1;SEMA6D;SEMA3B;SEMA5A;SEMA3G;TAPT1;SEMA5B;SEMA6B;SEMA4G;SEMA3A;SEMA3F;SEMA4D;SNAI2;NRTN;NRG1
prerank,regulation of apoptotic process (GO:0042981),0.35067162588821044,1.0858645784518375,0.23,0.8621725741720639,1.0,127/676,16.88%,SLIT2;THBS1;RASSF2;BMP4;CARD14;EGFR;MAP3K5;PERP;FSTL1;GRK5;HOXA5;TCIM;CYP1B1;SMAD6;VAV2;WNT11;CASP6;GCLC;ANXA4;PTK2B;UNC13B;CRADD;ARHGAP10;AKAP13;ERC1;FBXO10;NGF;SFRP4;PAWR;VEGFA;TGFB3;NTSR1;EGLN3;ANO6;GADD45G;GSK3B;NOTCH2;NDRG1;KRT18;SON;GAS1;ABL1;ERCC5;SERPINB9;TAX1BP1;SHC1;ANXA1;FOXO3;NF1;PROK2;CEACAM5;CLEC5A;PRDX5;TIAM1;BAG3;PLSCR3;CD44;SOS2;CREBBP;CASP2;BARD1;APEX1;WRN;IP6K2;ITGB1;TIAM2;ZFAND6;VCP;PTPA;SIX4;CIB1;BRMS1;RIPK2;ATF6;ANKRD13C;DNAJC3;MCL1;MAD2L1;PDCD2;NAA15;FGD1;FXN;ARF4;NIBAN2;CLU;MYD88;RPS6KA3;TRAF2;TRIO;RAF1;NSMF;RBM25;DPEP1;TMBIM4;ARL6IP5;FGD3;RRP1B;E2F1;MTDH;AATF;COPS5;HTATIP2;RNF122;PIM2;GNA13;SOX9;SRA1;PIDD1;TMEM219;BNIP1;NAA38;YME1L1;PRKDC;RNPS1;TRAF6;GOLPH3;MTCH1;FFAR4;UBE2O;SCRIB;GDNF;MAP3K10;PLEKHG2;USP47;IKBKB;TNFRSF12A;PLK3
prerank,synaptic vesicle cycle (GO:0099504),-0.34347923645615297,-1.0858589493012039,0.35,0.7506705814414137,1.0,11/30,24.06%,RIMS1;SNAP25;SYNDIG1;SYT7;SYT10;PLD2;RAB3A;BRSK1;SNCA;OTOF;SLC32A1
prerank,histone H3-K4 trimethylation (GO:0080182),0.5319521207759286,1.085445064631028,0.3842662632375189,0.8626923185771528,1.0,7/11,34.73%,WDR82;KMT2D;OGT;CTR9;TET3;PRDM9;TET2
prerank,protein monoubiquitination (GO:0006513),0.4292053673538002,1.085254551806332,0.36750998668442075,0.8625238302140761,1.0,10/36,17.80%,RNF126;FANCL;WAC;CUL3;KLHL22;UBE2B;UBE2D3;UBE2O;RNF20;DTL
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.458765200894769,1.0850902528042519,0.38024357239512857,0.8622633207189304,1.0,5/28,4.65%,PID1;PRKCD;IRS1;GRB10;PTPN2
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.4537622988127355,-1.0849441977964527,0.3567567567567568,0.7515605074313705,1.0,2/12,3.89%,IGF1;INSR
prerank,negative regulation of cellular catabolic process (GO:0031330),0.39425661561121056,1.0843793488406321,0.3684210526315789,0.8636379510710926,1.0,13/63,10.98%,MET;PTPN3;NELL1;EIF4G3;TIMP1;STAT3;TAB3;TIMP2;EIF4G2;RGP1;KLHL22;TAB2;MCL1
prerank,positive regulation of signal transduction (GO:0009967),0.35797525056533314,1.0837281471118674,0.3065015479876161,0.8648048387631938,1.0,50/238,14.70%,SMOC2;RSPO3;F3;CCN3;NTRK3;PTK2B;CRADD;PTGIS;RSPO4;IRS1;NRP1;SLC39A14;SMO;GRB10;ADAMTS3;LIMS1;TGFBR1;STAT3;SKI;DACT1;BMP6;TEDC2;CREBBP;SHANK1;SULF1;EVC;TRIM39;DMTN;CD80;ELF3;ARNT;FGFBP3;ITGAV;MYORG;AAK1;NEPRO;NLGN1;TRIM44;ULK3;DRD3;JAG1;KIF7;ITGB1BP1;DISC1;NPTN;SORL1;ITGB3;ZRANB1;DEPDC1B;PRKCA
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.541445445537941,1.0836666652902749,0.40032679738562094,0.8642550288219035,1.0,5/10,16.49%,EZR;SYNE4;RHOA;MYO9A;CAMSAP3
prerank,regulation of monocyte differentiation (GO:0045655),0.50318237054711,1.0834628433036853,0.3870967741935484,0.8640952206181008,1.0,1/14,0.23%,FOXP1
prerank,dendritic cell differentiation (GO:0097028),-0.36683876739476695,-1.0833856492708183,0.35855263157894735,0.7543639212657764,1.0,9/22,24.12%,LYN;AXL;FLT3;GAS6;CAMK4;CCL19;IRF8;PRTN3;TREM2
prerank,negative regulation of protein binding (GO:0032091),0.39087527952746765,1.083245888452492,0.35805330243337197,0.8639888070223691,1.0,28/71,23.91%,PRKCD;PTPRF;ADRB2;GSK3B;DACT1;AURKA;KDM1A;TMC8;ZFPM1;ITGB1BP1;DISC1;CARD16;SORL1;DDX11;DVL1;ADAM15;CDKN1A;PSME3IP1;PIN1;LRRK2;RALB;BAG2;SLPI;DNAJB2;STYX;DAB2;GNL3L;USP33
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.48288593985592704,1.0830367535338294,0.3724035608308605,0.8638581367392472,1.0,4/17,13.01%,ADAM9;FOXC2;CIB1;RET
prerank,hemopoiesis (GO:0030097),-0.2785284152356354,-1.082781470086798,0.2565789473684211,0.7543380193261349,1.0,15/87,8.17%,FLT1;MECOM;TEK;KIT;TGFBR3;SNRK;TOX;WNT5A;KDR;KIRREL3;ETV6;MEIS1;NOTCH4;CD34;FLT3LG
prerank,fatty acid transport (GO:0015908),-0.39859401780866854,-1.082699033519352,0.3343949044585987,0.7528233675874261,1.0,5/17,12.51%,ACSL1;APOE;PPARD;GOT2;FABP5
prerank,positive regulation of interleukin-17 production (GO:0032740),-0.37405471027079146,-1.0825041041978056,0.33807829181494664,0.7516802766044011,1.0,5/22,9.52%,RFTN1;SLC7A5;PRKCQ;IL18;SPHK1
prerank,regulation of chemokine production (GO:0032642),0.4289316759627975,1.0823197880044497,0.34832904884318766,0.8652346399860469,1.0,5/36,10.76%,FOXP1;IL33;TLR4;EGR1;EIF2AK2
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.4965147625822156,1.0821656202904115,0.39465875370919884,0.8649559423129392,1.0,7/16,24.42%,MCM2;RAD51;WRN;MCM7;RECQL5;HMGA1;RECQL
prerank,positive regulation of protein deacetylation (GO:0090312),0.5096967483698616,1.0818619052405767,0.3895705521472393,0.8651525748089958,1.0,7/14,24.47%,NIPBL;NNMT;BRMS1;SAP30BP;ZBTB7B;FNTA;AKAP8L
prerank,hydrogen peroxide catabolic process (GO:0042744),0.5232134814356832,1.0808618424921113,0.3758169934640523,0.8672333184121679,1.0,6/11,30.42%,PRDX5;CAT;PRDX2;PRDX1;GPX1;PXDN
prerank,ncRNA metabolic process (GO:0034660),0.43110660583138666,1.0808204785201034,0.38046272493573263,0.8666398404619957,1.0,6/37,9.20%,DDX17;AGO2;TUT7;DGCR8;TUT4;DTD2
prerank,receptor catabolic process (GO:0032801),0.46497683504916965,1.08055917011697,0.37464788732394366,0.8666249873503902,1.0,8/24,18.59%,NEDD4;AP2A2;KIF16B;BECN1;SH3GLB1;AP2B1;SMURF1;AP2A1
prerank,synaptic vesicle endocytosis (GO:0048488),-0.3417860109533949,-1.080198423384894,0.3333333333333333,0.7565224482466664,1.0,7/33,6.74%,DNAJC6;DNM3;PICALM;DNM1;SYT1;SNAP91;OPHN1
prerank,anterior/posterior axis specification (GO:0009948),-0.4049081601283621,-1.0796831129061792,0.34911242603550297,0.7562010607501398,1.0,2/15,3.34%,WLS;TBX3
prerank,dendritic spine morphogenesis (GO:0060997),-0.4089106011983583,-1.0796347282884287,0.3448275862068966,0.7545835920541083,1.0,4/15,4.20%,DOCK10;SHANK3;EPHB1;PAK3
prerank,ubiquinone metabolic process (GO:0006743),0.510867602955688,1.079593110383625,0.38450074515648286,0.8686498901363628,1.0,3/15,7.55%,COQ7;COQ10B;PDSS2
prerank,regulation of lipid biosynthetic process (GO:0046890),-0.3423094150743904,-1.0793838900896144,0.35714285714285715,0.7535837988407678,1.0,13/32,23.11%,APOE;PPARA;PRKAA2;ASAH1;AVIL;PRKAG2;ZBTB20;MID1IP1;PDK4;ASXL3;C3;AKT1;GPER1
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.33382192209005135,-1.0790477399829195,0.3281853281853282,0.752787799867862,1.0,9/35,9.75%,ITGA1;PDGFRB;PPP4R4;NUAK1;PPP1R15B;CALM1;HSP90AB1;CD300A;MAGI2
prerank,regulation of tube diameter (GO:0035296),-0.4404393141242835,-1.0788835325841815,0.3753943217665615,0.7498161643822149,1.0,4/13,4.44%,NOS3;ROCK2;NPR1;ACE
prerank,vascular process in circulatory system (GO:0003018),-0.4404393141242835,-1.0788835325841815,0.3753943217665615,0.7498161643822149,1.0,4/13,4.44%,NOS3;ROCK2;NPR1;ACE
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.389624683380416,1.078792891813379,0.34637514384349827,0.8701767739061443,1.0,15/78,14.13%,EGFR;PID1;PRKCE;LRP1;RANGRF;ATP2B4;PLS1;ZDHHC2;AGR2;ITGB1;RHOQ;CIB1;EPHB2;DLG1;PTPN9
prerank,I-kappaB phosphorylation (GO:0007252),0.5346188139733256,1.0783263553056521,0.39933993399339934,0.8708046286685189,1.0,3/10,10.51%,ERC1;TLR4;MAP3K7
prerank,negative regulation of bone remodeling (GO:0046851),0.5251217491170741,1.078217291909912,0.3939393939393939,0.8703844515218649,1.0,2/11,9.62%,UBASH3B;TMEM119
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.455251054118893,-1.0777221421707095,0.3838120104438642,0.7514864233531406,1.0,4/11,17.38%,EFNB2;MEF2C;MYOCD;GREM1
prerank,small GTPase mediated signal transduction (GO:0007264),0.3798388799230441,1.0776184417455774,0.36212624584717606,0.8714535864678953,1.0,18/103,8.90%,PLCE1;NTN1;CCNA2;FGF2;NRAS;KRAS;MRAS;SHOC2;G3BP2;SHC1;NF1;BCR;TIAM1;ARFIP2;TIAM2;ARHGAP31;SHTN1;KRIT1
prerank,histone H3-K9 demethylation (GO:0033169),0.528730837627491,1.077503248246897,0.4020926756352765,0.871068604372537,1.0,7/11,25.37%,JMJD1C;KDM1A;HR;KDM3B;PHF8;KDM3A;KDM4D
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.36543854238421525,1.0774849765187642,0.3495248152059134,0.8703975317700757,1.0,39/152,18.97%,RSPO3;EGFR;WNK1;GPC3;PLEKHA4;RSPO4;SFRP4;PSMB2;SKI;UBR5;DACT1;SULF1;PSMD11;TRPM4;PSMC1;VCP;USP34;TBL1X;PSMC6;CSNK1G3;JUP;RNF146;NRARP;DISC1;CSNK1G1;ZRANB1;DEPDC1B;PSMD1;UBE2B;CAPRIN2;PSMD4;USP47;PIN1;PSMA6;PRDM15;LRRK2;PSMD14;PSMD12;PSMD7
prerank,morphogenesis of an epithelium (GO:0002009),0.4518264826574896,1.077472426765068,0.3856749311294766,0.8697117456798964,1.0,3/25,7.44%,LRP6;RIPK4;VCL
prerank,negative regulation of angiogenesis (GO:0016525),0.38780050439552727,1.0772212950563063,0.36794582392776526,0.8697543779017669,1.0,21/84,16.30%,THBS1;SLC12A2;HOXA5;SEMA3E;ISM1;KLF4;EMILIN1;ATP2B4;SULF1;KRIT1;FOXC1;CREB3L1;MECP2;NIBAN2;SYNJ2BP;EFNA3;EPN1;CD160;E2F2;ALOX5;ADAMTS1
prerank,platelet aggregation (GO:0070527),0.43439972641951874,1.0772166520323163,0.3539473684210526,0.869056120909478,1.0,5/33,7.44%,UBASH3B;GNAS;CLIC1;FN1;VCL
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.46953249721481255,-1.0769288511589585,0.3871866295264624,0.7519845330330287,1.0,7/10,14.14%,GABRG3;GABRA2;GABRB2;GABRG1;GABRA5;GABRA1;GABRG2
prerank,DNA replication initiation (GO:0006270),0.42492840102059615,1.0767533712140747,0.38350785340314136,0.8696599870356981,1.0,11/37,18.52%,CDC45;MCM2;TOPBP1;PRIM1;POLE2;ORC3;PRIM2;MCM7;CDK2;CDC7;POLA2
prerank,regulation of cell population proliferation (GO:0042127),0.34656411253809577,1.0765415281812762,0.258,0.8695606135652933,1.0,114/691,12.96%,THBS1;ZBTB7C;SIX1;BMP4;EGFR;TCF7L2;ACER3;WNT9A;PGF;HES1;HDAC4;NTRK3;GRK5;CYP1B1;RBFOX2;SMAD6;PTPRU;BMP5;ABI1;PTK2B;FGF2;GAB2;SLURP1;ECRG4;TES;KRAS;NGF;CLMN;SFRP4;IRS1;VEGFA;TGFB3;BMPR1A;ID2;RAB25;NPR3;EGLN3;CLCF1;RNF126;CDK10;ELN;RARA;KLF4;LIMS1;TIMP1;S100B;TGFBR1;PTHLH;TBRG1;PTPN2;FOLR2;NR4A3;PDGFC;FGFR1;STAT3;SHC1;TCIRG1;KLF10;SKI;CNOT8;FRK;PROK2;LMNA;BMP6;CTF1;ERBB2;TIAM1;TGFBR2;NCK2;INHBA;UBE2A;STRN;TENM1;FN1;SMIM22;KITLG;IRF1;CEP43;MLXIPL;P3H3;TRPM4;P3H1;CUL3;CDKN2C;SFRP5;PPP2R5C;SIX4;CIB1;CDC123;ITGAV;CDK13;TTK;RHOA;TGFB1I1;GAREM1;EIF2AK2;MECP2;BTG3;FBXO5;JUP;SGK3;FXN;JAG1;GNRH1;IFI35;NIBAN2;CLU;CDKN1B;RAF1;MDM4;CELF1;CDKN3;IGFBP6;ITGB1BP1
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.4359950787593422,1.0764491225394006,0.3735408560311284,0.8690973007957842,1.0,8/33,11.71%,EGFR;PLCG2;ANXA1;LSM11;CCND1;RDX;ANKRD17;TFDP1
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.4072848630036231,-1.076064521248512,0.3258064516129032,0.7527393455944547,1.0,5/15,16.40%,DGKD;HIP1R;SNAP91;TNK2;BMP2K
prerank,hematopoietic stem cell differentiation (GO:0060218),0.5445218696189292,1.0757864675434023,0.3967479674796748,0.870273937476457,1.0,2/10,6.56%,MLLT3;HOXB4
prerank,carbohydrate homeostasis (GO:0033500),0.39005567353756704,1.0757582705725832,0.3717948717948718,0.8696435385251572,1.0,20/67,19.34%,TCF7L2;KCNB1;IRS1;PTPN2;KLF7;STAT3;ACSM2A;BACE2;CRY2;MLXIPL;CRTC2;HECTD4;MCU;SLC8B1;ALOX5;PAX6;ADCY8;TENT4B;PPARG;MBD5
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.46899667850968396,1.0757079740225615,0.37031900138696255,0.8690696078320651,1.0,4/20,1.98%,CACNA1C;CAMK2D;ANK2;ATP1B1
prerank,membrane depolarization during action potential (GO:0086010),0.45584706400390546,1.075678733651476,0.37988826815642457,0.8684362727867482,1.0,3/26,1.48%,KCNJ2;CACNA1C;CACNA1G
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.45032991133236766,1.0753548662309589,0.3853727144866385,0.8686464865357569,1.0,5/23,12.85%,CCN3;NLRP12;ZC3H12A;IFI35;CPNE1
prerank,histone lysine demethylation (GO:0070076),0.4520265200962611,1.075007072169291,0.37789904502046384,0.8689364110184854,1.0,11/25,25.37%,JMJD1C;KDM1A;HR;KDM5B;KDM3B;KDM2A;RIOX2;PHF8;KDM3A;KDM1B;KDM4D
prerank,protein alkylation (GO:0008213),0.4666550001090425,1.0749811068567838,0.4145985401459854,0.8683063904410658,1.0,6/22,12.34%,PCMT1;PRMT8;GSPT1;ETFBKMT;ETF1;EEF2KMT
prerank,neurogenesis (GO:0022008),0.41556836292825555,1.074485653581081,0.38,0.8690731927780618,1.0,4/43,5.34%,SIX1;CIT;THOC2;ANXA1
prerank,negative regulation of translational initiation (GO:0045947),0.5113946207075014,1.0744617265301564,0.38650306748466257,0.8684407974931106,1.0,4/13,10.76%,PAIP2;AGO2;EIF3E;EIF2AK1
prerank,oxoacid metabolic process (GO:0043436),-0.3443179299482447,-1.0744144193121634,0.35379061371841153,0.7555621223276868,1.0,9/27,26.79%,DDO;ENPP1;TPST1;MIF;SULT4A1;GRHPR;LIPT1;SULT2B1;AGXT
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.362989800246883,1.0742099088555732,0.35783783783783785,0.8684749316746522,1.0,34/138,19.02%,NR3C2;RARB;HDAC9;ESR1;NOTCH2;RARA;NR4A3;MNAT1;NR4A2;CREBBP;RORA;NCOR1;E2F3;NCOR2;RXRA;MED27;TBL1X;TEAD1;RXRB;NR2F1;NR1D1;GTF2E1;NR4A1;GTF2A2;TAF4;NR3C1;CDK7;E2F2;GTF2H3;YAP1;ESR2;TAF5;POLR2C;PPARG
prerank,protein deneddylation (GO:0000338),0.549117168549155,1.0739638040257429,0.40381558028616854,0.8684761323578841,1.0,5/10,19.75%,COPS7B;COPS5;COPS8;COPS3;COPS2
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.36082145442342595,-1.0739551995815628,0.32608695652173914,0.7551068995823594,1.0,11/24,18.13%,BCL2L1;NR1H3;AQP11;WFS1;CREB3;RACK1;NR1H2;XBP1;HSPA1A;UBXN1;SELENOS
prerank,nuclear envelope organization (GO:0006998),0.4680358257306979,1.073881186837031,0.3888888888888889,0.8679771753392792,1.0,10/20,26.54%,EMD;NUP93;LEMD2;NUP155;TOR1B;TOR1AIP1;SUN1;REEP3;REEP4;SUN2
prerank,ubiquinone biosynthetic process (GO:0006744),0.5079806008006285,1.0736926498649406,0.3857791225416036,0.8678105558197838,1.0,7/15,25.54%,COQ7;COQ10B;PDSS2;NDUFA9;COQ10A;UBIAD1;PDSS1
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.35871697051412554,1.0735369130338115,0.33539731682146545,0.8675343362142679,1.0,28/186,9.08%,NXN;TCF7L2;LRP6;TRABD2B;MLLT3;PTPRU;WNT11;PRICKLE1;MDFI;SFRP4;GSK3B;GRB10;PSMB2;GLI3;INVS;TLE2;EMD;NOG;LRP1;DACT1;TSKU;DKK3;PSMD11;CSNK1A1;NLK;CUL3;SFRP5;PSMC1
prerank,smooth muscle tissue development (GO:0048745),0.5363826083282527,1.0733606833288052,0.387459807073955,0.8673052644482805,1.0,3/10,5.44%,BMP4;SMO;NF1
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.4754418213502963,1.0729621370324636,0.3920704845814978,0.8677265359300976,1.0,6/18,19.46%,RFK;ABL1;FXN;SIRT3;GDNF;EDN3
prerank,regulation of myeloid cell differentiation (GO:0045637),0.39667962760395065,1.072911248745174,0.367561260210035,0.8671745946933836,1.0,7/62,7.02%,THBS1;HOXA5;PTK2B;NR4A3;KMT2C;ZBTB16;CREBBP
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.4664277415057239,1.072819156725073,0.36063218390804597,0.8667109977926081,1.0,7/21,20.01%,FZR1;CDC20;MAD2L1;FBXO5;RAB1A;UBE2S;BAG2
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.306462235733749,-1.0723288757764564,0.2978723404255319,0.7579468837043835,1.0,10/46,10.11%,SEMA6A;LYN;FBLN1;TIMP3;SPRED1;SIRPA;DAB2IP;LMO3;CNKSR3;RPS6KA6
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.4000877780524072,1.0721135494325054,0.37876960193003617,0.867988351456928,1.0,12/56,12.37%,LBP;ALPK1;PLCG2;TLR1;TAB3;IRAK4;TLR4;MAP3K7;TAB2;TLR8;MYD88;RPS6KA3
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.2929706304589607,-1.0718561451581217,0.3415841584158416,0.7575804878977802,1.0,10/57,8.28%,IGF1;LYN;IL31RA;KIT;ERBB4;IL6R;PARP14;GHR;IL18;NF2
prerank,tRNA methylation (GO:0030488),0.43187841630507,1.0714755512003178,0.40052015604681407,0.8690547517853049,1.0,13/34,28.89%,TRMT10A;ALKBH8;MTO1;METTL2A;METTL2B;TARBP1;TRMT61B;TRDMT1;FTSJ1;DALRD3;THADA;TRMT44;THUMPD2
prerank,cell projection organization (GO:0030030),0.4407490354389774,1.0712504481995346,0.3860845839017735,0.8690032947727885,1.0,5/30,7.71%,RHOJ;GSN;PARVA;ITGB1;RHOQ
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.41413482829441856,1.0712146540262761,0.3877038895859473,0.8684069340971167,1.0,10/49,13.88%,SMAD6;PMEPA1;GSK3B;DACT1;TMC8;LDLRAD4;CLU;RAF1;SORL1;ANKRD27
prerank,retinoid metabolic process (GO:0001523),0.3866901938806197,1.0709845874547093,0.3807829181494662,0.868351200157885,1.0,11/71,12.06%,GPC6;CYP1B1;ADH7;GPC3;RDH12;CYP2S1;LRP1;RLBP1;RBP1;DHRS3;DHRS13
prerank,calcium ion transport into cytosol (GO:0060402),-0.38179377877411175,-1.0709560167717558,0.3418181818181818,0.7585091671404828,1.0,7/21,7.87%,SLC8A1;RYR2;GRIN2A;GRIN2B;GRIN1;CACNA2D1;JPH1
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.3639012607453837,1.0709140151873806,0.357066950053135,0.8678482340261783,1.0,20/151,11.11%,BMPER;EGFR;TNFAIP8L3;NTRK3;PTK2B;FGF2;NRP1;NOTCH2;CCL3;CCL1;PDGFC;SHC1;CD44;ROR1;ABCA7;GATA4;CIB1;CCL7;GAREM1;RAP1A
prerank,quinone biosynthetic process (GO:1901663),0.5124565609146853,1.0704505019511374,0.4075757575757576,0.8685601889252966,1.0,3/14,7.55%,COQ7;COQ10B;PDSS2
prerank,DNA methylation (GO:0006306),0.46003463498129793,1.0702754618979005,0.3939393939393939,0.8683615539956598,1.0,7/23,18.46%,TEX15;EHMT1;DNMT3A;DMAP1;ATF7IP;ATRX;KMT2E
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.3796337748697221,1.069737858721659,0.3742953776775648,0.869169309516399,1.0,19/94,13.43%,MAP3K5;PRKCD;CYP1B1;DDX5;TMEM117;FHIT;ABL1;CHEK2;CASP2;IKBKE;CUL3;CUL1;POU4F1;MCL1;TRAF2;BRCA1;ARL6IP5;E2F1;RRP8
prerank,regulation of telomere capping (GO:1904353),0.45723909476364105,1.0697317847637722,0.3924963924963925,0.8684897626020674,1.0,9/23,23.82%,SMG6;NEK7;RAD50;MAP3K4;NBN;TNKS2;ATM;MAPKAPK5;USP7
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.43949054697342244,1.0694540950706761,0.3896276595744681,0.8685541172093167,1.0,8/31,17.68%,FZR1;DCUN1D5;CDC20;DCUN1D2;RAB1A;PIN1;DCUN1D1;UBE2S
prerank,cellular response to oxygen-containing compound (GO:1901701),0.35225929695773517,1.069441204818883,0.33669354838709675,0.8679085329583309,1.0,45/291,13.46%,SLIT2;EGFR;WNT9A;PID1;ADAM9;LBP;PRKCD;WNT11;IGFBP5;EZR;PTK2B;SLC26A6;IRS1;ESR1;CXCL2;FZD7;CAPN2;NR4A3;RRAGB;ATP2B4;PRDX5;LCOR;RORA;IP6K2;DMTN;ZC3H12A;TLR4;EGR1;AKAP9;CD80;VCP;PDCD4;POU4F1;RHOA;DHX36;PDK3;RAP1A;TRIM41;MYD88;NSMF;NR1D1;DPEP1;RET;TIRAP;CARD16
prerank,regulation of double-strand break repair (GO:2000779),0.42554919328854235,1.0692683380437062,0.3764404609475032,0.8677168803599002,1.0,17/39,26.12%,TWIST1;UBR5;RAD51;SETD2;SIRT6;SPIDR;KDM1A;TRIP12;DDX11;PPP4R2;ACTR2;DEK;PML;CHEK1;SLF1;ZCWPW1;MRNIP
prerank,gluconeogenesis (GO:0006094),-0.31769928095189404,-1.0689245483400447,0.35874439461883406,0.7624581153446452,1.0,15/39,23.62%,RBP4;SLC25A13;PGM1;PPARGC1A;GOT2;PGAM1;GAPDH;PCK2;MDH1;CRY1;ENO1;GAPDHS;GOT1;G6PC3;ALDOC
prerank,hepaticobiliary system development (GO:0061008),0.4826616068297261,1.0688624993961449,0.3945086705202312,0.8681518060958257,1.0,4/20,5.44%,MET;COBL;NIPBL;NF1
prerank,cytoskeleton organization (GO:0007010),0.37439404354341776,1.0684524076481905,0.3711453744493392,0.8686199468910518,1.0,21/114,11.72%,MICAL2;PLCE1;MARK1;FMNL2;RHOBTB1;STRIP2;ARHGAP10;CCL3;PPP2R3C;DIAPH1;SPRYD3;ZMYM4;DMTN;PCLO;RND3;MAST2;PDZD8;CCL7;RHOA;DPYSL2;FGD1
prerank,ether lipid biosynthetic process (GO:0008611),0.5396356830492947,1.0682649392885557,0.4072249589490969,0.8684370597111354,1.0,4/10,16.44%,AGPS;GNPAT;PEDS1;LPCAT2
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),-0.35995945145480057,-1.0681965993503064,0.33707865168539325,0.762909915201197,1.0,11/25,23.11%,CEMIP;AKAP6;CACNB2;TRPC1;CX3CL1;APLNR;PLCG1;THY1;SNCA;F2R;GPER1
prerank,proteasomal protein catabolic process (GO:0010498),0.3606625865413377,1.068121687986551,0.33575883575883575,0.8681295120944518,1.0,47/201,18.97%,WWP1;NEDD4;NFE2L2;WWP2;RNF126;PSMB2;UBE4B;SPSB2;UBE2A;PSMD11;FEM1B;RNF185;CUL3;PSMC1;VCP;MTA1;PPP2R5C;KLHL22;TBL1X;RAD23B;PSMC6;DDI2;NR1D1;UBE2K;COP1;SPOPL;RNF122;FBXO45;RNF41;SEL1L;PSMD1;UBE2B;NHLRC1;UBE2D3;PSMD4;AREL1;PSMA6;RBCK1;SMURF1;UBXN2B;PSMD14;SPOP;PSMD12;DDI1;RMND5A;ENC1;PSMD7
prerank,MAPK cascade (GO:0000165),-0.2385065757346663,-1.0679754954383973,0.1,0.7618922597469275,1.0,52/295,9.23%,IGF1;KSR1;RASAL2;IL31RA;TEK;TGFA;RASGRP3;PDGFRB;TNIK;KIT;SHANK3;PAK1;PIK3R1;ACTN2;MAP3K20;KL;RASGRF1;RASGRF2;RAPGEF2;MBP;KDR;NCAM1;FGF1;ERBB4;LRRC7;RIT2;CTSH;SPRED1;BCL2L1;GRIN2B;YWHAB;MAP4K4;PRKCQ;MEF2C;GRIN1;MAPK1;FRS2;DAB2IP;ZDHHC9;NRK;BTRC;PSMD8;RGL1;IL18;NRG2;FLT3LG;TNIP2;CALM1;FGFR4;PSMC3;PSMB4;GFRA2
prerank,cortical cytoskeleton organization (GO:0030865),0.41584900239384903,1.067397988446508,0.38143036386449186,0.8694705204823107,1.0,9/41,13.18%,FMNL2;RHOBTB1;EZR;PPP2R3C;RHOQ;RND3;RHOA;NLGN1;DLG1
prerank,regulation of stress-activated MAPK cascade (GO:0032872),-0.3069987266460827,-1.0672932599080562,0.3471502590673575,0.7620331178011859,1.0,11/47,10.31%,IGF1R;PHLPP1;TGFBR3;EPHB1;FOXO1;RAP2A;MAP4K4;MAPK1;DAB2IP;FAS;MAP2K1
prerank,diterpenoid metabolic process (GO:0016101),0.39517238168568736,1.0671681158250763,0.37965260545905705,0.8694153649367167,1.0,11/55,17.04%,GPC6;ADH7;GPC3;RDH12;LRP1;RLBP1;RBP1;DHRS3;GPC4;STRA6;PECR
prerank,excitatory postsynaptic potential (GO:0060079),-0.39375124269485234,-1.0670987135464214,0.34516129032258064,0.7609071774106022,1.0,5/19,5.95%,GRID2;GRIN2A;GRIN2B;MEF2C;GRIN1
prerank,high-density lipoprotein particle assembly (GO:0034380),0.5392455484703292,1.067007613142366,0.4,0.8691680892556352,1.0,2/10,7.32%,BMP1;ABCA7
prerank,regulation of sodium ion transport (GO:0002028),0.4344931002094973,1.0669616195250362,0.37433155080213903,0.8686094204866194,1.0,13/34,17.75%,NEDD4;WNK1;SLMAP;SNTA1;RANGRF;PER1;ATP2B4;ATP1A1;DLG1;SCN1B;SCN3B;SIK1;P2RX4
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.49275482792822467,1.066951683860268,0.38740157480314963,0.8679528816149791,1.0,3/15,5.87%,DSE;UST;BGN
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.5034764283832153,1.0668317709702964,0.40458015267175573,0.8676062730407547,1.0,4/13,10.92%,RANGRF;RIC3;ABCA7;TM9SF4
prerank,signal transduction in response to DNA damage (GO:0042770),0.41172323070694533,1.066830997239296,0.3880048959608323,0.8669179086872429,1.0,22/49,24.93%,NDRG1;ABL1;CHEK2;CLSPN;CEP63;MDM4;RAD17;E2F1;HINFP;BRIP1;ATRX;USP28;INTS7;DONSON;ATR;USP10;NBN;CHEK1;ATM;TP53;RAD9A;BID
prerank,regulation of store-operated calcium entry (GO:2001256),0.5324892886918793,1.0667885502096612,0.4016,0.8663515935476392,1.0,4/10,17.48%,SLC8B1;HOMER2;GRAMD2A;HOMER1
prerank,regulation of cation transmembrane transport (GO:1904062),-0.3427127632762771,-1.0667171768562398,0.3372093023255814,0.7602893925208216,1.0,7/29,3.85%,KCNIP4;CACNA1D;DPP10;KCNIP3;FGF12;CD63;KCNAB1
prerank,cell proliferation in forebrain (GO:0021846),0.5137267376761951,1.0666933976268431,0.3851132686084142,0.8659550595400344,1.0,3/10,9.42%,DOCK7;PCM1;HOOK3
prerank,negative regulation of apoptotic process (GO:0043066),0.345576062821106,1.0666202753748408,0.28672032193158953,0.8654583873090429,1.0,92/444,17.51%,THBS1;SIX1;BMP4;CARD14;EGFR;FSTL1;GRK5;TCIM;PRKCD;SMAD6;WNT11;GCLC;ANXA4;PTK2B;ARHGAP10;ERC1;NGF;VEGFA;TGFB3;NTSR1;CLCF1;GSK3B;NOTCH2;KLF4;KRT18;SON;ERCC5;SERPINB9;TAX1BP1;SHC1;ANXA1;PROK2;CEACAM5;CLEC5A;NFATC4;PRDX5;BAG3;NRBP2;NR4A2;CD44;CASP2;BARD1;POU3F4;ITGB1;ZFAND6;ZC3H12A;GATA4;SIX4;CIB1;RIPK2;POU4F1;QARS1;DNAJC3;MCL1;IGBP1;MAD2L1;NAA15;FXN;ARF4;NIBAN2;MYD88;RPS6KA3;RAF1;DPEP1;TMBIM4;MTDH;CARD16;AATF;COPS5;HTATIP2;PIM2;SOX9;PIDD1;PRKCA;CNTF;BNIP1;NAA38;YME1L1;PRKDC;TRAF6;GOLPH3;FFAR4;UBE2O;GDNF;USP47;IKBKB;PLK3;YAP1;RPS6KB1;RB1;AREL1;PCID2
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.46403433388052706,1.0664257319567658,0.39655172413793105,0.8639076699578159,1.0,8/20,23.47%,CDC20;KLHL22;TTK;MAD2L1;ZW10;MAD1L1;BUB3;ATM
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.46403433388052706,1.0664257319567658,0.39655172413793105,0.8639076699578159,1.0,8/20,23.47%,CDC20;KLHL22;TTK;MAD2L1;ZW10;MAD1L1;BUB3;ATM
prerank,spindle assembly checkpoint signaling (GO:0071173),0.46403433388052706,1.0664257319567658,0.39655172413793105,0.8639076699578159,1.0,8/20,23.47%,CDC20;KLHL22;TTK;MAD2L1;ZW10;MAD1L1;BUB3;ATM
prerank,phosphate-containing compound metabolic process (GO:0006796),0.3491786227371681,1.0658792529519499,0.3615702479338843,0.8647200288154024,1.0,35/198,14.05%,PLCE1;TNFAIP8L3;ALPL;PPP3CA;PLCZ1;PLPP3;PLPPR2;PLCB3;NUDT5;PLA2G4F;PLCG2;PLA2G15;STAT3;ACP3;PLA2G2C;IP6K1;PFKFB1;ACP4;NADK;LIMK2;IP6K2;PPIP5K1;GPI;TOP1;PFKP;INPP4A;DUSP28;EPHB2;ANGPTL3;DUSP5;AGK;OCRL;INPPL1;PIP4K2A;TIGAR
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.5184775267082338,1.0657937790974314,0.4015873015873016,0.8642621446123612,1.0,2/10,14.47%,PDE6A;PDE6B
prerank,metal ion transport (GO:0030001),-0.2853169970588246,-1.065595586147611,0.2767857142857143,0.7617947354231159,1.0,22/86,11.85%,ITPR1;CACNA1D;SLC8A1;CACNA1E;RYR2;TRPC3;ATP2C1;CALCRL;SLC39A8;CACNA1B;CACNA2D1;TRPC4;CACNG7;TRPC1;ATP2A3;NIPA1;SLC8A3;SLC30A1;NIPAL4;CACNG3;MMGT1;TPT1
prerank,heterotypic cell-cell adhesion (GO:0034113),0.4473348268005029,1.0653613562436135,0.38620689655172413,0.8647720683188433,1.0,10/25,18.39%,CD2;DSP;DSG2;PARVA;ITGB1;ITGAV;JUP;ITGB3;CXADR;ITGA5
prerank,smoothened signaling pathway (GO:0007224),0.43231045902086046,1.0653553530689694,0.3615894039735099,0.864110467795108,1.0,7/32,16.39%,SMO;GLI3;HIPK1;GLI2;ULK3;TMEM231;MAP3K10
prerank,receptor metabolic process (GO:0043112),0.39962397521265547,1.065319410041477,0.3774271844660194,0.8635071298457743,1.0,9/53,8.68%,RAMP1;NEDD4;CD9;LRP1;KIF16B;ITGB1;GRK4;PHETA2;BECN1
prerank,body fluid secretion (GO:0007589),-0.40533355759598183,-1.0650082123820033,0.35398230088495575,0.7617389067468173,1.0,4/15,12.15%,ERBB4;NPR1;SLC22A4;SLC22A2
prerank,negative regulation of bone mineralization (GO:0030502),0.5012937457087496,1.0647371757105837,0.3911671924290221,0.8644865324136362,1.0,4/13,10.56%,PTK2B;CCL3;TRPM4;BCOR
prerank,regulation of primary metabolic process (GO:0080090),0.36590887215115037,1.064423938182769,0.3531317494600432,0.864680467761896,1.0,36/126,19.88%,TNFAIP8L3;ID2;LDLR;PSMB2;CREBBP;NCOR1;NQO1;ABCA7;CHD9;PSMD11;NCOR2;RXRA;PSMC1;ACACA;TBL1X;GGPS1;ODC1;PSMC6;NCOA6;NR1D1;SREBF1;NFYA;PSMD1;AZIN1;PSMD4;SQLE;OAZ2;PSMA6;SCD;PSMD14;PSMD12;HMGCR;PSMD7;PPARG;TGS1;NR1D2
prerank,regulation of cell migration (GO:0030334),0.34373733547958035,1.0639058109396173,0.32965931863727455,0.8654679200433222,1.0,55/382,9.92%,SLIT2;F3;THBS1;EGFR;TMEFF2;CLIC4;DPYSL3;NTRK3;CDH1;ADAM9;TWIST2;PPP3CA;CCN1;SEMA3E;LMO4;CYP1B1;PTPRU;WNT11;IGFBP5;PTK2B;FGF2;SLURP1;SRGAP2;SRGAP3;ELP3;VEGFA;SMO;PHACTR1;CCL3;SEMA3C;TGFBR1;NOG;PDGFC;STAT3;ANXA1;FOXO3;NF1;SEMA3D;LMNA;MYOC;TIAM1;VCL;SMIM22;ITGB1;SULF1;ARSB;FAM107A;CEP43;CORO1C;RDX;CHRD;MIA3;CIB1;PIK3R3;CCL7
prerank,response to UV-B (GO:0010224),-0.42579654800030314,-1.0636718825201215,0.40233236151603496,0.7638202004668176,1.0,6/12,26.65%,MME;MFAP4;CRIP1;HYAL2;HYAL3;STK11
prerank,regulation of cellular component movement (GO:0051270),0.3994399171380289,1.063515200842661,0.40248447204968946,0.8658509052295617,1.0,11/49,12.55%,EGFR;ARAP1;CD9;VEGFA;TGFBR1;ABL1;DIAPH1;ERBB2;RHOA;IGBP1;RAF1
prerank,regulation of epithelial cell proliferation (GO:0050678),0.3765664023103314,1.0633670219595732,0.38672768878718533,0.8655929051588905,1.0,11/85,7.31%,BMP4;EGFR;TCF7L2;BMP5;FGF2;VEGFA;LIMS1;NR4A3;BMP6;ERBB2;SRSF6
prerank,receptor internalization (GO:0031623),0.41450285070250587,1.0631914072572228,0.38223938223938225,0.8653788127805666,1.0,6/44,8.04%,RAMP1;NEDD4;CD9;LRP1;ITGB1;GRK4
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.4537109632009936,1.0629064917764395,0.38687150837988826,0.8655151731239981,1.0,4/23,7.24%,HDAC4;CLK2;PFKFB1;NCOR1
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.45749792133312683,1.0626905163082045,0.39502762430939226,0.8654136165220483,1.0,5/22,15.75%,CD55;MAP3K7;ZBTB1;TRAF2;TRAF6
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.4177891888445548,1.0623697609754612,0.3779527559055118,0.865589979562252,1.0,23/39,36.44%,ERCC5;CHD1L;PARP1;GTF2H3;RFC1;ERCC4;UBB;UBA52;POLK;GTF2H4;RPS27A;DDB1;ERCC2;DDB2;POLD1;XPA;GTF2H5;GTF2H1;RFC2;RPA1;POLD4;ERCC3;FAN1
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.4141139631192013,1.062230394065622,0.3837638376383764,0.865311116718734,1.0,20/42,29.09%,WARS2;NARS2;EPRS1;EARS2;QARS1;CARS2;YARS1;VARS1;VARS2;FARSA;RARS2;LARS1;AIMP2;YARS2;CARS1;EEF1E1;NARS1;FARS2;PPA2;GARS1
prerank,protein polyubiquitination (GO:0000209),0.352456452668131,1.0619468580241815,0.3501006036217304,0.8653927410832915,1.0,69/297,18.97%,WWP1;FBXL7;NEDD4;FZR1;RNF144A;MKRN3;FBXO10;WWP2;RNF126;PSMB2;UBE4B;TRAF3IP2;RNF114;ANAPC5;UBR5;UBE2A;RNF115;NPEPPS;BARD1;FBXL20;PSMD11;ARIH1;CUL3;ANAPC10;PSMC1;CDC16;UBE4A;CUL1;ANAPC11;ANKIB1;FBXW8;FBXO27;HECTD2;UBE3C;PSMC6;DDA1;FBXO31;RNF146;TRAF2;BRCA1;UBE2K;TRIP12;RNF8;RNF41;PSMD1;UBE2B;NHLRC1;HERC6;UBE2D3;TRAF6;PSMD4;UBE2O;TRAF5;FBXO17;TMEM129;RNF20;AREL1;RNF14;PSMA6;UBE2S;DTL;RBCK1;SMURF1;PSMD14;SPOP;PSMD12;CHFR;RMND5A;PSMD7
prerank,positive regulation of cellular metabolic process (GO:0031325),0.3665020845415492,1.061892470121608,0.3734249713631157,0.8648546788737594,1.0,20/98,16.29%,THBS1;PID1;ANXA2;SFRP4;VEGFA;KLF4;ECE1;TGFBR2;INHBA;ZC3H12A;ACACA;CCNB1;XDH;NSF;STARD4;IFNLR1;RNF41;RAB1A;CDKN1A;SCRIB
prerank,presynaptic endocytosis (GO:0140238),0.45740145400066357,1.0618635059869546,0.4022503516174402,0.8642686865552168,1.0,8/24,17.62%,STON2;STON1;FCHO2;NLGN1;VAMP2;SYNJ2;CEL;SYNJ1
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.4205327070108497,1.0611126181968256,0.36675461741424803,0.8657248829165504,1.0,20/37,33.98%,ERCC5;CHD1L;PARP1;GTF2H3;RFC1;ERCC4;UBB;UBA52;POLK;GTF2H4;RPS27A;DDB1;ERCC2;DDB2;POLD1;XPA;GTF2H5;GTF2H1;RFC2;RPA1
prerank,regulation of alcohol biosynthetic process (GO:1902930),-0.43338503280083807,-1.0608809366650582,0.40816326530612246,0.7694803453040139,1.0,4/12,16.62%,CLCN2;KPNB1;H6PD;ABCA2
prerank,regulation of phosphate metabolic process (GO:0019220),0.4803223884384098,1.0605378950998017,0.4011713030746706,0.866663585695504,1.0,7/16,16.73%,SMG6;BARD1;IGBP1;RAD17;TIGAR;MCM7;IKBKB
prerank,cellular lipid catabolic process (GO:0044242),0.4402800188762054,1.0604423005635282,0.3917963224893918,0.8662541307482646,1.0,9/27,16.98%,CYP1B1;PLA2G15;ACBD5;LPIN2;ANGPTL3;ACOT8;ACOX1;ACADL;CEL
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.45842944858732315,-1.0604238698835464,0.39166666666666666,0.769070631655928,1.0,4/10,13.41%,DPP4;CST3;NOTCH1;CHADL
prerank,cellular protein metabolic process (GO:0044267),-0.24837423097272573,-1.0602111172576842,0.3333333333333333,0.767955052068808,1.0,84/396,12.58%,CP;IGF1;LTBP1;IGFBP2;IGFBP7;SPARCL1;CDH2;APOE;ST8SIA4;ST3GAL1;PAPPA;ST3GAL6;MSRA;APP;IGFBP3;CSF1;CST3;CTSH;EEF1A1;ITIH2;RPL37;IGFBP4;RPL27A;TNC;LGALS1;PLAT;QSOX1;RPL19;RPS13;EIF4EBP2;RPS9;RPS3;RPN2;RPS14;RPL18A;NOTUM;RPL38;LGMN;LAMB1;RPS19;RPS8;RPS11;RPL34;DAB2IP;VWA1;RPL18;RPL7;SERPIND1;ADORA2A;FAM20C;LTA4H;RPS25;RPL21;RPL23A;CHRM3;RPLP2;RPS21;RPL26;RPS4X;RPL41;GATA6;RPS29;RPL35A;RPL10A;SPP1;WFS1;RPL11;F5;SIAH2;RPS5;PDIA6;GAS6;RPS16;MFGE8;MRPL3;CHGB;RPL4;SERP1;RPS7;RPS23;APH1B;RPS15;LAMB2;LAMC1
prerank,regulation of neuroinflammatory response (GO:0150077),-0.391234333881144,-1.060034316692373,0.38170347003154576,0.766725209030885,1.0,6/19,16.74%,IGF1;IL18;CD200;SPHK1;NUPR1;CD200R1
prerank,regulation of ruffle assembly (GO:1900027),-0.36319398076183873,-1.059948096759109,0.3822525597269625,0.7652842214429013,1.0,4/23,6.29%,ARHGAP24;EPS8;EVL;EPS8L2
prerank,icosanoid metabolic process (GO:0006690),0.4169403097452755,1.0595407990784764,0.393173198482933,0.8680174804382847,1.0,10/40,19.06%,MGLL;CYP1B1;PTGIS;CYP2S1;DPEP1;ABCC1;ALOX5;DAGLB;MAPKAPK2;PON2
prerank,negative regulation of lymphocyte activation (GO:0051250),-0.3737010311755645,-1.059440319042898,0.3626373626373626,0.7650480522700147,1.0,15/21,39.94%,PAG1;PTPN22;SAMSN1;JAK3;BANK1;LST1;LAX1;IL4I1;DUSP3;LAPTM5;VTCN1;FOXJ1;TNFAIP3;FGL1;TNFAIP8L2
prerank,sphingosine biosynthetic process (GO:0046512),0.530042104388978,1.0594327933973373,0.41411042944785276,0.8669681861948638,1.0,1/11,0.70%,ACER3
prerank,sphingoid biosynthetic process (GO:0046520),0.530042104388978,1.0594327933973373,0.41411042944785276,0.8669681861948638,1.0,1/11,0.70%,ACER3
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.4595522935568316,1.05912885318475,0.4076517150395778,0.8671457456960375,1.0,9/25,26.10%,ZYG11B;RNF185;CUL3;VCP;CLPP;YME1L1;POMT2;OMA1;KLHL15
prerank,regulation of protein localization to nucleus (GO:1900180),0.4059744178867014,1.0590162611989007,0.40254777070063696,0.8667758111811676,1.0,4/43,7.29%,BMP4;GSK3B;CTNNA1;LIMK2
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.4344877229664077,-1.0589171455827417,0.39941690962099125,0.7648044486954727,1.0,3/13,19.16%,TMSB4X;HEY2;TAF1
prerank,reticulophagy (GO:0061709),0.5153023954825748,1.0587237153766125,0.41842900302114805,0.8669227802018307,1.0,4/12,12.46%,ULK2;TEX264;RB1CC1;UBA5
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.5242730718301902,1.058716759677104,0.42170542635658914,0.8662741628918291,1.0,7/11,28.77%,HIRA;ATRX;CABIN1;IPO4;ASF1A;HAT1;NASP
prerank,axon guidance (GO:0007411),0.35163410998127065,1.0585460583171384,0.375387797311272,0.8660601880658264,1.0,25/201,6.46%,SLIT3;SLIT2;NTN1;NFIB;SEMA3E;EZR;EFNA5;GAB2;UNC5C;SLIT1;NRP1;VEGFA;SMO;PDLIM7;NOTCH2;GRB10;SEMA3C;TMEFF1;EPHB3;KLF7;SPTAN1;LYPLA2;SHC1;SEMA3D;GLI2
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.3963586152137792,1.0582172876638751,0.40116959064327484,0.8663242677424895,1.0,18/60,19.08%,TCF7L2;MED13;MED24;CCND1;RUNX2;MED27;CCNB1;DHX36;MECP2;MED15;ATF7IP;MED31;SOX9;CDKN1A;MOV10;MED20;MED16;MED25
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.5060909694322573,1.057937358607282,0.4104134762633997,0.8663878085558466,1.0,1/11,3.01%,YBX3
prerank,focal adhesion assembly (GO:0048041),-0.37360431504622005,-1.057720474342958,0.3787375415282392,0.7664258499917188,1.0,3/21,2.26%,PEAK1;THSD1;ACTN2
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.5339953082986401,1.057345443577048,0.4144,0.8673032878192155,1.0,3/10,13.32%,LBP;IFI35;TIRAP
prerank,regulation of establishment of planar polarity (GO:0090175),0.3768915511100767,1.0567249121178381,0.38084632516703787,0.8683526407916282,1.0,25/88,18.97%,WNT11;PRICKLE1;FZD1;FZD7;PSMB2;AP2A2;DACT1;TIAM1;PSMD11;PSMC1;RHOA;PSMC6;PARD6A;PSMD1;DAAM1;DVL1;PSMD4;AP2B1;NPHP3;PSMA6;SMURF1;PSMD14;PSMD12;AP2A1;PSMD7
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.3653745204221114,1.0566709949590294,0.36745689655172414,0.8678193526236502,1.0,35/124,18.97%,TCF7L2;PPP3CA;WNT11;PDE6A;PRICKLE1;PLCB3;SFRP4;FZD1;FZD7;PSMB2;AP2A2;AGO2;TIAM1;PSMD11;NLK;SFRP5;PSMC1;RHOA;MAP3K7;PSMC6;NFATC1;PARD6A;PDE6B;PSMD1;DAAM1;DVL1;PSMD4;AP2B1;MOV10;PSMA6;SMURF1;PSMD14;PSMD12;AP2A1;PSMD7
prerank,positive regulation of cell development (GO:0010720),0.4258967740797715,1.056413471697948,0.4051948051948052,0.8678815447491625,1.0,1/31,0.35%,BMP4
prerank,muscle filament sliding (GO:0030049),-0.32391632537894205,-1.0559518467408757,0.33636363636363636,0.7678506329684773,1.0,15/38,31.16%,ACTN2;TPM2;DES;TMOD1;MYBPC1;TTN;VIM;MYL1;TPM1;MYL6;MYBPC2;TCAP;MYL3;ACTA1;MYH6
prerank,actin-myosin filament sliding (GO:0033275),-0.32391632537894205,-1.0559518467408757,0.33636363636363636,0.7678506329684773,1.0,15/38,31.16%,ACTN2;TPM2;DES;TMOD1;MYBPC1;TTN;VIM;MYL1;TPM1;MYL6;MYBPC2;TCAP;MYL3;ACTA1;MYH6
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.49958249930495635,1.0557667644482003,0.40853658536585363,0.8690234401949051,1.0,3/13,8.85%,PTGIS;NNMT;NUDT12
prerank,secondary palate development (GO:0062009),-0.4184955216262122,-1.055449044417033,0.3994082840236686,0.7676282634446646,1.0,4/14,3.01%,LEF1;CHD7;TGFBR3;WNT5A
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.44542526283401906,1.0551317595550482,0.39863013698630134,0.8699426681512408,1.0,5/24,5.77%,SEMA3E;NRP1;VEGFA;SEMA3C;SEMA3D
prerank,response to ethanol (GO:0045471),-0.41243658041412046,-1.0546340777016334,0.37119113573407203,0.7683057853191243,1.0,8/14,18.04%,GRIN2A;GRIN2B;ADCY7;GRIN1;GOT2;GLRA1;SDF4;SOD1
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.35303345330445574,1.0544895611623466,0.39148494288681207,0.8710409460881526,1.0,33/182,12.85%,FOXP1;BMP4;SLC24A3;FGF2;ITGB8;VEGFA;ESR1;BMPR1A;ID2;LDLR;WWP2;SMO;ZNF148;NOTCH2;KLF4;CCL3;EMILIN1;ATP2B4;AGO2;REL;AURKA;ZC3H12A;ATXN2;ANXA7;XDH;POU4F1;CREB3L1;TRAT1;MECP2;ATOH8;CD46;CELF1;CPNE1
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.40422520711075816,1.0540392709105277,0.39412484700122397,0.8716112639205278,1.0,22/52,26.47%,SAMD4A;CNOT8;TUT7;TUT4;EXOSC3;DCP1A;TNKS1BP1;EXOSC1;CNOT4;DIS3;EXOSC2;LSM4;EXOSC7;SAMD4B;CNOT1;CNOT11;EXOSC8;PAN3;DDX6;LSM1;PARN;PATL1
prerank,regulation of chemotaxis (GO:0050920),0.4316896464766303,1.0536568538488509,0.4131326949384405,0.8719757720140555,1.0,2/30,4.65%,THBS1;PTPN2
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.45286955392800426,1.052717952371495,0.40963855421686746,0.8738952484874207,1.0,1/23,0.09%,SLIT2
prerank,negative regulation of chemokine production (GO:0032682),-0.4176317281262346,-1.0526989942573763,0.38372093023255816,0.7718530077829545,1.0,4/14,15.92%,APOD;SIRPA;C1QTNF3;SIGIRR
prerank,macromolecule catabolic process (GO:0009057),0.4466031903662062,1.0524828356161375,0.4,0.8738296757146731,1.0,7/26,19.40%,NEDD4;KIF16B;BECN1;IDE;SH3GLB1;SMURF1;LRSAM1
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.41416426740499146,-1.0520576278406535,0.3875739644970414,0.7719607905153395,1.0,1/14,0.81%,MOXD1
prerank,synaptic vesicle exocytosis (GO:0016079),-0.3134401280709428,-1.0519670901288223,0.3466135458167331,0.7705953264956059,1.0,7/40,6.67%,UNC13C;RIMS1;RIMS2;SNAP25;SYT1;SYT7;SYT10
prerank,positive regulation of lipid transport (GO:0032370),-0.42468481996451063,-1.051604689927463,0.388268156424581,0.7699321258754609,1.0,4/12,14.65%,APOE;SPP1;DBI;ABCB4
prerank,intracellular protein transport (GO:0006886),0.3478680844280122,1.05099071211033,0.3691683569979716,0.8773241666979801,1.0,75/304,18.59%,PKD1;SGSM2;PRICKLE1;TLK1;GIPC1;STX11;KIF13A;HPS4;SEC16A;KATNB1;TMED5;TMED3;STAT3;RANGRF;LTBP2;HERC2;RAB43;RAB6A;NUP93;STRADA;BAG3;RAB24;ARFIP2;SEC31A;AP3B1;E2F3;NUP214;RANBP3;ARFGAP3;NUP153;XPO1;TNPO2;COPA;DESI1;C2CD5;SEC23IP;XPO4;TNPO3;NLGN1;CHP1;NSF;STX5;ARF4;IPO7;STX12;CTTN;NUP155;EHD1;NUTF2;TBC1D2B;SORL1;RAB21;EVI5;ARCN1;SCFD2;AP3D1;COPB2;NUP88;RABGAP1;XPO7;SNX8;RAB28;RAB1A;CSE1L;CAMSAP3;TBC1D8B;SNF8;RAB5B;STXBP1;SURF4;STX2;SMURF1;TBC1D5;TBC1D17;AP2A1
prerank,regulation of phospholipase C activity (GO:1900274),0.47576790102161975,1.0509126914562033,0.4212121212121212,0.8768644180719337,1.0,5/15,5.14%,NTRK3;FGF2;ESR1;ABL1;FGFR1
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.43674405162868507,1.0500795643742282,0.4102209944751381,0.8785277593590078,1.0,5/29,9.27%,SLIT2;PRKCD;LIMA1;SHANK1;KANK4
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.41306642071586586,1.0500352022753445,0.4037685060565276,0.8779815773666046,1.0,4/36,6.11%,EGFR;NPR3;ATP2B4;CYGB
prerank,telomere capping (GO:0016233),0.4704155450795674,1.0496202973744304,0.41228070175438597,0.8784769563157635,1.0,6/16,22.56%,TEN1;STN1;RAD50;PRKDC;NBN;DCLRE1A
prerank,protein localization to cell junction (GO:1902414),-0.3606946451498807,-1.0495924001668275,0.3781818181818182,0.773901055741932,1.0,4/22,6.32%,TJP1;CGNL1;HEG1;JAM3
prerank,negative regulation of blood pressure (GO:0045776),-0.4150148228546858,-1.0494022015419,0.4188034188034188,0.7728456263606113,1.0,2/13,7.84%,NOS3;PRCP
prerank,positive regulation of B cell activation (GO:0050871),-0.2994416156471365,-1.049101230944213,0.37349397590361444,0.7721283226886915,1.0,16/50,17.83%,BCL2;TFRC;SH3KBP1;MEF2C;VAV3;CD38;TNIP2;NFATC2;CD81;MIF;CD40;CD74;XBP1;NOD2;SHLD2;BTK
prerank,keratan sulfate catabolic process (GO:0042340),-0.4419365085100517,-1.0489599151686555,0.40359897172236503,0.7709063172101925,1.0,6/11,17.94%,FMOD;OGN;OMD;LUM;HEXB;GALNS
prerank,cellular response to growth factor stimulus (GO:0071363),0.3593187326478567,1.048868526692745,0.39490445859872614,0.8798401104837978,1.0,43/151,18.03%,BMP4;EGFR;NTRK3;TMEM100;SMAD9;NRP1;VEGFA;BMPR1A;KIDINS220;KLF4;LIMS1;TGFBR1;GAS1;EMD;HAS1;SHC1;ANXA1;BMP6;ERBB2;TGFBR2;CD44;KNSTRN;RUNX2;FOXC1;SYAP1;CIB1;RAB35;GAREM1;RAP1A;ITGB1BP1;NR4A1;EHD1;ACVR1;SOX9;NR3C1;URI1;SMAD4;CPNE3;RPS6KB1;IQGAP1;SMAD7;MTSS2;MAPKAPK2
prerank,neurotransmitter transport (GO:0006836),0.37311818733012164,1.0487663631901074,0.4004550625711035,0.8794331899546499,1.0,3/73,2.16%,SLC38A2;SLC38A1;UNC13B
prerank,regulation of RNA metabolic process (GO:0051252),0.3890847290415355,1.0486735792099722,0.41092636579572445,0.8790153781266515,1.0,14/59,17.54%,AHNAK2;MBNL1;AHNAK;CLK2;CLK1;SON;CLK4;CELF1;FUS;HNRNPH1;RRP1B;SNRNP70;MBNL2;PCBP4
prerank,stress fiber assembly (GO:0043149),0.47815019790282176,1.0480776043550752,0.42813455657492355,0.8793364344993412,1.0,5/15,10.42%,ITGB5;PHACTR1;ITGB1;CUL3;RHOA
prerank,contractile actin filament bundle assembly (GO:0030038),0.47815019790282176,1.0480776043550752,0.42813455657492355,0.8793364344993412,1.0,5/15,10.42%,ITGB5;PHACTR1;ITGB1;CUL3;RHOA
prerank,regulation of cellular component organization (GO:0051128),0.35781353073874483,1.0478901495558886,0.40216216216216216,0.8791815152373939,1.0,25/135,12.41%,PLCE1;NEDD4;SNCAIP;MLLT3;CAMK2D;STON2;DCUN1D5;ABL1;IRAK3;STON1;ALKBH4;RUFY1;AURKA;CDK11B;LTBP4;FAM107A;ARFGAP1;TMC8;SLITRK2;RAB4B;ANKRA2;RAP1A;HJURP;SGK3;TRAF2
prerank,regulation of lymphocyte differentiation (GO:0045619),0.47328018514797743,1.0478818721001981,0.4341317365269461,0.878531806760952,1.0,4/18,18.04%,CD2;ABL1;PRKDC;NCKAP1L
prerank,protein localization to cell periphery (GO:1990778),0.36065680119207627,1.047615463365104,0.41711229946524064,0.878576510659364,1.0,28/133,13.18%,KCNB2;LRP6;RAMP1;CDH1;ANK2;ATP1B1;EZR;FGF13;SLMAP;KCNB1;SEC16A;TTC7A;ZDHHC2;FCHO2;TSPAN17;RDX;EHD2;S100A10;GAK;C2CD5;ARL3;PLEKHF1;RAP1A;JUP;PIP5K1A;ITGB1BP1;EHD1;DLG1
prerank,mismatch repair (GO:0006298),0.43182110828444104,1.0473444159330205,0.40405405405405403,0.8786578161607224,1.0,7/27,20.49%,EXO1;ABL1;SETD2;MLH3;RNASEH2A;MCM9;MSH4
prerank,neuron fate commitment (GO:0048663),0.47903227858443787,1.047238169442766,0.43317972350230416,0.8783015888252886,1.0,4/14,16.03%,ID2;TGFBR1;POU4F1;PAX6
prerank,triglyceride metabolic process (GO:0006641),-0.30269840721594266,-1.0470897930725942,0.34554973821989526,0.7743907826940579,1.0,8/48,12.51%,APOE;LPGAT1;GK;PLAAT3;LPIN3;GPAM;DGAT1;FABP5
prerank,actin filament network formation (GO:0051639),0.5100548294374514,1.0469519728563423,0.428125,0.8784401885967839,1.0,2/11,6.00%,COBL;PLS1
prerank,mitotic nuclear division (GO:0140014),0.38441928217860966,1.046936909645373,0.4232558139534884,0.8778117935414339,1.0,21/71,20.70%,SMC4;NDEL1;CHEK2;SPICE1;STAG1;MISP;KNSTRN;TOGARAM1;KLHL22;RHOA;PPP2R2D;KIF3B;ZW10;OFD1;ABRAXAS2;SMC1A;UBE2S;STAG2;RAB11A;CCDC61;PIBF1
prerank,cell cycle checkpoint signaling (GO:0000075),0.5034288524510961,1.0468725128698941,0.43037974683544306,0.8773161120414342,1.0,6/12,22.78%,NABP1;ZW10;ZWILCH;CHFR;WEE1;PRCC
prerank,cellular component assembly (GO:0022607),0.34270593698797813,1.0467812830507106,0.39263803680981596,0.8768995689962311,1.0,43/253,12.60%,DPYSL3;RHOJ;HES1;BAIAP2L1;REPS2;GSN;EZR;CHAF1B;PTK2B;PKP1;GRHL2;PAWR;FZD1;GORASP2;LIMS1;SLC7A9;HAS1;PARVA;CALD1;PLS1;LIMA1;MNAT1;CREBBP;SHANK1;IKBKG;RHOQ;FAM107A;DMTN;BSN;CHAF1A;PCLO;TOGARAM1;EPRS1;TLCD1;RHOA;DET1;NLGN1;TEAD1;ZW10;RTN3;TRAF2;PARD3;MDM4
prerank,protein modification process (GO:0036211),0.3733429580843169,1.046731081772248,0.3923766816143498,0.876375666349823,1.0,23/76,19.97%,PLOD2;WWP2;ABL1;PHKA2;USP25;ST8SIA2;PHEX;TGM5;PARP1;ATG3;LOX;CSNK1G3;UBE2M;MAN2B1;UBE2D3;PRKDC;GGCX;PPP4R2;UBL5;UBE2S;UBA3;PARP4;YES1
prerank,regulation of organelle assembly (GO:1902115),0.37739611408287416,1.0467039200768395,0.3945818610129564,0.8757948012867106,1.0,22/73,21.07%,GSN;EZR;NPRL3;RABEP2;SPICE1;KIF9;RDX;SDCCAG8;ATXN2;ATG3;ATG5;PDCD6IP;TBC1D2B;EVI5;RABGAP1;CENPJ;TBC1D5;TBC1D17;ODAD3;CDKL1;TBC1D15;NPRL2
prerank,negative regulation of type I interferon production (GO:0032480),0.4071870807794088,1.046426842132401,0.41624365482233505,0.8759225149964283,1.0,15/40,24.42%,TAX1BP1;REL;IKBKE;MAVS;IFIH1;GPATCH3;PTPRS;PIN1;OTUD5;NLRX1;RELB;YY1;IRF3;LILRB1;NLRC3
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.4518977581575764,-1.0463877301691369,0.3900523560209424,0.7746347517014381,1.0,3/10,16.44%,PRKAA2;KLF15;MYOCD
prerank,cyclic purine nucleotide metabolic process (GO:0052652),-0.3765620725138248,-1.0463405661668723,0.4280442804428044,0.773153701982478,1.0,6/21,7.58%,ADCY5;ADCY1;GUCY1B1;NPR1;ADCY7;GUCY1A1
prerank,negative regulation of cell communication (GO:0010648),0.45271494324707673,1.0462708031438177,0.42158273381294964,0.8756387853782118,1.0,5/21,16.08%,UBASH3B;SRMS;NLRP12;ACVR1;HHIP
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.43087396300172,1.046263353043081,0.4213406292749658,0.8750014064499323,1.0,14/29,27.97%,TANK;IKBKG;IKBKE;TLR4;UBE2D3;IKBKB;TICAM1;CHUK;TRAF3;IRF3;UBB;UBA52;RPS27A;LY96
prerank,regulation of mRNA stability (GO:0043488),0.3601819395296393,1.0462521350313059,0.38835978835978835,0.8743733205662728,1.0,46/145,22.06%,PRKCD;SAMD4A;PSMB2;FASTKD1;ZC3H14;APEX1;NUP214;PSMD11;THRAP3;XPO1;PSMC1;PABPC1;DHX36;PSMC6;EXOSC3;CELF1;FUS;E2F1;DCP1A;PRKCA;PSMD1;CIRBP;PSMD4;MEX3D;EXOSC1;GDNF;FTO;PCID2;PCBP4;PSMA6;MAPKAPK2;PSMD14;PSMD12;DIS3;PUM2;SERBP1;IGF2BP3;PSMD7;EIF4G1;FASTKD3;EXOSC2;EXOSC7;PSME3;SAMD4B;PUM1;FMR1
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.4098702622193824,1.0458689909350758,0.41688654353562005,0.8747318633403409,1.0,7/38,8.14%,TANK;ESR1;PER1;NLRP12;RORA;TRIM39;ZC3H12A
prerank,tRNA aminoacylation (GO:0043039),0.4110218582673322,1.045223183516282,0.3926302414231258,0.8757646520723594,1.0,17/37,29.09%,WARS2;EPRS1;QARS1;YARS1;VARS1;FARSA;RARS2;LARS1;AIMP2;YARS2;GATC;CARS1;EEF1E1;NARS1;FARS2;PPA2;GARS1
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),-0.31889342383706787,-1.0435740265040423,0.36444444444444446,0.7792372345113442,1.0,10/34,18.85%,RBP4;WNT5A;SLC7A5;LACC1;DNAJB9;PTPN22;XBP1;NOD2;CD86;STX4
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.3787222351279232,1.04350569655271,0.4052443384982122,0.8798308975268431,1.0,13/66,16.91%,CDH1;PRKCD;ZIC1;UBR5;BAG3;LIMK2;ZC3H12A;MAVS;JUP;DMAP1;NMD3;CCT5;YAP1
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.42031601741855107,-1.0434399865736763,0.40058479532163743,0.7780009515732996,1.0,3/13,8.59%,DDO;ASPA;GOT2
prerank,dicarboxylic acid metabolic process (GO:0043648),0.3888884925497675,1.0433506952906093,0.4165651644336175,0.879614249849928,1.0,11/52,22.34%,ME1;GCLC;FOLR2;SLC25A32;ACOT8;SLC46A1;SLC19A1;DGLUCY;MTHFS;OGDH;NIT2
prerank,protein complex oligomerization (GO:0051259),0.37506873840110927,1.0430993685817238,0.4121004566210046,0.8796673848221293,1.0,20/85,17.48%,LRRC8D;ATL3;TMEM120A;MPP2;ATL2;G3BP2;PRMT8;ZC3H12A;CUTC;SLC9A1;MCU;ZBTB1;FUS;EHD1;PDCD6IP;RBMX;ATL1;YME1L1;ADCY8;HOMER1
prerank,protein heterotetramerization (GO:0051290),0.49445190932694505,1.0430732697592195,0.4195046439628483,0.8790846340090359,1.0,1/13,1.00%,PKD1
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.39668933909342535,-1.042858789790965,0.4069767441860465,0.7780161889778154,1.0,4/16,4.29%,IGF1;IGFBP2;IGFBP3;IGFBP4
prerank,regulation of myoblast differentiation (GO:0045661),0.41905549229906625,1.0425843343692491,0.42575558475689884,0.8798133597957456,1.0,2/32,0.35%,BOC;BMP4
prerank,positive regulation of glial cell differentiation (GO:0045687),0.4708350777484621,1.042475172687321,0.42727272727272725,0.8794542862473822,1.0,3/17,3.53%,HES1;ID2;CLCF1
prerank,determination of left/right symmetry (GO:0007368),0.4199368913928658,1.0421828982164887,0.4106910039113429,0.8796345590574528,1.0,11/37,18.88%,PITX2;SMO;DNAAF4;GALNT11;KIF3B;OFD1;MEGF8;NPHP3;ODAD2;MKKS;ODAD3
prerank,neural tube development (GO:0021915),0.4788773871430274,1.042026088117309,0.4253731343283582,0.8794017335955995,1.0,3/15,5.88%,PKD1;GRHL2;DACT1
prerank,protein polyglutamylation (GO:0018095),-0.4419726036621956,-1.0417308746388307,0.434010152284264,0.7793278595216117,1.0,6/11,22.17%,TTLL7;TTLL11;TPGS1;TTLL5;TTLL6;TTLL1
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.4476564576091386,1.04134240703035,0.4247538677918425,0.8805758843648133,1.0,5/22,16.55%,WNK1;KLF4;CD44;FLOT1;LCK
prerank,positive regulation of cyclase activity (GO:0031281),0.4921681472202879,1.0409624557705082,0.42835820895522386,0.8810087027305613,1.0,2/14,5.44%,CACNA1C;NF1
prerank,nucleocytoplasmic transport (GO:0006913),-0.30960139936571507,-1.0406003153829377,0.3981042654028436,0.7808302161504058,1.0,11/40,19.98%,ATXN1;ANP32A;BACH2;NPM1;GEMIN2;SNRPD3;DDX20;NXT2;SNRPG;RSRC1;LSG1
prerank,regulation of leukocyte migration (GO:0002685),0.471866019134964,1.040577845172302,0.4118476727785614,0.8814341235018074,1.0,5/16,18.04%,VEGFA;ANXA1;MIA3;HOXA7;NCKAP1L
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.46345181207113895,1.0402947365191673,0.43952802359882004,0.8815305308583704,1.0,5/18,11.45%,GSK3B;MDFIC;CTNNA1;POLR1A;CHP1
prerank,positive regulation of intracellular transport (GO:0032388),0.40713066788587904,1.040078756986859,0.43636363636363634,0.8814387536051459,1.0,11/38,17.08%,NEDD4;BCAS3;PCM1;TENM1;EHD2;PCNT;EHD1;SORL1;VAMP2;PLK3;OAZ2
prerank,brain development (GO:0007420),0.3585095137180709,1.03920694808853,0.4118268215417107,0.8831490192888919,1.0,15/136,7.67%,SLC23A1;PBX3;ZFHX3;NFIB;ADGRL2;PBX1;DMBX1;GRHL2;ZIC1;SHROOM4;NIPBL;NF1;TGFBR2;PAFAH1B1;PAFAH1B2
prerank,regulation of mitochondrial depolarization (GO:0051900),-0.45063907639530437,-1.0390108741298725,0.422680412371134,0.7834783477044032,1.0,3/10,3.37%,BCL2;DCN;KDR
prerank,membrane fusion (GO:0061025),-0.3161073172095019,-1.0389146376565435,0.35964912280701755,0.7821453841556268,1.0,7/33,12.18%,DNM3;RIMS1;DYSF;DNM1;MYOF;VAPA;HACE1
prerank,male gonad development (GO:0008584),-0.3297148979075296,-1.0389094553871543,0.3651452282157676,0.7805546822435679,1.0,5/34,9.05%,WNT4;KIT;WNT5A;MAMLD1;GATA6
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.4080408123503827,1.0388464100463088,0.4169934640522876,0.8834331955506095,1.0,8/36,10.51%,TCF7L2;PPP3CA;WNT11;PDE6A;PLCB3;AGO2;NLK;MAP3K7
prerank,sensory perception of taste (GO:0050909),0.5153895111659469,1.0387662435887761,0.4345718901453958,0.8829903804669401,1.0,1/10,2.93%,TAS1R3
prerank,RNA transport (GO:0050658),0.38552605496290665,1.0384434525865156,0.42758620689655175,0.8832077746938475,1.0,24/71,23.27%,SIDT2;SRSF11;U2AF2;THOC2;SRSF5;TGFBR2;SRSF6;NUP214;NUP153;ATXN2;CDC40;SRSF2;NUP155;SRSF1;RNPS1;FLOT1;CHTOP;HNRNPA2B1;SARNP;FMR1;DHX38;SRSF3;SRRM1;ZC3H11A
prerank,regulation of ERAD pathway (GO:1904292),0.5023171588033021,1.0384307570681934,0.4383561643835616,0.8825739606925523,1.0,6/11,22.38%,USP25;USP13;RNF185;HERPUD1;USP19;TMEM259
prerank,positive regulation of TORC1 signaling (GO:1904263),0.47472210036305934,1.0384300083697762,0.4241486068111455,0.8819231855562664,1.0,4/16,9.89%,TELO2;CLEC16A;RRAGB;KLHL22
prerank,peptidyl-lysine trimethylation (GO:0018023),0.4347452674148348,1.0382595747156593,0.4344262295081967,0.8817391777021305,1.0,11/26,28.79%,SETD2;WDR82;ETFBKMT;EEF2KMT;KMT5B;KMT2D;KMT5C;OGT;SETD5;CTR9;TET3
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.3590960869159899,1.0379855628139039,0.42410714285714285,0.8818250361073577,1.0,26/112,14.79%,ADAM9;SMAD6;COL3A1;SMAD9;TGFB3;ITGB5;BMPR1A;ID1;GDF10;LIMS1;TGFBR1;USP15;LTBP2;SKI;TGFBR2;ITGB1;SMAD2;NLK;RHOA;MAP3K7;COL1A2;PARD3;ACVR1;PARD6A;SOX9;NR3C1
prerank,embryonic heart tube morphogenesis (GO:0003143),0.39844110431788554,1.0378097133831707,0.40965346534653463,0.8816703959919854,1.0,5/44,8.39%,MICAL2;HES1;SMO;TGFBR2;GATA4
prerank,actin filament polymerization (GO:0030041),0.4349269757377788,1.0377084689568006,0.4428969359331476,0.881294381091226,1.0,6/29,11.18%,COBL;GSN;PSTPIP1;DIAPH1;FAM107A;WASHC5
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.3566290251935824,1.0371673278767806,0.412472647702407,0.8820989419338887,1.0,24/118,14.18%,BMPER;FMNL2;NEDD4;PID1;SIPA1L1;EFNA5;FGF2;GSK3B;PHLDB2;EPHB3;ARHGAP44;NF1;PROK2;ERBB2;ZMYM4;LZTS1;PDZD8;PHLDB1;NSMF;MARK2;ZDHHC15;SRCIN1;HTATIP2;ZRANB1
prerank,cellular calcium ion homeostasis (GO:0006874),0.3511314779545165,1.0370684486688435,0.410010649627263,0.8817038595996978,1.0,20/133,13.14%,SLC35G1;SLC24A3;CSRP3;ATP2C2;CAMK2D;ANK2;ATP1B1;CASR;CCL3;CCL1;ATP2B4;SLC10A7;PDZD8;CCL7;MCU;HERPUD1;DRD3;SLC8B1;CTRC;NPTN
prerank,glycolipid metabolic process (GO:0006664),0.39014419518696564,1.0370263062293825,0.41198501872659177,0.8811713492425218,1.0,3/47,3.41%,ST3GAL4;ESYT3;HEXA
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.48945857981048174,1.0369441977815268,0.43929712460063897,0.8807219234853635,1.0,5/13,21.00%,HES1;PIGU;MGAT5;JAK2;EGF
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.36095769220621005,1.036911445896741,0.41814159292035397,0.8801657287866294,1.0,25/104,18.20%,LRP6;CCNA2;ADRB2;TELO2;CDK12;ABL1;MNAT1;CCND1;CDKN2C;SYAP1;CIB1;CCNB1;RHOA;DUSP19;CAB39;CDKN1B;CDKN3;LRP5;CCNG1;CDK7;CCNT2;CDKN1A;SNF8;RB1;RALB
prerank,inner ear morphogenesis (GO:0042472),0.45203075133570647,1.0368965240170749,0.44935805991440797,0.8795585272290948,1.0,5/22,14.64%,SIX1;ZIC1;POU3F4;EPHB2;SOX9
prerank,regulation of catabolic process (GO:0009894),0.4677950874236154,1.0368065336412375,0.4264705882352941,0.8791512269016385,1.0,6/18,16.99%,CHEK2;ZDHHC2;ITGB1;ODC1;SNF8;FAP
prerank,negative regulation of blood coagulation (GO:0030195),0.40590490329412876,1.0365744111623776,0.4346153846153846,0.879122290111207,1.0,2/38,2.68%,F3;THBD
prerank,calcium import into the mitochondrion (GO:0036444),0.507682633801591,1.0365346063902663,0.4411302982731554,0.878579243435688,1.0,4/10,25.76%,MCU;MICU2;MCUB;MICU3
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.37587317771590567,1.0364712259623954,0.4044811320754717,0.8780967858431314,1.0,11/69,6.56%,PLCE1;PLCZ1;EZR;PIK3C2B;GAB2;NGF;PLCB3;IRS1;FGFR1;NF1;ERBB2
prerank,platelet degranulation (GO:0002576),0.3566528942488829,1.0363631390844668,0.4118942731277533,0.8777426472580819,1.0,15/118,9.60%,THBS1;PCDH7;LHFPL2;CD9;FAM3C;VEGFA;TGFB3;CD109;SYTL4;TIMP1;FN1;VCL;PHACTR2;TEX264;MAGED2
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.42329828201648584,1.0361698330475655,0.4314789687924016,0.8776396419433355,1.0,14/30,27.97%,TANK;IKBKG;IKBKE;TLR4;UBE2D3;IKBKB;TICAM1;CHUK;TRAF3;IRF3;UBB;UBA52;RPS27A;LY96
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.3367754234144932,-1.0359018850251671,0.38996138996138996,0.7872453759662115,1.0,9/28,11.81%,MAP2;CLASP2;STMN1;STMN4;MAPT;CAMSAP2;STMN3;FKBP4;MAP1A
prerank,negative regulation of MAPK cascade (GO:0043409),0.36602805176565484,1.035511766450035,0.41509433962264153,0.8788029391983091,1.0,21/87,16.61%,BMP4;PRKCD;EZR;CBLC;IRAK3;PTPN2;SPRED2;NF1;EMILIN1;ABCA7;TLR4;QARS1;IGBP1;EPHB2;SYNJ2BP;ITGB1BP1;DLG1;SORL1;TNIP1;SMAD4;PIN1
prerank,blood vessel diameter maintenance (GO:0097746),0.416931151134708,1.035079834184356,0.42894736842105263,0.8792564800443233,1.0,4/34,6.15%,KCNMB2;EDNRA;GCLC;ECE1
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.4245499292899062,1.0350426493077465,0.45539280958721706,0.8787296896449013,1.0,5/33,12.46%,DDX5;ESR1;DNAAF4;KDM1A;UBA5
prerank,regulation of monooxygenase activity (GO:0032768),0.44466313366633886,1.0348027080928792,0.4250720461095101,0.8787512061286253,1.0,2/23,6.11%,EGFR;CYGB
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.4345428911028136,1.0347186413689342,0.4231843575418994,0.8783694979052351,1.0,3/26,7.27%,ACER3;CYP1B1;NQO1
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.514786419855749,1.0345029478801568,0.45634266886326197,0.8782804298595106,1.0,2/10,4.17%,WNK1;ADA
prerank,regulation of interferon-beta production (GO:0032648),0.3986247396510334,1.0344657515973779,0.41299019607843135,0.8777419515212145,1.0,22/46,26.88%,REL;IRF1;TLR4;MAVS;IFIH1;RIPK2;TLR8;POLR3F;POLR3A;PTPRS;TIRAP;FLOT1;POLR3D;DHX9;RELB;TRAF3;YY1;IRF3;LILRB1;NLRC3;IRF5;PPM1B
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.4037661167098147,1.034322045189306,0.4227330779054917,0.8774871218611332,1.0,13/40,25.65%,PRKCD;ABL1;FEM1B;USP1;NSMCE1;MCL1;FBXO5;KMT5A;NEK4;FMR1;WDR76;SMYD2;UBE2V1
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.5376910875212215,1.0340881750674897,0.45818815331010454,0.8775036055680949,1.0,3/10,9.01%,PRKCD;CD9;RDX
prerank,cell-matrix adhesion (GO:0007160),0.3641433564841193,1.0338627813770422,0.4169453734671126,0.8774725018648846,1.0,22/95,13.73%,ITGBL1;PKD1;ADAM9;COL3A1;ITGB8;ITGB5;MSLN;EMILIN1;LYVE1;BCR;TIAM1;CD44;FN1;VCL;ITGB1;COL17A1;ITGAV;ANGPTL3;PIP5K1A;CTTN;ITGB1BP1;ITGB3
prerank,regulation of Rho protein signal transduction (GO:0035023),0.3786720924114257,1.0337316987505265,0.43684820393974505,0.8771877120800515,1.0,13/72,9.02%,ARHGEF28;MET;COL3A1;AKAP13;NRP1;ARHGDIB;ABL1;MYOC;BCR;GPR65;STARD13;GPR4;CUL3
prerank,cellular polysaccharide catabolic process (GO:0044247),0.4678568776575435,1.0336098351325211,0.44680851063829785,0.8768872605990524,1.0,4/16,15.09%,PYGB;PHKA2;PHKB;PGM2
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.4884182814465652,1.0335433155955216,0.4350453172205438,0.8764266111007197,1.0,4/13,13.58%,TMEM30B;SEC16A;TM9SF4;SORL1
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.4697818079022684,1.0330181560181126,0.42313323572474376,0.8771748872223468,1.0,5/15,18.33%,STAT3;IL17RA;TLR4;MYD88;TICAM1
prerank,response to exogenous dsRNA (GO:0043330),0.46709871613840187,1.0329902761746437,0.4312590448625181,0.87661043583597,1.0,9/18,19.69%,IRAK3;MAVS;IFIH1;CGAS;FLOT1;RALB;TICAM1;DHX9;COLEC12
prerank,actin filament organization (GO:0007015),0.3506341627653381,1.032850616863384,0.4164004259850905,0.8763316715974562,1.0,25/151,13.51%,DPYSL3;VILL;BAIAP2L1;COBL;RHOBTB1;ABI1;GSN;NLRP5;GAS2;SHROOM4;SHROOM3;FAT1;PLS1;ARHGAP17;FLII;DMTN;CORO1C;RND3;RHOA;SAMD14;GAS2L1;MCU;DLG1;INPPL1;DBN1
prerank,negative regulation of protein ubiquitination (GO:0031397),0.3918048851681599,1.0326001437388053,0.4299634591961023,0.8763707366716685,1.0,14/50,23.76%,NXN;U2AF2;ABL1;HDAC8;CHP1;FBXO5;SPOPL;USP4;SMAD7;BAG5;BAG2;GTPBP4;OGT;GNL3L
prerank,stem cell differentiation (GO:0048863),0.4005741969699146,1.0322023899934385,0.4320827943078913,0.8767618628740276,1.0,5/39,7.87%,LRP6;MLLT3;SETD2;HOXB4;PSMD11
prerank,signal transduction by p53 class mediator (GO:0072331),0.4180376491073471,1.0321352006361708,0.4278145695364238,0.8762945756244999,1.0,7/30,14.60%,DDX5;FHIT;NDRG1;POU4F1;MDM4;RRP8;ATRX
prerank,synaptic vesicle localization (GO:0097479),0.49391509062732175,1.0319733794343973,0.4390625,0.8761091049574876,1.0,5/13,17.62%,TMEM230;NLGN1;SPG11;KIF5B;SYNJ1
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.4954395222295684,1.0319140807073743,0.452914798206278,0.8756407843174666,1.0,4/13,6.60%,SEMA3E;NRP1;VEGFA;TGFBR2
prerank,positive regulation of protein phosphorylation (GO:0001934),0.33585420356948625,1.0318214096414824,0.43172690763052207,0.8752681683899257,1.0,54/348,12.73%,RASSF2;BMP4;CARD14;EGFR;SLCO3A1;PGF;NTRK3;DDR2;CCN1;BMP5;PTK2B;EFNA5;FGF2;NIBAN1;KRAS;NGF;NRP1;VEGFA;TGFB3;BMPR1A;GDF10;PLCG2;TGFBR1;ABL1;PDGFC;DOCK7;ATP2B4;BMP6;FAM20A;ERBB2;CD44;INHBA;TENM1;LIMK2;CCND1;AKAP9;CD80;MAVS;CIB1;TMEM119;PIK3R3;RIPK2;TTK;DUSP19;TAB2;TOM1L1;RAP1A;CAB39;RAD50;RB1CC1;BCAR3;RAF1;BRAT1;UBE2K
prerank,negative regulation of multicellular organismal process (GO:0051241),0.34427086975862287,1.0315336170618994,0.43653250773993807,0.875422364074415,1.0,29/199,9.72%,BMP4;EGFR;NFIB;SMAD6;BMP5;WNT11;HDAC9;GRHL2;ARHGDIB;ZNF423;NPR3;ID1;GSK3B;FOXC2;TIMP1;KLF7;SPRED2;DOCK7;ATP2B4;IP6K1;NLRP12;RAB11FIP3;SRSF6;IL17RD;TLR4;CORO1C;PARP3;ABHD6;ACOT11
prerank,organelle organization (GO:0006996),0.3387582942968315,1.0313797864739462,0.4117053481331988,0.8751974896090755,1.0,85/388,18.41%,MICAL2;PLCE1;ABCD3;MARK1;FMNL2;VPS13C;ATL3;STRIP2;ARHGAP21;ARHGAP10;GORASP2;BCAS3;CCL3;ATL2;SEC16A;RAB30;TMED5;GBF1;TMED3;FAM161A;RAB43;DIAPH1;LMAN2L;NRF1;SPRYD3;GOLGB1;SEC31A;SEC61A1;ZMYM4;ABCD1;DMTN;CSNK1A1;PLEKHM2;KIF9;PCLO;PNPLA3;GABPB1;MAST2;WDR81;PPRC1;LONP2;MIA3;GAK;VPS13D;PDZD8;CCL7;TSGA10IP;FBXW8;PLEKHF1;SEC23IP;PARP1;CENPT;DOP1B;DPYSL2;FGD1;ZW10;SPTSSB;FGD3;TRAPPC11;PDCD6IP;SIRT3;ZRANB1;ROPN1;MTFR1;TOR1B;FGD6;ATL1;BNIP1;YME1L1;CHMP2B;GOLPH3;ARFGEF1;RAB1A;MIEF2;HCFC1;POLG2;LARP4;SURF4;LRRK2;BAG5;COG3;CXADR;SH3D19;UBXN2B;ATP8B4
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.5238380446456744,1.030980692282667,0.4470774091627172,0.8756229598558647,1.0,4/10,18.33%,TLR4;MIA3;MYD88;TICAM1
prerank,histone H4-K8 acetylation (GO:0043982),0.4738526785996,1.030868843624185,0.4352409638554217,0.8746729805255476,1.0,9/15,27.20%,KANSL3;KANSL2;JADE2;HCFC1;PHF20;KANSL1;OGT;MCRS1;KAT8
prerank,histone H4-K5 acetylation (GO:0043981),0.4738526785996,1.030868843624185,0.4352409638554217,0.8746729805255476,1.0,9/15,27.20%,KANSL3;KANSL2;JADE2;HCFC1;PHF20;KANSL1;OGT;MCRS1;KAT8
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.44687774157559046,1.0305076475792467,0.43626062322946174,0.8749780101267254,1.0,3/22,4.65%,EZR;UBASH3A;PTPN2
prerank,organic hydroxy compound transport (GO:0015850),-0.3170721570241499,-1.0301741775766358,0.3972602739726027,0.8013603720912568,1.0,5/36,4.35%,SLCO2B1;SLCO1C1;NCOA1;RBP4;SLC5A3
prerank,regulation of synapse organization (GO:0050807),-0.3349737366016103,-1.02996015062591,0.3786764705882353,0.80032734191091,1.0,6/26,5.75%,IL1RAPL1;CTNNA2;WNT5A;ARHGAP22;EPHA4;MEF2C
prerank,cGMP metabolic process (GO:0046068),0.4948827835458729,1.0296971717199197,0.4493865030674847,0.8764821990737135,1.0,1/12,0.83%,GUCY2C
prerank,respiratory electron transport chain (GO:0022904),-0.3969722143957566,-1.02960375342859,0.4126984126984127,0.7997548704220881,1.0,4/14,13.53%,GPD2;SLC25A13;PPARGC1A;SDHA
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.4459425005108563,1.0292049227235416,0.46142649199417757,0.8770898682091316,1.0,10/21,26.17%,SMO;TEDC2;EVC;ULK3;KIF7;DLG5;TXNDC15;TUBD1;ARMC9;TTC23
prerank,establishment of mitotic spindle orientation (GO:0000132),0.4378753553128826,1.0289814204413106,0.4401650618982118,0.8770573659877368,1.0,8/23,18.39%,NDEL1;MISP;PAFAH1B1;ITGB1;MAD2L1;ZW10;SPDL1;UBXN2B
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),-0.35157682778853117,-1.0277829347340215,0.3906810035842294,0.8031503755029353,1.0,11/23,27.02%,ERRFI1;CBLB;SNX6;ZFYVE28;SOCS5;HYAL2;THY1;CAV1;GPRC5A;CHMP6;ZGPAT
prerank,respiratory chain complex IV assembly (GO:0008535),0.4436383218294071,1.0276322322972735,0.4417952314165498,0.8799339196293392,1.0,5/21,19.71%,COX16;COX15;SCO2;COA8;FASTKD3
prerank,sterol homeostasis (GO:0055092),0.3698659797507832,1.0276220710194237,0.4138755980861244,0.8793301361690489,1.0,13/65,13.31%,SOAT1;HDAC9;LDLR;TSKU;LIMA1;RORA;ABCD1;NPC1;ANGPTL3;SOAT2;NR1D1;EHD1;LRP5
prerank,regulation of adaptive immune response (GO:0002819),-0.37459608021478336,-1.0271265427354765,0.42524916943521596,0.8034160485182772,1.0,8/18,29.72%,AHR;ADCY7;SAMSN1;PYCARD;IRF7;FADD;IL4I1;SASH3
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.34055899589545713,-1.0267375048310272,0.3951048951048951,0.8028705181113466,1.0,6/26,9.20%,SLC30A10;PPARA;SLC5A3;GRIN1;SLC25A33;ABCB7
prerank,glucose homeostasis (GO:0042593),0.3652611992062363,1.0264201527985046,0.43101482326111745,0.8819226261775571,1.0,20/83,16.92%,TCF7L2;LRRC8D;KCNB1;IRS1;PTPN2;KLF7;STAT3;ACSM2A;BACE2;CRY2;MLXIPL;CRTC2;HECTD4;MCU;SLC8B1;NR1D1;ALOX5;PAX6;FOXK1;ADCY8
prerank,positive regulation of sodium ion transport (GO:0010765),-0.43260400785736386,-1.0264040759967243,0.42265193370165743,0.8022184653777993,1.0,8/12,31.14%,ANK3;CNKSR3;AHCYL1;WNK3;SCN5A;GPD1L;PKP2;SCN4B
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.33189555405704274,1.0263329863225092,0.4172517552657974,0.8815137682536149,1.0,122/476,21.01%,SIX1;BMP4;EGFR;ZFHX3;LRP6;NFIB;MAP3K5;HES1;HDAC4;CDH1;MLLT3;WNT11;FGF2;EHF;TGFB3;ZNF423;ESR1;ID2;FZD1;FZD7;FOXC2;ZIC1;RARA;ELF1;KLF4;GLI3;TGFBR1;MDFIC;MED13;STAT3;SHC1;FOXO3;CHEK2;ZBTB16;NFIL3;GLI2;GLIS2;INHBA;WAC;CREBBP;RORA;SERTAD3;MED24;IRF1;SMAD2;MLXIPL;EGR1;GATA4;THRAP3;RUNX2;RXRA;CD80;FOXC1;ILF2;TADA3;SIX4;GPATCH3;SMARCC1;TASP1;NSD1;TBL1X;TGFB1I1;ATOH8;TRIM44;TEAD1;NAA15;TP53INP2;CDKN1C;RXRB;NIBAN2;NCOA6;BRCA1;NR1D1;RET;E2F1;LRP5;NFYA;NFATC1;ACVR1;HINFP;SP3;PIM2;ATF7IP;PITHD1;SOX9;KAT6B;RNF111;HIVEP3;PAX6;SMAD4;FOXK1;IKBKB;YAP1;CHD8;ESR2;HCFC1;NEK4;RNF20;PCID2;RNF14;BRCA2;RGMB;KMT2E;PRDM11;MED16;PPARG;BRD4;USP21;USP16;HDAC2;EPC1;CHUK;CREBL2;NR1D2;FOXK2;ZBTB48;NKX2-1;ZXDC;MAP2K2;PML;EGF;CREB1
prerank,C21-steroid hormone metabolic process (GO:0008207),0.4451987746383927,1.0260919378165327,0.4512372634643377,0.8815385532447036,1.0,6/20,28.88%,FDX1;TSPO;STAR;STARD3NL;FDX2;FDXR
prerank,neural crest cell differentiation (GO:0014033),0.46079830343081013,1.0256513823896616,0.43722304283604135,0.882064949584333,1.0,1/18,0.72%,LRP6
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.3789850415353034,-1.0255331411791042,0.41935483870967744,0.8030387629730791,1.0,5/17,17.99%,SLC7A5;PRKCZ;PRKCQ;CEBPB;CD86
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.4772307990988422,1.0254357345115832,0.4433139534883721,0.881991056839656,1.0,5/14,22.84%,ATRX;BRCA2;ATR;XRCC5;TNKS2
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.39721365137837095,-1.0253772415312323,0.39156626506024095,0.8018416575507581,1.0,2/15,2.62%,OSBPL8;PPARA
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.41187062694122356,1.0252917717074135,0.45931758530183725,0.8817545916002371,1.0,11/37,16.49%,EFNA5;GSK3B;PHLDB2;FAM107A;PHLDB1;SKA3;GAS2L1;MARK2;MAP6;BICD1;CAMSAP3
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.45067542459818316,1.0250031088391975,0.4340974212034384,0.8818457350782521,1.0,9/18,26.14%,EZR;RDX;RAB21;SNX12;PTPN23;MAP2K2;DAB2;SRC;CHMP3
prerank,regulation of cell size (GO:0008361),0.4396865344886566,1.0242767778636341,0.45188284518828453,0.8831511613695826,1.0,5/23,10.42%,VAV2;EZR;RAP1GAP2;RDX;RHOA
prerank,protein-containing complex disassembly (GO:0032984),0.387725136134774,1.0241103367300015,0.4437577255871446,0.882978736358919,1.0,9/54,15.28%,LRP6;GSK3B;FZD1;LIX1L;CSNK1A1;VCP;SNX14;WIPI2;DVL1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.5065618512134873,1.023242438374046,0.4707740916271722,0.884593074330278,1.0,1/11,1.97%,GSN
prerank,regulation of histone acetylation (GO:0035065),-0.3267144819561422,-1.0230722203466385,0.3911290322580645,0.8065656041789733,1.0,11/33,24.43%,RPS6KA5;RAPGEF3;PPARGC1A;RPS6KA4;BRD7;MYOCD;GLYR1;SNCA;CTBP1;NOC2L;SPI1
prerank,macrophage activation involved in immune response (GO:0002281),0.48131224760315217,1.0226898556470716,0.4457831325301205,0.8853646261957003,1.0,3/13,12.13%,LBP;PLCG2;IFI35
prerank,response to iron ion (GO:0010039),-0.42680996473476784,-1.0224007760200928,0.4112903225806452,0.806893813823986,1.0,2/12,2.14%,BCL2;B2M
prerank,negative regulation of cytokine production (GO:0001818),0.34178507864896135,1.0222477081762869,0.4353312302839117,0.8859345644148632,1.0,24/163,11.28%,THBS1;EZR;ANXA4;HDAC9;CMKLR1;RARA;KLF4;IRAK3;TAX1BP1;ANXA1;C5AR2;INHBA;NLRP12;FN1;ABCD1;IKBKE;ZC3H12A;TLR4;MAVS;PDCD4;IFIH1;GPATCH3;ZFPM1;TLR8
prerank,inositol phosphate metabolic process (GO:0043647),0.3910888101977107,1.0219070438279385,0.43875,0.8862248775546971,1.0,11/46,13.19%,PLCE1;PLCZ1;FGF2;PLCB3;PLCG2;IP6K1;IP6K2;PPIP5K1;INPP4A;OCRL;INPPL1
prerank,sphingolipid metabolic process (GO:0006665),-0.25676395269364083,-1.0216590913664725,0.3958333333333333,0.8073831472624574,1.0,33/108,16.80%,ST6GALNAC3;ENPP2;PRKD1;CERS4;ACER2;CERT1;SGMS1;ELOVL7;UGCG;DEGS2;ESYT1;SMPD3;HACD3;CTSA;GAL3ST1;HACD1;ARV1;SPHK1;CSNK1G2;ASAH1;HACD2;VAPA;CERS2;SPNS2;CERK;ALDH3B1;CERS1;SMPD1;SPTLC2;ELOVL6;CLN8;ABCA2;SERINC1
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.45472559838492227,1.0215534717385493,0.4508990318118949,0.8865817627053779,1.0,6/19,9.10%,NRP1;VEGFA;LIMS1;ABL1;MYOC;S100A10
prerank,snRNA 3'-end processing (GO:0034472),0.4543965552899668,1.0215100600215836,0.45673758865248226,0.8860516029778818,1.0,11/19,24.95%,INTS5;EXOSC3;INTS6;INTS7;EXOSC2;EXOSC7;INTS1;INTS14;EXOSC8;INTS8;INTS2
prerank,regulation of oxidoreductase activity (GO:0051341),0.47757502661395596,1.0215093538170852,0.45305514157973176,0.8854254180994522,1.0,3/13,13.19%,ABL1;SZT2;ECSIT
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.42373012640886887,1.0215085797669254,0.43826322930800543,0.8848008287375717,1.0,5/25,11.61%,EXT1;B3GNT2;HAS1;B4GAT1;B3GNT9
prerank,endodermal cell fate commitment (GO:0001711),-0.44296373871678785,-1.021506652676788,0.4358288770053476,0.8061771606877608,1.0,2/10,20.48%,SOX17;LEO1
prerank,histone acetylation (GO:0016573),0.3689130782804937,1.0214538651768852,0.4457409568261377,0.8843220777954245,1.0,35/69,29.25%,EP400;PER1;CREBBP;TADA3;MAP3K7;ZZZ3;JADE2;DMAP1;MSL3;MORF4L1;NAA40;KAT6B;PHF20L1;TAF5;TRRAP;ATF2;BRCA2;PHF20;NAA60;EPC1;BRPF3;TAF12;YEATS2;KAT6A;TRIM16;MRGBP;CPA4;SGF29;TADA2A;KAT8;HAT1;KAT2B;BRD1;NAA50;BRD8
prerank,protein modification by small protein conjugation (GO:0032446),0.33795068244921794,1.0211952956766897,0.43693239152371344,0.8843907573137232,1.0,84/361,20.07%,WWP1;FBXL7;NEDD4;RNF144A;MKRN3;FBXO10;CBLC;NFE2L2;WWP2;TRIM55;DCUN1D5;HERC2;SPSB2;TRIM47;NUP93;UBE2A;WAC;SAE1;BARD1;NUP214;TRIM39;UVSSA;TSPAN17;TRPM4;NUP153;HIF3A;ARIH1;CUL3;VCP;CDC16;IFIH1;CUL1;ANAPC11;PEX13;FBXW8;DTX2;ATG3;TRPC4AP;DET1;KEAP1;TRIM44;TRIM41;ANAPC16;RNF138;UBA5;NUP155;BRCA1;UBE2K;RANBP2;UBE2M;UBR3;MIB1;RNF8;COMMD1;NUP88;FBXO45;RNF41;UBE2B;DCUN1D2;UBE2D3;MKRN2;PRKDC;RNF111;CNOT4;TMEM129;DCUN1D1;RNF20;AREL1;RNF14;UBE2S;NUP35;SMURF1;MYCBP2;CHFR;PIAS2;TRIM35;ENC1;NFX1;VCPIP1;UBA3;UBE2F;TRAF7;UBE2Z;BRAP
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.42367163311197065,1.0209743859030966,0.454172366621067,0.884334455483094,1.0,7/27,8.66%,TMEFF2;MET;ARAP1;PHLDB2;MYOC;SHANK1;RHPN2
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.3728709190602316,1.0209526046378803,0.4375,0.8837712467544717,1.0,11/72,10.10%,SLIT2;PRKCD;FGF13;LDLR;KATNB1;EMILIN1;LIMA1;SHANK1;KANK4;CIB1;HDGFL3
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.41582115350030835,1.020819410531931,0.4375,0.8834865911818718,1.0,4/30,6.78%,BMP4;MLLT3;HOXB4;INHBA
prerank,positive regulation of protein metabolic process (GO:0051247),0.35389887279490045,1.0205181697135883,0.4642857142857143,0.8836349693755051,1.0,26/110,18.27%,WWP1;NEDD4;FZR1;GPC3;WWP2;GSK3B;KLF4;DACT1;INHBA;BARD1;CD80;VCP;IDE;NSF;STX5;CLU;CDKN1B;SORL1;RNF41;RAB1A;SNF8;OAZ2;SLC25A37;AREL1;DTL;SMURF1
prerank,regulation of receptor binding (GO:1900120),-0.440456647818426,-1.0201140774478166,0.44072164948453607,0.8084417443724461,1.0,4/10,9.78%,GREM2;B2M;ATP2A2;ATP2A3
prerank,sulfation (GO:0051923),0.4977843075528315,1.0199546959681702,0.4535603715170279,0.8844984990931831,1.0,3/11,13.76%,UST;CHST5;SULT1A1
prerank,positive regulation of protein depolymerization (GO:1901881),-0.4194274183425452,-1.0199425102679598,0.4197860962566845,0.8073298762688358,1.0,6/11,16.56%,NES;SEMA5A;CFL2;STMN2;PLEK;TRPV4
prerank,autophagosome organization (GO:1905037),0.3861065721153792,1.0198762830998243,0.42627013630731103,0.8840824156571847,1.0,13/50,18.39%,ULK2;RAB43;BECN1;WDR45B;ATG3;TP53INP2;ULK3;RB1CC1;ATG5;STX12;WIPI2;RAB1A;UBXN2B
prerank,negative regulation of phosphatase activity (GO:0010923),0.4202500346874696,1.0198540542579664,0.44475524475524475,0.8835121743823676,1.0,6/25,15.16%,GSK3B;STYXL1;CRY2;PTPA;CHP1;URI1
prerank,phospholipid transport (GO:0015914),0.38400315607536556,1.019825912680605,0.4468354430379747,0.8829843920847402,1.0,12/52,15.78%,TNFAIP8L3;PITPNC1;LDLR;PITPNA;TMEM30B;SCARB2;ABCA7;ATP11A;ATP9B;ATP10A;ABCC1;PCTP
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.4918689744054465,1.019448740139585,0.4578696343402226,0.883346397087173,1.0,3/12,11.61%,B3GNT2;B4GAT1;B3GNT9
prerank,vesicle transport along microtubule (GO:0047496),0.4408802662356129,1.0194289573537734,0.4406779661016949,0.8827806896142475,1.0,7/23,16.15%,KIF13A;NDEL1;PAFAH1B1;KIF3B;KIF1C;KIF5B;RAB1A
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.3408255870162087,1.0193123830974238,0.46384297520661155,0.8824384293245061,1.0,28/190,12.85%,SLIT2;THBS1;CCN3;CIT;TANK;ESR1;NPRL3;PHLPP2;TWIST1;NF1;NDUFS3;PER1;ATP2B4;NLRP12;RORA;ABCA7;TRIM39;ZC3H12A;SFRP5;PPP2R5C;CIB1;XDH;MCL1;HERPUD1;DRD3;IFI35;NR1D1;CPNE1
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.5065385640154639,1.0192665967314365,0.465625,0.8819276605859404,1.0,5/11,17.75%,CCL3;PLCG2;TRAT1;P2RX5;P2RX4
prerank,mesenchymal cell development (GO:0014031),-0.3699827213424313,-1.0192274327446311,0.39603960396039606,0.8077173935585505,1.0,4/18,13.39%,CDH2;NOTCH1;HEY2;TAPT1
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.34421221255948803,1.018951476157742,0.470960929250264,0.8821163013808476,1.0,52/148,25.29%,USP2;EXO1;HIPK1;CHEK2;AURKA;EHMT1;BARD1;WRN;TOPBP1;CHD3;PPP2R5C;RBBP7;POU4F1;RAD50;MDM4;RAD17;BRCA1;MBD3;PRMT5;PIP4K2A;CCNG1;TAF4;BRIP1;KMT5A;CDK2;MLST8;PIN1;PLK3;TAF5;RMI2;PHF20;ATR;HDAC2;HEXIM1;PML;NBN;TBP;CHEK1;PRKAB1;TAF12;ATM;MAPKAPK5;TP53;TAF13;KAT6A;RBBP8;USP7;SMYD2;TAF7;MTOR;RAD9A;RAD9B
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.42301058405052294,1.018872949406389,0.44664031620553357,0.8816929559046074,1.0,9/26,14.63%,GSK3B;PLCG2;ATP2B4;CIB1;SLC9A1;RCAN1;CHP1;HOMER2;CHERP
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.2609957758708132,-1.0188532076124877,0.4222222222222222,0.8071519694506206,1.0,34/91,20.86%,CP;SLC30A10;APP;SLC39A10;TFRC;SLC39A8;SLC40A1;FTL;ABCB7;ATP6V1G1;SLC30A1;ATOX1;FTH1;SLC39A12;BOLA2;SLC31A1;COX19;FRRS1;ATP13A2;MT3;SOD1;CYB561A3;NDFIP1;MT2A;PRNP;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B;ALAS2
prerank,negative regulation of defense response (GO:0031348),0.3633579054332549,1.01854084946417,0.4425087108013937,0.8819454373524579,1.0,9/77,7.11%,CCN3;PRKCD;PTGIS;KLF4;TRAFD1;IRAK3;PTPN2;NLRP12;RORA
prerank,rRNA metabolic process (GO:0016072),-0.24998727517572747,-1.018354830968563,0.375,0.8069697494026008,1.0,46/160,18.59%,RPL37;RPL27A;RPL19;RPS9;RPS14;RPL18A;RPL38;RPS19;RPL34;MTREX;RPL18;RPL7;RPS25;RPL21;RPL23A;RPLP2;RPL26;RPL41;MAPT;RPL35A;RPL10A;RPL11;RPS16;EXOSC5;SNU13;RPL4;RPS7;DDX52;RPS15;RPL36;POP4;EXOSC9;RPL37A;RPL32;RPL29;DDX10;HEATR1;LYAR;RPL13;FBL;RCL1;RPL36A;RPL23;RPL17;RPL9;DDX27
prerank,cellular glucan metabolic process (GO:0006073),0.5098400022393976,1.0182854495332534,0.4642857142857143,0.8819988584952941,1.0,3/11,7.99%,GSK3B;PPP1R3C;PHKB
prerank,protein auto-ADP-ribosylation (GO:0070213),0.487328818051683,1.0181834490693222,0.45962732919254656,0.8816690989846521,1.0,6/12,22.84%,PARP3;PARP1;PARP12;PARP6;PARP2;TNKS2
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.4076301418755953,-1.0180833348670135,0.45244956772334294,0.8061493938349402,1.0,11/14,48.92%,PTGER3;OSMR;PTGS2;TNF;CREB3L3;IL6;OSM;FFAR2;IL1B;C2CD4B;IL6ST
prerank,C-terminal protein amino acid modification (GO:0018410),-0.4120293587210513,-1.0180350318226654,0.45081967213114754,0.8047023689701788,1.0,1/11,0.96%,AGBL4
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.42778167051103216,1.0178904718267832,0.45970937912813736,0.8817724213079372,1.0,7/29,16.35%,PKP1;THRAP3;PABPC1;FUS;E2F1;CIRBP;GDNF
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.45377683046666084,1.0177823172721958,0.45760233918128657,0.8814628974571107,1.0,4/20,8.72%,SMAD9;VEGFA;NFE2L2;RUNX2
prerank,dopamine metabolic process (GO:0042417),-0.3736030723087932,-1.017741289195628,0.429042904290429,0.8039954138464077,1.0,5/18,9.00%,MOXD1;MAOB;MAOA;COMT;GCH1
prerank,regulation of lipid storage (GO:0010883),0.43832289815170017,1.0171949433099086,0.45609065155807366,0.8823595414052474,1.0,9/22,25.58%,PTPN2;IKBKE;ZC3H12A;ITGAV;ITGB3;FTO;MEST;CRP;ALKBH7
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.3844787827856281,-1.0170262861816448,0.42071197411003236,0.8043004819205284,1.0,4/16,5.92%,APOD;PPARA;SIRPA;ADCY7
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.4905274705788509,1.0168444564140258,0.4660347551342812,0.8826189033992635,1.0,3/13,12.17%,NEDD4;EMILIN1;NIBAN2
prerank,mitochondrial fission (GO:0000266),-0.3823124984840922,-1.0167404780332576,0.43558282208588955,0.8035434535395307,1.0,6/16,22.53%,DNM3;DNM1;FIS1;MTFR2;MTFP1;MFF
prerank,negative regulation of mitochondrion organization (GO:0010823),-0.3247605157033825,-1.0167132372863026,0.408,0.8020573648532855,1.0,5/33,10.72%,IGF1;TFRC;BCL2L1;MAPT;PINK1
prerank,negative regulation of interleukin-1 beta production (GO:0032691),-0.3593443166805849,-1.0165426713533032,0.4340836012861736,0.8008937101300724,1.0,1/19,0.24%,IGF1
prerank,apoptotic nuclear changes (GO:0030262),-0.3443845781899375,-1.0162256882983893,0.3970037453183521,0.8001895910905501,1.0,10/24,23.55%,CECR2;KPNB1;BLCAP;HMGB1;CDK5RAP3;FOXL2;HMGB2;GPER1;ACVR1C;CASP3
prerank,rRNA 3'-end processing (GO:0031125),0.5095322170867146,1.0161755027468828,0.4752,0.8837092817749184,1.0,7/10,27.87%,ERI3;EXOSC3;ERI1;EXOSC2;EXOSC7;EXOSC8;ERI2
prerank,negative regulation of protein kinase B signaling (GO:0051898),-0.30674961577768517,-1.0159141165593866,0.4200913242009132,0.7994768003204236,1.0,16/38,23.11%,PHLPP1;PPARA;DAG1;MAGI2;PTPRJ;RACK1;THEM4;TSC2;SH2B3;HYAL2;PHLDA3;ARRB2;EPHA2;BANK1;AKT1;GPER1
prerank,positive regulation of protein transport (GO:0051222),0.37517028802834806,1.0157328859044625,0.46099290780141844,0.8842119054777982,1.0,17/67,17.08%,ADAM9;EZR;UNC13B;TGFB3;SYTL4;BCAS3;ACSL3;BMP6;PCM1;TENM1;PCNT;CHP1;APBB3;GOLPH3;VAMP2;PLK3;OAZ2
prerank,mitotic spindle assembly (GO:0090307),0.3936507876161915,1.015558223627645,0.456359102244389,0.8840204662456377,1.0,16/42,23.40%,CHEK2;SPICE1;STAG1;MISP;TOGARAM1;RHOA;KIF3B;OFD1;ABRAXAS2;SMC1A;STAG2;RAB11A;CCDC61;PIBF1;KIF23;ABRAXAS1
prerank,nucleosome assembly (GO:0006334),0.41723361798793207,1.0153610312693397,0.46938775510204084,0.8839409355004694,1.0,13/31,24.63%,CHAF1B;CHAF1A;HIRA;ATRX;SOX9;KAT6B;SMARCA5;NAA60;CABIN1;NAP1L1;IPO4;ASF1A;RSF1
prerank,proteoglycan biosynthetic process (GO:0030166),0.4128068362491314,1.0150525505504415,0.4497936726272352,0.8841236946250478,1.0,8/31,12.47%,EXT1;FOXL1;CHST13;XYLT1;CHST11;GAL3ST4;B3GALT6;GLCE
prerank,neuropeptide signaling pathway (GO:0007218),-0.2849141233612659,-1.0149333682574708,0.42857142857142855,0.8005722067484472,1.0,13/58,15.49%,SORT1;RAPGEF2;SORCS3;NXPH2;GLRA3;GLRA1;HCRTR2;CYSLTR2;SORCS1;CYSLTR1;NTS;OPRM1;NMU
prerank,negative regulation of ossification (GO:0030279),0.4280727867931631,1.0149006860156695,0.43375174337517436,0.8838985704976573,1.0,5/23,10.56%,SMAD6;PTK2B;CCL3;TRPM4;BCOR
prerank,mRNA stabilization (GO:0048255),0.4049683170176997,1.0148215029239618,0.45707070707070707,0.8835024625222702,1.0,13/40,18.86%,YBX3;THRAP3;PABPC1;ANGEL2;MYD88;FUS;E2F1;TIRAP;CIRBP;GDNF;MAPKAPK2;DHX9;SYNCRIP
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.3419240899391615,1.01477797248818,0.46659707724425886,0.8830046134338779,1.0,61/185,26.46%,PKD1;FZR1;ID2;PSMB2;ANAPC5;CDC14A;PCM1;AURKA;PAFAH1B1;PSMD11;CEP43;AKAP9;CUL3;ANAPC10;PSMC1;SDCCAG8;CDC16;CUL1;ANAPC11;CDC20;HAUS2;CCNB1;CEP63;PLK4;PSMC6;MAD2L1;PCNT;FBXO5;ANAPC16;ZW10;E2F1;PSMD1;OFD1;PSMD4;CDK2;CENPJ;PSMA6;UBE2S;CEP164;PSMD14;PSMD12;CETN2;PSMD7;NEK6;SFI1;PSME3;BUB3;YWHAE;CEP76;PSMD3;PSMB6;APPL2;UBB;INO80;CSNK1E;CDC6;KLHL18;CEP290;UBA52;ANAPC4;RPS27A
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.4829539654369075,1.0146422445303396,0.46248085758039814,0.8827459605563084,1.0,2/13,1.84%,CACNA1C;ANK2
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.40647523494493965,1.0145034202844352,0.4352791878172589,0.8824876646875415,1.0,7/34,14.13%,UBASH3B;PTPRF;PTPN2;ACP4;DUSP5;PTPRS;PTPN9
prerank,positive regulation of cell differentiation (GO:0045597),0.33546154529912453,1.014417910449024,0.47046843177189407,0.882095705665769,1.0,38/237,10.53%,CDON;BOC;BMP4;VWC2;DDR2;HOXA5;CCN1;TMEM100;CMKLR1;NGF;NELL1;TGFB3;BMPR1A;ID2;TGFBR1;ABL1;TWIST1;FGFR1;CTNNA1;ZBTB16;MEF2A;NBL1;BMP6;MAPK12;HOXB4;TIAM1;TGFBR2;KITLG;SMAD2;ZC3H12A;TRPM4;RUNX2;FOXC1;SYAP1;TMEM119;RHOA;TGFB1I1;DHX36
prerank,cellular response to leucine starvation (GO:1990253),0.5049567774947091,1.0144055999453325,0.4392220421393841,0.8815197034958591,1.0,4/10,24.23%,RRAGB;SESN3;LARS1;MTOR
prerank,megakaryocyte differentiation (GO:0030219),-0.4224606813307588,-1.0142294438119435,0.43380281690140843,0.8008570470782387,1.0,4/11,15.44%,KIT;TAL1;MED1;SH2B3
prerank,response to light stimulus (GO:0009416),0.3788404633978145,1.0141030384167906,0.47539015606242496,0.8816601296280512,1.0,14/55,20.11%,UBE4B;ERCC5;UBE2A;CRY2;UVSSA;USP1;CPT1B;PRIMPOL;UBE2B;CIRBP;PCLAF;DTL;COPS3;ERCC4
prerank,positive regulation of cation channel activity (GO:2001259),-0.29918500183059005,-1.0137844451168223,0.4112903225806452,0.800530590368906,1.0,5/40,4.30%,SHANK3;ANK3;AKAP6;ACTN2;TMSB4X
prerank,negative regulation of biomineral tissue development (GO:0070168),-0.35134426963673826,-1.0132966891279724,0.4,0.8002619551379827,1.0,8/21,10.61%,NOS3;ROCK2;ENPP1;ASPN;SRGN;NOTCH1;HEY2;GAS6
prerank,bile acid and bile salt transport (GO:0015721),-0.3358395972054885,-1.0132865042768036,0.4368231046931408,0.7987560542698781,1.0,3/24,2.03%,SLCO2B1;SLCO1C1;NCOA1
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.35945438554987874,1.0127556496126837,0.468013468013468,0.8844932339042446,1.0,27/86,24.41%,VEGFA;NFE2L2;EGLN3;PSMB2;BAG3;CREBBP;PSMD11;HIF3A;PSMC1;ARNT;PSMC6;PSMD1;PSMD4;PSMA6;PSMD14;PSMD12;PSMD7;HIF1AN;PSME3;CHEK1;TP53;PSMD3;DDIT3;PSMB6;KLF2;UBB;INO80
prerank,regulation of cellular amine metabolic process (GO:0033238),0.38735229139367805,1.0127513851790229,0.463768115942029,0.8838946115586939,1.0,17/50,23.94%,PSMB2;NQO1;PSMD11;PSMC1;ODC1;PSMC6;PSMD1;AZIN1;PSMD4;OAZ2;PSMA6;PSMD14;PSMD12;PSMD7;PSME3;PSMD3;PSMB6
prerank,peptide metabolic process (GO:0006518),0.3655469749433372,1.0125833134941917,0.440324449594438,0.8837300133879055,1.0,16/75,17.77%,PCSK5;CPQ;MMACHC;GSR;GSTT1;BACE2;NPEPPS;GSTA2;IDE;GSTT2;DPEP1;DMD;NLN;CPZ;GSTM4;APEH
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.41380780988920685,1.0123311597451379,0.46005154639175255,0.8831775898162587,1.0,9/32,17.82%,NUP93;NUP214;NUP153;NOL6;NUP155;RANBP2;NUP88;SSB;NUP35
prerank,tRNA export from nucleus (GO:0006409),0.41380780988920685,1.0123311597451379,0.46005154639175255,0.8831775898162587,1.0,9/32,17.82%,NUP93;NUP214;NUP153;NOL6;NUP155;RANBP2;NUP88;SSB;NUP35
prerank,regulation of inclusion body assembly (GO:0090083),0.49415039272919764,1.0123157051635001,0.46,0.882616732284823,1.0,1/11,1.41%,SNCAIP
prerank,protein phosphorylation (GO:0006468),0.32769792363728323,1.0121270063323906,0.46693386773547096,0.8824789955903841,1.0,109/479,18.17%,STK39;BMP4;EGFR;DCLK1;MAP3K5;PKD1;MARK1;CIT;GRK5;DDR2;CCNA2;WNK1;PRKCD;CAMK2D;ULK2;WNT11;PRKCE;ABI1;PTK2B;ERC1;TLK1;SRMS;BMPR1A;CLK2;GSK3B;CDK10;RARA;CDK12;HIPK1;TGFBR1;ABL1;IRAK3;EPHB3;USP15;FGFR1;FRK;CHEK2;STK16;NEK7;FAM20A;BCR;VRK3;STRADA;MAPK12;ERBB2;TGFBR2;NRBP2;AURKA;LIMK2;CDK11B;IKBKE;SMAD2;CSNK1A1;GRK4;TLR4;NLK;MAST2;TOP1;MAK;CLSPN;CDK16;CDK13;TTK;AAK1;PLK4;MAP3K7;EIF2AK2;EIF2AK1;PDK3;MAP3K3;CSNK1G3;EPHB2;CAB39;ULK3;SGK3;MAP3K1;RPS6KA3;MARK2;RET;CDKL2;CSNK1G1;ACVR1;MORC3;HTATIP2;PIM2;PRKCA;MARK3;CDK7;EEF2K;PRKDC;EFEMP1;CDK2;CDC7;MAP3K10;LCK;SIK1;IKBKB;FGFR3;GTF2H3;ERN2;RPS6KB1;SMAD7;NEK4;LRRK2;STK24;STK3;MAPKAPK2;COPS8;DDR1
prerank,extracellular transport (GO:0006858),0.4754635296084689,1.0120199484842127,0.4390625,0.8821497262707926,1.0,4/13,20.82%,WWP2;DNAAF4;SPAG17;DNAAF2
prerank,cilium assembly (GO:0060271),0.3304512127783169,1.0118641133117021,0.4747983870967742,0.8819394454433469,1.0,79/297,21.89%,PKD1;BBS9;ABLIM3;EXOC4;GSN;PTPDC1;IFT46;PDE6D;GBF1;FAM161A;PARVA;DZIP1;WDR35;CDC14A;PCM1;RAB11FIP3;PAFAH1B1;CEP43;TOGARAM1;AKAP9;CFAP43;EHD2;SDCCAG8;IFT52;MAK;DYNC2I2;HAUS2;ARL3;CEP63;PLK4;RFX2;PCNT;GALNT11;KIF3B;ARF4;OCRL;DISC1;EXOC7;EHD1;DYNC2I1;TMEM231;NPHP1;CEP19;TRAPPC14;OFD1;ATAT1;RAB1A;CCDC66;IFT43;NPHP3;ACTR2;CPLANE2;CEP20;CENPJ;PTPN23;DNAAF3;CEP164;MKKS;CETN2;ATP6V0D1;CLUAP1;IQCB1;NUDCD3;C2CD3;RAB11A;LZTFL1;HYLS1;SFI1;IFT22;EXOC2;TXNDC15;PIBF1;CEP89;ACTR3;EXOC5;TEKT2;RSPH9;DYNC2H1;TCTN1
prerank,protein homooligomerization (GO:0051260),0.3534429521244858,1.0117554066013217,0.4649122807017544,0.8816461193893478,1.0,19/114,13.63%,KCNJ2;SCARA5;DISP1;ATL3;TMEM120A;MPP2;ATL2;G3BP2;PRMT8;TRPM4;ACACA;TDO2;TK1;ZBTB1;FUS;ACOT13;EHD1;PDCD6IP;RBMX
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),-0.40445750324701346,-1.0115781391181178,0.45689655172413796,0.8020756536119079,1.0,5/13,15.51%,NR1H3;AQP11;WFS1;NR1H2;NUPR1
prerank,cell-substrate junction assembly (GO:0007044),-0.3266031294814993,-1.0113070419356691,0.41630901287553645,0.8013444255483768,1.0,13/33,21.54%,PEAK1;ITGA6;THSD1;ACTN2;DST;LAMC2;LAMC1;ARHGEF7;CD151;THY1;LAMB3;ACTN1;TESK2
prerank,zymogen activation (GO:0031638),0.39687120729786995,1.0108709136681189,0.44155844155844154,0.883320846216878,1.0,3/39,3.42%,PERP;CYFIP2;PRSS12
prerank,nucleotide-sugar metabolic process (GO:0009225),0.49122654451610215,1.010849662033579,0.4440894568690096,0.8827738813611874,1.0,4/12,17.83%,FUT8;GMDS;SLC35A3;GFPT1
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.3640770464333425,1.0108147441329653,0.44733861834654587,0.8822434709138754,1.0,26/83,17.24%,CDC45;MNAT1;INHBA;E2F3;CCND1;CUL3;CDKN2C;CUL1;GSPT1;CDK16;FBXO5;TFDP1;CDKN1B;CDKN3;E2F1;ACVR1;HINFP;PIM2;KHDRBS1;CDK7;CDK2;CDKN1A;CDC7;PLK3;RPS6KB1;RB1
prerank,negative regulation of stress fiber assembly (GO:0051497),0.4317414727500268,1.010687129787901,0.47092198581560285,0.8819651610904053,1.0,6/24,8.66%,TMEFF2;MET;ARAP1;PHLDB2;MYOC;RHPN2
prerank,positive regulation of neurogenesis (GO:0050769),0.36865182770505045,1.0106264464793475,0.45207100591715976,0.8815067195277978,1.0,13/68,13.38%,SLIT2;CUX1;NGF;VEGFA;TIAM1;TIAM2;KDM1A;FBXW8;RHOA;DISC1;NPTN;MAP6;PLXNB1
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.3777707071310803,-1.0104470270569519,0.4577922077922078,0.8021016702860522,1.0,8/18,17.56%,SHANK3;NRXN1;CACNG7;CACNG4;CACNG3;CACNG2;RELN;CACNG8
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.4664119852417373,1.010334878122909,0.48857142857142855,0.881625047373582,1.0,5/16,12.45%,ANK2;SEC16A;GBF1;MIA3;BCAP31
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.3381067946685877,-1.009549576009321,0.4115384615384615,0.803012906310425,1.0,3/27,3.26%,LPAR1;HTR2C;GRM1
prerank,cellular response to superoxide (GO:0071451),-0.427319940753185,-1.009546097798857,0.43370165745856354,0.8014974499316424,1.0,4/10,18.04%,NOS3;SOD3;MT3;SOD1
prerank,regulation of water loss via skin (GO:0033561),0.46726620732909496,1.0095178708614438,0.44661654135338347,0.8824742534961268,1.0,1/15,0.88%,MET
prerank,establishment of skin barrier (GO:0061436),0.46726620732909496,1.0095178708614438,0.44661654135338347,0.8824742534961268,1.0,1/15,0.88%,MET
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.4953163135575281,1.0090162769105286,0.47303543913713403,0.8831817108373392,1.0,3/12,16.92%,CLTRN;TRPM4;ADCY8
prerank,chromatin organization (GO:0006325),0.3452750236337828,1.0089255606120433,0.4631803628601921,0.8828136070177401,1.0,42/132,26.86%,TCF7L1;HDAC4;ESR1;NUDT5;HDAC8;MYSM1;HMG20A;SETD2;EHMT1;CHD1L;TOP1;SMARCC1;NPM3;ZBTB1;EZH1;DDX11;ATRX;SOX9;CHD1;KDM5B;SMARCA5;PBRM1;HCFC1;RB1;HDAC2;SATB2;ZBTB7A;HIRIP3;BAZ1A;SNAI1;BRWD1;TADA2B;INO80;SETD5;RSF1;KDM4D;HMGN1;SUPT4H1;BAZ2A;BAZ2B;SETD7;TADA2A
prerank,regulation of stem cell differentiation (GO:2000736),0.35949656919772327,1.0087356728891013,0.4685777287761852,0.8827071223482587,1.0,21/89,19.95%,HES1;BMPR1A;PSMB2;ABL1;HOXB4;PSMD11;PSMC1;EIF2AK2;PSMC6;JAG1;PSMD1;PRKDC;PTN;PSMD4;GDNF;YAP1;PSMA6;PSMD14;PSMD12;PSMD7;TCF12
prerank,mRNA metabolic process (GO:0016071),0.35326373722858195,1.0086616945814895,0.45222222222222225,0.8822920233310761,1.0,33/90,29.11%,DDX5;SRSF11;U2AF2;SON;SRSF5;LSM11;NUDT12;PRPF18;KIN;SRSF2;CELF1;SCAF11;SRSF1;PRPF8;SSB;CPSF3;HNRNPA2B1;NONO;CSTF3;TCERG1;AURKAIP1;TP53;AKAP8L;USP39;SUPT4H1;METTL16;PTBP1;DXO;SNRPB;ALKBH5;DHX15;YTHDF2;NUDT16L1
prerank,monocyte chemotaxis (GO:0002548),-0.3194926300536871,-1.00857313658542,0.44280442804428044,0.8025217243039674,1.0,5/32,7.45%,FLT1;IL6R;TNFRSF11A;RPS19;PTPRO
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.3835189845832747,-1.0084395439248135,0.45454545454545453,0.8013527623426546,1.0,6/16,17.41%,APOE;NUS1;GCH1;NOS1AP;TERT;HIF1A
prerank,positive regulation of type 2 immune response (GO:0002830),-0.37841698602434337,-1.0084283925110256,0.45588235294117646,0.799863866104764,1.0,6/14,17.99%,PRKCZ;IL18;CD81;CD74;NOD2;CD86
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.484492695140084,1.008364038441348,0.46567164179104475,0.8812655182890283,1.0,5/12,17.24%,ANAPC5;CUL3;CDC16;ANAPC11;RB1
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.484492695140084,1.008364038441348,0.46567164179104475,0.8812655182890283,1.0,5/12,17.24%,ANAPC5;CUL3;CDC16;ANAPC11;RB1
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.484492695140084,1.008364038441348,0.46567164179104475,0.8812655182890283,1.0,5/12,17.24%,ANAPC5;CUL3;CDC16;ANAPC11;RB1
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.43264981217223275,1.0081725936986827,0.4642857142857143,0.8811318289386648,1.0,3/21,6.89%,ADAM9;BACE2;SPPL2A
prerank,establishment of spindle orientation (GO:0051294),0.4144016797016049,1.0081578589323923,0.47925033467202144,0.8805803181070515,1.0,8/28,18.39%,NDEL1;MISP;PAFAH1B1;ITGB1;MAD2L1;ZW10;SPDL1;UBXN2B
prerank,nerve growth factor signaling pathway (GO:0038180),0.5007037644377316,1.0081041464863572,0.4856687898089172,0.8801213964970684,1.0,3/10,11.11%,NGF;KIDINS220;RAP1A
prerank,spindle assembly (GO:0051225),0.3649480768038423,1.0079702801700212,0.47473560517038776,0.879866374593055,1.0,21/67,20.70%,CHEK2;NEK7;SPICE1;STAG1;MISP;NCOR1;TOGARAM1;HAUS2;RHOA;CEP63;KIF3B;TUBGCP6;OFD1;ABRAXAS2;SMC1A;TUBGCP2;STAG2;NEK6;RAB11A;CCDC61;PIBF1
prerank,regulation of mitochondrial fission (GO:0090140),-0.33751109517527206,-1.0073407048186451,0.44404332129963897,0.8012406159393082,1.0,11/24,24.43%,DCN;KDR;SPIRE1;INF2;MAPT;PINK1;FIS1;STAT2;MFF;CYRIB;RALBP1
prerank,negative regulation of platelet activation (GO:0010544),0.46128886609858377,1.0072514159599237,0.4726443768996961,0.8811240575851627,1.0,3/16,3.02%,PRKCD;THBD;CD9
prerank,cell chemotaxis (GO:0060326),0.3679563677793811,1.0072336376478115,0.4556500607533414,0.8805760763959701,1.0,6/60,5.53%,CCN3;PRKCD;DEFB130A;NRP1;VEGFA;PARVA
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.4777414570495352,1.0072196367514303,0.4608433734939759,0.8800227273006379,1.0,3/13,7.66%,CD9;LDLR;ITGB1
prerank,membrane lipid catabolic process (GO:0046466),0.491878596295657,1.0071185643681533,0.4688,0.8796823483487299,1.0,2/10,8.26%,CYP1B1;PDXDC1
prerank,positive regulation of macroautophagy (GO:0016239),0.383374116963648,1.0065876034836383,0.4767879548306148,0.8804699181638913,1.0,16/48,20.21%,ADRB2;HSPB8;BAG3;WAC;IKBKG;PAFAH1B2;VPS13D;MAP3K7;SCOC;SH3GLB1;PIP4K2A;RALB;LRSAM1;GPSM1;EPM2A;SESN3
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.3653187802156381,-1.0063605884496414,0.42105263157894735,0.8022391934843606,1.0,5/18,14.26%,VCAM1;SLC39A8;JAM2;GCNT1;ITGA4
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.37134011235365505,1.0063433192225248,0.4831199068684517,0.8804662263406589,1.0,9/65,7.51%,EGFR;PTPN3;ARAP1;CBLC;RNF126;PTPN2;RNF115;MVB12B;AGR2
prerank,negative regulation of cell population proliferation (GO:0008285),0.3284532982790487,1.0062500998129773,0.4692849949647533,0.8801059355524038,1.0,66/351,14.69%,ZBTB7C;BMP4;CCN3;WNT9A;HES1;CYP1B1;SMAD6;PTPRU;BMP5;ABI1;IGFBP5;PTK2B;SLURP1;TES;NGF;CLMN;SFRP4;NELL1;TGFB3;CDK10;KLF4;PTHLH;EMD;TBRG1;PTPN2;NOG;KLF10;NF1;SKI;FRK;LMNA;NCK2;INHBA;STRN;TENM1;E2F3;IRF1;P3H3;P3H1;CDKN2C;SFRP5;PPP2R5C;CIB1;TGFB1I1;EIF2AK2;BTG3;TFDP1;CDKN1C;GNRH1;IFI35;NIBAN2;CDKN1B;RAF1;MDM4;CELF1;CDKN3;IGFBP6;ITGB1BP1;E2F1;PLXNB1;IFNLR1;MORC3;PIM2;CHERP;SOX9;RNF41
prerank,negative regulation of proteolysis (GO:0045861),0.40430634202387566,1.0059449475504711,0.4722222222222222,0.8802235353251283,1.0,6/34,7.88%,PTPN3;TIMP1;GAS1;ACP4;DNAJC1;TIMP2
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.47953485559402087,1.0059005949930298,0.4777777777777778,0.8797510391896184,1.0,3/13,6.64%,FGF2;FGFR1;SIRT6
prerank,response to lipopolysaccharide (GO:0032496),0.34122616831402974,1.005592973226141,0.46835443037974683,0.8799524572217144,1.0,27/138,19.05%,FOXP1;ADAM9;LBP;SMAD6;CXCL2;IRAK3;PALM3;ZC3H12A;TLR4;CD80;PDCD4;ERBIN;RHOA;TAB2;TRIM41;MYD88;RPS6KA3;NR1D1;TIRAP;CARD16;TRAF6;PDCD1LG2;OTUD5;MAPKAPK2;TICAM1;SRR;JAK2
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.39487311295050664,1.0053466200244756,0.46153846153846156,0.8799747690337174,1.0,13/37,21.18%,IGFBP5;FGF2;TGFB3;BMPR1A;NR4A3;PDCD4;CDKN1B;MEF2D;CDKN1A;ADAMTS1;PPARG;HTR1B;SOD2
prerank,peroxisome organization (GO:0007031),0.42360302962744345,1.0053262485054406,0.48871181938911024,0.8794447159985613,1.0,4/25,12.05%,ABCD3;ABCD1;LONP2;ACOT8
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.3402405345158704,-1.0052914864370448,0.46360153256704983,0.8037592715383866,1.0,10/25,18.76%,TMTC2;SLC8A1;ANK3;GRIN1;WFS1;JPH2;ATP13A2;MT3;CIB2;KCNA1
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.3636281448966793,1.0051010996873269,0.46745562130177515,0.8794262268301914,1.0,24/69,26.01%,NABP1;SNAPC2;INTS5;GTF2E1;INTS6;GTF2A2;POU2F1;CDK7;CCNT2;INTS7;TAF5;ELL2;POLR2C;CCNT1;ICE2;TAF8;TBP;INTS1;INTS14;TAF13;GTF2B;INTS8;INTS2;ELL
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.4486017616561748,1.0050812368138906,0.460545193687231,0.8788837798249625,1.0,2/18,1.67%,STK39;CAMK2D
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.48209360800068396,1.0050399478597434,0.48205928237129486,0.8783918636606982,1.0,6/12,28.88%,FDX1;TSPO;STAR;STARD3NL;FDX2;FDXR
prerank,prostaglandin biosynthetic process (GO:0001516),-0.3707287228116384,-1.004811533044642,0.4413793103448276,0.8035242425552024,1.0,11/18,24.50%,PTGDS;PTGS1;EDN1;TBXAS1;MIF;HPGDS;CD74;CBR1;PNPLA8;PTGS2;PRXL2B
prerank,mRNA catabolic process (GO:0006402),0.39380599496347674,1.0047285640165489,0.46766169154228854,0.878607506931636,1.0,5/44,8.85%,DDX5;TUT7;TUT4;THRAP3;NUDT12
prerank,protein localization to vacuole (GO:0072665),-0.3989065496843131,-1.0043469253662916,0.43515850144092216,0.8033708820473345,1.0,8/13,23.90%,RTN4;CD81;RNF128;ATP13A2;SH3BP4;GLMP;LAMTOR4;LAMTOR5
prerank,sphingolipid catabolic process (GO:0030149),0.4602021982431731,1.004277237950637,0.4665629860031104,0.8791152478279443,1.0,3/15,8.26%,ACER3;SMPDL3A;PDXDC1
prerank,establishment of protein localization to membrane (GO:0090150),0.36927326095225793,1.0041598468692063,0.47453703703703703,0.8788276875199292,1.0,16/66,17.37%,EGFR;NECTIN3;GORASP2;ZDHHC2;ZDHHC20;ZDHHC12;ATG3;NPC1;VPS37A;PARD3;ZDHHC15;VPS37B;RAB11B;AFDN;ZDHHC24;GOLGA7
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.4336307990124171,-1.0041083792826568,0.4412532637075718,0.8025106865901704,1.0,7/10,32.19%,RPS6KA6;HIPK2;KAT5;ING4;SP100;TFAP4;MUC1
prerank,regulation of keratinocyte migration (GO:0051547),0.4844152678411612,1.0040656291874983,0.48753894080996885,0.8784760701983522,1.0,1/12,1.31%,ADAM9
prerank,diol biosynthetic process (GO:0034312),0.4764938926208698,1.0040094690535082,0.4838235294117647,0.8780363748310216,1.0,1/15,0.70%,ACER3
prerank,cellular response to organic cyclic compound (GO:0071407),0.3439642087946378,1.0037975759019357,0.48089171974522293,0.8780014924076057,1.0,27/141,13.09%,EGFR;CDH1;CYP1B1;CASP6;IGFBP5;EZR;SLC26A6;ESR1;CCL3;NR4A3;CTNNA1;RAD51;DIAPH1;LCOR;RORA;SPIDR;DMTN;ZC3H12A;EGR1;AKAP9;ATP1A3;ATP1A1;POU4F1;RAP1A;JUP;BRCA1;ARL6IP5
prerank,modified amino acid transport (GO:0072337),0.4614491843500129,1.0037933838058315,0.46795827123695977,0.8774246954721671,1.0,4/15,8.48%,SLC5A6;FOLR2;SLC7A9;SLC25A32
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.40627356207942883,1.0035267176737952,0.4666666666666667,0.8774933643934398,1.0,10/32,24.60%,DDX5;FHIT;HIPK1;POU4F1;RRP8;USP28;CDIP1;PML;TP53;AEN
prerank,positive regulation of fat cell differentiation (GO:0045600),0.3807127854211037,1.0032456165133612,0.4585365853658537,0.8775693013284006,1.0,7/47,9.12%,SIX1;CMKLR1;ID2;ZBTB16;ZC3H12A;TRPM4;SYAP1
prerank,negative regulation of kinase activity (GO:0033673),0.37440201885345736,1.0031890594884085,0.465005931198102,0.8771316678772099,1.0,13/62,17.24%,LRP6;UBASH3B;NF1;CEP43;DUSP19;QARS1;CHP1;CDKN1C;CDKN1B;ITGB1BP1;DVL1;CEP85;RB1
prerank,response to histamine (GO:0034776),-0.4244153465680046,-1.0031223589484282,0.4578005115089514,0.8036475775797349,1.0,3/10,5.61%,GABRB3;GABRB1;GABRB2
prerank,plasma membrane organization (GO:0007009),0.3686709486702349,1.0028497890164565,0.46537059538274606,0.8773747781644009,1.0,11/61,11.82%,AHNAK2;DMKN;ANK2;ANO6;SYTL4;PLSCR3;ABCA7;ABCD1;EHD2;TLCD1;NSF
prerank,positive regulation of amyloid-beta formation (GO:1902004),-0.36604124450225106,-1.002555401343992,0.47416413373860183,0.803662821285868,1.0,8/18,16.99%,PICALM;ROCK2;ABCG1;EPHA4;LRRTM3;IFNGR1;ABCA2;GSK3A
prerank,positive regulation of multicellular organismal process (GO:0051240),0.32909565987279055,1.0025360197865663,0.5010141987829615,0.8775701597913685,1.0,62/308,17.56%,SIX1;BMP4;FOXD1;BMP1;LBP;ADRA1B;GNAS;FGF2;NLRP5;CMKLR1;ADRB2;VEGFA;TGFB3;BMPR1A;SMO;GADD45G;GRB10;TGFBR1;NOG;IL33;TWIST1;LRP1;PDGFC;ZBTB16;TSKU;AGO2;TIAM1;TGFBR2;SIRT6;INHBA;EHMT1;ABCA7;SMAD2;TRPM4;KDM1A;FOXC1;SIX4;TMEM119;DECR1;TGFB1I1;TRPM8;EIF2AK2;NLGN1;FBXO5;NIBAN2;KMT5B;SORL1;ACVR1;SOX9;INHBB;PTN;FFAR4;FLOT1;ACADL;GDNF;SMAD4;SYDE1;GLMN;BCL9L;ZBTB7B;HCRT;TLE6
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.3792560795177957,1.0020416635390896,0.4684014869888476,0.8782123405966713,1.0,15/51,18.04%,DCLK1;SRGAP2;SNX2;NGF;NBL1;SHTN1;CTTN;TRIO;PLXNB1;DBN1;ANKRD27;MAP1S;LRRK2;NYAP1;NCKAP1L
prerank,amyloid fibril formation (GO:1990000),-0.2868826677096448,-1.0020265996754025,0.453551912568306,0.8035267454246675,1.0,11/51,12.25%,B2M;TSPAN5;APP;CST3;ITM2B;HSPG2;TSPAN14;MAPT;SIAH2;MFGE8;APH1B
prerank,regulation of stress fiber assembly (GO:0051492),0.36503387091228173,1.001963657364517,0.4696969696969697,0.8778394542550805,1.0,16/74,10.42%,TMEFF2;MET;ARAP1;WNT11;SORBS3;NRP1;TGFB3;PHLDB2;TGFBR1;ABL1;MYOC;GPR65;RHPN2;S100A10;SLC9A1;RHOA
prerank,sister chromatid segregation (GO:0000819),0.4116451432614376,1.001876554378662,0.46344647519582244,0.8774957152892537,1.0,6/31,17.24%,SMC4;KNSTRN;KLHL22;ZW10;SMC1A;RB1
prerank,negative regulation of JNK cascade (GO:0046329),0.40496744713099864,1.0017780374139764,0.4837837837837838,0.8771637517641905,1.0,6/31,10.44%,KLHL31;PER1;DACT1;NCOR1;PDCD4;DUSP19
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.3494396441406643,1.001636723508835,0.4633077765607886,0.8769413669053683,1.0,31/109,21.13%,PPP3CA;VAV2;GAB2;PSMB2;PLCG2;NR4A3;SHC1;TAB3;IKBKG;NFATC3;PSMD11;PSMC1;CUL1;MAP3K7;TAB2;PSMC6;MAP2K4;MAP3K1;NFATC1;PSMD1;TRAF6;PSMD4;IKBKB;PSMA6;LAT;PSMD14;PSMD12;PSMD7;CHUK;FER;PSME3
prerank,cellular response to lectin (GO:1990858),0.34999159480841835,1.0016306726917543,0.4868131868131868,0.8757949868754623,1.0,31/104,24.68%,PRKCD;NRAS;KRAS;PSMB2;PLCG2;TAB3;CREBBP;IKBKG;PSMD11;PSMC1;CUL1;MAP3K7;TAB2;PSMC6;RAF1;PSMD1;TRAF6;PSMD4;IKBKB;PSMA6;PSMD14;PSMD12;PSMD7;CHUK;RELB;PSME3;PSMD3;PSMB6;PAK2;FBXW11;SRC
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.34999159480841835,1.0016306726917543,0.4868131868131868,0.8757949868754623,1.0,31/104,24.68%,PRKCD;NRAS;KRAS;PSMB2;PLCG2;TAB3;CREBBP;IKBKG;PSMD11;PSMC1;CUL1;MAP3K7;TAB2;PSMC6;RAF1;PSMD1;TRAF6;PSMD4;IKBKB;PSMA6;PSMD14;PSMD12;PSMD7;CHUK;RELB;PSME3;PSMD3;PSMB6;PAK2;FBXW11;SRC
prerank,cellular response to nutrient levels (GO:0031669),0.37122280438571326,1.0014118082418213,0.48406139315230223,0.8757612409033702,1.0,17/62,19.43%,KCNB1;CLEC16A;RRAGB;KLF10;VPS41;ZFYVE1;WRN;FAM107A;WDR45B;GAS2L1;SREBF1;WIPI2;INHBB;LRRK2;STK24;RALB;EIF4G1
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.3323217835632141,1.0012046938393795,0.5030737704918032,0.8756830693674076,1.0,33/214,13.32%,BMPER;EGFR;TNFAIP8L3;NTRK3;CCN1;EZR;PTK2B;FGF2;NRP1;NOTCH2;CCL3;CCL1;PTPN2;PDGFC;SPRED2;SHC1;EMILIN1;ERBB2;CD44;ROR1;ABCA7;FN1;TLR4;GATA4;CIB1;CCL7;GAREM1;RAP1A;EPHB2;SYNJ2BP;ITGB1BP1;DLG1;TIRAP
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.4627801686967846,1.0011968795198518,0.47846153846153844,0.8751214588332809,1.0,2/15,3.08%,PRKCE;IRS1
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.3756697713821039,-1.0008610682354402,0.46808510638297873,0.805082903455303,1.0,2/16,1.41%,SOX5;SOX6
prerank,regulation of peptidase activity (GO:0052547),-0.36346628442826756,-1.0003709217050774,0.4329268292682927,0.8049537802708533,1.0,6/19,16.92%,CST3;CTSH;NDUFA13;PINK1;PSMB8;ATP13A2
prerank,RNA splicing (GO:0008380),0.3544468446689131,1.0002569678722228,0.4664429530201342,0.8767824885896286,1.0,47/95,32.29%,MBNL1;CELF3;SRSF11;CDK12;DBR1;SNRNP48;PRPF18;SRSF2;FUS;SNRNP35;SCAF11;WBP4;RNPS1;PRPF8;RNPC3;WDR83;NONO;SYNCRIP;SNRNP40;PDCD7;SF3B3;DHX8;LSM4;TCERG1;LUC7L3;TARDBP;SRRM1;SRPK2;LSM1;USP39;SCNM1;PTBP1;ZCRB1;SMNDC1;SNRPB;DHX15;ZRSR2;HNRNPC;TRA2B;SRPK1;TXNL4A;PRPF3;SF3B2;SF3B1;NOL3;DDX39B;SRSF7
prerank,positive regulation of lyase activity (GO:0051349),0.476684109254966,1.0002281845621555,0.48214285714285715,0.8762884607744923,1.0,3/14,11.92%,CACNA1C;NF1;FXN
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.42756749240202246,-1.000078002633151,0.42857142857142855,0.8042705588271745,1.0,2/10,1.18%,VTN;PRKCB
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.4581059269844155,0.9999379893643874,0.47112462006079026,0.8764312517278634,1.0,6/15,14.70%,CAMK2D;NR4A3;MEF2A;SLC9A1;PARP1;PRKCA
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.34079227743413687,0.9996882597286825,0.48120300751879697,0.8764726376362703,1.0,39/149,21.82%,CARD14;SLCO3A1;EDA;ERC1;RAB7B;RIPK4;IRAK3;STAT3;TAB3;ROR1;IKBKG;TLR4;CIB1;RIPK2;MAP3K7;TAB2;EIF2AK2;CLU;MYD88;TRAF2;TIRAP;MTDH;CARD16;PIDD1;TRAF6;FLOT1;TRAF5;IKBKB;PSMA6;RBCK1;TICAM1;DHX9;CHUK;ZBTB7A;MID2;FER;NFKB2;CRNN;TRADD
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.34863397047720585,0.9994845398299219,0.4907103825136612,0.8763989347833145,1.0,31/105,24.68%,PRKCD;NRAS;KRAS;PSMB2;PLCG2;TAB3;CREBBP;IKBKG;PSMD11;PSMC1;CUL1;MAP3K7;TAB2;PSMC6;RAF1;PSMD1;TRAF6;PSMD4;IKBKB;PSMA6;PSMD14;PSMD12;PSMD7;CHUK;RELB;PSME3;PSMD3;PSMB6;PAK2;FBXW11;SRC
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.30296279348478267,-0.9994297760512733,0.4497354497354497,0.804545007747185,1.0,13/40,23.11%,IGF1;BCL2L1;PDCD5;PINK1;BCL2L11;TNFSF10;PYCARD;HGF;BIK;TRIAP1;MFF;AKT1;GPER1
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",-0.3464155309552607,-0.9993663766555029,0.43346007604562736,0.8032421017341487,1.0,6/25,10.12%,GRID2;GRIN2A;GRIN2B;MEF2C;GRIN1;GLRA1
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.30821372704210764,-0.9990368988060614,0.4460093896713615,0.8026072484374783,1.0,6/37,3.09%,IL1RAPL1;CADM1;GRID2;TENM3;TENM2;VCAM1
prerank,positive regulation of type I interferon production (GO:0032481),0.3634988153282774,0.9983980885281438,0.48786127167630056,0.8785987406279248,1.0,23/73,21.44%,SETD2;CREBBP;IRF1;TLR4;MAVS;IFIH1;RIPK2;DHX36;CGAS;TLR8;POLR3F;POLR3A;MYD88;POLR3K;POLR3E;PRKDC;FLOT1;POLR3D;DHX9;XRCC5;CHUK;NFKB2;IRF3
prerank,embryonic heart tube development (GO:0035050),0.468913076963427,0.99815944386889,0.47560975609756095,0.8786221175602387,1.0,2/14,3.09%,HES1;PITX2
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.42977855166162127,0.9973874410970498,0.46372688477951635,0.8798905396891394,1.0,3/19,3.77%,EXT1;HS6ST2;XYLT1
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.4315267395029607,0.9972767245003191,0.4745042492917847,0.8789846403344378,1.0,4/21,12.25%,EYA2;EYA4;MCL1;EYA3
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.4315267395029607,0.9972767245003191,0.4745042492917847,0.8789846403344378,1.0,4/21,12.25%,EYA2;EYA4;MCL1;EYA3
prerank,autophagosome assembly (GO:0000045),0.3771126255327618,0.996937108227487,0.46410891089108913,0.8792645276960921,1.0,13/52,18.39%,ULK2;RAB43;BECN1;WDR45B;ATG3;TP53INP2;RB1CC1;ATG5;STX12;WIPI2;RAB1A;SMURF1;UBXN2B
prerank,protein kinase A signaling (GO:0010737),0.4753869125640118,0.9968680483651173,0.4671875,0.8788602909814246,1.0,2/12,9.01%,EZR;RDX
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.4902905343106415,0.9968168103678519,0.48012718600953896,0.878407257629056,1.0,2/10,9.96%,AOC3;ETFBKMT
prerank,negative regulation of secretion (GO:0051048),-0.43616711472244185,-0.9966365253534842,0.4604904632152589,0.8076326963204068,1.0,7/10,31.90%,NR1H3;PTGER3;ERBB3;CD74;NRG1;VAMP8;TIFAB
prerank,positive regulation of interferon-beta production (GO:0032728),0.40286399693733776,0.9963907869464874,0.4791666666666667,0.8788118481494477,1.0,11/33,18.46%,IRF1;TLR4;MAVS;IFIH1;RIPK2;TLR8;POLR3F;POLR3A;FLOT1;POLR3D;DHX9
prerank,histone H2A ubiquitination (GO:0033522),0.44761289026791146,0.9962227288665495,0.4859675036927622,0.8786412066749812,1.0,9/17,30.68%,UBE2A;BCOR;RNF8;UBE2B;PCGF1;DDB1;RNF168;DTX3L;DDB2
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.4159113302810434,-0.9961385545524702,0.455026455026455,0.8074500413433643,1.0,7/11,32.19%,RPS6KA6;HIPK2;KAT5;ING4;SP100;TFAP4;MUC1
prerank,epithelial structure maintenance (GO:0010669),-0.41076483044732837,-0.9959878116185513,0.4745762711864407,0.8063718246126094,1.0,6/11,32.17%,RBP4;NOD2;MUC13;PIWIL4;STRAP;MUC6
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.46322392710343163,0.995928328378115,0.49554896142433236,0.8787714081541385,1.0,3/13,4.80%,RAMP1;SOAT1;IL33
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.42263588511123595,0.99577288883892,0.47214484679665736,0.878590520175514,1.0,2/23,1.65%,HES1;CYP1B1
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.44098438074618507,0.9956053355863493,0.5014164305949008,0.8784341220393334,1.0,12/18,37.99%,RNF185;MAN1B1;SEL1L;UBB;UBA52;RPS27A;RNF139;TRIM13;SYVN1;RNF5;EDEM2;AMFR
prerank,regulation of lipid metabolic process (GO:0019216),0.35149702902119023,0.9951553782968823,0.4856156501726122,0.8789592266617722,1.0,22/88,19.88%,TNFAIP8L3;ID2;CREBBP;RORA;NCOR1;ABCA7;CHD9;NCOR2;RXRA;ACACA;TBL1X;GGPS1;NCOA6;NR1D1;SREBF1;NFYA;SQLE;SCD;HMGCR;PPARG;TGS1;NR1D2
prerank,myelin assembly (GO:0032288),0.505872662689807,0.9951494130234934,0.5008156606851549,0.8784040984532252,1.0,2/10,4.26%,CD9;PMP22
prerank,regulation of neutrophil migration (GO:1902622),-0.433836507980375,-0.9951170832134584,0.45901639344262296,0.8072119744410227,1.0,3/10,9.52%,JAM3;RAC1;RHOH
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.37481249742487854,0.9947639941383828,0.49403341288782815,0.8787800267752999,1.0,17/59,19.08%,TCF7L2;MED13;TWIST1;MED24;CCND1;RUNX2;MED27;CCNB1;MECP2;MED15;MED31;SOX9;CDKN1A;MOV10;MED20;MED16;MED25
prerank,natural killer cell activation (GO:0030101),0.42563440369192496,0.9946472297331406,0.48044692737430167,0.8784656875483355,1.0,3/23,5.98%,PBX1;CD2;NFIL3
prerank,determination of bilateral symmetry (GO:0009855),0.4247389209372423,0.9945840298092541,0.4791666666666667,0.8780315316114095,1.0,8/25,18.88%,PITX2;DNAAF4;GALNT11;KIF3B;NPHP3;ODAD2;MKKS;ODAD3
prerank,regulation of protein secretion (GO:0050708),0.34462535381532317,0.9945145660863308,0.48968512486427795,0.8776397289424341,1.0,19/119,12.51%,SLC12A2;CACNA1C;ADAM9;EZR;UNC13B;DISP1;KCNB1;KCNS3;TGFB3;SYTL4;BMP6;DNAJC1;P3H1;DPH3;SERGEF;RAP1A;DRD3;SLC8B1;APBB3
prerank,RNA interference (GO:0016246),0.4520261300034128,0.9941532773330666,0.47569955817378495,0.8779401350761787,1.0,11/17,29.69%,AGO2;CELF1;DHX9;MRPL44;CLP1;DICER1;PRKRA;DROSHA;AGO1;TSN;TSNAX
prerank,cellular response to UV (GO:0034644),0.358105987081954,0.9940478362779978,0.4964871194379391,0.8776434573068075,1.0,22/76,24.41%,NEDD4;PRKCD;TIMP1;CREBBP;KDM1A;PARP1;DHX36;EIF2S1;ZBTB1;CARD16;USP28;CDKN1A;USP47;ACTR5;ATR;ERCC4;YY1;FMR1;CHEK1;HYAL1;TP53;INO80
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.40150572340988444,0.993942774400911,0.4946949602122016,0.8773204437489543,1.0,5/35,5.77%,MET;SEMA3E;NRP1;SEMA3C;SEMA3D
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.39207057730401224,0.9939087601118336,0.4796954314720812,0.8768311199180684,1.0,6/43,6.83%,EGFR;PTPN3;CBLC;RNF126;PTPN2;RNF115
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.39808219475469775,-0.9934619346204615,0.4699140401146132,0.8100618059205816,1.0,4/12,13.51%,LYN;CD300A;ELF2;PTPN22
prerank,positive regulation of response to external stimulus (GO:0032103),0.3390533106501398,0.993419933491133,0.505971769815418,0.8774430343308104,1.0,28/128,18.53%,THBS1;THBD;CCL3;CCL1;IL33;USP15;BMP6;IL17RA;NLRP12;TLR4;GPR4;PDCD4;ANKRD17;TLR8;POLR3F;IFI35;PRKCA;CNTF;AKIRIN2;PLSCR1;ABCC1;PTN;TNIP1;POLR3D;SCIMP;CCN4;DHX9;PUM2
prerank,muscle cell development (GO:0055001),-0.3215278430003282,-0.9930841586187414,0.466403162055336,0.8095141783055003,1.0,9/30,9.74%,IGF1;ENG;SLC8A1;SGCZ;DYSF;MYH11;MYOF;HEY2;BIN1
prerank,negative regulation of cell cycle (GO:0045786),0.36361275306834756,0.9927760730805927,0.4894859813084112,0.8784379179686195,1.0,18/73,19.69%,BMP4;PTPN3;GAS1;INHBA;FOXC1;PDCD4;ANGEL2;BTG3;MAD2L1;CDKN1C;IPO7;CDKN1B;NR4A1;SCRIB;RB1;TSPYL2;TRIM35;HEXIM1
prerank,GPI anchor biosynthetic process (GO:0006506),0.4080798957517312,0.9925235833579645,0.4703448275862069,0.878453886300443,1.0,16/30,33.00%,PGAP2;PIGT;PIGU;PIGO;PIGK;DPM1;MPPE1;GPAA1;PIGG;PGAP3;PIGB;PIGQ;PIGV;PIGA;PIGS;PIGP
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.502170373215284,0.9924780069741165,0.5008210180623974,0.8779995228448053,1.0,2/10,3.88%,PID1;GRB10
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.47021834558551845,0.9924018598359046,0.4930875576036866,0.8776158569700772,1.0,4/13,15.75%,PIK3AP1;IRAK4;MYD88;TRAF6
prerank,negative regulation of autophagy (GO:0010507),0.3712513838377016,0.9923785841967302,0.4745341614906832,0.877111366648322,1.0,24/54,25.36%,MET;EIF4G3;STAT3;TAB3;NRBP2;LZTS1;EIF4G2;KLHL22;TAB2;MCL1;RUBCN;SNRNP70;FOXK1;LRRK2;TLK2;EIF4G1;FOXK2;DAP;USP36;HTR2B;MTMR9;MTOR;SMCR8;TSC1
prerank,glutathione metabolic process (GO:0006749),0.38793675575720715,0.9921603238541187,0.49230769230769234,0.8770205225652503,1.0,7/38,12.95%,GCLC;MMACHC;GSR;GSTT1;GSTA2;GSTT2;DPEP1
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.33959126908854537,0.9919539725668166,0.49245689655172414,0.876968023210035,1.0,26/113,20.19%,TRABD2B;MPP7;UNC13B;CLTRN;VEGFA;ESR1;GSK3B;ERCC5;SPIDR;TLR4;CHD1L;VCP;PARP1;PSMC6;SH3GLB1;CLU;MYD88;TIRAP;CDC42EP2;GTF2H3;MED25;ATR;EIF4G1;FERMT2;ERCC4;LGALS3
prerank,regulation of protein-containing complex assembly (GO:0043254),0.34472031932179953,0.9918920658663973,0.5021834061135371,0.8765471568610522,1.0,25/110,18.20%,TRABD2B;GSN;MPP7;VEGFA;GSK3B;SPIDR;KIF9;TMC8;VCP;ANKRA2;EIF2AK2;HJURP;SH3GLB1;CLU;TRAF2;RAF1;TIRAP;SORL1;ATF7IP;CDC42EP2;HCFC1;RB1;STXBP1;FARP2;RALB
prerank,prostaglandin metabolic process (GO:0006693),-0.3287744240396928,-0.9918768892599853,0.46564885496183206,0.8112729220358796,1.0,8/26,15.87%,PTGDS;PTGS1;EDN1;TBXAS1;GSTM1;MIF;HPGDS;CD74
prerank,DNA recombination (GO:0006310),0.39034159862701523,0.9918657014617817,0.480719794344473,0.8760550037939389,1.0,17/37,34.14%,EXO1;RAD51;WRN;RAD50;RECQL5;RAD52;RAD51D;RECQL;RAD21;RAD54L;RAD51B;TSN;GEN1;RPAIN;ENDOG;RPA1;DMC1
prerank,regulation of osteoclast differentiation (GO:0045670),0.39729766050691945,0.9918219553408569,0.4889807162534435,0.8755880567704011,1.0,5/33,10.39%,UBASH3B;CCL3;TLR4;TCTA;POU4F1
prerank,pyruvate metabolic process (GO:0006090),0.37588960234913316,0.9915445854681241,0.4919454770755886,0.8757285524865489,1.0,6/52,10.46%,ME1;SLC16A1;NR4A3;PFKFB1;GPI;PDHA1
prerank,regulation of microtubule polymerization (GO:0031113),-0.2992540463759042,-0.9913275701396733,0.46445497630331756,0.8112330843486196,1.0,14/40,14.04%,OCLN;PAK1;MAP2;NAV3;RPS3;STMN1;CDK5RAP2;DYRK1A;RAC1;MAPT;CAMSAP2;CDH5;CLIP3;FES
prerank,cellular response to cytokine stimulus (GO:0071345),0.3214883202492294,0.9909305352842148,0.5362903225806451,0.8765999712729636,1.0,52/416,10.42%,F3;STK39;SLC12A2;DPYSL3;PID1;LBP;TANK;WNK1;NFAT5;FGF2;GAB2;IL22RA1;SLC26A6;PTGIS;YBX3;VEGFA;IL20RB;NFE2L2;CXCL2;CLCF1;GSK3B;GRB10;CCL3;CCL1;TIMP1;IRAK3;PTPN2;TWIST1;STAT3;SHC1;ANXA1;FOXO3;CTF1;NLRP12;IRAK4;RORA;FN1;ITGB1;ZFAND6;IRF1;ZC3H12A;CCND1;TLR4;EGR1;CD80;FOXC1;EPRS1;CIB1;CCL7;ERBIN;POU4F1;RHOA
prerank,protein localization to membrane (GO:0072657),0.3320606523787774,0.990757122735664,0.5191313340227508,0.8764633911791466,1.0,46/187,16.73%,KCNB2;LRP6;RAMP1;CDH1;ANK2;ATP1B1;EZR;FGF13;SLMAP;KCNB1;DLG2;SEC16A;TTC7A;ZDHHC2;FCHO2;TSPAN17;RDX;EHD2;S100A10;GAK;C2CD5;ARL3;PLEKHF1;TM9SF4;RAP1A;NPC1;NLGN1;JUP;SH3GLB1;PIP5K1A;NUP155;SYNJ2BP;ZDHHC15;ITGB1BP1;EHD1;DLG1;NRXN2;AP3D1;RAB11B;SCN3B;RAB40B;DVL1;PTN;FLOT1;SCRIB;IKBKB
prerank,regulation of protein polymerization (GO:0032271),-0.30396032917036964,-0.9904187000889291,0.472,0.8122749275551048,1.0,6/35,10.20%,ARHGAP28;ESAM;MAP2;PAK3;MAPT;CAMSAP2
prerank,regulation of superoxide anion generation (GO:0032928),0.4500611913638931,0.9902131159754712,0.4679186228482003,0.8772113132883327,1.0,1/14,1.64%,PRKCD
prerank,negative regulation of lyase activity (GO:0051350),-0.3712780430354065,-0.9900345383805161,0.45231607629427795,0.8118440666378662,1.0,3/16,8.27%,GRM3;ADGRV1;GABBR2
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),-0.31054549394577485,-0.9898831446958279,0.448559670781893,0.8108141069118974,1.0,5/33,5.75%,PRKG1;APOD;OGN;IGFBP3;MEF2C
prerank,negative regulation of transport (GO:0051051),-0.27850358802445024,-0.9897778703637413,0.430939226519337,0.8096062172867731,1.0,12/51,14.62%,PRKD1;MCTP1;CTTNBP2NL;DYSF;SIRPA;NR1H3;BST2;SYT11;RACK1;NR1H2;ERBB3;SNX3
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.3570838407556572,0.9897011958442935,0.4924506387921022,0.8778493385680861,1.0,7/75,5.44%,BMP4;LRP6;PRKCD;CBLC;ABL1;IRAK3;NF1
prerank,regulation of cell cycle process (GO:0010564),0.34571979565871774,0.9886165257463055,0.485838779956427,0.8798541800660022,1.0,27/104,21.06%,CCDC8;TXLNG;KIF13A;SETD2;AURKA;RAB11FIP3;KNSTRN;BECN1;CDK13;AHCTF1;PLK4;FBXO5;SH3GLB1;PRMT5;SOX9;CEP85;PIN1;PLK3;E4F1;RMI2;TTL;CETN2;BORA;MAD1L1;USP19;RAB11A;BIRC6
prerank,RNA stabilization (GO:0043489),0.40753627959214145,0.9885847581882641,0.5052356020942408,0.8793598547959637,1.0,10/33,20.56%,THRAP3;PABPC1;DHX36;TENT2;FUS;E2F1;CIRBP;GDNF;NAF1;TRDMT1
prerank,nucleosome organization (GO:0034728),0.3703691769630217,0.9884898117686276,0.4885954381752701,0.8790179977216005,1.0,23/55,29.87%,CHAF1B;SRCAP;SETD2;CHAF1A;SMARCC1;DMAP1;RNF8;ATRX;SOX9;KAT6B;SMARCA5;VPS72;NAA60;NAP1L1;HMGA1;ASF1A;INO80;RSF1;SMARCA4;NASP;BRDT;ANP32E;SMARCE1
prerank,negative regulation of organelle assembly (GO:1902116),0.3943532827738884,0.9884683863977619,0.47112860892388453,0.8785235518063074,1.0,9/35,17.77%,CDK10;RBM14;TMEM39A;STYXL1;LIMK2;BRCA1;SMAD4;YAP1;LRRK2
prerank,cellular response to catecholamine stimulus (GO:0071870),-0.3411287573017022,-0.9883355465349404,0.48161764705882354,0.8119672289464813,1.0,8/23,15.17%,PDE4B;RYR2;TGM2;GNG2;MAPK1;KCNQ1;SIRT2;APLP1
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.3020876066742657,-0.9883226901765119,0.4889867841409692,0.810564804262624,1.0,12/37,15.81%,CEMIP;APP;SPRED1;BMP7;MAPK1;CADM4;CALM1;SPHK1;WNK3;SIRT2;PRKAG2;STOX1
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.27534191110581785,-0.987846295818503,0.4918032786885246,0.8103916756859935,1.0,9/54,11.45%,NSA2;RPL7;NPM1;RPL23A;RPL26;RPL35A;RPL10A;RPL11;SNU13
prerank,snRNA transcription (GO:0009301),0.35707630066580764,0.9876374317106298,0.49227110582639716,0.8799535427970441,1.0,24/70,26.01%,NABP1;SNAPC2;INTS5;GTF2E1;INTS6;GTF2A2;POU2F1;CDK7;CCNT2;INTS7;TAF5;ELL2;POLR2C;CCNT1;ICE2;TAF8;TBP;INTS1;INTS14;TAF13;GTF2B;INTS8;INTS2;ELL
prerank,neuron apoptotic process (GO:0051402),-0.36055740052049845,-0.9875905014985776,0.504885993485342,0.8096431362583568,1.0,7/19,13.95%,BCL2;APP;TNFRSF21;FAS;GAPDH;ATN1;ERBB3
prerank,positive regulation of protein acetylation (GO:1901985),-0.40673735727759575,-0.9875824850060066,0.49222797927461137,0.8082086607496831,1.0,4/12,15.82%,RAPGEF3;PRKAA2;DDX3X;KAT5
prerank,cellular response to virus (GO:0098586),0.39914623343733413,0.9875174476421575,0.46908602150537637,0.8796903027174349,1.0,9/30,22.06%,GBF1;ZC3H12A;IFIH1;VWCE;RRP1B;GSDME;CHUK;IRF3;FMR1
prerank,positive regulation of calcium ion import (GO:0090280),-0.4015148296421317,-0.9873341720848502,0.4702702702702703,0.8074125863812263,1.0,2/12,3.42%,PDGFRB;CXCL12
prerank,apoptotic process (GO:0006915),0.3314047033878047,0.9872652396026925,0.5025799793601651,0.8797341473552269,1.0,54/203,21.82%,PLAGL1;CIT;PRKCD;CYFIP2;CASP6;PRKCE;PTK2B;EFNA5;CD2;PAWR;EGLN3;NOTCH2;RFK;MAGI3;MCM2;ZBTB16;TGFBR2;PLSCR3;CASP2;CDK11B;IKBKG;IRF1;FEM1B;SFRP5;PDCD4;CIB1;PARP1;MAP3K7;YARS1;MYD88;RAF1;BRAT1;PIDD1;PLSCR1;BNIP1;ADAM15;MAP3K10;PLK3;FAP;STK3;FAM162A;DAPK1;BCL2L13;JAK2;NUDT2;AIFM1;TRAF7;CDIP1;RELT;IAPP;DAP;IRF3;MRPS30;TRADD
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.3545220926147011,-0.9868724694565651,0.468013468013468,0.8071696599792586,1.0,6/18,10.66%,IL34;DAAM2;TNFRSF21;NOTCH1;TENM4;OPALIN
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.30344654294495,-0.9868165625909563,0.472,0.8059106127854453,1.0,10/34,17.16%,LYN;MFHAS1;LGR4;GRAMD4;DAB2IP;CD300A;SARM1;NLRP2B;TYRO3;CACTIN
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.4753237684191871,0.9866961066988622,0.49756888168557534,0.880576386896309,1.0,2/12,4.80%,CCL3;IL33
prerank,brain morphogenesis (GO:0048854),-0.39524532246204,-0.9864406597007698,0.4714285714285714,0.8054855217503862,1.0,2/12,2.59%,SHANK3;CTNNA2
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.4208972177420935,0.9862888160212419,0.4815340909090909,0.881026594418394,1.0,9/22,23.19%,GSK3B;STYXL1;CRY2;PTPA;MGAT5;IKBKB;NCKAP1L;LGALS3;BOD1L1
prerank,regulation of interleukin-6 production (GO:0032675),0.34808497896304613,0.9862808230631346,0.4745575221238938,0.8804853602300234,1.0,18/96,13.32%,LBP;RAB7B;PLCG2;IRAK3;TLR1;IL33;TWIST1;STAT3;C5AR2;IL17RA;NLRP12;ZC3H12A;TLR4;MAVS;IFIH1;TLR8;MYD88;TIRAP
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.4837361594541248,0.9861634482051882,0.5056726094003241,0.8802123771600382,1.0,1/11,2.93%,TAS1R3
prerank,positive regulation of innate immune response (GO:0045089),0.40927843797593855,0.9860767375447779,0.48333333333333334,0.879848264411767,1.0,10/30,18.46%,LBP;MAVS;TLR8;POLR3F;IFI35;UBE2K;AKIRIN2;PLSCR1;POLR3D;DHX9
prerank,autophagy of peroxisome (GO:0030242),0.4714202899633721,0.9860211886263888,0.4984423676012461,0.8794257993531744,1.0,8/12,30.27%,ACBD5;RB1CC1;NBR1;USP30;ATM;MAP1LC3B;SQSTM1;PIK3R4
prerank,regulation of macrophage cytokine production (GO:0010935),0.4616311639302548,0.985153236675267,0.4969230769230769,0.8809301066202451,1.0,3/13,4.61%,TGFB3;PLCG2;IRAK3
prerank,mitochondrial membrane organization (GO:0007006),-0.3124910416537015,-0.9849959246155673,0.4921259842519685,0.8078335940856844,1.0,7/32,17.52%,BCL2;BCL2L1;CHCHD6;APOOL;DNAJC11;MFN1;MTX1
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.4269406685054231,0.984942713863491,0.4764621968616263,0.8808727014265593,1.0,2/21,4.08%,FOXP1;ELF1
prerank,positive regulation of keratinocyte migration (GO:0051549),0.4952719557674941,0.9849028742385482,0.5064516129032258,0.8804025347408508,1.0,1/10,1.31%,ADAM9
prerank,regulation of protein autophosphorylation (GO:0031952),0.3927673025114295,0.984817789519719,0.506426735218509,0.8800458312534581,1.0,10/36,14.37%,RASSF2;VEGFA;PDGFC;NLRP12;PPP2R5C;TOM1L1;CHP1;RAD50;TNKS1BP1;RAP2C
prerank,negative regulation of cyclase activity (GO:0031280),-0.3886919539050462,-0.9847580003474455,0.4462809917355372,0.8070607643646923,1.0,3/14,8.27%,GRM3;ADGRV1;GABBR2
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.41325387930461654,0.9847150053666592,0.4946091644204852,0.8797208053667813,1.0,7/26,13.31%,EFNA5;CLTRN;KLF7;TRPM4;CDK16;NR1D1;LRP5
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.3398891165636231,0.9844425004294788,0.5098468271334792,0.8798197050757729,1.0,31/129,19.15%,FBXL7;CCNA2;PPP1R12B;CHEK2;MNAT1;PCM1;AURKA;PAFAH1B1;CEP43;AKAP9;SDCCAG8;CUL1;HAUS2;CCNB1;CEP63;PLK4;PCNT;PPP1R12A;KHDRBS1;CDK7;OFD1;CDK2;CDKN1A;PLK3;ARPP19;CENPJ;CEP164;CETN2;WEE1;FBXL6;BORA
prerank,positive regulation of JNK cascade (GO:0046330),0.35908061519243073,0.9843595688445139,0.49074074074074076,0.8794583182793014,1.0,6/70,3.81%,RASSF2;MAP3K5;PTK2B;SH3RF3;GADD45G;FZD7
prerank,plasma membrane repair (GO:0001778),0.4681776770978795,0.984301183827903,0.4789156626506024,0.8790433230375213,1.0,2/13,3.71%,AHNAK2;SYTL4
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.4267766901181775,0.9842536458560994,0.47150997150997154,0.8785913479798076,1.0,3/21,10.89%,FOXP1;IKBKG;TRAT1
prerank,protein mannosylation (GO:0035268),0.42285343091386335,0.9840896159466643,0.4854771784232365,0.8784219971584043,1.0,9/22,23.33%,TMTC1;LARGE1;DPY19L3;B4GAT1;TMTC3;DPM1;LARGE2;POMT2;POMT1
prerank,nervous system development (GO:0007399),0.3198100711427934,0.9839950281344206,0.5542168674698795,0.8780947807406294,1.0,47/429,7.68%,WWP1;PCDHB16;DCLK1;CRIM1;MET;PKD1;MBNL1;HES1;HDAC4;CDH1;ZIC4;RBFOX2;GSN;EFNA5;FGF13;FGF2;ECRG4;DMBX1;NGF;SOX14;PCDHB9;GRHL2;NELL1;ELP3;VEGFA;PCDHA1;SMO;ZIC1;NOTCH2;GLRB;PMP22;S100B;TGFBR1;NOG;PDGFC;STAT3;NF1;ZBTB16;DACT1;NBL1;SNTG2;ST8SIA2;GLIS2;INHBA;TENM1;FN1;SCRG1
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.38789813925464267,-0.9832206957360817,0.48427672955974843,0.8096774380937002,1.0,4/13,8.41%,SLC8A1;ANK3;PDE4D;CALM1
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.3833479794907629,0.9831695480209471,0.48886138613861385,0.8795000415819064,1.0,10/42,11.81%,PTK2B;NRP1;VEGFA;GSK3B;LIMS1;ABL1;MYOC;S100A10;CIB1;JUP
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.4075438076647544,0.983089481272729,0.503448275862069,0.8791452939779324,1.0,7/29,20.80%,BMP5;SPRED2;IL17RD;LDLRAD4;SMAD7;SDHAF2;NKX2-1
prerank,membrane lipid biosynthetic process (GO:0046467),0.3688620778132666,0.9830452463224671,0.49210206561360875,0.8786953106043123,1.0,4/58,3.51%,ST3GAL4;ACER3;PLPP3;SGMS2
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.4718988691525306,0.9830257455190958,0.5063492063492063,0.8781787678024037,1.0,3/13,11.61%,B3GNT2;B4GAT1;B3GNT9
prerank,myelination (GO:0042552),0.37126499429437654,0.9825140826728037,0.49302915082382764,0.8788653100232836,1.0,7/46,7.52%,ACER3;MARVELD1;PMP22;NF1;SKI;MYOC;ABCD1
prerank,aerobic respiration (GO:0009060),-0.3445634017579492,-0.9823784431099976,0.48639455782312924,0.8104687090361259,1.0,6/20,18.98%,UQCRH;UQCR10;UQCRC1;ME3;MTFR2;SDHC
prerank,liver development (GO:0001889),0.40267300557016983,0.9818176627377889,0.49867724867724866,0.8799620909410145,1.0,5/32,6.91%,MET;COBL;ANXA1;NF1;AURKA
prerank,protein glycosylation (GO:0006486),0.3318794429326624,0.9814198121665282,0.5158469945355191,0.8803438919624592,1.0,35/125,23.62%,ST3GAL4;PLOD2;FUT8;B3GNT2;MGAT4C;LARGE1;ST8SIA2;B4GALT1;ENTPD5;ALG12;B4GAT1;NPC1;B3GNT9;DPAGT1;POFUT1;MGAT1;GALNT10;MGAT5;OGA;GFPT1;COG3;DDOST;TMEM165;TUSC3;MPI;FUT2;DPM1;GCNT2;ALG8;LARGE2;FUT10;POMT2;POMT1;PGM3;OGT
prerank,pyrimidine-containing compound metabolic process (GO:0072527),-0.4037712133847413,-0.9813519456457851,0.46089385474860334,0.811850649092038,1.0,3/11,15.69%,ENPP3;SLC19A3;DCK
prerank,extracellular matrix assembly (GO:0085029),-0.34038043312765365,-0.9813237672347662,0.46885245901639344,0.8105026802366653,1.0,9/23,14.42%,QSOX1;LAMB1;MYH11;MFAP4;GPM6B;GAS6;LAMB2;FBLN5;EFEMP2
prerank,positive regulation of neuron migration (GO:2001224),-0.4076849250532892,-0.9810771534385633,0.48148148148148145,0.8097216550810282,1.0,3/11,7.11%,SEMA6A;RAPGEF2;DAB2IP
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.44898244081547134,0.9810046674610468,0.5064377682403434,0.8808205960774629,1.0,3/16,1.84%,CACNA1C;CAMK2D;ANK2
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.4021621825966036,-0.9808121813409154,0.45879120879120877,0.809027201189015,1.0,7/11,24.07%,PAK1;STMN1;RAC1;SIRT2;HGF;MST1R;BCAR1
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.3720573095566983,0.9807591285314061,0.5105853051058531,0.8808447104189755,1.0,12/50,16.26%,CCNA2;MNAT1;CCND1;CDKN2C;CCNB1;CDKN1C;CDKN1B;CDKN3;CCNG1;CDK7;CCNT2;CDKN1A
prerank,glutathione biosynthetic process (GO:0006750),0.4764195678697942,0.9807219080726091,0.5045454545454545,0.8803729242426075,1.0,1/11,1.99%,GCLC
prerank,cell cycle G2/M phase transition (GO:0044839),0.3378774837710332,0.9806371113453052,0.5256270447110142,0.8800347608628131,1.0,31/130,19.15%,FBXL7;CCNA2;PPP1R12B;CHEK2;MNAT1;PCM1;AURKA;PAFAH1B1;CEP43;AKAP9;SDCCAG8;CUL1;HAUS2;CCNB1;CEP63;PLK4;PCNT;PPP1R12A;KHDRBS1;CDK7;OFD1;CDK2;CDKN1A;PLK3;ARPP19;CENPJ;CEP164;CETN2;WEE1;FBXL6;BORA
prerank,positive regulation of cell death (GO:0010942),0.3646389634948821,0.980574712126662,0.5036585365853659,0.8796333817617527,1.0,12/59,14.07%,BMP4;MAP3K5;GSK3B;LRP1;ZC3H12A;EGR1;RIPK2;EIF2S1;CLU;CDKN1B;CELF1;HTATIP2
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.4631787272750153,0.9802825715046568,0.49928057553956834,0.8797696341981485,1.0,6/13,17.82%,RGPD1;KPNA1;KPNA2;RANBP2;KPNA4;NUP35
prerank,positive regulation of biosynthetic process (GO:0009891),0.3846012028641829,0.9802365776946554,0.49429657794676807,0.8793204663444405,1.0,6/40,10.84%,BMP4;TGFB3;PLCG2;MLXIPL;TLR4;CREB3L1
prerank,bicellular tight junction assembly (GO:0070830),-0.2938482458408636,-0.9802304417846505,0.4976958525345622,0.8090816263227427,1.0,6/46,3.74%,PARD6G;PECAM1;OCLN;CLDN5;ESAM;F11R
prerank,negative regulation of cellular component organization (GO:0051129),0.35746127749133083,0.9801686347897777,0.5022471910112359,0.8789246878702123,1.0,18/74,21.26%,TMEFF2;VEGFA;GSK3B;IRAK3;BMP6;ABCA7;TMC8;RDX;CLU;RAF1;SORL1;RUBCN;FAP;LRSAM1;XRCC5;LGALS3;DNAJB2;IAPP
prerank,protein O-linked mannosylation (GO:0035269),0.43117024096745826,0.9800733656365161,0.4837799717912553,0.8785953976188289,1.0,8/18,23.33%,TMTC1;LARGE1;B4GAT1;TMTC3;DPM1;LARGE2;POMT2;POMT1
prerank,negative regulation of signaling (GO:0023057),0.4098119279606093,0.9795752138490882,0.5062413314840499,0.8792445062140216,1.0,6/25,16.08%,UBASH3B;SRMS;NLRP12;TRAT1;ACVR1;HHIP
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.35510839613190576,0.979492781047468,0.5047732696897375,0.8788771355261561,1.0,14/74,11.27%,BMP5;TGFB3;PHLDB2;TGFBR1;TWIST1;SPRED2;TIAM1;TGFBR2;IL17RD;SMAD2;FOXC1;PHLDB1;TGFB1I1;LDLRAD4
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.3679828914894284,-0.9794737496867941,0.45751633986928103,0.8096781075547069,1.0,10/16,35.19%,ATP5PF;ATP5F1E;ATP5F1A;ATP5F1B;ATP5MC1;ATP5MC2;ATP5MC3;ATP5F1D;DMAC2L;STOML2
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.3767945289358302,0.9793013080572139,0.5127551020408163,0.8787799790827389,1.0,6/41,8.33%,LBP;RARA;IRAK3;C5AR2;ZC3H12A;TLR4
prerank,cardiac muscle contraction (GO:0060048),0.3918535672930932,0.9790226227257716,0.5013157894736842,0.8788641321769564,1.0,4/34,1.98%,CSRP3;CAMK2D;GSN;ATP1B1
prerank,regulation of MAP kinase activity (GO:0043405),0.34296498460331154,0.9788405479691915,0.5174746335963923,0.8787157268341924,1.0,13/92,7.25%,BMP4;EGFR;PRKCD;FGF2;CBLC;VEGFA;CDK12;IRAK3;PDGFC;FGFR1;NF1;ERBB2;TENM1
prerank,striated muscle cell development (GO:0055002),-0.3794436382768846,-0.9788312205505156,0.4789156626506024,0.8099439903979411,1.0,3/14,10.51%,PGM5;LMOD1;TMOD1
prerank,cholesterol homeostasis (GO:0042632),0.3524674731940748,0.9787379215932164,0.4892344497607656,0.8783865428882762,1.0,12/64,13.31%,SOAT1;HDAC9;LDLR;TSKU;LIMA1;RORA;NPC1;ANGPTL3;SOAT2;NR1D1;EHD1;LRP5
prerank,positive regulation of developmental process (GO:0051094),0.3284122525946609,0.9785860486530727,0.5363540569020021,0.8781848016696774,1.0,39/164,16.80%,BMP4;FOXD1;BMP1;COBL;BMP5;NLRP5;VEGFA;BMPR1A;PHLDB2;FGFR1;ZBTB16;LMNA;AGO2;AURKA;SHANK1;AGR2;FOXO6;TRPM4;CORO1C;TMEM119;PHLDB1;CDC20;MIEF1;NLGN1;MCU;FBXO5;NIBAN2;RPS6KA3;KMT5B;ZDHHC15;SORL1;ACVR1;SOX9;DVL1;PTN;DLG5;GDNF;MIEF2;SYDE1
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.3632944275685354,0.9783514704998786,0.5136094674556213,0.8781753065114335,1.0,12/67,10.42%,PGF;VAV2;CYFIP2;ABI1;PTK2B;NRP1;VEGFA;NCK2;SULF1;AAMP;ITGAV;RHOA
prerank,negative regulation of DNA replication (GO:0008156),0.46186563121956814,0.9782563425805247,0.4984423676012461,0.8778495710440193,1.0,7/13,25.26%,RAD17;TSPYL2;ATR;S100A11;WAPL;GTPBP4;CDC6
prerank,urogenital system development (GO:0001655),0.4837404697330286,0.9781633166994587,0.5109375,0.8775223658656282,1.0,4/11,14.64%,EPHB3;ANXA1;EPHB2;SOX9
prerank,sensory perception of chemical stimulus (GO:0007606),0.45523091456487413,0.9776327831548404,0.5140740740740741,0.8782255445538488,1.0,4/15,18.59%,GNAS;UBR3;ADCY3;MKKS
prerank,endosome organization (GO:0007032),0.3846285625348682,0.9775915080072175,0.4856770833333333,0.8777650096096844,1.0,10/41,15.95%,EEA1;WASHC4;CORO1C;PHETA2;HOOK3;PLEKHF1;WASHC5;ANXA8;ANXA8L1;CHMP2B
prerank,glycoprotein biosynthetic process (GO:0009101),0.3416560656520381,0.977360346661386,0.5079365079365079,0.8777470753953278,1.0,18/79,18.13%,ST3GAL4;FOXL1;B3GNT2;CHST13;XYLT1;LARGE1;ST8SIA2;CHST11;GAL3ST4;B3GALT6;NPC1;B3GNT9;MGAT1;TNIP1;GOLPH3;CHST12;COG3;DDOST
prerank,positive regulation of lamellipodium organization (GO:1902745),-0.3088951520464936,-0.9766170203406591,0.5038461538461538,0.8142837860874219,1.0,4/32,2.21%,AUTS2;ENPP2;OCLN;PIK3R1
prerank,regulation of neuron apoptotic process (GO:0043523),0.3411083091782422,0.9763284250673852,0.5057077625570776,0.8795890283550163,1.0,12/96,6.70%,SIX1;PTK2B;NGF;KCNB1;TGFB3;EGLN3;CLCF1;CCL3;FOXO3;NF1;NFATC4;NRBP2
prerank,cellular protein modification process (GO:0006464),0.3137609911408394,0.9759457474650958,0.611,0.8799485807882123,1.0,205/983,18.49%,THBS1;ST3GAL4;FBXL7;STK39;BMP4;DCLK1;MAP3K5;PLOD2;FSTL1;MARK1;PTP4A2;GRK5;PPP3CA;CCN1;PTPN3;WNK1;PRKCD;CAMK2D;PTPRU;WNT11;PRKCE;IGFBP5;GPC3;PTK2B;CCDC8;LOXL1;UST;COL3A1;B3GNT2;PTPRF;FBXO10;TLK1;BMPR1A;MSLN;DSP;DCAF6;EGLN3;WWP2;PPM1H;CLK2;GSK3B;CDK10;PSMB2;RARA;CDK12;TIMP1;HIPK1;TGFBR1;ABL1;IRAK3;LARGE1;FGFR1;ANXA1;PHKA2;DCAF4;FRK;CHEK2;USP25;NEK7;ZBTB16;SPSB2;MAN2A1;FAM20A;BCR;DCAF5;ST8SIA2;STRADA;ERBB2;TGFBR2;SIRT6;NRBP2;AURKA;LIMK2;ABCA7;FBXL20;CDK11B;FN1;PTPRA;IKBKE;PSMD11;CSNK1A1;CHST5;GRK4;PHEX;FEM1B;CKAP4;DUSP11;NLK;HIF3A;P3H1;MAST2;TGM5;TGM6;CUL3;PSMC1;WDR45B;PARP3;MAK;MIA3;PPP2R5C;CUL1;KLHL22;CDK16;RBBP7;RCN1;CDK13;FBXW8;AAK1;PARP1;PLK4;JMJD4;FBXO27;DNAJC3;CALU;ATG3;EIF2AK2;PDK3;LOX;PSMC6;DDA1;NPC1;CSNK1G3;KEAP1;SBF1;PIGT;KTN1;FBXO31;B3GNT9;PIGU;ATG5;SGK3;ARF4;MAP3K1;DUSP5;ILKAP;MARK2;COPS7B;PTPRS;UBE2M;PNPLA2;RET;CDKL2;MAN2B1;MXRA8;COP1;SIRT3;DCAF7;ACVR1;MORC3;COPS5;WIPI2;PTPN9;PIM2;COMMD1;PPP1R12A;MGAT1;PRKCA;ATG4B;RAB11B;PSMD1;PTPN21;MARK3;CDK7;UBLCP1;UBE2D3;PRKDC;PPP3CC;PSMD4;GGCX;PPP4R2;CDK2;OGA;RAB1A;PPP5C;LCK;UBL5;SIK1;FBXO17;IKBKB;PARP6;SHISA5;CEL;ERN2;DCUN1D1;TULP4;NEK4;SOCS3;PIGK;PSMA6;SDHAF2;UBE2S;LRRK2;DTL;STK24;STK3;COG3;MAPKAPK2;COPS8;DDOST;NUCB1;PARP2;NAA80;PSMD14;PPM1L;PSMD12
prerank,defense response to Gram-negative bacterium (GO:0050829),-0.28550015317085,-0.9759288364519144,0.4931506849315068,0.8146934497642946,1.0,19/42,28.11%,IL6R;OPTN;DEFA6;RPS19;GSDMD;MR1;CHGA;ADGRB1;PYCARD;ROMO1;MPEG1;RARRES2;HMGB2;SERPINE1;TREM2;SELP;TNFRSF14;NOS2;AQP1
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.35690332366106003,0.9758606163185166,0.5152941176470588,0.8795932881845284,1.0,8/73,4.96%,PRKCD;VAV2;CYFIP2;PRKCE;ABI1;PLCG2;ABL1;NR4A3
prerank,regulation of chromosome segregation (GO:0051983),0.4365088288343247,0.9757533297090445,0.49053857350800584,0.8792993822328027,1.0,6/16,25.26%,SMC6;SMC5;RMI2;PUM2;PUM1;CDC6
prerank,regulation of blood circulation (GO:1903522),0.39326242244802234,0.9757453606215836,0.5052356020942408,0.8787789799847328,1.0,3/34,6.15%,KCNMB2;CAMK2D;ECE1
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.4290121399684999,0.9755813546178675,0.5007194244604316,0.8786095475516734,1.0,12/20,29.69%,ZC3H7A;AGO2;PUM2;MRPL44;PUM1;TRIM71;DICER1;PRKRA;DROSHA;AGO1;TSN;TSNAX
prerank,positive regulation of cellular process (GO:0048522),0.3144689033077008,0.9752175367160285,0.5881763527054108,0.8789394195162099,1.0,82/565,12.68%,THBS1;BMP4;EGFR;ZFHX3;ACER3;LRP6;PGF;HES1;HDAC4;NTRK3;GRK5;LBP;PPP3CA;PRKCD;BMP5;PTK2B;FGF2;GAB2;KRAS;IRS1;VEGFA;TGFB3;RAB25;CLCF1;FZD7;RARA;TIMP1;S100B;TGFBR1;PTHLH;FOLR2;LRP1;PDGFC;FGFR1;SHC1;DDX49;TCIRG1;CNOT8;PROK2;LMNA;BMP6;CTF1;ERBB2;TIAM1;TGFBR2;UBE2A;ABCA7;FN1;KITLG;DNPH1;CEP43;ZC3H12A;MLXIPL;CCND1;TLR4;TRPM4;EIF4G2;CUL3;SMC6;CHRD;CIB1;CDC123;ACACA;ITGAV;KLHL22;RIPK2;SMC5;CDK13;TTK;DHX36;GAREM1;NSMCE1;ANKRD17;MECP2;POFUT2;FBXO5;FXN;CDKN1B;RPS6KA3;PARD3;BRAT1;CELF1
prerank,microvillus organization (GO:0032528),0.46836388739890367,0.9751357780396218,0.5022556390977444,0.8785808801909472,1.0,2/13,1.99%,FXYD5;EZR
prerank,cellular response to hexose stimulus (GO:0071331),0.4228254394347173,0.9748026193678572,0.4950911640953717,0.8788359634376465,1.0,4/23,3.32%,UNC13B;SLC26A6;KCNB1;SLC39A14
prerank,plasma membrane invagination (GO:0099024),0.40223359179578444,0.9746919373092571,0.4993324432576769,0.8785460872010982,1.0,5/29,12.14%,GULP1;GSN;ALKBH4;RHOA;SNX18
prerank,protein oxidation (GO:0018158),0.4703360248804057,0.9746477169372918,0.5095541401273885,0.8780930885720747,1.0,4/11,21.56%,LOXL1;LOX;TMX3;LOXL4
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.4694487674900577,0.9742257851623737,0.5121163166397416,0.8785163306128307,1.0,3/11,17.26%,ANXA1;ZC3H12A;SMAD7
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.39459633102381153,-0.9741447523161187,0.47398843930635837,0.8179533740166242,1.0,3/13,8.27%,GRM3;ADGRV1;GABBR2
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.3195039571464608,-0.9738950183290581,0.5146443514644351,0.817156751802431,1.0,10/29,20.24%,ACSL1;ELOVL7;ACSL4;HACD1;HACD2;ACSBG1;ACSL5;ELOVL6;HSD17B12;CBR4
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.39095426212265505,0.9734434817585705,0.5147849462365591,0.8798562551120661,1.0,10/33,19.72%,HOXA5;RAB7B;STAT3;FOXO3;INHBA;ARNT;PITHD1;PRKDC;NCKAP1L;ANKRD54
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.33010321192422065,-0.9733180153802014,0.4641509433962264,0.817233655296532,1.0,10/24,23.42%,BCL2;CXCL12;BCL2L1;TPT1;MIF;CD74;CDKN2D;TAF9;TRIAP1;SNAI2
prerank,protein ubiquitination (GO:0016567),0.31913298417232544,0.9726635144619888,0.5955955955955956,0.8811067646038832,1.0,106/471,19.10%,WWP1;FBXL7;NEDD4;RNF144A;MKRN3;FBXO10;CBLC;NFE2L2;SH3RF3;WWP2;RNF126;PSMB2;UBE4B;TRIM55;RNF114;HERC2;UBR5;FANCL;SPSB2;TRIM47;UBE2A;RNF115;NPEPPS;WAC;BARD1;FBXL20;TRIM39;PSMD11;UVSSA;TSPAN17;RNF185;HIF3A;ARIH1;CUL3;PSMC1;VCP;CDC16;UBE4A;CUL1;ANAPC11;KLHL22;PEX13;ANKIB1;FBXW8;DTX2;FBXO27;ATG3;HECTD2;TRPC4AP;UBE3C;PSMC6;DDA1;DET1;KEAP1;TRIM44;FBXO31;TRIM41;ANAPC16;RNF138;RNF146;TRAF2;BRCA1;UBE2K;UBR3;TRIP12;MIB1;RNF122;RNF8;COMMD1;FBXO45;RNF41;PSMD1;UBE2B;NHLRC1;HERC6;UBE2D3;MKRN2;PRKDC;RNF111;TRAF6;PSMD4;RNF141;UBE2O;RNF11;FBXO17;CNOT4;TMEM129;RNF20;AREL1;RNF14;PSMA6;UBE2S;DTL;RBCK1;SMURF1;MYCBP2;PSMD14;SPOP;PSMD12;CHFR;RMND5A;TRIM35;ENC1;PSMD7;NFX1;VCPIP1
prerank,regulation of interleukin-1 beta production (GO:0032651),0.35602946673377117,0.9726535663998426,0.5229885057471264,0.8805847398711812,1.0,11/66,13.46%,FOXP1;CCL3;STAT3;NLRP12;ZC3H12A;TLR4;EGR1;RIPK2;TLR8;MYD88;CARD16
prerank,erythrocyte differentiation (GO:0030218),-0.28697471881167613,-0.9724929259241456,0.5044642857142857,0.8180010072720495,1.0,16/44,18.28%,LYN;MFHAS1;KIT;TGFBR3;RPS14;RPS19;ALAS1;TAL1;ABCB10;MED1;CDK5RAP3;HIPK2;SH2B3;LYAR;IKZF1;JAK3
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.3411766719778382,-0.9722551180019164,0.49140893470790376,0.8171831759767417,1.0,5/19,15.54%,SLCO1C1;APP;WFS1;PAX8;MTPN
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.4014705950880714,0.9720237637591608,0.5151515151515151,0.8815783078325244,1.0,4/27,3.08%,TNFAIP8L3;PTK2B;FGF2;IRS1
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.3977863271318651,0.9719328636228085,0.5025974025974026,0.8812589973744432,1.0,13/31,16.49%,EZR;DLG2;SYNE4;ERBIN;RHOA;PARD3;SYNJ2BP;MARK2;DLG1;PDCD6IP;MYO9A;SCRIB;CAMSAP3
prerank,cellular response to metal ion (GO:0071248),0.33311723933861614,0.9715436802225049,0.5461454940282302,0.881631268655769,1.0,22/123,17.77%,EGFR;SLC12A2;CLIC4;CDH1;CAMK2D;DLG2;PLCG2;MEF2A;BMP6;DMTN;NLGN1;CDKN1B;CPNE8;CPNE1;DPEP1;TIGAR;ADD1;ADCY8;CPNE3;IQGAP1;P2RX4;LRRK2
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.3514021852439152,0.9709914843985402,0.5167243367935409,0.8823512410415927,1.0,13/72,16.78%,RBFOX2;FGF2;NOG;SHOC2;FGFR1;SPRED2;KIF16B;FGFRL1;TIA1;HNRNPH1;HNRNPM;FLRT2;FGFR3
prerank,cellular response to interferon-beta (GO:0035458),-0.3819079838570021,-0.9706158182052749,0.5029585798816568,0.8201187988103592,1.0,4/14,10.23%,NDUFA13;STAT1;AIM2;IFITM2
prerank,receptor clustering (GO:0043113),0.410496398333193,0.9705418693604082,0.5163120567375886,0.8828320066056188,1.0,10/27,19.89%,DLG2;NLGN1;SYNJ2BP;ITGB1BP1;DLG1;NRXN2;DVL1;PTN;SCRIB;ITGAL
prerank,cellular protein localization (GO:0034613),0.32086562583518585,0.970317222186734,0.5571428571428572,0.8828395162657316,1.0,65/285,18.59%,EGFR;CSRP3;PTPRU;ANK2;WNT11;SGSM2;TLK1;ID1;STX11;KIF13A;TMED5;TMED3;NIPBL;CNTLN;RRAGB;HERC2;RAB43;RIC3;RAB6A;RAB24;ARFIP2;SEC31A;AP3B1;VCL;ARFGAP3;WDR45B;COPA;SEC23IP;TM9SF4;PIGU;NSF;STX5;ARF4;STX12;CTTN;ZDHHC15;EHD1;TBC1D2B;RAB21;WIPI2;EVI5;DMD;ARCN1;SCFD2;AP3D1;BICD1;COPB2;NPHP1;USP4;RABGAP1;SNX8;RAB28;RAB1A;TBC1D8B;RAB5B;CPLANE2;STXBP1;PIGK;STX2;LRRK2;COG3;SMURF1;TBC1D5;TBC1D17;AP2A1
prerank,heart process (GO:0003015),0.45682269414224513,0.9702792552933812,0.5179407176287052,0.8823973951836586,1.0,1/14,1.15%,SGCD
prerank,response to interferon-gamma (GO:0034341),-0.26732202592498144,-0.9697286069187105,0.4605263157894737,0.8209811973869447,1.0,24/67,21.07%,WNT5A;SIRPA;IFITM1;IFITM3;GBP4;BST2;STAT1;GCH1;GBP7;GAPDH;IFITM2;AQP4;CX3CL1;GBP3;SHFL;CD40;CD74;CCL19;CD47;PDE12;NUB1;IRF8;CASP1;SNCA
prerank,transition metal ion homeostasis (GO:0055076),-0.32196209133256326,-0.9691320723841401,0.5138339920948617,0.8211462888027484,1.0,6/28,9.20%,CP;B2M;PICALM;SLC40A1;FTL;ABCB7
prerank,cristae formation (GO:0042407),-0.31597049306954184,-0.9690484544014097,0.5157894736842106,0.8199645434610078,1.0,14/27,30.28%,CHCHD6;ATP5PF;ATP5F1E;APOOL;ATP5F1A;DNAJC11;ATP5F1B;LETM1;UQCC3;ATP5MC1;ATP5MC2;ATP5MC3;AFG3L2;ATP5F1D
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.3781489833595474,0.9687346292994506,0.5006435006435006,0.8854436323894547,1.0,5/43,4.65%,PID1;PRKCD;IRS1;GRB10;PTPN2
prerank,membrane depolarization (GO:0051899),-0.3139576919177012,-0.968665437887955,0.5057915057915058,0.8194754847508858,1.0,18/32,23.43%,SCN7A;CACNA1E;CACNB4;CACNA1B;CACNG4;YWHAH;SCN1A;P2RX7;SCN9A;CACNG2;SCN3A;SCN2A;CACNA1I;KCNH2;SCN5A;CHRNA4;CACNA1H;CAV1
prerank,activation of adenylate cyclase activity (GO:0007190),-0.3029113647461047,-0.9685716501438543,0.4959016393442623,0.8183288877500099,1.0,5/35,5.92%,ADCY5;ADCY1;LGR4;CAP2;ADCY7
prerank,regulation of nervous system development (GO:0051960),0.37708114932091424,0.9684555033750378,0.5063451776649747,0.8855570420731496,1.0,7/37,16.91%,HES1;DOCK7;BHLHE40;HES3;PTN;NPHP3;YAP1
prerank,pentose-phosphate shunt (GO:0006098),0.47426111718057695,0.9676754766929727,0.5125,0.8867508693980355,1.0,7/11,29.07%,DERA;TKT;RPE;PGM2;PGLS;RPIA;SHPK
prerank,diacylglycerol metabolic process (GO:0046339),0.41072797353094137,0.9675722500742198,0.5006934812760055,0.8864461111374865,1.0,5/23,14.40%,PLCE1;PLA2G15;DGKA;PNPLA2;MOGAT1
prerank,folic acid-containing compound metabolic process (GO:0006760),0.42942865159836785,0.9673772184974367,0.5178826895565093,0.8863416287253616,1.0,8/19,28.12%,FOLR2;SLC25A32;SLC46A1;SLC19A1;MTHFS;GGH;SHMT1;FPGS
prerank,peptidyl-lysine methylation (GO:0018022),0.40083194135408584,0.9672649169185935,0.5081521739130435,0.8860540369666163,1.0,9/26,26.83%,SETD2;EHMT1;ETFBKMT;EEF2KMT;KMT5A;SMYD3;SETD6;SMYD2;SETD7
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.34665255874058964,0.9670832258482185,0.5305216426193119,0.8859290965630001,1.0,23/85,18.97%,WNT11;PRICKLE1;FZD1;FZD7;PSMB2;AP2A2;TIAM1;PSMD11;PSMC1;RHOA;PSMC6;PARD6A;PSMD1;DAAM1;DVL1;PSMD4;AP2B1;PSMA6;SMURF1;PSMD14;PSMD12;AP2A1;PSMD7
prerank,translational termination (GO:0006415),0.33778065305279686,0.9669908064355989,0.5247524752475248,0.8856231305694243,1.0,44/95,35.76%,MRPL33;MRPL40;MRPL42;MRPS27;MRPL11;GSPT1;MRPS2;ETF1;MRPL36;MRPL19;MRPL15;APEH;MRPL23;MRPL44;MRRF;GADD45GIP1;MRPS21;AURKAIP1;MRPS30;MRPL35;MRPL52;MRPL30;GFM2;MRPL10;MRPL48;MRPS18A;MRPS31;MRPL1;MRPL13;MRPL22;MRPS16;MRPL37;MRPS28;MRPS35;ERAL1;MTRF1;MRPL28;CHCHD1;ABCE1;MRPS7;MRPL14;MRPL32;MRPS9;MRPS18C
prerank,regulation of type I interferon production (GO:0032479),0.3471253790030352,0.9668144825389704,0.5074455899198167,0.8854875929100515,1.0,25/84,21.44%,TAX1BP1;CREBBP;IKBKE;IRF1;MAVS;IFIH1;GPATCH3;DHX36;CGAS;POLR3F;POLR3A;MYD88;TIRAP;POLR3K;POLR3E;PRKDC;POLR3D;PIN1;OTUD5;DHX9;XRCC5;NLRX1;TRAF3;NFKB2;IRF3
prerank,neuron projection fasciculation (GO:0106030),-0.41310277774979154,-0.9658616108119396,0.4946524064171123,0.8238567323768973,1.0,4/10,10.23%,CNTN4;EPHA4;RTN4;SEMA5A
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.38723175438719354,0.9658405281793049,0.5033738191632928,0.8871813576501224,1.0,13/38,18.53%,USP15;BMP6;ANKRD17;TLR8;POLR3F;IFI35;PRKCA;AKIRIN2;PLSCR1;POLR3D;SCIMP;DHX9;PUM2
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.3417680208384176,0.965705470862661,0.5179775280898876,0.8869619467748592,1.0,13/86,9.99%,EGFR;PRKCD;PTK2B;EFNA5;NRP1;VEGFA;PLCG2;ABL1;BMP6;CD44;DMTN;CD80;RIPK2
prerank,positive regulation of cellular senescence (GO:2000774),-0.40761219396772097,-0.9655732614537705,0.4893048128342246,0.8231362859980171,1.0,3/10,13.94%,B2M;YPEL3;ABI3
prerank,cellular response to nitrogen compound (GO:1901699),0.42683452123809995,0.9654562145472871,0.4978165938864629,0.886977272943615,1.0,8/20,22.06%,ATP2B4;SPIDR;DDI2;DDX11;RTF2;ATRX;DDI1;FMR1
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.31135172845199,-0.965171052045085,0.5148936170212766,0.822795888999963,1.0,17/32,23.94%,MAP2;CLASP2;NAV3;STMN1;DYRK1A;CAMSAP2;APC2;FKBP4;CDH5;CLIP3;MID1IP1;STMN2;SPEF1;TPX2;SNCA;CAMSAP1;TUBB4A
prerank,myeloid cell differentiation (GO:0030099),-0.27240796236003084,-0.9650820851050502,0.5454545454545454,0.8216580405395062,1.0,6/47,6.08%,LYN;MFHAS1;KIT;SNRK;RPS14;RPS19
prerank,microvillus assembly (GO:0030033),0.4577795863983774,0.9647394781833576,0.5150602409638554,0.8880733002014777,1.0,2/14,1.99%,FXYD5;EZR
prerank,regulation of metal ion transport (GO:0010959),-0.36594544625195113,-0.9645793404144891,0.5145631067961165,0.8215705236616598,1.0,7/16,14.54%,EPB41;SLC30A10;BCL2;CACNA2D1;ORAI1;CAMK2G;CAMK2B
prerank,chromosome condensation (GO:0030261),0.38298543225569204,0.9644873154387612,0.5232403718459495,0.8881434320799924,1.0,10/36,24.47%,SMC4;CCNB1;KMT5A;ERN2;RB1;NCAPH2;AIFM1;SMC2;PHF8;AKAP8L
prerank,negative regulation of gene expression (GO:0010629),0.3163529054114041,0.9641572949921731,0.598989898989899,0.8883524433522854,1.0,43/302,11.66%,FOXP1;BMP4;SLC24A3;SAMD4A;IGFBP5;HDAC9;FGF2;ITGB8;VEGFA;ESR1;BMPR1A;ID2;WWP2;SMO;ZNF148;NOTCH2;KLF4;CCL3;PAIP2;CNOT8;EMILIN1;ATP2B4;AGO2;REL;AURKA;NLRP12;NCOR1;EED;ZC3H12A;NCOR2;DNMT3A;NUDT12;EPRS1;ANXA7;RBBP7;XDH;POU4F1;DHX36;EIF2AK2;CREB3L1;MECP2;ATOH8;CD46
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.3679543242502795,0.9636258718232086,0.529113924050633,0.8890430186800489,1.0,6/43,8.33%,LBP;RARA;IRAK3;C5AR2;ZC3H12A;TLR4
prerank,translation (GO:0006412),-0.2184122854266855,-0.9633435867616001,0.7586206896551724,0.8233832805897492,1.0,62/208,20.45%,EEF1A1;RPL37;RPL27A;RPL19;RPS13;EIF4EBP2;RPS9;RPS3;RPS14;RPL18A;RPL38;RPS19;RPS8;RPS11;RPL34;RPL18;RPL7;EEF1G;EEF1B2;RPS25;RPL21;RPL23A;RPLP2;RPS21;RPL26;RPS4X;RPL41;RPS29;RPL35A;RPL10A;RPL11;RPS5;RPS16;MRPL3;RPL4;RPS7;RPS23;RPS15;TARS1;MRPS14;RPL36;MRPS33;RPS18;RPL37A;RPL32;RPS20;RPL29;RPL13;RPL36A;MRPL51;HARS1;RPL23;RPL17;DARS2;RPL9;EEF2;GTPBP1;RARS1;NDUFA7;MRPS11;MRPS5;AARS1
prerank,positive regulation of endocytosis (GO:0045807),-0.2768660280914077,-0.963342833970662,0.5561497326203209,0.8220050552034526,1.0,5/45,2.14%,VTN;SGIP1;APOE;NEDD4L;B2M
prerank,modulation by symbiont of entry into host (GO:0052372),-0.36560138557842253,-0.9629797395371404,0.5169230769230769,0.821588929448346,1.0,4/16,14.27%,HS3ST5;TRIM14;TRIM62;NECTIN2
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.3645530891134985,0.9628090666686502,0.5388291517323776,0.8903634297190356,1.0,17/53,23.94%,PSMB2;NQO1;PSMD11;PSMC1;ODC1;PSMC6;PSMD1;AZIN1;PSMD4;OAZ2;PSMA6;PSMD14;PSMD12;PSMD7;PSME3;PSMD3;PSMB6
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.33898684010324226,-0.9626673519135823,0.5175718849840255,0.8210102363582283,1.0,7/21,17.25%,SLC30A10;PPARA;ABCB7;PINK1;SIRT2;ABCD2;MT3
prerank,"transcription, DNA-templated (GO:0006351)",0.31927558140190143,0.9626613729176571,0.5708376421923474,0.8901697932231263,1.0,70/207,26.45%,RNMT;MLLT3;DDX5;AFF4;FOXO3;NFIX;MEF2A;MNAT1;NR4A2;MBD1;SNAPC2;NFIC;PARP1;TFDP1;POLR3A;NCOA6;CEBPD;GTF2E1;DRG1;ELOA;E2F1;PRMT5;NFYA;RBMX;NELFE;DDX21;GTF2A2;TAF4;POLR3K;CDK7;CCNT2;RNPS1;HOXD3;SMARCA5;PPP5C;HSF2BP;GTF2H3;ZBTB7B;UBTF;MED20;TAF5;DEK;POLR2C;MED16;NFX1;EPC1;COPS2;CREBL2;CCNT1;TTF1;RNGTT;TBP;GTF3C1;GTF3C4;TAF12;TP53;TAF13;GTF2B;GTF3A;TAF7;RO60;RSF1;CBFB;SMN1;SUPT4H1;ELL;GTF2H4;BAZ2A;TOPORS;TTF2
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.3306634288855065,-0.9624795760426855,0.4740484429065744,0.8201077416415075,1.0,4/24,15.33%,DACH1;RPS3;BLM;ACVRL1
prerank,membrane repolarization (GO:0086009),0.44695383409920475,0.9619634456124341,0.5170370370370371,0.8912410728869051,1.0,2/15,1.98%,KCNJ2;ATP1B1
prerank,production of siRNA involved in RNA interference (GO:0030422),0.47539284416252403,0.9619417018384411,0.534375,0.8907639739700549,1.0,7/10,29.69%,AGO2;MRPL44;DICER1;PRKRA;DROSHA;TSN;TSNAX
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.4021947301167175,0.9618302583428825,0.4993045897079277,0.8904666001994337,1.0,10/24,24.30%,PKD1;PTK2B;DNAAF4;NUDT15;PSMD14;ATP5IF1;TMF1;PSME3;RHBDF1;UBB
prerank,fluid transport (GO:0042044),0.450959357942293,0.9617494119757348,0.512630014858841,0.8901022167129791,1.0,1/12,2.44%,SLC26A6
prerank,telomere organization (GO:0032200),0.3696260969786148,0.9615608647973225,0.5038167938931297,0.8899936319932996,1.0,13/43,23.47%,APEX1;WRN;STN1;PARP3;PARP1;RAD50;PRKDC;ATR;XRCC5;ERCC4;NBN;RAD51D;ATM
prerank,regulation of JNK cascade (GO:0046328),0.3364229428382398,0.9614857984613419,0.5597765363128492,0.889626334867543,1.0,11/101,7.24%,RASSF2;EGFR;MAP3K5;PTK2B;KLHL31;SH3RF3;GADD45G;FZD7;PER1;DACT1;NCOR1
prerank,nuclear pore complex assembly (GO:0051292),0.4862620144678724,0.961313215973804,0.520259319286872,0.8894975690854555,1.0,3/10,10.34%,NUP93;NUP153;AHCTF1
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.41888598962904827,0.9612000489100125,0.5168374816983895,0.8892309130503832,1.0,9/22,17.75%,CAMK2D;NR4A3;MEF2A;GLRX3;SLC9A1;PARP1;PRKCA;SMAD4;P2RX4
prerank,lytic vacuole organization (GO:0080171),0.3885247385081477,0.9610815856513464,0.5477124183006536,0.8889797049443893,1.0,7/32,17.77%,HPS4;ACP3;ACP4;ARSB;HOOK3;GNPTAB;LRRK2
prerank,pseudouridine synthesis (GO:0001522),0.44943733407167374,0.9610546698603661,0.5199386503067485,0.8885080707748707,1.0,3/13,17.69%,PUS7L;RPUSD2;PUSL1
prerank,retinoic acid metabolic process (GO:0042573),-0.38016853075287454,-0.9609997347979994,0.5114285714285715,0.8226431866157486,1.0,2/14,2.27%,ALDH1A2;CYP26B1
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.41356288332589286,0.9607197279366261,0.5087719298245614,0.8887320291602725,1.0,8/21,20.16%,CCND1;CCNB1;MECP2;FBXO5;CDC7;DTL;BRD4;RAB11A
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.3833670108461637,-0.9602187593448724,0.4805194805194805,0.8232761314699364,1.0,2/12,1.39%,DOCK10;DOCK11
prerank,female gonad development (GO:0008585),-0.3357953550995546,-0.9601080567681767,0.5476190476190477,0.8222049858736101,1.0,8/19,22.26%,NR2F2;KIT;CEBPB;NUP107;SOD1;FOXL2;COL9A3;LHCGR
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.28773237031395976,-0.9595439570080133,0.5665236051502146,0.822228435859284,1.0,5/41,5.78%,TJP1;ANK3;PODXL;PIEZO1;BMP7
prerank,cellular response to cAMP (GO:0071320),0.392210318439261,0.9595084390302672,0.5135869565217391,0.8909048533248038,1.0,6/30,11.11%,IGFBP5;EZR;SLC26A6;DMTN;AKAP9;RAP1A
prerank,microtubule polymerization or depolymerization (GO:0031109),0.40004740642287157,0.9594641397368718,0.5313351498637602,0.8904818085857032,1.0,6/25,17.14%,FGF13;MAP7D3;KATNB1;HDGFL3;PIN1;CENPJ
prerank,actomyosin structure organization (GO:0031032),0.34269456272100657,0.9587295058938127,0.5406032482598608,0.8916314299573593,1.0,12/75,10.42%,EPB41L5;CIT;CSRP3;EPB41L2;ITGB5;PHACTR1;ALKBH4;FLII;ITGB1;CUL3;SIX4;RHOA
prerank,glucose metabolic process (GO:0006006),-0.2616949731517508,-0.9585916062055357,0.5209580838323353,0.8232468931039489,1.0,11/58,10.90%,APOD;RBP4;SLC25A13;PGM1;PPARGC1A;PPARD;AKR1A1;GOT2;PGAM1;GAPDH;PCK2
prerank,positive regulation of kinase activity (GO:0033674),0.33309913705324357,0.9585097824947413,0.5443592552026287,0.8916250766861735,1.0,12/107,7.12%,RASSF2;EGFR;MET;NTRK3;DDR2;CCN1;LMO4;PTK2B;EPHB3;FGFR1;ERBB2;ROR1
prerank,negative regulation of synaptic transmission (GO:0050805),-0.32339405384171105,-0.958180182904304,0.5496688741721855,0.8229201100804114,1.0,5/23,11.28%,SLC24A2;SYT11;SHANK2;SLC30A1;PLK2
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.4476507095838703,0.9578344009456323,0.5079365079365079,0.8926352536933041,1.0,4/15,13.94%,SRM;SMOX;TPH2;PAOX
prerank,calcium ion homeostasis (GO:0055074),0.336953395450053,0.9578321666592507,0.5345982142857143,0.8921061985495957,1.0,16/95,13.14%,SLC24A3;CSRP3;ATP2C2;ANK2;ATP1B1;CASR;CCL3;CCL1;ATP2B4;FAM20A;SLC10A7;CCL7;DRD3;SLC8B1;CTRC;NPTN
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.325277047207181,0.957686524637659,0.5636172450052577,0.8919178166023014,1.0,19/159,9.55%,PCDHB16;HMCN1;CDH11;GPC6;PKD1;FAT2;CDH1;MPZL2;PTPRF;PCDHB9;NECTIN3;DSG2;CEACAM5;TGFBR2;TENM1;ITGB1;EMB;SLITRK2;PCDHB3
prerank,establishment of protein localization to organelle (GO:0072594),0.35097229640954836,0.9573448121520997,0.5564705882352942,0.8921723508305837,1.0,15/72,16.18%,PRICKLE1;STAT3;NUP93;E2F3;NUP214;TSPAN17;NUP153;TNPO2;TNPO3;IPO7;NUP155;ZDHHC15;NUTF2;NUP88;CSE1L
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.37458256677258667,0.9572209098529355,0.5154639175257731,0.8919096150228163,1.0,15/36,23.71%,RAD51;EHMT1;EED;CBX5;RBBP7;TFDP1;BRCA1;E2F1;CDC7;EPC1;SUZ12;CHEK1;PCGF6;APAF1;RBBP8
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.3852502849175949,-0.9571584615771985,0.5205479452054794,0.8240796798289575,1.0,6/12,16.49%,PIK3R1;DAB2IP;BCL2L11;ERN1;BOK;XBP1
prerank,folic acid metabolic process (GO:0046655),0.4328763476944298,0.9566865325659856,0.5361271676300579,0.8926348499477718,1.0,8/18,28.12%,FOLR2;SLC25A32;SLC46A1;SLC19A1;PM20D2;MTHFS;SHMT1;FPGS
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.40770579842098165,-0.9562265966418128,0.5215189873417722,0.8251029759298399,1.0,2/10,6.47%,LYN;GHR
prerank,regulation of axonogenesis (GO:0050770),0.36016356527746307,0.9557702760881751,0.5504926108374384,0.8942220040733888,1.0,11/51,13.38%,SLIT2;SIPA1L1;NGF;GSK3B;EPHB3;TIAM1;TIAM2;RHOA;MARK2;MAP6;PLXNB1
prerank,positive regulation of lipid kinase activity (GO:0090218),0.39038118206483374,0.9554538591430712,0.5470430107526881,0.8944193538924716,1.0,4/29,3.08%,TNFAIP8L3;PTK2B;FGF2;IRS1
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.36351848703007816,0.9554369607643751,0.5499383477188656,0.8939262239560612,1.0,18/51,25.90%,SMG6;NEK7;TEN1;STN1;NAT10;CCT5;TENT4B;NAF1;MAP3K4;ATR;XRCC5;TNKS2;ATM;MAPKAPK5;GNL3L;CCT6A;SRC;PARN
prerank,cellular sodium ion homeostasis (GO:0006883),0.4410588268608784,0.9554019765234951,0.5249266862170088,0.8934774324852873,1.0,7/15,9.77%,SLC12A2;ATP1B1;ATP12A;ATP1A3;ATP1A4;ATP1A1;SLC9A1
prerank,diol metabolic process (GO:0034311),-0.3500570196821745,-0.9553934837495974,0.5242718446601942,0.8258632735176711,1.0,5/19,9.52%,NOS3;DEGS2;CALM1;GCH1;SPHK1
prerank,tight junction assembly (GO:0120192),-0.28667110131456336,-0.9553052693253751,0.525,0.8247406226594779,1.0,6/49,3.74%,PARD6G;PECAM1;OCLN;CLDN5;ESAM;F11R
prerank,positive regulation of cell killing (GO:0031343),-0.36876889689051046,-0.9550195922853415,0.5350877192982456,0.824124748903871,1.0,3/13,9.24%,WNT5A;NOX1;RAC1
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.3085630744960004,0.9544672700304527,0.648,0.8949914262350235,1.0,82/509,13.54%,F3;THBS1;EGFR;NR3C2;TNFAIP8L3;TCF7L2;MET;NTRK3;NEDD4;TCIM;ADRA1B;WNT11;NFAT5;FGF2;GAB2;PIK3AP1;ADRB2;AKAP13;IRS1;VEGFA;ESR1;CCL3;ALPK1;LIMS1;TRAF3IP2;S100B;PLCG2;TGFBR1;USP15;PDGFC;FGFR1;SHC1;RRAGB;TAB3;MYOC;ERBB2;REL;MIER1;NLRP12;STRN;IRAK4;ROR1;STYXL1;FN1;IKBKG;ITGB1;KITLG;IKBKE;HTR6;TLR4;BECN1;CD80;MAVS;PDCD4;ITGAV;MYORG;RIPK2;RHOA;DUSP19;MAP3K7;DHX36;TAB2;EIF2AK2;MAP3K3;CGAS;TRAT1;ANKRD17;NLGN1;TRIM44;IFI35;BCAR3;MYD88;TRAF2;BCAP31;CPNE1;ITGB1BP1;RET;TIRAP;PLXNB1;MTDH;CARD16;ZDHHC13
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.46944389221825344,0.9542887330752571,0.5277337559429477,0.894868185306916,1.0,3/10,14.30%,ESR1;PSMC6;ATF7IP
prerank,chondroitin sulfate metabolic process (GO:0030204),0.3914907705778309,0.9540765370143661,0.5166444740346205,0.8948300446045612,1.0,6/30,7.77%,DSE;CHST13;HEXA;BGN;CHST11;ARSB
prerank,chromatin remodeling (GO:0006338),0.3334580874799943,0.9540079847504144,0.5624309392265193,0.8944636962067901,1.0,26/100,20.51%,HDAC4;ESR1;NUDT5;SRCAP;MYSM1;CHD3;CHD1L;TOP1;SMARCC1;NPM3;ZBTB1;EZH1;MBD3;ATRX;SOX9;KDM5B;SMARCA5;CHD8;PBRM1;HCFC1;RB1;ACTR5;HDAC2;SATB2;ZBTB7A;BAZ1A
prerank,embryonic digit morphogenesis (GO:0042733),0.4221688534081287,0.9538023364183383,0.5361271676300579,0.8944383895018923,1.0,5/18,7.02%,GLI3;NOG;TWIST1;ECE1;CREBBP
prerank,ATP transport (GO:0015867),-0.40744740064029583,-0.9536886817545751,0.5320855614973262,0.8262404954855612,1.0,2/10,16.37%,ABCC6;CD47
prerank,sodium ion homeostasis (GO:0055078),0.4201568167343531,0.9533273578683532,0.5338865836791148,0.8949249144757054,1.0,7/21,9.77%,SLC12A2;ATP1B1;ATP12A;ATP1A3;ATP1A4;ATP1A1;SLC9A1
prerank,histone methylation (GO:0016571),0.3951356304196379,0.953252713263811,0.5213675213675214,0.8945675171856967,1.0,9/26,23.89%,PRMT8;CREBBP;EHMT1;NSD1;PRMT5;SMYD3;PRMT6;SETD6;SMYD2
prerank,cellular response to dsRNA (GO:0071359),0.4485568328225735,0.9530966653279483,0.5436447166921899,0.8943787546275591,1.0,7/15,19.69%,MAVS;IFIH1;CGAS;FLOT1;RALB;DHX9;COLEC12
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.40510097250832655,0.9528437503469825,0.5371669004207573,0.8944161529223345,1.0,11/24,26.46%,TAB3;IKBKG;AAMP;RIPK2;MAP3K7;TAB2;TRAF6;UBB;UBE2V1;UBA52;RPS27A
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.3607965572082637,-0.9528393804399548,0.49032258064516127,0.8270820797154,1.0,2/16,3.89%,IGF1R;INSR
prerank,regulation of intracellular signal transduction (GO:1902531),0.30999882068302625,0.9526766265587829,0.6552763819095477,0.8942860905379791,1.0,80/420,14.69%,RASSF2;EGFR;RHOJ;ARHGAP20;NTRK3;MOB3B;VAV2;ARAP1;USP2;EZR;CMKLR1;ARHGAP21;ARHGAP10;SRGAP2;SRGAP3;AKAP13;ARHGDIB;VEGFA;TELO2;EXO1;ITFG2;HIPK1;PLCG2;ARHGAP44;ARHGAP40;RRAGB;CHEK2;MYOC;BCR;ARHGAP17;TIAM1;SOS2;AURKA;NLRP12;EHMT1;STYXL1;BARD1;ENTPD5;IKBKG;WRN;TOPBP1;RHOQ;TIAM2;ZFAND6;ARHGAP31;CHD3;STARD13;GATA4;ARHGAP5;PPP2R5C;ITGAV;RBBP7;POU4F1;RHOA;NLGN1;FGD1;RAD50;PIP5K1A;TRAF2;TRIO;MDM4;RAD17;BRCA1;OCRL;CPNE1;TMBIM4;FGD3;DLG1;MBD3;PRMT5;PIP4K2A;CCNG1;TAF4;BRIP1;TRIP10;MYO9A;GNA13;DEPDC1B;PIDD1;RNF41
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.34124043966811063,0.9525288802544891,0.5440180586907449,0.8940865160120504,1.0,11/86,8.37%,CDC42EP5;MET;BAIAP2L1;PRKCE;PTK2B;KATNB1;CLIP1;NCK2;TENM1;TOGARAM1;AKAP9
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.4300546007969554,0.9524940336614122,0.5021961932650073,0.8936390274730512,1.0,3/16,3.27%,ZFPM2;FGF2;BMPR1A
prerank,sterol metabolic process (GO:0016125),-0.2671532659204156,-0.9521760990673735,0.547486033519553,0.8274634697046156,1.0,12/60,11.00%,CYP7B1;APOE;CYP27A1;CYP26B1;LIPA;ABCA5;ABCG1;INSIG2;PPARD;ARV1;MSMO1;OSBPL1A
prerank,response to cytokine (GO:0034097),0.32364299443409633,0.9518812860818875,0.5763813651137595,0.8945736305536375,1.0,22/141,11.14%,DPYSL3;HDAC4;PID1;ADAM9;AFF3;NFAT5;COL3A1;TIMP1;IRAK3;PTPN2;STAT3;ANXA1;SETD2;REL;NLRP12;IKBKE;TIMP2;POU4F1;RHOA;EIF2AK2;MCL1;IGBP1
prerank,protein secretion (GO:0009306),0.35665713230388524,0.9518145113866431,0.53836784409257,0.8941899815671408,1.0,7/56,9.50%,PCSK5;TANGO6;ANXA1;LTBP2;ARFGAP3;COPG1;MIA3
prerank,mitotic cell cycle phase transition (GO:0044772),0.3184512632214606,0.9517831829752259,0.5864197530864198,0.8937289672699248,1.0,50/204,19.15%,FBXL7;CCNA2;PPP1R12B;CHEK2;MNAT1;PCM1;INHBA;AURKA;PAFAH1B1;E2F3;CEP43;CCND1;AKAP9;CUL3;CDKN2C;SDCCAG8;CDC16;CUL1;GSPT1;HAUS2;CCNB1;CEP63;PLK4;PPP2R2D;PCNT;CDKN1B;CDKN3;E2F1;ACVR1;CCNG1;HINFP;PIM2;PPP1R12A;KHDRBS1;CDK7;OFD1;CDK2;CDKN1A;CDC7;PLK3;ARPP19;CENPJ;RPS6KB1;RB1;UBE2S;CEP164;CETN2;WEE1;FBXL6;BORA
prerank,positive regulation of transmembrane transport (GO:0034764),0.44804732856834806,0.9515639712884238,0.5198170731707317,0.8936977274307387,1.0,5/13,15.17%,SLC26A6;ANO6;NR4A3;C2CD5;AZIN1
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.3362473520259194,-0.9510291394299791,0.5238095238095238,0.8289326793872155,1.0,6/21,11.83%,CHSY3;CSGALNACT1;DCN;CHSY1;CHST3;CSPG5
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.45649047238680374,0.9509739661553422,0.5257410296411856,0.8945238868269395,1.0,2/12,1.98%,WNK1;ATP1B1
prerank,mRNA processing (GO:0006397),0.3157075175021684,0.9507732043944087,0.6253807106598985,0.8944489280229274,1.0,120/287,32.07%,RNMT;DDX5;SRSF11;U2AF2;SON;RBM14;THOC2;DBR1;SRSF5;MNAT1;SRSF6;SRRM2;SNRNP48;PABPC1;PRPF18;KIN;CDC40;SRSF2;CELF1;FUS;HNRNPH1;SNRNP35;U2SURP;RBMX;SCAF11;SRSF1;CHERP;WBP4;CDK7;HNRNPM;SNRNP70;LSM8;RNPS1;PRPF8;UBL5;RNPC3;GTF2H3;CPSF3;CHTOP;SYF2;GPKOW;HNRNPA2B1;USP49;WDR83;DHX9;POLR2C;NONO;SYNCRIP;RBM6;CSTF3;SARNP;GEMIN5;SNRNP40;CLP1;PDCD7;SF3B3;DHX8;PNN;LSM4;TCERG1;AURKAIP1;RNGTT;HNRNPH2;DHX38;SRSF3;SRRM1;SUGP1;PRCC;CCAR1;ZC3H11A;FIP1L1;AKAP8L;YTHDC1;HNRNPF;USP39;RBM4;SUPT4H1;GTF2H4;SNRNP200;CSTF1;PTBP1;RBM17;CMTR2;RAMAC;CMTR1;ZCRB1;WDR33;DNAJC8;RBM5;THOC1;GCFC2;SMNDC1;SNRPB;SNRPB2;ALKBH5;DHX15;ELAVL1;ZRSR2;HNRNPC;ERCC2;CSTF2T;TRA2A;UPF3B;DDX42;HNRNPR;TRA2B;WBP11;PPIL3;THOC5;TXNL4A;PRPF3;GTF2H5;ELAVL2;PPIH;NUDT21;SNW1;SF3B2;SF3B1;DDX39A;DDX39B
prerank,negative regulation of response to wounding (GO:1903035),0.42123534285356595,0.9506869258368692,0.5344827586206896,0.8941210036166048,1.0,4/19,15.90%,FGF2;CD109;PTPRS;ALOX5
prerank,response to steroid hormone (GO:0048545),0.3873382615305201,0.9506804438490812,0.5442708333333334,0.8936116340185637,1.0,7/31,16.91%,THBS1;TGFB3;ATP1A3;ATP1A1;NR3C1;URI1;YAP1
prerank,purine ribonucleotide transport (GO:0015868),0.4402287797603186,0.9504828964097457,0.5467836257309941,0.8935041953528979,1.0,1/16,1.13%,LRRC8D
prerank,selective autophagy (GO:0061912),0.35841470550167603,0.9503515439992194,0.5441696113074205,0.893254901972152,1.0,23/56,29.17%,ULK2;BECN1;WDR81;TEX264;ACBD5;PCNT;RB1CC1;ATG5;UBA5;NBR1;USP30;WDFY3;ATM;UBB;AMBRA1;UBE2V1;UBA52;ATG2A;MAP1LC3B;RPS27A;ATG14;UBE2N;SQSTM1
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.3127341544255976,0.949422920773172,0.6075050709939148,0.8947873074044045,1.0,58/248,18.49%,EGFR;TCF7L2;LRP6;MLLT3;CTNND2;WNK1;PTPRU;WNT11;GPC3;PRICKLE1;PLEKHA4;SFRP4;GSK3B;FZD7;PSMB2;GLI3;INVS;TLE2;EMD;NOG;UBR5;DACT1;DKK3;PSMD11;CSNK1A1;TRPM4;CUL3;SFRP5;PSMC1;VCP;USP34;TBL1X;PSMC6;CSNK1G3;JUP;RNF146;NRARP;IGFBP6;CSNK1G1;SOX9;PSMD1;UBE2B;DVL1;CAPRIN2;PSMD4;RBMS3;USP47;PIN1;NPHP3;CHD8;TLE6;PSMA6;SDHAF2;PRDM15;LRRK2;STK3;PSMD14;PSMD12
prerank,alpha-amino acid catabolic process (GO:1901606),-0.3046536814622427,-0.949399982575757,0.5375494071146245,0.8317825305506694,1.0,6/29,18.00%,DDO;ACADSB;GOT2;ALDH4A1;CBS;SARDH
prerank,tRNA transport (GO:0051031),0.38450580834918513,0.9493286053674138,0.5347043701799485,0.8944896912882715,1.0,9/35,17.82%,NUP93;NUP214;NUP153;NOL6;NUP155;RANBP2;NUP88;SSB;NUP35
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.3580723327385181,0.9491005031810299,0.5563380281690141,0.8944894691402276,1.0,10/59,8.63%,HMCN1;PKD1;FAT2;CDH1;MPZL2;NECTIN3;DSG2;CEACAM5;ITGB1;EMB
prerank,positive regulation of actin nucleation (GO:0051127),0.46077226948176303,0.9488389601802274,0.511326860841424,0.8945565300844671,1.0,5/11,25.04%,GSN;CYFIP1;FCHSD2;NCKAP1;WHAMM
prerank,peptidyl-lysine dimethylation (GO:0018027),0.4307730382836107,0.9487984455224194,0.521870286576169,0.8941262650912066,1.0,9/18,32.86%,SETD2;EHMT1;KMT2D;ASH1L;SMYD2;SETD7;SETMAR;EHMT2;PRDM9
prerank,rRNA processing (GO:0006364),-0.23464589576759698,-0.9487190261374144,0.5777777777777777,0.8321305573118329,1.0,46/172,18.59%,NSA2;RPL37;RPL27A;RPL19;RPS9;RPS14;RPL18A;RPL38;RPS19;RPL34;MTREX;RPL18;RPL7;RPS25;RPL21;RPL23A;RPLP2;RPL26;RPL41;RPL35A;RPL10A;RPL11;RPS16;EXOSC5;SNU13;RPL4;RPS7;DDX52;RPS15;RPL36;POP4;EXOSC9;RPL37A;RPL32;RPL29;DDX10;HEATR1;LYAR;RPL13;FBL;RCL1;RPL36A;RPL23;RPL17;RPL9;DDX27
prerank,fatty acid derivative biosynthetic process (GO:1901570),-0.294087553611342,-0.948653596974419,0.5244444444444445,0.8309678102106486,1.0,4/35,5.43%,PAM;ACSS3;FAR2;GGT5
prerank,mitochondrial translation (GO:0032543),0.33001470892218904,0.9481715326767488,0.574750830564784,0.8949804549116176,1.0,47/104,35.76%,MTIF3;MRPL33;MRPL40;MRPL42;NOA1;MRPS27;MRPL11;EARS2;MRPS2;MRPL36;MRPL19;MRPL15;MRPL23;MRPL44;MRRF;GADD45GIP1;MRPS21;AURKAIP1;MRPS30;MRPL35;MRPL52;RARS2;MTIF2;TSFM;MRPL30;GFM2;GATC;MRPL10;MRPL48;MRPS18A;MRPS31;MRPL1;MRPL13;MRPL22;MRPS16;MRPL37;MRPS28;MRPS35;ERAL1;MTRF1;MRPL28;CHCHD1;MRPS7;MRPL14;MRPL32;MRPS9;MRPS18C
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.38228849618552796,0.9481565676656544,0.5446194225721784,0.8944944747901399,1.0,11/37,21.80%,IFT46;WDR35;PCM1;IFT52;DYNC2I2;KIF3B;DYNC2I1;IFT43;CLUAP1;IFT22;DYNC2H1
prerank,regulation of cell division (GO:0051302),0.34399864598280466,0.9480705214442772,0.5530921820303384,0.8941474356945437,1.0,22/72,24.57%,MLLT3;NLRP5;KIF13A;SETD2;AURKA;RAB11FIP3;BECN1;CIB1;AHCTF1;PLK4;SH3GLB1;PIN1;PLK3;TLE6;PRDM15;CETN2;RAB11A;BIRC6;HTR2B;CALM2;ENTR1;PDXP
prerank,regulation of protein targeting to membrane (GO:0090313),0.38828767078734333,0.9478511832958656,0.5455764075067024,0.8941021017401757,1.0,9/28,16.37%,KCNB1;ERBB2;DMTN;CIB1;MIEF1;C2CD5;CHP1;ITGB1BP1;MIEF2
prerank,positive regulation of defense response to virus by host (GO:0002230),0.3966962509064796,0.9477807572600142,0.5135908440629471,0.8937456990130015,1.0,5/24,11.47%,TRAF3IP2;ZC3H12A;MAVS;CGAS;TRIM44
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.3821569178746698,0.9477160964036812,0.533508541392904,0.8933562084573887,1.0,7/33,16.55%,EZR;UBASH3A;PTPN2;IKBKG;TRAT1;CD160;LCK
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.3560242314846469,-0.9474192481308968,0.5590778097982709,0.8326772712273863,1.0,1/16,0.16%,AUTS2
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.3351795252849373,0.947370334855918,0.5741573033707865,0.8936274611839676,1.0,21/93,17.92%,RASSF2;MAP3K5;PTK2B;VEGFA;SH3RF3;MID1;GADD45G;FZD7;ZC3H12A;XDH;DUSP19;EIF2AK2;TRAF2;ARL6IP5;TIRAP;TRAF6;MAP3K10;TRAF5;SCIMP;MAP3K4;TRAF4
prerank,regulation of steroid metabolic process (GO:0019218),-0.3317851030933871,-0.9472009575969345,0.5389830508474577,0.8318785420922404,1.0,4/23,10.80%,APOE;ABCG1;ARV1;ASAH1
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.4422570656813887,0.9471800908018249,0.5248447204968945,0.8935126708977077,1.0,3/14,8.37%,ANK2;ATP1B1;AKAP9
prerank,regulation of adenylate cyclase activity (GO:0045761),0.40667870251226323,0.9471554875766632,0.5382436260623229,0.8930459578693597,1.0,3/22,5.44%,CACNA1C;PALM;NF1
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.4347841428325958,0.9471369766669173,0.5574963609898108,0.8925645415809441,1.0,4/16,14.70%,SLC39A14;ACP3;PRMT5;PRKCA
prerank,steroid biosynthetic process (GO:0006694),-0.26047801939667686,-0.9470032872068322,0.5642458100558659,0.8310792266795356,1.0,15/56,25.04%,CYP7B1;CYP27A1;INSIG2;MSMO1;OSBPL1A;PRKAG2;SCP2;OSBPL9;OSBPL3;OSBPL7;SRD5A1;CH25H;TM7SF2;FDFT1;SLC27A2
prerank,regulation of exit from mitosis (GO:0007096),0.3744601676157744,0.9469026531869973,0.5455729166666666,0.892555478367201,1.0,9/38,11.95%,ANAPC5;CDC14A;ANAPC10;CDC16;ANAPC11;CDC20;MAD2L1;ANAPC16;ZW10
prerank,snRNA processing (GO:0016180),0.4385342628760363,0.9468569989559744,0.5162287480680062,0.892134066942905,1.0,8/16,27.51%,INTS5;INTS6;INTS7;INTS1;INTS14;INTS8;INTS2;INTS9
prerank,regulation of hydrolase activity (GO:0051336),0.3417606563215082,0.9467316017544819,0.559953434225844,0.8918852520510426,1.0,18/71,14.94%,VAV2;SIPA1L1;EFNA5;EPHB3;ARHGAP44;SCARB2;NF1;PAFAH1B1;WRN;RDX;FGD1;OCRL;ITGB1BP1;FGD3;PLXNB1;ADAP1;FGD6;RABGAP1
prerank,regulation of cellular response to heat (GO:1900034),0.3406245836566617,0.9465377951384122,0.5399543378995434,0.8917982018149281,1.0,24/77,25.15%,CAMK2D;GSK3B;HSPB8;NUP93;BAG3;CREBBP;NUP214;HSPA1L;NUP153;CHORDC1;NUP155;RANBP2;NUP88;MLST8;NUP35;BAG5;MAPKAPK2;ATR;BAG2;HSPH1;YWHAE;ATM;MTOR;NUP98
prerank,positive regulation of mitotic nuclear division (GO:0045840),-0.2920495790723971,-0.9464889193708527,0.5416666666666666,0.8310450773570502,1.0,4/34,3.89%,IGF1;TGFA;PDGFRB;INSR
prerank,regulation of cell-substrate adhesion (GO:0010810),0.37129056084362116,0.9458879184322095,0.5322376738305942,0.8927245662397445,1.0,8/42,10.42%,VIT;FZD7;LIMS1;NF1;AGR2;DMTN;CORO1C;RHOA
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.4262761466694122,0.9458163955748409,0.5179856115107914,0.8923659789684086,1.0,6/18,24.07%,ANXA1;KLF9;FAM107A;NR3C1;SSTR2;REST
prerank,organic hydroxy compound biosynthetic process (GO:1901617),-0.2735990739524463,-0.9457267653863647,0.5495495495495496,0.8315485652283002,1.0,13/44,22.31%,CYP7B1;CYP27A1;INSIG2;MSMO1;OSBPL1A;ALOX12;PRKAG2;SCP2;OSBPL9;OSBPL3;OSBPL7;CH25H;TM7SF2
prerank,replication fork processing (GO:0031297),0.37236756852941194,0.9455440694061658,0.5328185328185329,0.8924470043394104,1.0,15/38,30.15%,RAD51;WRN;SMARCAL1;DDX11;PRIMPOL;ATRX;FAM111A;BRCA2;ATR;BOD1L1;SETMAR;THOC1;ZGRF1;MMS22L;GEN1
prerank,regulation of potassium ion transport (GO:0043266),0.38136443278342924,0.9453851156019447,0.5270092226613966,0.8922746101751011,1.0,3/31,2.10%,FHL1;ANK2;PTK2B
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.3457656583485761,0.9450931361388643,0.5548996458087367,0.8923818458551998,1.0,7/70,4.52%,PRKCD;VAV2;CYFIP2;PRKCE;ABI1;PLCG2;ABL1
prerank,hexose biosynthetic process (GO:0019319),-0.27598278974464907,-0.9450750988241197,0.5225225225225225,0.8318663025833004,1.0,15/42,23.62%,RBP4;SLC25A13;PGM1;PPARGC1A;GOT2;PGAM1;GAPDH;PCK2;MDH1;CRY1;ENO1;GAPDHS;GOT1;G6PC3;ALDOC
prerank,energy reserve metabolic process (GO:0006112),0.41921690442057064,0.9450470242694774,0.5369822485207101,0.8919694833620133,1.0,4/19,7.99%,PID1;GSK3B;PPP1R3C;PHKB
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.4208981561380536,0.944935886657175,0.5496503496503496,0.8916753007436368,1.0,5/19,18.91%,ADA;AMPD3;DGUOK;GMPR2;AMPD2
prerank,COPII-coated vesicle budding (GO:0090114),0.34774095484311857,0.9444508756968127,0.5812064965197216,0.8922142176989208,1.0,26/68,25.28%,SEC16A;SEC31A;SEC24B;SEC23A;CUL3;ANKRD28;MIA3;SEC24D;SEC23IP;PPP6R3;NSF;STX5;TRAPPC3;TRAPPC10;GOSR2;RAB1A;TRAPPC9;SEC23B;PPP6R1;TMED2;PPP6C;MCFD2;BET1;RAB1B;TRAPPC2L;USO1
prerank,receptor-mediated endocytosis (GO:0006898),0.322612401336978,0.9443712957784617,0.5954446854663774,0.891871344658614,1.0,15/132,8.04%,LRP6;RAMP1;NEDD4;ADRB2;CD9;IGF2R;LDLR;PDLIM7;COLEC11;AP2A2;SCARB2;LRP1;FCHO2;ITGB1;GRK4
prerank,fibrinolysis (GO:0042730),-0.3779325777700316,-0.9442972005841214,0.5343283582089552,0.8325129891574811,1.0,9/13,43.10%,PLAT;PLAU;SERPINE1;HRG;PLAUR;PLG;CPB2;GP1BA;F2
prerank,UV-damage excision repair (GO:0070914),0.4502677611382735,0.9442539614031787,0.515625,0.8916417129766852,1.0,6/12,30.91%,ACTR5;INO80;DDB1;POLA1;DDB2;XPA
prerank,histone ubiquitination (GO:0016574),0.4098669119428845,0.9442439660966858,0.5659259259259259,0.8911478365490771,1.0,5/21,17.43%,UBE2A;WAC;RNF8;UBE2B;RNF20
prerank,ncRNA transcription (GO:0098781),0.4475466686456351,0.9442421839465467,0.5350609756097561,0.8906394239583199,1.0,2/13,7.20%,POLR1G;SNAPC2
prerank,proteasome assembly (GO:0043248),0.46541937094087993,0.943813555323703,0.5531587057010786,0.8910955098730043,1.0,3/11,15.78%,ADRM1;PSMD11;PSMD4
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.44145517108493254,0.9434754297179532,0.543939393939394,0.8913363459939173,1.0,6/15,20.01%,ABL1;MAD2L1;FBXO5;SMAD7;BAG5;BAG2
prerank,negative regulation of response to external stimulus (GO:0032102),0.3288943221197532,0.9431902681073128,0.5757238307349666,0.8914672844713221,1.0,11/105,7.11%,CCN3;PRKCD;FGF2;PTGIS;CD109;KLF4;TRAFD1;IRAK3;PTPN2;NLRP12;RORA
prerank,adenine nucleotide transport (GO:0051503),0.43020479356367847,0.9431399031736485,0.5477888730385164,0.8910699954965728,1.0,1/17,1.13%,LRRC8D
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.3206596647869719,0.9430449909969213,0.576017130620985,0.8907606430644733,1.0,18/138,7.12%,EGFR;GUCY2C;MET;NTRK3;DDR2;PTPRU;ABI1;PTK2B;PTPRF;NGF;SRMS;EPHB3;POLR1G;FGFR1;SHC1;FRK;ERBB2;ROR1
prerank,protein localization to lysosome (GO:0061462),0.38910875038652454,0.9430263541359185,0.5668965517241379,0.8902895263054038,1.0,5/28,13.58%,NEDD4;SCARB2;SZT2;AP3M1;SORL1
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.39423498973455096,-0.9429844005661315,0.5370919881305638,0.8344424210084918,1.0,2/10,3.29%,ZEB2;RAPGEF2
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.340245086575349,0.9428848091053832,0.5654692931633836,0.8900689354761248,1.0,23/73,25.55%,HDAC4;POLR1G;POLR1A;EED;DNMT3A;MTA1;RBBP7;MECP2;TAF1D;DDX21;SMARCA5;GLMN;POLR1F;DEK;TASOR;EPC1;SUZ12;IGF2;TBP;PPHLN1;TDG;KDM1B;PPM1D
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.36608500152848744,-0.9427680339611101,0.5203488372093024,0.8336545023840493,1.0,4/14,6.54%,KIT;WNT5A;SEMA7A;GPRC5B
prerank,cardiac muscle cell development (GO:0055013),-0.3369846401812628,-0.9422810383454789,0.5211726384364821,0.833514928394307,1.0,5/20,8.55%,SORBS2;PDGFRB;SLC8A1;MYH11;HEY2
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.3515038331487018,-0.9422362347672399,0.5370370370370371,0.8322922801595348,1.0,10/17,37.90%,ALK;ADRA2A;MFSD2A;AKT1;APOC1;PRKAA1;PDE3B;PLIN5;CIDEA;TNF
prerank,heart looping (GO:0001947),0.36927233045797925,0.9418710705121611,0.5387547649301143,0.8918091545638667,1.0,4/40,8.39%,MICAL2;SMO;TGFBR2;GATA4
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.3437712989513953,0.941778260702373,0.5598591549295775,0.8914977761409258,1.0,7/71,4.52%,PRKCD;VAV2;CYFIP2;PRKCE;ABI1;PLCG2;ABL1
prerank,protein dephosphorylation (GO:0006470),0.3194651989879741,0.9413660711267549,0.5793901156677181,0.8918366356084539,1.0,28/135,16.31%,EYA2;UBASH3B;PPP3CA;PTPN3;PTPRU;PTPRF;EYA4;PPM1H;PTPN2;PTPRA;DUSP11;PPP2R5C;PPTC7;PPP2R2D;SBF1;DUSP5;EYA3;ILKAP;PTPRS;PTPN9;PPP1R12A;PTPN21;UBLCP1;NCK1;PPP3CC;PPP4R2;SSU72;PPP5C
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.3383357735536401,0.9410990714673458,0.5571748878923767,0.8919129939291137,1.0,26/85,22.38%,RNF144A;PRICKLE1;GSK3B;ZYG11B;USP13;CSNK1A1;RNF185;ARIH1;VCP;ANKIB1;PSMC6;DDA1;DET1;KEAP1;CLU;COP1;DVL1;TMTC3;SMAD7;RNF14;LRRK2;BAG2;DNAJB2;PIAS1;FMR1;TMEM259
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.3300872287538779,-0.9410360418794803,0.546031746031746,0.8340165038379916,1.0,4/21,5.10%,MFHAS1;PPP1R16B;PPP4R4;YWHAB
prerank,inorganic ion transmembrane transport (GO:0098660),-0.37960050645074483,-0.9407427758253089,0.5340909090909091,0.8334770482603897,1.0,5/12,22.14%,ABCC9;KCNJ8;PKD2L1;ABCC8;CACNA1H
prerank,protein autophosphorylation (GO:0046777),0.31698196696090314,0.9406404048497995,0.6017130620985011,0.8923660519736804,1.0,18/157,6.91%,STK39;EGFR;GRK5;DDR2;CAMK2D;ULK2;PTK2B;SRMS;CLK2;GSK3B;CDK12;ABL1;EPHB3;FGFR1;CHEK2;STK16;ERBB2;AURKA
prerank,COPII vesicle coating (GO:0048208),0.35074532361252303,0.9403117263618789,0.5668257756563246,0.8914929213103512,1.0,24/61,25.28%,SEC16A;SEC31A;SEC24B;SEC23A;CUL3;ANKRD28;SEC24D;SEC23IP;PPP6R3;NSF;STX5;TRAPPC3;TRAPPC10;GOSR2;RAB1A;TRAPPC9;PPP6R1;TMED2;PPP6C;MCFD2;BET1;RAB1B;TRAPPC2L;USO1
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.35074532361252303,0.9403117263618789,0.5668257756563246,0.8914929213103512,1.0,24/61,25.28%,SEC16A;SEC31A;SEC24B;SEC23A;CUL3;ANKRD28;SEC24D;SEC23IP;PPP6R3;NSF;STX5;TRAPPC3;TRAPPC10;GOSR2;RAB1A;TRAPPC9;PPP6R1;TMED2;PPP6C;MCFD2;BET1;RAB1B;TRAPPC2L;USO1
prerank,vesicle coating (GO:0006901),0.35074532361252303,0.9403117263618789,0.5668257756563246,0.8914929213103512,1.0,24/61,25.28%,SEC16A;SEC31A;SEC24B;SEC23A;CUL3;ANKRD28;SEC24D;SEC23IP;PPP6R3;NSF;STX5;TRAPPC3;TRAPPC10;GOSR2;RAB1A;TRAPPC9;PPP6R1;TMED2;PPP6C;MCFD2;BET1;RAB1B;TRAPPC2L;USO1
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.4746773603710666,0.9399644139224,0.5617977528089888,0.8911915473721648,1.0,1/10,1.64%,PRKCD
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.4746773603710666,0.9399644139224,0.5617977528089888,0.8911915473721648,1.0,1/10,1.64%,PRKCD
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.34167306056929,0.9398233991470988,0.5670103092783505,0.8909879280820071,1.0,15/75,14.03%,THBS1;HOXA5;SEMA3E;ISM1;KLF4;EMILIN1;ATP2B4;SULF1;KRIT1;FOXC1;MECP2;NIBAN2;SYNJ2BP;EFNA3;CD160
prerank,maturation of 5.8S rRNA (GO:0000460),0.427522604557981,0.939396296999369,0.5678832116788322,0.8913787853285196,1.0,9/17,23.69%,MPHOSPH6;C1D;URB1;EIF6;PRKDC;WDR12;PES1;RRP15;RPF1
prerank,positive regulation of growth (GO:0045927),0.34333796953439766,0.9393055210952344,0.5715976331360947,0.8910661600383953,1.0,13/64,12.59%,EGFR;TGFBR1;DDX49;ERBB2;AGR2;DNPH1;CEP43;EIF4G2;CIB1;KLHL22;FXN;RPS6KA3;BRAT1
prerank,response to insulin (GO:0032868),-0.24416874640659245,-0.9391063122862817,0.5984848484848485,0.8361635275583511,1.0,13/80,9.23%,TBC1D4;PIK3R1;SORT1;CPEB2;FOXO1;ENPP1;INSR;INSIG2;SLC25A33;MYO5A;LPIN3;RAB31;DENND4C
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-0.3683921620064877,-0.9385761562668619,0.5574712643678161,0.8361281333662178,1.0,4/14,14.28%,IL18;IL17D;PAEP;CD84
prerank,ribosomal subunit export from nucleus (GO:0000054),0.44389875799620193,0.9380442632591036,0.5523076923076923,0.8932550220434735,1.0,5/13,14.77%,LTV1;XPO1;EIF6;NUP88;NMD3
prerank,release of cytochrome c from mitochondria (GO:0001836),-0.34331109894835354,-0.9375522918441404,0.5394321766561514,0.8373598789598232,1.0,6/17,22.53%,BCL2;BCL2L1;BOK;FIS1;SFN;MFF
prerank,heme catabolic process (GO:0042167),0.43670159846410517,0.9375335922084447,0.5450381679389313,0.8933437263203466,1.0,3/14,15.68%,ABCG2;HMOX2;ABCC1
prerank,porphyrin-containing compound catabolic process (GO:0006787),0.43670159846410517,0.9375335922084447,0.5450381679389313,0.8933437263203466,1.0,3/14,15.68%,ABCG2;HMOX2;ABCC1
prerank,RNA processing (GO:0006396),0.3171728861882597,0.9374614722671686,0.614572333685322,0.8929773990178375,1.0,72/176,30.14%,MBNL1;DDX17;CELF3;SRSF11;CDK12;U2AF2;SON;SRSF5;TUT7;RBM39;TUT4;SNRNP48;DUSP11;PRPF18;KIN;RBM3;SRSF2;TENT2;CELF1;FUS;HNRNPH1;SNRNP35;SCAF11;BICD1;SRSF1;WBP4;RNPS1;PRPF8;FASTKD5;RNPC3;TENT4B;PABPC4;HNRNPA2B1;NONO;SYNCRIP;RBM6;CSTF3;MRPL44;SNRNP40;CLP1;PDCD7;SF3B3;DHX8;LSM4;TCERG1;AURKAIP1;LUC7L3;RNGTT;TARDBP;SRRM1;SRPK2;AKAP8L;HNRNPF;LSM1;USP39;RBM4;SUPT4H1;DICER1;SCNM1;PTBP1;DROSHA;ZCRB1;RBM5;THOC1;SNRPB;ALKBH5;DHX15;ZRSR2;HNRNPC;HNRNPR;PIWIL2;SRPK1
prerank,negative regulation of cholesterol transport (GO:0032375),-0.3938390229580734,-0.9373119740263756,0.5140449438202247,0.8366577183800569,1.0,3/10,26.72%,ABCA2;APOC1;SHH
prerank,positive regulation of histone acetylation (GO:0035066),-0.3284198531616232,-0.9372703400233584,0.5276752767527675,0.8354621275465437,1.0,11/23,32.39%,RPS6KA5;PPARGC1A;RPS6KA4;BRD7;WBP2;GLYR1;KAT7;SPHK2;PIH1D1;MUC1;RUVBL2
prerank,cardiac myofibril assembly (GO:0055003),0.4340165929794213,0.9372346454593438,0.5603715170278638,0.8929516976371373,1.0,2/15,5.87%,CSRP3;MEF2A
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.3160038207046144,0.9370835853847923,0.6031746031746031,0.8927508658469453,1.0,39/151,22.43%,ST3GAL4;PCSK5;ACER3;PLPP3;SGMS2;LARGE1;CHKB;GSTT1;INHBA;GAL3ST4;GSTA2;SLC44A3;ARG1;TYW5;LPIN2;LPCAT1;NMRAL1;KDSR;MOCOS;SPTSSB;DMD;ELOVL5;PCTP;TNIP1;GOLPH3;LPCAT2;LCAT;NANP;GSTM4;PPM1L;CEPT1;GSTO1;TYW1;CHAT;MOCS1;CERS6;HACD4;ELOVL2;PLPP1
prerank,positive regulation of protein secretion (GO:0050714),0.3494254773548725,0.9369946269497522,0.5687426556991775,0.8924255462488377,1.0,11/69,12.51%,TCF7L2;ADAM9;EZR;UNC13B;TGFB3;SYTL4;BMP6;TLR4;AACS;MCU;APBB3
prerank,negative regulation of macrophage activation (GO:0043031),-0.35285459991785306,-0.936958710865975,0.5260115606936416,0.8348807809777177,1.0,5/16,8.83%,IL31RA;NR1H3;LRFN5;SYT11;CD200
prerank,tricarboxylic acid metabolic process (GO:0072350),0.44983979901097293,0.9368381265499457,0.5411954765751211,0.8922212389579258,1.0,4/12,24.46%,ACO2;IDH3B;IREB2;IDH3A
prerank,positive regulation of signaling (GO:0023056),-0.29697835917100435,-0.9367492496538646,0.581081081081081,0.8341242508101689,1.0,8/37,10.18%,WLS;GRIK2;RIMS1;RIMS2;SYT1;LGI1;KCTD13;EDN1
prerank,regulation of embryonic development (GO:0045995),-0.29380702105062845,-0.9363610094362965,0.5622317596566524,0.8337573645380897,1.0,8/34,10.11%,PLCB1;CLASP2;INSR;DAG1;SOX17;CFL1;WDPCP;RPS6KA6
prerank,negative regulation of protein kinase activity (GO:0006469),0.33336917950696404,0.9358776100707067,0.5832389580973952,0.8938132073334849,1.0,20/88,17.24%,LRP6;UBASH3B;ABL1;NF1;ACP4;CEP43;CORO1C;DUSP19;QARS1;CHP1;CDKN1C;CDKN1B;ITGB1BP1;LRP5;SORL1;SRCIN1;DVL1;CDKN1A;CEP85;RB1
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.42900255833065426,0.9357890060522308,0.5379939209726444,0.8934986899867469,1.0,1/15,1.31%,ADAM9
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),-0.32554379458678806,-0.9354748159924106,0.5342960288808665,0.8345332127031401,1.0,5/21,8.85%,EPHA7;GRIN2B;GRIN1;AIM2;BIRC2
prerank,oligosaccharide metabolic process (GO:0009311),0.35353270872725895,0.935320551768088,0.5463786531130876,0.8939876372396421,1.0,6/46,9.09%,ST3GAL4;FUT8;ST8SIA2;B4GALT1;GAL3ST4;MAN1B1
prerank,sympathetic nervous system development (GO:0048485),0.43624297275572343,0.9345363696525653,0.5487627365356623,0.8950830118066789,1.0,2/15,5.44%,NRP1;NF1
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.4047074888755719,0.9345192106344757,0.5502183406113537,0.8946103786746251,1.0,6/20,20.86%,DCUN1D5;TGFBR1;EGR1;DCUN1D2;DCUN1D1;DNAJB2
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.44292123112080084,0.9339321823032797,0.5540540540540541,0.8953508691838813,1.0,4/13,11.45%,MDFIC;BARD1;NUP153;CHP1
prerank,negative regulation of interferon-gamma production (GO:0032689),0.3911657551193849,0.9338196160201124,0.5291666666666667,0.8950750978093697,1.0,4/23,8.33%,RARA;INHBA;ZC3H12A;TLR4
prerank,nuclear body organization (GO:0030575),-0.37514307958019744,-0.9337055783946654,0.5261845386533666,0.837500449554501,1.0,3/12,14.15%,ETS1;WRAP53;HIPK2
prerank,positive regulation by host of viral transcription (GO:0043923),-0.35707524564187654,-0.9336627437134887,0.5373134328358209,0.8362856727388281,1.0,1/15,0.53%,LEF1
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.3037319085906197,0.9336346451925741,0.6781029263370333,0.8949857604942228,1.0,47/390,7.75%,ARHGEF28;EGFR;MET;PGF;UBASH3B;NTRK3;DDR2;RBFOX2;VAV2;CYFIP2;ABI1;SIPA1L1;PTK2B;EFNA5;FGF2;ADRB2;NGF;IRS1;NRP1;VEGFA;SRMS;SLC39A14;GSK3B;FOXC2;GRB10;AP2A2;PTPN2;EPHB3;SHOC2;POLR1G;NR4A3;PDGFC;FGFR1;SPRED2;STAT3;SHC1;TCIRG1;KIF16B;FRK;NFATC4;ERBB2;TIAM1;NCK2;ROR1;ATP6V0A4;RHOQ;SULF1
prerank,negative regulation of neuron differentiation (GO:0045665),0.3995496423642643,0.9334348406517569,0.5350140056022409,0.894922691671594,1.0,5/22,14.64%,HES1;GSK3B;HES3;NEPRO;SOX9
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.39739607848781877,0.9329550981992084,0.562585969738652,0.8954646190328219,1.0,5/26,8.37%,MET;KATNB1;CLIP1;TOGARAM1;AKAP9
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.3301113114627688,0.9325264201856889,0.5873731679819617,0.8958667214135173,1.0,30/88,21.67%,VPS13A;EXOC4;VPS13C;GBF1;KIF16B;GOLGB1;STXBP6;SCAMP2;CLINT1;ARL3;ACBD3;DOP1B;SORL1;COMMD1;GOPC;VAMP2;SNAP23;GOLGA7;MON2;SH3D19;AP2A1;TXNDC5;AP1M1;EXOC2;SCAMP3;AP4E1;AP1S1;EXOC5;PUM1;ARFGEF2
prerank,mitotic sister chromatid segregation (GO:0000070),0.32762415184247107,0.9325061253143726,0.5853932584269663,0.8954034628250566,1.0,38/98,31.95%,SMC4;NIPBL;KNSTRN;BECN1;CUL3;KLHL22;CCNB1;POGZ;ZW10;PDCD6IP;KMT5A;SMC1A;CHMP2B;RB1;RAD21L1;REC8;SPDL1;NCAPH2;SMC2;RAB11A;PIBF1;PHF8;KIF23;INO80;AKAP8L;RAD21;CHMP3;KIF22;MIS12;CENPK;PLK1;CENPE;NAA50;TUBG1;NCAPD3;ESPL1;TEX14;SEH1L
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.4400193427421015,0.9324299548171986,0.5349922239502333,0.8950434579573696,1.0,6/13,23.59%,RENBP;SLC35A3;GFPT1;GNPDA1;UAP1;PGM3
prerank,embryonic hemopoiesis (GO:0035162),-0.39189146334519365,-0.9323885119723545,0.5363636363636364,0.8381367561824443,1.0,4/12,9.77%,KIT;KDR;FLT3LG;TAL1
prerank,chaperone-mediated protein complex assembly (GO:0051131),-0.3224619319479616,-0.9322583640042896,0.5751633986928104,0.8371321471292527,1.0,8/20,26.03%,HSP90AB1;HOPX;LONP1;HSPA1A;PTGES3L;HSPD1;BBS10;TMEM35A
prerank,positive regulation of neuron death (GO:1901216),0.36014310847401365,0.9321418064079604,0.5666666666666667,0.8951342610113743,1.0,9/46,12.19%,MAP3K5;GSK3B;CCL3;FOXO3;NF1;TLR4;EGR1;EIF2S1;CLU
prerank,regulation of ion transport (GO:0043269),0.33018796169890985,0.9321137690368377,0.5631517960602549,0.8946960087667127,1.0,6/76,5.86%,KCNJ2;NEDD4;KCNJ15;WNK1;WWP2;PER1
prerank,phosphatidylinositol metabolic process (GO:0046488),-0.2307609778127333,-0.9320688905828806,0.6590909090909091,0.8362905180633989,1.0,29/109,18.89%,PLCB1;INPP4B;PIP5K1B;PDGFRB;LPGAT1;PIK3R1;INPP5D;PIK3C2A;PLEKHA2;PLAAT3;PIK3R6;PTPN13;BMX;PITPNM2;CDIPT;MTMR3;MTMR10;PIK3CA;PIK3R5;CSF1R;PIP4K2B;MTMR14;PLEK;PLCG1;MTMR6;MTMR7;PIGW;PLEKHA3;INPP5B
prerank,regulation of lipid catabolic process (GO:0050994),0.41850474287141687,0.9318866908697331,0.5517241379310345,0.89468831347032,1.0,4/19,13.74%,ABCD1;LONP2;ANGPTL3;TYSND1
prerank,positive regulation of cell projection organization (GO:0031346),0.319762309706841,0.931534223062652,0.606359649122807,0.8949173402950952,1.0,25/115,13.83%,SLIT2;DPYSL3;NTRK3;CUX1;PTK2B;NGF;FZD1;KIDINS220;SCARB2;TIAM1;ROR1;STYXL1;TIAM2;ARSB;P3H1;FBXW8;RHOA;RAP1A;MARK2;RET;NPTN;MAP6;PLXNB1;SCN1B;ALKAL2
prerank,telomere maintenance via telomerase (GO:0007004),0.38544233033092823,0.9314371425010233,0.541782729805014,0.8946123887754414,1.0,8/28,22.26%,TELO2;ANKRD28;PPP6R3;RAD50;TNKS1BP1;CDK2;RFC1;PPP6C
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.3343595656185294,0.9310467247883344,0.5790080738177624,0.8949537680298235,1.0,9/76,12.30%,PLCE1;ADRA1B;CMKLR1;ESR1;C5AR2;GPR65;GPR4;DRD3;NMUR2
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.3441611677559176,-0.9306405216528437,0.5739644970414202,0.8383807633030387,1.0,7/17,23.43%,PPARA;PRKAA2;PPARD;PRKAG2;PDK4;FABP3;CAV1
prerank,positive regulation of lipid storage (GO:0010884),0.40284122429943026,0.9306214114330823,0.5588652482269504,0.8953773044803222,1.0,6/21,21.79%,IKBKE;ZC3H12A;PLIN3;EHD1;FITM2;OSBPL11
prerank,positive regulation of protein localization to membrane (GO:1905477),0.3233898639344658,0.9303085702308683,0.5986622073578596,0.8955353669806222,1.0,23/98,16.37%,EGFR;PRKCE;KCNB1;LRP1;RANGRF;ATP2B4;PLS1;ERBB2;AGR2;ITGB1;CIB1;MIEF1;C2CD5;EPHB2;CHP1;TFDP1;ITGB1BP1;DLG1;E2F1;PTPN9;PPP3CC;KIF5B;MIEF2
prerank,chondroitin sulfate catabolic process (GO:0030207),0.4403956754584648,0.9300930269999318,0.5391566265060241,0.8954860028402409,1.0,4/13,15.34%,HEXA;BGN;ARSB;IDUA
prerank,neuromuscular synaptic transmission (GO:0007274),0.41240856360407174,0.9298440141196337,0.5470085470085471,0.8954931335966908,1.0,6/18,21.08%,ERC1;ERC2;KIF1B;FCHSD2;CHRNB1;CHAT
prerank,triglyceride catabolic process (GO:0019433),0.4140769508364075,0.9297558881906473,0.5421511627906976,0.8951792952015819,1.0,3/19,12.97%,FABP12;PNPLA3;PNPLA2
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.3836224440540107,0.9297381173047481,0.5594125500667557,0.8947152833849291,1.0,5/30,7.92%,FSTL1;SFRP4;LTBP4;DKK3;SMAD2
prerank,receptor signaling pathway via STAT (GO:0097696),0.38265892397880563,0.9295702828742682,0.5414908579465542,0.8945476011171735,1.0,3/25,5.25%,PKD1;CLCF1;STAT3
prerank,negative regulation of transferase activity (GO:0051348),0.3915489113332911,0.9293946031504922,0.5724233983286908,0.8944347303075675,1.0,11/28,24.68%,GSK3B;ABL1;FBXO5;CDKN1C;CDKN1B;SMAD7;BAG5;ERCC4;NPRL2;TP53;SRC
prerank,regulation of viral genome replication (GO:0045069),-0.25815377549517643,-0.9288633501754151,0.6179775280898876,0.8414025149975007,1.0,17/56,17.41%,PPARA;IFIT1;HACD3;IFITM1;OAS2;IFITM3;BST2;PROX1;RNASEL;IFITM2;DDX3X;ADAR;SHFL;NR5A2;PARP10;BANF1;PDE12
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.3919100131483808,0.9288351933872404,0.5695006747638327,0.8951020516418794,1.0,5/27,8.63%,DDX5;TWIST1;SPRED2;CD44;KDM1A
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.42294133620971774,0.9284113364299422,0.5608628659476117,0.8955132506723522,1.0,9/16,29.80%,PARP3;KMT5B;PRKDC;KMT5C;KDM4D;PARP9;SMCHD1;SETMAR;DTX3L
prerank,peptidyl-tyrosine modification (GO:0018212),0.34416627936724237,0.9277924432888083,0.5884520884520884,0.8963124635724568,1.0,8/56,6.56%,EGFR;DDR2;ABI1;PTK2B;SRMS;ABL1;FGFR1;ERBB2
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.2925641326724404,-0.9277826492846152,0.5692307692307692,0.8427888828126935,1.0,6/31,8.94%,BCL2;TFDP2;YWHAB;HIP1R;PPP1R13B;YWHAH
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.3943407992487266,0.9274468871631294,0.5667144906743186,0.8965393566673366,1.0,8/23,16.08%,GPC3;GLI3;GLIS2;VCP;ULK3;KIF7;MEGF8;HHIP
prerank,glial cell differentiation (GO:0010001),0.38484304574735134,0.9273259763460746,0.560875512995896,0.8962808066195377,1.0,2/28,5.25%,NFIB;STAT3
prerank,positive regulation of lymphocyte proliferation (GO:0050671),-0.24488040834999417,-0.9272257690816134,0.6774193548387096,0.8428197921865218,1.0,21/63,21.91%,BCL2;VCAM1;TFRC;MEF2C;VAV3;CD38;IL18;NFATC2;CD81;MIF;CD40;CD74;CCL19;CD86;SLC7A1;JAK3;FGF10;CD276;GPR183;IL7;CD274
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.37715637016474995,0.9270612042122107,0.5589812332439679,0.896320007067126,1.0,7/33,13.01%,ADAM9;CYP1B1;FOXC2;ADA;CIB1;ITGB1BP1;RET
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.3735459601409739,0.9268333491235403,0.5555555555555556,0.8963081185824182,1.0,3/31,3.03%,CACNA1G;CLTRN;KCNB1
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.29458532141586663,-0.926752954193472,0.5778688524590164,0.8426466553849404,1.0,5/30,6.27%,IGF1;LYN;RASGRF1;TGM2;NOTCH1
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.44377672912713084,0.9266679474009765,0.5471698113207547,0.8961504809557496,1.0,1/11,0.92%,SCARA3
prerank,regulation of neurotransmitter transport (GO:0051588),-0.35431912315780795,-0.9266633350136592,0.564179104477612,0.8415629636076778,1.0,4/16,5.75%,MCTP1;RIMS1;MCTP2;MEF2C
prerank,positive regulation of transport (GO:0051050),-0.24456363648593935,-0.9264399862347488,0.6390977443609023,0.8408214750542405,1.0,24/85,18.37%,CAMK1D;APOE;NEDD4L;MERTK;IL15RA;ACTB;SIRPA;HIP1R;NR1H3;DOCK2;GATA2;SGK1;GAS6;CLIP3;SMPD1;BOK;TULP1;MLC1;CCL19;CD47;LYAR;GSK3A;CD151;PYCARD
prerank,regulation of protein processing (GO:0070613),0.4054924822792839,0.926277261874753,0.5453237410071943,0.8964737669539152,1.0,6/21,20.01%,TNP2;GAS1;ACP4;SNX12;LRRK2;BAG2
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.4113880005231038,0.9258205414718894,0.5635593220338984,0.896908133531424,1.0,4/21,10.53%,MED13;TWIST1;MED24;DHX36
prerank,ganglioside metabolic process (GO:0001573),-0.3248106274433899,-0.9255502222306725,0.5457413249211357,0.8415890648841372,1.0,3/20,7.52%,ST6GALNAC3;ST8SIA4;ST8SIA6
prerank,negative regulation of anoikis (GO:2000811),-0.36302842606557867,-0.9254800840196638,0.5811209439528023,0.8404849444891411,1.0,6/14,17.24%,TLE1;BCL2;NOTCH1;PIK3CA;PTK2;PDK4
prerank,membrane protein proteolysis (GO:0033619),0.3655376910250544,0.9250025665745822,0.5503875968992248,0.8981171873735342,1.0,7/37,15.75%,ADAM9;BACE2;SPPL2A;CLPP;RET;RBMX;TRAF6
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.432977718432647,0.9248580593045526,0.5454545454545454,0.8979314854577317,1.0,7/13,28.28%,SMUG1;UPP2;TDG;NEIL1;DUT;DCTPP1;NT5C
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.3896791875714848,-0.9245301609603755,0.5753768844221105,0.8414545923850582,1.0,5/10,15.43%,LPGAT1;NR1H3;NR1H2;ABCD2;MID1IP1
prerank,mononuclear cell differentiation (GO:1903131),0.39174879553789255,0.9245183927927274,0.5787234042553191,0.8981809447569613,1.0,2/24,3.16%,BMP4;VEGFA
prerank,glycerophospholipid catabolic process (GO:0046475),-0.30200108257498837,-0.9243111853462346,0.564748201438849,0.8406893561935223,1.0,3/27,6.73%,ENPP2;GPCPD1;ENPP6
prerank,lysosome organization (GO:0007040),0.3659773442960087,0.9236543140389079,0.5915492957746479,0.8995129999334204,1.0,15/36,30.46%,HPS4;ACP3;ACP4;ARSB;HOOK3;GNPTAB;LRRK2;TMEM165;MTOR;CLN3;HOOK1;VPS33A;MBTPS1;ACP2;LAMTOR1
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.44493606549746034,0.9235950137926647,0.5779816513761468,0.8991347267455253,1.0,3/13,8.63%,TWIST1;CD44;KDM1A
prerank,aggrephagy (GO:0035973),0.3863055608196586,0.9235377108776903,0.5781865965834428,0.8987691519740727,1.0,11/27,29.17%,WDR81;ACBD5;PCNT;ATG5;WDFY3;UBB;UBE2V1;UBA52;RPS27A;UBE2N;SQSTM1
prerank,Fc receptor signaling pathway (GO:0038093),0.3225635913821502,0.9234306499743518,0.6185226019845645,0.8984826361865268,1.0,30/110,21.13%,PPP3CA;VAV2;GAB2;PSMB2;PLCG2;SHC1;TAB3;IKBKG;NFATC3;PSMD11;PSMC1;CUL1;MAP3K7;TAB2;PSMC6;MAP2K4;MAP3K1;NFATC1;PSMD1;TRAF6;PSMD4;IKBKB;PSMA6;LAT;PSMD14;PSMD12;PSMD7;CHUK;FER;PSME3
prerank,positive regulation of bone resorption (GO:0045780),-0.37827736445149346,-0.9232263346265487,0.5824742268041238,0.8420861887600234,1.0,5/11,29.22%,TNFRSF11A;SPP1;PLEKHM1;ATP6AP1;MC4R
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.33698425241941277,0.9231335104918711,0.5993111366245695,0.8986062151187594,1.0,20/73,21.13%,PSMB2;ABL1;KITLG;PSMD11;FOXC1;PSMC1;DHX36;EIF2AK2;PSMC6;PDCD2;PSMD1;PRKDC;PSMD4;YAP1;PSMA6;PSMD14;PSMD12;PSMD7;TCF12;PSME3
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.44311513413599346,0.9227658806588478,0.552755905511811,0.8983545341700588,1.0,4/12,12.96%,EFNA5;DMTN;CORO1C;ITGB1BP1
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.44311513413599346,0.9227658806588478,0.552755905511811,0.8983545341700588,1.0,4/12,12.96%,EFNA5;DMTN;CORO1C;ITGB1BP1
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.40373715626530127,0.9227446536803066,0.6008771929824561,0.8979041287775728,1.0,4/18,19.71%,COX16;SCO2;COA8;FASTKD3
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.35657801988116306,0.922733229085973,0.5730478589420654,0.8974280755243031,1.0,15/46,17.24%,ZNF423;NPR3;ID1;FOXC2;DOCK7;IP6K1;TLR4;ABHD6;ACOT11;NR1D1;ACOT13;ADAMTS5;RHEB;PCTP;RB1
prerank,establishment of protein localization to extracellular region (GO:0035592),0.3654239009610951,0.9224598973220193,0.5719794344473008,0.8974951855084307,1.0,10/39,20.38%,TANGO6;LTBP2;ARFGAP3;COPG1;MIA3;SEL1L;TMEM167A;GOLPH3;TVP23B;TVP23A
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.3324446631044204,0.9220779462022811,0.6060254924681344,0.8978161645357509,1.0,5/75,3.32%,PLCE1;MGLL;GRK5;PDE6A;SLC39A14
prerank,protein-DNA complex assembly (GO:0065004),0.3200047532748878,0.9217684860486494,0.6111111111111112,0.8979662915869051,1.0,40/116,26.46%,CHAF1B;PSMB2;ERCC5;MCM2;RAD51;MNAT1;PSMD11;CHAF1A;CHD1L;PSMC1;PARP1;RAD23B;PSMC6;ORC3;ATRX;SOX9;PSMD1;MCM7;CDK7;KAT6B;PSMD4;SMARCA5;GTF2H3;PSMA6;PSMD14;PSMD12;CETN2;PSMD7;NAA60;PSME3;NAP1L1;PSMD3;PSMB6;ASF1A;UBB;RSF1;CDC6;UBA52;GTF2H4;RPS27A
prerank,acute-phase response (GO:0006953),0.44625504288065976,0.9217465501009354,0.5733113673805601,0.8975123461362358,1.0,1/12,1.41%,LBP
prerank,regulation of AMPA receptor activity (GO:2000311),-0.30615553869708556,-0.9214719060142763,0.5638297872340425,0.8448591946521737,1.0,9/25,17.56%,SHANK3;MEF2C;CACNG7;CACNG4;CACNG3;CACNG2;RELN;GSG1L;CACNG8
prerank,positive regulation of reproductive process (GO:2000243),0.3747687662560661,0.921254560390994,0.569390402075227,0.8980291686984472,1.0,4/31,6.78%,LHFPL2;VEGFA;AGO2;INHBA
prerank,melanosome organization (GO:0032438),0.3827646771864328,0.9211164433581626,0.5372124492557511,0.8978185377787067,1.0,8/26,21.96%,KIF13A;HPS4;AP3B1;LYST;AP3D1;BLOC1S5;AP1M1;PMEL
prerank,positive regulation of cell growth (GO:0030307),0.3192694631373022,0.9205888797764806,0.5960044395116537,0.898438802233293,1.0,16/96,13.51%,EGFR;NTN1;NGF;TGFBR1;DDX49;ERBB2;DNPH1;CEP43;EIF4G2;SHTN1;CIB1;KLHL22;FXN;RPS6KA3;BRAT1;DBN1
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.3747205195430968,-0.920400614113777,0.5734463276836158,0.8462499146380419,1.0,9/13,43.16%,MR1;NECTIN2;CYRIB;FADD;IL12A;IL12RB1;IL23A;IL12B;XCL1
prerank,long-chain fatty acid metabolic process (GO:0001676),0.34126164660486924,0.9197846516424235,0.5914994096812278,0.8996316090456533,1.0,13/64,17.98%,MGLL;CYP1B1;ACSL3;SLC27A3;ABCD1;PNPLA3;ACOT8;ACOX1;ELOVL5;ALOX5;ACADL;GSTM4;DAGLB
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.32223601692682763,0.9195816010616774,0.60734149054505,0.8995748810617016,1.0,18/101,11.57%,EGFR;PKD1;TCIM;FGF2;ADRB2;VEGFA;TELO2;PDGFC;FGFR1;ATP2B4;ERBB2;TENM1;CCND1;SYAP1;CIB1;RHOA;CCNYL1;CAB39
prerank,regulation of GTPase activity (GO:0043087),0.3031226569160554,0.9190989005122622,0.6288117770767613,0.9000642550946899,1.0,38/177,15.18%,WNK1;VAV2;ARAP1;WNT11;SIPA1L1;EFNA5;SGSM2;SRGAP2;GSK3B;BCAS3;CCL3;LIMS1;CCL1;EPHB3;ARHGAP44;NDEL1;NF1;ERBB2;ITGB1;RDX;S100A10;RGP1;RGS6;CCL7;RAP1A;FGD1;SNX18;BCAR3;OCRL;ITGB1BP1;FGD3;RRP1B;PLXNB1;EVI5;ADAP1;FGD6;RABGAP1;AFDN
prerank,regulation of amyloid fibril formation (GO:1905906),-0.35377671652976067,-0.919046122601243,0.5619047619047619,0.8481824448675018,1.0,3/15,7.84%,APOE;APP;PFDN5
prerank,sulfur compound catabolic process (GO:0044273),-0.27879732814308245,-0.9184161200975545,0.5958333333333333,0.8483457491919574,1.0,16/38,23.80%,FMOD;OGN;DCN;GGT5;OMD;LUM;CHAC2;CSPG5;HEXB;NCAN;GALNS;GGT1;CTH;MPST;ACAN;BCAN
prerank,mitotic spindle organization (GO:0007052),0.31206542005841403,0.9183130538550799,0.6445846477392219,0.9011668416005094,1.0,45/153,25.34%,NDEL1;CLIP1;CHEK2;SPICE1;AURKA;STAG1;MISP;PAFAH1B1;TOGARAM1;XPO1;VCP;PTPA;CDC20;TTK;CCNB1;AHCTF1;RHOA;MECP2;CENPT;MAD2L1;PCNT;KIF3B;ZW10;RANBP2;CENPL;OFD1;ABRAXAS2;SMC1A;ZWILCH;SPDL1;STAG2;MAD1L1;NEK6;RAB11A;CCDC61;PPP1CC;PIBF1;BUB3;TAOK1;KIF23;ABRAXAS1;TBCE;CENPP;NUP98;GPSM2
prerank,regulation of kinase activity (GO:0043549),0.3230357625718105,0.9178440296049027,0.6172140430351076,0.9016216472420575,1.0,10/89,7.12%,EGFR;PLCE1;MET;NTRK3;DDR2;LMO4;EPHB3;FGFR1;ERBB2;ROR1
prerank,amino sugar biosynthetic process (GO:0046349),0.43974345910510354,0.9176956090625565,0.5676100628930818,0.901440232136969,1.0,6/12,23.59%,RENBP;NANP;GFPT1;GNPDA1;UAP1;PGM3
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.3624675196700575,0.9175892214531622,0.5965834428383706,0.9011822853855838,1.0,9/41,18.40%,MGLL;CYP1B1;ABCD1;ACOT8;ACOX1;ELOVL5;ALOX5;DAGLB;SCD
prerank,long-term memory (GO:0007616),-0.3238505748695032,-0.9172099821553812,0.5454545454545454,0.8499755638686942,1.0,4/19,7.04%,APOE;RASGRF1;CPEB3;SGK1
prerank,positive regulation of integrin activation (GO:0033625),-0.3860912921807724,-0.9168799663106575,0.5474254742547425,0.8495121313686996,1.0,2/11,5.28%,RASIP1;PIEZO1
prerank,regulation of proteolysis (GO:0030162),0.351360643067932,0.9168181431531632,0.5877300613496933,0.9023458416986243,1.0,16/48,27.88%,PERP;CYFIP2;LTBP4;DNAJC1;SPOPL;SPOP;HDAC2;ASPH;TRAF3;AURKAIP1;OGT;FBXW11;TBC1D10A;CLN3;PLK1;BAD
prerank,positive regulation of peptidase activity (GO:0010952),0.3996185169606369,0.9166151337501424,0.561877667140825,0.9022762650553215,1.0,3/20,9.11%,TANK;MAPK12;VCP
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.3743198706818417,0.9161437667683385,0.5894308943089431,0.9027909433274788,1.0,4/30,7.82%,FHIT;GIPC1;WAC;TRIM39
prerank,neural crest cell migration (GO:0001755),0.3678983029978919,0.9161188657200007,0.596,0.9023521562510776,1.0,7/36,8.58%,SEMA3E;PITX2;NRP1;SEMA3C;SEMA3D;FN1;CORO1C
prerank,positive regulation of dendritic spine development (GO:0060999),-0.31871521940784436,-0.9159687759403788,0.56875,0.8503618336323596,1.0,8/20,15.97%,APOE;SHANK3;CPEB3;CUX2;LRP8;CAMK2B;DBNL;RELN
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.3866740131922072,-0.9156624430341193,0.5626740947075209,0.8498416271312748,1.0,3/10,14.01%,PRKCH;MED1;ETV4
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.31372630359315873,0.9154864814502596,0.6268656716417911,0.9031673588695401,1.0,33/129,19.59%,EGFR;WNK1;GPC3;PLEKHA4;SFRP4;PSMB2;UBR5;DACT1;PSMD11;TRPM4;PSMC1;VCP;USP34;TBL1X;PSMC6;CSNK1G3;JUP;RNF146;NRARP;CSNK1G1;PSMD1;UBE2B;CAPRIN2;PSMD4;USP47;PIN1;PSMA6;PRDM15;LRRK2;PSMD14;PSMD12;PSMD7;LGR6
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.3609926512523721,-0.9150738445232145,0.5864022662889519,0.8499702462186869,1.0,7/13,24.01%,PPP1R15B;WFS1;DNAJB9;RACK1;DDRGK1;UFL1;HSPA5
prerank,determination of heart left/right asymmetry (GO:0061371),0.35335468959174776,0.914940265782251,0.5891959798994975,0.9038259615318655,1.0,4/43,8.39%,MICAL2;SMO;TGFBR2;GATA4
prerank,mitochondrial translational termination (GO:0070126),0.32469467457049855,0.9145956661207116,0.6104190260475651,0.9040362196337728,1.0,40/88,35.76%,MRPL33;MRPL40;MRPL42;MRPS27;MRPL11;MRPS2;MRPL36;MRPL19;MRPL15;MRPL23;MRPL44;MRRF;GADD45GIP1;MRPS21;AURKAIP1;MRPS30;MRPL35;MRPL52;MRPL30;GFM2;MRPL10;MRPL48;MRPS18A;MRPS31;MRPL1;MRPL13;MRPL22;MRPS16;MRPL37;MRPS28;MRPS35;ERAL1;MTRF1;MRPL28;CHCHD1;MRPS7;MRPL14;MRPL32;MRPS9;MRPS18C
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.2995802858808575,-0.9141826628829555,0.592,0.8507521291815733,1.0,17/25,42.47%,PDCD5;PINK1;BCL2L11;TNFSF10;PYCARD;BIK;MFF;GPER1;PMAIP1;PLAUR;DNM1L;BMF;CIDEB;BBC3;HRK;MMP9;MOAP1
prerank,regulation of insulin secretion (GO:0050796),0.3221557542998065,0.9136582260024088,0.6427015250544662,0.905491110094539,1.0,7/101,3.08%,CCN3;TCF7L2;CACNA1C;EFNA5;KCNB1;KCNS3;IRS1
prerank,ncRNA export from nucleus (GO:0097064),0.3662679430901423,0.9134392428854567,0.5686777920410783,0.9054684223523016,1.0,9/36,17.82%,NUP93;NUP214;NUP153;NOL6;NUP155;RANBP2;NUP88;SSB;NUP35
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.3295898133195943,-0.913439097187454,0.5692307692307692,0.8512156224453639,1.0,4/19,6.97%,TJP1;NEXMIF;NOTCH1;NOTCH4
prerank,response to cAMP (GO:0051591),0.36086276752739443,0.9133134235786594,0.5814863102998696,0.9052365870946213,1.0,6/37,11.11%,IGFBP5;EZR;SLC26A6;DMTN;AKAP9;RAP1A
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.31797417608109635,0.9130333875588178,0.6241685144124168,0.9053067946667381,1.0,21/107,16.55%,SLC24A3;CSRP3;ATP2C2;ANK2;ATP1B1;CASR;SLC39A14;CCL3;CCL1;ATP2B4;SLC10A7;SLC39A13;CCL7;DRD3;SLC8B1;CTRC;NPTN;CHERP;SLC30A9;RMDN3;LCK
prerank,negative regulation of neurogenesis (GO:0050768),-0.2855799532197578,-0.9123649748830951,0.6150442477876106,0.8524292299379705,1.0,8/34,10.07%,B2M;RAPGEF2;RTN4;NOTCH1;MAG;YWHAH;RUFY3;ARHGDIA
prerank,bile acid metabolic process (GO:0008206),-0.3058828551081179,-0.9119648209013986,0.5833333333333334,0.8521428488323662,1.0,8/27,21.98%,CYP7B1;CYP27A1;OSBPL1A;SCP2;OSBPL9;OSBPL3;OSBPL7;CH25H
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.34896795381317103,0.9116683279441342,0.573791348600509,0.9076506356899912,1.0,14/42,26.46%,WRN;VCP;ZBTB1;POLI;PRIMPOL;PCLAF;DTL;RFC1;USP10;SPRTN;UBB;UBA52;POLK;RPS27A
prerank,negative regulation of RNA splicing (GO:0033119),0.4003420710642621,0.9114636060032916,0.5818965517241379,0.9075879058281735,1.0,5/19,17.54%,U2AF2;SRSF6;RBMX;RNPS1;PCBP4
prerank,insulin receptor signaling pathway (GO:0008286),0.3313695091405533,0.9114222933327595,0.6,0.9071735477962297,1.0,22/69,21.33%,IRS1;SLC39A14;GSK3B;FOXC2;GRB10;PTPN2;SHC1;TCIRG1;ATP6V0A4;RHOQ;PIK3R3;C2CD5;IDE;BCAR3;ATP6V1A;IRS4;AP3S1;ZNF106;ATP6V0D1;FER;SORBS1;IGF2
prerank,lamellipodium assembly (GO:0030032),0.37836845568650135,0.9112459442019237,0.5806451612903226,0.9070487287753464,1.0,7/26,8.22%,ABLIM3;SRGAP2;ARFIP2;VCL;ITGB1;DMTN;ABLIM2
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.33285066864397295,0.9109732776819605,0.6057142857142858,0.9071177607064081,1.0,28/76,27.83%,RNF144A;PRICKLE1;GSK3B;ZYG11B;CSNK1A1;ARIH1;VCP;ANKIB1;DDA1;DET1;KEAP1;CLU;COP1;DVL1;SMAD7;RNF14;LRRK2;SMURF1;BAG2;DNAJB2;PIAS1;DAB2;ARIH2;CSNK1E;AXIN1;SUMO1;RNF19A;PLK1
prerank,lipid droplet organization (GO:0034389),0.39418860044376025,0.9107860344799151,0.5595075239398085,0.9070127967455418,1.0,6/22,19.00%,ZFYVE1;SMIM22;PNPLA3;SQLE;CDS1;FITM2
prerank,regulation of microglial cell activation (GO:1903978),0.414299708511951,0.9106630110260051,0.5768025078369906,0.906774023836326,1.0,5/15,19.29%,LDLR;CCL3;NR1D1;CST7;TAFA3
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.4451091282137225,0.9106589522502926,0.583203732503888,0.9062902089699741,1.0,4/10,25.27%,BAG3;NCK1;HIF1AN;JUN
prerank,mitochondrial translational elongation (GO:0070125),0.3219309678861998,0.9105365047216104,0.6220472440944882,0.9060570011739274,1.0,39/88,35.76%,MRPL33;MRPL40;MRPL42;MRPS27;MRPL11;MRPS2;MRPL36;MRPL19;MRPL15;MRPL23;MRPL44;GADD45GIP1;MRPS21;AURKAIP1;MRPS30;MRPL35;MRPL52;TSFM;MRPL30;GFM2;MRPL10;MRPL48;MRPS18A;MRPS31;MRPL1;MRPL13;MRPL22;MRPS16;MRPL37;MRPS28;MRPS35;ERAL1;MRPL28;CHCHD1;MRPS7;MRPL14;MRPL32;MRPS9;MRPS18C
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.3348706929751894,0.9103474151852515,0.6364705882352941,0.9059413792727717,1.0,29/72,33.09%,ERCC5;MNAT1;UVSSA;COPS7B;COPS5;CDK7;GTF2H3;COPS8;POLR2C;COPS3;RFC1;COPS2;ERCC4;USP7;UBB;HMGN1;ERCC8;UBA52;POLK;GTF2H4;RPS27A;DDB1;ERCC2;POLD1;XPA;GTF2H5;COPS7A;GTF2H1;RFC2
prerank,lipid biosynthetic process (GO:0008610),0.3265427095186128,0.9102538483916496,0.590443686006826,0.9056518873764634,1.0,18/77,19.13%,ABCD3;ACSM2A;ACSM2B;AGPS;PDSS2;MBOAT1;ACACA;GGPS1;LPCAT1;PIP5K1A;GNPAT;SREBF1;ALOX5;SCD;HMGCR;NDUFAB1;FITM2;STAR
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.33931556098497634,0.9102307741292087,0.5932611311672683,0.9052046170814332,1.0,6/54,5.90%,THBS1;FGF2;VEGFA;FGFR1;NF1;ATP2B4
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.42891381317822436,0.91022009956928,0.5786259541984733,0.9047316780743417,1.0,6/14,22.06%,YBX3;ANGEL2;MYD88;TIRAP;MAPKAPK2;TARDBP
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.3802264627904067,0.9100847624735816,0.5932885906040268,0.9045266269965386,1.0,12/29,26.47%,CNOT8;EXOSC3;DCP1A;EXOSC1;DIS3;EXOSC2;LSM4;EXOSC7;EXOSC8;DDX6;LSM1;PATL1
prerank,positive regulation of phospholipase activity (GO:0010518),0.38993435952057676,0.9099403078496138,0.5525179856115108,0.9043370368858177,1.0,4/22,5.14%,NTRK3;FGF2;ESR1;FGFR1
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.44676433033443697,0.9096406816405318,0.5768621236133122,0.9044718555592729,1.0,4/10,14.64%,TGFBR2;CHRD;LRP5;SOX9
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.42936334850253555,0.9092316428951034,0.5763239875389408,0.904832152774017,1.0,3/14,9.01%,RARA;ANXA1;CD80
prerank,muscle tissue morphogenesis (GO:0060415),0.4126011711125852,0.9087621600183129,0.5828488372093024,0.9052713944735763,1.0,1/16,0.35%,BMP4
prerank,regulation of chondrocyte differentiation (GO:0032330),0.3836080930457789,0.9086564209422614,0.5854341736694678,0.9049900301393443,1.0,4/24,5.84%,WNT9A;TGFBR1;PTHLH;ZBTB16
prerank,cellular response to interleukin-7 (GO:0098761),0.40073338864753044,0.9082565310214415,0.5945165945165946,0.9048296617223528,1.0,2/17,5.25%,IRS1;STAT3
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.40073338864753044,0.9082565310214415,0.5945165945165946,0.9048296617223528,1.0,2/17,5.25%,IRS1;STAT3
prerank,polyol metabolic process (GO:0019751),0.34679006835448056,0.9077960155897106,0.6042713567839196,0.905302659992488,1.0,10/46,13.19%,PLCE1;PLCZ1;PLCB3;PLCG2;IP6K1;IP6K2;PPIP5K1;INPP4A;OCRL;INPPL1
prerank,T cell mediated immunity (GO:0002456),0.4361130227379184,0.9075989990946592,0.5873261205564142,0.9052039686588886,1.0,3/13,12.02%,CD55;CD46;JAG1
prerank,positive regulation of mitochondrion organization (GO:0010822),-0.25565429428015296,-0.9075650124004799,0.6666666666666666,0.8613108593911307,1.0,20/57,24.60%,DCN;KDR;SPIRE1;HIP1R;PPARGC1A;PDCD5;PINK1;BCL2L11;TNFSF10;BOK;FIS1;GSK3A;PYCARD;BIK;MFF;GPER1;TREM2;FBXO7;RALBP1;CAMKK2
prerank,regulation of wound healing (GO:0061041),0.3555693536885779,0.9072716261022149,0.5952080706179067,0.9053875703517588,1.0,11/42,16.83%,PRKCE;FGF2;CD109;ANXA1;SRSF6;ITGB1;DMTN;EPHB2;ALOX5;ARFGEF1;TNFRSF12A
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),-0.2734439806598467,-0.9072299849868508,0.631336405529954,0.860830904828936,1.0,6/40,5.12%,VTN;SGIP1;B2M;CD63;INSR;DGKD
prerank,post-translational protein modification (GO:0043687),0.2973982931202192,0.9070708285941076,0.7233400402414487,0.9053127581934717,1.0,68/332,19.18%,FBXL7;BMP4;FSTL1;PTP4A2;CCN1;IGFBP5;GPC3;CCDC8;FBXO10;MSLN;DCAF6;PSMB2;TIMP1;DCAF4;ZBTB16;SPSB2;DCAF5;FBXL20;FN1;DSCC1;PSMD11;FEM1B;CKAP4;HIF3A;CUL3;PSMC1;MIA3;CUL1;KLHL22;RBBP7;RCN1;FBXW8;FBXO27;DNAJC3;CALU;PSMC6;DDA1;KEAP1;KTN1;FBXO31;ESCO1;ATG5;COPS7B;UBE2M;PNPLA2;MXRA8;COP1;DCAF7;COPS5;COMMD1;RAB11B;PSMD1;PSMD4;RAB1A;FBXO17;SHISA5;DCUN1D1;TULP4;SOCS3;PSMA6;DTL;COPS8;NUCB1;PSMD14;PSMD12;COPS3;PSMD7;UBA3
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.3875589610695138,0.9070349215740111,0.5729442970822282,0.904899333297263,1.0,6/24,9.10%,NRP1;VEGFA;LIMS1;ABL1;MYOC;S100A10
prerank,cell-cell junction organization (GO:0045216),0.3326087013256502,0.9062192850926086,0.6347926267281107,0.9060664320900933,1.0,10/79,5.31%,CDH11;CDH1;CTNND2;PKP1;TGFB3;DSP;NECTIN3;DSG2;LIMS1;CTNNA1
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.30484037836749917,0.9060004882333245,0.6677083333333333,0.9060183991366209,1.0,21/161,9.08%,TCF7L2;LRP6;MLLT3;PTPRU;WNT11;PRICKLE1;SFRP4;GSK3B;PSMB2;GLI3;INVS;TLE2;EMD;NOG;DACT1;DKK3;PSMD11;CSNK1A1;CUL3;SFRP5;PSMC1
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.3954207929180631,0.9059876997094168,0.5977808599167822,0.9055555651843461,1.0,3/21,1.84%,CACNA1C;CAMK2D;ANK2
prerank,positive regulation of cytokine production (GO:0001819),0.2977349759517063,0.9053573167137972,0.7293997965412004,0.9063695108307454,1.0,52/292,17.40%,F3;FOXP1;LBP;CYP1B1;CD2;RAB7B;RARA;CCL1;PLCG2;TLR1;IL33;TWIST1;STAT3;ANXA1;IL17RA;CREBBP;RORA;IRF1;SULF1;TLR4;EGR1;GATA4;CD80;MAVS;ARNT;IFIH1;RIPK2;MAP3K7;DHX36;EIF2AK2;CGAS;ZFPM1;TLR8;POLR3F;CD46;POLR3A;MYD88;TRAF2;BRCA1;TIRAP;SORL1;POLR3K;POLR3E;PRKDC;TRAF6;RAB1A;FLOT1;SCRIB;POLR3D;GLMN;ZBTB7B;SCIMP
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.3199261221627667,0.9052838388872272,0.6362612612612613,0.9060408040017405,1.0,16/88,16.79%,TRABD2B;MPP7;VEGFA;GSK3B;EMILIN1;SLX4;SPIDR;VCP;SH3GLB1;CLU;TIRAP;PDCD6IP;PRKCA;CDC42EP2;FLOT1;SNF8
prerank,negative regulation of interleukin-6 production (GO:0032715),0.37571738909672947,0.9050270185533482,0.606353591160221,0.9060640758909145,1.0,5/27,8.33%,IRAK3;C5AR2;NLRP12;ZC3H12A;TLR4
prerank,regulation of neurotransmitter secretion (GO:0046928),-0.2911056318362818,-0.9045779568652481,0.6334661354581673,0.8656822534454246,1.0,7/32,11.27%,MCTP1;RIMS1;RIMS2;MCTP2;MEF2C;SYT11;SLC30A1
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.40072283803346626,0.9045535541891172,0.5783475783475783,0.9065190745890962,1.0,7/20,17.24%,TWIST1;FOXC1;POU4F1;NIBAN2;TRAF6;PAX6;RB1
prerank,negative regulation of establishment of protein localization (GO:1904950),-0.37922006685257675,-0.9041657201592932,0.5854341736694678,0.8654070194490097,1.0,6/10,18.80%,CORO2B;MAPT;TERF1;SNX3;PPM1F;NDFIP1
prerank,protein tetramerization (GO:0051262),0.3310944183577649,0.90400857117484,0.6014067995310668,0.907098571174698,1.0,7/67,10.61%,KCNJ2;PKD1;TRPM4;CUTC;ACACA;TDO2;TK1
prerank,regulation of inflammatory response (GO:0050727),0.2994219267822329,0.9038726042917916,0.6865828092243187,0.9068902495761035,1.0,36/190,19.20%,FOXP1;CCN3;MGLL;PRKCD;PIK3AP1;PTGIS;KLF4;CCL3;CCL1;PTPN2;IL33;ANXA1;IL17RA;NLRP12;RORA;TLR4;GPR4;PDCD4;IFI35;MYD88;CELF1;NR1D1;ABCC1;TNIP1;ALOX5;FFAR4;VAMP2;RB1;AREL1;PSMA6;DAGLB;CCN4;DHX9;PPARG;JAK2;BRD4
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.44376945233000537,0.9038516650365909,0.5847328244274809,0.9064480547085888,1.0,4/12,22.75%,TK1;UPP2;DHODH;UMPS
prerank,negative regulation of DNA binding (GO:0043392),0.37928538034157466,0.9034893394317558,0.6145251396648045,0.9066969498317609,1.0,5/28,13.24%,MDFI;SMO;KDM1A;CPNE1;E2F1
prerank,regulation of cholesterol metabolic process (GO:0090181),-0.32676872650079053,-0.9034337196402712,0.5910652920962199,0.8659152366603241,1.0,3/20,9.33%,APOE;KPNB1;ARV1
prerank,cardiac ventricle morphogenesis (GO:0003208),0.34821216651433606,0.9031753034170137,0.5928753180661578,0.9068627923289576,1.0,4/41,8.39%,BMP4;BMPR1A;TGFBR2;GATA4
prerank,regulation of pH (GO:0006885),0.43566568703775044,0.9029094503423571,0.580267558528428,0.9069312083221683,1.0,3/11,9.77%,ATP6V0A4;ATP1A4;SLC9A1
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.44048511212761254,0.9025315174709092,0.6022364217252396,0.9071858915739468,1.0,6/11,27.06%,STAT3;DHX9;PUM2;PUM1;FMR1;LIMD1
prerank,stress granule assembly (GO:0034063),0.40141600755784407,0.9024702538754064,0.5732044198895028,0.9068252252692457,1.0,5/20,15.49%,ATXN2;EIF2S1;UBAP2L;BICD1;CIRBP
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.3644364516973047,-0.9020422887046929,0.5892351274787535,0.8677582993972233,1.0,4/14,6.42%,RAPGEF2;PRKAR2B;PRKAR1B;PRKAR1A
prerank,protein targeting to membrane (GO:0006612),0.3223290116171629,0.9016274679618934,0.6440872560275546,0.9080039648584953,1.0,28/83,26.99%,ABCD3;PXMP2;SEC61A1;ZDHHC2;ABCD1;ZDHHC20;ACBD5;PEX13;ZDHHC12;ATG3;VPS37A;PARD3;ZDHHC15;VPS37B;SRP19;ZDHHC24;GOLGA7;PEX26;ZDHHC3;ATAD1;ZDHHC19;PEX3;RABGEF1;SRPRA;ZDHHC21;PEX11B;ALDH3A2;ZDHHC6
prerank,JNK cascade (GO:0007254),0.3555285714748115,0.9015040124819229,0.5984555984555985,0.9077815726389397,1.0,9/40,16.39%,MAP3K5;TAB3;IKBKG;RIPK2;MAP3K7;TAB2;MAP2K4;TRAF6;MAP3K10
prerank,regulation of G0 to G1 transition (GO:0070316),0.35014577540650943,0.9012376359408399,0.6033163265306123,0.9078493176048615,1.0,15/38,23.71%,RAD51;EHMT1;EED;CBX5;RBBP7;TFDP1;BRCA1;E2F1;CDC7;EPC1;SUZ12;CHEK1;PCGF6;APAF1;RBBP8
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.3566425621021661,0.9011971433188009,0.6126482213438735,0.9074505043631758,1.0,5/36,7.82%,FHIT;GIPC1;USP25;WAC;TRIM39
prerank,neuron projection organization (GO:0106027),0.41141759736583366,0.9007739624762829,0.5920471281296024,0.9078314983238818,1.0,4/15,9.69%,GSK3B;PLS1;ABCD1;ATP1A3
prerank,negative regulation of receptor binding (GO:1900121),0.4480047764982123,0.9003643814783368,0.6036184210526315,0.908151096695289,1.0,2/10,4.73%,PTPRF;NOG
prerank,positive regulation of stress fiber assembly (GO:0051496),0.35120852705505895,0.8998802529097243,0.6246819338422391,0.9086318416782782,1.0,10/44,10.42%,WNT11;SORBS3;NRP1;TGFB3;TGFBR1;ABL1;MYOC;GPR65;S100A10;RHOA
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.3506141147429463,0.8998533856991674,0.6052631578947368,0.9082008590876629,1.0,10/41,19.89%,SCARB2;NUP93;NUP214;NUP153;EIF6;NUP155;RANBP2;NUP88;NUP35;ZBTB7A
prerank,mesoderm development (GO:0007498),-0.31654775184696193,-0.8997745534425315,0.6134969325153374,0.871813581693896,1.0,8/18,18.30%,TIE1;TBX3;TBX1;BMX;GDF11;IKZF1;BTK;HCK
prerank,dendrite morphogenesis (GO:0048813),0.3568305656551979,0.8996196095621615,0.5979381443298969,0.9081843036931179,1.0,11/35,15.70%,CTNND2;PHACTR1;EPHB3;KLF7;MEF2A;SHANK1;FARP1;EPHB2;MAP6;DVL1;PTN
prerank,regulation of endocytic recycling (GO:2001135),0.44436777961257856,0.8987822531871499,0.6071428571428571,0.9093887300087049,1.0,4/11,14.80%,EHD2;EHD1;SORL1;RAB11B
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.3831985448388645,-0.8986311474165726,0.5848563968668408,0.8731935251164183,1.0,3/10,10.01%,PCGF5;ZFP57;PRMT7
prerank,positive regulation of microtubule polymerization (GO:0031116),0.37421921483658466,0.8974356137387756,0.5960526315789474,0.911614769107294,1.0,6/28,12.82%,MET;CLIP1;TOGARAM1;AKAP9;MECP2;DRG1
prerank,lamellipodium organization (GO:0097581),0.3693098702906894,0.8974036541479472,0.6144578313253012,0.9111900526526587,1.0,10/29,15.97%,ABLIM3;SNX2;ARFIP2;VCL;ITGB1;DMTN;ABLIM2;CTTN;CYFIP1;GOLPH3
prerank,termination of RNA polymerase II transcription (GO:0006369),0.36407733780692586,0.8968105573875708,0.6253298153034301,0.9118622155213679,1.0,16/33,33.91%,LSM11;SCAF8;SSU72;CPSF3;CSTF3;CLP1;MAZ;FIP1L1;TTF2;CSTF1;WDR33;SNRPB;CSTF2T;NUDT21;MED18;SNRPF
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.4158317531863305,0.8963533011157094,0.5993836671802774,0.9122747546754769,1.0,4/14,16.74%,PARP1;WDR48;FUS;ACTR2
prerank,primary alcohol metabolic process (GO:0034308),0.38067444070501,0.8963310907202474,0.6077127659574468,0.911834389206297,1.0,3/25,4.82%,CYP1B1;ADH7;RDH12
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.39478268313834514,0.896143171859523,0.5977337110481586,0.9117207146455371,1.0,10/19,34.50%,TEN1;STN1;NAT10;TENT4B;GNL3L;SRC;HNRNPC;EXOSC10;TERF2;XRN1
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.3633927152668297,-0.8961333576467848,0.5833333333333334,0.8776091601883492,1.0,3/12,10.31%,IL18;IL17D;PAEP
prerank,regulation of organelle organization (GO:0033043),0.3188498670786728,0.8959397821258074,0.6394948335246843,0.9116529033564696,1.0,20/80,17.53%,CLIC4;EZR;CAPN2;SCARB2;CLEC16A;DIAPH1;ARMH3;AKAP9;RDX;MAVS;STX5;MARK2;PLXNB1;TMEM33;GOLPH3;MIEF2;CAMSAP3;SYDE1;CPLANE2;SURF4
prerank,negative regulation of neuroinflammatory response (GO:0150079),-0.35275471969986677,-0.8958160176973385,0.6101694915254238,0.8770487651298748,1.0,6/14,17.22%,IGF1;SYT11;CD200;CX3CL1;CD200R1;GRN
prerank,positive regulation of natural killer cell activation (GO:0032816),-0.35055803461436114,-0.8957395940173349,0.5888888888888889,0.8759320125655904,1.0,4/13,15.39%,AXL;IL18;GAS6;TYROBP
prerank,cellular response to lipid (GO:0071396),0.2997253477680611,0.8955434452909726,0.7038934426229508,0.9119471945195581,1.0,35/191,16.93%,EGFR;WNT9A;PID1;ADAM9;LBP;WNT11;PTK2B;IRS1;ESR1;CXCL2;FZD7;LCOR;RORA;ZC3H12A;TLR4;CD80;PDCD4;ATP1A3;ATP1A1;POU4F1;RHOA;PDK3;TRIM41;MYD88;NR1D1;RET;CARD16;SOX9;NR3C1;URI1;ADAM15;TRAF6;PDCD1LG2;ADCY8;ADCY3
prerank,cytoplasmic translational initiation (GO:0002183),0.4030161979516473,0.8954435632318505,0.6,0.9116577681822253,1.0,8/17,30.49%,EIF3A;EIF4B;EIF2S2;EIF2D;EIF4G1;RBM4;DHX29;EIF4A2
prerank,fatty acid metabolic process (GO:0006631),0.30759400128461606,0.8950483649654002,0.6383207750269106,0.9119782991325928,1.0,25/115,19.06%,ABCD3;PLA2G15;ACSM2A;ACSM2B;ACSL3;SLC27A3;ACOT12;PNPLA3;ACBD5;ACOT11;ACACA;LPIN2;ANGPTL3;CPT1B;ACOT8;GNPAT;CPT1C;ACOX1;ALOX5;CEL;CROT;CRAT;NDUFAB1;PPARG;PON2
prerank,positive regulation of insulin secretion (GO:0032024),0.3638146446752993,0.8950245495885943,0.6071887034659821,0.9115416058695618,1.0,5/36,11.52%,TCF7L2;CLTRN;TRPM4;AACS;MCU
prerank,macrophage migration (GO:1905517),0.4180538137282555,0.893809235221434,0.5670731707317073,0.9134655501017803,1.0,4/13,25.02%,CCL3;P2RX4;LGALS3;P2RY12
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.3674226636560367,0.8937919642949259,0.5950752393980848,0.9130184594631306,1.0,8/29,22.26%,TELO2;ANKRD28;PPP6R3;RAD50;TNKS1BP1;CDK2;RFC1;PPP6C
prerank,negative regulation of interleukin-1 production (GO:0032692),-0.3031454568559765,-0.8934190119169786,0.6498316498316499,0.8799944696514204,1.0,4/23,14.47%,IGF1;GAS6;NLRP2B;CX3CL1
prerank,lymphocyte differentiation (GO:0030098),0.3259100905924539,0.8928175840890741,0.6403301886792453,0.9145225402103023,1.0,8/68,7.66%,HDAC4;HDAC9;PBX1;CLCF1;PLCG2;PTPN2;NFIL3;ITGB1
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.39788297487276353,0.8926727642423343,0.5795620437956205,0.9143391340882994,1.0,4/16,5.06%,NRP1;ABL1;NR4A3;PDGFC
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.3883333863696956,0.8926608757168167,0.5956834532374101,0.9138880542985016,1.0,4/21,13.48%,ANK2;SNTA1;AKAP9;SCN1B
prerank,neutrophil mediated immunity (GO:0002446),0.2903895287339941,0.8926108604112972,0.7917505030181087,0.9135067609822835,1.0,99/432,20.64%,CD55;PRKCD;ANXA2;GSN;TMC6;PYGB;NRAS;PKP1;DSP;STOM;IGF2R;ANO6;VNN1;BRI3;AP2A2;SPTAN1;PTGES2;TCIRG1;ACP3;FRK;RAB6A;DIAPH1;CLEC5A;RAB24;TMEM179B;CD44;B4GALT1;IRAK4;CRACR2A;VCL;PAFAH1B2;ARSB;PSMD11;TIMP2;CKAP4;ARG1;DERA;ANXA3;GPI;VCP;ILF2;ITGAV;RAB4B;CMTM6;CDK13;AMPD3;UBR4;RHOA;NDUFC2;DNAJC3;HMOX2;LPCAT1;RAP1A;CAB39;JUP;ATP11A;RNASE3;CPNE1;MAN2B1;NBEAL2;GDI2;RAP2C;CYFIP1;PSMD1;PGM2;KCMF1;C3AR1;ALOX5;GHDC;VAMP2;ACTR2;RAB5B;CPNE3;IQGAP1;SNAP23;GOLGA7;SURF4;APEH;NCKAP1L;DDOST;GLB1;ATP8B4;PSMD14;KMT2E;PSMD12;CAT;PSMD7;AGPAT2;TXNDC5;RAP2B;STK11IP;XRCC5;S100A11;ITGAL;CAPN1;LGALS3;AP1M1;FRMPD3;SLPI
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.395060972607318,0.892495160032256,0.5982658959537572,0.9132543725158869,1.0,7/20,25.76%,MCU;SLC8B1;YME1L1;MICU2;MCUB;PMPCB;MICU3
prerank,regulation of protein kinase C signaling (GO:0090036),0.4208495731478063,0.8923989939778003,0.5972434915773354,0.9129863926199016,1.0,2/14,3.16%,WNT11;VEGFA
prerank,macrophage chemotaxis (GO:0048246),0.43447500482405194,0.8921487354415293,0.5689102564102564,0.9130007898357358,1.0,1/10,4.13%,CCL3
prerank,outer dynein arm assembly (GO:0036158),0.40979663666329313,0.8918719372320753,0.6036308623298033,0.9130510754414919,1.0,5/15,20.51%,DNAAF4;ODAD2;ODAD3;DNAL1;DNAH17
prerank,negative regulation of protein localization to membrane (GO:1905476),0.38262198187446217,0.8917174264605525,0.6065573770491803,0.9128743905586868,1.0,9/24,27.41%,PID1;RHOQ;DMTN;ITGB1BP1;LZTFL1;TMBIM1;DAB2;NUMB;GDI1
prerank,nitric oxide metabolic process (GO:0046209),0.4080795309597346,0.8916648920941057,0.6099071207430341,0.9125006284745693,1.0,2/14,7.27%,CYP1B1;NQO1
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.4220571932601144,0.8915443795058497,0.602322206095791,0.912286461045174,1.0,5/15,24.07%,ANXA1;FAM107A;NR3C1;SSTR2;REST
prerank,axonal fasciculation (GO:0007413),-0.3584411303745088,-0.8914388931083456,0.6306818181818182,0.8833218769880685,1.0,4/12,10.23%,CNTN4;EPHA4;RTN4;SEMA5A
prerank,cellular response to ATP (GO:0071318),-0.3473162712930914,-0.8913094564273792,0.5709677419354838,0.8823644967754388,1.0,8/14,33.52%,P2RY1;P2RX7;CIB2;TAF1;HSP90B1;P2RX3;P2RY2;RYR3
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.3742027050082849,0.8910465983241457,0.6195054945054945,0.912792772729778,1.0,8/24,16.37%,KCNB1;ERBB2;CIB1;MIEF1;C2CD5;CHP1;ITGB1BP1;MIEF2
prerank,nitric oxide biosynthetic process (GO:0006809),0.4128662585114671,0.8909787212344915,0.6253918495297806,0.9124407042498172,1.0,2/13,7.27%,CYP1B1;NQO1
prerank,cellular response to thyroid hormone stimulus (GO:0097067),-0.3745355654844739,-0.8907563476675396,0.597667638483965,0.8823989917580861,1.0,7/12,20.08%,LMO2;CTSH;CTSB;MED1;CTSS;THRB;CTSL
prerank,negative regulation of developmental growth (GO:0048640),-0.28834769039527397,-0.8904852705714116,0.678714859437751,0.8817377496214611,1.0,6/30,6.99%,NKD1;MAP2;DCC;PTCH1;RTN4;MAG
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.35743558087446803,0.8901968180605432,0.626027397260274,0.9135006382757428,1.0,3/29,5.25%,PKD1;CLCF1;STAT3
prerank,neutrophil degranulation (GO:0043312),0.28947484244067284,0.8901549835484492,0.7939698492462312,0.9131028004987832,1.0,97/425,20.64%,CD55;PRKCD;ANXA2;GSN;TMC6;PYGB;NRAS;PKP1;DSP;STOM;IGF2R;ANO6;VNN1;BRI3;AP2A2;SPTAN1;PTGES2;TCIRG1;ACP3;FRK;RAB6A;DIAPH1;CLEC5A;RAB24;TMEM179B;CD44;B4GALT1;CRACR2A;VCL;PAFAH1B2;ARSB;PSMD11;TIMP2;CKAP4;ARG1;DERA;ANXA3;GPI;VCP;ILF2;ITGAV;RAB4B;CMTM6;CDK13;AMPD3;UBR4;RHOA;NDUFC2;DNAJC3;HMOX2;LPCAT1;RAP1A;CAB39;JUP;ATP11A;RNASE3;CPNE1;MAN2B1;NBEAL2;GDI2;RAP2C;CYFIP1;PSMD1;PGM2;KCMF1;C3AR1;ALOX5;GHDC;VAMP2;ACTR2;RAB5B;CPNE3;IQGAP1;SNAP23;GOLGA7;SURF4;APEH;NCKAP1L;DDOST;GLB1;ATP8B4;PSMD14;PSMD12;CAT;PSMD7;AGPAT2;TXNDC5;RAP2B;STK11IP;XRCC5;S100A11;ITGAL;CAPN1;LGALS3;AP1M1;FRMPD3;SLPI
prerank,nucleic acid-templated transcription (GO:0097659),0.3500210776239809,0.8898412602201149,0.6336760925449871,0.9132153913912305,1.0,12/42,19.84%,MEF2A;NR4A2;POLR3A;DRG1;E2F1;RNPS1;HOXD3;PPP5C;MED20;POLR2C;EPC1;CREBL2
prerank,phospholipid catabolic process (GO:0009395),-0.30236274547693365,-0.8895727648368691,0.6063492063492063,0.8826191820135004,1.0,3/24,6.73%,ENPP2;GPCPD1;ENPP6
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.4013507640039389,0.8887422187920357,0.5985294117647059,0.9149396111566054,1.0,7/18,24.42%,EMD;NF1;SKI;MORC3;MED25;TP53;NLRC3
prerank,vasoconstriction (GO:0042310),-0.37427002140415955,-0.8886313328159774,0.5924050632911393,0.8834937668213774,1.0,4/11,10.18%,SLC8A1;PIK3C2A;ACTA2;EDN1
prerank,cellular response to amino acid starvation (GO:0034198),0.32213042430920796,0.8880088915981819,0.6459054209919262,0.915941405204762,1.0,19/71,21.88%,MAP3K5;NPRL3;ITFG2;TCIRG1;RRAGB;SZT2;EIF2AK2;EIF2S1;SH3GLB1;ATP6V1A;RHEB;MLST8;CDKN1A;ATF2;ATP6V0D1;SESN3;NPRL2;DAP;LARS1
prerank,neutrophil activation involved in immune response (GO:0002283),0.28896380395295296,0.8879816273696347,0.7937625754527163,0.9155179262722756,1.0,97/428,20.64%,CD55;PRKCD;ANXA2;GSN;TMC6;PYGB;NRAS;PKP1;DSP;STOM;IGF2R;ANO6;VNN1;BRI3;AP2A2;SPTAN1;PTGES2;TCIRG1;ACP3;FRK;RAB6A;DIAPH1;CLEC5A;RAB24;TMEM179B;CD44;B4GALT1;CRACR2A;VCL;PAFAH1B2;ARSB;PSMD11;TIMP2;CKAP4;ARG1;DERA;ANXA3;GPI;VCP;ILF2;ITGAV;RAB4B;CMTM6;CDK13;AMPD3;UBR4;RHOA;NDUFC2;DNAJC3;HMOX2;LPCAT1;RAP1A;CAB39;JUP;ATP11A;RNASE3;CPNE1;MAN2B1;NBEAL2;GDI2;RAP2C;CYFIP1;PSMD1;PGM2;KCMF1;C3AR1;ALOX5;GHDC;VAMP2;ACTR2;RAB5B;CPNE3;IQGAP1;SNAP23;GOLGA7;SURF4;APEH;NCKAP1L;DDOST;GLB1;ATP8B4;PSMD14;PSMD12;CAT;PSMD7;AGPAT2;TXNDC5;RAP2B;STK11IP;XRCC5;S100A11;ITGAL;CAPN1;LGALS3;AP1M1;FRMPD3;SLPI
prerank,regulation of mitotic nuclear division (GO:0007088),0.33035556123589244,0.8878621767536273,0.6464019851116626,0.9152811539333688,1.0,17/55,22.41%,BMP4;CCDC8;AURKA;CDK13;CCNB1;TOM1L1;FBXO5;DRD3;PRMT5;LRP5;PIN1;BORA;EDN3;EGF;IGF2;AURKAIP1;CHEK1
prerank,regulation of gene silencing by miRNA (GO:0060964),0.3310216615220057,0.8877582625226657,0.6602870813397129,0.9150110655097595,1.0,23/62,29.26%,STAT3;NUP93;AGO2;NUP214;NUP153;NUP155;RANBP2;NUP88;NUP35;DHX9;PUM2;POLR2C;PPARG;EIF4G1;PUM1;FMR1;TRIM71;NUP98;LIMD1;POM121;AGO1;ELAVL1;SEC13
prerank,negative regulation of viral life cycle (GO:1903901),-0.34425662372451826,-0.887733106940967,0.627831715210356,0.8843914611984358,1.0,6/15,14.62%,LY6E;IFITM1;IFITM3;BST2;IFITM2;SNX3
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.4134665068321485,0.8872857858358472,0.613251155624037,0.9154483292770202,1.0,8/15,31.05%,CHEK2;RAD17;MDC1;ATF2;RAD9A;RAD9B;TIPIN;HUS1
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.3984113891592843,0.8872617125433742,0.5956204379562043,0.9150207494990038,1.0,4/15,17.26%,SKI;DACT1;ACVR1;SMAD7
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.3931476174383519,0.8868303372460318,0.5789473684210527,0.9153884383349886,1.0,5/16,19.23%,CREBBP;NAA15;NAA40;NAA80;NAA60
prerank,negative regulation of cell activation (GO:0050866),0.4101548201994316,0.8867276028145701,0.5927601809954751,0.915124088937398,1.0,3/14,5.81%,THBD;LDLR;EMILIN1
prerank,regulation of fatty acid oxidation (GO:0046320),0.3987961537292876,0.8866117879092845,0.5916305916305916,0.9148641986318636,1.0,8/16,24.13%,NR4A3;ABCD1;LONP2;TYSND1;SOX9;ACADL;ACADVL;APPL2
prerank,positive regulation of protein kinase activity (GO:0045860),0.30123223166405116,0.8866029842272862,0.6926315789473684,0.9144111481810785,1.0,31/148,18.20%,RASSF2;DDR2;CCN1;PRKCD;PTK2B;ADRB2;VEGFA;TELO2;STRADA;TGFBR2;EGR1;SYAP1;CLSPN;CIB1;RHOA;DUSP19;TAB2;TOM1L1;RAP1A;CAB39;CLU;MARK2;ITGB3;SRCIN1;TRAF6;CDKN1A;IQGAP1;STK3;TRAF4;LAT;RALB
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.3510744139013663,0.8865474331155996,0.6154838709677419,0.9140432149760227,1.0,20/36,30.19%,NECTIN3;GORASP2;KIF13A;NSF;AFDN;GOLPH3;VAMP2;GOLGA7;GOLGA4;SPTBN1;GOLPH3L;BBS2;RAB26;GCC2;GGA1;RILPL1;GGA2;SYS1;TRARG1;BLZF1
prerank,protein targeting (GO:0006605),0.30601288371122337,0.8863746861538048,0.6702586206896551,0.9139007495453704,1.0,42/118,27.43%,GIPC1;HPS4;KATNB1;LTBP2;SRPRB;SEC61A1;ZDHHC2;ZFAND6;ZDHHC20;LONP2;TIMM23;ZDHHC12;ATG3;NLGN1;VPS37A;BCAP31;PARD3;ZDHHC15;VPS37B;SORL1;TIMM9;ZDHHC24;TSPO;GOLGA7;PEX1;ZDHHC3;AP4E1;TIMM17B;PITRM1;AIP;FUT10;ZDHHC19;TIMM44;TOMM34;RABGEF1;SRPRA;ZDHHC21;KIF13B;TOMM20;AP4M1;ZDHHC6;TIMM13
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),-0.3839489783504036,-0.8861682856475298,0.5921052631578947,0.8866242082300769,1.0,7/11,43.90%,PRKCQ;NFKBID;IL12RB1;CARD9;IL23A;IL12B;CLEC6A
prerank,response to nutrient levels (GO:0031667),0.41059827825505857,0.8861398010895054,0.6142649199417758,0.9139066715315314,1.0,5/17,24.23%,KCNB1;FAM107A;RPS6KB1;EIF4G1;MTOR
prerank,axonal transport of mitochondrion (GO:0019896),-0.37310322097650395,-0.8859745082922279,0.5626740947075209,0.8858095894994152,1.0,2/11,17.41%,MAPT;HIF1A
prerank,cobalamin metabolic process (GO:0009235),0.3945240579611838,0.8855013011652803,0.594311377245509,0.9146507933770194,1.0,4/17,19.23%,MMACHC;CTRC;ABCC1;MMAB
prerank,positive regulation of neuron projection development (GO:0010976),0.31015610520108794,0.8849506171317666,0.6583710407239819,0.9152596155248017,1.0,21/85,13.83%,DPYSL3;NTRK3;COBL;BMP5;PTK2B;FZD1;KIDINS220;SCARB2;ROR1;STYXL1;ARSB;P3H1;DHX36;RAP1A;MARK2;ZDHHC15;RET;NPTN;SCN1B;DBN1;ALKAL2
prerank,second-messenger-mediated signaling (GO:0019932),-0.2349500688587691,-0.8847387799899814,0.7569444444444444,0.8872718607087662,1.0,13/82,10.18%,APOE;MCTP1;CCR9;NOS3;RYR2;GUCY1B1;MCTP2;DGKD;NDNF;GUCY1A1;CHRM3;SPHK1;EDN1
prerank,cellular response to lipopolysaccharide (GO:0071222),0.3078742921298297,0.8845781754064531,0.6766004415011038,0.9155123761054116,1.0,15/101,13.46%,ADAM9;LBP;PRKCE;CXCL2;CCL3;ZC3H12A;TLR4;CD80;PDCD4;RHOA;TRIM41;MYD88;NR1D1;MTDH;CARD16
prerank,phosphorylation (GO:0016310),0.2862528286377986,0.8840704502348845,0.7791164658634538,0.9160117773448808,1.0,78/385,18.10%,STK39;DCLK1;MAP3K5;MARK1;GRK5;WNK1;PRKCD;CAMK2D;WNT11;PRKCE;PTK2B;TLK1;BMPR1A;CLK2;GSK3B;CDK10;RARA;CDK12;HIPK1;TGFBR1;ABL1;IRAK3;FGFR1;STAT3;FRK;CHEK2;NEK7;FAM20A;NADK;BCR;STRADA;ERBB2;TGFBR2;NRBP2;AURKA;DGKA;LIMK2;CDK11B;IKBKE;CSNK1A1;GRK4;NLK;MAST2;TOP1;MAK;CDK16;CDK13;AAK1;PLK4;EIF2AK2;PDK3;EPHB2;SGK3;MAP3K1;AGK;MARK2;RET;CDKL2;ACVR1;MORC3;PIM2;PRKCA;MARK3;CDK7;PRKDC;CDK2;LCK;SIK1;IKBKB;ERN2;GNPTAB;NEK4;GNPTG;LRRK2;STK24;STK3;MAPKAPK2;COPS8
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.3831540445801349,0.8833300957761435,0.6002824858757062,0.9169625614658712,1.0,2/22,1.98%,ANK2;ATP1B1
prerank,regulation of viral release from host cell (GO:1902186),0.3881030760167017,0.8831572597772447,0.6195804195804195,0.9168185823555539,1.0,9/21,29.51%,VPS37B;CHMP2B;TRIM35;MID2;PML;CHMP3;DDB1;TRIM26;TSG101
prerank,nucleoside salvage (GO:0043174),0.4425728602021861,0.8827780900549769,0.6123076923076923,0.9171069413813548,1.0,2/10,12.29%,TK1;UPP2
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.24918572937124558,-0.8827609077988204,0.6855670103092784,0.8905449182782346,1.0,14/49,16.64%,BCL2;SGMS1;BCL2L1;DAPK2;NDUFA13;DDX3X;PINK1;BCL2L11;RACK1;NUPR1;UBQLN1;BOK;P4HB;FIS1
prerank,amyloid precursor protein catabolic process (GO:0042987),-0.34440605874848695,-0.8827269884683633,0.6285714285714286,0.8893433354748457,1.0,3/14,12.25%,ABCG1;DYRK1A;APH1B
prerank,actin cytoskeleton reorganization (GO:0031532),0.3232602645897739,0.8819559549269962,0.6417736289381564,0.9182209887221583,1.0,19/63,18.07%,GSN;EZR;SIPA1L1;NRP1;PHACTR1;ANXA1;PARVA;GPR65;DMTN;ANTXR1;RHOA;MCU;PIP5K1A;CTTN;PDLIM4;SYDE1;FARP2;S1PR2;CXADR
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.3829939804641864,0.8818591269982,0.6170520231213873,0.917946176902467,1.0,5/21,15.09%,DERA;GPI;TKT;RPE;PGM2
prerank,cellular amide metabolic process (GO:0043603),0.305729528369023,0.8809615326806871,0.6640969162995595,0.9192331200210709,1.0,12/102,9.72%,SLC5A6;PLPP3;VNN1;PLA2G15;FOLR2;ACSM2A;ACSM2B;NNMT;ACOT12;ACOT9;SLC25A32;ACOT11
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.30157692837988714,-0.8806988632226072,0.6323024054982818,0.8925799583642866,1.0,5/22,17.83%,WNT5A;SLC7A5;LACC1;NOD2;BTK
prerank,protein O-linked glycosylation via serine (GO:0018242),0.4372101475999498,0.8805338270767433,0.6196013289036545,0.9195824402371332,1.0,2/10,11.53%,GALNT13;POGLUT3
prerank,serine family amino acid metabolic process (GO:0009069),0.40120856229381613,0.880423233827035,0.6181277860326895,0.9193213578297108,1.0,1/16,1.99%,GCLC
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.37899317303085195,0.8800132508206779,0.6132208157524613,0.9196609402762462,1.0,4/24,10.84%,VEGFA;NFE2L2;ATF6;CREB3L1
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.3182769084473861,-0.8799670465714056,0.6089743589743589,0.8929166288991035,1.0,1/17,0.67%,CADM1
prerank,carnitine shuttle (GO:0006853),-0.35734583122148184,-0.87989984727814,0.6515580736543909,0.8917830279508544,1.0,4/11,15.43%,PRKAA2;ACACB;PRKAG2;MID1IP1
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.27530336148872825,-0.8793603927936833,0.6929460580912863,0.8916922366995721,1.0,18/33,30.21%,TGFA;AFAP1L2;DGKD;HIP1R;ADRA2A;HBEGF;HIP1;CCDC88A;FBXW7;CNOT9;NUP62;AKT1;GPER1;BTC;AGT;PDE6G;NCF1;PLAUR
prerank,Rho protein signal transduction (GO:0007266),0.3297418934368967,0.8793472900816023,0.6556372549019608,0.920471744112832,1.0,4/53,3.12%,NTN1;CDC42EP5;RHOJ;ARHGDIB
prerank,import into nucleus (GO:0051170),0.3229211702843217,0.8793173082491554,0.6613272311212814,0.9200661009829602,1.0,14/73,16.18%,PRICKLE1;STAT3;NUP93;E2F3;NUP214;NUP153;TNPO2;TNPO3;IPO7;NUP155;NUTF2;HTATIP2;NUP88;CSE1L
prerank,regulation of response to cytokine stimulus (GO:0060759),0.3909077078089965,0.8792617129765842,0.6103703703703703,0.9197059128618953,1.0,4/19,9.54%,ELF1;KLF4;MAVS;IFIH1
prerank,regulation of exocytosis (GO:0017157),-0.2595281453937319,-0.8791366056120983,0.6844660194174758,0.8909148110933196,1.0,12/46,18.85%,IL1RAPL1;CLASP2;CADPS;RIMS2;SYT1;STXBP5L;RAB3C;RAB13;RAB3A;LGI3;RAB15;STX4
prerank,N-glycan processing (GO:0006491),0.3841136627086113,0.8789283691042225,0.600864553314121,0.9199059335539793,1.0,5/18,12.53%,FUT8;MAN2A1;ST8SIA2;MAN1B1;GANAB
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),-0.3243113860200919,-0.8784859358748864,0.5968253968253968,0.8910766018968388,1.0,1/16,0.67%,CADM1
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.24971799793107624,-0.8781965287202905,0.7107843137254902,0.8904353414734005,1.0,15/46,27.28%,DGKB;DGKD;DGKG;GPAM;AGPAT4;PLD2;DGKZ;ABHD8;AGPAT5;ABHD4;LIPH;PLA2G4B;PLA2G5;LPCAT4;GPD1L
prerank,regulation of protein localization to cell surface (GO:2000008),-0.2800772581858928,-0.8780929015178479,0.6541666666666667,0.8894112734133965,1.0,13/33,18.85%,NEDD4L;ACTN2;PICALM;HSP90AB1;LEPROTL1;GPM6B;MAP1A;TAX1BP3;CTNNB1;TYROBP;ABCA2;BDNF;STX4
prerank,retinal metabolic process (GO:0042574),0.42973417131026326,0.8780500249962556,0.6321656050955414,0.9211633106853977,1.0,2/12,12.06%,CYP1B1;DHRS13
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.4098285537907763,0.8779758317189061,0.6366412213740458,0.920820687929665,1.0,2/13,7.70%,BMP5;DKK3
prerank,protein sumoylation (GO:0016925),0.3369539604375695,0.8778388097268702,0.644963144963145,0.9206189359084438,1.0,24/49,32.93%,NUP93;SAE1;NUP214;TRPM4;NUP153;IFIH1;NUP155;RANBP2;NUP88;NUP35;PIAS2;PIAS1;NUP98;TOPORS;SUMO1;PIAS3;POM121;UBE2I;PIAS4;STX1A;SEH1L;NUP54;TPR;AAAS
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.37297260512041347,-0.8778064221223165,0.6275510204081632,0.8888021459712969,1.0,4/11,15.16%,SLC30A10;PPARA;ABCB7;ABCD2
prerank,cellular response to starvation (GO:0009267),0.29722847987726103,0.8777537899507616,0.7112526539278131,0.920320317091751,1.0,34/147,18.85%,MAP3K5;NPRL3;ITFG2;CLEC16A;FOXO3;TCIRG1;RRAGB;KLF10;VPS41;ZFYVE1;WRN;ZC3H12A;BECN1;WDR45B;SZT2;EIF2AK2;GAS2L1;EIF2S1;ATG5;SH3GLB1;SREBF1;RRP8;WIPI2;ATP6V1A;RHEB;INHBB;MLST8;CDKN1A;SIK1;LRRK2;STK24;ATF2;RALB;ATP6V0D1
prerank,intermediate filament organization (GO:0045109),0.3970014233789293,0.8776918397979951,0.6225854383358098,0.9199698798169808,1.0,2/17,3.38%,PKP1;DSP
prerank,myeloid cell activation involved in immune response (GO:0002275),0.39301247679686113,0.8775762050113985,0.6160337552742616,0.9197198707798239,1.0,2/18,4.45%,LBP;PLCG2
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.4076568109787428,0.8773021290810551,0.6079881656804734,0.9197562515781101,1.0,5/14,16.31%,PPP3CA;PPTC7;PPP2R2D;NCK1;PPP5C
prerank,tRNA modification (GO:0006400),0.32389128510563453,0.8772180930649611,0.6654804270462633,0.9194308597568409,1.0,26/62,33.25%,TRMT10A;ALKBH8;TYW5;MTO1;ELP5;METTL2A;METTL2B;TARBP1;SSB;PUSL1;TRMT61B;THUMPD1;TRDMT1;TYW1;FTSJ1;ALKBH1;CDKAL1;THADA;TRMT44;THUMPD2;WDR4;PUS10;QTRT1;TRMT13;TPRKB;ANKRD16
prerank,peptide catabolic process (GO:0043171),0.3802063860901365,0.8771487523556013,0.6331938633193863,0.919091380005493,1.0,6/23,12.95%,CPQ;ECE1;XPNPEP1;NPEPPS;IDE;DPEP1
prerank,phosphate ion transport (GO:0006817),0.4014791389312998,0.8767686091032907,0.644793152639087,0.9193421688435897,1.0,2/16,13.55%,SLC34A2;SLC37A1
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.42939178008038414,0.8765241255606487,0.6251993620414673,0.9193287615254259,1.0,4/12,21.59%,BRCA1;ACADL;PIBF1;ACADVL
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.3174618263795392,0.8765092131238789,0.6792237442922374,0.9188859776059473,1.0,21/74,24.30%,VEGFA;NFE2L2;EGLN3;PSMB2;CREBBP;PSMD11;HIF3A;PSMC1;ARNT;PSMC6;PSMD1;PSMD4;PSMA6;PSMD14;PSMD12;PSMD7;HIF1AN;PSME3;PSMD3;PSMB6;UBB
prerank,peptidyl-glutamic acid modification (GO:0018200),-0.2979363274497384,-0.8762683552977587,0.6254180602006689,0.8908488684858293,1.0,3/24,4.88%,AGBL4;TTLL7;TTLL11
prerank,neuromuscular process controlling balance (GO:0050885),-0.35786419420223936,-0.8761787327304003,0.6084507042253521,0.8898049007086857,1.0,2/12,3.61%,NRXN1;PCDH15
prerank,regulation of dendrite development (GO:0050773),0.34897019205795643,0.8761291145917661,0.6128205128205129,0.9191493366726312,1.0,5/37,3.75%,MARK1;NEDD4;COBL;BMP5;GSK3B
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.41099884689362587,0.8761223590628124,0.5984962406015037,0.9186988766745124,1.0,3/13,5.94%,FSTL1;NOG;NBL1
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.38161378184750533,0.8757667914029454,0.6364963503649635,0.9189245804736805,1.0,6/21,10.42%,EFNA5;PTPRA;VCL;CORO1C;SLC9A1;RHOA
prerank,synapse organization (GO:0050808),0.30169418592776454,0.8751053364398442,0.6949516648764769,0.9197489486505568,1.0,9/125,3.02%,PCDHB16;GPC6;NEDD4;CDH1;CTNND2;SEMA3E;UNC13B;PTPRF;PCDHB9
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.3550851841990042,0.8749085564189304,0.6157965194109772,0.9196379183805522,1.0,16/30,28.09%,KIF13A;KRT18;SEC16A;NSF;GOLPH3;VAMP2;GOLGA7;GOLGA4;SPTBN1;GOLPH3L;BBS2;RAB26;GCC2;GGA1;GGA2;SYS1
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.4376922640280214,0.8746949361581103,0.6306027820710973,0.9191200250530169,1.0,4/10,23.19%,MPG;FTO;ASCC2;ALKBH1
prerank,DNA dealkylation (GO:0035510),0.4376922640280214,0.8746949361581103,0.6306027820710973,0.9191200250530169,1.0,4/10,23.19%,MPG;FTO;ASCC2;ALKBH1
prerank,negative regulation of metabolic process (GO:0009892),0.3293966220166138,0.8746130948850377,0.6516443361753959,0.9188082102028904,1.0,15/54,17.24%,ZNF423;NPR3;ID1;FOXC2;DOCK7;IP6K1;TLR4;ABHD6;ACOT11;NR1D1;ACOT13;ADAMTS5;RHEB;PCTP;RB1
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.32562000865503843,0.8745130436016582,0.6495726495726496,0.9185468773222673,1.0,19/53,24.30%,PKD1;DNAAF4;XPO1;DESI1;RAD23B;PSMC6;NUDT15;COMMD1;TMTC3;PSME3IP1;GLMN;PSMD14;TMF1;USP19;BAG2;PSME3;FMR1;RHBDF1;UBB
prerank,response to amino acid starvation (GO:1990928),0.31797357413077854,0.8744169329433045,0.6744186046511628,0.9182663682028473,1.0,19/72,21.88%,MAP3K5;NPRL3;ITFG2;TCIRG1;RRAGB;SZT2;EIF2AK2;EIF2S1;SH3GLB1;ATP6V1A;RHEB;MLST8;CDKN1A;ATF2;ATP6V0D1;SESN3;NPRL2;DAP;LARS1
prerank,transport along microtubule (GO:0010970),0.41331662897058397,0.8741116695944972,0.6103500761035008,0.9183573964706768,1.0,5/13,16.49%,ARHGAP21;BAG3;COPG1;SPG11;CAMSAP3
prerank,apoptotic DNA fragmentation (GO:0006309),-0.3334486798097967,-0.8740428045848181,0.632996632996633,0.8930571241535151,1.0,6/16,23.55%,CECR2;KPNB1;HMGB1;FOXL2;HMGB2;CASP3
prerank,cellular response to chemical stress (GO:0062197),-0.22101525763635083,-0.873354613441636,0.7647058823529411,0.893314268164067,1.0,31/96,18.85%,PRR5L;PRKD1;MSRA;CPEB2;FOXO1;PRKAA2;SOD3;PPARGC1A;NOX1;FAS;DDX3X;PINK1;FANCC;PIK3CA;ALDH3B1;SIRT2;NOX4;NCF2;CYCS;STOX1;ERO1A;LONP1;TRPV4;ATP13A2;MT3;SRXN1;HSPA1A;SOD1;ETV5;SELENOS;STX4
prerank,activation of protein kinase activity (GO:0032147),0.30567066920398245,0.8733247071795626,0.7122060470324748,0.9193954144290207,1.0,26/106,19.15%,CARD14;NTRK3;PRKCD;PTK2B;ADRB2;VEGFA;ABL1;ADCY9;STRADA;TGFBR2;CLSPN;MAP3K7;TOM1L1;TRAF2;MARK2;ITGB1BP1;TIRAP;ITGB3;TRAF6;MLST8;ADCY8;ADCY3;STK3;COPS8;JAK2;BORA
prerank,positive regulation of ion transport (GO:0043270),0.3334973711348177,0.8733090838171027,0.647594278283485,0.9189575605271759,1.0,11/48,17.75%,FHL1;ANK2;ANO6;CCL3;CRACR2A;DLG1;SCN1B;SCN3B;KIF5B;GDNF;P2RX4
prerank,regulated exocytosis (GO:0045055),0.29142271490109084,0.8732549958249183,0.7269874476987448,0.9185916331681994,1.0,18/173,9.60%,THBS1;PCDH7;LHFPL2;CLTRN;CD9;FAM3C;VEGFA;TGFB3;CD109;SYTL4;TIMP1;ARHGAP17;FN1;VCL;PHACTR2;PCLO;TEX264;MAGED2
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.2686436843223707,-0.8726622711721284,0.7149321266968326,0.8935374012944146,1.0,13/37,20.39%,BCL2;BCL2L1;RPS3;BCL2L11;RACK1;RPS7;NUPR1;BOK;SFPQ;FIS1;SOD1;EIF5A;MSX1
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.3523608856277665,0.8725951670533851,0.6422872340425532,0.9193977951069053,1.0,13/35,25.90%,NEK7;DHX36;CCT5;NAF1;MAP3K4;HNRNPA2B1;ATR;XRCC5;TNKS2;ATM;MAPKAPK5;CCT6A;PARN
prerank,substantia nigra development (GO:0021762),-0.26355690823231115,-0.8725678549499778,0.663594470046083,0.8924996888334226,1.0,10/37,13.20%,GNB4;MBP;MAOB;ACTB;PLP1;CALM1;YWHAH;BASP1;ATP5PF;SIRT2
prerank,positive regulation of protein processing (GO:0010954),0.380707295370894,0.872379489596879,0.609375,0.9193610117710206,1.0,2/19,2.92%,GSN;TNP2
prerank,neurotransmitter uptake (GO:0001504),0.4203502611011692,0.8723172760558211,0.6363636363636364,0.9190209266473178,1.0,1/12,0.16%,SLC38A1
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.40251710049322187,0.8720897482662747,0.614138438880707,0.9189736705988429,1.0,5/17,17.40%,CD55;BMP6;CARD16;PRKCA;SCIMP
prerank,response to muscle stretch (GO:0035994),0.40266102049987257,0.8719915180618428,0.6347569955817378,0.91867894364356,1.0,2/15,1.97%,CSRP3;GSN
prerank,cellular response to interferon-gamma (GO:0071346),0.3082360267400174,0.8718877625117851,0.6821793416572077,0.9184282921574898,1.0,11/88,9.92%,PRKCD;CAMK2D;SLC26A6;MID1;CCL3;CCL1;CD44;IRF1;TLR4;EPRS1;CCL7
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.3813380814100834,0.8716580627042869,0.6370262390670554,0.9183808984237993,1.0,3/20,9.27%,BMP4;TGFBR1;PDCD4
prerank,lysine catabolic process (GO:0006554),0.41872871418843594,0.8715925182974475,0.6251851851851852,0.91756959465067,1.0,5/12,24.55%,HYKK;SLC25A21;PHYKPL;OGDH;DLD
prerank,lysine metabolic process (GO:0006553),0.41872871418843594,0.8715925182974475,0.6251851851851852,0.91756959465067,1.0,5/12,24.55%,HYKK;SLC25A21;PHYKPL;OGDH;DLD
prerank,fatty acid transmembrane transport (GO:1902001),0.3901736359221262,0.8713961511860593,0.6382978723404256,0.9174632683854651,1.0,5/19,16.15%,ABCD3;ABCD1;ACACA;CPT1B;SLC25A20
prerank,regulation of gluconeogenesis (GO:0006111),0.36357784705325835,0.8710441708089661,0.640268456375839,0.9176571336096383,1.0,3/27,5.71%,CLK2;PTPN2;NNMT
prerank,negative regulation of intracellular protein transport (GO:0090317),0.3718007418499664,0.8701161351872914,0.6376404494382022,0.9189358402119612,1.0,6/22,17.77%,MDFIC;BARD1;DMTN;CHP1;ITGB1BP1;LRRK2
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.395034668451362,0.8700019577900824,0.636094674556213,0.918694059139322,1.0,4/16,17.98%,LDLR;PNPLA2;SREBF1;DAGLB
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.4284949199112206,0.8697109588699977,0.625,0.9187871347981738,1.0,1/10,3.22%,NFE2L2
prerank,negative regulation of translation (GO:0017148),0.3130950193622551,0.8695447926534,0.7,0.9186601939502373,1.0,29/87,26.50%,SAMD4A;IGFBP5;PAIP2;CNOT8;AGO2;EIF3E;EPRS1;DHX36;EIF2AK2;CELF1;MEX3D;FTO;TOB1;SYNCRIP;ENC1;DAPK1;IGF2BP3;CAPRIN1;SAMD4B;PUM1;FMR1;MALSU1;CNOT1;TRIM71;DDX6;TSC1;RBM4;METTL16;SHMT1
prerank,regulation of defense response to virus by host (GO:0050691),0.35113242963921776,0.8695445799093625,0.6445047489823609,0.9181980912369828,1.0,12/30,29.80%,TRAF3IP2;ZC3H12A;MAVS;CGAS;TRIM44;IFNLR1;DHX9;LILRB1;PARP9;IL4;IL23R;DTX3L
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.3220780281390624,-0.8693719777025091,0.6296296296296297,0.8983199324861084,1.0,2/17,3.20%,CTNNA2;WASF3
prerank,phospholipid translocation (GO:0045332),0.361391022846739,0.8687680506532964,0.6291666666666667,0.919244497684208,1.0,10/28,18.41%,ANO6;TMEM30B;PLSCR3;ABCA7;ATP11A;ATP9B;ATP10A;PLSCR1;ABCC1;ATP8B4
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.31466549750144934,0.8686080699960057,0.6734939759036145,0.919067427275301,1.0,9/69,10.39%,SIX1;PTK2B;NGF;TGFB3;CLCF1;NFATC4;NRBP2;SIX4;POU4F1
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.28962756293949127,-0.8685640962155318,0.6787003610108303,0.8988678817492703,1.0,2/23,6.25%,CADM1;PIK3R6
prerank,cellular response to retinoic acid (GO:0071300),0.33628000476635517,0.8681931455922114,0.6517967781908303,0.9193805740866354,1.0,4/42,3.81%,WNT9A;WNT11;PTK2B;FZD7
prerank,cellular response to interleukin-1 (GO:0071347),0.2934906154593834,0.8679031335627212,0.7103301384451545,0.9194568499550486,1.0,34/143,20.03%,TANK;PTGIS;PSMB2;CCL3;CCL1;IRAK3;TAB3;IRAK4;IKBKG;PSMD11;ZC3H12A;EGR1;PSMC1;CUL1;CCL7;RIPK2;MAP3K7;TAB2;MAP3K3;PSMC6;MYD88;NR1D1;RBMX;SOX9;PSMD1;TRAF6;PSMD4;IKBKB;PSMA6;PSMD14;PSMD12;PSMD7;CHUK;USP10
prerank,cellular response to increased oxygen levels (GO:0036295),-0.37769339129244217,-0.8676024715157928,0.6149425287356322,0.8996349310546667,1.0,3/11,10.14%,FOXO1;FAS;ATP6V1G1
prerank,negative regulation of immune effector process (GO:0002698),0.4037918959032056,0.867285086981979,0.6146496815286624,0.9201413210000604,1.0,1/13,1.19%,CD55
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.4173656643373758,0.8671097973854545,0.6344410876132931,0.920012126828667,1.0,1/12,1.67%,CAMK2D
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.3639180170780165,0.8670495507353764,0.6558988764044944,0.9196620024387102,1.0,4/27,10.51%,MAP3K5;IKBKG;CUL1;MAP3K7
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.39928821718108365,0.8667845722516567,0.649624060150376,0.9196986373739544,1.0,3/15,14.66%,ZC3H12C;ZC3H12A;ZC3H12B
prerank,response to thyroid hormone (GO:0097066),-0.35743947817477706,-0.8665677855525673,0.6460176991150443,0.900607763581044,1.0,7/13,20.08%,LMO2;CTSH;CTSB;MED1;CTSS;THRB;CTSL
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.3069625768874993,-0.8664106639782002,0.6453900709219859,0.8997035507591641,1.0,3/22,7.36%,APOE;PPARA;PPARD
prerank,regulation of mRNA polyadenylation (GO:1900363),0.38818679701606135,0.8663512002608833,0.6490455212922174,0.9200382580967811,1.0,6/17,21.60%,ZC3H14;NELFE;RNF20;VIRMA;CCNT1;ZC3H3
prerank,cellular response to radiation (GO:0071478),0.34193242647362065,0.8662659741522964,0.6606451612903226,0.9197385368739369,1.0,11/40,25.37%,TANK;RAD51;SPIDR;TNKS1BP1;CDKN1A;INTS7;TP53;INO80;RAD9A;RAD9B;KDM4D
prerank,regulation of protein localization to cell periphery (GO:1904375),0.387987143591146,0.8659686117186304,0.6328928046989721,0.919827966274818,1.0,8/18,27.83%,MISP;ZDHHC2;SPTBN1;VTI1B;STX8;MMP14;CLN3;PLK1
prerank,membrane lipid metabolic process (GO:0006643),0.37545334853588985,0.8659073388793981,0.6378299120234604,0.9194888780928798,1.0,5/22,14.15%,CYP1B1;TEX2;AGMO;AGK;TECR
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.3580168351291614,0.8658429662417072,0.643048128342246,0.9191456001264707,1.0,4/27,8.56%,MARK1;GSK3B;NDEL1;MBOAT1
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.31400604491501677,0.8655329828529585,0.6851211072664359,0.9192477651369729,1.0,18/73,19.38%,F3;CRADD;NGF;EGLN3;NLRP12;CASP2;VCP;XDH;PDCD2;TRAF2;PIDD1;MTCH1;LCK;FAM162A;BCL2L13;PPARG;JAK2;AIFM1
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.34800842743399163,0.865518073462707,0.64,0.9188199962397268,1.0,4/33,8.90%,TCF7L2;NFE2L2;CAST;KRIT1
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.3493736267423584,-0.8654884793096026,0.6243243243243243,0.9004346228292232,1.0,5/13,10.72%,NOS3;PPARA;TMSB4X;PPARGC1A;PINK1
prerank,regulation of axon extension (GO:0030516),0.34128502301269115,0.8654488742224898,0.6437086092715232,0.9184916341429278,1.0,7/37,13.51%,NTN1;GSK3B;ABL1;SHTN1;CTTN;PTPRS;DBN1
prerank,regulation of small molecule metabolic process (GO:0062012),-0.2858813436839758,-0.8654214163786853,0.6475095785440613,0.8993082892201076,1.0,3/28,3.27%,APOE;PPARA;PDK1
prerank,secondary alcohol metabolic process (GO:1902652),0.33614946351833,0.8653454868272581,0.6535433070866141,0.9182238618343548,1.0,12/42,18.89%,SOAT1;FDX1;TSKU;RXRA;ANGPTL3;SOAT2;IDH3B;GBA2;LCAT;SQLE;EBP;APOF
prerank,regulation of T cell mediated immunity (GO:0002709),0.4302743190905119,0.864791917206493,0.630718954248366,0.9188216924944647,1.0,2/10,11.56%,TRPM4;ZBTB1
prerank,"base-excision repair, gap-filling (GO:0006287)",0.33731013305323054,0.8647743697225714,0.6524633821571239,0.9183964934991923,1.0,6/35,19.19%,MPG;SMUG1;APEX1;PARP1;POLB;RFC1
prerank,regulation of developmental growth (GO:0048638),0.35265203609446416,0.8643118116919106,0.6510989010989011,0.9188020945310804,1.0,6/29,9.59%,SIX1;GSK3B;ABL1;NIPBL;AGR2;SIX4
prerank,regulation of histone modification (GO:0031056),0.4027762342216328,0.8642051249812435,0.6306990881458967,0.9185251783086147,1.0,8/13,34.19%,NNMT;IGF2;AKAP8L;SETD5;UBE2N;PARK7;FLCN;PARG
prerank,peripheral nervous system development (GO:0007422),0.3727337206614727,0.8641573457792401,0.634180790960452,0.9181653822225267,1.0,5/23,16.35%,NGF;PMP22;NF1;GFRA3;GDNF
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.3156409521942084,0.8640670597090089,0.6950934579439252,0.9178740374045632,1.0,17/69,24.00%,UBE4B;RNF185;MAN1B1;VCP;UBE4A;FBXO27;PSMC6;HERPUD1;SEL1L;FBXO17;TMEM129;ANKZF1;USP19;UBXN4;DNAJB2;RHBDD2;SEC61B
prerank,positive regulation of monooxygenase activity (GO:0032770),-0.28730655549777906,-0.8640197799196413,0.6505576208178439,0.9010607971501055,1.0,6/26,17.41%,APOE;NUS1;GCH1;NOS1AP;TERT;HIF1A
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.39298480391172036,0.8638267532005203,0.6510948905109489,0.9178492153210025,1.0,8/17,27.57%,TTK;ZW10;RB1;ZWILCH;SPDL1;BUB3;MTBP;MIS12
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.32824162854193684,-0.863741160453283,0.6348684210526315,0.9003962015505621,1.0,2/17,5.77%,LPGAT1;PLAAT3
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.2858098276390098,0.8636099051435177,0.7553735926305015,0.9177899048164171,1.0,55/208,20.27%,TANK;AKAP13;ESR1;ALPK1;TRAF3IP2;S100B;PLCG2;PER1;TAB3;REL;MIER1;NLRP12;IRAK4;RORA;ROR1;IKBKG;IKBKE;ZFAND6;TRIM39;ZC3H12A;MAVS;RIPK2;RHOA;MAP3K7;DHX36;TAB2;MAP3K3;ANKRD17;MYD88;TRAF2;NR1D1;CPNE1;TIRAP;MTDH;CARD16;ZDHHC13;DDX21;PIM2;PIDD1;TRAF6;TNIP1;PPP5C;TRAF5;IKBKB;SHISA5;MAP3K14;TRAF4;RBCK1;TICAM1;BRD4;NLRX1;CHUK;USP10;NEK6;MID2
prerank,positive regulation of T cell activation (GO:0050870),-0.23804838275405812,-0.863519580158316,0.7426900584795322,0.8995682239100774,1.0,22/62,24.36%,VCAM1;TFRC;SIRPA;PRKCQ;RHOH;DOCK8;CD81;CCL19;CD47;XBP1;NOD2;CD86;SLC7A1;JAK3;THY1;PYCARD;HSPD1;CD276;IL7;CD274;CCL2;CYRIB
prerank,histone H2B ubiquitination (GO:0033523),0.4321300968653961,0.8633842735240322,0.6231404958677685,0.9177391522112919,1.0,5/10,29.80%,WAC;RNF8;RNF20;CTR9;DTX3L
prerank,protein ADP-ribosylation (GO:0006471),0.35446519707086516,0.8633301614032353,0.6328437917222964,0.9173826377794146,1.0,9/28,19.48%,SIRT6;PARP3;PARP1;PARP12;ARF4;SIRT3;PARP6;PARP2;PARP4
prerank,erythrocyte development (GO:0048821),-0.3734828172345075,-0.8631994469358516,0.639686684073107,0.898959372150897,1.0,6/10,20.86%,ALAS1;ABCB10;MED1;SH2B3;LYAR;ALAS2
prerank,ribonucleoprotein complex assembly (GO:0022618),0.2960689392296696,0.8631558958985249,0.7244348762109796,0.9172572207500573,1.0,45/132,28.71%,RPSA;CELF3;LUC7L2;SRSF5;SRSF6;EIF3A;EIF6;PRPF18;CELF4;CELF1;PRMT5;SCAF11;SRSF1;PRKDC;NAF1;EIF4B;DHX9;EIF2S2;EIF2D;GEMIN5;TRAF7;CLP1;XRCC5;TGS1;LSM4;LUC7L3;RPL10;SRPK2;KHDC4;BRIX1;YTHDC1;USP39;SMN1;DICER1;SNRNP200;DHX29;GEMIN8;RPS27L;SNUPN;RAMAC;CELF6;RPL5;RBM5;GCFC2;SNRPB
prerank,positive regulation of histone deacetylation (GO:0031065),0.4210484140910676,0.8631198745665571,0.6387195121951219,0.9168648573335141,1.0,4/12,17.32%,VEGFA;NIPBL;SAP30BP;ZBTB7B
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.32188691504817424,0.8627529889683093,0.6603550295857988,0.9170726210240957,1.0,17/54,29.17%,NXN;U2AF2;HDAC8;CHP1;SPOPL;USP4;SMAD7;BAG5;BAG2;GTPBP4;OGT;GNL3L;SENP2;PIAS3;RPL5;DNAJA1;SQSTM1
prerank,cellular response to interleukin-6 (GO:0071354),0.3645659456201411,0.8626618263621297,0.625,0.9167724990909919,1.0,8/26,20.79%,PID1;PTGIS;STAT3;SMAD4;YAP1;SOCS3;JAK2;FER
prerank,negative regulation of macroautophagy (GO:0016242),0.36219692107701723,0.8624856053280544,0.6508379888268156,0.9166521185675237,1.0,11/26,25.36%,CLEC16A;TMEM39A;NRBP2;LZTS1;RUBCN;LRRK2;USP36;MTOR;SMCR8;MTM1;TSC1
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.4061788591420856,0.8624151945116836,0.6198473282442748,0.9163315768995873,1.0,2/13,5.15%,DDX5;SPRED2
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.3112212936607955,0.8622143507488597,0.7058139534883721,0.9162334438919504,1.0,11/70,10.42%,TMEFF2;SRGAP2;GRHL2;NRP1;RAB25;EPHB3;PARVA;FN1;ANTXR1;ITGAV;RHOA
prerank,isotype switching (GO:0045190),0.43235781878115287,0.8619728692201118,0.6580645161290323,0.9162493851156387,1.0,2/10,14.23%,EXOSC3;RNF8
prerank,regulation of transport (GO:0051049),-0.27038947318032974,-0.8618202268799221,0.7306122448979592,0.9007135227014182,1.0,8/36,14.04%,LEPR;EPB41;ICA1;ACTB;PINK1;ICA1L;MYO6;FES
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.356605715531879,0.8615629275066824,0.6634877384196185,0.916544391921421,1.0,6/28,10.55%,TAB3;IKBKG;AAMP;RIPK2;MAP3K7;TAB2
prerank,regulation of mRNA processing (GO:0050684),0.35348231901668326,0.8613125181076325,0.6727989487516426,0.9165790584158431,1.0,12/32,24.79%,SLTM;SON;RBM39;CDK11B;TIA1;KHDRBS1;DHX9;SRSF3;SRPK2;JMJD6;LARP7;YTHDC1
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.30070304947744164,0.8612277724982437,0.7067099567099567,0.9162807140236164,1.0,23/108,19.38%,F3;MAP3K5;GSN;CRADD;NGF;EGLN3;NLRP12;CASP2;VCP;XDH;PDCD2;TRAF2;BCAP31;ARL6IP5;PIDD1;MTCH1;LCK;FAM162A;DAPK1;BCL2L13;PPARG;JAK2;AIFM1
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.3543733951564589,0.8610644002527622,0.6493333333333333,0.9161182726341092,1.0,6/27,16.55%,NFAT5;NR4A3;CD44;RHOA;TRAF6;LCK
prerank,regulation of fat cell differentiation (GO:0045598),0.31040932780620134,0.8609882577508187,0.6935483870967742,0.9157946322001564,1.0,20/74,19.84%,ZFPM2;CMKLR1;ID2;ZBTB16;RORA;ZC3H12A;TRPM4;SYAP1;ZFPM1;TRIO;NR1D1;E2F1;LRP5;ALOX5;FTO;YAP1;CDS1;PPARG;FERMT2;CREBL2
prerank,positive regulation of stem cell proliferation (GO:2000648),0.38947330966171345,0.8608039286506992,0.6371681415929203,0.9156886662143283,1.0,3/17,11.31%,LTBP3;KDM1A;PDCD2
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.32441718040838086,0.8606728689701799,0.6802395209580838,0.915486084467428,1.0,3/57,1.74%,MAP3K5;PERP;CYFIP2
prerank,regulation of transposition (GO:0010528),0.40822009381872537,0.8605633952220331,0.6358118361153262,0.9152346223057094,1.0,1/13,5.55%,TEX15
prerank,dendritic cell migration (GO:0036336),-0.3184182812931976,-0.8605533031250643,0.6676300578034682,0.9021255565454741,1.0,6/16,22.72%,EPS8;HMGB1;CCL19;CCR5;GPR183;PIK3CG
prerank,response to reactive oxygen species (GO:0000302),0.3206158560330299,0.8599089513037504,0.6891385767790262,0.9159962354744116,1.0,2/54,1.31%,EGFR;ADAM9
prerank,positive regulation of double-strand break repair (GO:2000781),0.3361716551705898,0.8599057966730234,0.6583769633507853,0.915551614886436,1.0,17/39,27.84%,SPIDR;PARP3;PARP1;WDR48;KMT5B;FUS;DDX11;PRKDC;ACTR2;KMT5C;SLF1;ZCWPW1;KDM4D;MRNIP;PARP9;SMCHD1;SETMAR
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.31543394068220415,0.8598126958439971,0.6957547169811321,0.9152579192103977,1.0,11/70,12.41%,CRADD;NGF;GSK3B;HIPK1;BAG3;INHBA;CASP2;CIB1;ITGAV;MCL1;TRAF2
prerank,negative regulation of double-strand break repair (GO:2000780),0.35469245720836107,0.8597332470323423,0.6754507628294036,0.9149496687142376,1.0,5/30,13.28%,TWIST1;UBR5;HELB;CGAS;TRIP12
prerank,positive regulation of fibroblast proliferation (GO:0048146),-0.28155581412268865,-0.8593525642320011,0.7084870848708487,0.9034209650328802,1.0,10/27,18.59%,IGF1;WNT5A;CDK6;SPHK1;GAS6;CDK4;MIF;CD74;BMI1;PDGFRA
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.3729227748005688,0.8591259402281026,0.6362359550561798,0.9155912361552966,1.0,2/22,3.88%,NFE2L2;PSMB2
prerank,tetrapyrrole metabolic process (GO:0033013),0.380996382387608,0.8590805874028907,0.624813153961136,0.9152262805983763,1.0,4/18,19.23%,MMACHC;CTRC;ABCC1;MMAB
prerank,pre-replicative complex assembly (GO:0036388),0.3165617749954089,0.8587331519488571,0.6932084309133489,0.9154046483357458,1.0,22/64,28.26%,PSMB2;MCM2;PSMD11;PSMC1;PSMC6;ORC3;PSMD1;MCM7;PSMD4;PSMA6;PSMD14;PSMD12;PSMD7;PSME3;PSMD3;PSMB6;UBB;CDC6;UBA52;RPS27A;ORC6;PSMA5
prerank,ribosome biogenesis (GO:0042254),-0.20555425399603575,-0.8585009978889604,0.8775510204081632,0.9039669237759802,1.0,48/187,18.79%,RPL37;RPL27A;RPL19;RPS9;RPS14;RPL18A;RPL38;RPS19;RPL34;MTREX;RPL18;RPL7;RPS25;NPM1;RPL21;RPL23A;RPLP2;RPL26;RPL41;RPL35A;RPL10A;RPL11;RPS16;EXOSC5;SNU13;RPL4;RPS7;DDX52;RPS15;RPL36;POP4;EXOSC9;RPL37A;RPL32;RPL29;DDX10;HEATR1;LYAR;RPL13;FBL;RCL1;RRS1;RPL36A;RPL23;RPL17;RPL9;DDX27;SDAD1
prerank,positive regulation of heart rate (GO:0010460),-0.31169622165309363,-0.8581795419813234,0.65625,0.9034591240506309,1.0,6/17,11.34%,RYR2;PDE4D;ATP2A2;EDN1;ADM;KCNQ1
prerank,glycerophospholipid metabolic process (GO:0006650),-0.22317520389629658,-0.8581661678628844,0.7622377622377622,0.9022264973302642,1.0,6/75,6.73%,PLCB1;PDGFRB;GPCPD1;PLA1A;SERINC5;ENPP6
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.4270581841551764,0.857711193980873,0.631578947368421,0.9168232956397134,1.0,2/10,6.10%,VEGFA;BMP6
prerank,histone exchange (GO:0043486),0.3444251658000236,0.8575953107275129,0.6636828644501279,0.9165875880271418,1.0,15/37,29.38%,SRCAP;RBBP7;CENPT;HJURP;DMAP1;CENPL;RNF8;SMARCA5;VPS72;CENPW;CENPP;RSF1;CENPK;NASP;ANP32E
prerank,positive regulation of transferase activity (GO:0051347),0.29048455859345595,0.8575915841082251,0.7372881355932204,0.9161459004412145,1.0,16/142,7.79%,EGFR;MET;NTRK3;DDR2;LMO4;GRHL2;KLF4;DCUN1D5;CHTF18;EPHB3;FGFR1;NEK7;ERBB2;CHTF8;ROR1;DSCC1
prerank,negative regulation of interferon-beta production (GO:0032688),0.42857464416953545,0.8574271758439667,0.6625,0.9160290960670475,1.0,7/10,26.88%,REL;PTPRS;RELB;YY1;LILRB1;NLRC3;PPM1B
prerank,artery development (GO:0060840),0.36738273105223984,0.8573644387508985,0.6433566433566433,0.9156847117976925,1.0,5/23,5.44%,HES1;NRP1;VEGFA;TGFBR1;NF1
prerank,nuclear pore organization (GO:0006999),0.4020301250605324,0.8572840829516195,0.6145675265553869,0.9153682502986077,1.0,4/14,17.82%,NUP93;NUP153;AHCTF1;NUP35
prerank,synaptic vesicle recycling (GO:0036465),0.35131837771787083,0.8571567083405102,0.6577896138482024,0.9151530326463264,1.0,8/31,17.62%,STON2;STON1;FCHO2;NLGN1;VAMP2;SYNJ2;CEL;SYNJ1
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.2913694354305575,-0.8570366854550877,0.6867924528301886,0.9033552685645105,1.0,4/25,9.24%,APP;PICALM;ANKRD13A;RAC1
prerank,T cell receptor signaling pathway (GO:0050852),-0.20632500813488647,-0.8562346585238598,0.9016393442622951,0.9038146969093037,1.0,28/138,16.35%,PDE4B;RFTN1;PAK1;PIK3R1;TEC;FYB1;INPP5D;PAK3;TNFRSF21;PDE4D;PRKCQ;THEMIS;BTRC;PSMD8;PSMC3;PSMB4;PTPRJ;PAG1;MOG;PSMB3;PIK3CA;ICOSLG;PTPN22;PSMB8;BTN3A3;PSMA8;EIF2B1;PLCG1
prerank,intracellular lipid transport (GO:0032365),0.3748216304536915,0.8559114182372307,0.651685393258427,0.916926198380657,1.0,5/21,16.15%,ABCD3;ABCD1;ACACA;CPT1B;SLC25A20
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.4134485396296772,0.8558318131097655,0.6422893481717011,0.9166184480530886,1.0,3/12,16.55%,WNK1;MIA3;LCK
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.26412705761886257,-0.8556260103936738,0.7319148936170212,0.9038769019585478,1.0,10/39,12.34%,RPS14;RPS19;RPS25;NPM1;RPS5;RPS16;SNU13;RPS7;DDX52;RPS15
prerank,axonogenesis (GO:0007409),0.2822993080317949,0.8555859398025428,0.7825641025641026,0.9166285986355674,1.0,43/237,14.94%,SLIT3;SLIT2;SEMA3E;ULK2;EZR;EFNA5;GAB2;UNC5C;SLIT1;NRP1;PDLIM7;NOTCH2;GRB10;SEMA3C;S100B;EPHB3;KLF7;SPTAN1;LYPLA2;SHC1;DOCK7;SEMA3D;GLI2;PTPRA;SHTN1;EMB;SLITRK2;MAP1B;POU4F1;EPHB2;NIBAN2;SEMA4B;PARD3;RET;NPTN;SCN1B;EFNA3;SPG11;MAP1S;GFRA3;CYFIP1;PRKCA;ATL1
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.3255898781636717,0.8553667252834484,0.6770963704630788,0.9165763313195102,1.0,9/46,10.42%,TMEFF2;SRGAP2;NRP1;EPHB3;PARVA;FN1;ANTXR1;ITGAV;RHOA
prerank,cyclooxygenase pathway (GO:0019371),-0.3675189207014714,-0.855293419118436,0.6353887399463807,0.9033350497166649,1.0,5/10,17.59%,PTGDS;PTGS1;TBXAS1;HPGDS;CBR1
prerank,cytokine-mediated signaling pathway (GO:0019221),0.27648254504999364,0.8544985506493629,0.8856569709127382,0.9176916065790878,1.0,90/532,17.80%,F3;CARD14;LBP;PRKCD;CAMK2D;ANXA2;TNFRSF11B;PTK2B;FGF2;GAB2;IL22RA1;EDA;IRS1;VEGFA;IL20RB;CXCL2;CLCF1;MID1;PITPNA;GRB10;PSMB2;CCL3;IL17RE;LIMS1;CCL1;TIMP1;TRAF3IP2;IRAK3;IL33;TWIST1;STAT3;SHC1;ANXA1;FOXO3;TAB3;CTF1;IL17RA;CD44;IRAK4;RORA;FN1;IKBKG;IP6K2;GSTA2;ITGB1;IRF1;PSMD11;CCND1;EGR1;CD80;FOXC1;PSMC1;PDCD4;CUL1;CCL7;RIPK2;MAP3K7;TAB2;MAP3K3;MCL1;PSMC6;COL1A2;IFI35;MYD88;CDKN1B;TRAF2;CEBPD;INPPL1;IFNLR1;TXLNA;CNTF;CAPZA1;PSMD1;POU2F1;TRAF6;PSMD4;ALOX5;CDKN1A;SMAD4;TRAF5;LCK;IKBKB;TNFRSF12A;YAP1;MAP3K14;SOCS3;SERPINB2;PSMA6;HNRNPA2B1;TNFSF13B
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.34902034967645323,-0.8539196121094164,0.6386554621848739,0.9049812759611283,1.0,6/12,21.86%,BCL2;RPL26;MIF;CD74;TAF9;TRIAP1
prerank,regulation of response to external stimulus (GO:0032101),0.2925909548587589,0.8535761580037183,0.7329670329670329,0.9189098698274183,1.0,34/121,25.11%,FOXP1;MGLL;CD55;PDE6A;PIK3AP1;ANXA1;IRF1;GRK4;EPHB2;MYD88;CELF1;TIRAP;PDE6B;ALOX5;AREL1;PSMA6;P2RX4;STK24;DAGLB;JAK2;BRD4;NR1D2;TRAF3;FNTA;ERAP1;PPEF1;METAP2;PTGES;SETD6;CNGB1;APPL2;SBNO2;P2RY12;NLRP6
prerank,monocarboxylic acid metabolic process (GO:0032787),0.2960591559927128,0.8535238569237321,0.7264770240700219,0.9185464554894835,1.0,16/117,12.87%,ME1;SLC5A6;ADH7;SLC16A1;VNN1;CYP2S1;ACSL3;ACOT12;ACOT11;PDHA1;CKB;NPC1;ANGPTL3;CPT1B;GNPAT;CPT1C
prerank,histone H3-K4 methylation (GO:0051568),0.3605874192084437,0.8535122485155665,0.6467532467532467,0.9181235610074298,1.0,11/26,32.86%,KMT2C;WDR82;KMT2D;DPY30;OGT;SETMAR;CTR9;TET3;PAXIP1;MEN1;PRDM9
prerank,regulation of interleukin-17 production (GO:0032660),-0.2678806167610709,-0.8533822294140114,0.6819923371647509,0.9047545960823391,1.0,5/31,9.52%,RFTN1;SLC7A5;PRKCQ;IL18;SPHK1
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.38716346489702963,0.8530237599252254,0.6377840909090909,0.9185643298270124,1.0,2/18,5.81%,DDR2;EMILIN1
prerank,regulation of cell projection organization (GO:0031344),-0.33740490918624494,-0.8530186232145377,0.6656976744186046,0.9043128845860965,1.0,6/13,24.12%,CCL19;MFSD2A;SEMA4D;NTNG1;NTNG2;TREM2
prerank,mammary gland epithelium development (GO:0061180),-0.3391430855217261,-0.8529190422006063,0.6757575757575758,0.9032905137724705,1.0,2/14,3.82%,WNT4;ERBB4
prerank,axonal transport (GO:0098930),0.3456791148636371,0.852899732361851,0.6705882352941176,0.9183559536940228,1.0,9/36,18.54%,KIF1B;AP3B1;PAFAH1B1;KIF3B;AP3M1;RAB21;AP3D1;BLOC1S5;AP3S1
prerank,nuclear membrane organization (GO:0071763),0.3801330117757582,0.8526897221007605,0.6438953488372093,0.9182888220528345,1.0,7/19,27.83%,EMD;TOR1B;UBXN2B;TOR1AIP1;TARDBP;AKAP8L;PLK1
prerank,connective tissue development (GO:0061448),0.3442313357496361,0.8526079557365254,0.6683544303797468,0.9179774999919229,1.0,9/35,15.73%,PKD1;ITGB8;ZBTB16;CD44;SULF1;SLC39A13;LRP5;SOX9;HOXD3
prerank,regulation of keratinocyte differentiation (GO:0045616),-0.28683420153260825,-0.8525290779764902,0.672,0.9028867312407273,1.0,3/24,3.31%,ERRFI1;PRKCH;ROCK2
prerank,regulation of biomineral tissue development (GO:0070167),0.35754157310305823,0.8524406043276473,0.6621067031463749,0.9178230412840984,1.0,7/26,14.64%,DDR2;SGMS2;TXLNG;TWIST1;FBXO5;NBR1;SOX9
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.3575483680948708,0.8523377316161499,0.6657754010695187,0.9175533250928956,1.0,4/27,13.65%,GSR;CTPS2;AK4;AK1
prerank,inhibitory synapse assembly (GO:1904862),-0.3556241714549978,-0.8518611979146261,0.6296296296296297,0.9030870063222245,1.0,6/11,14.14%,WNT5A;GABRB3;GABRA2;GABRB2;GABRA1;GABRG2
prerank,mitochondrial protein processing (GO:0034982),-0.35539216111530864,-0.8514291036047572,0.6469002695417789,0.9027218982164472,1.0,1/11,1.81%,IMMP2L
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.34194671586173764,-0.8514231062977436,0.6612466124661247,0.9015169935074385,1.0,3/13,15.90%,ENPP1;TPST1;SULT4A1
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.32929556730514725,-0.8513148325720042,0.6592356687898089,0.900497366452723,1.0,5/14,18.13%,BCL2L1;CREB3;XBP1;HSPA1A;SELENOS
prerank,fat-soluble vitamin metabolic process (GO:0006775),-0.30524679473974464,-0.8510585154029027,0.6771929824561403,0.8997564648259254,1.0,3/22,9.47%,ALDH1A2;LGMN;CUBN
prerank,positive regulation of p38MAPK cascade (GO:1900745),-0.2913341758141877,-0.8509953483885906,0.6678200692041523,0.8986757242899497,1.0,5/22,9.52%,SASH1;MFHAS1;RELL1;BMP2;SPHK1
prerank,positive regulation of mitochondrial fission (GO:0090141),-0.3059087854050852,-0.8508611311737436,0.6964856230031949,0.8977487430676279,1.0,4/18,10.72%,DCN;KDR;SPIRE1;PINK1
prerank,cellular response to pH (GO:0071467),0.38030962056899653,0.8507836209993199,0.624633431085044,0.9198049851738244,1.0,5/17,23.09%,SLC9A1;CHP1;RAB11B;GPR68;HYAL1
prerank,regulation of gene silencing by RNA (GO:0060966),0.3284164306473628,0.8503260667333015,0.6803995006242197,0.9196911924591044,1.0,22/50,32.93%,NUP93;AGO2;NUP214;NUP153;NUP155;RANBP2;NUP88;NUP35;PUM2;POLR2C;EIF4G1;PUM1;FMR1;TRIM71;NUP98;POM121;AGO1;SEC13;SEH1L;NUP54;TPR;AAAS
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.3284164306473628,0.8503260667333015,0.6803995006242197,0.9196911924591044,1.0,22/50,32.93%,NUP93;AGO2;NUP214;NUP153;NUP155;RANBP2;NUP88;NUP35;PUM2;POLR2C;EIF4G1;PUM1;FMR1;TRIM71;NUP98;POM121;AGO1;SEC13;SEH1L;NUP54;TPR;AAAS
prerank,modulation by symbiont of host process (GO:0044003),-0.363262142858306,-0.8502267941533278,0.6459948320413437,0.897802092835215,1.0,3/10,18.46%,B2M;MRC1;ENO1
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.27728061276809934,0.8501875891922841,0.8118006103763988,0.919504065021475,1.0,68/306,19.84%,ST3GAL4;EXT1;RPSA;EXO1;LARGE1;TBRG1;ABCF1;CDC45;MCM2;MEF2A;TICRR;AGO2;NR4A2;INHBA;BARD1;GAL3ST4;WRN;TOPBP1;MRPL42;EIF4G2;HELB;TOP1;MRPL11;CLSPN;POLE2;GSPT1;RRBP1;KIN;RAD50;POLR3A;ORC3;RAD17;BRCA1;DRG1;E2F1;RNASEH2A;SRBD1;COPS5;MRPL36;BRIP1;MCM7;EEF2K;RNPS1;HOXD3;TNIP1;GTPBP2;PCLAF;FAM111A;GOLPH3;CDK2;PPP5C;CDC7;PABPC4;RECQL5;MED20;DONSON;MCM9;RMI2;MRPL23;POLA2;POLR2C;IGF2BP3;ATR;EIF4G1;MRRF;EPC1;ASMT;CREBL2
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.42245744672254715,0.8500554339071659,0.6500802568218299,0.9193019961705212,1.0,3/10,14.60%,KDM1A;BRCA1;ATRX
prerank,positive regulation of cilium assembly (GO:0045724),-0.309965458690255,-0.8500411938014293,0.6910828025477707,0.8969817127674289,1.0,4/18,15.17%,TAPT1;WRAP73;CEP120;CCDC88A
prerank,cellular response to arsenic-containing substance (GO:0071243),0.3940773618025585,0.8499573026616959,0.6601208459214502,0.9190391737738626,1.0,6/15,22.55%,ZC3H12A;VCP;DHX36;GSTO1;MKNK2;ZFAND1
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.38828783185079707,0.8499214669768859,0.6622418879056047,0.9186586651618323,1.0,5/16,20.17%,SCARB2;RORA;PDK3;FOXK1;FOXK2
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.3842018695453412,0.849095831854291,0.6455331412103746,0.9196517223280926,1.0,5/18,21.18%,NFE2L2;VNN1;BAG5;NONO;SOD2
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.3409091045592888,0.8489971183112746,0.6845637583892618,0.9193701235076636,1.0,4/34,3.08%,TNFAIP8L3;PTK2B;FGF2;IRS1
prerank,regulation of protein acetylation (GO:1901983),0.4170957564361359,0.8484719623024961,0.6545166402535658,0.9198713322917338,1.0,2/12,5.49%,GSK3B;FAM161A
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.4235131196990114,0.8482609354566063,0.6535947712418301,0.9198102460255095,1.0,5/11,17.75%,ATP2B4;LMNA;GLRX3;SMAD4;P2RX4
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.39835901480363667,0.8481253487064349,0.6539050535987749,0.9196009334247375,1.0,6/14,21.29%,CHKB;ETNK1;LPIN2;ETNPPL;CEPT1;ETNK2
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),-0.3381122545940464,-0.8480179676037745,0.6627565982404692,0.899791559751341,1.0,5/13,21.01%,AAR2;SRSF10;DDX20;PRPF31;SART3
prerank,microtubule nucleation (GO:0007020),0.37045883266625923,0.8480004932256308,0.6564327485380117,0.9193816179812972,1.0,5/20,17.14%,NDEL1;AKAP9;TUBGCP6;TUBGCP2;CENPJ
prerank,steroid metabolic process (GO:0008202),-0.22816667281390518,-0.8479715240216912,0.8068181818181818,0.8986890717708391,1.0,8/72,9.89%,CYP7B1;CYP27A1;CYP26B1;LIPA;LGMN;ARV1;CUBN;MSMO1
prerank,response to organonitrogen compound (GO:0010243),0.3361427522947354,0.8478862698610183,0.660574412532637,0.9191513427464069,1.0,6/38,14.84%,GLRB;IRAK3;RNF185;VCP;DRD3;SEL1L
prerank,positive regulation of interleukin-12 production (GO:0032735),-0.2749392671763451,-0.8477961944409816,0.7376425855513308,0.8978432013310959,1.0,1/31,0.06%,PLCB1
prerank,Notch signaling pathway (GO:0007219),0.312003623367273,0.8477359227312079,0.6814903846153846,0.9189678954726682,1.0,13/59,13.69%,HES1;PBX1;ZNF423;NOTCH2;GMDS;CREBBP;HES3;DTX2;GALNT11;JAG1;POFUT1;NRARP;MIB1
prerank,regulation of coagulation (GO:0050818),-0.34513761507215446,-0.8474847625767234,0.6675824175824175,0.897279168848372,1.0,5/11,27.61%,HS3ST5;F2R;CAV1;HRG;PROCR
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.422656476819124,0.847412123686781,0.6599378881987578,0.9190718895710407,1.0,2/11,9.11%,RNF185;VCP
prerank,protein-containing complex subunit organization (GO:0043933),0.2919060803345856,0.8473651519624295,0.7362030905077263,0.91871599358383,1.0,23/109,18.04%,HES1;REPS2;PTK2B;SLC7A9;MNAT1;CREBBP;SHANK1;IKBKG;DMTN;EPRS1;DET1;TEAD1;ZW10;TRAF2;PARD3;MDM4;SOX9;CAPZA1;TUBGCP2;VAMP2;YAP1;NUP35;NCKAP1L
prerank,regulation of cellular respiration (GO:0043457),-0.30907640743285997,-0.8467629744614658,0.6882352941176471,0.897524094620866,1.0,3/17,5.08%,CBFA2T3;IFNAR1;PRDM16
prerank,regulation of translational initiation (GO:0006446),0.3169090792630381,0.8466994159915296,0.6960193003618818,0.9193910760446468,1.0,17/63,23.19%,EIF4G3;PAIP2;AGO2;NCK2;EIF4G2;EIF3E;CDC123;DNAJC3;EIF5B;KHDRBS1;NCK1;RPS6KB1;EIF4B;EIF4G1;FMR1;MTIF2;ALKBH1
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.3801865005023798,0.8464323093220529,0.6621004566210046,0.919407498504585,1.0,3/18,8.36%,CCL3;TLR4;TCTA
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.36922335163667386,0.8463282134054891,0.6761768901569187,0.9191536598676037,1.0,2/20,4.17%,MET;ADA
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.35810704717733477,0.8461314869929228,0.6606145251396648,0.9190564224127546,1.0,4/24,10.34%,PID1;COQ10B;NR4A3;COX15
prerank,renal absorption (GO:0070293),0.41982335326299325,0.8456011218595023,0.6390625,0.919600857028141,1.0,2/10,9.60%,GSN;MAGED2
prerank,phosphatidic acid metabolic process (GO:0046473),-0.2380838421890354,-0.8454763686323199,0.7760416666666666,0.8988980727664904,1.0,15/48,27.28%,DGKB;DGKD;DGKG;GPAM;AGPAT4;PLD2;DGKZ;ABHD8;AGPAT5;ABHD4;LIPH;PLA2G4B;PLA2G5;LPCAT4;GPD1L
prerank,ceramide metabolic process (GO:0006672),0.32688942975255775,0.845120313265872,0.6948941469489415,0.9199871109058608,1.0,4/49,4.55%,ACER3;PLPP3;SGMS2;PLA2G15
prerank,dephosphorylation (GO:0016311),0.28485046221728616,0.8449511499736454,0.7455121436114044,0.9198538432144555,1.0,25/147,16.31%,ALPL;PPP3CA;PTPN3;PTPRU;PLPP3;PLPPR2;PTPRF;PPM1H;ACP3;ACP4;PTPRA;DUSP11;PPP2R5C;SBF1;DUSP28;DUSP5;ILKAP;PTPRS;PTPN9;PPP1R12A;PTPN21;UBLCP1;PPP3CC;PPP4R2;PPP5C
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.3214597163813914,0.8444557808561012,0.7103620474406991,0.9202743917115503,1.0,10/51,10.42%,WNT11;SORBS3;NRP1;TGFB3;TGFBR1;ABL1;MYOC;GPR65;S100A10;RHOA
prerank,cellular response to leucine (GO:0071233),0.4171042820222591,0.8443872022185855,0.6402535657686212,0.919531553754279,1.0,4/10,24.23%,KLHL22;SESN3;LARS1;MTOR
prerank,response to leucine (GO:0043201),0.4171042820222591,0.8443872022185855,0.6402535657686212,0.919531553754279,1.0,4/10,24.23%,KLHL22;SESN3;LARS1;MTOR
prerank,gene expression (GO:0010467),-0.1929430049859265,-0.8441408735380506,0.9090909090909091,0.9003860439918092,1.0,80/348,17.68%,RBPMS;NOVA1;TSPAN5;ATXN1;RBMS1;EEF1A1;RPL37;RPL27A;RPL19;RPS13;EIF4EBP2;RPS9;RPS3;RPS14;RPL18A;RPL38;PTMA;RPS19;RPS8;DTX1;RPS11;APOBEC1;RPL34;RPL18;ELAVL4;RPL7;TSPAN14;RPS25;ADARB2;RPL21;RPL23A;RPLP2;RPS21;RPL26;RPS4X;RPL41;RPS29;RPL35A;RPL10A;RNASEL;RPL11;MAGOH;RPS5;RPS16;MRPL3;RPL4;SMG7;PAX8;POLR2G;RPS7;RPS23;RPS15;DDX20;ADAR;MRPS14;RPL36;ANGPT2;THOC3;MRPS33;NOX4;NUP37;RPS18;RPL37A;RPL32;HHEX;RPS20;TSPAN15;HNRNPL;RPL29;THRB;NUP50;RPL13;TFIP11;NUP210;RPL36A;MRPL51;HARS1;RPL23;RPL17;NUP107
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.30462649610662695,0.8441130904113779,0.7097156398104265,0.9195869168639347,1.0,8/67,6.56%,EGFR;DDR2;ABI1;PTK2B;SRMS;ABL1;FGFR1;ERBB2
prerank,filopodium assembly (GO:0046847),0.3874603568590922,0.8441013953434802,0.654178674351585,0.919162415033698,1.0,6/16,17.88%,EZR;SRGAP2;FGD1;FGD3;FGD6;S1PR2
prerank,regulation of ATP biosynthetic process (GO:2001169),0.3801701307484671,0.8437189137895281,0.6519756838905775,0.919388527078748,1.0,4/16,13.61%,PID1;VCP;PARP1;AK4
prerank,RNA polyadenylation (GO:0043631),0.349722458177429,0.8427283680593992,0.6783783783783783,0.9202335133197618,1.0,10/26,23.87%,SCAF8;PABPC1;TENT2;SSU72;CPSF3;TENT4B;CSTF3;CLP1;FIP1L1;PAPOLG
prerank,mRNA polyadenylation (GO:0006378),0.349722458177429,0.8427283680593992,0.6783783783783783,0.9202335133197618,1.0,10/26,23.87%,SCAF8;PABPC1;TENT2;SSU72;CPSF3;TENT4B;CSTF3;CLP1;FIP1L1;PAPOLG
prerank,regulation of programmed cell death (GO:0043067),0.2836339328935755,0.8425862215898134,0.7502612330198537,0.9200357255425342,1.0,26/161,14.83%,ACER3;PERP;CASP6;CRADD;FBXO10;NDRG1;GAS1;ABL1;PLSCR3;CREBBP;CASP2;APEX1;WRN;VCP;BRMS1;POU4F1;CLU;TRAF2;RAF1;RBM25;TIGAR;HTATIP2;SOX9;SRA1;PIDD1;TMEM219
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.33512394275912416,0.8424100457698777,0.6754385964912281,0.9198948931467686,1.0,7/36,10.53%,CRADD;TGFBR1;NR4A2;STYXL1;TRIM39;GATA4;QARS1
prerank,regulation of fatty acid biosynthetic process (GO:0042304),-0.2763731538704163,-0.8424039379123659,0.7017543859649122,0.9026586105105308,1.0,7/26,17.24%,LPGAT1;PRKAA2;NR1H3;NR1H2;PRKAG2;MID1IP1;PDK4
prerank,regulation of protein metabolic process (GO:0051246),0.3259987825614502,0.8423669577023221,0.6827757125154895,0.9195402208840873,1.0,13/44,21.02%,CNDP1;LDLR;KLF4;CHEK2;ABCA7;ZDHHC2;LTBP4;ODC1;SPOPL;SNF8;SPOP;PM20D2;TRAF3
prerank,Golgi inheritance (GO:0048313),0.41211898688492976,0.8423555549370719,0.6498422712933754,0.9191181209498626,1.0,4/11,19.10%,GBF1;STX5;PLK3;VCPIP1
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.331119292741199,0.8417442041035196,0.6796482412060302,0.9197595102094906,1.0,7/39,13.81%,PIK3C2B;TTC7A;IP6K1;IP6K2;PIK3R3;PI4KB;PIP4K2A
prerank,cellular response to interleukin-12 (GO:0071349),-0.2483952511860299,-0.8416028210404042,0.7524271844660194,0.903009816430569,1.0,18/48,21.63%,PLCB1;SIRPA;CFL1;CNN2;LMNB1;TALDO1;MIF;MSN;LCP1;BOLA2;P4HB;CD47;SOD1;PSME2;JAK1;HNRNPDL;MTAP;PPIA
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.3833157869773306,0.8412710906439402,0.6598837209302325,0.9201208384703895,1.0,5/17,15.16%,BMP4;ATP1A3;ATP1A1;NR3C1;URI1
prerank,cellular response to glucose stimulus (GO:0071333),0.35279926857603866,0.8410468839217862,0.679399727148704,0.9200767659726504,1.0,6/30,10.80%,UNC13B;CLTRN;KCNB1;SLC39A14;MLXIPL;PDK3
prerank,mitotic nuclear membrane organization (GO:0101024),0.31748724685316276,0.8409724698780255,0.7041564792176039,0.9193237255245345,1.0,11/51,17.82%,EMD;CC2D1B;LMNA;NUP93;LEMD2;CCNB1;AHCTF1;NUP155;CHMP2B;LBR;NUP35
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.31748724685316276,0.8409724698780255,0.7041564792176039,0.9193237255245345,1.0,11/51,17.82%,EMD;CC2D1B;LMNA;NUP93;LEMD2;CCNB1;AHCTF1;NUP155;CHMP2B;LBR;NUP35
prerank,RNA metabolic process (GO:0016070),0.2914173243544167,0.8408063542994092,0.7731182795698924,0.9191674741293295,1.0,35/127,21.91%,RBFOX2;SIDT2;DDX17;FASTKD1;AGO2;RBM39;DDX24;ZC3H12A;DUSP11;ATXN2;DHX36;RBM3;TENT2;RNASE3;HNRNPH1;WTAP;RNASEH2A;RBMX;BICD1;HNRNPM;LSM8;FTO;PABPC4;HNRNPA2B1;DHX9;POLR2C;SYNCRIP;RBM6;MRPL44;SNRNP40;CLP1;DHX8;EXOSC7;RNGTT;HNRNPH2
prerank,receptor recycling (GO:0001881),0.4190015066122382,0.8407903006155176,0.6493506493506493,0.9187531843321604,1.0,4/10,21.67%,PHETA2;SORL1;RAB11B;ARFGEF2
prerank,regulation of execution phase of apoptosis (GO:1900117),0.40922012626433735,0.8407217796518249,0.6362229102167183,0.9184407906334437,1.0,5/11,25.31%,PTGIS;ZC3H12A;FAP;TP53;DLC1
prerank,regulation of interleukin-2 production (GO:0032663),0.3285346313199679,0.8405661974405625,0.6939820742637645,0.9182540755405649,1.0,9/43,16.99%,EZR;PLCG2;ANXA1;CD80;MAP3K7;TRAF2;HOMER2;TRAF6;GLMN
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.2908320801860673,-0.8403650180519945,0.7132616487455197,0.9042871789445388,1.0,11/22,20.39%,PLA2R1;RPL37;SPRED1;RPS7;RPS15;CDK5RAP3;HIC1;RPS20;RPL23;EIF5A;MSX1
prerank,granulocyte chemotaxis (GO:0071621),0.3116910550616704,0.8401701988472604,0.692588092345079,0.9185061651639247,1.0,5/55,5.34%,CXCL2;CCL3;CCL1;GBF1;ANXA1
prerank,membrane assembly (GO:0071709),0.33905460251323316,0.8397906076740078,0.6666666666666666,0.9187235920807477,1.0,11/34,18.39%,DMKN;ANXA2;S100A10;GAK;TLCD1;NLGN1;NRXN2;FLOT1;CEL;STX2;UBXN2B
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.32890784578223375,0.8393179868714037,0.7030075187969925,0.9190961218409883,1.0,12/42,19.38%,SRCAP;CHD3;SMARCC1;MBD3;DMAP1;RNF8;SMARCA5;CHD8;VPS72;PBRM1;ACTR5;HDAC2
prerank,regulation of macroautophagy (GO:0016241),0.29127629594475163,0.838955054159201,0.7522123893805309,0.919302076704171,1.0,24/105,20.21%,NEDD4;EXOC4;CLEC16A;RRAGB;NRBP2;WAC;IKBKG;PAFAH1B2;LZTS1;SNX32;MAP3K7;SCOC;RB1CC1;SH3GLB1;EXOC7;ATP6V1A;RHEB;MLST8;LRRK2;ATP6V0D1;GPSM1;CAPN1;EPM2A;SESN3
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.3884372085425871,0.8386336954959417,0.674884437596302,0.9194390875791294,1.0,6/15,16.49%,FGFR1;CELF4;BRCA1;CELF1;UBR3;CAMSAP3
prerank,nuclear membrane reassembly (GO:0031468),0.3158293087201165,0.838494229730485,0.7132352941176471,0.9192490899373761,1.0,12/54,18.39%,EMD;CC2D1B;LMNA;NUP93;LEMD2;CCNB1;AHCTF1;NUP155;CHMP2B;LBR;NUP35;UBXN2B
prerank,phospholipid dephosphorylation (GO:0046839),0.3315318618309352,0.8383115241367658,0.6783854166666666,0.9191351103827247,1.0,11/37,22.85%,PLPP3;PLPPR2;MTMR12;OCRL;PIP4P2;SYNJ2;SYNJ1;MTMR1;SACM1L;PLPP1;MTMR9
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.38048567410480183,0.8382406908114234,0.6544117647058824,0.9188090880311964,1.0,2/17,3.91%,NFE2L2;VNN1
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.3609308753437759,0.8381653823721839,0.6874115983026874,0.9185057705937741,1.0,9/23,22.78%,NABP1;ZW10;ZFYVE19;PLK3;ZWILCH;CHFR;WEE1;CHEK1;PRCC
prerank,defense response to bacterium (GO:0042742),0.2922247340391027,0.8380372835129847,0.7425968109339408,0.9183022851834554,1.0,12/105,13.32%,LBP;PRKCD;DEFB130A;SHC1;TLR4;ANXA3;MAVS;ANKRD17;MYD88;RNASE3;LYST;TIRAP
prerank,positive regulation of hormone secretion (GO:0046887),-0.311538116279131,-0.837843611091992,0.680379746835443,0.9079486232922525,1.0,3/17,10.18%,SPP1;C1QTNF3;EDN1
prerank,lipid translocation (GO:0034204),0.36802954509491453,0.837811257298863,0.6714905933429812,0.918247049027161,1.0,8/21,18.41%,TMEM30B;ABCA7;ATP11A;ATP9B;ATP10A;ABCC1;RFT1;ATP8B4
prerank,Ras protein signal transduction (GO:0007265),0.2865705352587549,0.8376016632358135,0.7553191489361702,0.9181661696108351,1.0,14/137,6.58%,PLCE1;NTN1;CDC42EP5;CCNA2;FGF2;NRAS;KRAS;ARHGDIB;MRAS;SHOC2;G3BP2;SHC1;NF1;TIAM1
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.3339964176346703,0.8370813122262508,0.6695979899497487,0.9186075943229002,1.0,16/38,28.77%,RBBP7;CENPT;HJURP;HIRA;CENPL;ATRX;SMARCA5;CABIN1;IPO4;CENPW;ASF1A;CENPP;RSF1;HAT1;CENPK;NASP
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.2793814043120899,0.8370576670308315,0.8319755600814664,0.9182062063907426,1.0,107/264,32.42%,DDX5;DDX17;SRSF11;U2AF2;RBM14;DBR1;SRSF5;SRSF6;SRRM2;SNRNP48;CDK13;PABPC1;CDC40;SRSF2;CELF4;FUS;HNRNPH1;SNRNP35;PRMT5;U2SURP;RBMX;SCAF11;SRSF1;CHERP;WBP4;HNRNPM;SNRNP70;LSM8;RNPS1;PRPF8;UBL5;RNPC3;CPSF3;SYF2;GPKOW;HNRNPA2B1;USP49;WDR83;DHX9;POLR2C;NONO;SYNCRIP;RBM6;CSTF3;GEMIN5;SNRNP40;CLP1;TGS1;PDCD7;SF3B3;DHX8;PNN;LSM4;HNRNPH2;DHX38;SRSF3;SRRM1;SUGP1;PRCC;CCAR1;SRPK2;FIP1L1;YTHDC1;HNRNPF;USP39;RBM4;SMN1;SCNM1;SNRNP200;GEMIN8;CSTF1;SNUPN;PTBP1;RBM17;ZCRB1;WDR33;DNAJC8;RBM5;GCFC2;SMNDC1;SNRPB;SNRPB2;DHX15;ELAVL1;ZRSR2;HNRNPC;CSTF2T;TRA2A;UPF3B;DDX42;HNRNPR;TRA2B;SRPK1;WBP11;PPIL3;TXNL4A;PRPF3;ELAVL2;PPIH;NUDT21;SNW1;SF3B2;SF3B1;DDX39A;DDX39B;SRSF7;SNRPA
prerank,negative regulation of cilium assembly (GO:1902018),0.40493199272663394,0.8366773273461244,0.662015503875969,0.9184262423034447,1.0,3/12,16.91%,CDK10;LIMK2;YAP1
prerank,positive regulation of interleukin-2 production (GO:0032743),0.356649871735806,0.8361966397661826,0.6989100817438693,0.9188289241471321,1.0,8/25,20.41%,PLCG2;ANXA1;CD80;MAP3K7;TRAF2;TRAF6;GLMN;SPTBN1
prerank,arachidonic acid secretion (GO:0050482),0.4188232113981093,0.8361685761991657,0.6773675762439807,0.9179970851426199,1.0,3/10,12.30%,ANXA1;DRD3;NMUR2
prerank,arachidonate transport (GO:1903963),0.4188232113981093,0.8361685761991657,0.6773675762439807,0.9179970851426199,1.0,3/10,12.30%,ANXA1;DRD3;NMUR2
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",-0.2927584893525792,-0.8361520742821661,0.7396226415094339,0.9100601783017398,1.0,7/23,24.94%,CECR2;KPNB1;HMGB1;FOXL2;HMGB2;CASP3;MUS81
prerank,cellular glucose homeostasis (GO:0001678),0.3254036739210509,0.8358212483452763,0.6861768368617683,0.9181451897526474,1.0,4/41,3.32%,LRRC8D;UNC13B;KCNB1;SLC39A14
prerank,regulation of macrophage differentiation (GO:0045649),0.38432189188005966,0.8353996070102313,0.6734059097978227,0.9184386881788305,1.0,3/15,6.78%,ID2;PTPN2;INHBA
prerank,positive regulation of hydrolase activity (GO:0051345),0.2820541551431763,0.8352320261424132,0.7746781115879828,0.9182983589668979,1.0,23/137,12.16%,ARAP1;WNT11;SGSM2;SRGAP2;GSK3B;BCAS3;CCL3;LIMS1;CCL1;NDEL1;NF1;MAPK12;ERBB2;WRN;ITGB1;S100A10;RGP1;RGS6;CCL7;RHOA;RAP1A;SNX18;BCAR3
prerank,ERAD pathway (GO:0036503),0.29844960110607716,0.8351220319859889,0.7322033898305085,0.9180558633468118,1.0,19/83,24.00%,UBE4B;USP13;RNF185;MAN1B1;VCP;UBE4A;FBXO27;PSMC6;HERPUD1;SEL1L;FBXO17;TMEM129;ANKZF1;USP19;UBXN4;DNAJB2;POMT2;RHBDD2;SEC61B
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.40311354482193806,0.8341689826122672,0.6612377850162866,0.9191991823288987,1.0,4/11,22.09%,STAT3;JAK2;STAT4;IL27RA
prerank,mRNA destabilization (GO:0061157),0.33266496045539234,0.8340870920817158,0.6803995006242197,0.9189016048917946,1.0,15/38,29.08%,TUT7;TUT4;ZC3H12A;DHX36;CELF1;MEX3D;MOV10;FTO;PUM1;TARDBP;CNOT1;TRIM71;METTL16;ROCK1;YTHDF2
prerank,interstrand cross-link repair (GO:0036297),0.3083598751967238,0.8339896570899114,0.6981818181818182,0.918630318505461,1.0,15/53,26.46%,RAD51;FANCL;SLX4;VCP;USP1;NEIL3;WDR48;RNF8;MCM9;ATR;ERCC4;DCLRE1A;UBB;UBA52;RPS27A
prerank,positive regulation of mononuclear cell migration (GO:0071677),-0.26908628639504306,-0.8338625163378098,0.7389705882352942,0.9132840963982937,1.0,7/29,12.53%,CXCL12;LGMN;JAM2;CREB3;GAS6;PLA2G7;HMGB1
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.35488133001713884,0.8335056049957508,0.6578947368421053,0.9190716674522252,1.0,4/24,10.98%,CCL3;FOXO3;NF1;MCL1
prerank,protein transport (GO:0015031),0.27379887705645184,0.8333247639661479,0.8704453441295547,0.9189451385991012,1.0,108/332,27.01%,RAMP1;TANGO6;SGSM2;TLK1;STX11;KIF13A;LRP1;TMED5;TMED3;TCIRG1;LTBP2;HERC2;RAB43;RAB6A;LMAN2L;RUFY1;RAB24;ARFIP2;SEC31A;AP3B1;SLC10A7;ATP6V0A4;ARFGAP3;COPG1;SCAMP2;COPA;MIA3;CMTM6;SEC23IP;KIF3B;NSF;STX5;ARF4;CLU;STX12;CTTN;ARL6IP5;EHD1;TBC1D2B;RAB21;EVI5;ATP6V1A;ARCN1;SCFD2;AP3D1;COPB2;RAB11B;SEL1L;RABGAP1;SNX8;TMEM167A;CHMP2B;GOLPH3;RAB28;RAB1A;VAMP2;TBC1D8B;RAB5B;STXBP1;GOLGA7;GOLGA4;STX2;TBC1D5;TBC1D17;AP2A1;ATP6V0D1;TVP23B;PPARG;EIF2D;LRSAM1;TVP23A;SPTBN1;IFT22;SCAMP3;TMED2;TBC1D15;STX17;GOLPH3L;STX8;ARF3;TOM1;SNX13;SCAMP1;BBS2;RABL3;ATP6V0A2;RAB26;FAM91A1;GCC2;TBCK;RAB1B;COPZ1;RIC1;ARL5C;USO1;NECAB3;CEP290;GGA1;RAB14;CHMP3;VPS26B;SYNRG;STXBP3;TBC1D10A;RCN3;AP4M1;GGA2;ATP6V0B
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.32363007698176155,0.8330585906906581,0.7130102040816326,0.9189637156242328,1.0,5/45,7.73%,PRKCD;CAMK2D;MID1;CD44;IRF1
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.3136201458073631,0.8325763370693996,0.7217496962332929,0.9193882378382426,1.0,11/52,16.60%,ABLIM3;HPS4;NPEPPS;SAE1;HSPA1L;TFDP1;SH3GLB1;E2F1;UBE2D3;PPP3CC;UBL5
prerank,regulation of response to oxidative stress (GO:1902882),-0.33869266094346095,-0.8317134534911281,0.6648351648351648,0.9162935582338568,1.0,3/11,15.81%,MCTP1;PINK1;STOX1
prerank,positive regulation of immune effector process (GO:0002699),0.3385341984500893,0.8316762990317722,0.6643741403026134,0.9204549923855145,1.0,3/27,11.66%,LBP;ANKRD17;CD46
prerank,regulation of vesicle-mediated transport (GO:0060627),0.2945519758764432,0.8315116399804932,0.7429218573046432,0.9202959833621175,1.0,27/91,23.82%,STON2;NRP1;RAB25;GAS1;ABL1;STON1;RUFY1;ARFGAP1;ITGAV;RAB4B;NSF;RAB21;RAB11B;VAMP2;RAB5B;CPLANE2;SNX12;LRRK2;STXBP5;RAB33B;RAB11A;BET1L;MAP2K2;CPLX2;RAB4A;RAB26;USP7
prerank,C4-dicarboxylate transport (GO:0015740),0.3931633443572893,0.8310292550137847,0.6661698956780924,0.9207013729272071,1.0,1/14,1.13%,LRRC8D
prerank,lymphocyte migration (GO:0072676),0.3346521309727716,0.830846049205983,0.6719787516600265,0.9205631287289283,1.0,4/32,13.01%,CCL3;CCL1;CCL7;RET
prerank,glycerol metabolic process (GO:0006071),-0.35635324506634336,-0.830538866465711,0.6853333333333333,0.9173612927402861,1.0,2/10,7.49%,GK;COQ2
prerank,negative regulation of histone methylation (GO:0031061),0.4151820636404999,0.8298104818495307,0.6683006535947712,0.9219028411208057,1.0,3/10,12.66%,KDM1A;BCOR;BRCA1
prerank,protein homotetramerization (GO:0051289),0.3142873399949113,0.8297584149987629,0.6980676328502415,0.9215603403793803,1.0,6/49,13.07%,KCNJ2;TRPM4;ACACA;TDO2;TK1;ACOT13
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.3517090852984748,0.8294784603291195,0.6736111111111112,0.9216124433045546,1.0,13/25,31.73%,DBR1;SCAF11;PRPF8;WDR83;SNRNP40;SF3B3;SRRM1;LSM1;SMNDC1;TRA2B;TXNL4A;PRPF3;SF3B1
prerank,regulation of defense response (GO:0031347),0.29745892186616874,0.8293381743967184,0.7281213535589265,0.9214241815671305,1.0,22/76,25.11%,FOXP1;MGLL;PIK3AP1;ANXA1;IRF1;MYD88;CELF1;TIRAP;ALOX5;AREL1;PSMA6;DAGLB;JAK2;BRD4;NR1D2;TRAF3;ERAP1;PTGES;SETD6;APPL2;SBNO2;NLRP6
prerank,epithelial cell development (GO:0002064),0.3572309886561512,0.8289037210513441,0.6826086956521739,0.9217216739358988,1.0,2/20,3.31%,GRHL2;RAB25
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.2971745383663677,-0.8286359064645336,0.6934865900383141,0.9197838941025241,1.0,7/21,18.13%,BCL2L1;CREB3;BCL2L11;BOK;XBP1;HSPA1A;SELENOS
prerank,positive regulation of GTPase activity (GO:0043547),0.2738643314068405,0.8285959735564097,0.8096707818930041,0.9218398770356308,1.0,44/188,18.48%,NTRK3;ARAP1;WNT11;SIPA1L1;SGSM2;SRGAP2;GSK3B;BCAS3;CCL3;LIMS1;CCL1;RAP1GAP2;NDEL1;DOCK7;NF1;BCR;GPR65;ERBB2;TIAM1;ITGB1;TIAM2;CORO1C;S100A10;RGP1;RGS6;CCL7;RAP1A;SNX18;BCAR3;PIP5K1A;PLXNB1;TBC1D2B;EVI5;SIPA1L2;RABGAP1;AFDN;SCRIB;PIN1;TBC1D8B;SYDE1;MTSS2;TBC1D5;CCDC125;TBC1D17
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.34194331139886697,-0.8285412271954582,0.6892655367231638,0.9187542659852652,1.0,4/11,23.43%,PTPRT;NF2;SH2B3;CAV1
prerank,lipoprotein transport (GO:0042953),-0.3500378009261119,-0.8283686753158515,0.6781002638522428,0.9178767986786991,1.0,3/10,11.59%,PRKCB;ZDHHC17;VMP1
prerank,regulation of microtubule depolymerization (GO:0031114),0.35083996330431794,0.8282636856861768,0.6753424657534246,0.9219668927965834,1.0,7/25,16.49%,FGF13;KATNB1;MAP1B;CIB1;HDGFL3;MAP1S;CAMSAP3
prerank,apical junction assembly (GO:0043297),0.3046545921979446,0.8281852093163191,0.7061728395061728,0.921683526917945,1.0,13/53,16.30%,MPP7;GRHL2;CTNNA1;STRN;VCL;PATJ;RHOA;PARD3;DLG1;PDCD6IP;PARD6A;AFDN;CLDN11
prerank,regulation of centriole replication (GO:0046599),0.3629427942619777,0.8281001442773944,0.6830985915492958,0.9214013635067396,1.0,5/18,17.14%,RBM14;SPICE1;PLK4;BRCA1;CENPJ
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.38923397496259926,0.8279962180689482,0.6890625,0.9211476012261453,1.0,4/14,12.96%,LIMS1;TIMP1;DMTN;ITGB1BP1
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.29382611755286225,0.8277881215011994,0.7452085682074409,0.9210515762676733,1.0,15/87,16.78%,RBFOX2;FGF2;SHOC2;FGFR1;SPRED2;KIF16B;CD44;FGFRL1;TIA1;HNRNPH1;ITGB1BP1;NR4A1;HNRNPM;FLRT2;FGFR3
prerank,positive regulation of TOR signaling (GO:0032008),0.3215720642441014,0.8277408901847384,0.7032679738562092,0.9206951352262298,1.0,10/40,19.12%,TELO2;CLEC16A;RRAGB;HTR6;KLHL22;RHEB;GOLPH3;MLST8;NCKAP1L;GPR137B
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.36530358278201885,0.8274522072700968,0.6850282485875706,0.9207553596232202,1.0,4/20,7.39%,NT5E;ANO6;PSTPIP1;ENTPD5
prerank,regulation of cell-cell adhesion (GO:0022407),0.32480126654908037,0.8273578634111115,0.7054973821989529,0.9204916032814647,1.0,5/39,7.40%,CDH1;EFNA5;ADA;EPHB3;ZDHHC2
prerank,negative regulation of viral genome replication (GO:0045071),-0.24493023551727366,-0.8272778944442006,0.7692307692307693,0.9188056058272875,1.0,11/40,17.35%,IFIT1;IFITM1;OAS2;IFITM3;BST2;PROX1;RNASEL;IFITM2;SHFL;PARP10;BANF1
prerank,fatty acid elongation (GO:0030497),-0.3339258660173113,-0.8268999948652122,0.6815642458100558,0.9182709032875177,1.0,5/13,15.51%,ELOVL7;HACD3;HACD1;HACD2;ELOVL6
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.34218178163840945,0.8266417277334615,0.6944444444444444,0.9212733400523213,1.0,12/31,26.47%,CNOT8;EXOSC3;DCP1A;EXOSC1;DIS3;EXOSC2;LSM4;EXOSC7;EXOSC8;DDX6;LSM1;PATL1
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.38625282221768525,0.8265026903980477,0.6827794561933535,0.921073658175014,1.0,4/15,17.04%,VCP;HERPUD1;SEL1L;TMEM129
prerank,lipid modification (GO:0030258),0.32925847389579976,0.825950657796554,0.7072192513368984,0.9216061843150712,1.0,5/37,8.56%,PLPP3;PLPPR2;MBOAT4;DGKA;MBOAT1
prerank,regulation of protein kinase A signaling (GO:0010738),0.3641979101632652,0.8257063707417068,0.6950146627565983,0.921561653823445,1.0,2/20,2.59%,TCIM;ADRB2
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.3004272008222031,0.8257002841189885,0.7298919567827131,0.9211435536285052,1.0,25/72,31.10%,ERCC5;ZC3H12A;CHD1L;PARP1;RAD50;DCP1A;GTF2H3;RFC1;ERCC4;UBB;UBA52;POLK;GTF2H4;DICER1;RPS27A;DXO;SETMAR;MEI4;DDB1;ERCC2;DCP1B;DDB2;POLD1;XPA;GTF2H5
prerank,positive regulation of MAPK cascade (GO:0043410),0.2717971993026203,0.8252668711689304,0.84560327198364,0.9214265037799055,1.0,23/245,7.32%,BMPER;EGFR;TNFAIP8L3;NTRK3;ADRA1B;PTK2B;FGF2;ADRB2;NRP1;VEGFA;MID1;NOTCH2;CCL3;CCL1;PLCG2;PDGFC;FGFR1;SHC1;ERBB2;CD44;ROR1;TENM1;ABCA7
prerank,genitalia development (GO:0048806),0.38690690893937424,0.8251387161995115,0.6563944530046225,0.9211950194975794,1.0,1/12,1.00%,PKD1
prerank,negative regulation of immune system process (GO:0002683),-0.3111483588500746,-0.8248392437022151,0.7189542483660131,0.9208843611439361,1.0,3/16,8.83%,LYN;IL17D;CD200
prerank,regulation of secretion (GO:0051046),-0.324777143476514,-0.8240931311966252,0.7352941176470589,0.9210494109863699,1.0,5/13,13.95%,OAS2;SGK1;KCNQ1;MYO6;ERBB3
prerank,iron ion transport (GO:0006826),-0.24411851995448242,-0.823967268457955,0.8195876288659794,0.9200940353968899,1.0,7/47,10.14%,CP;TFRC;SLC40A1;LMTK2;ABCB7;ATP6V0A1;ATP6V1G1
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.38281693364484487,0.8236363133577571,0.6854961832061068,0.9232550000813916,1.0,3/13,15.75%,NFAT5;RHOA;TRAF6
prerank,leukocyte cell-cell adhesion (GO:0007159),0.3448963781777592,0.8233349224125166,0.6778975741239892,0.9233258804111449,1.0,3/24,7.66%,EZR;NT5E;ITGB1
prerank,cellular iron ion homeostasis (GO:0006879),0.3094611810660318,0.8229534053002213,0.7174721189591078,0.9235029279142527,1.0,14/55,20.01%,SCARA5;ABCG2;SLC39A14;BMP6;GLRX3;CUL1;HMOX2;FXN;ATP6V1A;SMAD4;SLC46A1;ATP6V0D1;FLVCR1;IREB2
prerank,positive regulation of response to stimulus (GO:0048584),0.3177237675711966,0.8228286860746926,0.7142857142857143,0.9232881430468348,1.0,14/40,27.90%,PRKCD;CD80;MAVS;IFIH1;CGAS;NSMCE1;HOMER1;DHX9;CDKN2AIP;FMR1;HMGA1;EEF1E1;ACOX2;BCLAF1
prerank,spliceosomal snRNP assembly (GO:0000387),-0.25303713718329734,-0.8227558645450956,0.7695852534562212,0.9211749658831918,1.0,10/38,17.54%,GEMIN2;AAR2;PRMT7;SRSF10;SNRPD3;DDX20;PRPF31;CLNS1A;SNRPG;COIL
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.40058389985478937,0.8222693492212436,0.7015873015873015,0.9238002060143685,1.0,5/11,23.59%,RENBP;GFPT1;GNPDA1;UAP1;PGM3
prerank,positive regulation of cell cycle process (GO:0090068),0.28524605471150466,0.8221320386381026,0.7400681044267877,0.923598510323744,1.0,29/91,25.34%,CIT;PRKCE;GIPC1;CDC14A;AURKA;CUL3;CCNB1;RHOA;PLK4;MAD2L1;DRD3;LRP5;DDX11;ATRX;PLSCR1;CDC7;CXCR5;PCID2;UBXN2B;EDN3;USP19;EGF;IGF2;KIF23;PKN2;INO80;RAD21;CDC6;GPSM2
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.27011810942325015,-0.8220655966306457,0.7283018867924528,0.9212713296074937,1.0,4/29,5.60%,APOE;LPGAT1;PPARA;NR1H3
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.3630335941732385,0.8219925270348185,0.6804979253112033,0.9234137435623301,1.0,2/20,7.71%,PID1;RHOQ
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.3014551396198485,0.821196814782773,0.7381776239907728,0.9243210980345248,1.0,20/70,24.89%,PSMB2;ABL1;PSMD11;FOXC1;PSMC1;EIF2AK2;PSMC6;PSMD1;PRKDC;PSMD4;YAP1;PSMA6;PSMD14;PSMD12;PSMD7;TCF12;PSME3;PSMD3;PSMB6;CBFB
prerank,positive regulation of cellular respiration (GO:1901857),-0.3394053085243354,-0.820965259492237,0.6869806094182825,0.9221630428557444,1.0,4/11,16.57%,IFNAR1;PINK1;NUPR1;IL10RB
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.4123894281331754,0.8203198498920725,0.7098865478119936,0.9253391294303251,1.0,2/10,6.02%,PLS1;TSKU
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.40662941917057605,0.8202205074665123,0.6818897637795276,0.925082293435965,1.0,4/11,19.10%,ATL2;ATL1;BNIP1;VCPIP1
prerank,GPI anchor metabolic process (GO:0006505),0.3412838937851346,0.8200376629346272,0.6895104895104895,0.9249491753752054,1.0,10/26,27.93%,PGAP2;PIGU;PIGO;DPM1;MPPE1;PIGG;PGAP3;PIGB;PIGQ;PIGV
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.35307281830129783,0.8200181475016802,0.7213793103448276,0.9245577315735345,1.0,7/22,26.46%,EDEM3;RNF185;MAN1B1;SEL1L;UBB;UBA52;RPS27A
prerank,regulation of neurogenesis (GO:0050767),0.308828968631473,0.8200152283551059,0.7301204819277108,0.9241388211606264,1.0,15/55,24.13%,HES1;DOCK7;BHLHE40;PCM1;HOOK3;HES3;SORL1;PAX6;YAP1;FAIM;NUMBL;NAP1L1;HEYL;REST;APPL2
prerank,negative regulation of GTPase activity (GO:0034260),0.3485131074318313,0.8197543124659243,0.6994301994301995,0.924131486193401,1.0,8/22,20.57%,WNK1;BCAS3;RDX;RRP1B;ARFGEF1;LRRK2;GPSM1;TMED2
prerank,negative regulation of hippo signaling (GO:0035331),0.40167554636478797,0.8196524362666254,0.69375,0.9238799671609821,1.0,6/12,27.06%,CIT;MARK3;DLG5;WWC2;MAP2K3;LIMD1
prerank,negative regulation of inflammatory response (GO:0050728),0.2712253424376092,0.8192976470053015,0.8254963427377221,0.9240450487106154,1.0,15/182,8.15%,CCN3;RAMP1;PTGDR;PRKCD;PTGIS;ADRB2;KLF4;PLCG2;PTHLH;PTPN2;ADCY9;NLRP12;RORA;GPR27;HTR6
prerank,regulation of presynapse organization (GO:0099174),0.36231091632517265,0.8190741036273373,0.6837606837606838,0.923583965819667,1.0,1/18,0.61%,GPC6
prerank,regulation of presynapse assembly (GO:1905606),0.36231091632517265,0.8190741036273373,0.6837606837606838,0.923583965819667,1.0,1/18,0.61%,GPC6
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.34438284022154,0.8188739722851441,0.6951724137931035,0.9234797757206448,1.0,3/28,6.68%,CRADD;NGF;BAG3
prerank,monocarboxylic acid biosynthetic process (GO:0072330),-0.2277787886541942,-0.8184664290598024,0.8269230769230769,0.9256589759271527,1.0,4/59,3.36%,ALDH1A2;CYP7B1;CYP27A1;GATM
prerank,negative regulation of viral release from host cell (GO:1902187),0.3920956747559668,0.8180591030222264,0.6921898928024502,0.924402441720823,1.0,5/13,29.10%,TRIM35;MID2;PML;CHMP3;TRIM26
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.35517527889859546,0.8175432155400842,0.7201767304860088,0.9248127335364842,1.0,7/21,19.78%,PDZD8;MCU;BCAP31;SLC8B1;MICU2;MCUB;ANXA6
prerank,pre-miRNA processing (GO:0031054),0.3934666607432783,0.8172336240158332,0.6876923076923077,0.9248780921803936,1.0,8/14,28.66%,AGO2;TUT7;TUT4;MRPL44;DICER1;PRKRA;DROSHA;AGO1
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.31266155102688925,-0.8171261787080127,0.7113702623906706,0.9268885856419763,1.0,5/14,18.27%,RFFL;CCDC3;GAS6;NLRP2B;TRAIP
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.36262457688843075,0.8169591578421544,0.7073863636363636,0.924896763173395,1.0,5/20,16.34%,CNOT8;AGO2;EIF6;CELF1;MOV10
prerank,regulation of cell adhesion (GO:0030155),0.2831770250600758,0.8168972067056531,0.7785087719298246,0.924592402766008,1.0,20/129,14.70%,ZFHX3;PPP3CA;PTK2B;EFNA5;ARHGDIB;VEGFA;ABL1;EPHB3;ERBB2;ZDHHC2;GPR4;CHRD;MIA3;ITGAV;EPHB2;ITGB1BP1;RET;PLXNB1;PPP1R12A;PRKCA
prerank,chromatin assembly (GO:0031497),0.3267911636435573,0.8168810571246856,0.7137305699481865,0.924197918635391,1.0,12/38,24.63%,CHAF1B;CHAF1A;EZH1;ATRX;SOX9;KAT6B;SMARCA5;NAA60;NAP1L1;TP53;ASF1A;RSF1
prerank,glycerolipid metabolic process (GO:0046486),0.40008261124561706,0.8168517526826304,0.6948051948051948,0.9238263860480057,1.0,4/11,12.38%,PLA2G15;DGKA;PNPLA3;PIP5K1A
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.3509781906925818,0.816654856104791,0.6755994358251057,0.9237298395221599,1.0,6/24,13.73%,NEDD4;GRB10;EMILIN1;ARNT;NIBAN2;ITGB3
prerank,negative regulation of protein transport (GO:0051224),0.34715814312654175,0.8165793020223707,0.7046070460704607,0.9234491394841402,1.0,9/25,24.09%,WWP2;DPH3;SERGEF;DRD3;SNX12;HMGCR;CSK;PKDCC;RHBDF1
prerank,regulation of TORC1 signaling (GO:1903432),0.32969550390260116,0.8163093972052556,0.6945169712793734,0.923475318548421,1.0,6/33,10.23%,TELO2;ITFG2;CLEC16A;RRAGB;KLHL22;SZT2
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.2916050112748671,-0.8161879764948923,0.7572815533980582,0.9274025142757747,1.0,7/20,16.99%,BCL2;DCC;BCL2L1;FAS;ERBB3;BOK;GSK3A
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.383882297714125,0.8156321058088118,0.6911544227886057,0.9241903685047632,1.0,1/15,1.64%,PRKCD
prerank,negative regulation of developmental process (GO:0051093),0.2972411487711246,0.815567256416209,0.7558139534883721,0.9238693651243888,1.0,7/69,9.39%,BMP4;NFIB;WNT11;KLF7;FOXC1;SFRP5;PARP3
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),-0.32934444299774834,-0.8155560526149683,0.7306666666666667,0.9273468688640079,1.0,1/12,1.99%,PCGF5
prerank,negative regulation of neuron death (GO:1901215),0.28518411880313016,0.8155487914141123,0.7713310580204779,0.9234695756062862,1.0,11/93,10.39%,SIX1;PTK2B;NGF;TGFB3;CLCF1;GSK3B;NFATC4;NRBP2;IKBKG;SIX4;POU4F1
prerank,mitotic cytokinesis (GO:0000281),0.31097776113222786,0.8154578317316415,0.7436208991494532,0.923202961982109,1.0,8/47,13.34%,CIT;SON;TTC19;CNTROB;RAB35;ARL3;SNX18;PDCD6IP
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.3991223607757418,0.8153299183829297,0.6908809891808346,0.9230013590986516,1.0,3/11,17.87%,SMARCAL1;FBXO5;DONSON
prerank,defense response to tumor cell (GO:0002357),0.4116688837960666,0.8152070715291688,0.6761904761904762,0.9227838703725509,1.0,4/10,20.46%,KLF4;RBMS3;DAPK1;PRDX2
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.3846445524654219,0.8151882822279712,0.7364341085271318,0.9223954008406428,1.0,4/14,21.66%,USP15;ANKRD17;PUM2;PUM1
prerank,sarcomere organization (GO:0045214),0.341461153969145,0.8146548833218634,0.7048951048951049,0.9228132493246591,1.0,2/27,9.59%,CSRP3;SIX4
prerank,lipid oxidation (GO:0034440),-0.3378363914125874,-0.8138140862705412,0.7083333333333334,0.9294043292513511,1.0,3/12,12.99%,PPARGC1A;PLA2G7;ALOX12
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.36811917471385425,0.8134530343184158,0.6853448275862069,0.9243082090305251,1.0,4/17,17.04%,VCP;HERPUD1;SEL1L;TMEM129
prerank,endoderm development (GO:0007492),0.3840799297779167,0.813323736871496,0.7116564417177914,0.9240808971773251,1.0,3/13,12.23%,KIF16B;GATA4;DUSP5
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.35615315414882587,0.813311836791871,0.7059679767103348,0.9236810922538822,1.0,6/22,24.23%,ERBB2;WDR43;DDX11;UBTF;PHF8;MTOR
prerank,rRNA pseudouridine synthesis (GO:0031118),0.40104529041130127,0.8130257107571481,0.6918032786885245,0.9236900813574639,1.0,3/10,17.36%,RPUSD4;RPUSD2;NAF1
prerank,sensory perception of mechanical stimulus (GO:0050954),0.29299741457701833,0.8129473602628174,0.7856315179606026,0.9234148470522214,1.0,9/85,10.22%,PIEZO2;COL11A1;NIPBL;CDC14A;ROR1;POU3F4;ATP6V0A4;SLC52A3;TBL1X
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.3641547970332903,0.8127336707224683,0.6860119047619048,0.9233333707741657,1.0,5/18,21.66%,USP15;GPATCH3;ANKRD17;PUM2;PUM1
prerank,pore complex assembly (GO:0046931),0.35800870048631656,0.8126145968394632,0.6964539007092199,0.9231152484158349,1.0,5/19,15.18%,ANO6;NUP93;NUP153;AHCTF1;AFDN
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.3665049901651639,0.811722796675399,0.6982507288629738,0.9240952527571143,1.0,2/17,4.30%,ANK2;SNTA1
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.2929740592133917,0.811671630254704,0.7572590011614402,0.9237604877196484,1.0,20/72,22.68%,ELF1;HIPK1;IRAK3;PTPN2;TAX1BP1;SPPL2A;PALM3;IKBKG;TRIM44;TRAF2;IKBKB;SOCS3;RBCK1;JAK2;AGPAT2;CHUK;TRADD;PIAS1;VRK2;SPPL2B
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.3237787928391632,0.811546621573817,0.7410714285714286,0.9235305958948944,1.0,9/40,18.27%,PTK2B;TRIM39;XPO1;DESI1;RAD23B;CLU;COMMD1;GLMN;SMURF1
prerank,positive regulation of behavior (GO:0048520),-0.35024816853841745,-0.8110988371705965,0.6903553299492385,0.9331213901730064,1.0,3/10,10.36%,SGIP1;MEF2C;NPAS2
prerank,regulation of cellular component size (GO:0032535),0.33524482701129105,0.8110254695878293,0.6941489361702128,0.9239499540827691,1.0,4/30,9.01%,VAV2;EZR;RAP1GAP2;RDX
prerank,electron transport chain (GO:0022900),0.3735521020921135,0.8109912860204985,0.6957831325301205,0.9235933550587287,1.0,4/15,19.45%,ENOX2;ETFDH;ETFA;UQCRFS1
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.2705568457052543,-0.8109888704582837,0.7481203007518797,0.9320995945033521,1.0,5/25,5.82%,AFAP1L2;RBPJ;DGKD;HIP1R;RTN4
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.36695483068887036,0.8109621018810024,0.6851574212893553,0.9232233985834873,1.0,5/16,10.49%,CAMK2D;NR4A3;MEF2A;SLC9A1;PARP1
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.3833441332751679,0.8099047730931785,0.6712749615975423,0.9245443719641446,1.0,5/12,21.33%,IRS1;SORL1;ZBTB7B;SORBS1;IGF2
prerank,iron ion homeostasis (GO:0055072),0.3025717636286077,0.809753395496402,0.7438423645320197,0.9243829859431817,1.0,15/58,20.01%,SCARA5;BDH2;ABCG2;NEO1;BMP6;GLRX3;CUL1;HMOX2;FXN;ATP6V1A;SMAD4;SLC46A1;ATP6V0D1;FLVCR1;IREB2
prerank,organophosphate catabolic process (GO:0046434),-0.33818780366955287,-0.8095577959805766,0.7142857142857143,0.9335234147112486,1.0,1/11,1.30%,ENPP2
prerank,cardiac muscle cell differentiation (GO:0055007),0.34471048862446635,0.8094575602727656,0.70042194092827,0.9244517211428225,1.0,6/21,18.07%,AKAP13;VEGFA;ALPK3;ACVR1;SIK1;CXADR
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.2706928696471936,0.8089704540125733,0.867827868852459,0.9248440347338309,1.0,105/241,34.17%,DDX5;SRSF11;U2AF2;RBM14;DBR1;SRSF5;SRSF6;SRRM2;SNRNP48;PABPC1;CDC40;SRSF2;FUS;HNRNPH1;SNRNP35;U2SURP;RBMX;SRSF1;CHERP;WBP4;HNRNPM;SNRNP70;LSM8;RNPS1;PRPF8;UBL5;RNPC3;CPSF3;SYF2;GPKOW;HNRNPA2B1;USP49;WDR83;DHX9;POLR2C;NONO;SYNCRIP;RBM6;CSTF3;GEMIN5;SNRNP40;CLP1;PDCD7;SF3B3;DHX8;PNN;LSM4;HNRNPH2;DHX38;SRSF3;SRRM1;SUGP1;PRCC;CCAR1;FIP1L1;YTHDC1;HNRNPF;USP39;RBM4;SNRNP200;CSTF1;PTBP1;RBM17;ZCRB1;WDR33;DNAJC8;RBM5;GCFC2;SMNDC1;SNRPB;SNRPB2;DHX15;ELAVL1;ZRSR2;HNRNPC;CSTF2T;TRA2A;UPF3B;DDX42;HNRNPR;TRA2B;WBP11;PPIL3;TXNL4A;PRPF3;ELAVL2;PPIH;NUDT21;SNW1;SF3B2;SF3B1;DDX39A;DDX39B;SRSF7;SNRPA;SF3B6;PUF60;ALYREF;ESS2;PPIL1;EFTUD2;ZCCHC8;SNRPF;SRRT;SF3A2
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.35841499425201495,0.8085407582272622,0.697350069735007,0.9250826638457539,1.0,7/20,25.64%,PID1;RHOQ;CSK;TMBIM1;PKDCC;DAB2;NUMB
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.3423688096129041,0.8082844468752983,0.723489932885906,0.9250777703943361,1.0,7/26,24.07%,NFE2L2;VNN1;GATA4;LRRK2;BAG5;SOD2;REST
prerank,leukocyte tethering or rolling (GO:0050901),-0.2999822399783569,-0.8073209767102295,0.7378640776699029,0.9364319309928693,1.0,4/17,14.26%,VCAM1;JAM2;GCNT1;ITGA4
prerank,cellular response to fluid shear stress (GO:0071498),0.3848149792557518,0.8070635135526016,0.7006172839506173,0.9265807037187116,1.0,2/12,4.12%,NFE2L2;KLF4
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.29608172792437176,0.8068243871626892,0.7668571428571429,0.9265515114856345,1.0,23/71,26.46%,CAPN2;ZYG11B;VCP;IDE;DDI2;NR1D1;RNF123;CLPP;PDCD6IP;ZRANB1;RNF41;YME1L1;FAP;PSMA6;CHFR;DDI1;USP9X;CTSK;CTSO;OMA1;UBB;UBA52;RPS27A
prerank,regulation of autophagosome assembly (GO:2000785),0.3204106325476301,0.8067846125648912,0.7239101717305152,0.9261935308225013,1.0,12/33,25.30%,NPRL3;TMEM39A;SH3GLB1;PIP4K2A;LRRK2;RALB;LRSAM1;NPRL2;RAB1B;RAB3GAP1;SMCR8;MTM1
prerank,magnesium ion transport (GO:0015693),-0.3233814229263775,-0.8067737999320219,0.7027027027027027,0.9361788454390482,1.0,5/12,23.28%,NIPA1;NIPAL4;MMGT1;SLC41A1;NIPA2
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.30195498558241674,0.806646061082733,0.7461629279811098,0.9259924889058847,1.0,15/61,18.97%,PSMB2;NQO1;PSMD11;NCOR2;PSMC1;ODC1;PSMC6;PSMD1;AZIN1;PSMD4;OAZ2;PSMA6;PSMD14;PSMD12;PSMD7
prerank,pinocytosis (GO:0006907),-0.3473449795252649,-0.8065684809554264,0.6944444444444444,0.9353469228516799,1.0,5/10,28.66%,DOCK2;PYCARD;AHSG;PPT1;MAPKAPK3
prerank,inner dynein arm assembly (GO:0036159),0.4000506446278838,0.8064992968764256,0.6917057902973396,0.9258038795666014,1.0,1/11,5.27%,DNAAF4
prerank,mitochondrial genome maintenance (GO:0000002),-0.3333152543516839,-0.8064218483486296,0.7319884726224783,0.9344342736105287,1.0,2/11,6.98%,AKT3;SLC25A33
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.2612552807450422,-0.8064007600421883,0.7896678966789668,0.9332844818366341,1.0,11/28,24.12%,CTSC;DAB2IP;PSMC3;CDK5RAP3;PTK2;NUPR1;ECSCR;FBXW7;OSBPL7;DDRGK1;TREM2
prerank,protein K48-linked deubiquitination (GO:0071108),0.3486723660886446,0.8063844970095317,0.7096317280453258,0.9255746206182096,1.0,11/23,32.38%,USP25;USP34;OTUD5;OTUD4;OTUD3;VCPIP1;USP33;USP5;ATXN3;OTUD7B;USP8
prerank,regulation of cellular localization (GO:0060341),0.30288369805398285,0.8063699023193691,0.7379134860050891,0.9251814568300817,1.0,13/46,19.25%,CAMK2D;GSN;EFNA5;KDM1A;CDK16;PARP1;NR1D1;LRP5;PARD6A;DVL1;LRRK2;TTL;MAD1L1
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.34316104382004653,0.8062674298321867,0.7156862745098039,0.9249341055288054,1.0,7/23,24.08%,PDE6A;GRK4;PDE6B;FNTA;PPEF1;METAP2;CNGB1
prerank,development of primary male sexual characteristics (GO:0046546),0.3212357143900171,0.8061645610746095,0.7316421895861148,0.9246910532098468,1.0,5/34,9.59%,LHFPL2;INHBA;KITLG;GATA4;SIX4
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.3036388383062915,0.805926504061255,0.7336504161712247,0.9246397261848922,1.0,22/48,34.51%,ELOF1;POLR1G;POLR1A;TAF1D;DDX21;SMARCA5;POLR1F;DEK;TBP;CHEK1;HMGA1;ASF1A;KAT2B;ZMIZ1;SF3B1;KAT2A;TAF1C;MYBBP1A;BAZ1B;PADI2;TAF1A;PHF2
prerank,regulation of cell motility (GO:2000145),0.2782080192142587,0.8058229568240782,0.7993421052631579,0.9243879740234386,1.0,10/121,6.56%,EGFR;NTN1;LMO4;FGF2;ABL1;CCDC25;TWIST1;LMNA;DIAPH1;ERBB2
prerank,positive regulation of receptor internalization (GO:0002092),0.34012203594383555,0.8056863293907709,0.7215189873417721,0.9242065588629755,1.0,2/22,3.16%,SFRP4;VEGFA
prerank,negative regulation of cell division (GO:0051782),-0.34276649247031155,-0.8053866536287733,0.6910112359550562,0.9338118227538789,1.0,6/11,28.62%,TXNIP;BLM;CHMP4C;E2F7;MYC;E2F8
prerank,negative regulation of innate immune response (GO:0045824),0.31952875442889517,0.8050009275691256,0.7328947368421053,0.92485043417859,1.0,4/34,5.03%,TRAFD1;IRAK3;PTPN2;USP15
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.2881219170352248,0.8042972146296278,0.7760180995475113,0.9255208468146571,1.0,27/88,27.06%,SAMD4A;IGFBP5;NELL1;PAIP2;CNOT8;DNAJC1;EPRS1;RGP1;DHX36;EIF2AK2;TOB1;SYNCRIP;ENC1;DAPK1;IGF2BP3;CAPRIN1;SAMD4B;FMR1;MALSU1;CNOT1;TRIM71;RIC1;DDX6;TSC1;RBM4;SHMT1;CLN3
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.29505918765603734,0.8041017574848054,0.7621247113163973,0.9254313182556874,1.0,17/67,21.13%,ITGB5;PSMB2;IKBKG;PSMD11;PSMC1;ITGAV;PSMC6;PSMD1;PSMD4;IKBKB;SNAP23;PSMA6;PSMD14;PSMD12;PSMD7;CHUK;PSME3
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.36967692783025086,0.8039234441326213,0.7192192192192193,0.9252903971164392,1.0,4/15,16.22%,ADAM9;EHD2;EHD1;FLOT1
prerank,regulation of lymphocyte proliferation (GO:0050670),-0.30714399911712387,-0.8034470483896876,0.7048710601719198,0.9360248860358192,1.0,9/16,37.19%,AHR;PTPN22;TNFSF8;FGF10;LST1;IKZF3;IL12A;CD22;TNFSF9
prerank,negative regulation of viral process (GO:0048525),-0.22972941726207202,-0.8029593019579971,0.8245614035087719,0.9357155498130709,1.0,16/57,20.07%,IFIT1;TRIM14;IFITM1;OAS2;IFITM3;BST2;PROX1;STAT1;RNASEL;IFITM2;TRIM62;SHFL;PARP10;BANF1;N4BP1;ZFP36
prerank,regulation of mitochondrial translation (GO:0070129),0.3470765876468637,0.8027424270153374,0.7156862745098039,0.9267707224249001,1.0,6/21,23.19%,MRPS27;RPUSD4;FASTKD3;MALSU1;TSFM;ALKBH1
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.35106246090752624,-0.8022530220254324,0.7146666666666667,0.9357537845471418,1.0,5/10,23.71%,SACS;DNAJA4;HSPA1A;DNAJB6;HSPA2
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.39102766194383143,0.8000913243478157,0.7251655629139073,0.9306198630015292,1.0,2/10,17.26%,ZC3H12A;SMAD7
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.39487654271120654,0.799196966872232,0.707936507936508,0.9316216677000374,1.0,2/10,10.30%,KNSTRN;CCNB1
prerank,negative regulation of biosynthetic process (GO:0009890),-0.30398569495022565,-0.7988409236840983,0.7588235294117647,0.9405485348618102,1.0,3/16,9.20%,SLC30A10;PPARA;ABCB7
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.27886281780361555,0.7984440018358143,0.8139013452914798,0.9323913623226624,1.0,9/110,6.83%,RAMP1;ADGRL2;ADRA1B;GNAS;ADRB2;PTHLH;ADCY9;GPR65;PTGER1
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.2774792717398113,0.7981535104337067,0.8060344827586207,0.932415230689162,1.0,39/119,25.92%,PIK3C2B;FGF2;PLEKHA4;PLCG2;TTC7A;IP6K1;RUFY1;IP6K2;MTMR12;PIK3R3;PGAP2;PI4KB;INPP4A;SBF1;PIGU;PIP5K1A;OCRL;INPPL1;PIGO;PIP4K2A;SYNJ2;SOCS3;SYNJ1;CDS1;MTMR1;DPM1;MPPE1;ARF3;SACM1L;PIGG;MTMR9;RAB4A;TTC7B;PGAP3;PIGB;MBOAT7;MTM1;PIGQ;RAB14
prerank,heart morphogenesis (GO:0003007),0.29929295186891336,0.7980223217762206,0.7496902106567535,0.9321977142992116,1.0,12/50,15.77%,HES1;VEGFA;BMPR1A;TGFBR1;NOG;NIPBL;ZFPM1;MDM4;ACVR1;SOX9;FLRT2;MEGF8
prerank,homocysteine metabolic process (GO:0050667),-0.3263569884920016,-0.7979647239565977,0.7122507122507122,0.940843077728039,1.0,4/11,22.62%,NOX4;CBS;CTH;MPST
prerank,lipoprotein catabolic process (GO:0042159),0.38769392812200554,0.7976973599356599,0.7092084006462036,0.932281961769852,1.0,3/11,10.37%,LYPLA2;ABHD17B;LYPLAL1
prerank,positive regulation of JUN kinase activity (GO:0043507),0.34100830095396495,0.7968039073985943,0.704225352112676,0.9332920331884924,1.0,7/23,17.44%,MAP3K5;DUSP19;MAP3K7;TRAF2;TRAF6;MAP3K10;MAP3K4
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.366240357198471,0.7964676979796282,0.7272727272727273,0.9334040478461803,1.0,6/16,27.43%,HELB;CGAS;RMI2;POLQ;KLHL15;SMCHD1
prerank,cortical actin cytoskeleton organization (GO:0030866),0.35028631216445544,0.79557353587544,0.7368421052631579,0.9344257520057622,1.0,5/20,18.04%,FMNL2;RHOQ;DLG1;IKBKB;NCKAP1L
prerank,regulation of calcium-mediated signaling (GO:0050848),0.33393059976308703,0.7955367167684506,0.706777316735823,0.9340514673146765,1.0,8/25,17.77%,CMKLR1;CCL3;PLCG2;TRAT1;TMBIM4;P2RX5;P2RX4;LRRK2
prerank,acylglycerol homeostasis (GO:0055090),0.35000673815906436,0.7953687439000631,0.7244444444444444,0.9338980244936274,1.0,4/20,11.46%,ACSM2A;RORA;MLXIPL;ANGPTL3
prerank,neurotrophin signaling pathway (GO:0038179),-0.272869099842505,-0.7950580228938191,0.7416107382550335,0.9445617023510873,1.0,11/21,25.71%,SORT1;RAPGEF2;FRS2;NTRK2;MAGI2;NTF3;BDNF;CASP3;BCAR1;RAPGEF1;DDIT4
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.27009370756951695,0.794995879476029,0.8425531914893617,0.9340737618574347,1.0,10/152,6.83%,RAMP1;ADGRL2;GRK5;ADRA1B;GNAS;ADRB2;PTHLH;ADCY9;GPR65;PTGER1
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.3744481682040528,0.7948750678610804,0.6786271450858035,0.9338522435356045,1.0,4/12,21.19%,CD44;FLOT1;LCK;GCNT2
prerank,positive regulation of interferon-gamma production (GO:0032729),-0.22796970545224826,-0.7948518993347188,0.8736842105263158,0.9437259758946382,1.0,5/48,8.02%,IL1R1;PDE4B;SLC7A5;PDE4D;IL18
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.33970478466110154,0.7945252950473723,0.7340876944837341,0.9339771642743641,1.0,7/25,19.89%,TWIST1;NSD1;POU4F1;NIBAN2;TRAF6;RB1;ZBTB7A
prerank,cellular response to unfolded protein (GO:0034620),-0.270696782030825,-0.7944413168941279,0.784,0.943209684455384,1.0,10/26,24.01%,OPTN;HSPA8;DAB2IP;HSPA13;ABCB10;ERN1;HSPA1A;HSPD1;HSPA2;HSPA5
prerank,nuclear transport (GO:0051169),-0.29576214454083094,-0.7942558761885609,0.7337662337662337,0.942336922380146,1.0,6/16,19.15%,ANP32A;NPM1;PSIP1;NXT2;BANF1;RSRC1
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.3579208354800537,0.7941710833026877,0.7277936962750716,0.934123043872129,1.0,3/18,9.02%,MET;MYOC;CUL3
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.2797339787030329,0.7939879556105853,0.8058035714285714,0.9340039662691367,1.0,15/95,16.17%,ADAM9;LBP;CXCL2;ZC3H12A;TLR4;CD80;PDCD4;RHOA;TRIM41;MYD88;NR1D1;TIRAP;CARD16;TRAF6;PDCD1LG2
prerank,B cell activation (GO:0042113),0.28798050883778037,0.7939352456699633,0.7749120750293084,0.9336713457815534,1.0,6/68,7.66%,HDAC4;HDAC9;CLCF1;PLCG2;PTPN2;ITGB1
prerank,heart contraction (GO:0060047),0.30866230929554195,0.7935906556963599,0.7442159383033419,0.9338032880061404,1.0,3/41,1.98%,SGCD;CSRP3;ATP1B1
prerank,regulation of oxidative phosphorylation (GO:0002082),0.3679475930445449,0.7935108537281818,0.7207207207207207,0.9335229627157708,1.0,4/16,13.61%,ABCD1;MLXIPL;VCP;AK4
prerank,mammary gland development (GO:0030879),0.33845283803066206,0.7930191531568624,0.7222222222222222,0.9338762691911632,1.0,3/21,6.46%,VEGFA;TGFB3;GLI2
prerank,cellular response to alkaloid (GO:0071312),0.3661671016557083,0.7919755472496223,0.7332361516034985,0.9350617724112222,1.0,3/17,7.30%,CASP6;RAD51;SPIDR
prerank,ethanol metabolic process (GO:0006067),0.37551432075351954,0.7918872979149297,0.7072784810126582,0.934777686551857,1.0,3/12,13.95%,ADH7;SULT1A1;ADH5
prerank,regulation of protein ubiquitination (GO:0031396),0.2758218696253886,0.7916562364025084,0.8136714443219405,0.9347310551476934,1.0,19/108,18.27%,NXN;PRICKLE1;U2AF2;TGFBR1;HDAC8;FAM107A;CUL3;RIPK2;CHP1;BRCA1;SPOPL;COMMD1;USP4;TRAF6;SMAD7;DCUN1D1;LRRK2;BAG5;MYCBP2
prerank,myofibril assembly (GO:0030239),-0.24392052459182734,-0.7910821689337587,0.8432203389830508,0.9464911422083787,1.0,3/42,2.26%,PGM5;PDGFRB;ACTN2
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.3622975921363737,0.7908595879047187,0.709726443768997,0.935529709897288,1.0,2/15,5.02%,DDR2;LRP1
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.32358572181987466,0.7907187824948002,0.7385892116182573,0.935334610639761,1.0,12/28,29.80%,PARP3;KMT5B;PRKDC;ACTR2;KMT5C;KDM4D;MRNIP;PARP9;SMCHD1;SETMAR;NUDT16L1;DTX3L
prerank,P-body assembly (GO:0033962),0.3882603876339246,0.7906625338410727,0.7134502923976608,0.9350076342099806,1.0,8/12,36.84%,ATXN2;LSM4;DDX6;PATL1;LIMD1;LSM14A;LSM3;DYNC1H1
prerank,regulation of establishment of protein localization to telomere (GO:0070203),-0.3337185916323968,-0.7903890469391408,0.7235772357723578,0.9464450336736326,1.0,5/11,24.98%,WRAP53;TERF1;CCT8;CCT3;TCP1
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.31419685555597,0.7902641906657918,0.744,0.9351866178219146,1.0,2/36,1.65%,HES1;CYP1B1
prerank,aspartate family amino acid catabolic process (GO:0009068),-0.27697531728007535,-0.7900135967367985,0.7869415807560137,0.9458539216020135,1.0,3/19,8.59%,DDO;ASPA;GOT2
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.3398255010118312,-0.789859437629242,0.7209302325581395,0.9449341850031496,1.0,1/10,1.30%,ENPP2
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.3527065693404285,0.7894577112232047,0.7369186046511628,0.9360286744606946,1.0,2/18,5.70%,CMKLR1;C5AR2
prerank,innate immune response (GO:0045087),0.26287518192219295,0.7890194321544941,0.8830769230769231,0.9362908061910965,1.0,42/217,20.90%,LBP;PTK2B;SRMS;COLEC11;VNN1;ALPK1;S100B;PLCG2;FRK;ANKHD1;CLEC5A;SETD2;REL;CLPB;IRAK4;IKBKG;TRIM39;TLR4;MAVS;IFIH1;RIPK2;ANKRD17;TLR8;POLR3A;MYD88;RNASE3;IFNLR1;CAPZA1;ADAM15;LCK;IKBKB;TTC4;TRIM35;PPARG;COLEC12;CHUK;YES1;MID2;RELB;SLPI;FER;PML
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.35142579993970996,0.7889867579627499,0.7155172413793104,0.9359239059927483,1.0,2/18,9.50%,WNK1;MIA3
prerank,snRNA metabolic process (GO:0016073),0.3575042488084378,0.7888235420135964,0.739067055393586,0.9357567479657265,1.0,7/17,27.51%,INTS5;INTS6;INTS7;INTS1;INTS8;INTS2;INTS9
prerank,sphingoid metabolic process (GO:0046519),0.3791847803958981,0.7886293388347596,0.7320574162679426,0.9356635964231852,1.0,2/12,12.27%,PLPP3;KDSR
prerank,glutamate metabolic process (GO:0006536),0.3536465968723041,0.7883399583294011,0.7482014388489209,0.9356932742295144,1.0,1/19,1.99%,GCLC
prerank,cellular response to decreased oxygen levels (GO:0036294),0.292999899647263,0.7882337886833936,0.784037558685446,0.9354468668805157,1.0,12/65,14.05%,PTGIS;VEGFA;EGLN3;NDRG1;TWIST1;LMNA;NPEPPS;RORA;MDM4;CARD16;AK4;TIGAR
prerank,negative regulation of cation channel activity (GO:2001258),-0.25805533568251976,-0.7880698419377555,0.8338983050847457,0.946704759242623,1.0,6/26,18.36%,KCNAB1;SLC6A9;CALM1;UBQLN1;CASQ2;GNB5
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.34107271366629516,0.7880170299677167,0.7402945113788487,0.9353619735930021,1.0,7/25,17.40%,CD55;PLCG2;MAP3K7;TRAF2;CD160;TRAF6;SCIMP
prerank,Golgi ribbon formation (GO:0090161),0.3709204364233688,0.78797710442789,0.7364341085271318,0.9350075578568086,1.0,5/13,23.42%,TMED5;PRMT5;GOLPH3;VTI1A;GCC2
prerank,regulation of multicellular organismal development (GO:2000026),0.33397471490285724,0.7879271111284659,0.7375690607734806,0.9346689929540168,1.0,6/25,15.70%,NIPBL;MYSM1;EHMT1;DHX36;TRIP12;PTN
prerank,ruffle organization (GO:0031529),0.3629155318357121,0.7877386782775794,0.7400881057268722,0.9345437292123545,1.0,4/16,14.65%,LIMA1;ARFIP2;PIP5K1A;CYFIP1
prerank,monocarboxylic acid catabolic process (GO:0072329),0.3414786390251458,0.7875932811188937,0.7357357357357357,0.9343555902854047,1.0,6/21,16.98%,PLA2G15;ACBD5;LPIN2;ACOT8;ACOX1;CEL
prerank,icosanoid secretion (GO:0032309),0.38376926611470674,0.7874289907881921,0.7217928902627512,0.9341911153860714,1.0,3/12,12.30%,ANXA1;DRD3;NMUR2
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.344805105041189,0.7869141151630762,0.7264957264957265,0.9345678955382344,1.0,4/21,10.10%,FGF13;KATNB1;CIB1;HDGFL3
prerank,glycine metabolic process (GO:0006544),0.37851048587023806,0.7866864809410054,0.7027463651050081,0.934492509887275,1.0,4/12,26.50%,SDSL;GLYAT;DLD;SHMT1
prerank,lipoprotein localization (GO:0044872),-0.3199889419030161,-0.7864109638485663,0.732620320855615,0.9481293269055378,1.0,3/11,11.59%,PRKCB;ZDHHC17;VMP1
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),-0.27054356639643123,-0.7862364917028425,0.8135048231511254,0.9472224670980104,1.0,8/22,20.21%,PDE4B;CACNB4;CACNB2;CACNB1;NOS1AP;GNB5;STAC;STAC2
prerank,cellular response to hypoxia (GO:0071456),0.27418969074048266,0.7859730863951816,0.8421621621621621,0.9351508769669782,1.0,27/126,18.97%,PTGIS;VEGFA;EGLN3;PSMB2;NDRG1;TWIST1;LMNA;NPEPPS;CREBBP;RORA;PSMD11;HIF3A;PSMC1;ARNT;PSMC6;MDM4;CARD16;AK4;TIGAR;PSMD1;PSMD4;PLK3;PSMA6;PSMD14;PSMD12;FAM162A;PSMD7
prerank,establishment of mitotic spindle localization (GO:0040001),0.32484385187008685,0.7859638824493123,0.7473118279569892,0.9347544269530718,1.0,8/28,18.39%,NDEL1;MISP;PAFAH1B1;ITGB1;MAD2L1;ZW10;SPDL1;UBXN2B
prerank,fatty acid biosynthetic process (GO:0006633),0.295517210937841,0.78593965502393,0.7915194346289752,0.9343782329037863,1.0,11/63,18.96%,ABCD3;ACSM2A;ACSM2B;ABCD1;ACACA;TECR;ELOVL5;ALOX5;GSTM4;SCD;NDUFAB1
prerank,regulation of protein neddylation (GO:2000434),0.39367193721751387,0.7859033024957564,0.7203791469194313,0.9340253635076783,1.0,3/10,17.27%,DCUN1D5;DCUN1D2;DCUN1D1
prerank,regulation of neuron migration (GO:2001222),0.33335217032708975,0.7846115225439848,0.7377279102384292,0.9355336344089925,1.0,5/26,8.58%,COL3A1;SRGAP2;PHACTR1;NIPBL;SHTN1
prerank,positive regulation of viral genome replication (GO:0045070),-0.25138807673748864,-0.7839132798650903,0.8392156862745098,0.9498769993378476,1.0,10/29,21.99%,PPARA;IFIT1;HACD3;DDX3X;ADAR;NR5A2;PDE12;TARBP2;PPIA;TOP2B
prerank,regulation of biosynthetic process (GO:0009889),-0.3212691348861905,-0.7836424063535131,0.745945945945946,0.9491220059089881,1.0,4/11,26.30%,SLC25A33;MID1IP1;SNCA;SPHK2
prerank,regulation of telomerase activity (GO:0051972),0.30209881639028713,0.782812991173941,0.7735368956743003,0.9378433478134607,1.0,14/45,25.90%,GRHL2;KLF4;SMG6;NEK7;NAF1;MAP3K4;PARP4;XRCC5;ERCC4;ATM;MAPKAPK5;TP53;SRC;PARN
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.3265874772825661,0.7823697844330004,0.7672530446549392,0.9381138662173855,1.0,2/28,2.01%,MAP3K5;TMEM117
prerank,renal filtration (GO:0097205),0.39514669390618395,0.7821304648087846,0.7266982622432859,0.9380424874470261,1.0,4/10,18.12%,XPNPEP3;SULF1;TBC1D8B;MYO1E
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.3386999728802872,0.7817521733817463,0.7454031117397454,0.9382023745645328,1.0,6/22,16.22%,LBP;RAB7B;IFI35;NR1D1;TIRAP;FLOT1
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.3689053724511659,0.7815770823513233,0.7469325153374233,0.9380617771458852,1.0,4/14,13.65%,SMPDL3A;AK4;AK3;AK1
prerank,negative regulation of JUN kinase activity (GO:0043508),0.38945960528118606,0.7815449328883917,0.7388535031847133,0.9377035272082217,1.0,2/10,10.44%,PDCD4;DUSP19
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.3718037555155892,0.7810723902993182,0.7186544342507645,0.9379708709681752,1.0,3/13,18.60%,GLRX3;ISCA1;NFU1
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.31003726156503353,0.7803814632520778,0.7736351531291611,0.9385965117523112,1.0,4/37,7.82%,FHIT;GIPC1;WAC;TRIM39
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.3825728779453571,0.7798178464348827,0.7215189873417721,0.9390300909663049,1.0,2/10,5.02%,PTPN2;LRP1
prerank,regulation of microtubule-based movement (GO:0060632),-0.3272830398262119,-0.7797519870545297,0.7648725212464589,0.9542823097683044,1.0,4/11,25.45%,MAP2;CFAP298;NEFH;CCDC65
prerank,negative regulation of reproductive process (GO:2000242),0.3511955014930025,0.7795228516614446,0.745985401459854,0.939081749912776,1.0,3/17,7.75%,ARHGDIB;TIMP1;SULF1
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.37006984232025375,0.7792066364404048,0.7198142414860681,0.9391140090725868,1.0,2/12,8.33%,PLCG2;TLR4
prerank,ribosomal small subunit assembly (GO:0000028),0.35193724955049527,0.7790193401551314,0.7257575757575757,0.9389861942373653,1.0,1/16,1.40%,RPSA
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.3572369447543123,0.779001502182538,0.7341954022988506,0.9386088581613441,1.0,3/17,8.63%,TWIST1;CD44;KDM1A
prerank,protein localization to phagophore assembly site (GO:0034497),0.3768526696858388,0.7773930108520116,0.733433734939759,0.9406682238527333,1.0,3/11,21.17%,WDR45B;WIPI2;STX17
prerank,negative regulation of viral transcription (GO:0032897),-0.30582663776815566,-0.7770816663407993,0.7458100558659218,0.957241701887226,1.0,3/13,12.03%,TRIM14;IFITM3;TRIM62
prerank,negative regulation of interleukin-17 production (GO:0032700),0.3963710027215048,0.7768602156143156,0.747588424437299,0.9410136992743111,1.0,3/10,23.84%,TLR4;NCKAP1L;DDIT3
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.3707918126588757,0.7767017355679426,0.7288401253918495,0.940856310497712,1.0,6/12,29.53%,STX11;SNAP23;STX2;PRRT2;STX3;STX1A
prerank,neuromuscular process (GO:0050905),0.35461126356162787,0.7765672894625052,0.7387387387387387,0.9406538698539483,1.0,6/16,22.61%,SHANK1;PAFAH1B1;UBA5;STRA6;MYCBP2;PRRT2
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.3823917407106667,0.7762910310028975,0.7286821705426356,0.9406524556427619,1.0,2/11,10.53%,BARD1;DHX36
prerank,positive regulation of interleukin-10 production (GO:0032733),0.3190163616055996,0.7761983563730798,0.7479784366576819,0.9403897882096047,1.0,4/30,11.66%,PLCG2;STAT3;TLR4;CD46
prerank,regulation of DNA damage checkpoint (GO:2000001),0.39053371546547133,0.7760655470108343,0.7421383647798742,0.9401759846585083,1.0,6/10,33.74%,FEM1B;WDR76;THOC1;THOC5;DDX39B;RFWD3
prerank,cellular respiration (GO:0045333),0.3022017142674071,0.7754117719187108,0.7826633165829145,0.940744572704461,1.0,9/41,20.20%,COQ10B;NR4A3;ETFDH;COX15;ETFA;SIRT3;MTFR1;UQCRFS1;COQ10A
prerank,presynapse organization (GO:0099172),0.3866195131002461,0.7754025214245348,0.7369255150554676,0.940348686564285,1.0,3/10,15.28%,FZD1;NLGN1;DVL1
prerank,carbohydrate derivative transport (GO:1901264),0.3491619066586852,0.7753232695063248,0.7426900584795322,0.9400581647764249,1.0,2/18,7.41%,LBP;SLC10A7
prerank,mesenchyme morphogenesis (GO:0072132),0.3474641382128093,0.7751204540650344,0.7397058823529412,0.9399367295961955,1.0,6/17,14.64%,BMPR1A;NOG;SMAD2;MDM4;ACVR1;SOX9
prerank,intestinal absorption (GO:0050892),-0.3096848295312563,-0.7748000312874362,0.7575757575757576,0.9595181312783987,1.0,4/13,11.56%,UGCG;F11R;KCNQ1;ADRA2A
prerank,negative regulation of hydrolase activity (GO:0051346),0.29074464489656,0.7746107853223809,0.8110831234256927,0.9402805853296988,1.0,13/49,20.57%,WNK1;SLC39A14;BCAS3;RDX;CHP1;RRP1B;URI1;ARFGEF1;CST7;LRRK2;ATP5IF1;GPSM1;TMED2
prerank,peptidyl-lysine acetylation (GO:0018394),0.3801698572722062,0.7743371990931994,0.7320574162679426,0.940298566687951,1.0,2/10,11.84%,CREBBP;ESCO1
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.2904425925454229,0.7738341019532248,0.8021454112038141,0.940609205209173,1.0,18/52,23.18%,SHC1;LMNA;SRPRB;SEC31A;ARFGAP1;DNAJC3;DDX11;GOSR2;ADD1;ERN2;TSPYL2;GFPT1;ATP6V0D1;MYDGF;ACADVL;KDELR3;ZBTB17;KLHDC3
prerank,regulation of transforming growth factor beta production (GO:0071634),0.34481173260916875,0.7736475772638588,0.7363770250368189,0.9404536841354088,1.0,5/18,16.42%,ITGB8;FN1;ITGAV;CD46;SMAD4
prerank,homologous chromosome segregation (GO:0045143),-0.2718148359596252,-0.7732444212891865,0.7980132450331126,0.9607609284839678,1.0,9/20,41.85%,FMN2;FANCD2;SGO1;MEIOB;IHO1;SIRT7;RNF212B;MEIKIN;TERB2
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.2954187315665101,0.773157732353405,0.7650676506765067,0.9407364899994486,1.0,11/48,19.89%,NUP93;NUP214;NOA1;NUP153;EIF6;NUP155;RANBP2;TIGAR;NUP88;NUP35;ZBTB7A
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.3394838273015989,0.7731486390372277,0.7507246376811594,0.9403411070691831,1.0,3/20,5.77%,SEMA3E;SEMA3C;SEMA3D
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.37346208161304545,0.7731259942931132,0.7374045801526717,0.9399635093415709,1.0,5/11,25.90%,EXOSC3;TENT4B;EXOSC2;LARP7;PARN
prerank,response to peptide (GO:1901652),0.312342291534295,0.772929267053692,0.7609289617486339,0.9398447150900258,1.0,4/33,10.04%,IRS1;STAT3;ANXA1;ERBIN
prerank,negative regulation of TOR signaling (GO:0032007),-0.23639946315779814,-0.7723661573397007,0.8486238532110092,0.9609471784203479,1.0,10/36,19.79%,RNF152;PRKAA2;SPAAR;TNFAIP8L1;TSC2;CASTOR1;DEPTOR;GSK3A;SH3BP4;FNIP1
prerank,lysosome localization (GO:0032418),0.3060778801454302,0.7720821853816455,0.7940797940797941,0.9406688587600701,1.0,6/37,16.07%,SYTL4;NR4A3;NDEL1;PLEKHM2;MAP6;KIF5B
prerank,presynapse assembly (GO:0099054),0.3549449895897685,0.7719476512462771,0.744927536231884,0.9404571001668103,1.0,6/16,16.98%,FZD1;BSN;PCLO;NLGN1;DVL1;CEL
prerank,cellular response to insulin stimulus (GO:0032869),0.2641984516806232,0.7711803513507516,0.8552774755168662,0.9411810148292044,1.0,29/124,19.02%,HDAC9;IRS1;SLC39A14;GSK3B;FOXC2;GRB10;PTPN2;SHC1;TCIRG1;ATP6V0A4;RHOQ;EPRS1;SYAP1;PIK3R3;C2CD5;PARP1;IDE;LPIN2;BCAR3;ATP6V1A;INHBB;PRKDC;VAMP2;IRS4;RPS6KB1;AP3S1;ZNF106;ATP6V0D1;PPARG
prerank,cellular response to gamma radiation (GO:0071480),0.35352017902449434,0.7708418346209648,0.7444933920704846,0.9413042649879519,1.0,8/17,23.55%,WRN;KDM1A;YAP1;ATR;TLK2;XRCC5;ATM;TP53
prerank,positive regulation of protein ubiquitination (GO:0031398),0.2756487717824911,0.7706712164539625,0.8041237113402062,0.9411507880423052,1.0,16/80,18.27%,PRICKLE1;DCUN1D5;FAM107A;KDM1A;CUL3;MTA1;RIPK2;BRCA1;COMMD1;DCUN1D2;TRAF6;PIN1;SMAD7;DCUN1D1;LRRK2;MYCBP2
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.32083207169486305,0.7705710968982082,0.7600554785020804,0.9409000595674354,1.0,1/24,0.50%,PLCE1
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),-0.2994427078438212,-0.7705707837899802,0.7866242038216561,0.9625070899762781,1.0,8/15,28.92%,SORT1;FRS2;NTRK2;BDNF;CASP3;BCAR1;DDIT4;NGFR
prerank,regulation of cellular amide metabolic process (GO:0034248),0.3142441120315054,0.7703788024033479,0.7883116883116883,0.940763402933841,1.0,11/32,25.36%,PRKCD;FOXO3;ATXN2;RBM3;TIGAR;CYFIP1;GEMIN5;PUM3;RPL10;MAPKAPK5;TSC1
prerank,response to axon injury (GO:0048678),0.3406033288483272,0.7702491497206997,0.7478510028653295,0.9405421610484425,1.0,1/18,0.80%,DPYSL3
prerank,axonemal dynein complex assembly (GO:0070286),0.3186808232271886,0.770109820253268,0.7438356164383562,0.9403250176619059,1.0,8/28,21.78%,DNAAF4;ODAD2;DNAAF3;ODAD3;DNAL1;DNAH17;DNAAF2;DRC1
prerank,regulation of JUN kinase activity (GO:0043506),0.3081959847202659,0.7699962821552808,0.7801047120418848,0.9400954754469856,1.0,8/33,17.44%,MAP3K5;PDCD4;DUSP19;MAP3K7;TRAF2;TRAF6;MAP3K10;MAP3K4
prerank,gene silencing by miRNA (GO:0035195),0.31537871836280373,0.7698463337758277,0.7623497997329773,0.9399073433327602,1.0,15/32,29.53%,ZC3H7A;CNOT8;AGO2;EIF6;MOV10;PUM2;PUM1;CNOT1;TRIM71;RBM4;DICER1;PRKRA;LIMD1;AGO1;TNRC6C
prerank,regulation of protein dephosphorylation (GO:0035304),-0.23343414950496055,-0.7696185678228638,0.8599033816425121,0.962717413913353,1.0,10/37,15.30%,MFHAS1;PPP1R16B;YWHAB;CALM1;ANKLE2;CDH5;TIPRL;SMPD1;PPP1R2;PPP2R5A
prerank,mitochondrial transport (GO:0006839),-0.21520006816109644,-0.7693509264674938,0.9130434782608695,0.9619709819002586,1.0,16/53,27.19%,BCL2;BCL2L1;SLC25A13;TIMM17A;ABCB10;TOMM5;TOMM7;FIS1;TOMM22;TOMM40;TIMM10B;MFF;FBXO7;STARD3;PMAIP1;COX18
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.3724085443094847,0.769288367470414,0.7496062992125985,0.9403030350777131,1.0,4/12,23.81%,ATF7IP;TASOR;PPHLN1;RESF1
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.32563009589299113,0.7691203121139657,0.755464480874317,0.9401518180074454,1.0,6/26,11.59%,ANAPC5;CUL3;CDC16;ANAPC11;CCNB1;FBXO5
prerank,copper ion homeostasis (GO:0055070),-0.2835303630863074,-0.7688069676913026,0.7808641975308642,0.9616222143901098,1.0,6/17,19.92%,APP;ATOX1;SLC31A1;COX19;MT2A;PRNP
prerank,Golgi to plasma membrane transport (GO:0006893),0.293062961067151,0.768718609709182,0.7972636815920398,0.9403239383575427,1.0,19/47,23.42%,EXOC4;KIF13A;STXBP6;ARL3;NSF;COMMD1;GOLPH3;GOPC;VAMP2;GOLGA7;GOLGA4;SPTBN1;EXOC2;EXOC5;GOLPH3L;ARFGEF2;BBS2;RAB26;GCC2
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",-0.21984478093006526,-0.7683902348180732,0.9197860962566845,0.9610736178483877,1.0,15/53,26.78%,HTR2C;CALCRL;CHRM2;CHRM3;OPRM1;HTR2A;TSHR;LHCGR;HTR1F;CCL2;LPAR3;CHRM1;NPY;HRH1;AGT
prerank,regulation of mast cell degranulation (GO:0043304),-0.29983360008712406,-0.7667075797738757,0.8057142857142857,0.9624426460619804,1.0,4/14,14.28%,LYN;CD300A;FES;CD84
prerank,sterol transport (GO:0015918),0.3350574962100219,0.7664456821419572,0.7546628407460545,0.9431631726886485,1.0,3/19,16.45%,LDLR;NPC1;LCAT
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.38167533575276863,0.7661952013660239,0.7483870967741936,0.9431130809792112,1.0,4/11,23.84%,ATF6;CREB3L1;TP53;DDIT3
prerank,regulation of fibroblast proliferation (GO:0048145),0.2956586317361164,0.7660917199746288,0.7911392405063291,0.9428440885628676,1.0,6/45,7.37%,DDR2;EMD;PDGFC;NF1;SKI;FN1
prerank,regulation of vasculogenesis (GO:2001212),0.3562758265056073,0.765218711947789,0.7481031866464339,0.9436821185672302,1.0,3/14,11.11%,TMEM100;XDH;RAP1A
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.3242117365649701,0.7647588655300034,0.7651006711409396,0.9439440062050654,1.0,11/29,26.79%,ESR1;DNAAF4;UBA5;BRCA1;STRN3;YAP1;KMT2D;CNOT1;CBFB;AXIN1;KANK2
prerank,zinc ion transport (GO:0006829),0.3334421922449975,0.7644887347906694,0.7642045454545454,0.9439303971032835,1.0,4/21,8.44%,SLC39A14;SLC39A13;SLC39A11;SLC30A3
prerank,histone monoubiquitination (GO:0010390),0.32256015036643604,0.7633259911968385,0.7754820936639119,0.9451508884598541,1.0,9/24,30.68%,WAC;BCOR;RNF20;PCGF1;CTR9;DDB1;RNF168;DTX3L;DDB2
prerank,positive regulation of inflammatory response (GO:0050729),0.2671155523653807,0.7628038798048439,0.8076490438695163,0.9454964357785722,1.0,9/86,9.27%,LBP;CCL3;CCL1;IL33;IL17RA;NLRP12;TLR4;GPR4;PDCD4
prerank,male meiosis I (GO:0007141),0.3437775344203102,0.762550895215754,0.7561683599419449,0.9454558522299219,1.0,3/16,21.55%,SYCP3;HSF2BP;FOXJ3
prerank,glycogen biosynthetic process (GO:0005978),0.3646068032677481,0.7623434851884485,0.7476340694006309,0.9449435767063394,1.0,4/12,15.40%,PPP1R3C;NR1D1;PGM2;NHLRC1
prerank,glucan biosynthetic process (GO:0009250),0.3646068032677481,0.7623434851884485,0.7476340694006309,0.9449435767063394,1.0,4/12,15.40%,PPP1R3C;NR1D1;PGM2;NHLRC1
prerank,regulation of keratinocyte proliferation (GO:0010837),0.33030171624821314,0.7621046929304786,0.7615062761506276,0.944911040452166,1.0,3/22,7.31%,NOTCH2;KLF9;SRSF6
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.28238670105092134,0.760776507703305,0.8188405797101449,0.9463895008229616,1.0,14/54,22.68%,HIPK1;PTPN2;TAX1BP1;SPPL2A;IKBKG;TRAF2;UBE2K;CPNE1;CARD16;IKBKB;RBCK1;CHUK;TRADD;SPPL2B
prerank,protein lipidation (GO:0006497),0.2836561699954706,0.7601205224260498,0.791970802919708,0.9469390561243535,1.0,22/59,27.93%,ZDHHC2;HHAT;ZDHHC20;WDR45B;PGAP2;ZDHHC12;PIGU;ATG5;ZDHHC15;ZDHHC13;PIGO;WIPI2;ZDHHC3;DPM1;MPPE1;PIGG;PGAP3;PIGB;ZDHHC21;PIGQ;ZDHHC6;PIGV
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.3563786635274026,0.7598968396625899,0.7236641221374046,0.9468536209588796,1.0,5/13,21.33%,IRS1;SORL1;ZBTB7B;SORBS1;IGF2
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.3395463854891201,0.7593453475035756,0.7617647058823529,0.9472295311043929,1.0,7/18,24.14%,GSK3B;RAP1A;NLGN1;SLC4A8;LRRK2;FMR1;RAB3GAP1
prerank,mesoderm formation (GO:0001707),0.3426962921066238,0.7586396852024924,0.7481698389458272,0.9478072706252754,1.0,6/17,26.98%,ITGB1;SMAD2;ITGB3;SNAI1;CRB2;ITGA2
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.2994715421800012,0.7576788425950476,0.7950391644908616,0.9487959539059874,1.0,8/40,18.67%,PID1;ABL1;ABCD1;VCP;ARL6IP5;RNF122;LRRK2;ATP5IF1
prerank,proton transmembrane transport (GO:1902600),0.29920224928528794,0.7576509689151395,0.7866492146596858,0.9484232352426685,1.0,13/36,22.01%,ATP6V0A4;ATP12A;ATP1A3;ATP1A4;ATP1A1;SLC9A1;COX15;ATP6V1A;UCP3;SLC46A1;ATP6V0D1;ATP5PO;SLC25A27
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.3472675090563614,0.7575974605759722,0.766566265060241,0.94809722675785,1.0,2/15,9.02%,PLCG2;CUL3
prerank,activation of GTPase activity (GO:0090630),0.26936711566598737,0.7574714288675354,0.8531390134529148,0.9478766929117317,1.0,23/89,18.48%,NTRK3;SIPA1L1;SGSM2;BCAS3;RAP1GAP2;DOCK7;BCR;GPR65;TIAM1;TIAM2;CORO1C;PIP5K1A;TBC1D2B;EVI5;SIPA1L2;RABGAP1;SCRIB;TBC1D8B;SYDE1;MTSS2;TBC1D5;CCDC125;TBC1D17
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.30602581062564344,0.7566356388729033,0.7820855614973262,0.948684259101117,1.0,8/32,21.08%,CHKB;SLC44A3;LPIN2;LPCAT1;PCTP;LCAT;CEPT1;CHAT
prerank,negative regulation of gluconeogenesis (GO:0045721),0.37166502150230274,0.7565778667701101,0.7449139280125195,0.9483645622247645,1.0,2/11,16.70%,CLK2;SIK1
prerank,myoblast fusion (GO:0007520),0.36565157143075544,0.7562466904766215,0.753030303030303,0.9484190732767765,1.0,3/12,14.00%,CD9;ADAM12;ADAMTS5
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.2964691848664336,0.7561393977870076,0.8134715025906736,0.9481790603892527,1.0,8/37,12.31%,STAT3;PER1;IL17RA;ABCD1;ZC3H12A;TLR4;PDCD4;MYD88
prerank,regulation of urine volume (GO:0035809),0.38421439136860475,0.7559328304345756,0.7496087636932708,0.9480776444410212,1.0,1/10,3.33%,NPR3
prerank,rRNA catabolic process (GO:0016075),0.3461377380134758,0.7556609376259158,0.7737226277372263,0.9480499785907401,1.0,6/16,24.31%,EXOSC3;ERN2;DIS3;EXOSC2;EXOSC7;EXOSC8
prerank,regulation of autophagy of mitochondrion (GO:1903146),-0.2703604105029544,-0.7555940469536686,0.832807570977918,0.9776362626395448,1.0,7/19,24.60%,PINK1;ATP13A2;GSK3A;FBXW7;FZD5;FBXO7;CAMKK2
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.3478753359927058,0.7553399438983657,0.7709251101321586,0.9481075273600832,1.0,7/15,25.40%,ATL2;RTN3;TMEM33;ATL1;ZFYVE27;REEP3;REEP4
prerank,cardiac atrium morphogenesis (GO:0003209),0.34440995855718376,0.7548637449942013,0.7645305514157973,0.9484136452567532,1.0,4/16,11.24%,NOTCH2;NOG;GATA4;ZFPM1
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.3318414327909714,0.7547467791928751,0.7737226277372263,0.948183982314438,1.0,5/19,15.53%,CUX1;FBXW8;DHX36;DBN1;CAPRIN2
prerank,retrograde axonal transport (GO:0008090),0.3470232836726001,0.7544465983260864,0.7676923076923077,0.9481918050011805,1.0,4/16,16.07%,DLG2;PAFAH1B1;KIF1C;KIF5B
prerank,regulation of actin filament-based movement (GO:1903115),0.3696916860210236,0.7543373574596686,0.7767441860465116,0.9479474732589747,1.0,1/10,1.84%,ANK2
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.2750683973853201,0.754200492375003,0.838452787258248,0.9477336791758808,1.0,17/70,21.13%,ITGB5;PSMB2;IKBKG;PSMD11;PSMC1;ITGAV;PSMC6;PSMD1;PSMD4;IKBKB;SNAP23;PSMA6;PSMD14;PSMD12;PSMD7;CHUK;PSME3
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.36560206441776366,0.754124043586537,0.7527733755942948,0.9474393621713608,1.0,4/11,14.64%,TGFBR2;CHRD;LRP5;SOX9
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.38338926819216457,0.7540767863978244,0.7572347266881029,0.9471060267351991,1.0,2/10,8.33%,IL33;TLR4
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.3487151918585281,0.7539252492800025,0.7642642642642643,0.9469197395904113,1.0,3/15,12.31%,TLR4;EIF2AK2;MYD88
prerank,error-free translesion synthesis (GO:0070987),0.3207072352215079,0.7535395034120693,0.7704225352112676,0.9470850166454784,1.0,12/22,35.31%,VCP;RFC1;SPRTN;UBB;UBA52;RPS27A;POLD1;RFC2;RPA1;RCHY1;POLDIP2;REV1
prerank,regulation of Golgi organization (GO:1903358),-0.2820537513550546,-0.7530316729085006,0.804953560371517,0.9800150537547454,1.0,6/17,14.97%,USP6NL;MAPK1;MYO5A;CAMSAP2;MAP2K1;PDE4DIP
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.28981749355949044,0.7529967056143636,0.8107448107448108,0.9474381447866153,1.0,8/45,12.31%,CCL3;STAT3;NLRP12;TLR4;EGR1;RIPK2;TLR8;MYD88
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.33533401072874647,0.7523062539040257,0.7606461086637298,0.9480112693604859,1.0,4/18,22.82%,ERBB2;WDR43;UBTF;PHF8
prerank,regulation of extracellular matrix organization (GO:1903053),0.3519751064297306,0.7521629164772999,0.7522522522522522,0.9478019146587668,1.0,6/15,18.17%,DDR2;LRP1;FAP;RB1;ANGPTL7;DDR1
prerank,establishment of melanosome localization (GO:0032401),-0.2781519327556268,-0.7519397929676407,0.8037974683544303,0.9803608899522128,1.0,4/19,12.19%,SHROOM2;BBS5;MYO5A;MREG
prerank,microtubule-based transport (GO:0099111),0.352559836736144,0.7519181120556819,0.750402576489533,0.9477460044022913,1.0,3/13,20.82%,DNAAF4;SPAG17;DNAAF2
prerank,"phototransduction, visible light (GO:0007603)",0.34501603887698024,0.7518238271857783,0.7591463414634146,0.9474675720425276,1.0,1/14,2.13%,PDE6A
prerank,vesicle organization (GO:0016050),-0.21619130208755846,-0.7516325582641433,0.9040404040404041,0.9795848204953821,1.0,6/46,7.94%,SORT1;DNM1;FNBP1L;SRGN;RAB22A;CD34
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.2537797108861637,0.7509762251018464,0.899581589958159,0.9481817935975784,1.0,45/172,23.22%,PIK3C2B;FGF2;PLEKHA4;PLCG2;CHKB;RUFY1;DGKA;SLC44A3;ETNK1;PNPLA3;MTMR12;PIK3R3;LPIN2;PI4KB;LPCAT1;INPP4A;SBF1;HDHD5;PIP5K1A;AGK;GNPAT;OCRL;CPNE1;INPPL1;PIP4K2A;PLSCR1;TAMM41;PCTP;ETNPPL;LPCAT2;LCAT;SYNJ2;CPNE3;SYNJ1;CDS1;CEPT1;AGPAT2;MTMR1;CHAT;ETNK2;ARF3;SACM1L;MTMR9;RAB4A;PLA2G12A
prerank,endocytic recycling (GO:0032456),0.2851090891629877,0.7507218318747497,0.8226002430133658,0.9481049587843774,1.0,12/50,19.48%,RAB11FIP3;EHD2;RAB35;CMTM6;VPS39;EHD1;ANKRD27;RAB11B;SNF8;SNX12;PTPN23;VPS52
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.3175686619920751,0.7501653328180294,0.7875862068965517,0.9484557629058938,1.0,6/24,12.45%,SEC31A;SEC24B;SEC23A;SEC24D;IDE;BCAP31
prerank,N-terminal protein amino acid modification (GO:0031365),0.3476557026914749,0.749992988892783,0.7708978328173375,0.9482875357466324,1.0,7/14,31.47%,NAA15;NAA40;NAA60;METAP2;NAA50;METAP1D;NTMT1
prerank,cellular response to calcium ion (GO:0071277),0.27311435538172374,0.749920866028316,0.832552693208431,0.9479878042156096,1.0,13/67,17.21%,CLIC4;CAMK2D;PLCG2;MEF2A;DMTN;NLGN1;CPNE8;CPNE1;DPEP1;ADD1;ADCY8;CPNE3;IQGAP1
prerank,regulation of aerobic respiration (GO:1903715),0.34512022442534557,0.7497900580966687,0.7526395173453997,0.9477643084700774,1.0,4/15,13.61%,ABCD1;VCP;IDE;AK4
prerank,regulation of secretion by cell (GO:1903530),0.2827281392673521,0.7488854653721058,0.8276729559748428,0.9486195907327879,1.0,16/54,24.09%,SNCAIP;DISP1;ANXA1;DNAJC1;P3H1;NSF;RAB21;VAMP2;CPLANE2;HCRT;STXBP5;FMR1;CPLX2;RAB26;RIC1;RHBDF1
prerank,regulation of immunoglobulin production (GO:0002637),0.3122798298387638,0.748782526176138,0.7830832196452933,0.9483578455576327,1.0,3/23,11.40%,CLCF1;GPI;EPHB2
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.3144237571468374,0.7483797181758756,0.7959183673469388,0.9485062806231848,1.0,5/26,16.22%,LBP;TLR1;IFI35;TIRAP;FLOT1
prerank,membrane organization (GO:0061024),0.24863814410704285,0.7474879081221929,0.9211873080859775,0.9492944860850435,1.0,41/227,17.62%,EGFR;REPS2;ANK2;STON2;ADRB2;IGF2R;LDLR;STX11;AP2A2;EMD;SCARB2;NUP93;FCHO2;CORO1C;GAK;TLCD1;LEMD2;AAK1;NPC1;CHP1;SH3GLB1;CTTN;NUP155;OCRL;PDCD6IP;TMEM33;EPN1;AP3D1;TOR1B;TRIP10;EPS15L1;CHMP2B;MTCH1;AP2B1;GAPVD1;LPCAT2;VAMP2;SYNJ2;ACTR2;SNAP23;SYNJ1
prerank,positive regulation of ruffle assembly (GO:1900029),-0.3059589043442771,-0.7468478263196995,0.8184438040345822,0.9850751311738352,1.0,2/13,6.29%,EPS8;EPS8L2
prerank,regulation of cellular catabolic process (GO:0031329),0.27403111066253516,0.7467501289852677,0.8299643281807372,0.9498715023991432,1.0,15/62,20.03%,ABL1;SCARB2;CISD2;RRAGB;USP13;WDR41;ABCD1;LONP2;KEAP1;TYSND1;PIP4K2A;LRRK2;DAPK1;GPR137B;USP10
prerank,RNA methylation (GO:0001510),0.27769978177352633,0.7464347570821092,0.8362779740871613,0.9498954764000936,1.0,20/60,29.90%,TRMT10A;ALKBH8;MTO1;WTAP;METTL2A;METTL2B;TARBP1;VIRMA;TRMT61B;TGS1;TRDMT1;FTSJ1;MTERF4;FTSJ3;METTL16;THADA;TRMT44;CMTR1;THUMPD2;METTL5
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.34081431446379945,0.7460680389735438,0.7716763005780347,0.9499888411732048,1.0,4/18,8.90%,PTK2B;BCAS3;SHTN1;KRIT1
prerank,negative regulation of axonogenesis (GO:0050771),0.30977793853094254,0.7458195464866925,0.8063186813186813,0.9499086730820401,1.0,2/27,2.21%,ULK2;FGF13
prerank,long-chain fatty acid transport (GO:0015909),0.31114083068127396,0.7456369171509823,0.8074369189907038,0.9497575281805031,1.0,9/30,19.97%,ABCD3;ACSL3;ABCD1;ACACA;CPT1B;SLC25A20;RPS6KB1;PPARG;SPX
prerank,organelle fusion (GO:0048284),0.3195434912337306,0.7450393588724523,0.7988505747126436,0.9501796972350337,1.0,7/22,27.92%,EEA1;MIEF1;MIEF2;MIGA1;USP30;CHCHD3;BAX
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.2970214112148103,0.7447651618050664,0.8078381795195955,0.9501523658445798,1.0,5/35,11.40%,MET;ARHGAP44;MYOC;CUL3;EPHB2
prerank,protein N-linked glycosylation (GO:0006487),0.27145943224591,0.7444185521828692,0.8289473684210527,0.9502483834945478,1.0,18/66,23.59%,FUT8;MGAT4C;ALG13;B4GALT1;ENTPD5;ALG12;DPAGT1;MGAT1;MGAT5;GFPT1;DDOST;TMEM165;ALG14;TUSC3;DPM1;ALG8;MCFD2;PGM3
prerank,sensory perception of smell (GO:0007608),0.36652460742904025,0.7441801776148688,0.7683881064162754,0.9501737628918238,1.0,5/11,28.45%,UBR3;ADCY3;MKKS;BEST2;BBS4
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.27879746493373336,0.7440688840273089,0.8608490566037735,0.9499346265251888,1.0,9/56,13.34%,CIT;SON;TTC19;ALKBH4;RAB35;ARL3;RHOA;SNX18;PDCD6IP
prerank,cellular response to acid chemical (GO:0071229),0.30759127766508787,0.7436972117859072,0.771505376344086,0.9500403165525896,1.0,3/27,5.41%,VEGFA;CAPN2;RRAGB
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.2559830627642544,-0.743188261532355,0.8396946564885496,0.9889398676024117,1.0,6/24,15.71%,AKAP6;PDE4D;JPH1;CALM1;JPH2;CASQ2
prerank,cellular protein catabolic process (GO:0044257),0.2790131557696367,0.7425937329146494,0.8355029585798817,0.9511456318209054,1.0,12/59,18.59%,CAPN2;AP2A2;TCIRG1;CHEK2;IDE;RNF123;CLPP;YME1L1;AP2B1;FAP;PSMA6;AP2A1
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.295372376942571,-0.7423743252943187,0.815625,0.9888205905201489,1.0,4/15,17.78%,HECW2;CDC23;ANAPC7;TACC3
prerank,endothelial cell differentiation (GO:0045446),0.36424159036733345,0.7422114273783372,0.7850609756097561,0.9512810719928727,1.0,1/12,1.02%,FSTL1
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.25404326760398843,-0.7421633570384002,0.8268551236749117,0.9878909187832055,1.0,7/23,16.68%,PARP14;NR1H3;STAT1;HSP90AB1;NR1H2;IFNGR1;NLRC5
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.2627834606558502,0.7417273452700522,0.8627671541057368,0.9515461559623577,1.0,12/90,10.73%,GNAS;CMKLR1;ADRB2;VEGFA;GADD45G;GRB10;PDGFC;SIRT6;EHMT1;KDM1A;DECR1;TRPM8
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.36472464514287894,0.741165165254071,0.7601880877742947,0.9518842918949542,1.0,2/11,12.01%,ADRB2;DRD3
prerank,regulation of receptor internalization (GO:0002090),0.29305593038830086,0.7409667265005022,0.8106355382619974,0.951749853616398,1.0,11/35,24.96%,SFRP4;VEGFA;ATXN2;FLOT1;TBC1D5;EGF;ATAD1;FMR1;RIN3;SCYL2;MKLN1
prerank,ketone body metabolic process (GO:1902224),0.37291757157163435,0.7408099818133951,0.775,0.9515612494959147,1.0,3/10,17.06%,BDH2;AACS;HMGCS2
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.2865437127595616,-0.7404616242744257,0.8453947368421053,0.9889543182593963,1.0,5/15,19.42%,SAMHD1;USP18;NLRC5;CACTIN;STAT2
prerank,regulation of erythrocyte differentiation (GO:0045646),0.29476450869195037,0.7396231002003417,0.806282722513089,0.9527762967385279,1.0,6/35,11.24%,HOXA5;STAT3;FOXO3;INHBA;ARNT;ZFPM1
prerank,cellular macromolecule catabolic process (GO:0044265),0.2870434925795091,0.7390457627006859,0.8480392156862745,0.953155815704459,1.0,9/49,17.46%,SIDT2;CHEK2;IDE;FBXO27;RNASE3;RNASEH2A;OGA;FBXO17;PABPC4
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.30254607444780873,0.7388867701747481,0.8224932249322493,0.9529761060944762,1.0,11/32,25.90%,NEK7;CCT5;NAF1;MAP3K4;ATR;XRCC5;TNKS2;ATM;MAPKAPK5;CCT6A;PARN
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.30108680963926365,0.7385956881421957,0.8119325551232166,0.9529679305451099,1.0,9/32,19.20%,ID2;CDC45;CDK16;FBXO5;TFDP1;E2F1;HINFP;RB1;BRD4
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.33786071516722416,0.7381901967343739,0.7661169415292354,0.9531096603792574,1.0,2/17,4.33%,ANO6;CCL1
prerank,regulation of p38MAPK cascade (GO:1900744),0.2870196626312852,0.7379495011594958,0.8153446033810143,0.9530409978917397,1.0,7/35,13.18%,EZR;VEGFA;GADD45G;PER1;ZC3H12A;XDH;DLG1
prerank,ovarian follicle development (GO:0001541),0.34757867313267365,0.7379192704185971,0.8042813455657493,0.9526850118110817,1.0,2/13,6.78%,VEGFA;INHBA
prerank,protein destabilization (GO:0031648),0.2945267373965097,0.737879978980016,0.8015564202334631,0.9523406449630064,1.0,4/32,12.71%,GSN;CREBBP;CUL3;NR1D1
prerank,regulation of interferon-gamma production (GO:0032649),-0.19938554518065066,-0.7377885723049209,0.9432624113475178,0.9912818756925007,1.0,21/71,24.36%,IL1R1;PDE4B;SLC7A5;PDE4D;SIRPA;AXL;IL18;GAS6;HMGB1;TLR7;PTPN22;CD47;PYCARD;PRNP;HSPD1;CD276;FZD5;CD274;NR1H4;VSIR;CYRIB
prerank,ncRNA processing (GO:0034470),-0.1768388019035484,-0.7377372791935443,1.0,0.9901238643392416,1.0,46/200,17.53%,RPL37;RPL27A;RPL19;LIN28B;RPS9;RPS14;RPL18A;RPL38;RPS19;RPL34;MTREX;RPL18;RPL7;RPS25;RPL21;RPL23A;RPLP2;RPL26;RPL41;RPL35A;RPL10A;RPL11;RPS16;EXOSC5;AGO4;SNU13;RPL4;RPS7;DDX52;RPS15;ADAR;RPL36;POP4;EXOSC9;RPL37A;RPL32;RPL29;DDX10;HEATR1;LYAR;RPL13;FBL;RCL1;RPL36A;RPL23;RPL17
prerank,response to peptide hormone (GO:0043434),0.2839590863236965,0.7370845291584811,0.8115763546798029,0.9529820681047406,1.0,4/43,5.34%,IGFBP5;IRS1;STAT3;ANXA1
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.24876480903192574,0.7370059567452668,0.9083245521601686,0.9526906595457464,1.0,39/158,20.27%,AKAP13;ALPK1;TRAF3IP2;S100B;TAB3;REL;MIER1;IRAK4;ROR1;IKBKG;IKBKE;MAVS;RIPK2;RHOA;MAP3K7;DHX36;TAB2;MAP3K3;ANKRD17;MYD88;TRAF2;TIRAP;MTDH;CARD16;ZDHHC13;DDX21;PIM2;TRAF6;PPP5C;TRAF5;IKBKB;SHISA5;MAP3K14;RBCK1;TICAM1;BRD4;CHUK;NEK6;MID2
prerank,regulation of microtubule nucleation (GO:0010968),-0.330093450594703,-0.7366281798906087,0.7876106194690266,0.9903013484017507,1.0,4/10,17.82%,PAK1;CKAP5;ARHGEF7;HSPA1A
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.3028793277466487,-0.7365860897158447,0.7627118644067796,0.9891520866857172,1.0,2/12,10.29%,ACTB;LAMA5
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.26015388361859404,0.7364300248913613,0.8842696629213483,0.9530553905552905,1.0,24/94,19.76%,PSMB2;IRAK3;TAB3;IRAK4;IKBKG;PSMD11;EGR1;PSMC1;CUL1;RIPK2;MAP3K7;TAB2;MAP3K3;PSMC6;MYD88;PSMD1;TRAF6;PSMD4;IKBKB;PSMA6;PSMD14;PSMD12;PSMD7;CHUK
prerank,peptide hormone secretion (GO:0030072),0.30708931369153947,0.7362357938822611,0.8094575799721836,0.9529253786450204,1.0,6/26,19.46%,ANXA1;LTBP4;CDK16;FFAR4;RAB1A;EDN3
prerank,regulation of ATP metabolic process (GO:1903578),0.27764480088907395,0.7361540515989629,0.8329268292682926,0.9526381233903596,1.0,12/54,19.89%,NUP93;ABCD1;NUP214;NUP153;EIF6;NUP155;RANBP2;AK4;NUP88;NUP35;ATP5IF1;ZBTB7A
prerank,stress-activated MAPK cascade (GO:0051403),0.27418526586917513,0.7355078827163893,0.8317422434367542,0.9531023986723793,1.0,20/61,26.46%,MAP3K5;TAB3;IKBKG;CUL1;RIPK2;MAP3K7;TAB2;MAP2K4;TRAF6;MAP3K10;IKBKB;CHUK;SH2D3C;MAP2K3;UBB;FBXW11;ARHGEF6;UBE2V1;UBA52;RPS27A
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.32399655652255455,0.735359336751642,0.7872968980797637,0.9529031179370627,1.0,6/17,17.88%,VEGFA;VCL;PPP1R12A;ADD1;IKBKB;S1PR2
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.2867668780186227,0.735217782307295,0.8258145363408521,0.9526893738156056,1.0,9/41,19.89%,NUP93;NUP214;NUP153;EIF6;NUP155;RANBP2;NUP88;NUP35;ZBTB7A
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.362375535896605,0.7348425934831089,0.795751633986928,0.9527899875817378,1.0,2/10,7.37%,TSKU;FN1
prerank,necroptotic process (GO:0070266),0.33585011919804086,0.7341502290987827,0.7663690476190477,0.9533085554460884,1.0,2/16,8.33%,TRPM7;TLR4
prerank,amide biosynthetic process (GO:0043604),0.28290682054224103,0.7335375061242524,0.8345679012345679,0.9537469609820929,1.0,7/47,14.18%,PCSK5;SGMS2;ARG1;NMRAL1;AGK;SPTSSB;DMD
prerank,mitotic cytokinetic process (GO:1902410),0.3205194894858302,0.7334038227942947,0.8,0.9535223723558067,1.0,4/20,15.95%,CNTROB;RHOA;PDCD6IP;CHMP2B
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.2629762285764363,-0.7332145232515286,0.8323170731707317,0.9924177459888182,1.0,7/19,24.98%,CORO2B;WRAP53;CEP120;CCT8;CCT3;TREM2;TCP1
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),0.3570080307157497,0.7332081182778778,0.7968,0.9533880636050015,1.0,2/11,13.04%,LDLR;SREBF1
prerank,granulocyte differentiation (GO:0030851),0.3274904236530761,0.7328951233106865,0.7817403708987162,0.9533964555378066,1.0,8/18,20.90%,RARA;RXRA;E2F1;CDK2;CDKN1A;LBR;DEK;PML
prerank,positive regulation of autophagy (GO:0010508),0.26432481365827165,0.732502691485365,0.8805460750853242,0.953524866153978,1.0,23/81,21.07%,GSK3B;TPCN1;FOXO3;WAC;IKBKG;PAFAH1B2;ZC3H12A;ATF6;PLEKHF1;MAP3K7;SCOC;SH3GLB1;MTDH;PIM2;PLK3;LRRK2;TICAM1;DAPK1;GPSM1;EPM2A;SESN3;MID2;NPRL2
prerank,negative regulation of protein depolymerization (GO:1901880),0.31096830964636574,0.7324023991624029,0.808066759388039,0.9532532506092781,1.0,5/24,10.10%,FGF13;KATNB1;LIMA1;CIB1;HDGFL3
prerank,negative regulation of immune response (GO:0050777),0.24688935602901982,0.7322534969774359,0.9165775401069519,0.9530597285735216,1.0,11/154,8.15%,RAMP1;PTGDR;COL3A1;ADRB2;PLCG2;TRAFD1;PTHLH;IRAK3;ADCY9;GPR27;HTR6
prerank,cellular biogenic amine metabolic process (GO:0006576),0.3531374665776872,0.7321759876995998,0.779788838612368,0.9527768751957185,1.0,3/12,17.08%,SRM;ODC1;OAZ2
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.331656887398257,0.7320601480180401,0.766566265060241,0.9525362783286999,1.0,6/17,21.18%,TGFB3;PDCD4;CDKN1B;CDKN1A;PPARG;SOD2
prerank,maturation of LSU-rRNA (GO:0000470),-0.2432734315901604,-0.7320542589242892,0.8771929824561403,0.9926973291529555,1.0,5/26,11.45%,NSA2;RPL7;RPL10A;RPL7L1;SNU13
prerank,neutrophil chemotaxis (GO:0030593),0.2724622355253864,0.7319327800380322,0.8252427184466019,0.9523054458038115,1.0,4/53,5.08%,CXCL2;CCL3;CCL1;GBF1
prerank,cellular response to oxidative stress (GO:0034599),0.2523443175942999,0.7317188855724926,0.9033659066232356,0.9522007680324646,1.0,34/118,25.98%,EGFR;PRKCD;NFE2L2;GSR;ABL1;FOXO3;PRDX5;GPX8;ZC3H12A;ARNT;PARP1;KEAP1;EIF2S1;CCS;VKORC1L1;STX2;LRRK2;CAT;DAPK1;NUDT2;CHUK;PRDX2;FER;SOD2;VRK2;ZFAND1;RAD52;TP53;WNT16;RBM11;JUN;MPV17;TXNRD1;AIF1
prerank,regulation of steroid biosynthetic process (GO:0050810),0.3529835832472049,0.7312215186643457,0.7673343605546995,0.9524423311988808,1.0,2/11,8.34%,BMP5;EGR1
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.32950981481403907,0.7310983599956042,0.7976710334788938,0.9522097462137288,1.0,2/18,7.14%,GSK3B;MPV17L
prerank,negative regulation of interleukin-2 production (GO:0032703),0.328397635885441,0.7310532269733051,0.7994143484626647,0.9518764572791096,1.0,1/18,1.99%,EZR
prerank,melanosome localization (GO:0032400),-0.26333331827850165,-0.7310142554457477,0.840531561461794,0.9928057195730978,1.0,4/21,12.19%,SHROOM2;BBS5;MYO5A;MREG
prerank,maintenance of protein localization in organelle (GO:0072595),-0.2613060491361131,-0.7307535426859255,0.8255451713395638,0.9919191806736583,1.0,7/19,24.01%,PINK1;TAF3;TAPT1;ARL2BP;HK2;AKT1;HSPA5
prerank,linoleic acid metabolic process (GO:0043651),-0.28042519446666825,-0.7302601705659216,0.8507936507936508,0.9913643594279438,1.0,3/17,12.99%,ACSL1;FADS2;ALOX12
prerank,striated muscle cell differentiation (GO:0051146),0.3325893596652752,0.7300591343981981,0.7931547619047619,0.9527839910606505,1.0,2/16,5.65%,AKAP13;SKI
prerank,macroautophagy (GO:0016236),0.2507361911018924,0.7298630362753991,0.9,0.952646557290599,1.0,41/118,29.73%,TCIRG1;VPS41;LIX1L;ZFYVE1;BECN1;VCP;ACBD5;VPS39;ATG3;SNX14;ULK3;RB1CC1;ATG5;VPS37A;VTA1;VPS37B;PIP4K2A;WIPI2;NBR1;ATG4B;CHMP2B;SNF8;TBC1D5;TMEM74;STX17;VTI1B;PRKAB1;SRC;AMBRA1;ARL8B;CHMP3;MAP1LC3B;TOMM20;CLN3;ATG14;VPS33A;HGS;SQSTM1;ATG12;TSG101;UBXN6
prerank,histone H2A monoubiquitination (GO:0035518),-0.2658982160194173,-0.7298247360409635,0.8459016393442623,0.9907282823218185,1.0,4/17,19.04%,PCGF5;RING1;BMI1;KDM2B
prerank,regulation of cilium assembly (GO:1902017),0.266034500389207,0.7290101278473383,0.8626045400238949,0.9533800981451457,1.0,15/62,20.95%,CDK10;RABEP2;LIMK2;SDCCAG8;ATG3;ATG5;TBC1D2B;EVI5;RABGAP1;YAP1;TBC1D5;TBC1D17;ODAD3;CDKL1;TBC1D15
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.28107697163562284,0.7289270069407459,0.8604060913705583,0.9530945466319438,1.0,10/48,15.55%,HIPK1;ABL1;CHEK2;CASP2;IKBKE;MCL1;BRCA1;E2F1;USP28;PRKDC
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.28889547855340003,0.7287016075849458,0.8098404255319149,0.9530043911569039,1.0,6/38,12.19%,PTGIS;KLF4;ATP2B4;ZC3H12A;TLR4;CLU
prerank,chromatin disassembly (GO:0031498),0.3511909286937522,0.7286838504087138,0.8106060606060606,0.9522430271882468,1.0,7/14,34.65%,SMARCC1;HMGA1;SMARCA4;SMARCE1;ARID2;SMARCD3;SMARCC2
prerank,nucleosome disassembly (GO:0006337),0.3511909286937522,0.7286838504087138,0.8106060606060606,0.9522430271882468,1.0,7/14,34.65%,SMARCC1;HMGA1;SMARCA4;SMARCE1;ARID2;SMARCD3;SMARCC2
prerank,positive regulation of viral life cycle (GO:1903902),-0.2521396541024731,-0.728108114117769,0.8701754385964913,0.9917317877304593,1.0,5/22,16.32%,LGALS1;AXL;CD74;P4HB;TYRO3
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.2923114827131189,-0.728056882627154,0.8409090909090909,0.9906083247021787,1.0,1/13,0.40%,RNF152
prerank,cholesterol metabolic process (GO:0008203),0.26144615687216904,0.7280084330418078,0.8579881656804734,0.9527178156477865,1.0,15/68,18.89%,SOAT1;FDX1;TSKU;RXRA;GGPS1;ANGPTL3;SOAT2;GBA2;LCAT;SQLE;LBR;CEL;EBP;HMGCR;APOF
prerank,protein acetylation (GO:0006473),0.2966091764664678,0.7279318320896211,0.8267716535433071,0.9524277450623853,1.0,13/30,29.23%,CREBBP;DSCC1;NAA15;ESCO1;NAT10;NAA40;NAA80;NAA60;KAT6A;GTF2B;HAT1;KAT2B;NAA50
prerank,positive regulation of chemokine production (GO:0032722),0.28331400776190896,0.7277200956888941,0.8389937106918239,0.9523095167919675,1.0,8/44,13.32%,IL33;TWIST1;IL17RA;TLR4;EGR1;MAVS;EIF2AK2;TIRAP
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.3564406471192232,0.7269979079884664,0.7808,0.952858920034007,1.0,2/10,8.37%,DLGAP4;AKAP9
prerank,regulation of intracellular transport (GO:0032386),0.28781078241459845,0.726676266802903,0.8472584856396866,0.9528715849819193,1.0,6/38,17.77%,GAS1;NDEL1;NUP214;GRIPAP1;RAB11B;LRRK2
prerank,hexose metabolic process (GO:0019318),-0.2177692410952758,-0.7264817770165515,0.9144385026737968,0.9913180112889274,1.0,5/39,9.19%,APOD;PGM1;PPARD;AKR1A1;PMM2
prerank,neutrophil migration (GO:1990266),0.26856684902759737,0.7257338145419961,0.8403869407496977,0.9536796678048726,1.0,6/58,9.92%,CXCL2;CCL3;CCL1;GBF1;IRAK4;CCL7
prerank,positive regulation of telomerase activity (GO:0051973),0.29225216085016725,0.7257239770758529,0.8138020833333334,0.9533010399994174,1.0,3/33,5.82%,GRHL2;KLF4;NEK7
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.2506179625287664,0.725562282509731,0.8977395048439182,0.9531137824693329,1.0,19/125,14.06%,NDEL1;CLIP1;SETD2;AURKA;PAFAH1B1;XPO1;PTPA;CDC20;TTK;CCNB1;AHCTF1;MECP2;CENPT;MAD2L1;PCNT;KIF3B;ZW10;RANBP2;CENPL
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.3453299752439146,0.7251144144807049,0.7935779816513762,0.9533057542616203,1.0,3/12,21.96%,TICRR;WDR18;NBN
prerank,centromere complex assembly (GO:0034508),0.2892276659074862,0.7240293747484239,0.8320512820512821,0.9542537608824945,1.0,16/36,32.12%,RBBP7;CENPT;POGZ;HJURP;CENPL;SMARCA5;CENPW;CENPP;RSF1;MIS12;CENPK;NASP;CENPE;HELLS;CENPN;CENPV
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.3019799195255596,-0.7240209256081449,0.8277777777777777,0.9931755611410037,1.0,5/11,21.86%,BCL2;MIF;CD74;TAF9;TRIAP1
prerank,regulation of interleukin-10 production (GO:0032653),-0.21008484039140557,-0.7235489650337918,0.9361702127659575,0.9925622325241488,1.0,13/44,21.91%,PRKCZ;TNFRSF21;TRIB2;CD34;HMGB1;TYROBP;CD47;NOD2;JAK3;PYCARD;HSPD1;AGER;CD274
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.34980047974453166,0.7234961539002128,0.7935779816513762,0.9545609229445909,1.0,5/12,22.02%,ANKRD13C;KDELR2;RER1;KDELR3;GPAA1
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.30328827954053916,0.723083660301079,0.8260869565217391,0.9546927417019803,1.0,4/27,6.63%,CHST13;XYLT1;BGN;CHST11
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.212432566439748,-0.7224515686402819,0.9523809523809523,0.9927082755891382,1.0,11/57,12.34%,RPL38;RPS19;RPL7;RPS25;NPM1;RPL26;RPL35A;RPL11;RPS16;RPS7;RPS15
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.3239938983394651,0.7223589674191688,0.8204022988505747,0.9552383242415896,1.0,7/19,23.59%,RENBP;GFPT1;SLC35D1;GNPDA1;UAP1;MPI;PGM3
prerank,cardiocyte differentiation (GO:0035051),0.3585627508224892,0.7219570674574888,0.802547770700637,0.9553623486780504,1.0,1/10,2.61%,AKAP13
prerank,insulin secretion (GO:0030073),0.3166995492174207,0.7218278495572827,0.802275960170697,0.9551505073617413,1.0,2/19,5.34%,CLTRN;ANXA1
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.260601241865938,0.7212360006771459,0.8855218855218855,0.9554916369016672,1.0,26/84,25.56%,SAMD4A;IGFBP5;PAIP2;CNOT8;ABCA7;EPRS1;DHX36;EIF2AK2;RTN3;CLU;SORL1;PIN1;TOB1;SYNCRIP;ENC1;DAPK1;IGF2BP3;CAPRIN1;SAMD4B;FMR1;MALSU1;CNOT1;TRIM71;DDX6;TSC1;RBM4
prerank,multivesicular body organization (GO:0036257),0.29230883788518897,0.7208505342739128,0.8272727272727273,0.9555969046776872,1.0,11/31,30.23%,VPS37A;VTA1;VPS37B;PDCD6IP;CHMP2B;SNF8;RAB11A;CHMP3;HGS;TSG101;IST1
prerank,positive regulation of exocytosis (GO:0045921),-0.2234716334422006,-0.7205416746205924,0.9139344262295082,0.9938566756252717,1.0,3/35,5.01%,CLASP2;CADPS;SMPD3
prerank,zinc ion transmembrane transport (GO:0071577),0.3112950502451123,0.7205190338942307,0.8316690442225392,0.9556186591819056,1.0,4/22,8.44%,SLC39A14;SLC39A13;SLC39A11;SLC30A3
prerank,positive regulation of cellular component organization (GO:0051130),0.250755099757853,0.7204949670559841,0.8997772828507795,0.9552571153942709,1.0,22/107,17.53%,TRABD2B;MPP7;GPC3;VEGFA;TGFB3;GSK3B;TGFBR1;LRP1;SPIDR;PLEKHM2;VCP;CDC20;SH3GLB1;CLU;ATP10A;TIRAP;CDC42EP2;FLOT1;ADD1;RB1;PTPN23;SURF4
prerank,negative regulation of hormone secretion (GO:0046888),-0.30956353872399733,-0.7200934480679936,0.8416666666666667,0.9931909715771374,1.0,2/10,13.04%,GJA1;RAB11FIP1
prerank,DNA conformation change (GO:0071103),0.32670691913075056,0.7197984796784972,0.8020833333333334,0.9557471167955801,1.0,2/17,9.17%,ABL1;TOP1
prerank,histone H3-K36 demethylation (GO:0070544),-0.30911218249268957,-0.7197122645914584,0.8166666666666667,0.9924404773443478,1.0,1/10,2.66%,KDM7A
prerank,regulation of response to interferon-gamma (GO:0060330),0.33078462569115086,0.7195238321250562,0.812960235640648,0.9556850476806915,1.0,6/14,26.95%,PTPN2;SOCS3;JAK2;PIAS1;SUMO1;PARP9
prerank,amyloid-beta metabolic process (GO:0050435),0.3231071549564649,0.7191459683867658,0.8078602620087336,0.9557777130932402,1.0,4/16,17.77%,BACE2;ABCA7;IDE;APEH
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.2374418889029053,-0.7191365400695131,0.8793103448275862,0.9919855606780744,1.0,12/26,26.88%,INSR;HSP90AB1;EDN1;NOS1AP;DDAH1;DDAH2;TMEM106A;AKT1;PTGS2;ASS1;CD36;TLR6
prerank,multivesicular body assembly (GO:0036258),0.29295559752629635,0.7188427472039128,0.825065274151436,0.955772280725118,1.0,11/30,30.23%,VPS37A;VTA1;VPS37B;PDCD6IP;CHMP2B;SNF8;RAB11A;CHMP3;HGS;TSG101;IST1
prerank,cochlea morphogenesis (GO:0090103),-0.31736322887284174,-0.718109291504816,0.8062678062678063,0.9920324423016758,1.0,8/10,33.87%,TBX18;TBX1;MYO3B;PAX2;MYO3A;HPN;TIFAB;HOXA1
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.3004566840953624,0.7180451712628682,0.8367071524966262,0.956384264753488,1.0,7/27,21.29%,PLA2G15;CHKB;ETNK1;LPIN2;ETNPPL;CEPT1;ETNK2
prerank,regulation of platelet aggregation (GO:0090330),0.3283193919172839,0.7175421166095696,0.7946026986506747,0.9566142256605613,1.0,3/17,7.87%,PRKCD;CD9;DMTN
prerank,regulation of mitochondrion organization (GO:0010821),0.27487786468047215,0.7168664868942031,0.85625,0.9570611057567375,1.0,11/47,23.72%,PID1;GSK3B;PLSCR3;SREBF1;GOLPH3;MIEF2;LRRK2;PRMT6;IAPP;USP36;OMA1
prerank,acylglycerol metabolic process (GO:0006639),0.2833090288414264,0.7168660142389458,0.8449809402795425,0.9566727172482368,1.0,7/37,14.84%,MGLL;LYPLA2;DGKA;PNPLA3;ABHD6;PNPLA2;SEL1L
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.23228985716844863,-0.7167067328391675,0.9283018867924528,0.9924828009403207,1.0,13/29,34.20%,CADM1;NECTIN2;TYROBP;CYRIB;SPI1;FADD;NOS2;SLAMF6;ITGAM;CD226;IL12A;CRTAM;IL12RB1
prerank,negative regulation by host of viral transcription (GO:0043922),0.34034856918521855,0.7166305487985422,0.8072100313479624,0.9565879369102325,1.0,4/12,25.27%,CCL3;TARDBP;REST;JUN
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.28632183665987154,0.7166220844847552,0.835357624831309,0.95620946641247,1.0,11/31,20.71%,SIPA1L1;ARHGAP44;DHX36;NLGN1;ZDHHC15;DBN1;SRCIN1;CAPRIN2;LRRK2;PDLIM5;CAPRIN1
prerank,neuron projection extension (GO:1990138),0.2892106362051492,0.7165332162697552,0.8506056527590848,0.9559249572652152,1.0,7/32,17.21%,ULK2;NRP1;MAP1B;CPNE1;SPG11;CYFIP1;IQGAP1
prerank,regulation of epithelial cell differentiation (GO:0030856),0.3249914904703464,0.7156660929738189,0.8074626865671641,0.9565993220725122,1.0,2/17,4.71%,DSPP;KLF7
prerank,T cell differentiation in thymus (GO:0033077),0.33471798682942544,0.7155186698104884,0.828101644245142,0.9563900748534798,1.0,1/14,4.18%,GLI3
prerank,positive regulation of interleukin-1 production (GO:0032732),0.26959208358862147,0.7153497163368148,0.8566308243727598,0.9562169428806886,1.0,8/51,12.31%,CCL3;STAT3;NLRP12;TLR4;EGR1;RIPK2;TLR8;MYD88
prerank,positive regulation of viral transcription (GO:0050434),0.30683809161496584,0.7148798982130398,0.8270042194092827,0.9563946858568818,1.0,8/25,28.96%,MDFIC;NELFE;DHX9;POLR2C;CCNT1;RSF1;SUPT4H1;NELFA
prerank,leukotriene biosynthetic process (GO:0019370),-0.27586199614222406,-0.7145185177249149,0.8403361344537815,0.9939055973541797,1.0,6/14,27.23%,GGT5;LTA4H;GGT1;PLA2G5;ALOX5AP;MGST2
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.31487819774480386,0.7128811527431742,0.8217391304347826,0.9584040175963076,1.0,5/20,19.00%,ACSM2A;ACSL3;ACACA;SCD;FITM2
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.3271231837390286,0.7125899131247146,0.8105263157894737,0.958367359568627,1.0,4/15,19.00%,LDLR;SREBF1;SIK1;FITM2
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.28984771058791753,0.7123108525730109,0.8348993288590604,0.9583352171401762,1.0,10/30,24.68%,TEN1;STN1;NIBAN2;NAT10;CDKN1A;TENT4B;ERCC4;TP53;GNL3L;SRC
prerank,regulation of autophagy (GO:0010506),0.2353942301327213,0.7121301161710982,0.9398340248962656,0.9581775462617036,1.0,46/216,20.27%,MET;NEDD4;EXOC4;EIF4G3;GSK3B;TPCN1;ABL1;STAT3;CISD2;FOXO3;RRAGB;USP13;TAB3;WDR41;ZC3H12A;EIF4G2;SNX32;KLHL22;ATF6;PLEKHF1;TAB2;MCL1;KEAP1;RB1CC1;SH3GLB1;SREBF1;EXOC7;MTDH;PIP4K2A;ATP6V1A;PIM2;RUBCN;RHEB;MLST8;FOXK1;LRRK2;TICAM1;ATP6V0D1;DAPK1;GPR137B;TLK2;EIF4G1;USP10;CAPN1;FOXK2;MID2
prerank,cellular response to inorganic substance (GO:0071241),0.314152501928756,0.7120547468734358,0.836676217765043,0.9578900170614593,1.0,9/21,22.06%,SPIDR;DDI2;DPEP1;DDX11;RTF2;ATRX;CDK2;DDI1;FMR1
prerank,negative regulation of lymphocyte proliferation (GO:0050672),-0.22097620666502732,-0.7119345348934334,0.9259259259259259,0.99571257497133,1.0,10/31,26.53%,LYN;TNFRSF21;CD300A;CEBPB;TYROBP;CD86;CD274;LST1;RC3H1;IL4I1
prerank,B cell activation involved in immune response (GO:0002312),0.3414042622879441,0.7107109382845316,0.8431061806656102,0.9591835084297893,1.0,2/13,14.23%,EXOSC3;RNF8
prerank,positive regulation of ATPase activity (GO:0032781),-0.2110820450208185,-0.7105400244580048,0.9158415841584159,0.9960944030328794,1.0,5/41,11.59%,ATP1B3;RYR2;ATP1B2;DYNLL2;VMP1
prerank,positive regulation of catalytic activity (GO:0043085),0.2808394340810847,0.7100368153578693,0.8532110091743119,0.959614831691014,1.0,8/37,21.33%,BCAS3;ABL1;WRN;CIB1;FXN;CHTOP;XRCC5;IGF2
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.32810775075781484,0.7096336568707398,0.8088235294117647,0.9597145202184784,1.0,5/16,23.64%,ZC3H12A;DHX36;MOV10;TARDBP;TRIM71
prerank,regulation of dephosphorylation (GO:0035303),-0.27269138199741005,-0.7092485747003942,0.8379204892966361,0.9963919833152399,1.0,4/15,13.54%,PPP1R16B;MTMR3;SMG7;CDK5RAP3
prerank,phagosome-lysosome fusion (GO:0090385),0.3522496384787642,0.7089274787792322,0.7837423312883436,0.960156671370061,1.0,1/10,3.81%,RAB7B
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.29974091018260474,0.7079953052048878,0.8321775312066574,0.9608912581052023,1.0,9/23,25.30%,MTMR12;OCRL;PIP4P2;SYNJ2;SYNJ1;MTMR1;SACM1L;MTMR9;MTM1
prerank,positive regulation of defense response (GO:0031349),0.25090599573169253,0.7077744696350229,0.9003436426116839,0.9607805605054348,1.0,19/89,19.40%,CCL3;CCL1;IL33;IL17RA;NLRP12;TLR4;GPR4;PDCD4;TLR8;POLR3F;IFI35;AKIRIN2;PLSCR1;ABCC1;TNIP1;POLR3D;CCN4;DHX9;LRSAM1
prerank,indolalkylamine catabolic process (GO:0046218),0.3525684427258424,0.7073646201408779,0.8151001540832049,0.9608747417435352,1.0,2/10,18.32%,TDO2;IDO2
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.25575565288230134,0.7071848779039868,0.9003397508493771,0.9603194891240133,1.0,19/78,24.22%,AP2A2;SEC31A;SEC24B;SEC23A;SEC24D;DCTN5;KIF3B;DCTN4;CTSE;CAPZA1;KLC1;AP2B1;LAG3;AP2A1;AP1M1;AP1S1;KIF23;KIF15;KIFAP3
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.25575565288230134,0.7071848779039868,0.9003397508493771,0.9603194891240133,1.0,19/78,24.22%,AP2A2;SEC31A;SEC24B;SEC23A;SEC24D;DCTN5;KIF3B;DCTN4;CTSE;CAPZA1;KLC1;AP2B1;LAG3;AP2A1;AP1M1;AP1S1;KIF23;KIF15;KIFAP3
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.2266257942027427,-0.703871061015726,0.8921933085501859,1.0,1.0,13/29,30.75%,NR1H3;PLAAT3;NR1H2;DBI;TMEM86B;PNPLA8;PLA2G4B;PLA2G5;LPCAT4;MBOAT2;PLA2G4C;PLBD1;PLB1
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.2923314114716658,0.7036300673600199,0.8416779431664412,0.9641165994010121,1.0,7/27,26.06%,ZC3H12C;ZC3H12A;ZC3H12B;CPSF3;CSTF3;PARN;DICER1
prerank,vasodilation (GO:0042311),0.34392386471154474,0.7033911614154655,0.816793893129771,0.9640100990649433,1.0,1/13,2.59%,ADRB2
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.3139942762888081,0.7029151789954255,0.8356164383561644,0.9641725377350353,1.0,3/18,9.01%,EZR;DACT1;RDX
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.2517084817147537,-0.702719804300926,0.8825503355704698,1.0,1.0,1/20,0.78%,NR2F2
prerank,steroid hormone biosynthetic process (GO:0120178),0.2875926557737954,0.702463965744464,0.8709239130434783,0.9643198477821899,1.0,8/29,29.93%,FDX1;TSPO;STAR;STARD3NL;HSD17B2;FDX2;FDXR;DHCR7
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.30344072061200156,0.7016389695132373,0.8234463276836158,0.9648928874156925,1.0,2/23,8.56%,PLA2G4F;MBOAT1
prerank,positive regulation of mitochondrial translation (GO:0070131),0.33208309254403046,0.7013632300656854,0.8245083207261724,0.9648166227349249,1.0,3/14,19.71%,MRPS27;RPUSD4;FASTKD3
prerank,cilium-dependent cell motility (GO:0060285),-0.2464274744733037,-0.7007468137224566,0.8838709677419355,1.0,1.0,11/22,33.88%,CFAP44;CFAP54;CCDC39;DNAH3;EFHC1;EFHC2;CCDC65;RFX3;DNAH2;TEKT5;DNAH1
prerank,positive regulation of vasculogenesis (GO:2001214),0.3510630290357103,0.7005038602296529,0.8138041733547352,0.9654039815352214,1.0,2/10,11.11%,TMEM100;RAP1A
prerank,positive regulation of cell aging (GO:0090343),-0.2889760610548663,-0.7003827649123369,0.8346883468834688,1.0,1.0,3/11,13.94%,B2M;YPEL3;ABI3
prerank,defense response to fungus (GO:0050832),0.3211237131504811,0.7001733621341005,0.8409425625920471,0.9654089164735258,1.0,1/17,4.45%,PLCG2
prerank,regulation of centrosome cycle (GO:0046605),0.30204343571586856,0.6995388784552061,0.851063829787234,0.9657411143312921,1.0,4/21,15.95%,AURKA;NAT10;PDCD6IP;CHMP2B
prerank,secretory granule organization (GO:0033363),-0.29540684660559324,-0.698564931003824,0.8133704735376045,1.0,1.0,6/10,37.65%,SRGN;ABCA1;F2R;BLOC1S1;F2RL3;BLOC1S3
prerank,regulation of lamellipodium morphogenesis (GO:2000392),-0.2912272856301324,-0.6985510888105637,0.8319559228650137,1.0,1.0,5/11,21.57%,ENPP2;PDPN;ARHGEF7;CORO1B;KANK1
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.3253766315444107,0.6978847291385867,0.8159509202453987,0.9672926257396965,1.0,3/14,16.55%,IKBKG;TRAT1;LCK
prerank,positive regulation of response to wounding (GO:1903036),0.2994494489249825,0.696902564518127,0.8445078459343794,0.9680425599732304,1.0,7/24,16.07%,PRKCE;ANXA1;ITGB1;DMTN;CNTF;PTN;ARFGEF1
prerank,tryptophan catabolic process (GO:0006569),0.3424733481783222,0.6968687736639148,0.8159126365054602,0.9676888477999637,1.0,2/11,18.32%,TDO2;IDO2
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.292988640158135,0.6960301253552363,0.8286908077994429,0.968260716591628,1.0,7/25,19.72%,STAT3;FOXO3;INHBA;ARNT;PRKDC;NCKAP1L;ANKRD54
prerank,histone H3 acetylation (GO:0043966),0.269840653913961,0.6959787367296385,0.8738255033557047,0.9679386908812755,1.0,18/40,28.81%,PER1;TADA3;MAP3K7;JADE2;KAT6B;TAF5;BRCA2;NAA60;PHF14;BRPF3;TAF12;YEATS2;KAT6A;TRIM16;SGF29;TADA2A;KAT2B;BRD1
prerank,cardiac ventricle development (GO:0003231),0.3177196520737802,0.6959111997463848,0.8316251830161054,0.9676334692591648,1.0,5/20,16.94%,HES1;GATA4;MDM4;TMEM65;STRA6
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.2397109604937782,0.6957534362586704,0.9460946094609461,0.9674273247420324,1.0,8/116,8.15%,RAMP1;PTGDR;ADRB2;PLCG2;PTHLH;ADCY9;GPR27;HTR6
prerank,toxin transport (GO:1901998),0.3551993744152835,0.6956823601044755,0.8259493670886076,0.9671229556193451,1.0,2/10,14.99%,ANTXR1;RAB40B
prerank,positive regulation of T cell differentiation (GO:0045582),0.27615409808631364,0.6955946238400494,0.8617157490396927,0.9668345501170083,1.0,7/36,18.04%,VNN1;GLI3;GLI2;ZBTB1;CD46;NKAP;NCKAP1L
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.2381264427527445,0.6947788019287597,0.9455930359085963,0.9673779895893129,1.0,8/117,8.15%,RAMP1;PTGDR;ADRB2;PLCG2;PTHLH;ADCY9;GPR27;HTR6
prerank,histone lysine methylation (GO:0034968),0.2847555819352356,0.6944266693890424,0.8648293963254593,0.9673869442687396,1.0,14/33,32.86%,WDR82;SMYD3;PRDM5;KMT2D;DPY30;SETD6;SMYD2;SETMAR;PAXIP1;DOT1L;SETDB1;MEN1;EHMT2;PRDM9
prerank,regulation of histone methylation (GO:0031060),0.3259172619822882,0.6943188652550273,0.8204334365325078,0.9671201165179902,1.0,3/13,17.18%,NNMT;NSD1;CHTOP
prerank,inner mitochondrial membrane organization (GO:0007007),-0.2072393154881563,-0.6942840301349066,0.9742268041237113,1.0,1.0,19/47,30.28%,NDUFA13;CHCHD6;ATP5PF;ATP5F1E;APOOL;ATP5F1A;DNAJC11;ATP5F1B;MTX1;ROMO1;TIMM10B;MTX3;LETM1;UQCC3;ATP5MC1;ATP5MC2;ATP5MC3;AFG3L2;ATP5F1D
prerank,regulation of necroptotic process (GO:0060544),0.29528705490252766,0.6942641088614516,0.8406827880512091,0.9667947471728001,1.0,3/23,16.22%,YBX3;PDCD6IP;FLOT1
prerank,RNA destabilization (GO:0050779),0.3092089499526379,0.6940708831281599,0.8092566619915849,0.9666241094706494,1.0,9/18,29.08%,ZC3H18;CELF1;MEX3D;FTO;PUM1;METTL16;DXO;ROCK1;YTHDF2
prerank,negative regulation of cell development (GO:0010721),0.2935880715050502,0.6938885258925379,0.8453038674033149,0.966459237590734,1.0,10/25,24.40%,GSK3B;PTHLH;PCM1;HOOK3;SORL1;PAX6;RFLNA;REST;APPL2;LILRB1
prerank,miRNA mediated inhibition of translation (GO:0035278),0.3380442212301338,0.693626475283444,0.8263565891472868,0.9659993073529963,1.0,6/11,29.53%,AGO2;EIF6;TRIM71;RBM4;AGO1;TNRC6C
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.3380442212301338,0.693626475283444,0.8263565891472868,0.9659993073529963,1.0,6/11,29.53%,AGO2;EIF6;TRIM71;RBM4;AGO1;TNRC6C
prerank,long-term synaptic potentiation (GO:0060291),0.3096144205880399,0.6935520020681363,0.8464788732394366,0.9656915007539705,1.0,3/21,6.08%,PTK2B;MPP2;NFATC4
prerank,plasma membrane tubulation (GO:0097320),-0.2744913096723727,-0.6933390151850521,0.8674033149171271,1.0,1.0,2/13,10.75%,FNBP1L;MICALL1
prerank,negative regulation of nervous system development (GO:0051961),0.31381740151648124,0.6932990212634611,0.8537666174298375,0.9655995279163339,1.0,5/17,16.03%,SLIT1;PCM1;HOOK3;SORL1;PAX6
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.27363235554451104,-0.6926741147646972,0.8361581920903954,1.0,1.0,4/14,23.22%,TFRC;NECTIN2;SHLD2;SHLD3
prerank,mitochondrion distribution (GO:0048311),-0.2801730105001231,-0.6924923471054778,0.870026525198939,1.0,1.0,4/12,16.77%,MAPT;ARMC1;ATCAY;CLUH
prerank,intracellular sterol transport (GO:0032366),0.32326006178825895,0.6910782900806098,0.8260211800302572,0.9677441176652649,1.0,6/13,24.55%,NPC1;STARD4;STAR;SERAC1;RELCH;OSBP
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.27514325377792603,0.6907453927589128,0.8773466833541927,0.967732833397001,1.0,1/39,0.67%,TCF7L2
prerank,programmed necrotic cell death (GO:0097300),0.31123664326983064,0.6900131376857667,0.8286558345642541,0.9681774818387724,1.0,2/18,8.33%,TRPM7;TLR4
prerank,regulation of endocytosis (GO:0030100),0.25927331416451566,0.6894628361085031,0.9018912529550828,0.9684129445120632,1.0,9/61,9.93%,GPC3;STON2;ABL1;LRP1;STON1;RUFY1;ABCA7;ARFGAP1;RAB4B
prerank,defense response to protozoan (GO:0042832),-0.2832333737559003,-0.6878060609881758,0.834733893557423,1.0,1.0,3/12,15.37%,GBP4;GBP7;CD40
prerank,negative regulation of viral entry into host cell (GO:0046597),0.3366684043359259,0.6878029232220495,0.8243243243243243,0.9698450186628053,1.0,1/12,1.97%,GSN
prerank,cardiac cell development (GO:0055006),0.3354749580976155,0.6877757131126634,0.8608964451313755,0.9694936848543446,1.0,4/11,18.07%,VEGFA;ALPK3;JAG1;CXADR
prerank,translational elongation (GO:0006414),0.23967507236513988,0.6874611190661428,0.9394939493949395,0.9694412919597626,1.0,42/101,35.76%,MRPL33;MRPL40;MRPL42;MRPS27;MRPL11;MRPS2;MRPL36;MRPL19;MRPL15;EEF2K;GTPBP2;MRPL23;MRPL44;GADD45GIP1;MRPS21;AURKAIP1;MRPS30;MRPL35;MRPL52;TSFM;MRPL30;GFM2;LTN1;MRPL10;MRPL48;MRPS18A;MRPS31;MRPL1;MRPL13;MRPL22;MRPS16;MRPL37;MRPS28;MRPS35;ERAL1;MRPL28;CHCHD1;MRPS7;MRPL14;MRPL32;MRPS9;MRPS18C
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.3011008835702087,0.6869748862852066,0.8549075391180654,0.9695994414132378,1.0,7/19,27.11%,HIPK1;USP28;CDIP1;PML;TP53;AEN;RPS27L
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.24003048911125707,0.686576052172551,0.9342403628117913,0.9696482563428216,1.0,35/95,32.28%,PCM1;PAFAH1B1;CEP43;AKAP9;SDCCAG8;HAUS2;CEP63;PLK4;PCNT;NPHP1;OFD1;CENPJ;CEP164;CETN2;IQCB1;C2CD3;RAB11A;SFI1;CEP89;TCTN1;YWHAE;CEP76;RPGRIP1L;CSNK1E;CEP290;CEP162;PLK1;ACTR1A;CEP72;CEP131;CEP97;CEP57;TUBG1;NDE1;CSNK1D
prerank,ESCRT complex disassembly (GO:1904896),0.3457576895993054,0.6864836942131469,0.8338557993730408,0.968968324570119,1.0,2/10,15.95%,VTA1;CHMP2B
prerank,ESCRT III complex disassembly (GO:1904903),0.3457576895993054,0.6864836942131469,0.8338557993730408,0.968968324570119,1.0,2/10,15.95%,VTA1;CHMP2B
prerank,positive regulation of DNA recombination (GO:0045911),0.2851359698814346,0.6864818453118152,0.8616874135546335,0.9685882084486402,1.0,14/27,34.35%,PARP1;WDR48;KMT5B;FUS;ACTR2;KMT5C;ZCWPW1;MRNIP;PAXIP1;ERCC2;ARID2;PRDM9;SHLD1;HMCES
prerank,synaptic vesicle membrane organization (GO:0048499),0.3104639933346144,0.6855480817976186,0.837593984962406,0.9692404376205889,1.0,5/17,22.61%,STX11;AP3D1;SNAP23;STX2;PRRT2
prerank,protein K48-linked ubiquitination (GO:0070936),0.2610566804560941,0.6850934039227079,0.8969325153374234,0.9693495832648118,1.0,10/54,15.49%,RNF126;UBR5;UBE2A;RNF115;CUL3;RNF146;UBE2K;RNF8;UBE2B;UBE2D3
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.2935430013756737,0.6850821639988723,0.862371888726208,0.9689773505525785,1.0,2/23,3.95%,ID2;DSG2
prerank,mitotic nuclear membrane disassembly (GO:0007077),-0.2848238982035742,-0.68467085024475,0.8803191489361702,1.0,1.0,1/12,1.18%,PRKCB
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.32096200745170367,0.6844313572505968,0.851963746223565,0.9692867732956375,1.0,7/13,32.75%,CCNB1;MAD2L1;PCID2;GEN1;DUSP1;LCMT1;TPR
prerank,regulation of cellular protein metabolic process (GO:0032268),0.26417051959480153,0.6842875531874933,0.9021065675340768,0.9690651947091444,1.0,13/47,23.49%,CNDP1;KLF4;FOXO3;INHBA;ATXN2;RBM3;CYFIP1;EIF4G1;GEMIN5;PM20D2;PUM3;RPL10;MAPKAPK5
prerank,peptidyl-asparagine modification (GO:0018196),0.27953968021546804,0.6841693208776213,0.8841961852861036,0.9687991475594633,1.0,9/31,22.54%,FUT8;MGAT1;MGAT5;DDOST;TUSC3;HIF1AN;DPM1;ALG8;MCFD2
prerank,positive regulation of T cell cytokine production (GO:0002726),0.30432809235218927,0.6840680973809036,0.8490566037735849,0.9685129900531496,1.0,4/20,15.75%,CD55;MAP3K7;TRAF2;TRAF6
prerank,negative regulation of centrosome duplication (GO:0010826),0.33404540327943144,0.683735655049943,0.8369905956112853,0.9684807708154454,1.0,2/11,12.66%,RBM14;BRCA1
prerank,Golgi to lysosome transport (GO:0090160),-0.2811813468964764,-0.6829520945634517,0.8467741935483871,1.0,1.0,1/11,2.40%,SORT1
prerank,regulation of T cell proliferation (GO:0042129),0.2508647053965507,0.6826745115374692,0.8870392390011891,0.9692516139661546,1.0,18/61,28.14%,ANXA1;NCK2;ARG1;CD80;CD46;NCK1;PDCD1LG2;DLG5;GLMN;NCKAP1L;IL27;LGALS3;SDC4;LILRB1;AIF1;PTPRC;IL4;IL23R
prerank,heterochromatin assembly (GO:0031507),0.2969634261531223,0.6818507316047596,0.8594202898550725,0.9697361003065305,1.0,8/20,32.12%,EZH1;RRP8;HMGA1;BAZ2A;SMCHD1;ZNFX1;HELLS;CENPV
prerank,ncRNA catabolic process (GO:0034661),0.2862134092309296,0.6818193954545865,0.8695073235685752,0.9693887606188943,1.0,11/28,29.56%,TUT4;EXOSC3;ERN2;TENT4B;DIS3;EXOSC2;EXOSC7;EXOSC8;PARN;NUDT16L1;SND1
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.24663492209854612,0.6808317317353565,0.9083333333333333,0.9700533489189347,1.0,19/67,22.62%,RABEP2;DMTN;RDX;SDCCAG8;ATG3;ATG5;TBC1D2B;EVI5;RABGAP1;P2RX4;TBC1D5;TBC1D17;ODAD3;CDKL1;ABITRAM;FER;TBC1D15;FMR1;TRPM2
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.2871793442895862,0.6807817675753325,0.8375838926174497,0.969720468438216,1.0,7/26,17.84%,FGF2;PLCG2;IBTK;SLC8B1;CHERP;LCK;ITPR2
prerank,acetyl-CoA metabolic process (GO:0006084),0.31247896130471303,0.6780032816690938,0.8360902255639098,0.9722130001445574,1.0,8/15,33.77%,ACACA;TDO2;HMGCS2;MVD;MVK;HMGCS1;ACAT1;PMVK
prerank,negative regulation of fat cell differentiation (GO:0045599),0.2713181796389345,0.677796960416493,0.8891820580474934,0.9720519116785947,1.0,5/34,13.24%,ZFPM2;RORA;ZFPM1;TRIO;E2F1
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.34277007886255056,0.6775473797831093,0.8351145038167939,0.9719207279061185,1.0,3/10,21.32%,VPS9D1;ATP5PD;ATP5PO
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.33469853119340615,0.6767805813352825,0.8483412322274881,0.9723798064200977,1.0,1/10,7.38%,APEX1
prerank,cranial nerve development (GO:0021545),0.33072873296706323,0.6762504007809572,0.8701923076923077,0.9725441550833639,1.0,3/11,11.91%,ATOH7;POU4F1;TMEM126A
prerank,glycoprotein catabolic process (GO:0006516),-0.24911423660051474,-0.6759170688539141,0.9161290322580645,1.0,1.0,1/17,1.47%,ADAMTS9
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.33223529398925794,0.6757781811163818,0.8449367088607594,0.9726393717619649,1.0,1/11,4.08%,ELOF1
prerank,T cell activation (GO:0042110),0.24741352703886926,0.6755890728642437,0.9122401847575058,0.9724534586995781,1.0,6/69,6.77%,PPP3CA;CD2;ADA;PTPN2;NCK2;CD44
prerank,mitochondrial fusion (GO:0008053),0.3003621145528677,0.673709106960466,0.8652173913043478,0.9740615342937683,1.0,6/18,27.92%,MIEF1;MIEF2;MIGA1;USP30;CHCHD3;BAX
prerank,positive regulation of leukocyte migration (GO:0002687),0.2816074695911455,0.6736997614962393,0.8699861687413555,0.9736874574819152,1.0,6/27,20.19%,VEGFA;MIA3;PTN;NCKAP1L;EDN3;LGALS3
prerank,oogenesis (GO:0048477),-0.2559744490709908,-0.6734090095310101,0.8947368421052632,1.0,1.0,1/15,2.64%,FMN2
prerank,regulation of amyloid-beta clearance (GO:1900221),0.310387786044667,0.6728492336361526,0.8609865470852018,0.9742132561411566,1.0,4/16,18.62%,LRP1;ABCA7;CLU;HMGCR
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.31987694625816177,0.6727580687931493,0.8564885496183207,0.9739221332216772,1.0,13/13,68.04%,FIP1L1;CSTF2T;NUDT21;CPSF4L;NCBP2;NCBP1;CPSF4;CPSF7;TUT1;CPSF1;CPSF6;CSTF2;CPSF2
prerank,protein import into peroxisome matrix (GO:0016558),-0.27349917289464154,-0.6721822252215314,0.8940217391304348,1.0,1.0,2/12,9.17%,PEX5L;PEX5
prerank,mitochondrial transcription (GO:0006390),0.3308216605254499,0.6720196229341123,0.8233387358184765,0.9742943171532467,1.0,2/10,18.35%,FOXO3;MTERF2
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.24289755488172177,0.6717483415180684,0.9377123442808607,0.9741916376206158,1.0,19/79,24.22%,AP2A2;SEC31A;SEC24B;SEC23A;SEC24D;DCTN5;KIF3B;DCTN4;CTSE;CAPZA1;KLC1;AP2B1;LAG3;AP2A1;AP1M1;AP1S1;KIF23;KIF15;KIFAP3
prerank,protein palmitoylation (GO:0018345),0.2782351853197458,0.6715208294192355,0.8647925033467202,0.9740578083850435,1.0,10/30,22.44%,ZDHHC2;HHAT;ZDHHC20;ZDHHC12;ZDHHC15;ZDHHC13;ZDHHC24;GOLGA7;ZDHHC3;ZDHHC19
prerank,regulation of cardiac muscle contraction (GO:0055117),0.27176437996975955,0.6711524279431086,0.872870249017038,0.9740509323192829,1.0,4/34,9.77%,ANK2;ATP1B1;ZC3H12A;SLC9A1
prerank,melanosome transport (GO:0032402),0.3021597554758393,0.6709752997311734,0.8560830860534124,0.9734650506610611,1.0,6/18,23.15%,MLPH;RAB11B;BLOC1S5;MKKS;RAB11A;BBS2
prerank,pigment granule transport (GO:0051904),0.3021597554758393,0.6709752997311734,0.8560830860534124,0.9734650506610611,1.0,6/18,23.15%,MLPH;RAB11B;BLOC1S5;MKKS;RAB11A;BBS2
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.304772442869253,0.6697785568556395,0.855072463768116,0.9743022853011486,1.0,5/17,19.43%,SPRED2;DMTN;PARD3;SMAD7;EIF4G1
prerank,vitamin D metabolic process (GO:0042359),-0.2670533378667275,-0.6687471700606569,0.9103641456582633,1.0,1.0,2/13,9.47%,LGMN;CUBN
prerank,serine family amino acid catabolic process (GO:0009071),-0.2932398640384074,-0.6682366595343777,0.8578947368421053,1.0,1.0,5/10,32.08%,CBS;GLDC;GCSH;THNSL2;DAO
prerank,Notch signaling involved in heart development (GO:0061314),0.33044027308675605,0.667402845746771,0.8470948012232415,0.9762996184613973,1.0,3/11,12.02%,NOTCH2;GALNT11;JAG1
prerank,regulation of cell aging (GO:0090342),0.3294184288819343,0.667197379831768,0.8621794871794872,0.9761262332949924,1.0,4/11,23.76%,LMNA;NEK4;NEK6;RSL1D1
prerank,glycosphingolipid metabolic process (GO:0006687),0.2569820503045448,0.6660437230948959,0.8948717948717949,0.9768904798425376,1.0,3/42,4.64%,ESYT3;HEXA;LARGE1
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.31547142856398297,0.6660239932708474,0.8656716417910447,0.9761485437298164,1.0,5/15,23.22%,AGO2;PABPC1;DHX36;TOB1;CNOT1
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.31547142856398297,0.6660239932708474,0.8656716417910447,0.9761485437298164,1.0,5/15,23.22%,AGO2;PABPC1;DHX36;TOB1;CNOT1
prerank,cellular response to glucose starvation (GO:0042149),0.2571112847792849,0.6658220382339558,0.8931788931788932,0.9759632818654922,1.0,7/41,13.43%,ITFG2;FOXO3;ZC3H12A;BECN1;SZT2;SH3GLB1;RRP8
prerank,positive regulation of protein maturation (GO:1903319),0.33161294082864445,0.665494671223832,0.8557993730407524,0.9759131767403483,1.0,1/11,2.92%,TNP2
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.2498345665378462,-0.6653819029809911,0.9226361031518625,1.0,1.0,5/15,21.86%,BCL2;MIF;CD74;TAF9;TRIAP1
prerank,female gamete generation (GO:0007292),-0.21155575057985707,-0.6653549540872665,0.9496402877697842,1.0,1.0,2/29,3.65%,FMN2;DIAPH2
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.268967452282201,-0.6652436679479948,0.8964497041420119,1.0,1.0,4/13,11.88%,TNRC6B;CPEB3;POLR2G;BTG2
prerank,establishment of spindle localization (GO:0051293),0.31472678869292586,0.6649008345435269,0.8399390243902439,0.9761397179727431,1.0,1/14,2.23%,NLRP5
prerank,regulation of defense response to virus (GO:0050688),0.31514884303109786,0.6646590715694008,0.8597285067873304,0.9759920414094474,1.0,7/14,33.41%,IFNLR1;DHX9;TRAF3;PPM1B;TRAF3IP1;RNF26;C1QBP
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.30126509156386394,0.6644791622114855,0.872093023255814,0.9757969078646018,1.0,4/17,23.22%,PLA2G4F;LPCAT1;SERAC1;PLA2G12A
prerank,regulation of cilium movement (GO:0003352),0.3338399106348613,0.6636908973409005,0.8296875,0.976200474967938,1.0,4/10,24.73%,CFAP43;ODAD2;DRC1;DNAH11
prerank,microtubule anchoring (GO:0034453),0.3117201376062191,0.6632981496072734,0.8524046434494196,0.9762022316117532,1.0,5/12,23.42%,PCM1;BICD1;CAMSAP3;BICD2;GCC2
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.2836249137361282,0.6631730362584318,0.8504672897196262,0.9759381292819388,1.0,9/24,22.85%,FGF2;PLCG2;IBTK;CHERP;LCK;ITPR2;ANXA6;TRPM2;HTR2B
prerank,nuclear membrane disassembly (GO:0051081),-0.2633759983068494,-0.6628089671430435,0.8753387533875339,1.0,1.0,1/14,1.18%,PRKCB
prerank,replicative senescence (GO:0090399),-0.2684934424271864,-0.6627977604565092,0.9171428571428571,1.0,1.0,2/12,5.73%,PLA2R1;MME
prerank,DNA catabolic process (GO:0006308),-0.27853107344632766,-0.6622502415792962,0.8815028901734104,1.0,1.0,11/11,72.17%,MUS81;ISG20;REXO4;XRN2;DNASE1;FBH1;DNASE1L3;DNASE1L1;DNASE1L2;DFFB;SETMAR
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.2682363565880537,0.6618089499142105,0.8855989232839838,0.9769295964673747,1.0,5/30,15.15%,ABCD3;ABCD1;ACOX1;TECR;ELOVL5
prerank,cell junction maintenance (GO:0034331),-0.2650243819751942,-0.6612097847253898,0.9337175792507204,1.0,1.0,5/14,23.64%,CLDN1;CSF1R;CBLN2;F2R;PRTN3
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.24850829589967102,-0.6610706158922579,0.884375,1.0,1.0,8/17,27.76%,MMGT1;EMC7;SGTA;BAG6;EMC6;EMC1;GET1;EMC10
prerank,cardiolipin metabolic process (GO:0032048),0.31144258367942634,0.6608008291795947,0.8606431852986217,0.9775200495278829,1.0,4/13,25.44%,PLSCR3;TAMM41;HADHA;LCLAT1
prerank,chromatin remodeling at centromere (GO:0031055),0.27160327236821213,0.660540008308618,0.8823529411764706,0.9773902810134825,1.0,13/31,32.12%,RBBP7;CENPT;HJURP;CENPL;SMARCA5;CENPW;CENPP;RSF1;CENPK;NASP;HELLS;CENPN;CENPV
prerank,cellular biogenic amine catabolic process (GO:0042402),-0.2824393591421362,-0.6604928116780577,0.8689839572192514,1.0,1.0,4/10,18.00%,SLC44A1;COMT;ALDH7A1;SARDH
prerank,carboxylic acid catabolic process (GO:0046395),0.31969597554428675,0.6602397678420536,0.8620689655172413,0.9772904122438075,1.0,3/12,18.55%,RENBP;ACOT8;GNPDA1
prerank,peptidyl-amino acid modification (GO:0018193),0.3312553858299492,0.660127700087022,0.8728139904610492,0.9770169939041751,1.0,2/10,22.31%,FKBP10;METAP2
prerank,maintenance of gastrointestinal epithelium (GO:0030277),-0.26076453244090075,-0.6598644105731494,0.9043478260869565,1.0,1.0,1/12,2.52%,RBP4
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.281605451076956,0.6591107547876844,0.8953804347826086,0.9776166803164011,1.0,3/24,11.03%,PLA2G4F;PLA2G15;LPCAT1
prerank,regulation of lymphocyte migration (GO:2000401),0.3282281359055831,0.6587247762032272,0.8520900321543409,0.9776163141343875,1.0,2/10,12.50%,MIA3;SLC8B1
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.2890241393741196,0.6585570841729547,0.8680351906158358,0.9774092477996088,1.0,2/19,7.27%,RIC3;NQO1
prerank,regulation of phosphatase activity (GO:0010921),0.28067698228122445,0.6583931033863205,0.9041095890410958,0.9771784715349402,1.0,9/24,27.60%,PTPA;PPP6R3;CHP1;URI1;PPP6R1;PPP6R2;MTMR9;TSC1;ZCCHC9
prerank,regulation of cytokine production (GO:0001817),0.2270858238423525,0.6583391380492923,0.9728260869565217,0.9768492987551244,1.0,20/126,19.11%,FOXP1;HDAC9;IL33;ANXA1;C5AR2;PER1;NLRP12;MAST2;IFIH1;EIF2AK2;NPTN;ALOX5;FFAR4;FLOT1;GLMN;TWSG1;MAPKAPK2;CCN4;IGF2BP3;AGPAT2
prerank,detection of visible light (GO:0009584),0.29420966677523025,0.6580269426020222,0.8580152671755725,0.9767663344879992,1.0,1/16,2.89%,CACNA1F
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.28274652246241105,0.6574993043991216,0.8903133903133903,0.9768859054060618,1.0,3/20,12.45%,CAMK2D;HERPUD1;BCAP31
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.24615234336961905,-0.6569277945621157,0.8969072164948454,1.0,1.0,10/17,35.19%,ATP5PF;ATP5F1E;ATP5F1A;ATP5F1B;ATP5MC1;ATP5MC2;ATP5MC3;ATP5F1D;DMAC2L;STOML2
prerank,regulation of spindle assembly (GO:0090169),0.2762112602275135,0.6563070900872912,0.8804347826086957,0.977664916420502,1.0,10/25,32.75%,DRG1;PDCD6IP;CHMP2B;SENP6;GPSM2;CHMP3;PLK1;CEP97;RNF4;TPR
prerank,alpha-amino acid metabolic process (GO:1901605),-0.1940022577297367,-0.6557454399588728,0.9783783783783784,1.0,1.0,16/45,26.52%,ASPA;SLC25A13;ASPG;GOT2;NOX4;CBS;ASNS;FOLH1;GPT2;GOT1;DDAH1;DDAH2;ASS1;KYAT3;NAT8L;PYCR1
prerank,photoreceptor cell development (GO:0042461),0.3064763277324589,0.6549405668477526,0.8776119402985074,0.9785905668337288,1.0,2/14,10.41%,VEGFA;ARL3
prerank,gas transport (GO:0015669),0.3295982192899582,0.6548599719459178,0.8330605564648118,0.9782833479672489,1.0,1/10,6.11%,CYGB
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.2432641768145638,0.6546622036547839,0.9284876905041032,0.9780790067436738,1.0,11/62,17.97%,YBX3;NFE2L2;VNN1;NDUFS3;CREB3L1;MCL1;HERPUD1;CLU;URI1;LRRK2;BAG5
prerank,non-motile cilium assembly (GO:1905515),0.2671535746467376,0.6540865152291286,0.8986666666666666,0.9782680577760147,1.0,10/30,30.22%,PCM1;TOGARAM1;DISC1;C2CD3;PIBF1;CEP89;RPGRIP1L;CEP290;BBS4;GORAB
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.32689796090980405,0.6533842676803201,0.8471337579617835,0.9785450937645372,1.0,1/10,3.59%,ANO6
prerank,icosanoid biosynthetic process (GO:0046456),-0.2818106875657935,-0.6531690513527271,0.8979057591623036,1.0,1.0,4/10,27.23%,LTA4H;PLA2G5;ALOX5AP;MGST2
prerank,maturation of SSU-rRNA (GO:0030490),-0.20802112534811934,-0.6508665495836524,0.9761904761904762,1.0,1.0,6/34,11.98%,RPS14;RPS19;RPS8;RPS16;SNU13;DDX52
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.21611796848163684,-0.6507162506022067,0.926829268292683,1.0,1.0,10/29,22.65%,RPS14;RPS19;RPS8;RPS21;RPS16;HEATR1;RRS1;MRPS11;WDR46;NOP9
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.26830442836325225,0.6506641500094216,0.9152542372881356,0.9807230232354797,1.0,4/30,12.66%,BMP5;GSK3B;TRAF2;BRCA1
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.28076063828405895,0.649924548526952,0.9012693935119888,0.9810417573459046,1.0,5/23,16.07%,KIF1B;HOOK3;KIF1C;MAP6;KIF5B
prerank,response to muramyl dipeptide (GO:0032495),0.32049769687457824,0.6493741642517916,0.8606060606060606,0.9811775649671326,1.0,3/12,11.69%,RIPK2;ERBIN;TRIM41
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.31205866254637843,0.6483247807906632,0.8747993579454254,0.9817524642032212,1.0,4/12,15.15%,ABCD1;ACOT8;ACOX1;ELOVL5
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.2320252172226073,-0.648000594328409,0.9240506329113924,1.0,1.0,7/18,22.19%,PIK3R1;BCL2L11;ERN1;BOK;XBP1;BAG6;RNFT1
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.28492981459818184,0.6478000627758871,0.8791848617176128,0.9818372950405042,1.0,4/20,16.70%,BMP5;BRCA1;ACADL;SIK1
prerank,negative regulation of catalytic activity (GO:0043086),-0.21971064378833993,-0.6477052037182484,0.934931506849315,1.0,1.0,3/24,6.27%,NES;IFIT1;NOTCH1
prerank,regulation of histone H3-K9 acetylation (GO:2000615),-0.28936864069846235,-0.6473656266564705,0.8579545454545454,1.0,1.0,1/10,2.90%,RAPGEF3
prerank,regulation of sister chromatid cohesion (GO:0007063),0.31024786031545176,0.6464646171724205,0.8586466165413534,0.9826336471007145,1.0,5/12,24.69%,HDAC8;DDX11;RB1;WAPL;RAD21
prerank,positive regulation of interleukin-13 production (GO:0032736),0.32340156899226,0.6462354823386701,0.8592,0.9824555594457933,1.0,1/10,4.07%,RARA
prerank,regulation of anoikis (GO:2000209),0.28095378402969956,0.6460564530015255,0.8909883720930233,0.9822367897828645,1.0,7/19,18.39%,CEACAM5;ITGB1;BRMS1;ANKRD13C;MCL1;SIK1;ITGA5
prerank,DNA strand elongation involved in DNA replication (GO:0006271),-0.2351579946311146,-0.6459466989577729,0.9218241042345277,1.0,1.0,5/18,24.67%,LIG3;MCMDC2;RFC4;PCNA;LIG1
prerank,regulation of myelination (GO:0031641),-0.21916573755853125,-0.6457758959685383,0.9372822299651568,1.0,1.0,5/25,17.15%,TNFRSF21;TENM4;JAM2;SIRT2;NSUN5
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.22888897980259512,0.6444669737065883,0.9491525423728814,0.9833005932856254,1.0,17/87,19.71%,COX16;NDUFS3;TTC19;NDUFC2;NDUFB4;TMEM126A;SCO2;ECSIT;COA8;NUBPL;NDUFA12;SDHAF2;NDUFAB1;AIFM1;UQCRFS1;NDUFA9;FASTKD3
prerank,positive regulation of secretion (GO:0051047),0.3180177143215568,0.6442750717045442,0.8727858293075684,0.983102254654467,1.0,1/11,5.85%,ACSL3
prerank,protein acylation (GO:0043543),0.25980814402159186,0.644111720920106,0.9093298291721419,0.9828574720881229,1.0,8/38,13.54%,CREBBP;ZDHHC2;HHAT;ZDHHC20;ZDHHC12;NAT10;ZDHHC15;ZDHHC13
prerank,positive regulation of chromatin organization (GO:1905269),0.31540428299189266,0.6436459206032116,0.8890625,0.98289351643672,1.0,2/12,14.60%,MIER1;ATRX
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.22616208211850927,0.6431710063734984,0.9556313993174061,0.9829306970305319,1.0,31/83,32.28%,PCM1;AURKA;PAFAH1B1;CEP43;AKAP9;SDCCAG8;HAUS2;CEP63;PLK4;PCNT;OFD1;CDK2;CENPJ;CEP164;CETN2;SFI1;YWHAE;CEP76;TP53;CSNK1E;CEP290;PLK1;NEK10;ACTR1A;CEP72;GTSE1;CEP131;CEP57;TUBG1;NDE1;CSNK1D
prerank,response to amino acid (GO:0043200),0.2624924973757955,0.6428517144763117,0.9032697547683923,0.982832486227448,1.0,3/31,5.41%,CAPN2;GLRB;RRAGB
prerank,sulfur amino acid metabolic process (GO:0000096),0.27778172755843067,0.6424780466525122,0.8994490358126722,0.9827707957552121,1.0,4/24,19.35%,GCLC;DPEP1;ADO;GADL1
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.2612820704176376,0.6418905826623963,0.9205479452054794,0.9828614639742278,1.0,3/30,7.87%,PRKCD;PTPN2;DMTN
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),-0.22330036788703955,-0.6414387840686969,0.9391891891891891,1.0,1.0,1/22,0.78%,NR2F2
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.26074271591722264,-0.6414205592928286,0.9164265129682997,1.0,1.0,2/12,7.84%,APOE;PFDN5
prerank,CENP-A containing chromatin organization (GO:0061641),0.2676744140695193,0.6414094588558271,0.8986842105263158,0.9825383758152111,1.0,10/29,28.77%,RBBP7;CENPT;HJURP;CENPL;SMARCA5;CENPW;CENPP;RSF1;CENPK;NASP
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.2676744140695193,0.6414094588558271,0.8986842105263158,0.9825383758152111,1.0,10/29,28.77%,RBBP7;CENPT;HJURP;CENPL;SMARCA5;CENPW;CENPP;RSF1;CENPK;NASP
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.2609395988132359,-0.6412774095002638,0.8988095238095238,1.0,1.0,2/13,11.38%,NOS3;ALDH4A1
prerank,piRNA metabolic process (GO:0034587),0.2828193488621706,0.6410490877508053,0.8981348637015782,0.9824606345324721,1.0,1/19,5.55%,TEX15
prerank,ribosomal large subunit assembly (GO:0000027),-0.21405753073314399,-0.6408719512425429,0.96,1.0,1.0,13/24,40.14%,RPL23A;RPL11;RRS1;NLE1;DDX28;RPF2;FASTKD2;RPL24;RSL24D1;RPL6;NOP2;PPAN;RPL3L
prerank,regulation of actomyosin structure organization (GO:0110020),0.30342541837086173,0.6404668035648641,0.875,0.9825779831219859,1.0,2/13,9.77%,AKAP13;SLC9A1
prerank,organonitrogen compound catabolic process (GO:1901565),0.23769574368299523,0.6401401175523329,0.9479289940828403,0.982495257749144,1.0,10/57,19.40%,CPQ;PLA2G15;NPEPPS;RENBP;PDXDC1;IDE;ADO;GNPDA1;GADL1;LRSAM1
prerank,tryptophan metabolic process (GO:0006568),0.3157192290317369,0.6401170718570434,0.8930232558139535,0.9821403821268309,1.0,2/11,18.32%,TDO2;IDO2
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.2615430217786036,0.6393003959831354,0.9170068027210885,0.9824637330734644,1.0,8/30,22.54%,FUT8;MGAT1;MGAT5;DDOST;TUSC3;DPM1;ALG8;MCFD2
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.3010314526295764,0.6389390313422229,0.8722397476340694,0.982388101444424,1.0,5/13,19.11%,MAVS;IFIH1;TRIM44;DHX9;AGPAT2
prerank,negative regulation of B cell activation (GO:0050869),0.27705556832290495,0.6387773633963797,0.8935574229691877,0.9821476108922247,1.0,3/21,9.39%,ID2;INHBA;PARP3
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.3034492015565283,0.6386471864342609,0.8854003139717426,0.9818756466757685,1.0,2/14,7.49%,DDX18;URB1
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.2679271325731857,-0.638245729903036,0.8954423592493298,1.0,1.0,5/11,21.47%,INPP1;IMPA2;INPP5B;INPP5A;INPP5J
prerank,inositol phosphate dephosphorylation (GO:0046855),-0.2679271325731857,-0.638245729903036,0.8954423592493298,1.0,1.0,5/11,21.47%,INPP1;IMPA2;INPP5B;INPP5A;INPP5J
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.3022708819207077,0.6370498355514205,0.8885448916408669,0.9828369254203548,1.0,1/13,4.08%,ELOF1
prerank,mitochondrial outer membrane permeabilization (GO:0097345),-0.25439477649422404,-0.6368379709527308,0.9247648902821317,1.0,1.0,13/13,74.59%,BCL2L11;RHOT2;PMAIP1;BMF;MOAP1;BNIP3;BLOC1S2;VDAC2;RTL10;BNIP3L;BAX;BAD;RHOT1
prerank,tRNA 5'-leader removal (GO:0001682),-0.24983368878651455,-0.6364435766259384,0.9196428571428571,1.0,1.0,7/13,38.77%,POP4;RPP14;POP7;RPP40;RPP21;POP1;RPP25
prerank,cellular response to topologically incorrect protein (GO:0035967),0.2583347593868497,0.6364377731939077,0.9187418086500655,0.9829638003868759,1.0,3/31,8.57%,HSPB8;BAG3;HSPA1L
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),-0.24420722135007847,-0.6364212260151676,0.9212827988338192,1.0,1.0,16/16,75.61%,AGER;CYRIB;FADD;IL12A;IL12RB1;IL23A;CEACAM1;KLRD1;IL12B;RIPK3;XCL1;KLRC1;STX7;IL23R;PTPRC;LILRB1
prerank,microtubule bundle formation (GO:0001578),0.2496075404380012,0.6362945169943871,0.9202059202059202,0.9827126601128535,1.0,7/42,16.20%,CLIP1;TOGARAM1;NAV1;GAS2L1;CHP1;MAP1S;CCDC66
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.28749072666207787,0.6353410235309288,0.8976608187134503,0.9831532686935305,1.0,4/17,17.40%,MID1;EIF2AK2;ARL6IP5;SCIMP
prerank,negative regulation of histone modification (GO:0031057),0.3011830950056854,0.6351368267479894,0.893455098934551,0.9829353869868385,1.0,5/14,24.01%,TWIST1;BRCA1;THAP7;PRMT6;TAF7
prerank,motile cilium assembly (GO:0044458),-0.25884008274162273,-0.6351317969132074,0.9182561307901907,1.0,1.0,7/12,38.30%,BBS5;CCDC39;SPATA6;BBOF1;CCDC40;RSPH6A;DNAAF1
prerank,cellular response to UV-A (GO:0071492),0.3121946292451208,0.6345745961342765,0.8990536277602523,0.983033911408666,1.0,1/11,4.34%,TIMP1
prerank,TOR signaling (GO:0031929),-0.2143160395012516,-0.6345364542363077,0.9485294117647058,1.0,1.0,5/26,15.17%,PRR5L;EIF4EBP2;PINK1;TIPRL;CCDC88A
prerank,prostanoid metabolic process (GO:0006692),-0.2513757815986181,-0.634393959613782,0.924119241192412,1.0,1.0,3/13,15.39%,PTGS1;GSTM1;HPGDS
prerank,triglyceride homeostasis (GO:0070328),0.26631784114753,0.6327778683585121,0.9252717391304348,0.9841411673578375,1.0,4/26,11.46%,ACSM2A;RORA;MLXIPL;ANGPTL3
prerank,protein import into mitochondrial matrix (GO:0030150),0.278241153763739,0.6325586067621503,0.9172932330827067,0.98394779106925,1.0,7/18,28.52%,TIMM23;TIMM17B;GRPEL2;TIMM44;DNLZ;TOMM20;GRPEL1
prerank,tRNA 5'-end processing (GO:0099116),-0.24204782490117283,-0.631900307418179,0.91875,1.0,1.0,7/15,38.77%,POP4;RPP14;POP7;RPP40;RPP21;POP1;RPP25
prerank,protein mono-ADP-ribosylation (GO:0140289),0.3095608810936183,0.6317811531120918,0.8824451410658307,0.9842174126444756,1.0,4/11,19.48%,PARP3;PARP12;PARP6;PARP4
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.1974858235648306,-0.6315630877171676,0.9705882352941176,1.0,1.0,17/32,38.76%,DEFA6;RPS19;PGLYRP1;GAPDH;ROMO1;RPL39;HRG;CCL13;CXCL14;CXCL5;CXCL1;RPL30;PF4;PPBP;CAMP;CXCL10;PGLYRP3
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.2759463682922251,0.6309366258075689,0.8942172073342737,0.9841593674819725,1.0,10/22,26.99%,ZDHHC2;ZDHHC20;ZDHHC12;ZDHHC15;ZDHHC24;GOLGA7;ZDHHC3;ZDHHC19;ZDHHC21;ZDHHC6
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.2759463682922251,0.6309366258075689,0.8942172073342737,0.9841593674819725,1.0,10/22,26.99%,ZDHHC2;ZDHHC20;ZDHHC12;ZDHHC15;ZDHHC24;GOLGA7;ZDHHC3;ZDHHC19;ZDHHC21;ZDHHC6
prerank,phagolysosome assembly (GO:0001845),0.3072843245639761,0.6309303670639719,0.8805970149253731,0.9837879615014234,1.0,1/12,3.81%,RAB7B
prerank,regulation of protein localization (GO:0032880),-0.17795101307927758,-0.6305512443274344,0.9779005524861878,1.0,1.0,18/58,24.73%,MAP2;PICALM;TRIM14;WDPCP;MMD2;HSP90AB1;ATCAY;RACK1;RABGAP1L;FBXW7;TRIM46;PPM1F;MMD;TRIM67;UFL1;DNAJB6;TRIM17;ADCYAP1
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.2798543923879283,0.6298644726236012,0.9004524886877828,0.9842846549178734,1.0,6/19,24.61%,DNAAF4;OFD1;NPHP3;SPAG17;DNAAF2;CFAP53
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.26274751743275093,0.62922375677799,0.9090909090909091,0.9844295977161021,1.0,8/24,25.55%,EED;DNMT3A;RBBP7;TASOR;EPC1;SUZ12;PPHLN1;PPM1D
prerank,maintenance of protein location in nucleus (GO:0051457),0.2727013011849979,0.6282580699300239,0.9236311239193083,0.9848293173148283,1.0,9/20,30.51%,BARD1;MORC3;PML;TAF8;SUN1;TOPORS;SUN2;BBS4;SUPT7L
prerank,T cell homeostasis (GO:0043029),0.3139152721589629,0.6280933967943393,0.8839427662957074,0.9845929079587445,1.0,1/10,4.70%,PPP2R3C
prerank,negative regulation of defense response to virus (GO:0050687),-0.26890967296466006,-0.6279991286274199,0.9222520107238605,1.0,1.0,10/10,73.13%,TSPAN6;TARBP2;PCBP2;MUL1;ITCH;ILRUN;C1QBP;RNF26;TRAF3IP1;PPM1B
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.26656316742825403,0.6274054324866523,0.8945908460471568,0.9847552120810459,1.0,6/25,21.99%,GPI;PFKP;ADPGK;FOXK1;FOXK2;PKM
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.2537413299543397,-0.6265802163427238,0.9037974683544304,1.0,1.0,1/12,2.27%,CYP26B1
prerank,regulation of immune response (GO:0050776),0.2118816457662373,0.6258696581979519,0.9806451612903225,0.9856056456783506,1.0,7/135,8.40%,FOXP1;COL3A1;RAET1E;SPPL2A;ITGB1;IRF1;COL17A1
prerank,regulation of lamellipodium organization (GO:1902743),0.2904573890960662,0.6256756034268842,0.8936484490398818,0.9853787928284035,1.0,2/14,7.87%,CD44;DMTN
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.30209184494913727,0.6254412965377818,0.8983050847457628,0.9851919587760486,1.0,2/13,8.33%,IL33;TLR4
prerank,positive regulation of isotype switching (GO:0045830),0.2812256274961806,0.6254218590583944,0.8929663608562691,0.984832921191403,1.0,2/15,12.74%,CLCF1;KMT5B
prerank,eye photoreceptor cell development (GO:0042462),0.28995368927129866,0.6248240371651312,0.910581222056632,0.9849282105054981,1.0,6/15,28.45%,VEGFA;CRB2;RPGRIP1L;CEP290;TOPORS;BBS4
prerank,regulation of T cell differentiation (GO:0045580),0.2473101797463645,0.6242086266659872,0.9324324324324325,0.9850306986691666,1.0,2/33,4.52%,CD2;ABL1
prerank,defense response to Gram-positive bacterium (GO:0050830),0.24133813114571395,0.6230375468155742,0.9408672798948752,0.9855462670890908,1.0,4/40,13.32%,LBP;MYD88;RNASE3;TIRAP
prerank,intracellular pH reduction (GO:0051452),-0.19517921848611822,-0.6226494227950444,0.967479674796748,1.0,1.0,11/33,26.38%,DMXL2;CLCN3;ATP6V0A1;ATP6V1G1;RAB39A;ATP6V0E2;ATP6V0D2;RAB38;ATP6V0C;RAB20;ATP6V1E1
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),-0.22806907378335947,-0.6223639896628878,0.9437869822485208,1.0,1.0,16/16,77.22%,PIGW;PIGM;PIGZ;PIGL;PIGN;PIGF;PIGC;PIGX;DPM2;PIGH;PIGP;PIGA;PIGV;PIGQ;PIGB;PIGG
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.2703382061475994,0.622238539694992,0.896700143472023,0.9857677541324429,1.0,2/20,7.24%,CLK2;NCOR1
prerank,positive regulation of nervous system process (GO:0031646),0.2788668674599159,0.6220562764667066,0.9196428571428571,0.9855326505546796,1.0,4/18,17.41%,UNC13B;PARD3;CST7;HCRT
prerank,regulation of innate immune response (GO:0045088),0.2323247143345406,0.6220491328270872,0.9501216545012166,0.9851624555513445,1.0,11/57,18.46%,TRAFD1;IRAK3;IRF1;TLR8;POLR3F;IFI35;TIRAP;AKIRIN2;PLSCR1;POLR3D;DHX9
prerank,negative regulation of T cell proliferation (GO:0042130),0.25514125697709644,0.62145754599434,0.9232876712328767,0.9852310467979379,1.0,6/28,16.99%,ARG1;CD80;PDCD1LG2;DLG5;SCRIB;GLMN
prerank,placenta development (GO:0001890),-0.25477087417054756,-0.6208296634520656,0.9355742296918768,1.0,1.0,4/12,21.26%,PTK2;SOD1;ADAM19;E2F7
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.24289706340409817,0.6205513170943798,0.9494584837545126,0.985565720466275,1.0,10/44,17.96%,CNOT8;AGO2;ZC3H12A;PABPC1;DHX36;CELF1;MEX3D;MOV10;FTO;TOB1
prerank,response to gamma radiation (GO:0010332),0.2641567354457544,0.6196901163850977,0.9046961325966851,0.9858573918241034,1.0,8/24,23.55%,WRN;KDM1A;YAP1;ATR;TLK2;XRCC5;ATM;TP53
prerank,regulation of cytoplasmic translation (GO:2000765),0.28700157508401913,0.6196065676969597,0.8926974664679582,0.9855444842055983,1.0,5/14,22.06%,YBX3;DHX36;DHX9;PKM;FMR1
prerank,cellular response to oxygen levels (GO:0071453),-0.27518699390063595,-0.619134594625171,0.9013333333333333,1.0,1.0,2/10,10.14%,CPEB4;ATP6V1G1
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.24424728583731165,-0.6189516603222084,0.9278996865203761,1.0,1.0,9/13,43.91%,BRSK2;UBAC2;ERLEC1;UBE2J1;SVIP;DERL2;DERL3;OS9;YOD1
prerank,intracellular protein transmembrane transport (GO:0065002),0.23664274524065007,0.6179078240195333,0.9262187088274044,0.986435876309991,1.0,15/42,30.74%,SEC61A1;TIMM23;C2CD5;PEX26;PEX1;AIFM1;TIMM17B;GRPEL2;TIMM44;DNLZ;SEC61B;TOMM20;GRPEL1;PEX2;PEX7
prerank,positive regulation of signaling receptor activity (GO:2000273),0.2477509825525769,0.6176896448989249,0.9362808842652796,0.986220205404208,1.0,4/36,11.40%,ADRB2;NRP1;ITGB1;EPHB2
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.2403251579816543,0.6175810657618303,0.9543726235741445,0.9859242844257664,1.0,5/47,8.14%,PTGIS;CLK2;ATP2B4;MPV17L;ZC3H12A
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.2642293239670634,-0.6159342517420391,0.8925619834710744,1.0,1.0,7/10,32.39%,ZNHIT6;ZNHIT3;TAF9;NUFIP1;RUVBL1;PIH1D1;RUVBL2
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.23808626860048976,-0.615315832316292,0.9244186046511628,1.0,1.0,14/14,76.22%,ERN1;CPSF2;CSTF2;CPSF6;CPSF1;TUT1;CPSF7;CPSF4;NCBP1;NCBP2;CPSF4L;NUDT21;CSTF2T;FIP1L1
prerank,'de novo' posttranslational protein folding (GO:0051084),0.2521886418683667,0.615196334606312,0.9272486772486772,0.9873021519632241,1.0,4/30,15.69%,ENTPD5;HSPA1L;GAK;SDF2
prerank,carbohydrate derivative catabolic process (GO:1901136),0.279496286049462,0.6151713712794395,0.9070100143061517,0.9869466380777626,1.0,5/18,16.72%,DERA;FBXO27;BPGM;OGA;FBXO17
prerank,mRNA modification (GO:0016556),0.27002284351124933,0.614981492017788,0.9081920903954802,0.9867067371132081,1.0,6/22,27.92%,RPUSD2;WTAP;VIRMA;TRMT61B;METTL16;CMTR1
prerank,regulation of acute inflammatory response (GO:0002673),-0.2293537649940338,-0.6148165272894419,0.941717791411043,1.0,1.0,18/18,77.10%,OSMR;NLRP3;GSTP1;CREB3L3;IL6;OSM;FFAR2;DNASE1;PLA2G2D;C2CD4B;IL6ST;F12;C2CD4A;DNASE1L3;ADAM8;KLKB1;IL4;PTGES
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.22890540321243083,0.6146128358911542,0.9564705882352941,0.9866036276542656,1.0,19/55,27.92%,CRADD;TGFBR1;STYXL1;TRIM39;BECN1;TRAF2;BCAP31;GSDME;LCK;TNFRSF12A;TRAF7;PML;TP53;DDIT3;PAK2;BID;BAD;BCLAF1;BAX
prerank,kinetochore organization (GO:0051383),0.29746267716858726,0.6144818292417268,0.9022082018927445,0.986330563571013,1.0,5/13,28.95%,CENPT;POGZ;CENPW;MIS12;CENPE
prerank,negative regulation of autophagosome assembly (GO:1902902),0.28825144591030594,0.6130935827538023,0.8925233644859814,0.9869870179718699,1.0,9/13,36.62%,TMEM39A;LRRK2;SMCR8;MTM1;SEC22B;PHF23;CHMP4A;CHMP4B;SCFD1
prerank,positive regulation of immunoglobulin production (GO:0002639),0.2489571349597237,0.6130318855156794,0.9329758713136729,0.9866604213938798,1.0,4/31,12.74%,CLCF1;GPI;EPHB2;KMT5B
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.29152028812565906,0.6128502704441172,0.9076005961251863,0.986415381748705,1.0,3/13,16.34%,CNOT8;ZC3H12A;MOV10
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.269055382408411,-0.6114127021878942,0.918918918918919,1.0,1.0,4/10,24.98%,WRAP53;CCT8;CCT3;TCP1
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.2544518283962564,0.6109480205404737,0.9237967914438503,0.9874277047700837,1.0,5/30,12.19%,TWIST1;CD44;KDM1A;FBXO5;CLU
prerank,protein prenylation (GO:0018342),0.308455213106522,0.6091091329842059,0.9052969502407705,0.9884005381319365,1.0,10/10,69.17%,FNTA;PGGT1B;RABGGTB;RCE1;RABGGTA;CHM;FNTB;AIPL1;PTAR1;CHML
prerank,inositol phosphate catabolic process (GO:0071545),-0.24604179145392757,-0.6077383928922327,0.8940217391304348,1.0,1.0,5/12,21.47%,INPP1;IMPA2;INPP5B;INPP5A;INPP5J
prerank,negative regulation of activated T cell proliferation (GO:0046007),-0.2573059595173905,-0.6076086641789927,0.9125,1.0,1.0,4/10,24.92%,PRKAR1A;PRNP;CD274;RC3H1
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.2557403536886679,0.6070187637703542,0.9171195652173914,0.9894477841983711,1.0,2/26,4.61%,TRAFD1;IRAK3
prerank,positive regulation of telomere capping (GO:1904355),0.2771988946846786,0.6061731643233355,0.9290123456790124,0.9896478382856194,1.0,4/17,23.49%,NEK7;MAP3K4;TNKS2;MAPKAPK5
prerank,negative regulation of cellular metabolic process (GO:0031324),0.23857031567498635,0.6051382598092021,0.9446589446589446,0.9899838887622262,1.0,7/37,13.77%,NCOR1;ATXN2;ITGAV;TRAT1;BRCA1;ITGB3;AATF
prerank,positive regulation of histone modification (GO:0031058),0.2434412570876164,0.6048323156503412,0.9400798934753661,0.9898086634101091,1.0,12/33,29.29%,NIPBL;KDM1A;BRCA1;SAP30BP;CHTOP;ZBTB7B;FMR1;TADA2B;AKAP8L;TADA2A;UBE2N;PAXIP1
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.2968860419172376,0.6040074537450397,0.8995215311004785,0.9899704603618139,1.0,3/11,28.67%,DDX11;MTOR;SMARCA4
prerank,glutathione derivative biosynthetic process (GO:1901687),-0.20978171634563814,-0.6037275730117092,0.9565217391304348,1.0,1.0,9/20,27.56%,AKR1A1;MGST1;GSTA4;GSTM1;HPGDS;GSTK1;GSTM5;MGST2;GSTM2
prerank,glutathione derivative metabolic process (GO:1901685),-0.20978171634563814,-0.6037275730117092,0.9565217391304348,1.0,1.0,9/20,27.56%,AKR1A1;MGST1;GSTA4;GSTM1;HPGDS;GSTK1;GSTM5;MGST2;GSTM2
prerank,positive regulation of dephosphorylation (GO:0035306),0.2511311138542859,0.6035486331716049,0.9394736842105263,0.9899222738512266,1.0,9/27,25.31%,PRKCD;PTPA;NSMF;PIN1;MTMR9;CALM2;SRC;CNEP1R1;DLC1
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.2777505324647206,0.60268651949262,0.9097525473071325,0.990146765482879,1.0,2/15,7.28%,SRPRB;SEC61A1
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.18166593109158755,-0.6021048607565341,0.9913793103448276,1.0,1.0,14/38,28.61%,NDUFB9;NDUFA4;NDUFA13;NDUFC1;NDUFV3;NDUFB11;NDUFA7;NDUFA11;NDUFB6;NDUFB8;NDUFA3;NDUFA1;NDUFB10;NDUFA2
prerank,regulation of TOR signaling (GO:0032006),0.21748714981488465,0.5982292960874388,0.9732246798603027,0.9926687468867342,1.0,15/67,25.36%,NPRL3;TELO2;ITFG2;RRAGB;HTR6;RHEB;GOLPH3;MLST8;EPM2A;NPRL2;LARS1;MAPKAPK5;TBCK;SMCR8;TSC1
prerank,organelle fission (GO:0048285),0.25596749320154205,0.5982103709857501,0.9454545454545454,0.9923081900841948,1.0,5/24,14.26%,CORO1C;MIEF1;WASHC5;ACOT8;MTFR1
prerank,glycolytic process (GO:0006096),-0.197234726557912,-0.5977958957684197,0.993127147766323,1.0,1.0,14/28,34.78%,PGM1;PGAM1;PGAM4;GAPDH;HK2;ENO1;GAPDHS;ALDOC;PFKM;PFKL;HKDC1;ALDOB;ENO4;HK3
prerank,spermatid development (GO:0007286),0.24306035923470162,0.5970984369099441,0.9470198675496688,0.9926457616840003,1.0,5/32,18.59%,CIB1;RFX2;SYCP3;RNF8;MKKS
prerank,regulation of hormone secretion (GO:0046883),0.27279628527864486,0.5966929233104787,0.934984520123839,0.9925202847237492,1.0,3/15,19.46%,ANXA1;VAMP2;EDN3
prerank,regulation of glucose metabolic process (GO:0010906),0.2413061338943453,0.5965153896353568,0.9410977242302544,0.9922720654245365,1.0,7/34,23.82%,IRS1;RORA;PDK3;FOXK1;FOXK2;OGT;USP7
prerank,phosphatidylcholine metabolic process (GO:0046470),0.21551692417873766,0.5963403089708277,0.9789473684210527,0.9920028746674271,1.0,10/70,16.45%,PLA2G4F;PLA2G15;CHKB;SLC44A3;MBOAT1;LPIN2;LPCAT1;PCTP;LPCAT2;LCAT
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.2303109353944468,0.5956928944087796,0.9508196721311475,0.9920398026423538,1.0,12/46,21.72%,ANXA2;PITPNA;GSTA2;PDCD4;CAPZA1;SERPINB2;HNRNPA2B1;JAK2;GSTO1;SOD2;AIP;STAT4
prerank,myelin maintenance (GO:0043217),0.2988885694081481,0.5955630588042091,0.9036544850498339,0.9917516466354456,1.0,2/10,12.19%,ABCD1;CLU
prerank,regulation of programmed necrotic cell death (GO:0062098),-0.21281825578675104,-0.5952003622611125,0.9487179487179487,1.0,1.0,4/20,15.51%,BIRC2;ASAH1;MLKL;NUPR1
prerank,protein targeting to mitochondrion (GO:0006626),0.22262242026975235,0.5951832531510063,0.9689054726368159,0.9916123990590539,1.0,21/52,29.24%,TIMM23;BCAP31;AGK;TIMM9;TSPO;AIFM1;TIMM17B;PITRM1;AIP;PMPCB;GRPEL2;TIMM44;TOMM34;DNLZ;TOMM20;MIPEP;SAMM50;TIMM13;GRPEL1;TIMM10;IMMP1L
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.19978465299229403,-0.5949229283739396,0.9695817490494296,1.0,1.0,7/25,24.01%,HSPA8;HSPA13;ERO1A;HSPA1A;HSPE1;HSPA2;HSPA5
prerank,transcription preinitiation complex assembly (GO:0070897),0.2838928743146917,0.5933817164911932,0.9074675324675324,0.9923609263347911,1.0,5/12,24.01%,GTF2A2;TBP;TAF12;GTF2B;TAF7
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.27454280934930336,0.591892128444743,0.9155145929339478,0.9929320286813504,1.0,3/13,20.23%,NRP1;PLXNB1;PLXNA4
prerank,regulation of mitotic spindle assembly (GO:1901673),0.2621365170311503,0.5910589095325262,0.9234042553191489,0.9930616507709333,1.0,7/19,32.75%,DRG1;PDCD6IP;CHMP2B;CHMP3;PLK1;CEP97;TPR
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.2645169581865022,0.5907685901929481,0.9321266968325792,0.9928606985810964,1.0,3/16,20.49%,SLX4;ERCC4;MSH4
prerank,mitochondrial gene expression (GO:0140053),0.22591940072627908,0.5886327362674032,0.9681528662420382,0.9937549229488459,1.0,9/42,24.87%,FOXO3;NOA1;MRPS2;FASTKD5;MRPL23;MRPS21;RARS2;GFM2;GATC
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.2653618252428267,0.5847539453329234,0.9348148148148148,0.9956372859980359,1.0,7/18,24.68%,STAT3;SMAD4;YAP1;SOCS3;JAK2;FER;SRC
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.27031442093411834,0.5839364845855345,0.9203007518796993,0.9957163939772196,1.0,4/13,22.09%,STAT3;IL27;JAK2;IL27RA
prerank,mRNA methylation (GO:0080009),0.27694853526240004,0.5839117570126894,0.9348148148148148,0.9953563430877114,1.0,5/15,27.92%,WTAP;VIRMA;TRMT61B;METTL16;CMTR1
prerank,regulation of viral transcription (GO:0046782),0.23045802255825326,0.5835089284900762,0.9527950310559006,0.9952109513903865,1.0,11/39,25.88%,MDFIC;NELFE;UBP1;DHX9;POLR2C;HEXIM1;CCNT1;MID2;LARP7;RSF1;SUPT4H1
prerank,rRNA transcription (GO:0009303),0.2665162623602123,0.5833076059977976,0.9314868804664723,0.9949555053435968,1.0,4/17,23.90%,POLR1G;GTF3C1;GTF3C4;GTF3A
prerank,regulation of hemopoiesis (GO:1903706),0.29299141329904554,0.5810703165741394,0.9276729559748428,0.9958567169344237,1.0,5/10,24.89%,MYSM1;CREBBP;PTN;LGALS3;CBFB
prerank,mitochondrion organization (GO:0007005),0.19474156703925977,0.5802366849844213,0.9989440337909187,0.9959280814045157,1.0,48/165,28.97%,PID1;VPS13C;MEF2A;NRF1;GABPB1;WDR81;PPRC1;VPS13D;TIMM23;MIEF1;PARP1;BCAP31;SIRT3;RAB5IF;MTFR1;TIMM9;YME1L1;NUBPL;MIEF2;TSPO;HCFC1;POLG2;LRRK2;MIGA1;CXADR;AIFM1;TIMM17B;PITRM1;AIP;USP30;TIMM44;TOMM34;SLC25A36;OMA1;BID;MTM1;RHOT1;MPV17;MGME1;TOMM20;CHCHD3;SAMM50;TIMM13;MTX2;BAX;PISD;HIGD1A;TIMM10
prerank,dendritic cell chemotaxis (GO:0002407),-0.22587494648050654,-0.5798581907968956,0.9505813953488372,1.0,1.0,10/14,40.10%,HMGB1;CCL19;CCR5;GPR183;PIK3CG;CCL5;CCR1;CCR2;CCR6;CXCR2
prerank,transcription by RNA polymerase III (GO:0006383),0.2429691785883199,0.5762645643843602,0.9562841530054644,0.9977634072719704,1.0,9/27,26.01%,SNAPC2;POLR3K;ICE2;TBP;GTF3C1;GTF3C4;GTF3A;RO60;ELL
prerank,negative regulation of DNA recombination (GO:0045910),0.22200308916038897,0.5761239936714666,0.9701863354037267,0.9974766059048301,1.0,6/43,18.58%,HELB;PARP3;CGAS;ATRX;RMI2;POLR2C
prerank,copper ion transport (GO:0006825),0.28132929994404143,0.576101567315097,0.9332247557003257,0.9971175888981592,1.0,2/11,13.86%,CUTC;SLC31A2
prerank,negative regulation of histone acetylation (GO:0035067),0.28304886002052515,0.5760738646973805,0.917057902973396,0.9967667174016309,1.0,3/11,24.01%,BRCA1;THAP7;TAF7
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.24411524700269913,-0.5757181172677033,0.9307692307692308,1.0,1.0,10/10,75.61%,ARRB2;CEACAM1;KLRD1;KLRC1;LGALS9;FCGR2B;CLEC12B;CX3CR1;PTPRC;LILRB1
prerank,myeloid dendritic cell activation (GO:0001773),0.27798674673678425,0.5752376787339126,0.9362041467304625,0.9968544851687925,1.0,2/12,12.90%,TGFBR2;BATF3
prerank,regulation of axon regeneration (GO:0048679),0.2763708653156203,0.5748573268954562,0.9191290824261276,0.9966936534991861,1.0,4/12,17.91%,PTPRS;CNTF;PTN;STK24
prerank,regulation of cytoplasmic transport (GO:1903649),0.27952722614977943,0.5733902324540561,0.9037267080745341,0.9970815365441196,1.0,5/11,26.14%,LRRK2;MAP2K2;USP7;SRC;CHMP3
prerank,RNA modification (GO:0009451),0.21531130462771858,0.5715908883772425,0.9771634615384616,0.997659419635799,1.0,13/54,26.82%,PUS7L;TYW5;NAT10;ELP5;SSB;THUMPD1;TRDMT1;FTSJ1;JMJD6;ALKBH1;PARN;FTSJ3;CDKAL1
prerank,phospholipid homeostasis (GO:0055091),0.276325963118828,0.5702767405125646,0.9162861491628614,0.9979687705420295,1.0,2/11,11.46%,TLCD1;ANGPTL3
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.2649616363789045,0.5696400203480855,0.9223880597014925,0.9979339047335158,1.0,3/14,13.93%,AGR2;TMEM33;COPS5
prerank,cellular protein-containing complex assembly (GO:0034622),0.1930521878509343,0.5683459128497872,0.996822033898305,0.9982215962408317,1.0,42/160,25.15%,ADRB2;CLTRN;NUP93;TIAM1;NCK2;FCHO2;ADRM1;PSMD11;SMAD2;STXBP6;NUP153;AHCTF1;CENPT;POGZ;CLU;TRAF2;RAB5IF;DMD;SRP19;NCK1;PSMD4;SMAD4;VAMP2;STXBP1;EIF4B;DNAAF3;DHX9;MKKS;TBCD;AIFM1;CLTB;DNAAF2;CALY;DRC1;TBCC;GTF2B;OMA1;TBCE;CENPW;BBS12;SRC;NUP98
prerank,protein autoprocessing (GO:0016540),0.25860084270177336,0.5666733476098552,0.9632352941176471,0.9986758902164892,1.0,5/17,23.72%,FXN;PIDD1;FAM111A;SPRTN;OMA1
prerank,V(D)J recombination (GO:0033151),-0.23537123664928683,-0.5642258721888119,0.9525065963060686,1.0,1.0,4/11,24.67%,HMGB1;LIG3;HMGB2;LIG1
prerank,regulation of lipid kinase activity (GO:0043550),0.27715050856209095,0.561935010125514,0.9312,1.0,1.0,3/11,17.24%,WDR81;PIK3R3;RB1
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.2735230081536059,0.5615675796090335,0.9282296650717703,1.0,1.0,4/11,27.78%,JAK2;HDAC2;TAF7;IL4
prerank,mitotic metaphase plate congression (GO:0007080),0.20982696292972133,0.5597069017825753,0.9812967581047382,1.0,1.0,10/51,20.70%,BECN1;CUL3;CCNB1;ZW10;PDCD6IP;CHMP2B;SPDL1;MAD1L1;RAB11A;PIBF1
prerank,phagosome maturation (GO:0090382),0.22274120447458273,0.5580166295756744,0.9759493670886076,1.0,1.0,3/35,7.52%,TCIRG1;RAB43;ATP6V0A4
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.23070576882892638,-0.5564263758417299,0.9611111111111111,1.0,1.0,2/11,15.71%,CALM1;CASQ2
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.23070576882892638,-0.5564263758417299,0.9611111111111111,1.0,1.0,2/11,15.71%,CALM1;CASQ2
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.2765517114357047,0.555033315527948,0.943089430894309,1.0,1.0,3/10,20.70%,PTPN2;SOCS3;PIBF1
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.20960173198877002,0.554901793661498,0.97712833545108,1.0,1.0,17/46,28.97%,TIMM23;BCAP31;TIMM9;TSPO;AIFM1;TIMM17B;PITRM1;AIP;GRPEL2;TIMM44;TOMM34;DNLZ;TOMM20;TIMM13;HK1;GRPEL1;TIMM10
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.23626890967296463,-0.553391871791857,0.948509485094851,1.0,1.0,10/10,76.39%,SELENOS;ZNF692;SIRT7;DGKQ;PDK2;FBP1;SDHAF3;GNMT;USP7;OGT
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.23681779745732343,0.5524342223252499,0.9702127659574468,1.0,1.0,11/22,32.17%,DUSP5;PPP5C;PPM1D;PPM1B;PPM1A;DUSP7;DUSP10;DUSP16;DUSP4;PPP2CB;DUSP1
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.22939748650347397,-0.5519640982731812,0.9530026109660574,1.0,1.0,1/11,5.11%,AHR
prerank,vacuolar acidification (GO:0007035),0.24016440264379288,0.5516448909716379,0.9609826589595376,1.0,1.0,2/21,7.52%,TCIRG1;ATP6V0A4
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.2536167354730456,0.5514983021837497,0.9416909620991254,1.0,1.0,1/16,2.99%,PLCB3
prerank,regulation of neuron projection arborization (GO:0150011),0.2539994360256159,0.5490413057777745,0.9452887537993921,1.0,1.0,8/15,30.10%,MYO9A;DVL1;MOV10;FZD4;DVL2;DLG4;DVL3;GRIP1
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.276239297590184,0.5489782487455246,0.9409937888198758,1.0,1.0,3/10,24.89%,ZBTB7B;NCKAP1L;CBFB
prerank,cilium movement (GO:0003341),0.2082553838342815,0.5484660787430585,0.9821882951653944,1.0,1.0,11/48,24.73%,DNAAF4;CAMSAP3;ODAD2;SPAG17;ODAD3;DNAH17;DNAAF2;TEKT2;RSPH9;CFAP53;DNAH11
prerank,regulation of isotype switching (GO:0045191),0.25449750313906366,0.547520939103703,0.9580093312597201,1.0,1.0,7/14,34.35%,PARP3;KMT5B;KMT5C;IL4;PAXIP1;SHLD1;HMCES
prerank,synaptonemal complex organization (GO:0070193),0.25325223195928015,0.5471220861313725,0.9540581929555896,1.0,1.0,5/15,27.49%,RAD21L1;REC8;P3H4;RAD21;SYCE2
prerank,synaptonemal complex assembly (GO:0007130),0.25325223195928015,0.5471220861313725,0.9540581929555896,1.0,1.0,5/15,27.49%,RAD21L1;REC8;P3H4;RAD21;SYCE2
prerank,phasic smooth muscle contraction (GO:0014821),-0.23289767247530108,-0.546195014766086,0.9637305699481865,1.0,1.0,2/10,10.90%,EDN1;PTGER3
prerank,lipid homeostasis (GO:0055088),0.2042913894131571,0.5446965757508797,0.98562874251497,1.0,1.0,12/57,19.88%,ACOX3;ABCD1;MLXIPL;PNPLA3;TLCD1;RBP1;ANGPTL3;PNPLA2;ACOX1;FITM2;PPARG;NR1D2
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.2675781265370225,0.5429732334559867,0.9547657512116317,1.0,1.0,3/10,23.54%,DRD3;FMR1;CBARP
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.23526588224272812,0.5429714428885848,0.9517045454545454,1.0,1.0,3/21,13.00%,VEGFA;KDM1A;DISC1
prerank,protein insertion into ER membrane (GO:0045048),0.21285055862084354,0.542877785267028,0.9781491002570694,1.0,1.0,6/37,16.76%,TRAM2;EMD;STX5;EMC8;VAMP2;EMC2
prerank,glutamine family amino acid metabolic process (GO:0009064),0.2225021476099217,0.5421741580517038,0.9707835325365206,1.0,1.0,1/33,1.99%,GCLC
prerank,heterocycle biosynthetic process (GO:0018130),0.25577856267065463,0.5397286220524544,0.9435364041604755,1.0,1.0,4/14,27.12%,MOCOS;ALOX5;MOCS1;LIAS
prerank,homologous chromosome pairing at meiosis (GO:0007129),-0.17628205128205127,-0.5394619544189653,0.9925373134328358,1.0,1.0,29/29,82.41%,FANCD2;TEX11;BAG6;TRIP13;SYCP2;MEIOB;TEX12;STAG3;IHO1;SIRT7;RNF212B;HORMAD1;TERB2;SYCP1;MAJIN;RNF212;SYCE3;KASH5;SYCE1;TERB1;PRDM9;ANKRD31;MEI4;SYCE2;ZCWPW1;RAD21;P3H4;REC8;RAD21L1
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.26055330096227,0.5388658311805441,0.9503875968992248,1.0,1.0,1/11,4.96%,NR4A3
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.2271686697954558,0.5382965448895305,0.9545454545454546,1.0,1.0,4/25,17.75%,KLF4;TLR4;CLU;P2RX4
prerank,regulation of centrosome duplication (GO:0010824),0.2210166124786258,0.5379945330742265,0.9655629139072848,1.0,1.0,10/30,30.41%,SPICE1;NAT10;PDCD6IP;CHMP2B;CENPJ;CEP76;CHMP3;CCNF;GEN1;CEP131
prerank,positive regulation of organelle assembly (GO:1902117),0.20771186426756608,0.5374657904121417,0.9789864029666254,1.0,1.0,20/44,30.93%,G3BP2;PLK4;SH3GLB1;PDCD6IP;PIP4K2A;RALB;LRSAM1;CNOT1;ENTR1;RAB3GAP1;SDC4;GPSM2;STX18;BBS4;ARHGAP35;KCTD17;FSCN1;RAB3GAP2;PIP4K2C;SDC1
prerank,regulation of establishment of protein localization (GO:0070201),0.24883445596014514,0.5368801348703153,0.9404388714733543,1.0,1.0,7/14,33.20%,SPIDR;GAPVD1;CENPJ;CEP290;DNAJA1;PTP4A3;CEP295
prerank,hydrogen peroxide metabolic process (GO:0042743),0.23523680891059356,0.5364028753270165,0.9797395079594791,1.0,1.0,7/19,30.42%,PRDX5;ACOX1;CAT;PRDX2;PRDX1;GPX1;PXDN
prerank,sterol biosynthetic process (GO:0016126),-0.1612689228471832,-0.5355581681796298,0.9877551020408163,1.0,1.0,9/33,24.53%,INSIG2;ARV1;MSMO1;PRKAG2;NSDHL;CH25H;TM7SF2;FDFT1;ACAT2
prerank,immunoglobulin mediated immune response (GO:0016064),-0.22482205317398782,-0.5348143492982718,0.9705882352941176,1.0,1.0,5/10,36.76%,CD81;CD74;FCER1G;CD27;CARD9
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.22289692874825165,-0.5337165772719883,0.9665738161559888,1.0,1.0,1/12,5.74%,PRKCQ
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.25505685709278314,0.5318738935201616,0.9592476489028213,1.0,1.0,7/12,36.55%,MAD1L1;MIS12;CENPE;RMDN1;SEH1L;CHAMP1;CENPC
prerank,branched-chain amino acid catabolic process (GO:0009083),0.2309417953511647,0.5317007275512593,0.9661495063469676,1.0,1.0,2/20,8.05%,AUH;HIBCH
prerank,branched-chain amino acid metabolic process (GO:0009081),0.2309417953511647,0.5317007275512593,0.9661495063469676,1.0,1.0,2/20,8.05%,AUH;HIBCH
prerank,peptidyl-arginine modification (GO:0018195),0.249175733825338,0.5315753806913107,0.9519519519519519,1.0,1.0,2/15,13.29%,PRMT8;PRMT5
prerank,negative regulation by host of viral process (GO:0044793),-0.2380636799796121,-0.5302448534467642,0.963276836158192,1.0,1.0,2/10,11.77%,PSMC3;VAPA
prerank,regulation of myoblast fusion (GO:1901739),0.25750247709144664,0.5280027196742937,0.9593114241001565,1.0,1.0,3/11,16.22%,EHD2;EHD1;FLOT1
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.2672503954708649,0.5276413534571082,0.9427662957074722,1.0,1.0,3/10,24.01%,BRCA1;THAP7;TAF7
prerank,positive regulation of osteoclast differentiation (GO:0045672),-0.20519891995725748,-0.5261403269145783,0.9741379310344828,1.0,1.0,1/14,3.58%,CSF1
prerank,protein catabolic process (GO:0030163),0.19945498799112563,0.5258255426139609,0.991715976331361,1.0,1.0,11/59,19.40%,CHEK2;VCP;IDE;FBXO27;DDI2;NR1D1;RNF41;OGA;FBXO17;DDI1;LRSAM1
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.24851403172215564,0.5230177005575923,0.953198127925117,1.0,1.0,1/12,7.28%,SEC61A1
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.2296504299912021,0.5219482995091353,0.981021897810219,1.0,1.0,4/19,18.04%,PPP2R3C;ZBTB1;PRKDC;NCKAP1L
prerank,regulation of spindle organization (GO:0090224),-0.18989747820205605,-0.5210483184380943,0.991044776119403,1.0,1.0,5/18,21.64%,MAP9;GNAI1;TACC3;TPX2;NUP62
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.2101775492428515,0.5210318607053109,0.9844632768361582,1.0,1.0,15/31,34.36%,TIMM23;PEX26;PEX1;AIFM1;TIMM17B;GRPEL2;TIMM44;DNLZ;TOMM20;GRPEL1;PEX2;PEX7;PEX10;TIMM21;DNAJC15
prerank,B cell mediated immunity (GO:0019724),0.26426893202310936,0.5207297418175887,0.9646697388632872,1.0,1.0,1/10,11.28%,TLR8
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.24190038587488744,0.5205934980944964,0.96759941089838,1.0,1.0,4/15,17.96%,AGO2;PABPC1;TENT4B;TOB1
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.22308774771706394,-0.5197031067651304,0.9773299748110831,1.0,1.0,3/10,20.96%,RNF125;DHX58;TSPAN6
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.25175321028381165,0.5159785474919647,0.95141065830721,1.0,1.0,2/11,14.42%,AGK;TIMM9
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.1713890808569454,-0.5158294665674771,1.0,1.0,1.0,24/24,82.89%,LIG3;RFC4;RPA3;PCNA;LIG1;UBC;XRCC1;POLD2;RFC5;POLE;RPA2;LIG4;RFC3;POLD3;POLD4;RPA1;RFC2;POLD1;RPS27A;POLK;UBA52;UBB;RFC1;POLB
prerank,innate immune response in mucosa (GO:0002227),-0.21924587427314104,-0.513873199913345,0.9601139601139601,1.0,1.0,1/10,6.02%,DEFA6
prerank,tRNA metabolic process (GO:0006399),0.23414917480292863,0.5137965177914515,0.9766081871345029,1.0,1.0,5/17,30.59%,DTD2;SSB;YARS2;FARS2;RPP30
prerank,alanine transport (GO:0032328),0.2542466626850165,0.5113762064563705,0.9560260586319218,1.0,1.0,2/10,20.17%,SLC38A3;SLC36A4
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.1932547966827295,-0.5104860738714357,0.9835526315789473,1.0,1.0,5/16,25.63%,LEPROTL1;VPS36;CHMP4C;CHMP5;CHMP6
prerank,regulation of lymphocyte activation (GO:0051249),-0.2095012145615105,-0.5091903550546696,0.975,1.0,1.0,6/12,33.67%,PAG1;DCAF15;IKZF3;THEMIS2;CCL5;CRTAM
prerank,lipoxygenase pathway (GO:0019372),-0.20503275823419528,-0.5054043258115913,0.9787878787878788,1.0,1.0,5/14,27.60%,ALOX12;GPX4;PTGS2;ALOX5AP;ALOXE3
prerank,autophagosome maturation (GO:0097352),0.20406466170738358,0.5052848787476848,0.9851951547779273,1.0,1.0,12/32,29.51%,LIX1L;VCP;SNX14;WIPI2;STX17;VTI1B;CHMP3;MAP1LC3B;CLN3;ATG14;VPS33A;TSG101
prerank,protein-DNA complex disassembly (GO:0032986),0.23496965643655288,0.5052450187685863,0.9706314243759178,1.0,1.0,7/16,34.65%,SMARCC1;HMGA1;SMARCA4;SMARCE1;ARID2;SMARCD3;SMARCC2
prerank,cellular response to amino acid stimulus (GO:0071230),0.20469151504002925,0.504860839294795,0.9813581890812251,1.0,1.0,4/33,12.56%,CAPN2;RRAGB;KLHL22;NSMF
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.19709908326007788,-0.5036711917605166,0.9776536312849162,1.0,1.0,15/15,80.31%,ERN1;FAM98B;TSEN15;CSTF2;TSEN34;TSEN2;CPSF1;RTCB;DDX1;CPSF4;ZBTB8OS;TRPT1;TSEN54;RTRAF;CLP1
prerank,aromatic amino acid family catabolic process (GO:0009074),0.2356059208260753,0.502474120530772,0.9791666666666666,1.0,1.0,5/15,32.36%,TDO2;IDO2;HGD;GSTZ1;KYNU
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.23564554551586353,0.5022879966242634,0.9727126805778491,1.0,1.0,4/13,25.16%,BMS1;KRI1;NOP14;TBL3
prerank,mitochondrion transport along microtubule (GO:0047497),0.24037629325750023,0.5022296455559124,0.9696969696969697,1.0,1.0,4/13,25.95%,MAP1S;UBB;RHOT1;SYBU
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.19708670810573242,-0.5012333048584524,0.978319783197832,1.0,1.0,14/14,80.31%,FAM98B;TSEN15;CSTF2;TSEN34;TSEN2;CPSF1;RTCB;DDX1;CPSF4;ZBTB8OS;TRPT1;TSEN54;RTRAF;CLP1
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.20552326706749086,-0.5009486793088808,0.9885057471264368,1.0,1.0,3/11,23.83%,HMGB1;CD274;VSIR
prerank,negative regulation of ATPase activity (GO:0032780),0.22664523914169565,0.4996333265035494,0.983751846381093,1.0,1.0,6/16,27.50%,ATP5IF1;PXK;TP53;TSC1;THADA;TNNI3
prerank,RNA catabolic process (GO:0006401),0.19211376293745408,0.4991082849267853,0.9912609238451935,1.0,1.0,12/46,29.56%,SIDT2;NUDT12;RNASE3;RNASEH2A;PABPC4;EXOSC7;METTL16;DXO;YTHDF2;NUDT16L1;ZPR1;SND1
prerank,T cell activation involved in immune response (GO:0002286),-0.19900809843681336,-0.4987690853619469,0.967741935483871,1.0,1.0,12/12,80.12%,LCP1;CD74;FCER1G;MDK;F2RL1;IFNK;TNFSF18;ICAM1;SLC11A1;EIF2AK4;LILRB1;ITGAL
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.22424774099549205,0.49727796375498123,0.9762611275964391,1.0,1.0,6/16,30.63%,SRSF1;WBP4;PRPF39;SFSWAP;SNRNP200;WBP11
prerank,canonical glycolysis (GO:0061621),0.21391374884973177,0.49719328267690455,0.9842632331902719,1.0,1.0,5/24,21.99%,GPI;PFKP;FOXK1;FOXK2;PKM
prerank,glucose catabolic process to pyruvate (GO:0061718),0.21391374884973177,0.49719328267690455,0.9842632331902719,1.0,1.0,5/24,21.99%,GPI;PFKP;FOXK1;FOXK2;PKM
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.1675775569163241,-0.4953005974288318,0.9865319865319865,1.0,1.0,7/23,27.19%,NDUFA13;BCL2L11;TOMM22;ROMO1;TIMM10B;PMAIP1;COX18
prerank,modulation by host of symbiont process (GO:0051851),0.20372566522240645,0.49521340577681916,0.9906291834002677,1.0,1.0,8/31,25.27%,CCL3;RRP1B;SAP30BP;CHD1;CCNT1;TARDBP;REST;JUN
prerank,nucleus organization (GO:0006997),0.1883074830573626,0.49505902998412143,0.9975216852540273,1.0,1.0,13/47,26.54%,NUP93;LEMD2;NUP155;PDCD6IP;CHMP2B;NUP35;USP36;SUN1;REEP3;NUP98;REEP4;CHMP3;SUN2
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.18477013761917993,0.49362148393936905,0.998812351543943,1.0,1.0,13/56,26.55%,NDUFS3;NDUFC2;NDUFB4;TMEM126A;ECSIT;NUBPL;NDUFA12;NDUFAB1;NDUFA9;NDUFB2;NDUFAF7;NDUFS2;NDUFV1
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.18477013761917993,0.49362148393936905,0.998812351543943,1.0,1.0,13/56,26.55%,NDUFS3;NDUFC2;NDUFB4;TMEM126A;ECSIT;NUBPL;NDUFA12;NDUFAB1;NDUFA9;NDUFB2;NDUFAF7;NDUFS2;NDUFV1
prerank,regulation of DNA recombination at telomere (GO:0072695),-0.17428869801557562,-0.4926649646892847,0.9967532467532467,1.0,1.0,6/19,32.95%,POLR2G;TERF1;POLR2J;POLR2H;POLR2K;POLR2F
prerank,negative regulation of DNA recombination at telomere (GO:0048239),-0.17428869801557562,-0.4926649646892847,0.9967532467532467,1.0,1.0,6/19,32.95%,POLR2G;TERF1;POLR2J;POLR2H;POLR2K;POLR2F
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.2112121195811075,-0.4924206807583625,0.9822784810126582,1.0,1.0,5/10,27.76%,MMGT1;EMC7;EMC6;EMC1;EMC10
prerank,protein localization to mitochondrion (GO:0070585),-0.20790857301359572,-0.4911245848268096,0.9888888888888889,1.0,1.0,4/11,27.19%,PINK1;HK2;AKT1;COX18
prerank,coenzyme A metabolic process (GO:0015936),0.22813745502964244,0.49082058023154557,0.9637462235649547,1.0,1.0,5/14,31.96%,PPCDC;CROT;DCAKD;COASY;ACAT1
prerank,regulation of T cell activation (GO:0050863),0.1888142471311432,0.4874830345990236,0.9897567221510883,1.0,1.0,2/42,4.52%,CD2;ABL1
prerank,DNA strand elongation (GO:0022616),0.2153751275178029,0.4872761865096885,0.9913294797687862,1.0,1.0,6/18,30.28%,RAD50;MCM7;NBN;GINS3;POLA1;GINS1
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.2041303119703722,-0.48652122107095114,0.988950276243094,1.0,1.0,10/10,79.61%,MTMR3;MFSD2A;MTMR2;DNAJC19;ABCA3;PHB2;GNB3;MTMR4;MTMR9;MTMR1
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.240726169216331,0.4862221060515836,0.9763779527559056,1.0,1.0,2/10,17.83%,PFKP;GFPT1
prerank,positive regulation of myelination (GO:0031643),0.23700217770345056,0.48540970111533926,0.9676898222940227,1.0,1.0,4/11,29.70%,PARD3;CST7;DICER1;TNFRSF1B
prerank,ribosome assembly (GO:0042255),0.1835368677958734,0.4847374306415246,0.995,1.0,1.0,3/47,10.73%,RPSA;EIF6;MRPS2
prerank,peptidyl-methionine modification (GO:0018206),0.22925497429980096,0.48320006877815375,0.9892307692307692,1.0,1.0,3/12,22.31%,NAA15;NAA60;METAP2
prerank,phagosome acidification (GO:0090383),0.2028958700820387,0.482553658813954,0.9917808219178083,1.0,1.0,4/26,18.85%,TCIRG1;ATP6V0A4;ATP6V1A;ATP6V0D1
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.17532435087626452,-0.4814750314852339,0.98989898989899,1.0,1.0,10/18,37.55%,DCP2;CCT8;CCT3;TCP1;RUVBL1;NHP2;NOP10;RUVBL2;SHQ1;CCT4
prerank,positive regulation of viral process (GO:0048524),0.17837067138766857,0.4790799000713931,0.9976303317535545,1.0,1.0,13/60,25.88%,MDFIC;TMEM39A;STAU1;PABPC1;KPNA2;NELFE;DHX9;POLR2C;CCNT1;SRPK2;PKN2;RSF1;SUPT4H1
prerank,DNA biosynthetic process (GO:0071897),0.2189577235293177,0.47847180051895244,0.9898550724637681,1.0,1.0,1/16,7.50%,WRN
prerank,regulation of rRNA processing (GO:2000232),0.21815598886352683,0.4775014694283447,0.9742424242424242,1.0,1.0,6/16,31.82%,WDR43;USP36;KAT2B;YTHDF2;RIOK1;UTP15
prerank,tetrahydrofolate metabolic process (GO:0046653),-0.20915196786140228,-0.47243562687626955,0.9828080229226361,1.0,1.0,10/10,79.10%,MTHFD2;SHMT2;MTHFD1L;MTHFD2L;DHFR;MTHFD1;MTHFR;TYMS;SHMT1;MTHFS
prerank,regulation of stem cell population maintenance (GO:2000036),0.21455223849366314,0.47230837733699055,0.9807407407407407,1.0,1.0,7/18,33.10%,WDR43;PTN;CNOT1;REST;ELAVL1;KAT2A;CNOT3
prerank,negative regulation of receptor internalization (GO:0002091),-0.19429801487709433,-0.4720558202379774,0.9888888888888889,1.0,1.0,4/12,25.17%,ANKRD13A;ANKRD13B;NECAB2;UBQLN2
prerank,sulfur amino acid catabolic process (GO:0000098),0.23541492345507575,0.471316036033654,0.9834983498349835,1.0,1.0,2/10,19.35%,ADO;GADL1
prerank,tRNA processing (GO:0008033),0.17398589874540032,0.47043608085952443,1.0,1.0,1.0,17/61,32.12%,TRMT10A;TYW5;ELP5;SSB;CLP1;THUMPD1;TRDMT1;FTSJ1;PTCD1;CDKAL1;FARS2;RTRAF;TRNT1;WDR4;RPP30;QTRT1;TSEN54
prerank,mucosal immune response (GO:0002385),0.21659981132590533,0.4690681900651408,0.9869942196531792,1.0,1.0,2/15,13.75%,RNASE3;IFNLR1
prerank,transferrin transport (GO:0033572),0.18717356898363285,0.46801909154132093,0.9974025974025974,1.0,1.0,5/33,18.85%,TCIRG1;ATP6V0A4;ATP6V1A;RAB11B;ATP6V0D1
prerank,antibacterial humoral response (GO:0019731),-0.175711044463283,-0.46729955795395717,0.9871794871794872,1.0,1.0,1/16,6.02%,DEFA6
prerank,negative regulation of T cell activation (GO:0050868),0.18349244484423477,0.46522438249648984,0.9974424552429667,1.0,1.0,9/35,24.40%,ARG1;CD80;PDCD1LG2;DLG5;GLMN;NCKAP1L;LGALS3;SDC4;LILRB1
prerank,cellular amino acid catabolic process (GO:0009063),0.16535173741281387,0.4646481561625573,1.0,1.0,1.0,8/87,10.95%,UROC1;AUH;HIBCH;ARG1;SDSL;TDO2;HYKK;SLC25A21
prerank,positive regulation of cellular protein localization (GO:1903829),0.168923136938525,0.4625841700329208,1.0,1.0,1.0,11/69,19.57%,GSK3B;RANGRF;RIC3;LIMK2;ABCA7;TM9SF4;PARD6A;BICD1;YAP1;GPR137B;FERMT2
prerank,regulation of lysosomal lumen pH (GO:0035751),0.21914269745209564,0.4618617483064496,0.9811616954474097,1.0,1.0,4/12,28.51%,LRRK2;TMEM165;CLN3;VPS33A
prerank,positive regulation of rRNA processing (GO:2000234),0.22581779961506226,0.4545206975598287,0.9857594936708861,1.0,1.0,1/10,10.74%,WDR43
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.19965435018707592,0.45336849067963153,0.9858757062146892,1.0,1.0,3/22,17.15%,IRF1;CD46;LAG3
prerank,positive regulation of exosomal secretion (GO:1903543),0.20787808516227285,0.45267153878836236,0.9854439592430859,1.0,1.0,6/15,30.93%,PDCD6IP;SNF8;SDC4;HGS;TSG101;SDC1
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.22450741370518146,0.45249458697149125,0.9853420195439739,1.0,1.0,3/10,22.85%,PARD3;PLPP1;HTR2B
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.18880427971963729,0.4502123136574685,0.9959072305593452,1.0,1.0,4/25,15.95%,VCP;VTA1;LYST;CHMP2B
prerank,rRNA methylation (GO:0031167),-0.15239650731829887,-0.4494594388738213,1.0,1.0,1.0,22/22,84.79%,ZCCHC4;BUD23;FBL;NSUN5;MRM2;TFB2M;TRMT112;FDXACB1;FBLL1;NOP2;NSUN4;MRM1;DIMT1;TFB1M;EMG1;NSUN3;METTL5;METTL16;FTSJ3;MTERF4;MRM3;METTL15
prerank,meiosis I (GO:0007127),0.19094920839609428,0.44915367178372845,0.9917808219178083,1.0,1.0,7/23,34.21%,SYCP3;HSF2BP;FOXJ3;ZCWPW1;BRDT;ZSCAN21;PTTG1
prerank,leukotriene metabolic process (GO:0006691),0.19846420288782968,0.4484113891181838,0.9895366218236173,1.0,1.0,5/19,22.98%,DPEP1;ABCC1;ALOX5;MAPKAPK2;ABCC10
prerank,methylguanosine-cap decapping (GO:0110156),0.22633069460092264,0.44748353936525015,0.9767080745341615,1.0,1.0,4/10,29.67%,DCP1A;LSM1;PATL1;DCP1B
prerank,response to unfolded protein (GO:0006986),0.1692957944575763,0.44520343463810763,0.996268656716418,1.0,1.0,14/48,30.60%,HSPB8;BAG3;HSPA1L;HERPUD1;TOR1B;DNAJC4;DNAJB2;HSPH1;DDIT3;ERP44;BAX;DNAJA1;HSPA14;BAK1
prerank,regulation of mitotic spindle organization (GO:0060236),0.17982232126629577,0.44317545366024985,0.9973924380704041,1.0,1.0,10/35,30.53%,PARP3;DRG1;PDCD6IP;CHMP2B;BORA;GPSM2;CHMP3;PLK1;FSD1;CEP97
prerank,modulation by host of viral genome replication (GO:0044827),0.2104562323894745,0.4391821007802724,0.9831029185867896,1.0,1.0,1/13,8.14%,ZC3H12A
prerank,positive regulation of immune response (GO:0050778),0.1598757906603582,0.43775421161303535,1.0,1.0,1.0,8/64,18.46%,TLR8;POLR3F;CD46;IFI35;AKIRIN2;PLSCR1;POLR3D;DHX9
prerank,rRNA modification (GO:0000154),-0.15465743636170792,-0.43571843231075236,0.9966101694915255,1.0,1.0,10/21,36.53%,ZCCHC4;BUD23;FBL;MRM2;NHP2;TFB2M;NOP10;TRMT112;TSR3;FBLL1
prerank,coenzyme A biosynthetic process (GO:0015937),-0.18180048195116838,-0.4347503488050626,1.0,0.9995090746092342,1.0,1/11,7.71%,PANK1
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),-0.18180048195116838,-0.4347503488050626,1.0,0.9995090746092342,1.0,1/11,7.71%,PANK1
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),-0.18180048195116838,-0.4347503488050626,1.0,0.9995090746092342,1.0,1/11,7.71%,PANK1
prerank,midbody abscission (GO:0061952),-0.15692807169843004,-0.43155544097776455,0.9937694704049844,0.9987191660876661,1.0,8/17,33.55%,CHMP4C;CEP55;CHMP5;CHMP6;KIF20A;VPS4B;CHMP7;CHMP2A
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.1931548008616016,0.43139082056064687,0.9941089837997055,1.0,1.0,5/16,28.81%,PTPN2;SOCS3;PIBF1;ADIPOR1;HGS
prerank,positive regulation of translational initiation (GO:0045948),0.19396925390077113,0.429358023798223,0.997134670487106,1.0,1.0,7/18,32.06%,CDC123;KHDRBS1;RPS6KB1;MTOR;YTHDF2;HABP4;EIF2B5
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.18172556163780532,0.42918429218593934,0.9973009446693657,1.0,1.0,4/26,17.87%,IRAK3;IRF1;FLOT1;OTUD4
prerank,carbohydrate catabolic process (GO:0016052),0.16916374222719896,0.4271127475783635,0.996031746031746,1.0,1.0,7/38,21.99%,PFKFB1;DERA;GPI;MAN2B1;LDHA;NEU3;PKM
prerank,regulation of exosomal secretion (GO:1903541),0.18772193742425392,0.4270936102642454,0.9915254237288136,1.0,1.0,7/19,30.93%,PDCD6IP;SNF8;SDC4;CHMP3;HGS;TSG101;SDC1
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.2074779970612085,0.42650341292964533,0.9920760697305864,0.9998725089475298,1.0,3/11,24.17%,CCT5;LARP7;CCT6A
prerank,regulation of protein localization to Cajal body (GO:1904869),0.2074779970612085,0.42650341292964533,0.9920760697305864,0.9998725089475298,1.0,3/11,24.17%,CCT5;LARP7;CCT6A
prerank,secondary alcohol biosynthetic process (GO:1902653),0.17133835938123984,0.42482270463647864,0.9960106382978723,0.9996681582723723,1.0,10/30,30.66%,GGPS1;SQLE;LBR;EBP;HMGCR;MVD;MVK;LSS;DHCR7;HMGCS1
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.20432790199180578,0.42458035229048424,0.9918962722852512,0.9993307858634024,1.0,2/11,18.33%,MAVS;TICAM1
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.2059293493224194,0.4206308748628953,0.9871589085072231,0.9993248330617386,1.0,3/11,24.07%,GATA4;LANCL1;REST
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.19968149589273548,0.41576225089683444,0.9936,0.9993704547534005,1.0,4/12,24.90%,CCT5;GNL3L;CCT6A;GNL3
prerank,axoneme assembly (GO:0035082),0.16723910621182458,0.414312029721954,0.9986595174262735,0.9991233162714744,1.0,6/31,21.78%,TOGARAM1;DNAAF3;SPAG17;DNAAF2;RSPH9;DRC1
prerank,cholesterol biosynthetic process (GO:0006695),0.16540032965171222,0.41061595817053126,0.9973368841544608,0.9990569014820935,1.0,10/31,30.66%,GGPS1;SQLE;LBR;EBP;HMGCR;MVD;MVK;LSS;DHCR7;HMGCS1
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.19975159185998462,0.4000271971437002,0.9901639344262295,0.9994044544480114,1.0,3/10,24.41%,ATRX;CDC7;INO80
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.1824689187492152,0.3976219318640836,0.9970014992503748,0.999197541746436,1.0,15/15,81.77%,CCT5;NAF1;CCT6A;DKC1;CCT2;CCT7;CCT4;SHQ1;RUVBL2;NOP10;NHP2;RUVBL1;TCP1;CCT3;CCT8
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.1968548262552649,0.3967804109016156,0.9935275080906149,0.9988968205742834,1.0,1/10,10.53%,DHX36
prerank,covalent chromatin modification (GO:0016569),-0.14987128775036104,-0.3842891618332355,1.0,0.9995806708653995,1.0,14/14,85.03%,HLCS;MT3;UFL1;SIRT1;MBD2;AURKB;SIRT7;AURKC;HDAC1;PARK7;HELLS;SETD5;PARP2;CHD1
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.15332950247349897,0.37018704845620676,0.998641304347826,0.9997172709050394,1.0,8/31,30.84%,MOCOS;ALOX5;STAR;MOCS1;LIAS;FDXR;LSS;DHRS11
prerank,acyl-CoA biosynthetic process (GO:0071616),0.17056325001448935,0.3677042235586948,1.0,0.9994291694441654,1.0,2/16,18.40%,ACACA;SCD
prerank,phosphate ion transmembrane transport (GO:0035435),0.17006717308054475,0.3474649284797808,0.9969924812030075,0.9995519376538866,1.0,12/12,83.01%,SLC37A1;SLC25A3;SLC25A30;SLC20A1;SLC25A14;SLC25A11;SLC37A4;SLC37A2;XPR1;SLC25A10;SLC37A3;SLC20A2
